PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Franks, KM; Isaacson, JS				Franks, KM; Isaacson, JS			Strong single-fiber sensory inputs to olfactory cortex: Implications for olfactory coding	NEURON			English	Article							PIRIFORM CORTEX; SYNAPTIC-TRANSMISSION; ODOR MAPS; BULB; SYSTEM; RAT; REPRESENTATIONS; DISCRIMINATION; FACILITATION; INFORMATION	Olfactory information is first encoded in a combinatorial fashion by olfactory bulb glomeruli, which individually represent distinct chemical features of odors. This information is then transmitted to piriform (olfactory) cortex, via axons of olfactory bulb mitral and tufted (M/T) cells, where it is presumed to form the odor percept. However, mechanisms governing the integration of sensory information in mammalian olfactory cortex are unclear. Here we show that single M/T cells can make powerful connections with cortical pyramidal cells, and coincident input from few M/T cells is sufficient to elicit spike output. These findings suggest that odor coding is broad and distributed in olfactory cortex.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Franks, KM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	kf2189@columbia.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004682] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC04682] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Cang JH, 2003, J NEUROSCI, V23, P4108; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DEVOR M, 1976, J COMP NEUROL, V166, P31, DOI 10.1002/cne.901660104; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Jinks A, 1999, PERCEPTION, V28, P395, DOI 10.1068/p2898; Kanter ED, 1996, J NEUROSCI, V16, P307; Kapur A, 1997, J NEUROPHYSIOL, V78, P2546, DOI 10.1152/jn.1997.78.5.2546; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; PRICE JL, 1975, J COMP NEUROL, V162, P321, DOI 10.1002/cne.901620304; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; STEVENS CF, 1969, J NEUROPHYSIOL, V32, P184, DOI 10.1152/jn.1969.32.2.184; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; YCAJAL SR, 1909, HISTOLOGIE SYSTEME N; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	36	97	98	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					357	363		10.1016/j.neuron.2005.12.026	http://dx.doi.org/10.1016/j.neuron.2005.12.026			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446140	Bronze			2022-12-28	WOS:000235260900008
J	Shen, K				Shen, K			Think globally, act locally: Local translation and synapse formation in cultured Aplysia neurons	NEURON			English	Editorial Material							PROTEIN-SYNTHESIS; DENDRITIC SPINES; DENTATE GYRUS; POLYRIBOSOMES; BASE	Synapse formation is initiated by cell-cell contact between appropriate pre- and postsynaptic cells and is followed by recruitment of protein complexes in both pre- and postsynaptic compartments. In this issue of Neuron, Lyles et al. show that in cultured Aplysia neurons, clustering of an mRNA at nascent synapses is not only induced by the recognition between synaptic partners, but is also required for further synaptic development and maintenance.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, 371 Serra Mall, Stanford, CA 94305 USA.							Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Hu JY, 2004, NEURON, V43, P373, DOI 10.1016/j.neuron.2004.07.011; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; STEWARD O, 1983, PROG BRAIN RES, V58, P131, DOI 10.1016/S0079-6123(08)60013-8; STEWARD O, 1982, J NEUROSCI, V2, P284; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9	9	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 2	2006	49	3					323	325		10.1016/j.neuron.2006.01.011	http://dx.doi.org/10.1016/j.neuron.2006.01.011			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446134	Bronze			2022-12-28	WOS:000235260900002
J	Eljaschewitsch, E; Witting, A; Mawrin, C; Lee, T; Schmidt, PM; Wolf, S; Hoertnagl, H; Raine, CS; Schneider-Stock, R; Nitsch, R; Ullrich, O				Eljaschewitsch, E; Witting, A; Mawrin, C; Lee, T; Schmidt, PM; Wolf, S; Hoertnagl, H; Raine, CS; Schneider-Stock, R; Nitsch, R; Ullrich, O			The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells	NEURON			English	Article							CB1 CANNABINOID RECEPTORS; SIGNAL-REGULATED KINASE; FOCAL CEREBRAL-ISCHEMIA; ACTIVATION; INHIBITION; EXPRESSION; INCREASES; RELEASE; 2-ARACHIDONOYLGLYCEROL; STIMULATION	Endocannabinoids are released after brain injury and believed to attenuate neuronal damage by binding to CB, receptors and protecting against excitotoxicity. Such excitotoxic brain lesions initially result in primary destruction of brain parenchyma, which attracts macrophages and microglia. These inflammatory cells release toxic cytokines and free radicals, resulting in secondary neuronal damage. In this study, we show that the endocannabinoid system is highly activated during CNS inflammation and that the endocannabinoid anandamide (AEA) protects neurons from inflammatory damage by CB1/2 receptor-mediated rapid induction of mitogen-activated protein kinase phosphatase-1 (MKP-1) in microglial cells associated with histone H3 phoshorylation of the mkp-1 gene sequence. As a result, AEA-induced rapid MKP-1 expression switches off MAPK signal transduction in microglial cells activated by stimulation of pattern recognition receptors. The release of AEA in injured CNS tissue might therefore represent a new mechanism of neuro-immune communication during CNS injury, which controls and limits immune response after primary CNS damage.	Otto Von Guericke Univ, Fac Med, Inst Immunol, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Fac Med, Inst Pathol, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Fac Med, Inst Neuropathol, D-39120 Magdeburg, Germany; Charite, Ctr Anat, D-10098 Berlin, Germany; Charite, Inst Pharmacol, D-10098 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Albert Einstein Coll Med, Bronx, NY 10461 USA; Univ Washington, Magnuson Hlth Sci Ctr, Seattle, WA 98105 USA	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle	Ullrich, O (corresponding author), Otto Von Guericke Univ, Fac Med, Inst Immunol, Leipzig Str 44, D-39120 Magdeburg, Germany.	oliver.ullrich@medizin.uni-magdeburg.de	Schmidt, Peter/V-3882-2019; Wolf, Susanne/AAA-6598-2022; Nitsch, Robert/AAI-9129-2021; Wolf, Susanne/A-1907-2011; Schneider-Stock, Regine/H-8863-2012	Schmidt, Peter/0000-0003-1340-9086; Wolf, Susanne/0000-0003-0922-8418	NHLBI NIH HHS [N01-HO-3284] Funding Source: Medline; NIMH NIH HHS [R24MH59724] Funding Source: Medline; NINDS NIH HHS [NS11920, NS08952] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH059724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011920, P01NS011920, R01NS008952] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; BOUABOULA M, 1995, J BIOL CHEM, V270, P13973, DOI 10.1074/jbc.270.23.13973; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chaperon F, 1999, CRIT REV NEUROBIOL, V13, P243, DOI 10.1615/CritRevNeurobiol.v13.i3.20; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Derkinderen P, 1996, SCIENCE, V273, P1719, DOI 10.1126/science.273.5282.1719; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Franklin A, 2003, J NEUROSCI, V23, P7767; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; GALLILY R, 2002, EUR J PHARMACOL, V406, P5; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GOMEZ DP, 2000, BIOCHEM J, V347, P369; Guo YL, 1998, J BIOL CHEM, V273, P10362, DOI 10.1074/jbc.273.17.10362; Guzman M, 2001, J MOL MED-JMM, V78, P613, DOI 10.1007/s001090000177; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HOWLETT AC, 1984, LIFE SCI, V35, P1803, DOI 10.1016/0024-3205(84)90278-9; Jackson SJ, 2005, J NEUROL SCI, V233, P21, DOI 10.1016/j.jns.2005.03.002; Jacobsson SOP, 2000, BIOCHEM PHARMACOL, V60, P1807, DOI 10.1016/S0006-2952(00)00492-5; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Killestein J, 2002, NEUROLOGY, V58, P1404, DOI 10.1212/WNL.58.9.1404; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kuwae T, 1999, FEBS LETT, V459, P123, DOI 10.1016/S0014-5793(99)01226-0; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATSUDA LA, 1988, MOL PHARM, V34, P605; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PIOMELLI D, 1990, TRENDS PHARMACOL SCI, V11, P367, DOI 10.1016/0165-6147(90)90182-8; Pryce G, 2005, TRENDS NEUROSCI, V28, P272, DOI 10.1016/j.tins.2005.03.006; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Sarker KP, 2000, FEBS LETT, V472, P39, DOI 10.1016/S0014-5793(00)01425-3; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Shapiro PS, 1998, J BIOL CHEM, V273, P1788, DOI 10.1074/jbc.273.3.1788; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Thompson AJ, 2002, NEUROLOGY, V58, P1323, DOI 10.1212/WNL.58.9.1323; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trettel J, 2003, J NEUROPHYSIOL, V89, P2334, DOI 10.1152/jn.01037.2002; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Waksman Y, 1999, J PHARMACOL EXP THER, V288, P1357; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Witting A, 2004, J NEUROCHEM, V89, P1555, DOI 10.1111/j.1471-4159.2004.02544.x; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101	74	344	352	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					67	79		10.1016/j.neuron.2005.11.027	http://dx.doi.org/10.1016/j.neuron.2005.11.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387640	Bronze			2022-12-28	WOS:000236699300010
J	Maximov, A; Sudhof, TC				Maximov, A; Sudhof, TC			Autonomous function of synaptotagmin 1 in triggering synchronous release independent of asynchronous release	NEURON			English	Article							CORE VESICLE EXOCYTOSIS; TRANSMITTER RELEASE; SYNAPTIC VESICLES; CA2+ BINDING; I FUNCTIONS; NEUROTRANSMITTER; DEPRESSION; DROSOPHILA; SENSOR	Ca2+ triggers neurotransmitter release in at least two principal modes, synchronous and asynchronous release. Synaptotagmin 1 functions as a Ca2+ sensor for synchronous release, but its role in asynchronous release remains unclear. We now show that in cultured cortical neurons stimulated at low frequency (<= 0.1 Hz), deletion of synaptotagmin 1 blocks synchronous GABA and glutamate release without significantly increasing asynchronous release. At higher stimulation frequencies (>= 4 Hz), deletion of synaptotagmin 1 also alters only synchronous, not asynchronous, release during the stimulus train, but dramatically enhances "delayed asynchronous release" following the stimulus train. Thus synaptotagmin 1 functions as an autonomous Ca2+ sensor independent of asynchronous release during isolated action potentials and action potential trains, but restricts asynchronous release induced by residual Ca2+ after action potential trains. We propose that synaptotagmin 1 occupies release "slots" at the active zone, possibly in a Ca2+- independent complex with SNARE proteins that are freed when action potential-induced Ca2+ influx activates synaptotagmin 1.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu						Atluri PP, 1998, J NEUROSCI, V18, P8214; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Cummings DD, 1996, J NEUROSCI, V16, P5312; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Jensen K, 2000, BRAIN RES, V880, P198, DOI 10.1016/S0006-8993(00)02746-3; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kirischuk S, 2003, J PHYSIOL-LONDON, V548, P753, DOI 10.1113/jphysiol.2002.037036; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; PERIN MS, 1991, J BIOL CHEM, V266, P615; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; Tokuoka H, 2003, NEURON, V38, P521, DOI 10.1016/S0896-6273(03)00290-3; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	27	170	177	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					547	554		10.1016/j.neuron.2005.09.006	http://dx.doi.org/10.1016/j.neuron.2005.09.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301172	Bronze			2022-12-28	WOS:000233677300009
J	Yuste, R				Yuste, R			Origin and classification of neocortical interneurons	NEURON			English	Editorial Material							NONPYRAMIDAL CELLS; CEREBRAL-CORTEX; DIVERSITY; NEURONS; RAT; SUBTYPES; NETWORK	Neocortical interneurons are very diverse in morphological, physiological, molecular, and developmental characteristics. Recent work is discovering strong correlations between these phenotypic features, confirming the intuition of Cajal and Lorente that distinct classes of interneurons; exist, each presumably mediating a different circuit function. A paper by Butt et al. in this issue of Neuron describes correlations between the developmental origin of interneurons and their anatomical, electrophysiological, and molecular properties. An effort to standardize the nomenclature of interneurons is underway. Because different interneuron subtypes have different ontogenic origin, they could be classified based on their developmental specification by transcription factors.	Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute	Yuste, R (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA.							Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; CAJAL SRY, 1923, RECUERDOS MI VIDA HI; Cauli B, 1997, J NEUROSCI, V17, P3894; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; DENO RL, 1992, MOTOR RES, V9, P3; Eliot T. S., 1944, 4 Q; Fairen A., 1984, CEREB CORTEX, V1, P201; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	18	58	58	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 23	2005	48	4					524	527		10.1016/j.neuron.2005.11.012	http://dx.doi.org/10.1016/j.neuron.2005.11.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301166	Bronze			2022-12-28	WOS:000233677300003
J	Freeman, MR				Freeman, MR			Glial (and neuronal) cells missing	NEURON			English	Editorial Material							RETINAL AXONS; DROSOPHILA; SWITCH; CARTRIDGE; HEDGEHOG; BRAIN; FATE	The Glial cells missing transcription factor is necessary and sufficient to induce glial-cell fates in the Drosophila embryonic nervous system. A study by Chotard et al. in this issue of Neuron reveals that this "master regulator" of glial cell fate specification is also required (gasp!) to generate neurons.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Freeman, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 719 Lazare Res Bldg 364 Plantat St, Worcester, MA 01605 USA.			Freeman, Marc/0000-0003-3481-3715				Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Vincent S, 1996, DEVELOPMENT, V122, P131	8	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					163	165		10.1016/j.neuron.2005.10.002	http://dx.doi.org/10.1016/j.neuron.2005.10.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242394	Bronze			2022-12-28	WOS:000232838700003
J	Leutgeb, JK; Leutgeb, S; Treves, A; Meyer, R; Barnes, CA; McNaughton, BL; Moser, MB; Moser, EI				Leutgeb, JK; Leutgeb, S; Treves, A; Meyer, R; Barnes, CA; McNaughton, BL; Moser, MB; Moser, EI			Progressive Transformation of Hippocampal Neuronal Representations in "Morphed" Environments	NEURON			English	Article							PLACE CELLS; ATTRACTOR DYNAMICS; NEURAL-NETWORKS; VISUAL-STIMULI; MEMORY; CA3; FIELDS; MODEL; TASK; CUES	Hippocampal neural codes for different, familiar environments are thought to reflect distinct attractor states, possibly implemented in the recurrent CA3 network. A defining property of an attractor network is its ability to undergo sharp and coherent transitions between pre-established (learned) representations when the inputs to the network are changed. To determine whether hippocampal neuronal ensembles exhibit such discontinuities, we recorded in CA3 and CA1 when a familiar square recording enclosure was morphed in quantifiable steps into a familiar circular enclosure while leaving other inputs constant. We observed a gradual noncoherent progression from the initial to the final network state. In CA3, the transformation was accompanied by significant hysteresis, resulting in more similar end states than when only square and circle were presented. These observations suggest that hippocampal cell assemblies are capable of incremental plastic deformation, with incongruous information being incorporated into pre-existing representations.	Norwegian Univ Sci & Technol, Ctr Biol Mem, NO-7489 Trondheim, Norway; Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, I-34014 Trieste, Italy; Univ Arizona, Neural Syst Mem & Aging, Tucson, AZ 85724 USA	Norwegian University of Science & Technology (NTNU); International School for Advanced Studies (SISSA); University of Arizona	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Mem, NO-7489 Trondheim, Norway.	edvard.moser@cbm.ntnu.no	Treves, Alessandro/B-2318-2009	TREVES, Alessandro/0000-0001-7246-5673; Leutgeb, Jill/0000-0002-2014-842X				Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Anderson MI, 2003, J NEUROSCI, V23, P8827; [Anonymous], 1998, NEURAL NETWORKS BRAI; Bartlett MS, 1998, NETWORK-COMP NEURAL, V9, P399, DOI 10.1088/0954-898X/9/3/008; Battaglia FP, 1998, PHYS REV E, V58, P7738, DOI 10.1103/PhysRevE.58.7738; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Fenton AA, 2000, J GEN PHYSIOL, V116, P191, DOI 10.1085/jgp.116.2.191; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; Gothard KM, 1996, J NEUROSCI, V16, P823; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hetherington PA, 1997, BEHAV NEUROSCI, V111, P20, DOI 10.1037/0735-7044.111.1.20; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jarosiewicz B, 2004, J NEUROSCI, V24, P5070, DOI 10.1523/JNEUROSCI.5650-03.2004; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Kunec S, 2005, J NEUROPHYSIOL, V94, P70, DOI 10.1152/jn.00731.2004; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lukashin AV, 1996, BIOL CYBERN, V74, P255, DOI 10.1007/BF00652226; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Paz-Villagran V, 2004, EUR J NEUROSCI, V20, P1379, DOI 10.1111/j.1460-9568.2004.03570.x; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	53	232	233	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					345	358		10.1016/j.neuron.2005.09.007	http://dx.doi.org/10.1016/j.neuron.2005.09.007			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242413	Bronze			2022-12-28	WOS:000232838700022
J	Ahern, CA; Horn, R				Ahern, CA; Horn, R			Focused electric field across the voltage sensor of potassium channels	NEURON			English	Article							SHAKER K+ CHANNEL; GATING CHARGE; ION CHANNELS; TRANSMEMBRANE MOVEMENT; S4; MECHANISM; RESIDUES; SEGMENT; PORE	Voltage-gated ion channels respond to changes in membrane potential by movement of their voltage sensors across the electric field between cytoplasmic and extracellular solutions. The principal voltage sensors in these proteins are positively charged S4 segments. The absolute magnitude of S4 movement discriminates two competing classes of gating models. In one class, the movement is < 10 angstrom due to the fact that the electric field is focused by aqueous crevices in the channel protein. In an alternative model, based in part on the crystal structure of a potassium channel, the side chains of S4 arginines move their charges across the bilayer's electric field, a distance of > 25 angstrom. Here, using tethered charges attached to an S4 segment, we provide evidence that the electric field falls across a distance of < 4 angstrom, supporting a model in which the relative movement between S4 and the electric field is very small.	Jefferson Med Coll, Dept Physiol, Inst Hyperexcitabil, Philadelphia, PA 19107 USA	Jefferson University	Horn, R (corresponding author), Jefferson Med Coll, Dept Physiol, Inst Hyperexcitabil, 1020 Locust St, Philadelphia, PA 19107 USA.	Richard.Horn@jefferson.edu	Tuluc, Petronel/C-2527-2011	Ahern, Christopher/0000-0002-7975-2744	NIAMS NIH HHS [AR41691] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041691] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Nguyen TP, 2002, J GEN PHYSIOL, V120, P419, DOI 10.1085/jgp.20028636; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	28	118	119	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					25	29		10.1016/j.neuron.2005.08.020	http://dx.doi.org/10.1016/j.neuron.2005.08.020			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202706	Bronze			2022-12-28	WOS:000232625700007
J	Kassai, H; Aiba, A; Nakao, K; Nakamura, K; Katsuki, M; Xiong, WH; Yau, KW; Imai, H; Shichida, Y; Satomi, Y; Takao, T; Okano, T; Fukada, Y				Kassai, H; Aiba, A; Nakao, K; Nakamura, K; Katsuki, M; Xiong, WH; Yau, KW; Imai, H; Shichida, Y; Satomi, Y; Takao, T; Okano, T; Fukada, Y			Farnesylation of retinal transducin underlies its translocation during light adaptation	NEURON			English	Article							PROTEIN GAMMA-SUBUNIT; CARBOXYL METHYLTRANSFERASE; CRAYFISH PHOTORECEPTORS; DEPENDENT TRANSLOCATION; ALPHA-SUBUNIT; BETA; CELLS; PHOTOTRANSDUCTION; COMPLEX; BINDING	G proteins are posttranslationally modified by isoprenylation: either farnesylation or geranylgeranylation. The gamma subunit of retinal transducin (T alpha/T beta gamma) is selectively farnesylated, and the farnesylation is required for light signaling mediated by transducin in rod cells. However, whether and how this selective isoprenylation regulates cellular functions remain poorly understood. Here we report that knockin mice expressing geranylgeranylated T gamma showed normal rod responses to dim flashes under dark-adapted conditions but exhibited impaired properties in light adaptation. Of note, geranylgeranylation of T gamma suppressed light-induced transition of T beta gamma from membrane to cytosol, and also attenuated its light-dependent translocation from the outer segment to the inner region, an event contributing to retinal light adaptation. These results indicate that, while the farnesylation of transducin is interchangeable with the geranylgeranylation in terms of the light signaling, the selective farnesylation is important for visual sensitivity regulation by providing sufficient but not excessive membrane anchoring of T beta gamma.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan; Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Cell Biol, Kobe, Hyogo 6500017, Japan; RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; Okazaki Natl Res Inst, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Lab Prot & Profiling & Funct Proteom, Inst Prot Res, Suita, Osaka 5650871, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Kobe University; RIKEN; Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Johns Hopkins University; Kyoto University; Japan Science & Technology Agency (JST); Osaka University; Japan Science & Technology Agency (JST)	Fukada, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	吉孝, 深田/G-5090-2014	Aiba, Atsu/0000-0002-8192-0778; zhong wei, he gui/0000-0002-3066-3564; Satomi, Yoshinori/0000-0002-8991-1040; Imai, Hiroo/0000-0003-0729-0322; Okano, Toshiyuki/0000-0001-6740-6265	NATIONAL EYE INSTITUTE [R01EY014596, R37EY006837, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-15S1, R01 EY006837-17, R01 EY006837, R37 EY006837-15, R01 EY006837-18, R01 EY014596-03, R01 EY014596-01, R01 EY014596, R01 EY006837-16A1, R01 EY014596-02, R37 EY006837] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-01, R01 DC006904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Chen FY, 1997, BIOCHEM BIOPH RES CO, V233, P370, DOI 10.1006/bbrc.1997.6460; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fogg VC, 2001, J BIOL CHEM, V276, P41797, DOI 10.1074/jbc.M107661200; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; FUKADA Y, 1989, J BIOL CHEM, V264, P5937; FUKADA Y, 1994, J BIOL CHEM, V269, P5163; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Hardie R, 2002, NEURON, V34, P3, DOI 10.1016/S0896-6273(02)00650-5; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; Kassai H, 2005, RAPID COMMUN MASS SP, V19, P269, DOI 10.1002/rcm.1782; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; KUO CH, 1989, MOL BRAIN RES, V6, P1, DOI 10.1016/0169-328X(89)90022-3; KUO CH, 1989, BIOCHEM BIOPH RES CO, V162, P1063, DOI 10.1016/0006-291X(89)90781-X; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Matsuda T, 2000, METHOD ENZYMOL, V316, P465; Matsuda T, 1998, BIOCHEMISTRY-US, V37, P9843, DOI 10.1021/bi973194c; Mendez A, 2003, J NEUROSCI, V23, P3124; Myung CS, 1999, J BIOL CHEM, V274, P16595, DOI 10.1074/jbc.274.23.16595; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh Jr EN, 2000, HDB BIOL PHYS, V3; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tanaka H, 1996, BIOCHEM BIOPH RES CO, V223, P587, DOI 10.1006/bbrc.1996.0939; Terakita A, 1996, VISUAL NEUROSCI, V13, P539, DOI 10.1017/S095252380000821X; Terakita A, 1998, J COMP PHYSIOL A, V183, P411, DOI 10.1007/s003590050267; WILLIAMS DE, 1964, ANN NY ACAD SCI, V121, P373, DOI 10.1111/j.1749-6632.1964.tb14210.x; Zhang HB, 2003, MOL VIS, V9, P231	52	38	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					529	539		10.1016/j.neuron.2005.07.025	http://dx.doi.org/10.1016/j.neuron.2005.07.025			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102536	Green Accepted, Bronze			2022-12-28	WOS:000231411100010
J	Genovesio, A; Brasted, PJ; Mitz, AR; Wise, SP				Genovesio, A; Brasted, PJ; Mitz, AR; Wise, SP			Prefrontal cortex activity related to abstract response strategies	NEURON			English	Article							NEURONAL-ACTIVITY; WORKING-MEMORY; FRONTAL-CORTEX; VISUOSPATIAL ATTENTION; VISUAL CATEGORIZATION; PARKINSONS-DISEASE; TEMPORAL-ORDER; SINGLE NEURONS; BASAL GANGLIA; TASK	Many monkeys adopt abstract response strategies as they learn to map visual symbols to responses by trial and error. According to the repeat-stay strategy, if a symbol repeats from a previous, successful trial, the monkeys should stay with their most recent response choice. According to the change-shift strategy, if the symbol changes, the monkeys should shift to a different choice. We recorded the activity of prefrontal cortex neurons while monkeys chose responses according to these two strategies. Many neurons had activity selective for the strategy used. In a subsequent block of trials, the monkeys learned fixed stimulus-response mappings with the same stimuli. Some neurons had activity selective for choosing responses based on fixed mappings, others for choosing based on abstract strategies. These findings indicate that the prefrontal cortex contributes to the implementation of the abstract response strategies that monkeys use during trial-and-error learning.	NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Wise, SP (corresponding author), NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA.	stevenwise@mail.nih.gov		Genovesio, Aldo/0000-0003-2521-143X; , Andrew/0000-0002-8045-0970	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001092] Funding Source: NIH RePORTER; NIMH NIH HHS [Z01 MH001092-27] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Brass M, 2003, NEUROIMAGE, V20, P1026, DOI 10.1016/S1053-8119(03)00357-4; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; BUNGE SA, 2005, IN PRESS COGN AFFECT; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Folstein JR, 2004, J EXP PSYCHOL LEARN, V30, P1026, DOI 10.1037/0278-7393.30.5.1026; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Gaffan D, 2002, J NEUROSCI, V22, P7288; Gaffan D, 2002, PHILOS T R SOC B, V357, P1111, DOI 10.1098/rstb.2002.1110; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; GREEN CG, 1966, SIGNAL DETECTION THE; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Huettel SA, 2004, NEUROREPORT, V15, P1883, DOI 10.1097/00001756-200408260-00009; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; Koski L, 2002, NEUROPSYCHOLOGIA, V40, P1059, DOI 10.1016/S0028-3932(01)00140-3; Lau HC, 2004, NEUROIMAGE, V21, P1407, DOI 10.1016/j.neuroimage.2003.10.034; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; Miller EK, 1996, J NEUROSCI, V16, P5154; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Parker A, 1998, NEUROPSYCHOLOGIA, V36, P259, DOI 10.1016/S0028-3932(97)00112-7; Pessoa L, 2003, J NEUROSCI, V23, P3990; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Pinker S., 1999, WORD RULES; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; Shohamy D, 2004, BEHAV NEUROSCI, V118, P676, DOI 10.1037/0735-7044.118.4.676; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Swainson R, 2001, NEUROCASE, V7, P433, DOI 10.1076/neur.7.5.433.16248; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; Zhang J, 1997, J NEUROSCI, V17, P2227	69	147	147	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					307	320		10.1016/j.neuron.2005.06.006	http://dx.doi.org/10.1016/j.neuron.2005.06.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039571	Green Accepted, Bronze			2022-12-28	WOS:000230693900016
J	Francis, MM; Evans, SP; Jensen, M; Madsen, DM; Mancuso, J; Norman, KR; Maricq, AV				Francis, MM; Evans, SP; Jensen, M; Madsen, DM; Mancuso, J; Norman, KR; Maricq, AV			The Ror receptor tyrosine kinase CAM-1 is required for ACR-16-mediated synaptic transmission at the C. elegans neuromuscular junction	NEURON			English	Article							CAENORHABDITIS-ELEGANS; POSTSYNAPTIC DIFFERENTIATION; ACETYLCHOLINE-RECEPTORS; HOMEODOMAIN PROTEIN; FUNCTIONAL-ANALYSIS; GENE ENCODES; EXPRESSION; UNC-13; MUSK; GABA	Nicotinic (cholinergic) neurotransmission plays a critical role in the vertebrate nervous system, underlies nicotine addiction, and nicotinic receptor dysfunction leads to neurological disorders. The C. elegans neuromuscular junction (NMJ) shares many characteristics with neuronal synapses, including multiple classes of postsynaptic currents. Here, we identify two genes required for the major excitatory current found at the C. elegans NMJ: acr-16, which encodes a nicotinic AChR subunit homologous to the vertebrate alpha 7 subunit, and cam-1, which encodes a Ror receptor tyrosine kinase. acr-16 mutants lack fast cholinergic current at the NMJ and exhibit synthetic behavioral deficits with other known AChR mutants. In cam-1 mutants, ACR-16 is mislocalized and ACR-16-dependent currents are disrupted. The postsynaptic deficit in cam-1 mutants is accompanied by alterations in the distribution of cholinergic vesicles and associated synaptic proteins. We hypothesize that CAM-1 contributes to the localization or stabilization of postsynaptic ACR-16 receptors and presynaptic release sites.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu		francis, michael/0000-0002-8076-6668; jensen, michael/0000-0002-4517-822X	NIDA NIH HHS [DA016754, DA05992] Funding Source: Medline; NIGMS NIH HHS [F32 GM066579] Funding Source: Medline; NIMH NIH HHS [R01 MH067747, MH067747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA005992, K01DA016754] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ballivet M, 1996, J MOL BIOL, V258, P261, DOI 10.1006/jmbi.1996.0248; Bamber BA, 1999, J NEUROSCI, V19, P5348; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Fleming JT, 1997, J NEUROSCI, V17, P5843; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Gally C, 2003, J NEUROSCI, V23, P2591; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Jin YS, 1999, J NEUROSCI, V19, P539; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Koga M, 1999, DEVELOPMENT, V126, P5387; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MILLER DM, 1995, DEVELOPMENT, V121, P2877; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKKEMA PG, 1993, GENETICS, V135, P385; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsen G, 2000, NAT NEUROSCI, V3, P126, DOI 10.1038/72066; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	51	103	128	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					581	594		10.1016/j.neuron.2005.04.010	http://dx.doi.org/10.1016/j.neuron.2005.04.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944127	Bronze			2022-12-28	WOS:000229294300010
J	Vigh, J; Li, GL; Hull, C; von Gersdorff, L				Vigh, J; Li, GL; Hull, C; von Gersdorff, L			Long-term plasticity mediated by mGluR1 at a retinal reciprocal synapse	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TIGER SALAMANDER RETINA; TEMPORAL CONTRAST ADAPTATION; ROD BIPOLAR CELLS; AMACRINE CELLS; GANGLION-CELLS; RAT RETINA; EXOCYTOSED PROTONS; GABA(C) RECEPTORS; FEEDBACK	The 1 low of information across the retina is controlled by reciprocal synapses between bipolar cell terminals and amacrine cells. However, the synaptic delays and proparties of plasticity at these synapses are not known. Here we report that glutamate release from goldfish Mb-type bipolar cell terminals can trigger fast (delay of 2-3 ms) and transient GABA(A) IPSCs and a much slower and more sustained GABA(C) feedback. Synaptically released glutamate activated mGIuR1 receptors on amacrine cells and, depending on the strength of presynaptic activity, potentiated subsequent feedback. This poststimulus enhancement of GABAergic feedback lasted for up to 10 min. This form of mGluR1-mediated long-term synaptic plasticity may provide retinal reciprocal synapses with adaptive capabilities.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	von Gersdorff, L (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	vongersd@ohsu.edu	Vigh, Jozsef/F-7531-2012; Li, Geng-Lin/I-7998-2014	Li, Geng-Lin/0000-0001-7053-4284; Hull, Court/0000-0002-0360-8367; Vigh, Jozsef/0000-0001-9862-5049	NEI NIH HHS [R01 EY014043] Funding Source: Medline; NINDS NIH HHS [F31 NS042506] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS042506] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; Bruno V, 1999, NEUROPHARMACOLOGY, V38, P199, DOI 10.1016/S0028-3908(98)00159-2; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Cook PB, 2000, J NEUROSCI, V20, P806, DOI 10.1523/JNEUROSCI.20-02-00806.2000; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Freed MA, 2003, NEURON, V38, P89, DOI 10.1016/S0896-6273(03)00166-1; Fyk-Kolodziej B, 2004, J COMP NEUROL, V475, P518, DOI 10.1002/cne.20199; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Hoffpauir BK, 2002, J NEUROPHYSIOL, V88, P1766, DOI 10.1152/jn.2002.88.4.1766; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Jacobs AL, 1998, J NEUROPHYSIOL, V80, P447, DOI 10.1152/jn.1998.80.1.447; JOHNSON RG, 1987, ANN NY ACAD SCI, V493, P162, DOI 10.1111/j.1749-6632.1987.tb27198.x; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Klooster J, 2001, J COMP NEUROL, V441, P155, DOI 10.1002/cne.1404; Koulen P, 1997, J NEUROSCI, V17, P2200; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Kreimborg KM, 2001, J NEUROCHEM, V77, P452, DOI 10.1046/j.1471-4159.2001.00225.x; Lapointe V, 2004, J PHYSIOL-LONDON, V555, P125, DOI 10.1113/jphysiol.2003.053603; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Lukasiewicz PD, 2004, VISION RES, V44, P3289, DOI 10.1016/j.visres.2004.07.023; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsui K, 2001, J NEUROPHYSIOL, V86, P2285, DOI 10.1152/jn.2001.86.5.2285; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Pang JJ, 2002, VISION RES, V42, P19, DOI 10.1016/S0042-6989(01)00258-9; Protti DA, 1998, J NEUROSCI, V18, P3715; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Roska B, 1998, J NEUROSCI, V18, P3451; SAITO T, 1982, J COMP NEUROL, V205, P161, DOI 10.1002/cne.902050207; Shen W, 2001, J PHYSIOL-LONDON, V530, P55, DOI 10.1111/j.1469-7793.2001.0055m.x; Singer JH, 2003, J NEUROSCI, V23, P10923; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; TABB JS, 1992, J BIOL CHEM, V267, P15412; TAKAHASHI KI, 1992, J NEUROPHYSIOL, V67, P1633, DOI 10.1152/jn.1992.67.6.1633; Tozzi A, 2001, J NEUROPHYSIOL, V85, P2490, DOI 10.1152/jn.2001.85.6.2490; Vigh J, 2003, EUR J NEUROSCI, V17, P2237, DOI 10.1046/j.1460-9568.2003.02652.x; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Watanabe S, 2000, J NEUROPHYSIOL, V84, P1826, DOI 10.1152/jn.2000.84.4.1826; Werner, 2004, VISUAL NEUROSCIENCES, P320; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong KY, 2005, J NEUROPHYSIOL, V93, P94, DOI 10.1152/jn.00270.2004; Yang XL, 2002, J PHYSIOL-LONDON, V539, P239, DOI 10.1113/jphysiol.2001.013110; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005; Zhang J, 2002, J NEUROSCI, V22, P10871; Zhang JA, 1997, VISUAL NEUROSCI, V14, P553, DOI 10.1017/S0952523800012219	66	26	26	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					469	482		10.1016/j.neuron.2005.03.027	http://dx.doi.org/10.1016/j.neuron.2005.03.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882646	Green Accepted, Bronze			2022-12-28	WOS:000229011400018
J	Saghatelyan, A; Roux, P; Migliore, M; Rochefort, C; Desmaisons, D; Charneau, P; Shepherd, GM; Lledo, PM				Saghatelyan, A; Roux, P; Migliore, M; Rochefort, C; Desmaisons, D; Charneau, P; Shepherd, GM; Lledo, PM			Activity-dependent adjustments of the inhibitory network in the olfactory bulb following early postnatal deprivation	NEURON			English	Article							NARIS-OCCLUDED RATS; NMDA RECEPTORS; GRANULE CELLS; MITRAL CELLS; GABA RELEASE; INTRINSIC EXCITABILITY; RECIPROCAL SYNAPSES; SUBVENTRICULAR ZONE; GENERATED NEURONS; CALCIUM INFLUX	The first-order sensory relay for olfactory processing, the main olfactory bulb (MOB), retains the ability to acquire new interneurons throughout life. It is therefore a particularly appropriate region for studying the role of experience in sculpting neuronal networks. We found that nostril closure decreased the number of newborn granule cells in the MOB, the complexity of their dendritic arborization, and their spine density, without affecting the preexisting population of granule cells. Accordingly, the frequency of miniature synaptic inhibitory events received by mitral cells was reduced. However, due to a compensatory increase in newborn granule cell excitability, action potential-dependent GABA release was dramatically enhanced, thus counteracting the reduction in spine density and leading to an unaltered synchronization of mitral cell firing activity. Together, this study reveals a unique form of adaptive response brought about exclusively by the cohort of newborn cells and used to maintain normal functioning of the MOB.	Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, F-75015 Paris, France; Inst Pasteur, Platform Dynam Imaging, F-75015 Paris, France; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Inst Pasteur, Lab Mol Virol & Vectorol, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yale University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lledo, PM (corresponding author), Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, F-75015 Paris, France.	pmlledo@pasteur.fr	CHARNEAU, Pierre/M-1565-2017; Migliore, Michele/D-7448-2011	CHARNEAU, Pierre/0000-0003-1184-5773; Migliore, Michele/0000-0002-7584-6292; Saghatelyan, Armen/0000-0003-4962-0465; rochefort, christelle/0000-0001-8466-5218				Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; Baker H, 1999, J NEUROSCI, V19, P9313; BENSON TE, 1984, J NEUROSCI, V4, P638; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BRUNJES PC, 1985, DEV BRAIN RES, V22, P1, DOI 10.1016/0165-3806(85)90063-X; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Cang JH, 2003, J NEUROSCI, V23, P4108; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Castillo PE, 1999, J NEUROSCI, V19, P9180; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cudmore RH, 2004, J NEUROPHYSIOL, V92, P341, DOI 10.1152/jn.01059.2003; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Egger V, 2003, J NEUROSCI, V23, P7551; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; Fiske BK, 2001, J COMP NEUROL, V431, P311; FRAZIERCIERPIAL L, 1989, J COMP NEUROL, V289, P481, DOI 10.1002/cne.902890312; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; GUTHRIE KM, 1991, SYNAPSE, V8, P61, DOI 10.1002/syn.890080109; Halabisky B, 2000, J NEUROSCI, V20, P5124; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Johnson BA, 1996, DEV BRAIN RES, V92, P24, DOI 10.1016/0165-3806(95)00197-2; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Leon M, 1998, ANN NY ACAD SCI, V855, P104, DOI 10.1111/j.1749-6632.1998.tb10551.x; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Lledo PM, 2004, NEUROSCIENTIST, V10, P292, DOI 10.1177/1073858404263460; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Matsutani S, 2000, J COMP NEUROL, V418, P402; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; MEISAMI E, 1981, BRAIN RES, V221, P81, DOI 10.1016/0006-8993(81)91065-9; MEISAMI E, 1986, INT J DEV NEUROSCI, V4, P431, DOI 10.1016/0736-5748(86)90025-0; Migliore M, 2005, J COMPUT NEUROSCI, V18, P151, DOI 10.1007/s10827-005-6556-1; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; NAJBAUER J, 1995, BRAIN RES, V674, P245, DOI 10.1016/0006-8993(94)01448-Q; Nakajima T, 1998, ANAT RECORD, V250, P238; Petreanu L, 2002, J NEUROSCI, V22, P6106; Philpot BD, 1998, NEUROSCIENCE, V85, P969, DOI 10.1016/S0306-4522(97)00667-2; PRICE JL, 1970, J CELL SCI, V7, P91; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; ROSSELLIAUSTIN L, 1990, DEV BRAIN RES, V51, P135, DOI 10.1016/0165-3806(90)90267-3; Saghatelyan A, 2003, J PHYSIOL-PARIS, V97, P517, DOI 10.1016/j.jphysparis.2004.01.009; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Schrader LA, 2002, MOL NEUROBIOL, V25, P51; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; STAHL B, 1990, CELL TISSUE RES, V259, P275, DOI 10.1007/BF00318449; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; WILSON DA, 1992, NEUROSCIENCE, V49, P183, DOI 10.1016/0306-4522(92)90086-H; WILSON DA, 1990, NEUROSCI LETT, V116, P250, DOI 10.1016/0304-3940(90)90082-K; WILSON DA, 1995, BRAIN RES, V677, P238, DOI 10.1016/0006-8993(95)00151-F; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	67	122	128	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					103	116		10.1016/j.neuron.2005.02.016	http://dx.doi.org/10.1016/j.neuron.2005.02.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820697	Bronze			2022-12-28	WOS:000228228600012
J	Yazawa, I; Giasson, BI; Sasaki, R; Zhang, B; Joyce, S; Uryu, K; Trojanowski, JQ; Lee, VMY				Yazawa, I; Giasson, BI; Sasaki, R; Zhang, B; Joyce, S; Uryu, K; Trojanowski, JQ; Lee, VMY			Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration	NEURON			English	Article							PARKINSONS-DISEASE; CYTOPLASMIC INCLUSIONS; NEUROFILAMENT PHOSPHORYLATION; LEWY BODIES; WILD-TYPE; PROTEIN; DEMENTIA; MICE; TRANSECTION; MICROGLIA	Transgenic (Tg) mice overexpressing human wild-type alpha-synuclein in oligodendrocytes under the control of the 2,' 3'-cyclic nucleotide X-phosphodiesterase (CNP) promoter are shown here to recapitulate features of multiple system atrophy (MSA), including the accumulation of filamentous human alpha-synuclein aggregates in oligodendrocytes linked to their degeneration and autophagocytosis of myelin. Significantly, endogenous mouse (x-synuclein also accumulated in normal and degenerating axons and axon terminals in association with oligodendroglia and neuron loss and slowly progressive motor impairments. Our studies demonstrate that overexpression of alpha-synuclein in oligodendrocytes of mice results in MSA-like degeneration in the CNS and that a-synuclein inclusions in oligodendrocytes participate in the degeneration of neurons in MSA.	Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu			NIA NIH HHS [AG-09215] Funding Source: Medline; NINDS NIH HHS [NS-044233] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009215] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; Baba M, 1998, AM J PATHOL, V152, P879; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; GLASSON BI, 2002, NEURON, V34, P521; GLASSON BI, 2000, J NEUROSCI RES, V59, P528; GOLDSTEIN ME, 1987, J NEUROSCI, V7, P1586; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; Gravel M, 1998, J NEUROSCI RES, V53, P393; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; HEDREEN JC, 1994, J NEUROPATH EXP NEUR, V53, P663, DOI 10.1097/00005072-199411000-00013; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jakes R, 1999, NEUROSCI LETT, V269, P13, DOI 10.1016/S0304-3940(99)00411-5; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KLOSEN P, 1990, BRAIN RES, V526, P259, DOI 10.1016/0006-8993(90)91230-E; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuo A, 1998, AM J PATHOL, V153, P735, DOI 10.1016/S0002-9440(10)65617-9; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; NAKAZATO Y, 1990, J NEUROPATH EXP NEUR, V49, P521, DOI 10.1097/00005072-199009000-00007; PAPP MI, 1994, BRAIN, V117, P235, DOI 10.1093/brain/117.2.235; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; PETERS A, 1991, FINE STRUCTURE NERVO, P298; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; YAMADA T, 1990, NEUROSCI LETT, V120, P163, DOI 10.1016/0304-3940(90)90028-8	43	229	236	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					847	859		10.1016/j.neuron.2005.01.032	http://dx.doi.org/10.1016/j.neuron.2005.01.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797547	Bronze			2022-12-28	WOS:000228031300007
J	Engel, D; Jonas, P				Engel, D; Jonas, P			Presynaptic action potential amplification by voltage-gated Na+ channels in hippocampal mossy fiber boutons	NEURON			English	Article							MOTOR-NERVE TERMINALS; SHORT-TERM PLASTICITY; SODIUM-CHANNEL; RAT HIPPOCAMPUS; PYRAMIDAL NEURONS; AUXILIARY SUBUNIT; MEMORY SEQUENCES; SLOW RECOVERY; GRANULE CELLS; CA3 REGION	Action potentials in central neurons are initiated near the axon initial segment, propagate into the axon, and finally invade the presynaptic terminals, where they trigger transmitter release. Voltage-gated Na+ channels are key determinants of excitability, but Na+ channel density and properties in axons and presynaptic terminals of cortical neurons have not been examined yet. In hippocampal mossy fiber boutons, which emerge from parent axons en passant, Na+ channels are very abundant, with an estimated number of similar to2000 channels per bouton. Presynaptic Na+ channels show faster inactivation kinetics than somatic channels, suggesting differences between subcellular compartments of the same cell. Computational analysis of action potential propagation in axon-multibouton structures reveals that Na+ channels in boutons preferentially amplify the presynaptic action potential and enhance Ca2+ inflow, whereas Na+ channels in axons control the reliability and speed of propagation. Thus, presynaptic and axonal Na+ channels contribute differentially to mossy fiber synaptic transmission.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804; Engel, Dominique/0000-0002-5962-3152				Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 1997, J NEUROSCI, V17, P6512; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; DREYER F, 1987, J PHYSIOL-LONDON, V386, P455, DOI 10.1113/jphysiol.1987.sp016544; Efron B, 1998, INTRO BOOTSTRAP; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V533, P921; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V532, P385, DOI 10.1111/j.1469-7793.2001.0385f.x; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Geiger JRP, 2002, PFLUG ARCH EUR J PHY, V443, P491, DOI 10.1007/s00424-001-0735-3; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GOLDMAN L, 1973, J GEN PHYSIOL, V61, P361, DOI 10.1085/jgp.61.3.361; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Gong B, 1999, J COMP NEUROL, V412, P342; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JACKSON MB, 1995, J PHYSIOL-LONDON, V483, P597, DOI 10.1113/jphysiol.1995.sp020609; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jung HY, 1997, J NEUROSCI, V17, P6639; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P453, DOI 10.1098/rspb.1965.0015; Katz B., 1969, RELEASE NEURAL TRANS; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; LINDGREN CA, 1989, J PHYSIOL-LONDON, V414, P201, DOI 10.1113/jphysiol.1989.sp017684; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LUSCHER HR, 1990, BIOPHYS J, V58, P1377, DOI 10.1016/S0006-3495(90)82484-X; LUSCHER HR, 1990, BIOPHYS J, V58, P1389, DOI 10.1016/S0006-3495(90)82485-1; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Marty Alain, 1995, P31; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; OXFORD GS, 1981, J GEN PHYSIOL, V77, P1, DOI 10.1085/jgp.77.1.1; RITCHIE JM, 1957, J PHYSIOL-LONDON, V136, P80, DOI 10.1113/jphysiol.1957.sp005744; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sakmann Bert, 1995, P637; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Sampo B, 2000, P NATL ACAD SCI USA, V97, P3666, DOI 10.1073/pnas.97.7.3666; Sangrey TD, 2004, J NEUROPHYSIOL, V91, P2541, DOI 10.1152/jn.00646.2003; Schaller KL, 2000, J COMP NEUROL, V420, P84; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Smith MR, 1998, J NEUROSCI, V18, P6093; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Waxman Stephen G., 1995, P218; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; Yu FH, 2003, J NEUROSCI, V23, P7577	70	152	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					405	417		10.1016/j.neuron.2004.12.048	http://dx.doi.org/10.1016/j.neuron.2004.12.048			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694327	Bronze			2022-12-28	WOS:000226787700013
J	Steffenach, HA; Witter, M; Moser, MB; Moser, EI				Steffenach, HA; Witter, M; Moser, MB; Moser, EI			Spatial memory in the rat requires the dorsolateral band of the entorhinal cortex	NEURON			English	Article							POSITIONAL FIRING PROPERTIES; NUCLEUS-REUNIENS-THALAMI; FREELY MOVING RATS; VENTRAL HIPPOCAMPUS; WORKING-MEMORY; FUNCTIONAL-DIFFERENTIATION; RETROHIPPOCAMPAL LESIONS; PARAHIPPOCAMPAL REGION; PARASUBICULUM DISRUPT; EXCITOTOXIC LESIONS	The extensive connections of the entorhinal cortex with the hippocampus and the neocortex point to this region as a major interface in the hippocampal-neocortical interactions underlying memory. We asked whether hippocampal-dependent recall of spatial memory depends on the entorhinal cortex, and, if so, which parts are critical. After training in a Morris water maze, rats received fiber-sparing lesions in the dorsolateral band of the entorhinal cortex, which mediates much of the visuospatial input to the dorsal hippocampus. These lesions entirely disrupted retention and retarded new learning. Spatial memory was spared by lesions in the ventromedial band, which connects primarily with ventral hippocampus, but these lesions reduced defensive behavior on an elevated plus maze, mirroring the effects of damage to ventral hippocampus. The results suggest that the functional differences between dorsal and ventral hippocampus reflect their connectivity with modules of the entorhinal cortex that are differently linked to the rest of the cortex.	Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway; Vrije Univ Amsterdam, Med Ctr, Dept Anat, Res Inst Neurosci, NL-1007 MB Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway.	edvard.moser@cbm.ntnu.no						Aggleton JP, 2000, HIPPOCAMPUS, V10, P466, DOI 10.1002/1098-1063(2000)10:4<466::AID-HIPO13>3.3.CO;2-P; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Bannerman DM, 2001, EXP BRAIN RES, V141, P281; Bannerman DM, 2001, EXP BRAIN RES, V141, P304; BOUFFARD JP, 1988, BEHAV NEUROSCI, V102, P828, DOI 10.1037/0735-7044.102.6.828; Burwell RD, 2004, J NEUROSCI, V24, P3826, DOI 10.1523/JNEUROSCI.0410-04.2004; Burwell RD, 1998, NEUROREPORT, V9, P3013, DOI 10.1097/00001756-199809140-00017; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; CHO YH, 1995, NEUROBIOL LEARN MEM, V64, P285, DOI 10.1006/nlme.1995.0011; Cho YH, 1996, BEHAV NEUROSCI, V110, P436, DOI 10.1037/0735-7044.110.3.436; CHO YH, 1994, EUR J NEUROSCI, V6, P1265, DOI 10.1111/j.1460-9568.1994.tb00316.x; de Hoz L, 2004, PLOS BIOL, V2, P1233, DOI 10.1371/journal.pbio.0020225; de Hoz L, 2003, HIPPOCAMPUS, V13, P587, DOI 10.1002/hipo.10079; DOLLEMANVANDERWEEL, 1996, J COMP NEUROL, V364, P637; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ferbinteanu J, 2003, NEUROSCI LETT, V345, P131, DOI 10.1016/S0304-3940(03)00473-7; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Galani R, 2002, NEUROBIOL LEARN MEM, V77, P1, DOI 10.1006/nlme.2000.3998; HERKENHAM M, 1978, J COMP NEUROL, V177, P589, DOI 10.1002/cne.901770405; HOLSCHER C, 1994, BEHAV BRAIN RES, V63, P187, DOI 10.1016/0166-4328(94)90090-6; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; JARRARD LE, 1984, BEHAV NEUROSCI, V98, P946, DOI 10.1037/0735-7044.98.6.946; Jarrard LE, 2004, HIPPOCAMPUS, V14, P434, DOI 10.1002/hipo.10194; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kesner RP, 1998, HIPPOCAMPUS, V8, P416, DOI 10.1002/(SICI)1098-1063(1998)8:4<416::AID-HIPO9>3.0.CO;2-E; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Liu P, 2004, HIPPOCAMPUS, V14, P107, DOI 10.1002/hipo.10161; Liu P, 2001, BEHAV NEUROSCI, V115, P112, DOI 10.1037/0735-7044.115.1.112; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Naber PA, 1999, EUR J NEUROSCI, V11, P4119, DOI 10.1046/j.1460-9568.1999.00835.x; Naber PA, 2001, HIPPOCAMPUS, V11, P105; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; Oswald CJP, 2003, BEHAV NEUROSCI, V117, P588, DOI 10.1037/0735-7044.117.3.588; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Pouzet B, 1999, EUR J NEUROSCI, V11, P123, DOI 10.1046/j.1460-9568.1999.00413.x; RASMUSSEN M, 1989, PSYCHOBIOLOGY, V17, P335; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SCHENK F, 1985, EXP BRAIN RES, V58, P11; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1990, J NEUROSCI, V10, P420; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; WITTER MP, 1989, NEUROLOGY NEUROBIOLO, V52, P53; Witter MP, 1988, NEUROSCI RES COMMUN, V2, P61; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202	68	240	251	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 20	2005	45	2					301	313		10.1016/j.neuron.2004.12.044	http://dx.doi.org/10.1016/j.neuron.2004.12.044			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664181	Bronze			2022-12-28	WOS:000226451500016
J	Griffith, LC				Griffith, LC			Watching the fly brain learn	NEURON			English	Editorial Material							MEMORY TRACE; DROSOPHILA; NEURONS; DOPAMINE	The peptidergic dorsal paired medial (DPM) neurons, which innervate the mushroom bodies in Drosophila, have been widely hypothesized to be part of the unconditioned stimulus (US) pathway of odor-shock classical conditioning. In the December 2 issue of Cell, Yu et al., using functional imaging techniques, report the surprising finding that DPMs contain odor-specific memory traces and send integrated information about the conditioned stimulus (CS) to the mushroom bodies. These findings provide important new insight into the circuitry of learning in Drosophiia.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav & Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, 415 S St, Waltham, MA 02454 USA.			Griffith, Leslie/0000-0003-3164-9876	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054408-10, R01 GM054408] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McGuire SE, 2004, SCI STKE, V2004, pp16; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	15	0	0	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 19	2006	49	2					171	174		10.1016/j.neuron.2006.01.001	http://dx.doi.org/10.1016/j.neuron.2006.01.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423691	Bronze			2022-12-28	WOS:000234979900004
J	Daniels, RW; Collins, CA; Chen, K; Gelfand, MV; Featherstone, DE; DiAntonio, A				Daniels, RW; Collins, CA; Chen, K; Gelfand, MV; Featherstone, DE; DiAntonio, A			A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle	NEURON			English	Article							QUANTAL SIZE; NEUROMUSCULAR-JUNCTION; RELEASE; EXPRESSION; LOCALIZATION; RECEPTORS; SYNAPSES; VGLUT1; SITES	Quantal size is the postsynaptic response to the release of a single synaptic vesicle and is determined in part by the amount of transmitter within that vesicle. At glutamatergic synapses, the vesicular glutamate transporter (VGLUT) fills vesicles with glutamate. While elevated VGLUT expression increases quantal size, the minimum number of transporters required to fill a vesicle is unknown. In Drosophila DVGLUT mutants, reduced transporter levels lead to a dose-dependent reduction in the frequency of spontaneous quantal release with no change in quantal size. Quantal frequency is not limited by vesicle number or impaired exocytosis. This suggests that a single functional unit of transporter is both necessary and sufficient to fill a vesicle to completion and that vesicles without DVGLUT are empty. Consistent with the presence of empty vesicles, at dvglut mutant synapses synaptic vesicles are smaller, suggesting that vesicle filling and/or transporter level is an important determinant of vesicle size.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	diantonio@wustl.edu		DiAntonio, Aaron/0000-0002-7262-0968; Collins, Catherine/0000-0002-1608-6692	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051453, R01NS043171, R01NS045628] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM08151, T32 GM008151] Funding Source: Medline; NINDS NIH HHS [R01 NS045628-03, R01 NS043171, R01 NS051453, R01 NS045628, R01 NS045628-04, NS043171, NS045628, NS041543, R01 NS045628-01, R01 NS045628-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Franks KM, 2003, J NEUROSCI, V23, P3186; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gong LW, 2003, J NEUROSCI, V23, P7917; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pothos EN, 2000, J NEUROSCI, V20, P7297; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	18	131	143	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					11	16		10.1016/j.neuron.2005.11.032	http://dx.doi.org/10.1016/j.neuron.2005.11.032			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387635	Green Accepted, Bronze			2022-12-28	WOS:000236699300005
J	Deuel, TAS; Liu, JS; Corbo, JC; Yoo, SY; Rorke-Adams, LB; Walsh, CA				Deuel, TAS; Liu, JS; Corbo, JC; Yoo, SY; Rorke-Adams, LB; Walsh, CA			Genetic interactions between doublecortin and doublecortin-like kinase in neuronal migration and axon outgrowth	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; CYCLIN-DEPENDENT KINASE-5; LISSENCEPHALY SYNDROME; CEREBRAL-CORTEX; MESSENGER-RNA; BRAIN; MICE; GROWTH; DOMAIN; DCX	Although mutations in the human doublecortin gene (DCX) cause profound defects in cortical neuronal migration, a genetic deletion of Dcx in mice produces a milder defect. A second locus, doublecortin-like kinase (Dclk), encodes a protein with similar "doublecortin domains" and microtubule stabilization properties that may compensate for Dcx. Here, we generate a mouse with a Dclk mutation that causes no obvious migrational abnormalities but show that mice mutant for both Dcx and Dclk demonstrate perinatal lethality, disorganized neocortical layering, and profound hippocampal cytoarchitectural disorganization. Surprisingly, Dcx(-/y);Dclk(-/-) mutants have widespread axonal defects, affecting the corpus callosum, anterior commissure, subcortical fiber tracts, and internal capsule. Dcx/Dclk-deficient dissociated neurons show abnormal axon outgrowth and dendritic structure, with defects in axonal transport of synaptic vesicle proteins. Dcx and Dclk may directly or indirectly regulate microtubule-based vesicle transport, a process critical to both neuronal migration and axon outgrowth.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr,Div Genet,Childrens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr,Div Genet,Childrens, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu		Corbo, Joseph/0000-0002-9323-7140; Walsh, Christopher/0000-0002-0156-2238	NINDS NIH HHS [P01 NS40043] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; Berg MJ, 1998, NEUROLOGY, V50, P1143, DOI 10.1212/WNL.50.4.1143; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burgess HA, 2001, J BIOL CHEM, V276, P36397, DOI 10.1074/jbc.M105153200; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; Caviness V S Jr, 1982, Brain Res, V256, P293; Corbo JC, 2002, J NEUROSCI, V22, P7548; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; des Portes V, 1998, CELL, V92, P51; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P9264, DOI 10.1021/bi025934+; Lin PT, 2000, J NEUROSCI, V20, P9152; LoTurco J, 2004, NEURON, V41, P175, DOI 10.1016/S0896-6273(04)00006-6; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mizuguchi M, 1999, AM J PATHOL, V155, P1713, DOI 10.1016/S0002-9440(10)65486-7; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paglini G, 2001, EMBO REP, V2, P1139, DOI 10.1093/embo-reports/kve250; Ross ME, 1997, HUM MOL GENET, V6, P555, DOI 10.1093/hmg/6.4.555; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shirasu M, 2000, NEUROSCI RES, V37, P265, DOI 10.1016/S0168-0102(00)00125-5; Silverman MA, 1999, J BIOL CHEM, V274, P2631, DOI 10.1074/jbc.274.5.2631; Sossey-Alaoui K, 1999, GENOMICS, V56, P121, DOI 10.1006/geno.1998.5718; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Viot G, 2004, AM J MED GENET A, V126A, P123, DOI 10.1002/ajmg.a.20569; Vreugdenhil E, 1999, J NEUROBIOL, V39, P41, DOI 10.1002/(SICI)1097-4695(199904)39:1<41::AID-NEU4>3.0.CO;2-X	49	219	224	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					41	53		10.1016/j.neuron.2005.10.038	http://dx.doi.org/10.1016/j.neuron.2005.10.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387638	Bronze			2022-12-28	WOS:000236699300008
J	Rivest, S				Rivest, S			Cannabinoids in microglia: A new trick for immune surveillance and neuroprotection	NEURON			English	Editorial Material							IN-VIVO; BRAIN; CELLS; GLUCOCORTICOIDS; PLAY	Microglia are the resident immune cells of the brain, and they are under permanent activity to patrol the cerebral microenvironment. A proper inhibitory feedback onto these cells is critical during both intact and injury conditions. In this issue of Neuron, Eljaschewitsch and colleagues report that such feedback is provided by the endogenous cannabinoid anandamine and CB1/2 receptor signaling, which ultimately leads to mitogen-activated protein kinase phosphatase-1 (MKP-1) induction. MKP-1 interferes with lipopolysaccharide-induced toll-like receptor 4 signaling and limits brain damage due to exaggerated microglial reactivity following acute NMDA injury.	Univ Laval, Mol Endocrinol Lab, CHUL Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Dept Anat & Physiol, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Rivest, S (corresponding author), Univ Laval, Mol Endocrinol Lab, CHUL Res Ctr, 2705 Boul Laurier, Quebec City, PQ G1V 4G2, Canada.			Rivest, Serge/0000-0002-6082-770X				Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; Nadeau S, 2002, J IMMUNOL, V169, P3370, DOI 10.4049/jimmunol.169.6.3370; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Schilling D, 2002, J IMMUNOL, V169, P5874, DOI 10.4049/jimmunol.169.10.5874; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; TURRIN NP, 2006, IN PRESS J NEUROSCI; Vallieres L, 2003, J NEUROSCI, V23, P5197	13	19	20	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 5	2006	49	1					4	8		10.1016/j.neuron.2005.12.004	http://dx.doi.org/10.1016/j.neuron.2005.12.004			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387633	Bronze			2022-12-28	WOS:000236699300003
J	MacLean, JN; Watson, BO; Aaron, GB; Yuste, R				MacLean, JN; Watson, BO; Aaron, GB; Yuste, R			Internal dynamics determine the cortical response to thalamic stimulation	NEURON			English	Article							CAT VISUAL-CORTEX; MEMBRANE-POTENTIAL FLUCTUATIONS; RAT SOMATOSENSORY CORTEX; BARREL CORTEX; SPINY STELLATE; SYNAPTIC CONNECTIONS; RECURRENT ACTIVITY; LAYER 4; NEURONS; CELLS	Although spontaneous activity occurs throughout the neocortex, its relation to the activity produced by external or sensory inputs remains unclear. To address this, we used calcium imaging of mouse thalamocortical slices to reconstruct, with single-cell resolution, the spatiotemporal dynamics of activity of layer 4 in the presence or absence of thalamic stimulation. We found spontaneous neuronal coactivations corresponded to intracellular UP states. Thalamic stimulation of sufficient frequency (>10 Hz) triggered cortical activity, and UP states, indistinguishable from those arising spontaneously. Moreover, neurons were activated in identical and precise spatiotemporal patterns in thalamically triggered and spontaneous events. The similarities between cortical activations indicate that intracortical connectivity plays the dominant role in the cortical response to thalamic inputs. Our data demonstrate that precise spatiotemporal activity patterns can be triggered by thalamic inputs and indicate that the thalamus serves to release intrinsic cortical dynamics.	Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute	MacLean, JN (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA.	jm2107@columbia.edu	Watson, Brendon/GON-4927-2022	MacLean, Jason/0000-0002-8021-8063				Abeles M., 1991, CORTICONICS; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Beierlein M, 2002, J NEUROSCI, V22, P9885; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FERSTER D, 1992, PROG BRAIN RES, V90, P423; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Fregnac Y, 1996, J PHYSIOL-PARIS, V90, P113, DOI 10.1016/S0928-4257(97)81412-X; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Llinas R., 2002, I VORTEX NEURONS SEL; MACLEAN JN, 2004, LOADING ACUTE BRAIN; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; Varga C, 2002, J NEUROSCI, V22, P6186; Wilson CJ, 1996, J NEUROSCI, V16, P2397; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	45	284	285	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					811	823		10.1016/j.neuron.2005.09.035	http://dx.doi.org/10.1016/j.neuron.2005.09.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337918	Bronze			2022-12-28	WOS:000233927300019
J	Butt, SJB; Fuccillo, M; Nery, S; Noctor, S; Kriegstein, A; Corbin, JG; Fishell, G				Butt, SJB; Fuccillo, M; Nery, S; Noctor, S; Kriegstein, A; Corbin, JG; Fishell, G			The temporal and spatial origins of cortical interneurons predict their physiological subtype	NEURON			English	Article							MEDIAL GANGLIONIC EMINENCE; GABAERGIC CELL SUBTYPES; DOUBLE BOUQUET CELLS; MORPHOLOGICAL-CHARACTERISTICS; PYRAMIDAL CELLS; VISUAL-CORTEX; BRAIN-SLICES; NEURONS; EXPRESSION; DIVERSITY	Interneurons of the cerebral cortex represent a heterogeneous population of cells with important roles in network function. At present, little is known about how these neurons are specified in the developing telencephalon. To explore whether this diversity is established in the early progenitor populations, we conducted in utero fate-mapping of the mouse medial and caudal ganglionic eminences (MGE and CGE, respectively), from which most cortical interneurons arise. Mature interneuron subtypes were assessed by electrophysiological and immunological analysis, as well as by morphological reconstruction. At E13.5, the MGE gives rise to fast-spiking (FS) interneurons, whereas the CGE generates predominantly regular-spiking interneurons (RSNP). Later at E15.5, the CGE produces RSNP classes distinct from those generated from the E13.5 CGE. Thus, we provide evidence that the spatial and temporal origin of interneuron precursors in the developing telencephalic eminences predicts the intrinsic physiological properties of mature interneurons.	NYU, Med Ctr, Dev Gen Program, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	New York University; New York University; Columbia University; Columbia University	Fishell, G (corresponding author), NYU, Med Ctr, Dev Gen Program, 550 1St Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu	Butt, Simon/I-2689-2019; Nery, Susana Vaz/P-4518-2014	Butt, Simon/0000-0002-2399-0102; Fishell, Gordon/0000-0002-9640-9278; Fuccillo, Marc/0000-0002-6569-706X; Vaz Nery, Susana/0000-0002-2399-7785				Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Anderson SA, 2001, DEVELOPMENT, V128, P353; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Chow A, 1999, J NEUROSCI, V19, P9332; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Dodt HU, 1998, HISTOCHEM J, V30, P141, DOI 10.1023/A:1003291218707; Du J, 1996, J NEUROSCI, V16, P506; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Peters A, 1997, J NEUROCYTOL, V26, P779, DOI 10.1023/A:1018518515982; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Sharma K, 2001, NEURON, V29, P321, DOI 10.1016/S0896-6273(01)00208-2; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; SOMOGYI P, 1981, J COMP NEUROL, V195, P547, DOI 10.1002/cne.901950402; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sussel L, 1999, DEVELOPMENT, V126, P3359; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	48	412	417	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					591	604		10.1016/j.neuron.2005.09.034	http://dx.doi.org/10.1016/j.neuron.2005.09.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301176	Bronze			2022-12-28	WOS:000233677300013
J	Snyder, SH				Snyder, SH			Neuroscience at Johns Hopkins	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; NITRIC-OXIDE SYNTHASE; LONG-TERM DEPRESSION; HUMAN COLOR-VISION; BEHAVIORAL ABNORMALITIES; SOMATOSENSORY CORTEX; SYMPATHETIC NEURONS; INTERACTING PROTEIN; MOLECULAR-GENETICS; MYASTHENIA-GRAVIS		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			NIDA NIH HHS [DA00074, DA000266] Funding Source: Medline; NIMH NIH HHS [MH18501] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel JJ, 1926, P NATL ACAD SCI USA, V12, P132, DOI 10.1073/pnas.12.2.132; ABEL JJ, 1897, T ASSOC AM PHYSICIAN, V12, P461; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; BODIAN D, 1966, SCIENCE, V151, P1093, DOI 10.1126/science.151.3714.1093; BODIAN D, 1955, SCIENCE, V122, P105, DOI 10.1126/science.122.3159.105; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; Cushing H, 1909, J AMER MED ASSOC, V53, P249; Dandy WE, 1918, ANN SURG, V68, P5, DOI 10.1097/00000658-191807000-00002; Dandy WE, 1913, J AMER MED ASSOC, V61, P2216, DOI 10.1001/jama.1913.04350260014006; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; Fitzgerald PJ, 2004, J NEUROSCI, V24, P11193, DOI 10.1523/JNEUROSCI.3481-04.2004; GAY L, 1949, T ASSOC AM PHYSICIAN, V52, P196; GEY GO, 1952, CANCER RES, V12, P264; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Harrison RG, 1907, P SOC EXP BIOL MED, V4, P140; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KUFFLER SW, 1952, COLD SPRING HARB SYM, V17, P281, DOI 10.1101/SQB.1952.017.01.026; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LASAGNA L, 1954, J PHARMACOL EXP THER, V112, P356; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; LOGAN WJ, 1971, NATURE, V234, P297, DOI 10.1038/234297b0; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Marshall WH, 1937, SCIENCE, V85, P388, DOI 10.1126/science.85.2207.388; Meyer A., 1915, JAMA-J AM MED ASSOC, V65, P860; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; NUCLFORA FC, 2001, SCIENCE, V291, P2423; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; PERT CB, 1973, SCIENCE, V179, P1011, DOI 10.1126/science.179.4077.1011; PETERHANS E, 1991, TRENDS NEUROSCI, V14, P112, DOI 10.1016/0166-2236(91)90072-3; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Richter CP, 1938, AM J PHYSIOL, V122, P734, DOI 10.1152/ajplegacy.1938.122.3.734; RICHTER CP, 1960, P NATL ACAD SCI USA, V46, P1506, DOI 10.1073/pnas.46.11.1506; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; SACHS MB, 1980, J ACOUST SOC AM, V68, P858, DOI 10.1121/1.384825; Snyder SH, 2002, ARCH GEN PSYCHIAT, V59, P983, DOI 10.1001/archpsyc.59.11.983; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TOYKA KV, 1977, NEW ENGL J MED, V296, P125, DOI 10.1056/NEJM197701202960301; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; WAGNER HN, 1983, SCIENCE, V221, P1264, DOI 10.1126/science.6604315; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wong DT, 2005, NAT REV DRUG DISCOV, V4, P764, DOI 10.1038/nrd1821; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Young R, 2003, WA SCI TECHNOL, V3, P255, DOI 10.2166/ws.2003.0034; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	78	2	2	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					201	211		10.1016/j.neuron.2005.10.005	http://dx.doi.org/10.1016/j.neuron.2005.10.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242401	Bronze			2022-12-28	WOS:000232838700010
J	Tiedge, H				Tiedge, H			RNA reigns in neurons	NEURON			English	News Item							SPINAL MUSCULAR-ATROPHY; FRAGILE-X-SYNDROME; MESSENGER-RNA; TRANSLATION; AXONS; LOCALIZATION; TRAFFICKING; TRANSPORT	A workshop entitled "RNA Control of Neuronal Function" was recently held in Kfar Blum, Israel. The main topics discussed at the meeting included neuronal RNA targeting mechanisms and the contributing codes and components, translational control mechanisms in dendrites and axons, and the relevance of these mechanisms for neuronal development, plasticity, and dysfunction.	SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Tiedge, H (corresponding author), SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	htiedge@downstate.edu			NINDS NIH HHS [R01 NS046769] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046769] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Muslimov IA, 2002, J NEUROSCI, V22, P4293, DOI 10.1523/JNEUROSCI.22-11-04293.2002; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Smith R, 2004, NEUROSCIENTIST, V10, P495, DOI 10.1177/1073858404266759; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005	19	11	13	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 6	2005	48	1					13	16		10.1016/j.neuron.2005.09.002	http://dx.doi.org/10.1016/j.neuron.2005.09.002			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16273717	Green Accepted, Bronze			2022-12-28	WOS:000232625700005
J	Lu, W; Ziff, EB				Lu, W; Ziff, EB			PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking	NEURON			English	Article							LONG-TERM DEPRESSION; KINASE-C-ALPHA; DOMAIN-CONTAINING PROTEINS; BINDING-PROTEIN; HIPPOCAMPAL-NEURONS; DIFFERENTIAL PALMITOYLATION; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; SUBUNIT	PICK1 and ABP/GRIP bind to the AMPA receptor (AMPAR) GluR2 subunit C terminus. Transfer of the receptor from ABP/GRIP to PICK1, facilitated by GluR2 S880 phosphorylation, may initiate receptor trafficking. Here we report protein interactions that regulate these steps. The PICK1 BAR domain interacts intermolecularly with the ABP/GRIP linker 11 region and intramolecularly with the PICK1 PDZ domain. Binding of PKC alpha or GluR2 to the PICK1 PDZ domain disrupts the intramolecular interaction and facilitates the PICK1 BAR domain association with ABP/GRIP. Interference with the PICK1-ABP/GRIP interaction impairs S880 phosphorylation of GluR2 by PKC and decreases the constitutive surface expression of GluR2, the NMDA-induced endocytosis of GluR2, and recycling of internalized GluR2. We suggest that the PICK1 interaction with ABP/GRIP is a critical step in controlling GluR2 trafficking.	NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University; New York University	Ziff, EB (corresponding author), NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA.	edward.ziff@med.nyu.edu	Lu, Wei/E-8110-2011; Lu, Wei/S-5617-2018	Lu, Wei/0000-0001-6668-8432; Ziff, Edward/0000-0001-7389-8649	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067229] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fu J, 2003, J NEUROSCI, V23, P7592; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yamazaki M, 2001, NEUROSCI LETT, V304, P81, DOI 10.1016/S0304-3940(01)01766-9	49	174	191	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					407	421		10.1016/j.neuron.2005.07.006	http://dx.doi.org/10.1016/j.neuron.2005.07.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055064	Bronze			2022-12-28	WOS:000231051900011
J	Bamji, SX				Bamji, SX			Cadherins: Actin with the cytoskeleton to form synapses	NEURON			English	Review							N-CADHERIN; REDISTRIBUTION; NEUROLIGIN; ADHESION; PROTEINS; CATENIN; SYNCAM	Classic cadherins are calcium-dependent homophilic cell adhesion molecules that are enriched at synapses and thought to function in target recognition and adhesion at synaptic junctions. This brief review highlights evidence that cadherins and their associated catenins play a role in directing the development of pre- and postsynaptic specializations. In particular, the question of whether cadherin regulation of the actin cytoskeleton at discrete contact sites translates into the assembly of synaptic compartments will be explored.	Univ British Columbia, Brain Res Ctr, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Bamji, SX (corresponding author), Univ British Columbia, Brain Res Ctr, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	sbamji@itsa.ucsf.edu						Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benson DL, 1998, J NEUROSCI, V18, P6892; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Goodwin M, 2004, J MOL HISTOL, V35, P839, DOI 10.1007/s10735-004-1833-2; Hering H, 2003, J NEUROSCI, V23, P11759; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Lippman J, 2005, J NEUROBIOL, V64, P47, DOI 10.1002/neu.20149; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	29	50	53	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					175	178		10.1016/j.neuron.2005.06.024	http://dx.doi.org/10.1016/j.neuron.2005.06.024			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039559	Bronze			2022-12-28	WOS:000230693900004
J	Glascher, J; Buchel, C; Nord, N				Glascher, J; Buchel, C; Nord, N			Formal learning theory dissociates brain regions with different temporal integration	NEURON			English	Article							SKIN-CONDUCTANCE RESPONSES; HUMAN AMYGDALA; NEURAL SUBSTRATE; VENTRAL STRIATUM; FUNCTIONAL MRI; FEAR; ACTIVATION; PREDICTION; EMOTION; MODELS	Learning can be characterized as the extraction of reliable predictions about stimulus occurrences from past experience. In two experiments, we investigated the interval of temporal integration of previous learning trials in different brain regions using implicit and explicit Pavlovian fear conditioning with a dynamically changing reinforcement regime in an experimental setting. With formal learning theory (the Rescorla-Wagner model), temporal integration is characterized by the learning rate. Using fMRI and this theoretical framework, we are able to distinguish between learning-related brain regions that show long temporal integration (e.g., amygdala) and higher perceptual regions that integrate only over a short period of time (e.g., fusiform face area, parahippocampal place area). This approach allows for the investigation of learning-related changes in brain activation, as it can dissociate brain areas that differ with respect to their integration of past learning experiences by either computing long-term outcome predictions or instantaneous reinforcement expectancies.	Univ Hamburg, Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Glascher, J (corresponding author), Univ Hamburg, Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Martinistr 52, D-20246 Hamburg, Germany.	glaescher@uke.uni-hamburg.de	Gläscher, Jan/H-2930-2019	Gläscher, Jan/0000-0002-1020-7115				Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carter RM, 2003, P NATL ACAD SCI USA, V100, P1399, DOI 10.1073/pnas.0334049100; Cheng DT, 2003, BEHAV NEUROSCI, V117, P3, DOI 10.1037/0735-7044.117.1.3; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dayan P, 2001, COMPUTATIONAL NEUROS; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Ekman P., 1976, PICTURES FACIAL AFFE; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; ESTEVES F, 1994, PSYCHOPHYSIOLOGY, V31, P375, DOI 10.1111/j.1469-8986.1994.tb02446.x; Falls William A., 1995, P177; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glascher J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-45; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Knight DC, 2003, P NATL ACAD SCI USA, V100, P15280, DOI 10.1073/pnas.2535780100; Knight DC, 1999, NEUROREPORT, V10, P3665, DOI 10.1097/00001756-199911260-00037; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MILLER RR, 1995, PSYCHOL BULL, V117, P363, DOI 10.1037/0033-2909.117.3.363; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pizzella V, 1999, NEUROREPORT, V10, P3809, DOI 10.1097/00001756-199912160-00016; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vogel EH, 2004, BRAIN RES BULL, V63, P173, DOI 10.1016/j.brainresbull.2004.01.005; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; WOLTER J, 1993, INTEGR PHYS BEH SCI, V28, P163, DOI 10.1007/BF02691221; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	54	49	49	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					295	306		10.1016/j.neuron.2005.06.008	http://dx.doi.org/10.1016/j.neuron.2005.06.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039570	Bronze			2022-12-28	WOS:000230693900015
J	Ruthazer, ES				Ruthazer, ES			You're perfect, now change - Redefining the role of developmental plasticity	NEURON			English	Review							PRIMARY VISUAL-CORTEX; CRITICAL-PERIOD; COLUMNS; XENOPUS; MAP; EXPERIENCE; CELLS	The receptive field properties of neurons in the developing brain can in many cases be remarkably similar to those of adult neurons. This raises the question of why these same neurons need the capacity for such impressive developmental plasticity, most clearly demonstrated by the rewiring that occurs in response to sensory deprivation. The roles of developmental neuronal plasticity in the assimilation of neurons into a larger network, including temporal and cross-modal integration, are discussed.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Ruthazer, ES (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	edward.ruthazer@mcgill.ca	Ruthazer, Edward S/P-5935-2014; Ruthazer, Edward/H-4782-2019	Ruthazer, Edward S/0000-0003-0452-3151; Ruthazer, Edward/0000-0003-0452-3151				Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Lee LJ, 2005, J NEUROSCI, V25, P2304, DOI 10.1523/JNEUROSCI.4902-04.2005; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Udin SB, 1999, PROG NEUROBIOL, V59, P81, DOI 10.1016/S0301-0082(98)00096-3	17	14	14	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 24	2005	45	6					825	828		10.1016/j.neuron.2005.03.008	http://dx.doi.org/10.1016/j.neuron.2005.03.008			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797544	Bronze			2022-12-28	WOS:000228031300004
J	Tadin, D; Blake, R				Tadin, D; Blake, R			Motion perception getting better with age?	NEURON			English	Editorial Material								Older people can discriminate visual motion of large, high-contrast stimuli better than young adults. This surprising result, reported by Betts et al. in this issue of Neuron, suggests weaker center-surround antagonism in senescence, perhaps attributable to age-related reduction in GABA-mediated inhibition.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University	Tadin, D (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA.			Tadin, Duje/0000-0003-1571-5589				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; BALL K, 1986, J GERONTOL, V41, P176, DOI 10.1093/geronj/41.2.176; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; PACK CC, 2005, IN PRESS NEUROPHYSIO; Sekuler R., 2000, OXFORD TXB GERIATRIC, P874; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; TADIN D, 2005, IN PRESS SEEING SPAT; Wist ER, 2000, EXP BRAIN RES, V134, P295, DOI 10.1007/s002210000466	10	23	23	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 3	2005	45	3					325	327		10.1016/j.neuron.2005.01.017	http://dx.doi.org/10.1016/j.neuron.2005.01.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694315	Bronze			2022-12-28	WOS:000226787700001
J	Paulus, W				Paulus, W			Toward establishing a therapeutic window for rTMS by theta burst stimulation	NEURON			English	Editorial Material							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; FREQUENCY; PLASTICITY; HUMANS	In this issue of Neuron, Huang et al. show that a version of the classic theta burst stimulation protocol used to induce LTP/LTD in brain slices can be adapted to a transcranial magnetic stimulation (TMS) protocol to rapidly produce long lasting (up to an hour), reversible effects on motor cortex physiology and behavior. These results may have important implications for the development of clinical applications of rTMS in the treatment of depression, epilepsy, Parkinson's, and other diseases.	Univ Gottingen, Dept Clin Neurophysiol, D-37075 Gottingen, Germany	University of Gottingen	Paulus, W (corresponding author), Univ Gottingen, Dept Clin Neurophysiol, D-37075 Gottingen, Germany.		Paulus, Walter/A-3544-2009	Paulus, Walter/0000-0001-5549-8377				Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iyer MB, 2003, J NEUROSCI, V23, P10867; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Nitsche MA, 2004, CEREB CORTEX, V14, P1240, DOI 10.1093/cercor/bhh085; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Tergau F, 1999, LANCET, V353, P2209, DOI 10.1016/S0140-6736(99)01301-X; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002	11	49	64	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 20	2005	45	2					181	183		10.1016/j.neuron.2005.01.008	http://dx.doi.org/10.1016/j.neuron.2005.01.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664167	Bronze			2022-12-28	WOS:000226451500002
J	O'Doherty, JP; Buchanan, TW; Seymour, B; Dolan, RJ				O'Doherty, JP; Buchanan, TW; Seymour, B; Dolan, RJ			Predictive neural coding of reward preference involves dissociable responses in human ventral midbrain and ventral striatum	NEURON			English	Article							TEMPORAL DIFFERENCE MODELS; ACTIVATION; FMRI	Food preferences are acquired through experience and can exert strong influence on choice behavior. In order to choose which food to consume, it is necessary to maintain a predictive representation of the subjective value of the associated food stimulus. Here, we explore the neural mechanisms by which such predictive representations are learned through classical conditioning. Human subjects were scanned using fMRI while learning associations between arbitrary visual stimuli and subsequent delivery of one of five different food flavors. Using a temporal difference algorithm to model learning, we found predictive responses in the ventral midbrain and a part of ventral striatum (ventral putamen) that were related directly to subjects' actual behavioral preferences. These brain structures demonstrated divergent response profiles, with the ventral midbrain showing a linear response profile with preference, and the ventral striatum a bivalent response. These results provide insight into the neural mechanisms underlying human preference behavior.	UCL, Wellcome Dept Imaging Neurosci, Inst Neurol, London WC1N 3BG, England; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of London; University College London; California Institute of Technology; University of Iowa	O'Doherty, JP (corresponding author), UCL, Wellcome Dept Imaging Neurosci, Inst Neurol, 12 Queen Sq, London WC1N 3BG, England.	jdoherty@hss.caltech.edu	O'Doherty, John P/F-1204-2013	Dolan, Ray/0000-0001-9356-761X; Seymour, Ben/0000-0003-1724-5832; Buchanan, Tony/0000-0002-9166-8457	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Cox SML, 2005, J NEUROSCI, V25, P2733, DOI 10.1523/JNEUROSCI.3360-04.2005; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Duvernoy HM, 1999, HUMAN BRAIN; GORN GJ, 1982, J MARKETING, V46, P94, DOI 10.2307/1251163; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Karachi C, 2002, J COMP NEUROL, V450, P122, DOI 10.1002/cne.10312; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wilkinson D, 2004, NAT REV NEUROSCI, V5, P67, DOI 10.1038/nrn1302	25	251	254	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					157	166		10.1016/j.neuron.2005.11.014	http://dx.doi.org/10.1016/j.neuron.2005.11.014			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387647	Bronze, Green Submitted			2022-12-28	WOS:000236699300017
J	Jo, YH; Chen, YJJ; Chua, SC; Talmage, DA; Role, LW				Jo, YH; Chen, YJJ; Chua, SC; Talmage, DA; Role, LW			Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit	NEURON			English	Article							CB1 CANNABINOID RECEPTOR; LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE; ENDOGENOUS CANNABINOIDS; FOOD-INTAKE; HYPOTHALAMIC CONTROL; ENERGY-BALANCE; REPORTER GENE; SR 141716; IN-VITRO	Recently developed therapeutics for obesity, targeted against cannabinoid receptors, result in decreased appetite and sustained weight loss. Prior studies have demonstrated CB1 receptors (CB1 Rs) and leptin modulation of cannabinoid synthesis in hypothalamic neurons. Here, we show that depolarization of perifornical lateral hypothalamus (LH) neurons elicits a CB1R-mediated suppression of inhibition in local circuits thought to be involved in appetite and "natural reward." The depolarization-induced decrease in inhibitory tone to LH neurons is blocked by leptin. Leptin inhibits voltage-gated calcium channels in LH neurons via the activation of janus kinase 2 (JAK2) and of mitogen-activated protein kinase (MAPK). Leptin-deficient mice are characterized by both an increase in steady-state voltage-gated calcium currents in LH neurons and a CB1R-mediated depolarization-induced suppression of inhibition that is 6-fold longer than that in littermate controls. Our data provide direct electrophysiological support for the involvement of endocannabinoids and leptin as modulators of hypothalamic circuits underlying motivational aspects of feeding behavior.	Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA.	yjo@aecom.yu.edu	Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X; Jo, Young-Hwan/0000-0001-6939-8000; Talmage, David/0000-0003-4627-3007	NATIONAL CANCER INSTITUTE [R01CA079737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022061] Funding Source: NIH RePORTER; NCI NIH HHS [CA79737] Funding Source: Medline; NIDDK NIH HHS [DK57621, R01 DK057621] Funding Source: Medline; NINDS NIH HHS [R01 NS022061, NS22061, R01 NS022061-22, R01 NS022061-21, R01 NS022061-23] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Broberger C, 1998, J COMP NEUROL, V402, P460; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cvetkovic V, 2003, NEUROSCIENCE, V116, P31, DOI 10.1016/S0306-4522(02)00557-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Funahashi H, 1999, NEUROSCI LETT, V264, P117, DOI 10.1016/S0304-3940(99)00186-X; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Gao XB, 2003, J NEUROPHYSIOL, V90, P3978, DOI 10.1152/jn.00593.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Hao SZ, 2000, EUR J PHARMACOL, V392, P147, DOI 10.1016/S0014-2999(00)00059-5; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Isokawa M, 2005, J PHYSIOL-LONDON, V567, P1001, DOI 10.1113/jphysiol.2005.094219; Jo YH, 2005, J NEUROSCI, V25, P11133, DOI 10.1523/JNEUROSCI.3638-05.2005; Jo YH, 2002, J NEUROPHYSIOL, V88, P2501, DOI 10.1152/jn.00352.2002; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kim J, 2002, J NEUROSCI, V22, P10182; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Ladyman SR, 2004, ENDOCRINOLOGY, V145, P3704, DOI 10.1210/en.2004-0338; Lawrence CB, 1999, CURR OPIN NEUROBIOL, V9, P778, DOI 10.1016/S0959-4388(99)00032-X; Lee JW, 2003, EXP BIOL MED, V228, P175, DOI 10.1177/153537020322800207; Maccarrone M, 2003, J BIOL CHEM, V278, P13318, DOI 10.1074/jbc.M211248200; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Williams CM, 2002, PHYSIOL BEHAV, V76, P241, DOI 10.1016/S0031-9384(02)00725-4; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	55	178	181	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1055	1066		10.1016/j.neuron.2005.10.021	http://dx.doi.org/10.1016/j.neuron.2005.10.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364907	Bronze, Green Accepted			2022-12-28	WOS:000234301700019
J	Witten, IB; Knudsen, EI				Witten, IB; Knudsen, EI			Why seeing is believing: Merging auditory and visual worlds	NEURON			English	Review							SUPERIOR COLLICULUS; MULTISENSORY INTEGRATION; SPACE MAP; BARN OWL; LOCALIZATION PATHWAY; INFERIOR COLLICULUS; POPULATION CODES; CUE COMBINATION; OPTIC TECTUM; VENTRILOQUISM	Vision may dominate our perception of space not because of any inherent physiological advantage of visual over other sensory connections in the brain, but because visual information tends to be more reliable than other sources of spatial information, and the central nervous system integrates information in a statistically optimal fashion. This review discusses recent experiments on audiovisual integration that support this hypothesis. We consider candidate neural codes that would enable optimal integration and the implications of optimal integration for perception and plasticity.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	Witten, IB (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	iwitten@stanford.edu						Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; Aschersleben G, 2003, INT J PSYCHOPHYSIOL, V50, P157, DOI 10.1016/S0167-8760(03)00131-4; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; CANON LK, 1970, J EXP PSYCHOL, V84, P141, DOI 10.1037/h0028925; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; COCHRAN W. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P102; DeBello WM, 2004, J NEUROSCI, V24, P6853, DOI 10.1523/JNEUROSCI.0480-04.2004; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Feldman DE, 1997, J NEUROSCI, V17, P6820; Gutfreund Y, 2002, SCIENCE, V297, P1556, DOI 10.1126/science.1073712; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HWOARD IP, 1966, HUMAN SPATIAL ORIENT; Hyde PS, 2000, J COMP NEUROL, V421, P146, DOI 10.1002/(SICI)1096-9861(20000529)421:2<146::AID-CNE2>3.0.CO;2-5; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; King AJ, 2004, CURR BIOL, V14, pR335, DOI 10.1016/j.cub.2004.04.018; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; KNILL DC, 1996, PECEPTION BEYESIAN I; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; Landy MS, 2001, J OPT SOC AM A, V18, P2307, DOI 10.1364/JOSAA.18.002307; Lewald J, 2002, LEARN MEMORY, V9, P268, DOI 10.1101/lm.51402; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Populin LC, 2002, J NEUROSCI, V22, P2826, DOI 10.1523/JNEUROSCI.22-07-02826.2002; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; RADEAU M, 1974, Q J EXP PSYCHOL, V26, P63, DOI 10.1080/14640747408400388; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Rice JA, 1988, MATH STAT DATA ANAL; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stein BE., 1993, MERGING SENSES; WALLACE MT, 1992, EXP BRAIN RES, V91, P484; WARREN DH, 1981, PERCEPT PSYCHOPHYS, V30, P557, DOI 10.3758/BF03202010; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Woods TM, 2004, CURR BIOL, V14, P1559, DOI 10.1016/j.cub.2004.08.059; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	52	113	114	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					489	496		10.1016/j.neuron.2005.10.020	http://dx.doi.org/10.1016/j.neuron.2005.10.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269365	Bronze			2022-12-28	WOS:000233250100009
J	Shmuelof, L; Zohary, E				Shmuelof, L; Zohary, E			Dissociation between ventral and dorsal fMRl activation during object and action recognition	NEURON			English	Article							FUNCTIONAL-PROPERTIES; CORTEX; PERCEPTION; ANTERIOR; AREAS; REPRESENTATION; ORGANIZATION; MECHANISMS; IMITATION; PATHWAYS	Neuropsychological case studies suggest the existence of two functionally separate visual streams: the ventral pathway, central for object recognition; and the dorsal pathway, engaged in visually guided actions. However, a clear dissociation between the functions of the two streams has not been decisively shown in intact humans. In this study, we demonstrate dissociation between dorsal and ventral fMRI activation patterns during observation of object manipulation video clips. Parietal areas, such as anterior intraparietal sulcus (aIPS) display grasp viewing-dependent adaptation (i.e., fMR adaptation during repeated viewing of the same object-grasping movement) as well as a contralateral preference for the viewed manipulating hand. Ventral regions, such as the fusiform gyrus, show similar characteristics (i.e., adaptation, contralateral preference), but these depend on object identity. Our results support the hypothesized functional specialization in the visual system and suggest that parietal areas (such as aIPS) are engaged in action recognition, as well as in action planning.	Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Zohary, E (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel.	udiz@lobster.ls.huji.ac.il						AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; LEICHT R, 1977, EXP BRAIN RES, V27, P479; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; MOUNTCASTLE VB, 1981, J NEUROSCI, V1, P1218; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Nitschke MF, 1996, BRAIN, V119, P1023; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405	28	168	172	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					457	470		10.1016/j.neuron.2005.06.034	http://dx.doi.org/10.1016/j.neuron.2005.06.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055068	Bronze			2022-12-28	WOS:000231051900015
J	Ransohoff, RM; Trapp, BD				Ransohoff, RM; Trapp, BD			Taking two TRAILS	NEURON			English	Editorial Material							APOPTOSIS-INDUCING LIGAND; MULTIPLE-SCLEROSIS; DISEASE		Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Ransohoff, RM (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Bradl M, 2003, J NEUROL NEUROSUR PS, V74, P1364, DOI 10.1136/jnnp.74.10.1364; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Hilliard B, 2001, J IMMUNOL, V166, P1314, DOI 10.4049/jimmunol.166.2.1314; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Ransohoff RM, 2002, TRENDS IMMUNOL, V23, P512, DOI 10.1016/S1471-4906(02)02321-9; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Waxman SG, 2005, BRAIN, V128, P5, DOI 10.1093/brain/awh353	12	8	8	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					355	356		10.1016/j.neuron.2005.04.028	http://dx.doi.org/10.1016/j.neuron.2005.04.028			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882629	Bronze			2022-12-28	WOS:000229011400001
J	Van Raay, TJ; Moore, KB; Iordanova, I; Steele, M; Jamrich, M; Harris, WA; Vetter, ML				Van Raay, TJ; Moore, KB; Iordanova, I; Steele, M; Jamrich, M; Harris, WA; Vetter, ML			Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; CELL-DIFFERENTIATION; STEM-CELLS; TRANSCRIPTION FACTORS; VERTEBRATE RETINA; EYE DEVELOPMENT; LENS INDUCTION; HOMEOBOX GENE; WNT-SIGNAL	Progenitors in the developing central nervous system acquire neural potential and proliferate to expand the pool of precursors competent to undergo neuronal differentiation. The formation and maintenance of neural-competent precursors are regulated by SoxB1 transcription factors, and evidence that their expression is regionally regulated suggests that specific signals regulate neural potential in subdomains of the developing nervous system. We show that the frizzled (Fz) transmembrane receptor Xfz5 selectively governs neural potential in the developing Xenopus retina by regulating the expression of Sox2. Blocking either Xfz5 or canonical Writ signaling within the developing retina inhibits Sox2 expression, reduces cell proliferation, inhibits the onset of proneural gene expression, and biases individual progenitors toward a nonneural fate, without altering the expression of multiple progenitor markers. Blocking Sox2 function mimics these effects. Rescue experiments indicate that Sox2 is downstream of Xfz5. Thus, Fz signaling can regulate the neural potential of progenitors in the developing nervous system.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Utah System of Higher Education; University of Utah; University of Cambridge; Baylor College of Medicine; Baylor College of Medicine	Vetter, ML (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.	monica.vetter@neuro.utah.edu	Van Raay, Terry/AAA-7342-2021	Moore, Kathryn/0000-0002-6993-152X; Vetter, Monica/0000-0001-6262-8504; Van Raay, Terence/0000-0003-0196-1041	NEI NIH HHS [EY122074, R01 EY014954-03, R01 EY014954, EY14954] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014954] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BELECKYADAMS T, 1997, OPHTHALMOL VIS SCI, V38, P1298; Buescher M, 2002, DEVELOPMENT, V129, P4193; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Burns CJ, 2002, DEV DYNAM, V225, P536, DOI 10.1002/dvdy.10189; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fuhrmann S, 2003, GENE EXPR PATTERNS, V3, P659, DOI 10.1016/S1567-133X(03)00107-8; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Harris WA, 1998, INT J DEV BIOL, V42, P299; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HERMAN JP, 1993, DEV DYNAM, V197, P307, DOI 10.1002/aja.1001970408; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HUANG S, 1993, J NEUROSCI, V13, P3193; Hutcheson DA, 2002, METHODS, V28, P402, DOI 10.1016/S1046-2023(02)00259-1; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jin EJ, 2002, MECH DEVELOP, V116, P173, DOI 10.1016/S0925-4773(02)00128-4; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kishi M, 2000, DEVELOPMENT, V127, P791; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Levine EM, 2004, SEMIN CELL DEV BIOL, V15, P63, DOI 10.1016/j.semcdb.2003.09.001; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Overton PM, 2002, DEVELOPMENT, V129, P4219; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.0.CO;2-C; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sasai Y, 2001, INT J DEV BIOL, V45, P321; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Sumanas S, 2001, MECH DEVELOP, V103, P133, DOI 10.1016/S0925-4773(01)00327-6; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; VANRAAY T, 2004, IN PRESS DEV NEUROSC, V5, P367; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vetter ML, 2001, DEV DYNAM, V221, P146, DOI 10.1002/dvdy.1145; Zhang L, 2003, DEVELOPMENT, V130, P4177, DOI 10.1242/dev.00626; Zhou XL, 2000, MECH DEVELOP, V91, P327, DOI 10.1016/S0925-4773(99)00270-1; ZIMMERMAN K, 1993, DEVELOPMENT, V119, P221; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	76	138	145	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					23	36		10.1016/j.neuron.2005.02.023	http://dx.doi.org/10.1016/j.neuron.2005.02.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820691	Bronze			2022-12-28	WOS:000228228600006
J	Marie, H; Morishita, W; Yu, X; Calakos, N; Malenka, RC				Marie, H; Morishita, W; Yu, X; Calakos, N; Malenka, RC			Generation of silent synapses by acute in vivo expression of CaMKIV and CREB	NEURON			English	Article							LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; HIPPOCAMPAL SYNAPTIC PLASTICITY; AMPA RECEPTOR TRAFFICKING; KINASE TYPE IV/GR; TRANSCRIPTION FACTORS; DENDRITIC SPINES; DOPAMINE NEURONS; PYRAMIDAL CELLS; NEURAL ACTIVITY	The transcription factor CREB is critical for several forms of experience-dependent plasticity in a range of species and is commonly activated in neurons by calcium/calmodulin-dependent protein kinase IV (CaMKIV). Surprisingly, little is known about the neural circuit adaptations caused by activation of CaMKIV and CREB. Here, we use viral-mediated gene transfer in vivo to examine the consequences of acute expression of constitutively active forms of CaMKIV and CREB on synaptic function in the rodent hippocampus. Acute expression of active CaMKIV or CREB caused an enhancement of both NMDA receptor-mediated synaptic responses and long-term potentiation (LTP). This was accompanied by electrophysiological and morphological changes consistent with the generation of "silent synapses," which provide an ideal substrate for further experience-dependent modifications of neural circuitry and which may also be important for the consolidation of long-term synaptic plasticity and memories.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Marie, Hélène/F-1404-2011	Marie, Hélène/0000-0003-2310-6097	NIMH NIH HHS [MH63394] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, R37MH063394] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Balschun D, 2003, J NEUROSCI, V23, P6304; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gass P, 1998, LEARN MEMORY, V5, P274; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Murphy DD, 1997, P NATL ACAD SCI USA, V94, P1482, DOI 10.1073/pnas.94.4.1482; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; YUSTE R, 2000, IMAGING NEURONS LAB; Zhai R, 2000, MOL CELL NEUROSCI, V15, P417, DOI 10.1006/mcne.2000.0839; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	59	177	185	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					741	752		10.1016/j.neuron.2005.01.039	http://dx.doi.org/10.1016/j.neuron.2005.01.039			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748849	Bronze			2022-12-28	WOS:000227446700013
J	Mayberg, HS; Lozano, AM; Voon, V; McNeely, HE; Seminowicz, D; Hamani, C; Schwalb, JM; Kennedy, SH				Mayberg, HS; Lozano, AM; Voon, V; McNeely, HE; Seminowicz, D; Hamani, C; Schwalb, JM; Kennedy, SH			Deep brain stimulation for treatment-resistant depression	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; MAJOR DEPRESSION; PARKINSONS-DISEASE; PROJECTIONS; RECOVERY; NEUROBIOLOGY; PREDICTORS; METABOLISM; DIAGNOSIS; STRESS	Treatment-resistant depression is a severely disabling disorder with no proven treatment options once multiple medications, psychotherapy, and electroconvulsive therapy have failed. Based on our preliminary observation that the subgenual cingulate region (Brodmann area 25) is metabolically overactive in treatment resistant depression, we studied whether the application of chronic deep brain stimulation to modulate BA25 could reduce this elevated activity and produce clinical benefit in six patients with refractory depression. Chronic stimulation of white matter tracts adjacent to the subgenual cingulate gyrus was associated with a striking and sustained remission of depression in four of six patients. Antidepressant effects were associated with a marked reduction in local cerebral blood flow as well as changes in downstream limbic and cortical sites, measured using positron emission tomography. These results suggest that disrupting focal pathological activity in limbic-cortical circuits using electrical stimulation of the subgenual cingulate white matter can effectively reverse symptoms in otherwise treatment-resistant depression.	Univ Toronto, Baycrest Ctr, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Neurol, Toronto, ON M6A 2E1, Canada; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Univ Toronto, Toronto Western Hosp, Res Inst, Hlth Network, Toronto, ON M5P 2P2, Canada; Univ Toronto, Hlth Network, Div Neurosurg, Toronto, ON M5P 2P2, Canada; Univ Toronto, Hlth Network, Dept Psychiat, Toronto, ON M5P 2P2, Canada; Univ Toronto, Ctr Addict & Mental Hlth, Dept Psychiat, Neuropsychol Lab, Toronto, ON M5T 1R8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M6A 2E1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; Emory University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Mayberg, HS (corresponding author), Univ Toronto, Baycrest Ctr, Rotman Res Inst, Toronto, ON M6A 2E1, Canada.	hmayber@emory.edu; lozano@uhnres.utoronto.ca	Hamani, Clement/D-8889-2012; McNeely, Heather/AAU-2876-2021; Voon, Valerie/O-7038-2017; Seminowicz, David/F-8732-2015; Schwalb, Jason M./AAQ-4932-2021; Lozano, Andres M/A-5058-2012; kennedy, sidney/Q-1926-2016	Voon, Valerie/0000-0001-6790-1776; Seminowicz, David/0000-0003-3111-3756; Schwalb, Jason M./0000-0002-8714-161X; kennedy, sidney/0000-0001-5339-7185; Schlaepfer, Thomas/0000-0003-0612-9692; Lozano, Andres M./0000-0001-8257-3694				Abosch A, 2003, CAN J NEUROL SCI, V30, pS72, DOI 10.1017/S0317167100003279; [Anonymous], 2000, Am J Psychiatry, V157, P1; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Brody A L, 2001, Semin Clin Neuropsychiatry, V6, P102, DOI 10.1053/scnp.2001.21837; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Dalgleish T, 2004, AM J PSYCHIAT, V161, P1913, DOI 10.1176/appi.ajp.161.10.1913; Davis KD, 1997, NAT MED, V3, P671, DOI 10.1038/nm0697-671; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; First MB., 2001, CLIN INTERVIEW DSM I; FOX PT, 1984, J CEREBR BLOOD F MET, V4, P329, DOI 10.1038/jcbfm.1984.49; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Freedman LJ, 2000, J COMP NEUROL, V421, P172; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; Gabbott PLA, 1997, J COMP NEUROL, V381, P389, DOI 10.1002/(SICI)1096-9861(19970519)381:4<389::AID-CNE1>3.0.CO;2-Z; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Hyman SE, 1996, AM J PSYCHIAT, V153, P151; JURGENS U, 1977, EXP BRAIN RES, V29, P75; KARTSOUNIS LD, 1991, BRAIN, V114, P2657, DOI 10.1093/brain/114.6.2657; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kennedy SH, 2003, BIPOLAR DISORD, V5, P36, DOI 10.1111/j.1399-2406.2003.00058.x; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kumar R, 2003, NEUROLOGY, V61, P1601, DOI 10.1212/01.WNL.0000096012.07360.1C; *LANC UK ECT REV G, 2003, LANCET, V361, P799; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; LANG PJ, 1999, A4 IAPS CTR RES PSYC; Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; Malizia AL, 1997, J PSYCHOPHARMACOL, V11, P179, DOI 10.1177/026988119701100211; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mottaghy FM, 2002, PSYCHIAT RES-NEUROIM, V115, P1, DOI 10.1016/S0925-4927(02)00032-X; *NAT I MENT HLTH, 1970, MAN ECDEU ASS BATT, P2; Nemeroff Charles B, 2002, Psychopharmacol Bull, V36 Suppl 2, P6; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nobler MS, 2001, AM J PSYCHIAT, V158, P305, DOI 10.1176/appi.ajp.158.2.305; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Ongur D, 1998, J COMP NEUROL, V401, P480; Sackeim HA, 2001, NEUROPSYCHOPHARMACOL, V25, P713, DOI 10.1016/S0893-133X(01)00271-8; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Spreen O, 1998, COMPENDIUM NEUROPSYC; Thase ME, 1997, J CLIN PSYCHIAT, V58, P23; Vaidya VA, 2001, BRIT MED BULL, V57, P61, DOI 10.1093/bmb/57.1.61; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; *WHO, 2001, WORLD HLTH REP 2001, pCH2; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	65	2506	2627	21	485	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					651	660		10.1016/j.neuron.2005.02.014	http://dx.doi.org/10.1016/j.neuron.2005.02.014			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748841	Bronze			2022-12-28	WOS:000227446700005
J	Schoppa, NE				Schoppa, NE			Synchronization of olfactory bulb mitral cells by precisely timed inhibitory inputs	NEURON			English	Article							HIPPOCAMPUS IN-VITRO; GAP-JUNCTIONS; GAMMA-OSCILLATIONS; DENDRODENDRITIC INHIBITION; GABAERGIC INTERNEURONS; SYNAPTIC-INTERACTIONS; RECEPTOR ACTIVATION; NEURAL ASSEMBLIES; OUTPUT NEURONS; ODOR	Synchronized oscillatory activity at the gamma frequency (30-70 Hz) is thought to be important for information processing in many sensory systems. Here, I used patch-clamp recordings in neuron pairs in rat olfactory bulb slices to assess the mechanisms underlying such "gamma" activity in the olfactory system. Patterned electrical stimulation of afferents that mimicked a natural odor stimulus elicited rapidly synchronized spikes (lag <= 5 ms) in mitral cells, along with oscillatory activity at the gamma (similar to 50 Hz) frequency. Analysis of coupling potentials, combined with dendritic sectioning, indicated that mitral cell synchrony was mainly driven by inhibitory postsynaptic potentials (IPSPs) imposed by GABAergic granule cells. Recordings in granule cell pairs indicated that granule cells were themselves synchronized by their excitatory inputs from mitral cells, providing a means to coordinate GABA release. These results demonstrate that rapid synchrony can emerge in a network through the precise back-and-forth interplay between neuronal populations.	Univ Colorado, Dept Physiol & Biophys, Ctr Hlth Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Schoppa, NE (corresponding author), Univ Colorado, Dept Physiol & Biophys, Ctr Hlth Sci, Aurora, CO 80045 USA.	nathan.schoppa@uchsc.edu			NIDCD NIH HHS [DC006640] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006640] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bozza TC, 2001, CURR BIOL, V11, pR687, DOI 10.1016/S0960-9822(01)00409-2; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; Cang JH, 2003, J NEUROSCI, V23, P4108; Carlson GC, 2000, J NEUROSCI, V20, P2011; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Davison AP, 2003, J NEUROPHYSIOL, V90, P1921, DOI 10.1152/jn.00623.2002; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; FREEMAN WJ, 1972, J NEUROPHYSIOL, V35, P762, DOI 10.1152/jn.1972.35.6.762; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Khazipov R, 2003, J NEUROSCI, V23, P5337; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Migliore M, 2005, J COMPUT NEUROSCI, V18, P151, DOI 10.1007/s10827-005-6556-1; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; REYHER CKH, 1991, J NEUROSCI, V11, P1485; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	52	151	157	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					271	283		10.1016/j.neuron.2005.11.038	http://dx.doi.org/10.1016/j.neuron.2005.11.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423700	Bronze			2022-12-28	WOS:000234979900013
J	Shinza-Kameda, M; Takasu, E; Sakurai, K; Hayashi, S; Nose, A				Shinza-Kameda, M; Takasu, E; Sakurai, K; Hayashi, S; Nose, A			Regulation of layer-specific targeting by reciprocal expression of a cell adhesion molecule, capricious	NEURON			English	Article							AXON GUIDANCE; DROSOPHILA; MOTONEURONS; FLAMINGO; PROTEIN; LAR	Layer-specific innervation is a major form of synaptic targeting in the central nervous system. In the Drosophila visual system, photoreceptors R7 and R8 connect to targets in distinct layers of the medulla, a ganglion of the optic lobe. We show here that Capricious (CAPS), a transmembrane protein with leucine-rich repeats (LRRs), is a layer-specific cell adhesion molecule that regulates photoreceptor targeting in the medulla. During the period of photoreceptor targeting, caps is specifically expressed in R8 and its target layer but not in R7 or its recipient layer. caps loss-of-function mutations cause local targeting errors by R8 axons, including layer change. Conversely, ectopic expression of caps in R7 redirects R7 axons to terminate in the CAPS-positive R8 recipient layer. CAPS promotes homophilic cell adhesion in transfected S2 cells. These results suggest that CAPS regulates layer-specific targeting by mediating specific axon-target interaction.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Riken Ctr Dev Biol, Morphogenet Signaling Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Tokyo; University of Tokyo; RIKEN	Nose, A (corresponding author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	nose@phys.s.u-tokyo.ac.jp	Hayashi, Shigeo/N-5128-2015; Hayashi, Shigeo/J-9628-2019	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290; Makiko, Kameda/0000-0002-9867-3195				Abrell S, 2001, MECH DEVELOP, V109, P3, DOI 10.1016/S0925-4773(01)00511-1; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Butler SJ, 1997, DEVELOPMENT, V124, P781; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GARRITY PA, 1995, CELL, V83, P177, DOI 10.1016/0092-8674(95)90159-0; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; MEINERTZHAGEN IA, 1991, DEV DROSOPHILA MELAN, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Stowers RS, 1999, GENETICS, V152, P1631; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Sun Q, 2000, DEVELOPMENT, V127, P801; Taniguchi H, 2000, J NEUROBIOL, V42, P104, DOI 10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019	29	74	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					205	213		10.1016/j.neuron.2005.11.013	http://dx.doi.org/10.1016/j.neuron.2005.11.013			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423695	Bronze			2022-12-28	WOS:000234979900008
J	Helfrich-Forster, C				Helfrich-Forster, C			PDF has found its receptor	NEURON			English	Editorial Material							PIGMENT-DISPERSING FACTOR; DROSOPHILA-MELANOGASTER; CIRCADIAN CLOCK; NEUROPEPTIDE; NEURONS; RHYTHMS; GENE; SYSTEM; BRAIN; CELLS	The neuropeptide pigment-dispersing factor (PDF) is a crucial component of the insect circadian clock, but the identity of its receptor has long remained a mystery. In this issue of Neuron, three papers (Hyun et al., Lear et al., and Mertens et al.) identify the PDF receptor.	Univ Regensburg, Inst Zool, D-93040 Regensburg, Germany	University of Regensburg	Helfrich-Forster, C (corresponding author), Univ Regensburg, Inst Zool, Univ Str 31, D-93040 Regensburg, Germany.			Helfrich-Forster, Charlotte/0000-0002-0859-9092				Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HOMBERG U, 1991, CELL TISSUE RES, V266, P343, DOI 10.1007/BF00318190; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Schneider NL, 2005, J NEUROSCI, V25, P5138, DOI 10.1523/JNEUROSCI.5138-A-04.2005	13	10	10	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					161	163		10.1016/j.neuron.2005.10.004	http://dx.doi.org/10.1016/j.neuron.2005.10.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242393	Bronze			2022-12-28	WOS:000232838700002
J	Oesch, N; Euler, T; Taylor, WR				Oesch, N; Euler, T; Taylor, WR			Direction-selective dendritic action potentials in rabbit retina	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; GANGLION-CELLS; RECEPTIVE-FIELDS; CALCIUM SIGNALS; GRANULE CELLS; MITRAL CELLS; PROPAGATION; MECHANISMS; INHIBITION; INITIATION	Dendritic spikes that propagate toward the soma are well documented, but their physiological role remains uncertain. Our in vitro patch-clamp recordings and two-photon calcium imaging show that direction-selective retinal ganglion cells (DSGCs) utilize orthograde dendritic spikes during physiological activity. DSGCs signal the direction of image motion. Excitatory subthreshold postsynaptic potentials are observed in DSGCs for motion in all directions and provide a weakly tuned directional signal. However, spikes are generated over only a narrow range of motion angles, indicating that spike generation greatly enhances directional tuning. Our results indicate that spikes are initiated at multiple sites within the dendritic arbors of DSGCs and that each dendritic spike initiates a somatic spike. We propose that dendritic spike failure, produced by local inhibitory inputs, might be a critical factor that enhances directional tuning of somatic spikes.	Oregon Hlth Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Oregon Health & Science University; Max Planck Society	Taylor, WR (corresponding author), Oregon Hlth Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA.	taylorw@ohsu.edu		Taylor, William/0000-0002-6806-3249; Oesch, Nicholas/0000-0001-6972-0741; Euler, Thomas/0000-0002-4567-6966	NEI NIH HHS [EY014888] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014888] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; AMTHOR FR, 1991, VISUAL NEUROSCI, V6, P197, DOI 10.1017/S0952523800006210; AMTHOR FR, 1993, J NEUROPHYSIOL, V69, P2174, DOI 10.1152/jn.1993.69.6.2174; AMTHOR FR, 1984, BRAIN RES, V298, P187, DOI 10.1016/0006-8993(84)91167-3; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1948, DOI 10.1152/jn.1997.78.4.1948; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GRZYWACZ NM, 1990, BIOL CYBERN, V64, P41, DOI 10.1007/BF00203629; GRZYWACZ NM, 1994, VISUAL NEUROSCI, V11, P1019, DOI 10.1017/S0952523800003953; GRZYWACZ NM, 1987, SYNAPSE, V1, P417, DOI 10.1002/syn.890010506; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; He SG, 1999, J NEUROSCI, V19, P8049; Hidaka S, 2004, J NEUROSCI, V24, P10553, DOI 10.1523/JNEUROSCI.3319-04.2004; Hu EH, 2003, J NEUROSCI, V23, P6768; HUGUENARD J, 1998, P NATL ACAD SCI USA, V86, P2473; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; KASUGA A, 1993, NEUROSCIENCE, V118, P899; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; Lowe G, 2002, J NEUROPHYSIOL, V88, P64, DOI 10.1152/jn.2002.88.1.64; MACVICAR BA, 1982, J NEUROPHYSIOL, V47, P579, DOI 10.1152/jn.1982.47.4.579; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; Pinato G, 2005, J NEUROPHYSIOL, V93, P1285, DOI 10.1152/jn.00807.2004; POGGIO T, 1973, KYBERNETIK, V13, P223, DOI 10.1007/BF00274887; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; TURNER RW, 1989, J NEUROPHYSIOL, V62, P1375, DOI 10.1152/jn.1989.62.6.1375; TURNER RW, 1991, J NEUROSCI, V11, P2270; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; VANEY DI, 1994, J NEUROSCI, V14, P6301; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; WYATT HJ, 1975, J NEUROPHYSIOL, V38, P613, DOI 10.1152/jn.1975.38.3.613; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; YANG G, 1994, J NEUROSCI, V14, P5267; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920	64	113	114	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					739	750		10.1016/j.neuron.2005.06.036	http://dx.doi.org/10.1016/j.neuron.2005.06.036			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129402	Green Submitted, Bronze			2022-12-28	WOS:000231782700014
J	Hollenbeck, PJ				Hollenbeck, PJ			Mitochondria and neurotransmission: Evacuating the synapse	NEURON			English	Review							AXONAL-TRANSPORT; CA2+; TERMINALS; MOTILITY; RELEASE; PROTEIN; NEURONS; MILTON	An abundance of mitochondria has been the hallmark of synapses since their first ultrastructural description 50 years ago. Mitochondria have been shown to be essential for synaptic form and function in many systems, but until recently it has not been clear exactly what role(s) they play in neurotransmission. Now, evidence from the nervous system of Drosophila identifies the specific subcellular events that are most dependent upon nearby mitochondria.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hollenbeck, PJ (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	phollenb@purdue.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027073] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS027073-18, R01 NS027073] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barrett EF, 2001, J GEN PHYSIOL, V118, P79, DOI 10.1085/jgp.118.1.79; Brodin L, 1999, PHILOS T R SOC B, V354, P365, DOI 10.1098/rstb.1999.0388; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hollenbeck, 1996, FRONT BIOSCI, V1, pD91; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; Ohnuma K, 1999, BIOPHYS J, V76, P1819, DOI 10.1016/S0006-3495(99)77342-X; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ratner N, 1998, J NEUROSCI, V18, P7717; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; VALLEE RB, 1991, ANNU REV NEUROSCI, V14, P59, DOI 10.1146/annurev.ne.14.030191.000423; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018	22	79	81	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					331	333		10.1016/j.neuron.2005.07.017	http://dx.doi.org/10.1016/j.neuron.2005.07.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055057	Green Accepted, Bronze			2022-12-28	WOS:000231051900004
J	Pearson, RA; Dale, N; Llaudet, E; Mobbs, P				Pearson, RA; Dale, N; Llaudet, E; Mobbs, P			ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation	NEURON			English	Article							RECEPTOR-MEDIATED STIMULATION; VENTRICULAR ZONE; DEVELOPING NEOCORTEX; CALCIUM WAVES; DNA-SYNTHESIS; CELL-PROLIFERATION; PURINE RELEASE; ALBINO RETINA; CHICK RETINA; MULLER GLIA	The retinal pigment epithelium (RPE) plays an essential role in the normal development of the underlying neural retina, but the mechanisms by which this regulation occurs are largely unknown. Ca(2+) transients, induced by the neurotransmitter ATP acting on purinergic receptors, both increase proliferation and stimulate DNA synthesis in neural retinal progenitor cells. Here, we show that the RPE regulates proliferation in the underlying neural retina by the release of a soluble factor and identify that factor as ATP. Further, we show that this ATP is released by efflux through gap junction connexin 43 hemichannels, the opening of which is evoked by spontaneous elevations of Ca(2+) in trigger cells in the RPE. This release mechanism is localized within the RPE cells to the membranes facing the neural retina, a location ideally positioned to influence neural retinal development. ATP released from RPE hemichannels speeds both cell division and proliferation in the neural retina.	UCL, Dept Physiol, London WC1E 6BT, England; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Warwick	Pearson, RA (corresponding author), UCL, Inst Child Hlth, Dev Biol Unit, London WC1N 1EH, England.	rachael.pearson@ich.ucl.ac.uk	Dale, Nicholas/C-7772-2011; Pearson, Rachael/Y-3339-2018	Dale, Nicholas/0000-0003-2196-2949; Pearson, Rachael/0000-0002-1107-1969; Llaudet, Enrique/0000-0003-1136-0602	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams RJ, 1996, J NEUROSCI, V16, P7610; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Ballerini P, 1996, NEUROREPORT, V7, P2533, DOI 10.1097/00001756-199611040-00026; BECKER DL, 1995, J CELL SCI, V108, P1455; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bittman K, 1997, J NEUROSCI, V17, P7037; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Cai L, 1997, J NEUROSCI, V17, P2088; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; Ciccarelli R, 2000, GLIA, V29, P202, DOI 10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.3.CO;2-3; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cusato K, 2003, J NEUROSCI, V23, P6413; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fischer AJ, 2003, GLIA, V43, P70, DOI 10.1002/glia.10218; Frank C, 1999, J Sci Med Sport, V2, P190, DOI 10.1016/S1440-2440(99)80173-X; Gourine AV, 2005, J NEUROSCI, V25, P1211, DOI 10.1523/JNEUROSCI.3763-04.2005; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Ilia M, 1996, DEV BRAIN RES, V95, P176; Ilia M, 2000, J COMP NEUROL, V420, P437; Jeffery G, 1997, TRENDS NEUROSCI, V20, P165, DOI 10.1016/S0166-2236(96)10080-1; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Milenkovic I, 2003, INVEST OPHTH VIS SCI, V44, P1211, DOI 10.1167/iovs.02-0260; Moll V, 2002, INVEST OPHTH VIS SCI, V43, P766; Morita M, 2003, J NEUROSCI, V23, P10944; NEARY JT, 1994, NEUROREPORT, V5, P1617, DOI 10.1097/00001756-199408150-00019; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Pearson R, 2002, J NEUROSCI, V22, P7569; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Rachel RA, 2002, J NEUROSCI, V22, P4249, DOI 10.1523/JNEUROSCI.22-11-04249.2002; RATHBONE MP, 1992, NEUROSCI RES, V13, P1, DOI 10.1016/0168-0102(92)90030-G; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Ryu JK, 2003, J NEUROSCI RES, V72, P352, DOI 10.1002/jnr.10507; Stout C, 2003, GLIA, V43, P265, DOI 10.1002/glia.10257; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sugioka M, 1996, J PHYSIOL-LONDON, V493, P855, DOI 10.1113/jphysiol.1996.sp021428; Sugioka M, 1999, INT J DEV NEUROSCI, V17, P135, DOI 10.1016/S0736-5748(98)00066-5; Syed MM, 2004, J NEUROPHYSIOL, V91, P1999, DOI 10.1152/jn.01129.2003; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	48	251	253	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 2	2005	46	5					731	744		10.1016/j.neuron.2005.04.024	http://dx.doi.org/10.1016/j.neuron.2005.04.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924860	Bronze			2022-12-28	WOS:000229689800008
J	Hayashi, Y; Majewska, AK				Hayashi, Y; Majewska, AK			Dendritic spine geometry: Functional implication and regulation	NEURON			English	Editorial Material							LONG-TERM POTENTIATION; CORTEX IN-VIVO; HIPPOCAMPAL SPINES; CALCIUM DYNAMICS; VISUAL-CORTEX; ADULT CORTEX; PLASTICITY; COMPARTMENTALIZATION; DEPRIVATION; TRANSIENT	Dendritic spines are tiny protrusions on dendritic shafts where most excitatory synapses are located. Recent advances in imaging technologies have given us great insight into the function of spines as biochemical compartments. Here we review recent evidence suggesting that the geometry of dendritic spines controls postsynaptic calcium signaling and is bidirectionally regulated during synaptic plasticity.	MIT, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Hayashi, Y (corresponding author), MIT, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA.		Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Majewska, Ania/0000-0002-2167-6849				FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Helmchen F, 2002, TRENDS NEUROSCI, V25, P438, DOI 10.1016/S0166-2236(02)02232-4; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Majewska A, 2000, J NEUROSCI, V20, P1722; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	25	160	163	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 19	2005	46	4					529	532		10.1016/j.neuron.2005.05.006	http://dx.doi.org/10.1016/j.neuron.2005.05.006			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944122	Bronze			2022-12-28	WOS:000229294300005
J	Noguchi, J; Matsuzaki, M; Ellis-Davies, GCR; Kasai, H				Noguchi, J; Matsuzaki, M; Ellis-Davies, GCR; Kasai, H			Spine-neck geometry determines NMDA receptor-dependent Ca2+ signaling in dendrites	NEURON			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; HIPPOCAMPAL-NEURONS; CALCIUM DYNAMICS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; CHROMAFFIN CELLS; RAT HIPPOCAMPUS; SILENT SYNAPSES; ADULT CORTEX	Increases in cytosolic Ca2+ concentration ([Ca2+](i)) mediated by NMDA-sensitive glutamate receptors (NMDARs) are important for synaptic plasticity. We studied a wide variety of dendritic spines on rat CA1 pyramidal neurons in acute hippocampal slices. Two-photon uncaging and Ca2+ imaging revealed that NMDAR-mediated currents increased with spine-head volume and that even the smallest spines contained a significant number of NMDARs. The fate of Ca2+ that entered spine heads through NMDARs was governed by the shape (length and radius) of the spine neck. Larger spines had necks that permitted greater efflux of Ca2+ into the dendritic shaft, whereas smaller spines manifested a larger increase in [Ca2+](i) within the spine compartment as a result of a smaller Ca2+ flux through the neck. Spine-neck geometry is thus an important determinant of spine Ca2+ signaling, allowing small spines to be the preferential sites for isolated induction of long-term potentiation.	Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448787, Japan; Grad Inst Adv Studies, SOKENDAI, Okazaki, Aichi 4448787, Japan; Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Drexel University; University of Tokyo	Kasai, H (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448787, Japan.	hkasai@nips.ac.jp		Matsuzaki, Masanori/0000-0003-3872-4322; Noguchi, Jun/0000-0002-8350-791X; Kasai, Haruo/0000-0003-2327-9027	NIGMS NIH HHS [R01 GM053395, R01 GM053395-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBRITTON NL, 1992, SCIENCE, V258, P1812; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; COSS RG, 1985, BEHAV NEURAL BIOL, V44, P151, DOI 10.1016/S0163-1047(85)90170-0; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; DiGregorio DA, 1997, J PHYSIOL-LONDON, V505, P585, DOI 10.1111/j.1469-7793.1997.585ba.x; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Groc L, 2002, J NEUROSCI, V22, P5552; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Helmchen F, 2002, TRENDS NEUROSCI, V25, P438, DOI 10.1016/S0166-2236(02)02232-4; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Johnston D., 1995, FDN CELLULAR NEUROPH; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim CH, 1999, J NEUROSCI, V19, P4314; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korkotian E, 2004, EUR J NEUROSCI, V20, P2649, DOI 10.1111/j.1460-9568.2004.03691.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mori H, 2003, LIFE SCI, V74, P329, DOI 10.1016/j.lfs.2003.09.020; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NICHOLLS JG, NEUROL BRAIN; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Rall W., 1970, EXCITATORY SYNAPTIC, P175; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Shouval HZ, 2002, BIOL CYBERN, V87, P383, DOI 10.1007/s00422-002-0362-x; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tyzio R, 1999, J NEUROSCI, V19, P10372; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	61	305	312	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					609	622		10.1016/j.neuron.2005.03.015	http://dx.doi.org/10.1016/j.neuron.2005.03.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944129	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000229294300012
J	Person, AL; Perkel, DJ				Person, AL; Perkel, DJ			Unitary IPSPs drive precise thalamic spiking in a circuit required for learning	NEURON			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; SONG SYSTEM; FOREBRAIN NUCLEUS; BASIC PROCESS; NEURONS; PROJECTION; DISINHIBITION; STIMULATION; MECHANISMS; EXPRESSION	Song learning in birds requires a basal ganglia-thalamo-pallial loop that contains a calyceal GABAergic synapse in the thalamus. Information processing within this circuit is critical for proper song development; however, it is unclear whether activation of the inhibitory output of the basal ganglia structure Area X can drive sustained activity in its thalamic target, the medial portion of the dorsolateral thalamic nucleus (DLM). We show that high-frequency, random activation of this GABAergic synapse can drive precisely timed firing in DLM neurons in brain slices in the absence of excitatory input. Complex IPSP trains, including spike trains recorded in vivo, drive spiking in slices with high reproducibility, even between animals. Using a simple model, we can predict much of DLM's response to natural stimulus trains. These data elucidate basic rules by which thalamic relay neurons translate IPSPs into suprathreshold output and demonstrate extrathalamic GABAergic activation of thalamus.	Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Perkel, DJ (corresponding author), Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA.	perkel@u.washington.edu			NIDCD NIH HHS [P30 DC04661] Funding Source: Medline; NIGMS NIH HHS [T-32 GM07108] Funding Source: Medline; NIMH NIH HHS [MH066128] Funding Source: Medline; NINDS NIH HHS [F31 NS049732] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066128, R56MH066128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS049732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BERGER TW, 1987, ADV METHODS PHYSL SY, V1; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; DENIAU JM, 1985, BRAIN RES, V334, P227, DOI 10.1016/0006-8993(85)90214-8; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Dobrunz LE, 1999, NEURON, V22, P157, DOI 10.1016/S0896-6273(00)80687-X; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Farries MA, 2002, J NEUROSCI, V22, P3776; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; Gauck V, 2000, J NEUROSCI, V20, P3006; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hessler NA, 1999, J NEUROSCI, V19, P10461; ISAACSON JS, 1995, J NEUROPHYSIOL, V73, P964, DOI 10.1152/jn.1995.73.3.964; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Luo MM, 1999, J NEUROSCI, V19, P6700; Luo MM, 2002, J NEUROPHYSIOL, V88, P1903, DOI 10.1152/jn.2002.88.4.1903; Luo MM, 2001, J NEUROSCI, V21, P6836, DOI 10.1523/JNEUROSCI.21-17-06836.2001; Luo MM, 1999, J COMP NEUROL, V403, P68; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Porcello DM, 2003, J NEUROPHYSIOL, V89, P177, DOI 10.1152/jn.00667.2002; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHERMAN SM, 2001, EXPLORING THALAMUS, P263; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; THOMSON AM, 1988, NEUROSCIENCE, V25, P491, DOI 10.1016/0306-4522(88)90253-9; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; UEKI A, 1983, EXP BRAIN RES, V49, P116; Ulrich D, 1997, J NEUROSCI, V17, P2348; Ulrich D, 1997, J NEUROPHYSIOL, V78, P1748, DOI 10.1152/jn.1997.78.3.1748; Vates GE, 1997, J COMP NEUROL, V380, P275; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346; ZHOU N, 1992, HEARING RES, V60, P20, DOI 10.1016/0378-5955(92)90054-Q	52	94	97	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					129	140		10.1016/j.neuron.2004.12.057	http://dx.doi.org/10.1016/j.neuron.2004.12.057			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820699	Bronze			2022-12-28	WOS:000228228600014
J	Golde, TE; Janus, C				Golde, TE; Janus, C			Homing in on intracellular A beta?	NEURON			English	Editorial Material							ALZHEIMERS-DISEASE; TRANSGENIC MICE; A-BETA-42; PROTEIN		Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Golde, TE (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.							Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Ohyagi Y, 2000, NEUROREPORT, V11, P167, DOI 10.1097/00001756-200001170-00033; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786	12	20	20	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					639	642		10.1016/j.neuron.2005.02.013	http://dx.doi.org/10.1016/j.neuron.2005.02.013			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748837	Bronze			2022-12-28	WOS:000227446700001
J	Mayer, ML				Mayer, ML			Crystal structures of the GluR5 and GluR6 ligand binding cores: Molecular mechanisms underlying kainate receptor selectivity	NEURON			English	Article							HIGH-AFFINITY LIGAND; AMINO-ACID-RESIDUES; GLUTAMATE-RECEPTOR; ION-CHANNEL; SYM 2081; ACTIVATION; AGONIST; IDENTIFICATION; MOLSCRIPT; DOMAIN	Little is known about the molecular mechanisms underlying differences in the ligand binding properties of AMPA, kainate, and NMDA subtype glutamate receptors. Crystal structures of the GluR5 and GluR6 kainate receptor ligand binding cores in complexes with glutamate, 2S,4R-4-methylglutamate, kainate, and quisqualate have now been solved. The structures reveal that the ligand binding cavities are 40% (GIuR5) and 16% (GluR6) larger than for GluR2. The binding of AMPA- and GluR5-selective agonists to GluR6 is prevented by steric occlusion, which also interferes with the high-affinity binding of 2S,4R-4-methylglutamate to AMPA receptors. Strikingly, the extent of domain closure produced by the GluR6 partial agonist kainate is only 3degrees less than for glutamate and 11degrees greater than for the GluR2 kainate complex. This, together with extensive interdomain contacts between domains 1 and 2 of GluR5 and GluR6, absent from AMPA receptors, likely contributes to the high stability of GluR5 and GluR6 kainate complexes.	NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mayer, ML (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	mlm@helix.nih.gov	Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019	Mayer, Mark/0000-0003-4378-8451	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Dingledine R, 1999, PHARMACOL REV, V51, P7; Donevan SD, 1998, J PHARMACOL EXP THER, V285, P539; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fleck MW, 2003, J NEUROSCI, V23, P1219; FLIPPEN JL, 1976, ACTA CRYSTALLOGR B, V32, P951, DOI 10.1107/S0567740876004299; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hoo K, 1999, NEUROPHARMACOLOGY, V38, P1811, DOI 10.1016/S0028-3908(99)00133-1; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Jones KA, 1997, NEUROPHARMACOLOGY, V36, P853, DOI 10.1016/S0028-3908(97)00066-X; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nielsen MM, 2003, MOL PHARMACOL, V63, P19, DOI 10.1124/mol.63.1.19; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robert A, 2004, BIOPHYS J, V86, p355A; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Swanson GT, 1998, MOL PHARMACOL, V53, P942; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Takahashi H, 2004, ACTA CRYSTALLOGR D, V60, P1846, DOI 10.1107/S0907444904019420; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; Zhou LM, 1997, J PHARMACOL EXP THER, V280, P422	52	227	235	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					539	552		10.1016/j.neuron.2005.01.031	http://dx.doi.org/10.1016/j.neuron.2005.01.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721240	Bronze			2022-12-28	WOS:000227099700010
J	Vallstedt, A; Klos, JM; Ericson, J				Vallstedt, A; Klos, JM; Ericson, J			Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTRAL NEURAL-TUBE; HOMEODOMAIN TRANSCRIPTION FACTOR; PDGF ALPHA-RECEPTOR; SONIC HEDGEHOG; MOTOR-NEURON; PROGENITOR CELLS; STEM-CELLS; SUBVENTRICULAR ZONE; ROOF PLATE	Studies have indicated that oligodendrocytes in the spinal cord originate from a ventral progenitor domain defined by expression of the oligodendrocyte-determining bHLH proteins Olig1 and Olig2. Here, we provide evidence that progenitors in the dorsal spinal cord and hindbrain also produce oligodendrocytes and that the specification of these cells may result from a dorsal evasion of BMP signaling over time. Moreover, we show that the generation of ventral oligodendrocytes in the spinal cord depends on Nkx6.1 and Nkx6.2 function, while these homeodomain proteins in the anterior hindbrain instead suppress oligodendrocyte specification. The opposing roles for Nkx6 proteins in the spinal cord and hindbrain, in turn, appear to reflect that oligodendrocytes are produced by distinct ventral progenitor domains at these axial levels. Based on these findings, we propose that oligodendrocytes derive from several distinct positional origins and that the activation of Olig1/2 at different positions is controlled by distinct genetic programs.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Ericson, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	johan.ericson@cmb.ki.se	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Ericson, Johan/0000-0002-8019-7127				Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gorski JA, 2002, J NEUROSCI, V22, P6309; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Hall A, 1996, DEVELOPMENT, V122, P4085; Hall AK, 2004, J NEUROSCI RES, V76, P1, DOI 10.1002/jnr.20019; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Liem KF, 2000, DEVELOPMENT, V127, P4855; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Liu RG, 2003, DEVELOPMENT, V130, P6221, DOI 10.1242/dev.00868; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Qi YC, 2001, DEVELOPMENT, V128, P2723; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Spassky N, 2000, GLIA, V29, P143, DOI 10.1002/(SICI)1098-1136(20000115)29:2<143::AID-GLIA7>3.3.CO;2-4; Sussman CR, 2000, J NEUROSCI RES, V59, P413, DOI 10.1002/(SICI)1097-4547(20000201)59:3<413::AID-JNR16>3.3.CO;2-7; VALERIUS MT, 1995, DEV DYNAM, V203, P337, DOI 10.1002/aja.1002030306; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	61	239	242	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					55	67		10.1016/j.neuron.2004.12.026	http://dx.doi.org/10.1016/j.neuron.2004.12.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629702	Bronze			2022-12-28	WOS:000226217100009
J	Park, YY; Jo, J; Isaac, JTR; Cho, K				Park, YY; Jo, J; Isaac, JTR; Cho, K			Long-term depression of kainate receptor-mediated synaptic transmission	NEURON			English	Article							MOSSY FIBER SYNAPSES; PROTEIN-KINASE-C; DEPENDENT REGULATION; AMPA RECEPTORS; EXPRESSION; PICK1; ACID; POTENTIATION; TRAFFICKING; ACTIVATION	Kainate receptors (KARs) have been shown to be involved in hippocampal mossy fiber long-term potentiation (LTP); however, it is not known if KARs are involved in the induction or expression of long-term depression (LTD), the other major form of long-term synaptic plasticity. Here we describe LTD of KAR-mediated synaptic transmission (EPSCKA LTD) in perirhinal cortex layer II/III neurons that is distinct from LTD of AMPAR-mediated transmission, which also coexists at the same synapses. Induction of EPSCKA LTD requires a rise in postsynaptic Ca2+ but is independent of NMDARs or T-type voltage-gated Ca2+ channels; however, it requires synaptic activation of inwardly rectifying KARs and release of Ca2+ from stores. The synaptic KARs are regulated by tonically activated mGluR5, and expression of EPSCKA LTD occurs via a mechanism involving mGluR5, PKC, and PICK1 PDZ domain interactions. Thus, we describe the induction and expression mechanism of a form of synaptic plasticity, EPSCKA LTD.	Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Bristol, Dept Anat, Sch Med Sci, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Sheffield; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Cho, K (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	k.cho@sheffield.ac.uk		Cho, Kwangwook/0000-0001-6724-7073	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003011, ZIANS003011] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; BAHN S, 1994, J NEUROSCI, V14, P5525; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Cho K, 2000, NAT NEUROSCI, V3, P150, DOI 10.1038/72093; Cho K, 2003, J PHYSIOL-LONDON, V548, P723, DOI 10.1113/jphysiol.2003.040188; Chung HJ, 2000, J NEUROSCI, V20, P7258; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Frerking M, 2002, J NEUROSCI, V22, P7434; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; More JCA, 2004, NEUROPHARMACOLOGY, V47, P46, DOI 10.1016/j.neuropharm.2004.03.005; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Overstreet LS, 1997, NEUROPHARMACOLOGY, V36, P831, DOI 10.1016/S0028-3908(97)00031-2; PELLICCIARI R, 1995, J MED CHEM, V38, P3717, DOI 10.1021/jm00019a002; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WISDEN W, 1993, J NEUROSCI, V13, P3582	39	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					95	106		10.1016/j.neuron.2005.11.035	http://dx.doi.org/10.1016/j.neuron.2005.11.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387642	Bronze			2022-12-28	WOS:000236699300012
J	Goodchild, RE; Kim, CE; Dauer, WT				Goodchild, RE; Kim, CE; Dauer, WT			Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope	NEURON			English	Article							MODEL; ATPASES; MOUSE	An enigmatic feature of many genetic diseases is that mutations in widely expressed genes cause tissue-specific illness. One example is DYT1 dystonia, a neurodevelopmental disease caused by an in-frame deletion (Delta gag) in the gene encoding torsinA. Here we show that neurons from both torsinA null (Tor1a(-/-)) and homozygous disease mutant "knockin" mice (Tor1a(Delta gag/Delta gag)) contain severely abnormal nuclear membranes, although non-neuronal cell types appear normal. These membrane abnormalities develop in postmigratory embryonic neurons and subsequently worsen with further neuronal maturation, a finding evocative of the developmental dependence of DYT1 dystonia. These observations demonstrate that neurons have a unique requirement for nuclear envelope localized torsinA function and suggest that loss of this activity is a key molecular event in the pathogenesis of DYT1 dystonia.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Dauer, WT (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.	wtd3@columbia.edu		Dauer, William/0000-0003-1775-7504	NICHD NIH HHS [R01 HD045708-01A1] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altman J, 2001, DEV HUMAN SPINAL COR; Bandmann O, 2002, NEUROPEDIATRICS, V33, P1, DOI 10.1055/s-2002-23590; Basham SE, 1999, DEV BIOL, V215, P253, DOI 10.1006/dbio.1999.9447; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Gerace L, 2004, P NATL ACAD SCI USA, V101, P8839, DOI 10.1073/pnas.0402441101; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Koh YH, 2004, HUM MOL GENET, V13, P2019, DOI 10.1093/hmg/ddh208; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Peters A., 1991, FINE STRUCTURE NERVO; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; SHALE H, 1987, MOVEMENT DISORD, V2, P321, DOI 10.1002/mds.870020411; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13	28	291	300	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					923	932		10.1016/j.neuron.2005.11.010	http://dx.doi.org/10.1016/j.neuron.2005.11.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364897	Bronze			2022-12-28	WOS:000234301700009
J	Tsodyks, M				Tsodyks, M			Attractor neural networks and spatial maps in hippocampus	NEURON			English	Editorial Material							MEMORY; REPRESENTATION; CORTEX	Attractor neural network theory has been proposed as a theory for long-term memory. Recent studies of hippocampal place cells, including a study by Leutgeb et al. in this issue of Neuron, address the potential role of attractor dynamics in the formation of hippocampal representations of spatial maps.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tsodyks, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.		tsodyks, misha/J-4430-2013	Tsodyks, Misha/0000-0002-5661-4349				Amit DJ, 2003, CEREB CORTEX, V13, P1139, DOI 10.1093/cercor/bhg103; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; MURRAY EA, 2000, NEW COGNITIVE NEUROS; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	12	15	16	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					168	169		10.1016/j.neuron.2005.10.006	http://dx.doi.org/10.1016/j.neuron.2005.10.006			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242397	Bronze			2022-12-28	WOS:000232838700006
J	Eaton, BA; Davis, GW				Eaton, BA; Davis, GW			LIM Kinase1 controls synaptic stability downstream of the type IIBMP receptor	NEURON			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; MOTOR-NEURON DEGENERATION; DEVELOPING NERVOUS-SYSTEM; TUMOR-SUPPRESSOR GENE; WISHFUL-THINKING; II RECEPTOR; IN-VIVO; PRESYNAPTIC TERMINALS; SIGNAL-TRANSDUCTION; ZINC-FINGER	Here, we demonstrate that the BMP receptor Wishful Thinking (Wit) is required for synapse stabilization. In the absence of BMP signaling, synapse disassembly and retraction ensue. Remarkably, downstream Smad-mediated signaling cannot fully account for the stabilizing activity of the BMP receptor. We identify LIM Kinase1 (DLIMK1)-dependent signaling as a second, parallel pathway that confers the added synapse-stabilizing activity of the BMP receptor. We show that DLIMK1 binds a region of the Wit receptor that is necessary for synaptic stability but is dispensable for Smad-mediated synaptic growth. A genetic analysis demonstrates that DLIMK1 is necessary, presynaptically, for synapse stabilization, but is not necessary for normal synaptic growth or function. Furthermore, presynaptic expression of DLIMK1 in a wit or mad mutant significantly rescues synaptic stability, growth, and function. DLIMK1 localizes near synaptic micro-tubules and functions independently of ADF/cofilin, highlighting a novel requirement for DLIMK1 during synapse stabilization rather than actin-dependent axon outgrowth.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047342] Funding Source: NIH RePORTER; NINDS NIH HHS [NS047342] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; CARONI P, 1992, J NEUROSCI, V12, P3849; Caroni P, 1997, J CELL BIOL, V136, P679, DOI 10.1083/jcb.136.3.679; CHENG AK, 1995, MECH DEVELOP, V52, P187, DOI 10.1016/0925-4773(95)00400-U; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; CRAYMER L, 1980, DROSOPH INF SERV, V55, P200; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Endo M, 2003, J NEUROSCI, V23, P2527; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Horch HW, 1999, NEURON, V23, P353; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Keshishian H, 2002, NEURON, V33, P491, DOI 10.1016/S0896-6273(02)00597-4; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lom B, 1999, J NEUROSCI, V19, P9928; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; MIZUNO K, 1994, ONCOGENE, V9, P1605; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; PROSCHEL C, 1995, ONCOGENE, V11, P1271; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Stewart BA, 1996, J NEUROSCI, V16, P3877; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Wang JY, 2000, J COMP NEUROL, V416, P319, DOI 10.1002/(SICI)1096-9861(20000117)416:3<319::AID-CNE4>3.0.CO;2-Q; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239; Wu GY, 1999, J NEUROSCI, V19, P4472; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang EJ, 2004, J BIOL CHEM, V279, P8903, DOI 10.1074/jbc.M311913200; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	69	129	133	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					695	708		10.1016/j.neuron.2005.08.010	http://dx.doi.org/10.1016/j.neuron.2005.08.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129399	Bronze			2022-12-28	WOS:000231782700011
J	Thiagarajan, TC; Lindskog, M; Tsien, RW				Thiagarajan, TC; Lindskog, M; Tsien, RW			Adaptation to synaptic inactivity in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; GLUTAMATE-RECEPTOR SUBUNITS; AMPA RECEPTORS; QUANTAL SIZE; CREB PHOSPHORYLATION; NMDA RECEPTORS; CA2+ CHANNELS; EXPRESSION; RELEASE; PLASTICITY	In response to activity deprivation, CNS neurons undergo slow adaptive modification of unitary synaptic transmission. The changes are comparable in degree to those induced by brief intense stimulation, but their molecular basis is largely unknown. Our data indicate that prolonged AMPAR blockade acts through loss of Ca2+ entry through L-type Ca2+ channels to bring about an increase in both vesicle pool size and turnover rate, as well as a postsynaptic enhancement of the contribution of GluR1 homomers, concentrated at the largest synapses. The changes were consistent with a morphological scaling of overall synapse size, but also featured a dramatic shift toward synaptic drive contributed by the Ca2+-permeable homomeric GluR1 receptors. These results extend beyond "synaptic homeostasis" to involve more profound changes that can be better described as "metaplasticity."	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Beckman Ctr, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Beckman Ctr, Stanford, CA 94305 USA.	rwtsien@stanford.edu	Lindskog, Maria/F-1729-2011	Lindskog, Maria/0000-0002-4178-2825				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; De Sarro G, 2005, CURR TOP MED CHEM, V5, P31; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Eid T, 2002, EUR J NEUROSCI, V15, P517, DOI 10.1046/j.0953-816x.2001.01887.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Glavinovic MI, 1998, PFLUG ARCH EUR J PHY, V435, P193; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; HARRIS RA, 1995, FASEB J, V9, P1454, DOI 10.1096/fasebj.9.14.7589987; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Johnston Tom H, 2004, Curr Opin Investig Drugs, V5, P720; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kingsbury TJ, 2003, J BIOL CHEM, V278, P40744, DOI 10.1074/jbc.M303082200; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Magee JC, 1996, J NEUROPHYSIOL, V76, P3460, DOI 10.1152/jn.1996.76.5.3460; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; PASCHEN W, 1995, J NEUROSCI METH, V56, P21, DOI 10.1016/0165-0270(94)00085-U; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Perucca E, 1997, PHARMACOL RES, V35, P241, DOI 10.1006/phrs.1997.0124; Pickard L, 2000, J NEUROSCI, V20, P7922; Pravettoni E, 2000, DEV BIOL, V227, P581, DOI 10.1006/dbio.2000.9872; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; TAVERNA FA, 1994, EUR J PHARM-MOLEC PH, V267, pR3, DOI 10.1016/0922-4106(94)90161-9; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wang XY, 2005, J NEUROSCI, V25, P343, DOI 10.1523/JNEUROSCI.3252-04.2005; Washburn MS, 1997, J NEUROSCI, V17, P9393; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Ying Z, 1998, BRAIN RES, V798, P239, DOI 10.1016/S0006-8993(98)00421-1	67	380	388	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					725	737		10.1016/j.neuron.2005.06.037	http://dx.doi.org/10.1016/j.neuron.2005.06.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129401	Bronze			2022-12-28	WOS:000231782700013
J	Delmas, P; Coste, B; Gamper, N; Shapiro, MS				Delmas, P; Coste, B; Gamper, N; Shapiro, MS			Phosphoinositide lipid second messengers: New paradigms for calcium channel modulation	NEURON			English	Review							RECEPTOR-MEDIATED INHIBITION; SIGNALING MICRODOMAINS; MUSCARINIC INHIBITION; ARACHIDONIC-ACID; K+ CHANNELS; CURRENTS; PATHWAYS	Neuronal Ca2+ channels are key transducers coupling excitability to cellular function. As such, they are tightly regulated by multiple G protein-signaling pathways that finely tune their activity. In addition to fast, direct G beta gamma modulation of Ca2+ channels, a slower G alpha(q/11)-mediated mechanism has remained enigmatic despite intensive study. Recent work suggests that membrane phosphoinositides are crucial determinants of Ca2+ channel activity. Here, we discuss their role in Ca2+ channel modulation and the leading theories that seek to elucidate the underlying molecular details of the so-called "mysterious" G(q/11)-mediated signal.	Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA; IFR Jean Roche, Fac Med, Lab Neurophysiol Cellulaire, CNRS,UMR 6150, F-13916 Marseille, France	University of Texas System; University of Texas Health San Antonio; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Delmas, P (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	delmas.p@jean-roche.univ-mrs.fr; shapirom@uthscsa.edu		Gamper, Nikita/0000-0001-5806-0207				BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Delmas P, 1998, EUR J NEUROSCI, V10, P1654, DOI 10.1046/j.1460-9568.1998.00170.x; Ford CP, 2004, EUR J NEUROSCI, V20, P2990, DOI 10.1111/j.1460-9568.2004.03786.x; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Haley JE, 2000, J NEUROSCI, V20, P3973; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Liu LW, 2000, J PHYSIOL-LONDON, V525, P391, DOI 10.1111/j.1469-7793.2000.00391.x; Liu LW, 2004, EUR BIOPHYS J BIOPHY, V33, P255, DOI 10.1007/s00249-003-0387-7; Liu LW, 2003, P NATL ACAD SCI USA, V100, P295, DOI 10.1073/pnas.0136826100; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Stewart AE, 1999, J NEUROPHYSIOL, V81, P72, DOI 10.1152/jn.1999.81.1.72; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	27	72	75	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					179	182		10.1016/j.neuron.2005.07.001	http://dx.doi.org/10.1016/j.neuron.2005.07.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039560	Bronze			2022-12-28	WOS:000230693900005
J	Rust, NC; Schwartz, O; Movshon, JA; Simoncelli, EP				Rust, NC; Schwartz, O; Movshon, JA; Simoncelli, EP			Spatiotemporal elements of macaque V1 receptive fields	NEURON			English	Article							CATS STRIATE CORTEX; PRIMARY VISUAL-CORTEX; COMPLEX CELLS; FUNCTIONAL ARCHITECTURE; CORTICAL-NEURONS; GAIN-CONTROL; RESPONSES; SELECTIVITY; CONTRAST; SIGNALS	Neurons in primary visual cortex (V1) are commonly classified as simple or complex based upon their sensitivity to the sign of stimulus contrast. The responses of both cell types can be described by a general model in which the outputs of a set of linear filters are nonlinearly combined. We estimated the model for a population of V1 neurons by analyzing the mean and covariance of the spatiotemporal distribution of random bar stimuli that were associated with spikes. This analysis reveals an unsuspected richness of neuronal computation within V1. Specifically, simple and complex cell responses are best described using more linear filters than the one or two found in standard models. Many filters revealed by the model contribute suppressive signals that appear to have a predominantly divisive influence on neuronal firing. Suppressive signals are especially potent in direction-selective cells, where they reduce responses to stimuli moving in the nonpreferred direction.	NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Howard Hughes Med Inst, New York, NY 10003 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA	New York University; Howard Hughes Medical Institute; New York University; Salk Institute; Howard Hughes Medical Institute	Rust, NC (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	rust@cns.nyu.edu		Simoncelli, Eero/0000-0002-1206-527X	NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [EY 2017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; Bialek W, 2005, FEATURES DIMENSIONS; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CHANDLER JP, 1969, BEHAV SCI, V14, P81; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Forte J, 2002, VISUAL NEUROSCI, V19, P31, DOI 10.1017/S0952523801191030; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Horwitz GD, 2005, J NEUROPHYSIOL, V93, P2263, DOI 10.1152/jn.00743.2004; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Lau B, 2002, P NATL ACAD SCI USA, V99, P8974, DOI 10.1073/pnas.122173799; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Livingstone MS, 2003, J NEUROPHYSIOL, V89, P2743, DOI 10.1152/jn.00822.2002; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rust NC, 2004, NEUROCOMPUTING, V58, P793, DOI 10.1016/j.neucom.2004.01.128; Schwartz O, 2002, ADV NEUR IN, V14, P269; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1266, DOI 10.1152/jn.1985.53.5.1266; Touryan J, 2002, J NEUROSCI, V22, P10811; VANSTEVENINCK RD, 1988, P ROY SOC LOND B BIO, V234, P269	39	315	317	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 16	2005	46	6					945	956		10.1016/j.neuron.2005.05.021	http://dx.doi.org/10.1016/j.neuron.2005.05.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953422	Bronze, Green Published			2022-12-28	WOS:000229922500013
J	Zhu, YH; Pak, D; Qin, Y; McCormack, SG; Kim, MJ; Baumgart, JP; Velamoor, V; Auberson, YR; Osten, P; van Aelst, L; Sheng, M; Zhu, JJ				Zhu, YH; Pak, D; Qin, Y; McCormack, SG; Kim, MJ; Baumgart, JP; Velamoor, V; Auberson, YR; Osten, P; van Aelst, L; Sheng, M; Zhu, JJ			Rap2-JNK removes synaptic AMPA receptors during depotentiation	NEURON			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; PROTEOMIC ANALYSIS; PUTATIVE EFFECTOR; PYRAMIDAL NEURONS; PLASTICITY; KINASE; TRAFFICKING; SUBUNIT	The related small GTPases Ras and Rap1 are important for signaling synaptic AMPA receptor (-R) trafficking during long-term potentiation (LTP) and longterm depression (LTD), respectively. Rap2, which shares 60% identity to Rap1, is present at excitatory synapses, but its functional role is unknown. Here, we report that Rap2 activity, stimulated by NR2A-containing NMDA-R activation, depresses AMPA-R-mediated synaptic transmission via activation of JNK rather than Erk1/2 or p38 MAPK. Moreover, Rap2 controls synaptic removal of AMPA-Rs with long cytoplasmic termini during depotentiation. Thus, Rap2-JNK pathway, which opposes the action of the NR2A-containing NMDA-R-stimulated Ras-ERK1/2 signaling and complements the NR2B-containing NMDA-R-stimulated Rapl-p38 MAPK signaling, channels	Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA; MIT, Ctr Res Neurosci, RIKEN, Howard Hughes Med Inst,Picower Ctr Learning & Mem, Cambridge, MA 02139 USA; Cold Spring Harbor Lab, Canc Res Ctr, Cold Spring Harbor, NY 11724 USA; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of Virginia; University of Virginia; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Cold Spring Harbor Laboratory; Novartis; Max Planck Society	Zhu, JJ (corresponding author), Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA.	jjzhu@virginia.edu	Auberson, Yves/AAF-6538-2019; Baumgart, Joel/K-3139-2014	Auberson, Yves/0000-0001-5800-4811; Baumgart, Joel/0000-0002-1109-2567; Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [R01 NS051241, R01 NS051241-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051241] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAR MF, 2000, SYNAPSES, V1, P455; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; PIZON V, 1988, ONCOGENE, V3, P201; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	50	166	174	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					905	916		10.1016/j.neuron.2005.04.037	http://dx.doi.org/10.1016/j.neuron.2005.04.037			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953419	Bronze			2022-12-28	WOS:000229922500010
J	Hasselmo, M				Hasselmo, M			Expecting the unexpected: Modeling of neuromodulation	NEURON			English	Editorial Material							ATTENTION; PERFORMANCE; NEURONS	An important aspect of decision-making is the need to make interpretations and predictions in the face of uncertain information. In this issue of Neuron, Yu and Dayan describe a model of the role of acetylcholine and norepinephrine in balancing top-down expectation and bottom-up sensory input in guiding behavior. The model builds from data on physiological effects of modulators regulating the balance of cortical feedback and thalamic input.	Boston Univ, Dept Psychol, Ctr Memory & Brain, Boston, MA 02215 USA; Boston Univ, Program Neurosci, Boston, MA 02215 USA	Boston University; Boston University	Hasselmo, M (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.			Hasselmo, Michael/0000-0002-9925-6377				Aston-Jones G, 1998, Adv Pharmacol, V42, P755; Baxter MG, 1999, BEHAV NEUROSCI, V113, P486, DOI 10.1037/0735-7044.113.3.486; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Phillips JM, 2000, PSYCHOPHARMACOLOGY, V150, P112, DOI 10.1007/s002130000437; Sara SJ, 1998, CR ACAD SCI III-VIE, V321, P193, DOI 10.1016/S0764-4469(97)89821-6; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	9	7	7	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 19	2005	46	4					526	528		10.1016/j.neuron.2005.05.007	http://dx.doi.org/10.1016/j.neuron.2005.05.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944121	Bronze			2022-12-28	WOS:000229294300004
J	Polleux, F				Polleux, F			Genetic mechanisms specifying cortical connectivity: Let's make some projections together	NEURON			English	Review							OCULAR-DOMINANCE COLUMNS; MOUSE BARREL CORTEX; VISUAL-SYSTEM; THALAMOCORTICAL PROJECTIONS; IN-VIVO; MICE; NEURONS; TOPOGRAPHY; NEOCORTEX; GROWTH		Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Polleux, F (corresponding author), Univ N Carolina, Ctr Neurosci, Dept Pharmacol, 105 Mason Farm Rd,CB7250, Chapel Hill, NC 27599 USA.	polleux@med.unc.edu	Polleux, Franck/H-9948-2014	Polleux, Franck/0000-0003-4313-0481				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barone P, 1996, J COMP NEUROL, V374, P1, DOI 10.1002/(SICI)1096-9861(19961007)374:1<1::AID-CNE1>3.0.CO;2-7; Batardiere A, 2002, CEREB CORTEX, V12, P453, DOI 10.1093/cercor/12.5.453; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 2002, CURR OPIN NEUROBIOL, V12, P104, DOI 10.1016/S0959-4388(02)00297-0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Cutforth T, 1997, CURR OPIN NEUROBIOL, V7, P48, DOI 10.1016/S0959-4388(97)80119-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HATTEN ME, 2004, IN PRESS ANN REV NEU; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huffman KJ, 2004, J NEUROSCI, V24, P8917, DOI 10.1523/JNEUROSCI.2086-04.2004; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Marin O, 2003, NEURON, V39, P388, DOI 10.1016/S0896-6273(03)00471-9; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2003, DEVELOPMENT, V130, P2929, DOI 10.1242/dev.00514; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Tayler TD, 2003, CURR OPIN NEUROBIOL, V13, P90, DOI 10.1016/S0959-4388(03)00004-7; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WURST W, 1995, GENETICS, V139, P889	45	25	25	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					395	400		10.1016/j.neuron.2005.04.017	http://dx.doi.org/10.1016/j.neuron.2005.04.017			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882638				2022-12-28	WOS:000229011400010
J	Conner, JM; Chiba, AA; Tuszynski, MH				Conner, JM; Chiba, AA; Tuszynski, MH			The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury	NEURON			English	Article							PRIMARY MOTOR CORTEX; ALZHEIMERS-DISEASE; NUCLEUS BASALIS; SOMATOSENSORY CORTEX; MAGNETIC STIMULATION; AUDITORY-CORTEX; DOUBLE-BLIND; REORGANIZATION; RAT; NEURONS	A reorganization of cortical representations is postulated as the basis for functional recovery following many types of nervous system injury. Neuronal mechanisms underlying this form of cortical plasticity are poorly understood. The present study investigated the hypothesis that the basal forebrain cholinergic system plays an essential role in enabling the cortical reorganization required for functional recovery following brain injury. The results demonstrate that functional recovery following cortical injury requires basal forebrain cholinergic mechanisms and suggest that the basis for this recovery is the cholinergic-dependent reorganization of motor representations. These findings raise the intriguing possibility that deficits in cholinergic function may limit functional outcomes following nervous system injury.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Conner, JM (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	jmconner@ucsd.edu			NIA NIH HHS [5P01 AG10435] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG010435] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Baxter MG, 2001, METH MOL B, V166, P249; BOOK AA, 1992, BRAIN RES, V590, P350, DOI 10.1016/0006-8993(92)91121-T; CASTROALAMANCOS MA, 1992, EUR J NEUROSCI, V4, P853, DOI 10.1111/j.1460-9568.1992.tb00195.x; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; COHEN LG, 1991, J CLIN NEUROPHYSIOL, V8, P56, DOI 10.1097/00004691-199101000-00007; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; DONOGHUE JP, 1987, BRAIN RES, V408, P367, DOI 10.1016/0006-8993(87)90407-0; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; Friel KM, 2000, NEUROREHAB NEURAL RE, V14, P187, DOI 10.1177/154596830001400304; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; GEULA C, 1989, NEUROSCIENCE, V33, P469, DOI 10.1016/0306-4522(89)90399-0; Geula C, 1996, CEREB CORTEX, V6, P165, DOI 10.1093/cercor/6.2.165; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jang SH, 2002, AM J PHYS MED REHAB, V81, P844, DOI 10.1097/00002060-200211000-00007; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P617, DOI 10.1113/jphysiol.1975.sp011034; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; JONES TA, 1994, J NEUROSCI, V14, P2140; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; Kaas JH, 2000, PROG BRAIN RES, V128, P173; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN BE, 1988, BRAIN RES, V443, P261, DOI 10.1016/0006-8993(88)91620-4; Loubinoux I, 2002, NEUROIMAGE, V15, P26, DOI 10.1006/nimg.2001.0957; Manunta Y, 2004, J NEUROPHYSIOL, V92, P1445, DOI 10.1152/jn.00079.2004; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; MCGEER PL, 1984, NEUROLOGY, V34, P741, DOI 10.1212/WNL.34.6.741; METHERATE R, 1990, SYNAPSE, V6, P133, DOI 10.1002/syn.890060204; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Rouiller EM, 1998, EUR J NEUROSCI, V10, P729, DOI 10.1046/j.1460-9568.1998.00075.x; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; Smith DE, 1999, P NATL ACAD SCI USA, V96, P10893, DOI 10.1073/pnas.96.19.10893; SMITH ML, 1995, NEUROSCIENCE, V67, P679, DOI 10.1016/0306-4522(95)00076-U; TORRES EM, 1994, NEUROSCIENCE, V63, P95, DOI 10.1016/0306-4522(94)90010-8; WEBSTER HH, 1991, SOMATOSENS MOT RES, V8, P327, DOI 10.3109/08990229109144756; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2	53	170	179	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 21	2005	46	2					173	179		10.1016/j.neuron.2005.03.003	http://dx.doi.org/10.1016/j.neuron.2005.03.003			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848797	Bronze			2022-12-28	WOS:000228674800005
J	Holt, CE; Dickson, BJ				Holt, CE; Dickson, BJ			Sugar codes for axons?	NEURON			English	Review							HEPARAN-SULFATE PROTEOGLYCANS; FIBROBLAST-GROWTH-FACTOR; CHONDROITIN SULFATE; CELL-SURFACE; NERVOUS-SYSTEM; VISUAL-SYSTEM; SLIT PROTEIN; OPTIC TRACT; GUIDANCE; RECEPTOR	Proteoglycans are complex macromolecules with the potential for extraordinary diversity. Several recent studies have demonstrated important roles for heparan sulfate and chondroitin sulfate proteoglycans (HSPGs and CSPGs) in axon pathfinding and have linked HSPGs to specific signaling pathways. More speculatively, there are hints of a "sugar code," in which specific sugar modifications might act instructively in guidance decisions. This raises the intriguing possibility that the complexity of neuronal wiring may in part reflect the complexity of proteoglycan modifications.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Cambridge; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Holt, CE (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk; barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; HALFTER W, 1993, J NEUROSCI, V13, P2863; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Irie A, 2002, DEVELOPMENT, V129, P61; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Morio H, 2003, BIOCHEM BIOPH RES CO, V301, P317, DOI 10.1016/S0006-291X(02)03031-0; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SNOW DM, 1991, DEVELOPMENT, V113, P1473; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Walz A, 2002, J NEUROBIOL, V53, P330, DOI 10.1002/neu.10113; Walz A, 1997, DEVELOPMENT, V124, P2421; WANG LS, 1992, NEURON, V8, P701, DOI 10.1016/0896-6273(92)90091-Q; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	28	85	88	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 21	2005	46	2					169	172		10.1016/j.neuron.2005.03.021	http://dx.doi.org/10.1016/j.neuron.2005.03.021			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848796	Green Accepted, Bronze			2022-12-28	WOS:000228674800004
J	Sakurai, T; Nagata, R; Yamanaka, A; Kawamura, H; Tsujino, N; Muraki, Y; Kageyama, H; Kunita, S; Takahashi, S; Goto, K; Koyama, Y; Shioda, S; Yanagisawa, M				Sakurai, T; Nagata, R; Yamanaka, A; Kawamura, H; Tsujino, N; Muraki, Y; Kageyama, H; Kunita, S; Takahashi, S; Goto, K; Koyama, Y; Shioda, S; Yanagisawa, M			Input of orexin/hypocretin by a genetically encoded neurons revealed tracer in mice	NEURON			English	Article							BASAL FOREBRAIN; OREXIN NEURONS; ADENOSINERGIC MODULATION; HYPOCRETIN NEURONS; ACTIVE NEURONS; SLEEP; RAT; EXPRESSION; NARCOLEPSY; HYPOTHALAMUS	The finding of orexin/hypocretin deficiency in narcolepsy patients suggests that this hypothalamic neuropeptide plays a crucial role in regulating sleep/wakefulness states. However, very little is known about the synaptic input of orexin/hypocretin-producing neurons (orexin neurons). We applied a transgenic method to map upstream neuronal populations that have synaptic connections to orexin neurons and revealed that orexin neurons receive input from several brain areas. These include the amygdala, basal forebrain cholinergic neurons, GABAergic neurons in the preoptic area, and serotonergic neurons in the median/paramedian raphe nuclei. Monoamine-containing groups that are innervated by orexin neurons do not receive reciprocal connections, while cholinergic neurons in the basal forebrain have reciprocal connections, which might be important for consolidating wakefulness. Electrophysiological study showed that carbachol excites almost one-third of orexin neurons and inhibits a small population of orexin neurons. These neuroanatomical findings provide important insights into the neural pathways that regulate sleep/ wakefulness states.	Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med Sci, Lab Animal Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; Japan Sci & Technol Corp, ERATO, Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan; Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; Fukushima Univ, Sch Med, Fac Symbiot Syst Sci, Fukushima 9601295, Japan; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); Showa University; Fukushima Medical University; Fukushima University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sakurai, T (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan.	stakeshi@md.tsukuba.ac.jp	Yamanaka, Akihiro/F-2914-2011; Oka, Yoshitaka/C-9670-2010; Yamanaka, Akihiro/AAD-8641-2021	Oka, Yoshitaka/0000-0002-3482-3051; Yamanaka, Akihiro/0000-0001-6099-7306; Muraki, Yo/0000-0001-6891-3074				Adrien J, 2002, SLEEP MED REV, V6, P341, DOI 10.1053/smrv.2001.0200; Alam MN, 1999, J PHYSIOL-LONDON, V521, P679, DOI 10.1111/j.1469-7793.1999.00679.x; ALAM MN, 1995, AM J PHYSIOL-REG I, V269, pR1240, DOI 10.1152/ajpregu.1995.269.5.R1240; Benca RM, 2000, BRAIN RES, V879, P130, DOI 10.1016/S0006-8993(00)02761-X; Broberger C, 1998, J COMP NEUROL, V402, P460; Chamberlin NL, 2003, NEUROSCIENCE, V119, P913, DOI 10.1016/S0306-4522(03)00246-X; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Glass JD, 2003, J NEUROSCI, V23, P7451; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Jouvet M, 1999, NEUROPSYCHOPHARMACOL, V21, pS24, DOI 10.1038/sj.npp.1395333; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; KOYAMA Y, 1994, NEUROSCI RES, V19, P31, DOI 10.1016/0168-0102(94)90005-1; Leander P, 1998, J COMP NEUROL, V399, P73; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; McGinty D, 2003, FRONT BIOSCI-LANDMRK, V8, pS1074, DOI 10.2741/1159; Morairty S, 2004, NEUROSCIENCE, V123, P451, DOI 10.1016/j.neuroscience.2003.08.066; Moriguchi T, 2002, J BIOL CHEM, V277, P16985, DOI 10.1074/jbc.M107962200; Muraki Y, 2004, J NEUROSCI, V24, P7159, DOI 10.1523/JNEUROSCI.1027-04.2004; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; PETROV T, 1992, J COMP NEUROL, V318, P18, DOI 10.1002/cne.903180103; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2003, CURR OPIN CLIN NUTR, V6, P353, DOI 10.1097/00075197-200307000-00001; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Satoh S, 2004, NEUROREPORT, V15, P1127, DOI 10.1097/00001756-200405190-00009; Strecker RE, 2000, BEHAV BRAIN RES, V115, P183, DOI 10.1016/S0166-4328(00)00258-8; Szymusiak R, 2000, BEHAV BRAIN RES, V115, P171, DOI 10.1016/S0166-4328(00)00257-6; Terao A, 2003, NEUROSCIENCE, V116, P187, DOI 10.1016/S0306-4522(02)00695-4; Thakkar MM, 2003, NEUROSCIENCE, V122, P1107, DOI 10.1016/j.neuroscience.2003.08.006; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	46	355	367	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					297	308		10.1016/j.neuron.2005.03.010	http://dx.doi.org/10.1016/j.neuron.2005.03.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848807	Bronze			2022-12-28	WOS:000228674800015
J	Allan, DW; Park, D; St Pierre, SE; Taghert, PH; Thor, S				Allan, DW; Park, D; St Pierre, SE; Taghert, PH; Thor, S			Regulators acting in combinatorial codes also act independently in single differentiating neurons	NEURON			English	Article							TRANSCRIPTION FACTOR; DROSOPHILA-MELANOGASTER; BHLH PROTEIN; CELL FATE; GENE; EXPRESSION; SPECIFICATION; ELEGANS; IDENTITY; SANPODO	In the Drosophila ventral nerve cord, a small number of neurons express the LIM-homeodomain gene apterous (ap). These ap neurons can be subdivided based upon axon pathfinding and their expression of neuropeptidergic markers. ap, the zinc finger gene squeeze, the bHLH gene dimmed, and the BMP pathway are all required for proper specification of these cells. Here, using several ap neuron terminal differentiation markers, we have resolved how each of these factors contributes to ap neuron diversity. We find that these factors interact genetically and biochemically in subtype-specific combinatorial codes to determine certain defining aspects of ap neuron subtype identity. However, we also find that ap, dimmed, and squeeze additionally act independently of one another to specify certain other defining aspects of ap neuron subtype identity. Therefore, within single neurons, we show that single regulators acting in numerous molecular contexts differentially specify multiple subtype-specific traits.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Thor, S (corresponding author), Linkoping Univ, IFM, Div Biol, Campus Valla, S-58183 Linkoping, Sweden.	taghertp@thalamus.wustl.edu; steth@ifm.liu.se	Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X	NINDS NIH HHS [NS21749] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021749] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama-Oda Y, 1998, DEV GENES EVOL, V208, P578, DOI 10.1007/s004270050217; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRAND M, 1990, ROUX ARCH DEV BIOL, V198, P275, DOI 10.1007/BF00377394; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; Castanon I, 2001, DEVELOPMENT, V128, P3145; CHIN AC, 1990, DNA CELL BIOL, V9, P263, DOI 10.1089/dna.1990.9.263; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Dye CA, 1998, DEVELOPMENT, V125, P1845; EIPPER BA, 1993, ANN NY ACAD SCI, V680, P147, DOI 10.1111/j.1749-6632.1993.tb19681.x; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Herrero P, 2003, J COMP NEUROL, V457, P123, DOI 10.1002/cne.10555; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lemercier C, 1998, EMBO J, V17, P1412, DOI 10.1093/emboj/17.5.1412; LICHTSTEINER S, 1995, EMBO J, V14, P3937, DOI 10.1002/j.1460-2075.1995.tb00065.x; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Melloul D, 2004, ANN NY ACAD SCI, V1014, P28, DOI 10.1196/annals.1294.003; Newman AP, 2000, CURR BIOL, V10, P1479, DOI 10.1016/S0960-9822(00)00827-7; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; PAPP A, 1991, NUCLEIC ACIDS RES, V19, P623, DOI 10.1093/nar/19.3.623; Park DK, 2004, DEV BIOL, V269, P95, DOI 10.1016/j.ydbio.2004.01.015; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Skeath JB, 1998, DEVELOPMENT, V125, P1857; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; STRUHL K, 1991, NEURON, V7, P177, DOI 10.1016/0896-6273(91)90256-Y; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Thor S, 2002, CURR OPIN GENET DEV, V12, P558, DOI 10.1016/S0959-437X(02)00340-4; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; Zhu LQ, 2004, MOL CELL BIOL, V24, P2673, DOI 10.1128/MCB.24.7.2673-2681.2004	46	63	65	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					689	700		10.1016/j.neuron.2005.01.026	http://dx.doi.org/10.1016/j.neuron.2005.01.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748845	Bronze			2022-12-28	WOS:000227446700009
J	Wilson, CJ				Wilson, CJ			The mechanism of intrinsic amplification of hyperpolarizations and spontaneous bursting in striatal cholinergic interneurons	NEURON			English	Article							TONICALLY ACTIVE NEURONS; SPINY PROJECTION NEURONS; POTASSIUM CURRENT; MUSCARINIC RECEPTORS; MEMBRANE-PROPERTIES; PRIMATES STRIATUM; DOPAMINE RELEASE; ACETYLCHOLINE; RESPONSES; CURRENTS	Striatal cholinergic interneurons pause their ongoing firing in response to sensory stimuli that have acquired meaning as a signal for learned behavior. In slices, these cells exhibit both spontaneous activity patterns and spontaneous pauses very similar to those seen in vivo. The mechanisms responsible for ongoing firing and spontaneous pauses were studied in striatal slices using perforated patch recordings. All hyperpolarizations, whether spontaneous or generated by current injection, were amplified and shaped by two hyperpolarization-activated currents. Hyperpolarization onsets were regeneratively amplified by a potassium current (KIR) whose activation promoted further hyperpolarization. The termination of hyperpolarizations was controlled by a time-dependent nonspecific cation current (HCN). The duration and even the sizes of spontaneous and driven hyperpolarizations and pauses in spontaneous activity in cholinergic interneurons are largely autonomous properties of the neuron, rather than reflections of characteristics of the input eliciting the response.	Univ Texas, Dept Biol, San Antonio, TX 78249 USA	University of Texas System	Wilson, CJ (corresponding author), Univ Texas, Dept Biol, 6900 North Loop,1604 West, San Antonio, TX 78249 USA.	charles.wilson@utsa.edu	Wilson, Charles/D-2529-2011	Wilson, Charles/0000-0002-9004-2145	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037760, R01NS037760] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37760] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; AKINS PT, 1990, NATURE, V344, P240, DOI 10.1038/344240a0; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 1999, J NEUROSCI, V19, P5586; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; Choe H, 1998, J GEN PHYSIOL, V112, P433, DOI 10.1085/jgp.112.4.433; Crunelli V, 2002, PHILOS T R SOC B, V357, P1675, DOI 10.1098/rstb.2002.1155; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Farries MA, 2002, J NEUROSCI, V22, P3776; Gabel LA, 1999, J NEUROPHYSIOL, V81, P1418, DOI 10.1152/jn.1999.81.3.1418; HAGIWARA S, 1978, J PHYSIOL-LONDON, V279, P167, DOI 10.1113/jphysiol.1978.sp012338; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; KAWAGUCHI Y, 1992, J NEUROPHYSIOL, V67, P1669, DOI 10.1152/jn.1992.67.6.1669; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Lin JY, 2004, EUR J NEUROSCI, V20, P1219, DOI 10.1111/j.1460-9568.2004.03576.x; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; Partridge JG, 2002, J NEUROSCI, V22, P2541, DOI 10.1523/JNEUROSCI.22-07-02541.2002; Reynolds JNJ, 2004, J NEUROSCI, V24, P9870, DOI 10.1523/JNEUROSCI.3225-04.2004; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; SHIMONI Y, 1992, J PHYSIOL-LONDON, V448, P709, DOI 10.1113/jphysiol.1992.sp019066; SILVER MR, 1990, J GEN PHYSIOL, V96, P109, DOI 10.1085/jgp.96.1.109; STANDEN NB, 1978, J PHYSIOL-LONDON, V280, P169, DOI 10.1113/jphysiol.1978.sp012379; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Yamada H, 2004, J NEUROSCI, V24, P3500, DOI 10.1523/JNEUROSCI.0068-04.2004; YAMAGUCHI K, 1990, J PHYSL, V426, P49; Zhang WL, 2002, J NEUROSCI, V22, P6347; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	39	116	117	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					575	585		10.1016/j.neuron.2004.12.053	http://dx.doi.org/10.1016/j.neuron.2004.12.053			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721243	Bronze			2022-12-28	WOS:000227099700013
J	Chen, YA; Yu, FH; Surmeier, DJ; Scheuer, T; Catterall, WA				Chen, YA; Yu, FH; Surmeier, DJ; Scheuer, T; Catterall, WA			Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C	NEURON			English	Article							BRAIN SODIUM-CHANNELS; RAT HIPPOCAMPAL-NEURONS; CA1 PYRAMIDAL NEURONS; ALPHA-SUBUNIT; TRANSMEMBRANE SEGMENT; ACTION-POTENTIALS; SELECTIVE PHOSPHORYLATION; STRUCTURAL REARRANGEMENT; MOLECULAR DETERMINANTS; FUNCTIONAL MODULATION	Neurotransmitters modulate sodium channel availability through activation of G protein-coupled receptors, cAMP-dependent protein kinase (PKA), and protein kinase C (PKC). Voltage-dependent slow inactivation also controls sodium channel availability, synaptic integration, and neuronal firing. Here we show by analysis of sodium channel mutants that neuromodulation via PKA and PKC enhances intrinsic slow inactivation of sodium channels, making them unavailable for activation. Mutations in the S6 segment in domain III (N1466A,D) either enhance or block slow inactivation, implicating S6 segments in the molecular pathway for slow inactivation. Modulation of N1466A channels by PKC or PKA is increased, whereas modulation of N1466D is nearly completely blocked. These results demonstrate that neuromodulation by PKA and PKC is caused by their enhancement of intrinsic slow inactivation gating. Modulation of slow inactivation by neurotransmitters acting through G protein-coupled receptors, PKA, and PKC is a flexible mechanism of cellular plasticity controlling the firing behavior of central neurons.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu		Yu, Frank/0000-0001-9306-1731	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043065, R37NS034696, R01NS015751, R01NS034696] Funding Source: NIH RePORTER; NINDS NIH HHS [NS43065, NS15751, NS34696] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balser JR, 2001, TRENDS CARDIOVAS MED, V11, P229, DOI 10.1016/S1050-1738(01)00116-5; Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; Brunet S, 2005, J GEN PHYSIOL, V126, P311, DOI 10.1085/jgp.200509333; Cannon SC, 1996, ANNU REV NEUROSCI, V19, P141, DOI 10.1146/annurev.ne.19.030196.001041; Cantrell AR, 1999, J NEUROSCI, V19, P5301; Cantrell AR, 1997, J NEUROSCI, V17, P7330; Cantrell AR, 2002, MOL CELL NEUROSCI, V21, P63, DOI 10.1006/mcne.2002.1162; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; Carr DB, 2002, J NEUROSCI, V22, P6846; CARR DB, 2000, NEURON, V26, P13; Chen Y, 2005, J NEUROSCI, V25, P507, DOI 10.1523/JNEUROSCI.4089-04.2005; Colbert CM, 1997, J NEUROSCI, V17, P6512; COSTA MRC, 1982, J BIOL CHEM, V257, P7918; COSTA MRC, 1984, CELL MOL NEUROBIOL, V4, P291, DOI 10.1007/BF00733592; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; Cummins TR, 1996, BIOPHYS J, V71, P227, DOI 10.1016/S0006-3495(96)79219-6; DASCAL N, 1991, NEURON, V6, P165, DOI 10.1016/0896-6273(91)90131-I; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Featherstone DE, 1996, BIOPHYS J, V71, P3098, DOI 10.1016/S0006-3495(96)79504-8; Gonzalez-Burgos G, 2001, J NEUROPHYSIOL, V86, P1671, DOI 10.1152/jn.2001.86.4.1671; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Jung HY, 1997, J NEUROSCI, V17, P6639; Kontis KJ, 1997, J GEN PHYSIOL, V110, P403, DOI 10.1085/jgp.110.4.403; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; Linford NJ, 1998, P NATL ACAD SCI USA, V95, P13947, DOI 10.1073/pnas.95.23.13947; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Mitrovic N, 2000, J GEN PHYSIOL, V115, P707, DOI 10.1085/jgp.115.6.707; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; Nau C, 1999, MOL PHARMACOL, V56, P404, DOI 10.1124/mol.56.2.404; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; O'Reilly JP, 2001, BIOPHYS J, V81, P2100, DOI 10.1016/S0006-3495(01)75858-4; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; ROSSIE S, 1987, J BIOL CHEM, V262, P12735; ROSSIE S, 1989, J BIOL CHEM, V264, P14220; ROSSIE S, 1987, J BIOL CHEM, V262, P17530; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; Ruff RL, 2000, NEUROLOGY, V54, P2191, DOI 10.1212/WNL.54.11.2191; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; Smith RD, 1996, J NEUROSCI, V16, P1965; Smith RD, 1997, J NEUROSCI, V17, P6086; Struyk AF, 2002, J GEN PHYSIOL, V120, P509, DOI 10.1085/jgp.20028672; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Surmeier D. James, 1997, Japanese Journal of Psychopharmacology, V17, P105; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Vedantham V, 1998, J GEN PHYSIOL, V111, P83, DOI 10.1085/jgp.111.1.83; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; Vilin YY, 2001, BIOPHYS J, V80, P2221, DOI 10.1016/S0006-3495(01)76195-4; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; Yarov-Yarovoy V, 2002, J BIOL CHEM, V277, P35393, DOI 10.1074/jbc.M206126200; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	71	116	117	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					409	420		10.1016/j.neuron.2006.01.009	http://dx.doi.org/10.1016/j.neuron.2006.01.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446144	Bronze			2022-12-28	WOS:000235260900012
J	Engbert, R				Engbert, R			Flick-induced flips in perception	NEURON			English	Editorial Material							LATERAL GENICULATE-NUCLEUS; EYE-MOVEMENTS; COVERT ATTENTION; MICROSACCADES; FIXATION; CORTEX	Microsaccades are miniature eye movements produced involuntarily during visual fixation of stationary objects. Since their first description more than 40 years ago, the role of microsaccades in vision has been controversial. In this issue, Martinez-Conde and colleagues present a solution to the long-standing research problem connecting this basic oculomotor function to visual perception, by showing that microsaccades may control peripheral vision during visual fixation by inducing flips in bistable peripheral percepts in head-unrestrained viewing. Their study provides new insight into the functional connectivity between oculomotor function and visual perception.	Univ Potsdam, Dept Psychol, D-14415 Potsdam, Germany	University of Potsdam	Engbert, R (corresponding author), Univ Potsdam, Dept Psychol, D-14415 Potsdam, Germany.		Engbert, Ralf/AAC-4860-2020	Engbert, Ralf/0000-0002-2909-5811				COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; Steinman R., 2003, VISUAL NEUROSCIENCES, P1339	12	10	10	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 19	2006	49	2					168	170		10.1016/j.neuron.2006.01.005	http://dx.doi.org/10.1016/j.neuron.2006.01.005			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423689	Bronze			2022-12-28	WOS:000234979900002
J	Shu, TZ; Tseng, HC; Sapir, T; Stern, P; Zhou, Y; Sanada, K; Fischer, A; Coquelle, FM; Reiner, O; Tsai, LH				Shu, TZ; Tseng, HC; Sapir, T; Stern, P; Zhou, Y; Sanada, K; Fischer, A; Coquelle, FM; Reiner, O; Tsai, LH			Doublecortin-like kinase controls neurogenesis by regulating mitotic spindles and M phase progression	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; DIEKER LISSENCEPHALY GENE; CYTOPLASMIC DYNEIN; NEURONAL POLARITY; PROGENITOR CELLS; LIS1; PHOSPHORYLATION; ENCODES; TAU; MUTATIONS	The mechanisms controlling neurogenesis during brain development remain relatively unknown. Through a differential protein screen with developmental versus mature neural tissues, we identified a group of developmentally enriched microtubule-associated proteins (MAPs) including doublecortin-like kinase (DCLK), a protein that shares high homology with doublecortin (DCX). DCLK, but not DCX, is highly expressed in regions of active neurogenesis in the neocortex and cerebellum. Through a dynein-dependent mechanism, DCLK regulates the formation of bipolar mitotic spindles and the proper transition from prometaphase to metaphase during mitosis. In cultured cortical neural progenitors, DCLK RNAi Lentivirus disrupts the structure of mitotic spindles and the progression of M phase, causing an increase of cell-cycle exit index and an ectopic commitment to a neuronal fate. Furthermore, both DCLK gain and loss of function in vivo specifically promote a neuronal identity in neural progenitors. These data provide evidence that DCLK controls mitotic division by regulating spindle formation and also determines the fate of neural progenitors during cortical neurogenesis.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; MIT, Canc Res Ctr, Cambridge, MA 02139 USA; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Weizmann Institute of Science	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	Reiner, Orly/E-9455-2010; SANADA, YOSHIKADO/G-5014-2014	Reiner, Orly/0000-0001-7560-9599; Fischer, Andre/0000-0001-8546-1161; Sanada, Kamon/0000-0002-0280-8957; COQUELLE, Frederic/0000-0002-5483-8787	FOGARTY INTERNATIONAL CENTER [R03TW007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER; FIC NIH HHS [R03TW007048] Funding Source: Medline; NINDS NIH HHS [NS37007] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Beghini A, 2003, ONCOGENE, V22, P2581, DOI 10.1038/sj.onc.1206336; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Edelman AM, 2005, J BIOL CHEM, V280, P8531, DOI 10.1074/jbc.M411027200; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HOEHI M, 1992, EUR J BIOCHEM, V203, P43; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Lin PT, 2000, J NEUROSCI, V20, P9152; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Paglini G, 2000, NEUROCHEM RES, V25, P37, DOI 10.1023/A:1007531230651; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; SLOBODA RD, 1998, CELL LAB MANUEL; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6	67	112	116	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					25	39		10.1016/j.neuron.2005.10.039	http://dx.doi.org/10.1016/j.neuron.2005.10.039			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387637	Bronze			2022-12-28	WOS:000236699300007
J	Lear, BC; Merrill, CE; Lin, JM; Schroeder, A; Zhang, LY; Allada, R				Lear, BC; Merrill, CE; Lin, JM; Schroeder, A; Zhang, LY; Allada, R			A G protein-coupled receptor, groom-of-PDF, is required for PDF neuron action in circadian behavior	NEURON			English	Article							DROSOPHILA-MELANOGASTER; PACEMAKER NEURONS; CLOCK GENES; RHYTHMS; BRAIN; TRANSCRIPTION; TIMELESS; MUTANTS; SYSTEM; OUTPUT	The neuropeptide Pigment-Dispersing Factor (PDF) plays a critical role in mediating circadian control of behavior in Drosophila. Here we identify mutants (groom-of-PDF; gop) that display phase-advanced evening activity and poor free-running rhythmicity, phenocopying pdf mutants. In gop mutants, a spontaneous retrotransposon disrupts a coding exon of a G protein-coupled receptor, CG13758. Disruption of the receptor is accompanied by phase-advanced oscillations of the core clock protein PERIOD. Moreover, effects on circadian timing induced by perturbation of PDF neurons require gop. Yet PDF oscillations themselves remain robust in gop mutants, suggesting that GOP acts downstream of PDF. gop is expressed most strongly in the dorsal brain in regions that lie in proximity to PDF-containing nerve terminals. Taken together, these studies implicate GOP as a PDF receptor in Drosophila.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.	r-allada@northwestern.edu	Lear, Bridget/A-1350-2013					Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; DRYSDALE R, 1991, GENETICS, V127, P497; DUSHAY MS, 1989, J BIOL RHYTHM, V4, P1, DOI 10.1177/074873048900400101; Gelbart WM, 2002, NUCLEIC ACIDS RES, V30, P106; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2003, MICROSC RES TECHNIQ, V62, P94, DOI 10.1002/jemt.10357; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hendricks JC, 2004, SLEEP, V27, P334, DOI 10.1093/sleep/27.2.334; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1998, CURR OPIN NEUROBIOL, V8, P652, DOI 10.1016/S0959-4388(98)80095-0; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; WILL BM, 1981, J MOL BIOL, V153, P897, DOI 10.1016/0022-2836(81)90458-7; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	34	180	184	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					221	227		10.1016/j.neuron.2005.09.008	http://dx.doi.org/10.1016/j.neuron.2005.09.008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242403	Bronze			2022-12-28	WOS:000232838700012
J	Lee, JLC; Di Ciano, P; Thomas, KL; Everitt, BJ				Lee, JLC; Di Ciano, P; Thomas, KL; Everitt, BJ			Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior	NEURON			English	Article							SELF-ADMINISTERED COCAINE; FEAR MEMORY; EXCITOTOXIC LESIONS; 2ND-ORDER SCHEDULE; NUCLEUS-ACCUMBENS; PROTEIN-SYNTHESIS; CENTRAL AMYGDALA; STIMULI; CONSOLIDATION; RATS	Maladaptive memories that associate environmental stimuli with the effects of drugs of abuse are known to be a major cause of relapse to, and persistence of, a drug addictive habit. However, memories may be disrupted after their acquisition and consolidation by impairing their reconsolidation. Here, we show that infusion of Zif268 antisense oligodeoxynucleotides into the basolateral amygdala, prior to the reactivation of a well-learned memory for a conditioned stimulus (CS)-cocaine association, abolishes the acquired conditioned reinforcing properties of the drug-associated stimulus and thus its impact on the learning of a new cocaine-seeking response. Furthermore, we show that reconsoliclation of CS-fear memories also requires Zif268 in the amygdala. These results demonstrate that appetitive CS-drug memories undergo reconsoliclation in a manner similar to aversive memories and that this amygdala-dependent reconsolidation can be disrupted to reduce the impact of drug cues on drug seeking.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Lee, JLC (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	jlcl2@cam.ac.uk	Thomas, Kerrie L/A-6509-2010; Lee, Jonathan LC/A-9629-2008	Thomas, Kerrie L/0000-0003-3355-9583; Lee, Jonathan LC/0000-0002-2284-2482; Everitt, Barry/0000-0003-4431-6536	Medical Research Council [G9537855] Funding Source: Medline; MRC [G9537855] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; Bebien M, 2003, ONCOGENE, V22, P1836, DOI 10.1038/sj.onc.1206334; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Ciccocioppo R, 2004, NAT NEUROSCI, V7, P495, DOI 10.1038/nn1219; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Di Ciano P, 2003, BEHAV NEUROSCI, V117, P952, DOI 10.1037/0735-7044.117.5.952; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; DSM-IV-TR, 2000, DIAGN STAT MAN MENT, V4th; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Everitt B.J., 2000, AMYGDALA FUNCTIONAL, P353; Fuchs RA, 1998, PSYCHOPHARMACOLOGY, V135, P151, DOI 10.1007/s002130050496; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; GOLDBERG SR, 1975, PHARMACOL REV, V27, P325; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Kruzich PJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-14-j0002.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Maren S, 2003, EUR J NEUROSCI, V18, P3080, DOI 10.1111/j.1460-9568.2003.03063.x; Meil WM, 1996, BEHAV PHARMACOL, V7, P754; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Ranaldi R, 1996, PSYCHOPHARMACOLOGY, V128, P89, DOI 10.1007/s002130050114; Robledo P, 1996, BEHAV NEUROSCI, V110, P981, DOI 10.1037/0735-7044.110.5.981; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Thomas KL, 2003, EUR J NEUROSCI, V17, P1964, DOI 10.1046/j.1460-9568.2003.02617.x; Wang SH, 2005, J NEUROSCI, V25, P830, DOI 10.1523/JNEUROSCI.4716-04.2005; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	45	281	300	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 15	2005	47	6					795	801		10.1016/j.neuron.2005.08.007	http://dx.doi.org/10.1016/j.neuron.2005.08.007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	967IN	16157275	Bronze			2022-12-28	WOS:000232085000008
J	Roux, B				Roux, B			The art of dissecting the function of a potassium channel	NEURON			English	Editorial Material								The essential function of potassium channels is to selectively facilitate the passage of K ions across the cell membrane by lowering the energy barrier that opposes this process. In this issue of Neuron, Chatelain et al. report the results from an elegant study that sheds new light on the microscopic factors that modulate the function of these important membrane channels.	Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	Cornell University	Roux, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, 1300 York Ave, New York, NY 10021 USA.							Allen TW, 2004, J GEN PHYSIOL, V124, P679, DOI 10.1085/jgp.200409111; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943	4	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 15	2005	47	6					777	778		10.1016/j.neuron.2005.08.031	http://dx.doi.org/10.1016/j.neuron.2005.08.031			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157271	Bronze			2022-12-28	WOS:000232085000004
J	Machens, CK; Gollisch, T; Kolesnikova, O; Herz, AVM				Machens, CK; Gollisch, T; Kolesnikova, O; Herz, AVM			Testing the efficiency of sensory coding with optimal stimulus ensembles	NEURON			English	Article							GRASSHOPPER CHORTHIPPUS-BIGUTTULUS; INFORMATION-TRANSMISSION; NATURALISTIC STIMULI; ENTROPY; EMERGENCE; MECHANISM; ACRIDIDAE	According to Barlow's seminal "efficient coding hypothesis," the coding strategy of sensory neurons should be matched to the statistics of stimuli that occur in an animal's natural habitat. Using an automatic search technique, we here test this hypothesis and identify stimulus ensembles that sensory neurons are optimized for. Focusing on grasshopper auditory receptor neurons, we find that their optimal stimulus ensembles differ from the natural environment, but largely overlap with a behaviorally important sub-ensemble of the natural sounds. This indicates that the receptors are optimized for peak rather than average performance. More generally, our results suggest that the coding strategies of sensory neurons are heavily influenced by differences in behavioral relevance among natural stimuli.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; Bernstein Ctr Computat Neurosci, D-10099 Berlin, Germany	Cold Spring Harbor Laboratory; Humboldt University of Berlin	Machens, CK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	machens@cshl.edu		Machens, Christian/0000-0003-1717-1562; Gollisch, Tim/0000-0003-3998-533X				Attias H, 1998, ADV NEUR IN, V10, P103; Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Borst A, 2003, J COMPUT NEUROSCI, V14, P23, DOI 10.1023/A:1021172200868; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Chacron MJ, 2003, NATURE, V423, P77, DOI 10.1038/nature01590; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; ECKHORN R, 1976, BIOL CYBERN, V22, P49, DOI 10.1007/BF00340232; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Gollisch T, 2005, PLOS BIOL, V3, P144, DOI 10.1371/journal.pbio.0030008; Gollisch T, 2002, J NEUROSCI, V22, P10434; Hauser, 1996, EVOL COMMUN; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; Hyvarinen A, 2000, ADV NEUR IN, V12, P827; Johnson DH, 1996, J COMPUT NEUROSCI, V3, P275, DOI 10.1007/BF00161089; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Machens CK, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228104; Machens CK, 2003, NAT NEUROSCI, V6, P341, DOI 10.1038/nn1036; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Meyer J, 1996, J EXP BIOL, V199, P1631; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Reinagel P, 2001, CURR OPIN NEUROBIOL, V11, P437, DOI 10.1016/S0959-4388(00)00231-2; REINAGEL P., 1999, NETWORK COMPUTATION, V10, P1; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rieke F., 1997, SPIKES EXPLORING NEU; ROMER H, 1976, J COMP PHYSIOL, V109, P101; RONACHER B, 1985, J COMP PHYSIOL A, V157, P631, DOI 10.1007/BF01351357; SCHAETTE R, 2005, IN PRESS J NEUROPHYS; Schneidman E, 2000, ADV NEUR IN, V12, P178; Schreiber S, 2002, NEURAL COMPUT, V14, P1323, DOI 10.1162/089976602753712963; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; VONHELVERSEN D, 1994, PROG ZOOL, V39, P253; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7	43	74	74	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					447	456		10.1016/j.neuron.2005.06.015	http://dx.doi.org/10.1016/j.neuron.2005.06.015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055067	Bronze			2022-12-28	WOS:000231051900014
J	Goto, Y; Grace, AA				Goto, Y; Grace, AA			Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: Disruption by cocaine sensitization	NEURON			English	Article							LONG-TERM DEPRESSION; IN-VIVO; FUNCTIONAL CONNECTIVITY; HIPPOCAMPAL-FORMATION; LATERAL AMYGDALA; CORTEX; NEURONS; RAT; SCHIZOPHRENIA; MODULATION	The prefrontal cortex and the hippocampus exhibit converging projections to the nucleus accumbens and have functional reciprocal connections via indirect pathways. As a result, information processing between these structures is likely to be bidirectional. Using evoked potential measures, we examined the interactions of these inputs on synaptic plasticity within the accumbens. Our results show that the direction of information flow between the prefrontal cortex and limbic structures determines the synaptic plasticity that these inputs exhibit within the accumbens. Moreover, this synaptic plasticity at hippocampal and prefrontal inputs selectively involves dopamine D1 and D2 activation or inactivation, respectively. Repeated cocaine administration disrupted this synaptic plasticity at hippocampal and prefrontal cortical inputs and goal-directed behavior in the spatial maze task. Thus, interactions of limbic-prefrontal cortical synaptic plasticity and its dysfunction within the accumbens could underlie complex information processing deficits observed in individuals following psychostimulant administration.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goto, Y (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	goto@bns.pift.edu		Grace, Anthony/0000-0003-1864-5504	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057440, R01MH057440] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57440] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; Della-Maggiore V, 2000, J NEUROSCI, V20, P8410, DOI 10.1523/JNEUROSCI.20-22-08410.2000; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Finch DM, 1996, HIPPOCAMPUS, V6, P495; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Floresco SB, 2001, J NEUROSCI, V21, P6370, DOI 10.1523/JNEUROSCI.21-16-06370.2001; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; FUSTER JM, 1997, PREFRONTAL CORTEX; Gilboa A, 2004, BIOL PSYCHIAT, V55, P263, DOI 10.1016/j.biopsych.2003.08.004; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; HALL H, 1985, EUR J PHARMACOL, V111, P191, DOI 10.1016/0014-2999(85)90756-3; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Jackson ME, 2001, J NEUROCHEM, V78, P920, DOI 10.1046/j.1471-4159.2001.00499.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kolb B, 2003, P NATL ACAD SCI USA, V100, P10523, DOI 10.1073/pnas.1834271100; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kyd RJ, 2003, CEREB CORTEX, V13, P444, DOI 10.1093/cercor/13.5.444; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Mangiavacchi S, 2004, EUR J NEUROSCI, V20, P649, DOI 10.1111/j.1460-9568.2004.03511.x; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Mulder AB, 1997, EUR J NEUROSCI, V9, P1603, DOI 10.1111/j.1460-9568.1997.tb01518.x; ODONNELL P, 1994, BRAIN RES, V634, P105, DOI 10.1016/0006-8993(94)90263-1; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Ragozzino ME, 2002, BEHAV NEUROSCI, V116, P105, DOI 10.1037/0735-7044.116.1.105; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seamans JK, 1998, J NEUROSCI, V18, P1613; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; Silbersweig D, 1996, MOL PSYCHIATR, V1, P367; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Stanton PK, 2003, J NEUROSCI, V23, P5936; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; VOORN P, 1986, J COMP NEUROL, V251, P84, DOI 10.1002/cne.902510106; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wall PM, 2001, BEHAV BRAIN RES, V127, P99, DOI 10.1016/S0166-4328(01)00355-2; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; [No title captured]	54	162	168	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					255	266		10.1016/j.neuron.2005.06.017	http://dx.doi.org/10.1016/j.neuron.2005.06.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039567	Bronze			2022-12-28	WOS:000230693900012
J	Kreher, SA; Kwon, JY; Carlson, JR				Kreher, SA; Kwon, JY; Carlson, JR			The molecular basis of odor coding in the Drosophila larva	NEURON			English	Article							OLFACTORY SENSORY MAP; ANTENNAL LOBE; MELANOGASTER MEIGEN; NERVOUS-SYSTEM; FLY BRAIN; RECEPTORS; NEURONS; ORGANIZATION; INFORMATION; EXPRESSION	We hive analyzed the molecular basis of odor coding in the Drosophila larva. A subset of Or genes is found to be expressed in larval olfactory receptor neurons (ORNs). Using an in vivo expression system and electrophysiology, we demonstrate that these genes encode functional odor receptors and determine their response spectra with 27 odors. The receptors vary in their breadth of tuning, exhibit both excitation and inhib tion, and show different onset and termination kinetics. An individual receptor appears to transmit signa Is via a single ORN to a single glomerulus in the larval antennal lobe. We provide a spatial map of odor information in the larval brain and find that ORNs with related functional specificity map to related spatial positions. The results show how one family of receptors underlies odor coding in two markedly different olfactory systems; they also provide a molecular mechanism to explain longstanding observations of larval odor discrimination.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu			NIDCD NIH HHS [DC04729] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; Cobb M, 1996, GENETICS, V144, P1577; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fox AN, 2002, CHEM SENSES, V27, P453, DOI 10.1093/chemse/27.5.453; Friedrich RW, 2004, NATURE, V430, P511, DOI 10.1038/430511a; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Hertweck H, 1931, Z WISS ZOOL ABT A, V139, P559; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Oppliger FY, 2000, J INSECT PHYSIOL, V46, P135, DOI 10.1016/S0022-1910(99)00109-2; Park Y, 1997, J NEUROBIOL, V33, P199, DOI 10.1002/(SICI)1097-4695(199708)33:2<199::AID-NEU8>3.0.CO;2-Y; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; RODRIGUES V, 1980, OLFACTORY BEHAV DROS; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SIDDIQI O, 1983, OLFACTORY NEUROGENET; SINGH RN, 1984, INT J INSECT MORPHOL, V13, P255, DOI 10.1016/0020-7322(84)90001-1; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7	52	223	227	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					445	456		10.1016/j.neuron.2005.04.007	http://dx.doi.org/10.1016/j.neuron.2005.04.007			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882644	Bronze			2022-12-28	WOS:000229011400016
J	Mehta, SQ; Hiesinger, PR; Beronja, S; Zhal, RG; Schulze, KL; Verstreken, P; Cao, Y; Zhou, Y; Tepass, U; Crair, MC; Bellen, HJ				Mehta, SQ; Hiesinger, PR; Beronja, S; Zhal, RG; Schulze, KL; Verstreken, P; Cao, Y; Zhou, Y; Tepass, U; Crair, MC; Bellen, HJ			Mutations in Drosophila sec15 reveal a function in neuronal targeting for a subset of exocyst components	NEURON			English	Article							REPRESSIBLE CELL MARKER; VISUAL-SYSTEM; PLASMA-MEMBRANE; SEC6/8 COMPLEX; NEURITE OUTGROWTH; MAMMALIAN EXOCYST; EPITHELIAL-CELLS; GOLGI TRANSPORT; MOSAIC ANALYSIS; NERVOUS-SYSTEM	The exocyst is a complex of proteins originally identified in yeast that has been implicated in polarized secretion. Components of the exocyst have been implicated in neurite outgrowth, cell polarity, and cell viability. We have isolated an exocyst component, sec15, in a screen for genes required for synaptic specificity. Loss of sec15 causes a targeting defect of photoreceptors that coincides with mislocalization of specific cell adhesion and signaling molecules. Additionally, sec15 mutant neurons fail to localize other exocyst members like Sec5 and Sec8, but not Sec6, to neuronal terminals. However, loss of sec15 does not cause cell lethality in contrast to loss of sec5 or sec6. Our data suggest a role of Sec15 in an exocyst-like subcomplex for the targeting and subcellular distribution of specific proteins. The data also show that functions of other exocyst components persist in the absence of sec15, suggesting that different exocyst components have separable functions.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; University of Toronto	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, 1 Baylor Pl, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Verstreken, Patrik/AAC-7591-2022; Zhai, R. Grace/AGZ-3936-2022	Verstreken, Patrik/0000-0002-5073-5393; Beronja, Slobodan/0000-0002-6769-9261; Zhai, Rong/0000-0002-7599-1430; Bellen, Hugo/0000-0001-5992-5989; Mehta, Sunil/0000-0003-3020-4939	NEI NIH HHS [R01 EY015788, EY07001] Funding Source: Medline; NIMH NIH HHS [MH62639] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062639] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andrews HK, 2002, TRAFFIC, V3, P906, DOI 10.1034/j.1600-0854.2002.31206.x; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Elul TM, 2003, J NEUROSCI, V23, P6567; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; FROHLICH A, 1983, J NEUROSCI, V3, P2336; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hiesinger PR, 1999, J NEUROSCI, V19, P7548, DOI 10.1523/JNEUROSCI.19-17-07548.1999; Hiesinger PR, 2001, J COMP NEUROL, V429, P277, DOI 10.1002/1096-9861(20000108)429:2<277::AID-CNE8>3.0.CO;2-8; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Meinertzhagen Ian A., 1993, P1363; Murthy M, 2004, DEVELOPMENT, V131, P377, DOI 10.1242/dev.00931; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Newsome TP, 2000, DEVELOPMENT, V127, P851; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Scheibel T, 2004, J MOL NEUROSCI, V23, P13, DOI 10.1385/JMN:23:1-2:013; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Spang A, 2004, CURR BIOL, V14, pR33, DOI 10.1016/j.cub.2003.12.021; STARK WS, 1989, J NEUROGENET, V5, P127, DOI 10.3109/01677068909066203; Stowers RS, 1999, GENETICS, V152, P1631; Symons JR, 2002, BIOCHEM J, V365, P513, DOI 10.1042/BJ20020381; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vik-Mo EO, 2003, NEUROSCIENCE, V119, P73, DOI 10.1016/S0306-4522(03)00065-4; Wang S, 2004, J BIOL CHEM, V279, P35958, DOI 10.1074/jbc.M313778200; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	66	113	115	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					219	232		10.1016/j.neuron.2005.02.029	http://dx.doi.org/10.1016/j.neuron.2005.02.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848801	Bronze			2022-12-28	WOS:000228674800009
J	Siapas, AG; Lubenov, EV; Wilson, MA				Siapas, AG; Lubenov, EV; Wilson, MA			Prefrontal phase locking to hippocampal theta oscillations	NEURON			English	Article							TIME-DEPENDENT REORGANIZATION; STOCHASTIC POINT PROCESSES; LONG-TERM POTENTIATION; NEURONAL SPIKE TRAINS; DIRECT PROJECTION; ANESTHETIZED RAT; UNIT DISCHARGES; CORTEX PATHWAY; AMMONS HORN; IN-VIVO	The interactions between cortical and hippocampal circuits are critical for memory formation, yet their basic organization at the neuronal network level is not well understood. Here, we demonstrate that a significant portion of neurons in the medial prefrontal cortex of freely behaving rats are phase locked to the hippocampal theta rhythm. In addition, we show that prefrontal neurons phase lock best to theta oscillations delayed by approximately 50 ms and confirm this hippocampo-prefrontal directionality and timing at the level of correlations between single cells. Finally, we find that phase locking of prefrontal cells is predicted by the presence of significant correlations with hippocampal cells at positive delays up to 150 ms. The theta-entrained activity across cortico-hippocampal circuits described here may be important for gating information flow and guiding the plastic changes that are believed to underlie the storage of information across these networks.	CALTECH, Computat & Neural Syst Program, Div Biol, Div Engn & Appl Sci, Pasadena, CA 91125 USA; MIT, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Dept Biol, Cambridge, MA 02139 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT)	Siapas, AG (corresponding author), CALTECH, Computat & Neural Syst Program, Div Biol, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	thanos@caltech.edu						ALONSO A, 1987, EXP BRAIN RES, V67, P502, DOI 10.1007/BF00247283; Bassant MH, 2001, HIPPOCAMPUS, V11, P809, DOI 10.1002/hipo.1096; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BRILLINGER DR, 1976, AM MATH MON, V83, P16, DOI 10.2307/2318824; BUZSAKI G, 1985, ELECTROEN CLIN NEURO, V61, P77, DOI 10.1016/0013-4694(85)91075-2; BUZSAKI G, 1983, BRAIN RES, V266, P334, DOI 10.1016/0006-8993(83)90665-0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; COLOM LV, 1988, BRAIN RES, V460, P329, DOI 10.1016/0006-8993(88)90377-0; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; FERINO F, 1987, EXP BRAIN RES, V65, P421; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Floresco SB, 1997, J NEUROSCI, V17, P1880; FOX SE, 1986, EXP BRAIN RES, V62, P495; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Gambini JP, 2002, BRAIN RES, V926, P137, DOI 10.1016/S0006-8993(01)03321-2; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Halliday D.M., 1999, TIME FREQUENCY DOMAI, P503, DOI DOI 10.1007/978-3-642-58552-4_18; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; HU H, 2002, J PHYSL, V543, P783; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; JAY TM, 1992, EUR J NEUROSCI, V4, P1285, DOI 10.1111/j.1460-9568.1992.tb00154.x; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; KOCSIS B, 1992, J NEUROPHYSIOL, V68, P1463, DOI 10.1152/jn.1992.68.4.1463; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Miller R., 1991, CORTICOHIPPOCAMPAL I; Natsume K, 1999, HIPPOCAMPUS, V9, P500, DOI 10.1002/(SICI)1098-1063(1999)9:5<500::AID-HIPO3>3.0.CO;2-F; Pare D, 1996, J NEUROSCI, V16, P3334; Pedemonte M, 1996, EXP BRAIN RES, V112, P41; Pedemonte M., 2001, SLEEP RES, VOnline4, P51; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; Takehara K, 2003, J NEUROSCI, V23, P9897; Takita M, 1999, EUR J NEUROSCI, V11, P4145, DOI 10.1046/j.1460-9568.1999.00870.x; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VINOGRADOVA OS, 1977, ZH VYSSH NERV DEYAT+, V27, P1165; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Zar, 2011, BIOSTAT ANAL	52	691	701	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					141	151		10.1016/j.neuron.2005.02.028	http://dx.doi.org/10.1016/j.neuron.2005.02.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820700	Bronze			2022-12-28	WOS:000228228600015
J	Niell, CM; Smith, SJ				Niell, CM; Smith, SJ			Functional imaging reveals rapid development of visual response properties in the zebrafish tectum	NEURON			English	Article							IN-VIVO; RETINOTECTAL PROJECTION; SYNAPSE FORMATION; DENDRITIC ARBOR; MAP FORMATION; VERTEBRATE; SYNAPTOGENESIS; PSYCHOPHYSICS; CONNECTIONS; MODULATION	The visual pathway from the retina to the optic tectum in fish and frogs has long been studied as a model for neural circuit formation. Although morphological aspects, such as axonal and dendritic arborization, have been well characterized, less is known about how this translates into functional properties of tectal neurons during development. We developed a system to provide controlled visual stimuli to larval zebrafish, while performing two-photon imaging of tectal neurons loaded with a fluorescent calcium indicator, allowing us to determine visual response properties in intact fish. In relatively mature larvae, we describe receptive field sizes, visual topography, and direction and size selectivity. We also characterize the onset and development of visual responses, beginning when retinal axons first arborize in the tectum. Surprisingly, most of these properties are established soon after dendrite growth and synaptogenesis begin and do not require patterned visual experience or a protracted period of refinement.	Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cell Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Smith, SJ (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA 94305 USA.	sjsmith@stanford.edu		Smith, Stephen/0000-0002-2290-8701	NINDS NIH HHS [NS043461] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043461] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Baier H, 1996, DEVELOPMENT, V123, P415; Baier H, 2000, CURR OPIN NEUROBIOL, V10, P451, DOI 10.1016/S0959-4388(00)00116-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; Chapman B, 1996, J NEUROSCI, V16, P6443; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Easter SS, 1996, DEV BIOL, V180, P646; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fetcho JR, 1998, HISTOCHEM J, V30, P153, DOI 10.1023/A:1003243302777; Fraser S E, 1992, Curr Opin Neurobiol, V2, P83, DOI 10.1016/0959-4388(92)90167-J; Hutson LD, 2002, CURR OPIN NEUROBIOL, V12, P87, DOI 10.1016/S0959-4388(02)00294-5; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; OROURKE NA, 1986, DEV BIOL, V114, P265, DOI 10.1016/0012-1606(86)90191-0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2407, DOI 10.1016/0306-4522(82)90204-4; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2427, DOI 10.1016/0306-4522(82)90205-6; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; VANEGAS H, 1984, DEV RETINOTECTAL PRO; Westerfield M, 1993, ZEBRAFISH BOOK; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	32	158	161	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					941	951		10.1016/j.neuron.2005.01.047	http://dx.doi.org/10.1016/j.neuron.2005.01.047			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797554	Bronze			2022-12-28	WOS:000228031300014
J	Robinson, JM; Deutsch, C				Robinson, JM; Deutsch, C			Coupled tertiary folding and oligomerization of the T1 domain of Kv channels	NEURON			English	Article							SHAKER K+ CHANNEL; GATED POTASSIUM CHANNEL; TETRAMERIZATION DOMAIN; INACTIVATION; SUBUNIT; BETA; DETERMINANTS; ACTIVATION; INTERFACE; PROTEINS	Acquisition of secondary, tertiary, and quaternary structure is critical to the fabrication, assembly, and function of ion channels, yet the relationship between these biogenic events remains unclear. We now address this issue in voltage-gated K+ channels (Kv) for the T1 domain, an N-terminal Kv recognition domain that is responsible for subfamily-specific, efficient assembly of Kv subunits. This domain forms a 4-fold symmetric tetramer. We have identified residues along the axial T1-T1 interface that are critical for tertiary and quaternary structure, shown that mutations at one end of the axial T1 interface can perturb the crosslinking of an intersubunit cysteine pair at the other end, and demonstrated that tertiary folding and tetramerization of this Kv domain are coupled. A threshold level of tertiary folding is required for monomers to oligomerize. Coupling between tertiary and quaternary structure formation may be a common feature in the biogenesis of multimeric proteins.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Deutsch, C (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	cid@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052302] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 52302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; CHAHINE M, 1992, J MOL CELL CARDIOL, V24, P1231, DOI 10.1016/0022-2828(92)93090-7; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hebert DN, 1998, BIOCHEM CELL BIOL, V76, P867, DOI 10.1139/bcb-76-5-867; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MARQUARDT T, 1993, J BIOL CHEM, V268, P19618; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; SHEN NV, 1993, NEURON, V11, P67; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	38	45	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					223	232		10.1016/j.neuron.2004.12.043	http://dx.doi.org/10.1016/j.neuron.2004.12.043			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664174				2022-12-28	WOS:000226451500009
J	Goodrich, LV				Goodrich, LV			Hear, hear for the zebrafish	NEURON			English	Editorial Material							LATERAL-LINE; HAIR-CELLS; CADHERIN-23; CHANNEL	Our senses of hearing and balance rely on the function of specialized receptor neurons called "hair cells." In this issue of Neuron, Grant et al. report a series of elegant zebrafish experiments that reveal a previously unappreciated role for glia in the regulation of hair cell proliferation and differentiation. This work is a beautiful example of how zebrafish are particularly useful model systems for studying hair cell development and function.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goodrich, LV (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.							Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Grant KA, 2005, NEURON, V45, P69, DOI 10.1016/j.neuron.2004.12.020; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484	7	9	9	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					3	5		10.1016/j.neuron.2004.12.027	http://dx.doi.org/10.1016/j.neuron.2004.12.027			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629695	Bronze			2022-12-28	WOS:000226217100002
J	Kramer, I; Sigrist, M; de Nooij, JC; Taniuchi, I; Jessel, TM; Arber, S				Kramer, I; Sigrist, M; de Nooij, JC; Taniuchi, I; Jessel, TM; Arber, S			A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification	NEURON			English	Article							NEUROTROPHIC FACTOR; GENE-EXPRESSION; NERVE GROWTH; ABSENCE; TRKC; IDENTIFICATION; INNERVATION; ACTIVATION; AFFERENTS; PHENOTYPE	Subpopulations of sensory neurons in the dorsal root ganglion (DRG) can be characterized on the basis of sensory modalities that convey distinct peripheral stimuli, but the molecular mechanisms that underlie sensory neuronal diversification remain unclear. Here, we have used genetic manipulations in the mouse embryo to examine how Runx transcription factor signaling controls the acquisition of distinct DRG neuronal subtype identities. Runx3 acts to diversify an Ngn1-independent neuronal cohort by promoting the differentiation of proprioceptive sensory neurons through erosion of TrkB expression in prospective TrkC(+) sensory neurons. In contrast, Runx1 controls neuronal diversification within Ngn1-dependent TrkA(+) neurons by repression of neuropeptide CGRP expression and controlling the fine pattern of laminar termination in the dorsal spinal cord. Together, our findings suggest that Runx transcription factor signaling plays a key role in sensory neuron diversification.	Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; NYU, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA	University of Basel; Friedrich Miescher Institute for Biomedical Research; Columbia University; Howard Hughes Medical Institute; New York University; Howard Hughes Medical Institute; New York University	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068; Arber, Silvia/0000-0002-6261-250X				Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Baudet C, 2000, DEVELOPMENT, V127, P4335; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Friedel RH, 1997, P NATL ACAD SCI USA, V94, P12670, DOI 10.1073/pnas.94.23.12670; Funfschilling U, 2004, J COMP NEUROL, V480, P392, DOI 10.1002/cne.20359; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hellard D, 2004, DEV BIOL, V275, P34, DOI 10.1016/j.ydbio.2004.07.021; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Rini D, 2001, GENE, V273, P13, DOI 10.1016/S0378-1119(01)00579-0; Scott SA, 1992, SENSORY NEURONS DIVE; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang YK, 1996, NATURE, V379, P823, DOI 10.1038/379823a0; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	35	181	185	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					379	393		10.1016/j.neuron.2006.01.008	http://dx.doi.org/10.1016/j.neuron.2006.01.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446142	Bronze			2022-12-28	WOS:000235260900010
J	Wong, KY; Dunn, FA; Berson, DM				Wong, KY; Dunn, FA; Berson, DM			Photoreceptor adaptation in intrinsically photosensitive retinal ganglion cells	NEURON			English	Article							PUPILLARY LIGHT REFLEX; SUPRACHIASMATIC NUCLEUS; MAMMALIAN PINEAL; DARK-ADAPTATION; VISUAL PATHWAY; PHASE-SHIFTS; TIME-SCALE; MELANOPSIN; SENSITIVITY; RESPONSES	A rare type of mammalian retinal ganglion cell (RGC) expresses the photopigment melanopsin and is a photoreceptor. These intrinsically photosensitive RGCs (ipRGCs) drive circadian-clock resetting, pupillary constriction, and other non-image-forming photic responses. Both the light responses of ipRGCs and the behaviors they drive are remarkably sustained, raising the possibility that, unlike rods and cones, ipRGCs do not adjust their sensitivity according to lighting conditions ("adaptation"). We found, to the contrary, that ipRGC sensitivity is plastic, strongly influenced by lighting history. When exposed to a constant, bright background, the background-evoked response decayed, and responses to superimposed flashes grew in amplitude, indicating light adaptation. After extinction of a light-adapting background, sensitivity recovered progressively in darkness, indicating dark adaptation. Because these adjustments in sensitivity persisted when synapses were blocked, they constitute "photoreceptor adaptation" rather than "network adaptation." Implications for the mechanisms generating various non-image-forming visual responses are discussed.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Wong, KY (corresponding author), Brown Univ, Dept Neurosci, 190 Thayer St,Box 1953, Providence, RI 02912 USA.	kwoon_wong@brown.edu		Wong, Kwoon/0000-0001-9279-7827	NEI NIH HHS [R01 EY017137, T01 EY102793, F32 EY016678] Funding Source: Medline; NIMH NIH HHS [5 T32 MH19118] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY016678, R01EY017137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019118] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; Behn D, 2003, DOC OPHTHALMOL, V106, P153, DOI 10.1023/A:1022511918823; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Calvert PD, 2002, ADV EXP MED BIOL, V514, P37; CERVETTO L, 1985, EXP BIOL, V44, P147; Coogan AN, 2005, EUR J NEUROSCI, V22, P158, DOI 10.1111/j.1460-9568.2005.04193.x; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dowling J. E., 1987, RETINA APPROACHABLE; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FUORTES MGF, 1964, J PHYSIOL-LONDON, V172, P239, DOI 10.1113/jphysiol.1964.sp007415; Gomez MD, 1997, J GEN PHYSIOL, V109, P371, DOI 10.1085/jgp.109.3.371; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; GROOS GA, 1980, J COMP PHYSIOL, V135, P349, DOI 10.1007/BF00657651; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Lisman JE, 2002, ADV EXP MED BIOL, V514, P507; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; MARTIN C, 1990, J NEURAL TRANSM-GEN, V79, P81, DOI 10.1007/BF01251003; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MEIJER JH, 1992, BRAIN RES, V598, P257, DOI 10.1016/0006-8993(92)90191-B; Meijer JH, 1998, J NEUROSCI, V18, P9078; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Nelson DE, 1999, AM J PHYSIOL-REG I, V277, pR1351, DOI 10.1152/ajpregu.1999.277.5.R1351; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; OHBA N, 1972, VISION RES, V12, P953, DOI 10.1016/0042-6989(72)90017-X; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; PERLMAN I, 1978, J PHYSIOL-LONDON, V278, P161, DOI 10.1113/jphysiol.1978.sp012298; Perlman I, 1998, PROG RETIN EYE RES, V17, P523, DOI 10.1016/S1350-9462(98)00005-6; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Rodieck R.W., 1998, 1 STEPS SEEING; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; SHIMOMURA K, 1994, J BIOL RHYTHM, V9, P97, DOI 10.1177/074873049400900201; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; THIELE G, 1987, BRAIN RES, V424, P10, DOI 10.1016/0006-8993(87)91187-5; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4; TREJO LJ, 1982, VISION RES, V22, P1163, DOI 10.1016/0042-6989(82)90081-5; Van Gelder R N, 2001, Ophthalmic Genet, V22, P195, DOI 10.1076/opge.22.4.195.2215; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x	57	155	161	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1001	1010		10.1016/j.neuron.2005.11.016	http://dx.doi.org/10.1016/j.neuron.2005.11.016			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364903	Bronze			2022-12-28	WOS:000234301700015
J	Safo, PK; Regehr, WG				Safo, PK; Regehr, WG			Endocannabinoids control the induction of cerebellar LTD	NEURON			English	Article							LONG-TERM DEPRESSION; NITRIC-OXIDE RELEASE; METABOTROPIC GLUTAMATE RECEPTORS; PHOSPHOLIPASE-C-BETA; ENDOGENOUS CANNABINOIDS; PURKINJE-CELLS; PARALLEL FIBERS; SYNAPTIC-TRANSMISSION; RETROGRADE INHIBITION; PRESYNAPTIC INHIBITION	The long-term depression (LTD) of parallel fiber (PF) synapses onto Purkinje cells plays a central role in motor learning. Endocannabinoid release and LTD induction both depend upon activation of the metabotropic glutamate receptor mGluR1, require postsynaptic calcium increases, are synapse specific, and have a similar dependence on the associative activation of PF and climbing fiber synapses. These similarities suggest that endocannabinoid release could account for many features of cerebellar LTD. Here we show that LTD induction is blocked by a cannabinoid receptor (CB1R) antagonist, by inhibiting the synthesis of the endocannabinoid 2-arachidonyl glycerol (2-AG), and is absent in mice lacking the CB1R. Although CB1Rs are prominently expressed presynaptically at PF synapses, LTD is expressed postsynaptically. In contrast, a previously described transient form of inhibition mediated by endocannabinoids is expressed presynaptically. This indicates that Purkinje cells release 2-AG that activates CB1Rs to both transiently inhibit release and induce a postsynaptic form of LTD.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044396] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM20444] Funding Source: Medline; NINDS NIH HHS [R01-NS044396] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Alger BE, 2002, PROG NEUROBIOL, V68, P247; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Boxall AR, 1996, EUR J NEUROSCI, V8, P2209, DOI 10.1111/j.1460-9568.1996.tb00743.x; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; CARROLL R, 1992, LIPIDS, V27, P305, DOI 10.1007/BF02536481; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Dittman JS, 1996, J NEUROSCI, V16, P1623; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; Hartell Nicholas A, 2002, Cerebellum, V1, P3, DOI 10.1080/147342202753203041; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hillion P, 1999, J OPT A-PURE APPL OP, V1, P459, DOI 10.1088/1464-4258/1/4/307; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Kimura S, 1998, J NEUROSCI, V18, P8551; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; LevRam V, 1997, LEARN MEMORY, V4, P169, DOI 10.1101/lm.4.1.169; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; Linden DJ, 2003, SCIENCE, V301, P1682, DOI 10.1126/science.1090462; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Namiki S, 2005, J PHYSIOL-LONDON, V566, P849, DOI 10.1113/jphysiol.2005.088799; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; PITLER TA, 1992, J NEUROSCI, V12, P4122; Raymond JL, 1998, J NEUROSCI, V18, P9112; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Shibuki K, 1997, J PHYSIOL-LONDON, V498, P443, DOI 10.1113/jphysiol.1997.sp021870; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stefano GB, 2000, PHARMACOL RES, V42, P317, DOI 10.1006/phrs.2000.0702; Stefano George B, 2003, Med Sci Monit, V9, pRA63; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Thams P, 1997, BIOCHEM PHARMACOL, V53, P1077, DOI 10.1016/S0006-2952(96)00813-1; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	87	201	208	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					647	659		10.1016/j.neuron.2005.09.020	http://dx.doi.org/10.1016/j.neuron.2005.09.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301180	Bronze			2022-12-28	WOS:000233677300017
J	Chatelain, FC; Alagem, N; Xu, Q; Pancaroglu, R; Reuveny, E; Minor, DL				Chatelain, FC; Alagem, N; Xu, Q; Pancaroglu, R; Reuveny, E; Minor, DL			The pore helix dipole has a minor role in inward rectifier channel function	NEURON			English	Article							RECTIFYING K+ CHANNEL; X-RAY-STRUCTURE; POTASSIUM CHANNELS; ION CONDUCTION; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; MOLECULAR-BASIS; HIGH-THROUGHPUT; AMINO-TERMINUS; BA2+ BLOCK	Ion channels lower the energetic barrier for ion passage across cell membranes and enable the generation of bioelectricity. Electrostatic interactions between permeant ions and channel pore helix dipoles have been proposed as a general mechanism for facilitating ion passage. Here, using genetic selections to probe interactions of an exemplar potassium channel blocker, barium, with the inward rectifier Kir2.1, we identify mutants bearing positively charged residues in the potassium channel signature sequence at the pore helix C terminus. We show that these channels are functional, selective, resistant to barium block, and have minimally altered conductance properties. Both the experimental data and model calculations indicate that barium resistance originates from electrostatics. We demonstrate that potassium channel function is remarkably unperturbed when positive charges occur near the permeant ions at a location that should counteract pore helix electrostatic effects. Thus, contrary to accepted models, the pore helix dipole seems to be a minor factor in potassium channel permeation.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Weizmann Institute of Science	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, Calif Inst Quantitat Biomed Res, Box 2532, San Francisco, CA 94143 USA.	minor@itsa.ucsf.edu		CHATELAIN, Franck C./0000-0002-8426-8893	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049272] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049272, R01 NS049272-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alagem N, 2001, J PHYSIOL-LONDON, V534, P381, DOI 10.1111/j.1469-7793.2001.00381.x; Allen TW, 2004, J GEN PHYSIOL, V124, P679, DOI 10.1085/jgp.200409111; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; AQVIST J, 1991, P NATL ACAD SCI USA, V88, P2026, DOI 10.1073/pnas.88.5.2026; ARMSTRONG CM, 1980, BIOPHYS J, V30, P473, DOI 10.1016/S0006-3495(80)85108-3; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; GABER RF, 1988, MOL CELL BIOL, V8, P2848, DOI 10.1128/MCB.8.7.2848; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kandel E., 2000, PRINCIPLES NEURAL SC; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kubo Y, 1998, FEBS LETT, V435, P69, DOI 10.1016/S0014-5793(98)01038-2; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LOCKHART DJ, 1992, SCIENCE, V257, P947, DOI 10.1126/science.1502559; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; MacKinnon R, 2004, ANGEW CHEM INT EDIT, V43, P4265, DOI 10.1002/anie.200400662; MINO RDL, 1999, CELL, V96, P879; Miranda JJL, 2003, PROTEIN SCI, V12, P73, DOI 10.1110/ps.0224203; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nakamura H, 1996, Q REV BIOPHYS, V29, P1, DOI 10.1017/S0033583500005746; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Numann R, 2001, TRENDS CARDIOVAS MED, V11, P54, DOI 10.1016/S1050-1738(01)00086-X; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; RASHIN AA, 1995, J PHYS CHEM, V89, P5588; Reuveny E, 1996, BIOPHYS J, V70, P754, DOI 10.1016/S0006-3495(96)79615-7; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SITKOFF D, 1994, BIOPHYS J, V67, P2251, DOI 10.1016/S0006-3495(94)80709-X; Vergara C, 1999, J GEN PHYSIOL, V114, P365, DOI 10.1085/jgp.114.3.365; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zhou H, 1996, AM J PHYSIOL-CELL PH, V271, pC1949, DOI 10.1152/ajpcell.1996.271.6.C1949; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	51	48	48	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					833	843		10.1016/j.neuron.2005.08.022	http://dx.doi.org/10.1016/j.neuron.2005.08.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157278	Bronze, Green Accepted			2022-12-28	WOS:000232085000011
J	Hasenstaub, A; Shu, YS; Haider, B; Kraushaar, U; Duque, A; McCormick, DA				Hasenstaub, A; Shu, YS; Haider, B; Kraushaar, U; Duque, A; McCormick, DA			Inhibitory postsynaptic potentials carry synchronized frequency information in active cortical networks	NEURON			English	Article							RAT FRONTAL-CORTEX; CAT VISUAL-CORTEX; NEURONS IN-VIVO; PYRAMIDAL CELLS; SOMATOSENSORY CORTEX; ELECTRICAL SYNAPSES; NEOCORTICAL NEURONS; AUDITORY-CORTEX; CEREBRAL-CORTEX; GABAERGIC INTERNEURONS	Temporal precision in spike timing is important in cortical function, interactions, and plasticity. We found that, during periods of recurrent network activity (UP states), cortical pyramidal cells in vivo and in vitro receive strong barrages of both excitatory and inhibitory postsynaptic potentials, with the inhibitory potentials showing much higher power at all frequencies above approximately 10 Hz and more synchrony between nearby neurons. Fast-spiking inhibitory interneurons discharged strongly in relation to higher-frequency oscillations in the field potential in vivo and possess membrane, synaptic, and action potential properties that are advantageous for transmission of higher-frequency activity. Intracellular injection of synaptic conductances having the characteristics of the recorded EPSPs and IPSPs reveal that IPSPs are Important in controlling the timing and probability of action potential generation in pyramidal cells. Our results support the hypothesis that inhibitory networks are largely responsible for the dissemination of higher-frequency activity in cortex.	Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Kobelt, Liza/F-5926-2011; Shu, Yousheng/AAC-3881-2020	Shu, Yousheng/0000-0002-2834-2876; Kraushaar, Udo/0000-0002-4660-1093; Haider, Bilal/0000-0002-6382-1426				BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Fellous JM, 2001, J NEUROPHYSIOL, V85, P1782, DOI 10.1152/jn.2001.85.4.1782; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; Fregnac Y, 2003, J PHYSIOLOGY-PARIS, V97, P441, DOI 10.1016/j.jphysparis.2004.02.004; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gao WJ, 2003, P NATL ACAD SCI USA, V100, P2836, DOI 10.1073/pnas.262796399; Gibson JR, 2005, J NEUROPHYSIOL, V93, P467, DOI 10.1152/jn.00520.2004; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Jones MS, 2000, J NEUROPHYSIOL, V84, P1505, DOI 10.1152/jn.2000.84.3.1505; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann EO, 2005, J PHYSIOL-LONDON, V562, P55, DOI 10.1113/jphysiol.2004.078758; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Varela JA, 1999, J NEUROSCI, V19, P4293; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0	60	434	444	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					423	435		10.1016/j.neuron.2005.06.016	http://dx.doi.org/10.1016/j.neuron.2005.06.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055065	Bronze			2022-12-28	WOS:000231051900012
J	Zhaoping, L				Zhaoping, L			Border ownership from intracortical interactions in visual area V2	NEURON			English	Article							CONTRAST POLARITY; CORTICAL AREAS; CORTEX; MONKEY; V1; INTEGRATION; MODEL; ATTENTION; NEURONS; CONTEXT	A border between two image regions normally belongs to only one of the regions; determining which one it belongs to is essential for surface perception and figure-ground segmentation. Border ownership is signaled by a class of V2 neurons, even though its value depends on information coming from well outside their classical receptive fields. I use a model of V2 to show that this visual area is able to generate the ownership signal by itself, without requiring any top-down mechanism or external explicit labels for figures, T junctions, or corners. In the model, neurons have spatially local classical receptive fields, are tuned to orientation, and receive information (from V1) about the location and orientation of borders. Border ownership signals that model physiological observations arise through finite range, intraareal interactions. Additional effects from surface features and attention are discussed. The model licenses testable predictions.	UCL, Dept Psychol, London WC1E 6BT, England	University of London; University College London	Zhaoping, L (corresponding author), UCL, Dept Psychol, Mortimer St, London WC1E 6BT, England.	z.li@ucl.ac.uk						Angelucci A, 2002, J NEUROSCI, V22, P8633; Bair W, 2003, J NEUROSCI, V23, P7690; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; FINKEL LH, 1994, AM SCI, V82, P224; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GROSSBERG S, 1994, PERCEPT PSYCHOPHYS, V55, P48, DOI 10.3758/BF03206880; He ZJ, 1998, PERCEPTION, V27, P313, DOI 10.1068/p270313; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heider B, 2000, EUR J NEUROSCI, V12, P4117, DOI 10.1046/j.1460-9568.2000.00293.x; HEITGER F, 1992, VISION RES, V32, P963, DOI 10.1016/0042-6989(92)90039-L; Kikuchi M, 2001, LECT NOTES COMPUT SC, V2130, P1069; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P59, DOI 10.1088/0954-898X/10/1/004; Li ZP, 2001, NEURAL COMPUT, V13, P1749, DOI 10.1162/08997660152469332; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nakayama K, 1995, VISUAL COGNITION INV, P1; Nishimura H, 2004, NEUROCOMPUTING, V58, P843, DOI 10.1016/j.neucom.2004.01.136; Popple AV, 2003, VISION RES, V43, P739, DOI 10.1016/S0042-6989(03)00080-4; Rubin E., 2001, VISUAL PERCEPTION ES, P225; Tamura H, 1996, EUR J NEUROSCI, V8, P300, DOI 10.1111/j.1460-9568.1996.tb01214.x; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; von der Heydt R, 2003, PERCEPTUAL ORGANIZATION IN VISION: BEHAVIORAL AND NEURAL PERSPECTIVES, P281; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Yu C, 2002, J VISION, V2, DOI 10.1167/2.3.4; Zhaoping L, 2002, PHILOS T R SOC B, V357, P1877, DOI 10.1098/rstb.2002.1158; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	29	106	107	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					143	153		10.1016/j.neuron.2005.04.005	http://dx.doi.org/10.1016/j.neuron.2005.04.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996554	Bronze, Green Submitted			2022-12-28	WOS:000230464000014
J	Shen, Y; Linden, DJ				Shen, Y; Linden, DJ			Long-term potentiation of neuronal glutamate transporters	NEURON			English	Article							PROTEIN-KINASE-C; CLIMBING FIBER ACTIVATION; SYNAPTIC CURRENTS; KAINATE RECEPTORS; CEREBELLAR; SPILLOVER; EAAT4; EXPRESSION; DEPRESSION; LOCALIZATION	Persistent, use-dependent modulation of synaptic strength has been demonstrated for fast synaptic transmission mediated by glutamate and has been hypothesized to underlie persistent behavioral changes ranging from memory to addiction. Glutamate released at synapses is sequestered by the action of excitatory amino acid transporters (EAATs) in glia and postsynaptic neurons. So, the efficacy of glutamate transporter function is crucial for regulating glutamate spillover to adjacent presynaptic and postsynaptic receptors and the consequent induction of plastic or excitotoxic processes. Here, we report that tetanic stimulation of cerebellar climbing fiber-Purkinje cell synapses results in long-term potentiation (LTP) of a climbing fiber-evoked glutamate transporter current recorded in Purkinje cells. This LTP is postsynaptically expressed and requires activation of an mGluR1/PKC cascade. Together with a simultaneously induced long-term depression (LTD) of postsynaptic AMPA receptors, this might reflect an integrated antiexcitotoxic cellular response to strong climbing fiber synaptic activation, as occurs following an ischemic episode.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe ST, Baltimore, MD 21205 USA.	dlinden@jhmi.edu			NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R37MH051106, R29MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Brasnjo G, 2004, P NATL ACAD SCI USA, V101, P6273, DOI 10.1073/pnas.0308149101; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Cho K, 2003, J PHYSIOL-LONDON, V548, P723, DOI 10.1113/jphysiol.2003.040188; Davis KE, 1998, J NEUROSCI, V18, P2475; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; Espinoza-Rojo M, 2000, NEUROREPORT, V11, P2827, DOI 10.1097/00001756-200008210-00043; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; Gonzalez MI, 1997, J NEUROSCI RES, V50, P585; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; Huang H, 2004, J NEUROSCI, V24, P5659, DOI 10.1523/JNEUROSCI.1338-04.2004; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Huang YHH, 2004, J NEUROSCI, V24, P4551, DOI 10.1523/JNEUROSCI.5217-03.2004; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; More JCA, 2003, BRIT J PHARMACOL, V138, P1093, DOI 10.1038/sj.bjp.0705148; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Reichelt W, 2002, J NEUROPHYSIOL, V87, P1974, DOI 10.1152/jn.00704.2001; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Shen Y, 2002, NAT NEUROSCI, V5, P725, DOI 10.1038/nn895; Shigeri Y, 2001, J NEUROCHEM, V79, P297, DOI 10.1046/j.1471-4159.2001.00588.x; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Stoffel W, 2004, MOL BRAIN RES, V128, P170, DOI 10.1016/j.molbrainres.2004.06.026; Takayasu Y, 2004, EUR J NEUROSCI, V19, P1285, DOI 10.1111/j.1460-9568.2004.03224.x; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Welsh JP, 2002, ADV NEUROL, V89, P331; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	43	27	29	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					715	722		10.1016/j.neuron.2005.04.033	http://dx.doi.org/10.1016/j.neuron.2005.04.033			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924858	Bronze			2022-12-28	WOS:000229689800006
J	Xiong, WC; Mei, L				Xiong, WC; Mei, L			An unconventional role of neurotransmission in synapse formation	NEURON			English	Editorial Material							NEUROMUSCULAR-JUNCTION; CHOLINE-ACETYLTRANSFERASE; NEUREGULIN; CDK5; EXPRESSION; MUSCLE	How do presynatic inputs regulate synapse formation? In this issue of Neuron, Lin et al. show that the neurotransmitter acetylcholine decreases the stability of AChR clusters. This dispersing activity, which requires the serine/threonine kinase Cdk5, cooperates with positive signals from motoneurons to ensure high concentration of AChRs at the neuromuscular junction.	Med Coll Georgia, Dept Neurol, Program Dev Neurobiol, Inst Mol Med & Genet, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Xiong, WC (corresponding author), Med Coll Georgia, Dept Neurol, Program Dev Neurobiol, Inst Mol Med & Genet, Augusta, GA 30912 USA.		Mei, Lin/G-8755-2012					Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Trinidad JC, 2004, J BIOL CHEM, V279, P31622, DOI 10.1074/jbc.M400044200; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	15	2	2	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 19	2005	46	4					521	523		10.1016/j.neuron.2005.05.008	http://dx.doi.org/10.1016/j.neuron.2005.05.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944118	Bronze			2022-12-28	WOS:000229294300001
J	Yu, AJ; Dayan, P				Yu, AJ; Dayan, P			Uncertainty, neuromodulation, and attention	NEURON			English	Article							LOCUS-COERULEUS NEURONS; PARTIAL FORNIX SECTION; BASAL FOREBRAIN; VISUAL-CORTEX; SYNAPTIC-TRANSMISSION; FRONTAL-CORTEX; NORADRENERGIC HYPERACTIVITY; VISUOSPATIAL ATTENTION; BAYESIAN INTEGRATION; CORTICAL PLASTICITY	Uncertainty in various forms plagues our interactions with the environment. In a Bayesian statistical framework, optimal inference and prediction, based on unreliable observations in changing contexts, require the representation and manipulation of different forms of uncertainty. We propose that the neuromodulators acetylcholine and norepinephrine play a major role in the brain's implementation of these uncertainty computations. Acetylcholine signals expected uncertainty, coming from known unreliability of predictive cues within a context. Norepinephrine signals unexpected uncertainty, as when unsignaled context switches produce strongly unexpected observations. These uncertainty signals interact to enable optimal inference and learning in noisy and changeable environments. This formulation is consistent with a wealth of physiological, pharmacological and behavioral data implicating acetylcholine an norepinephrine in specific aspects of a range of cognitive processes. Moreover, the model suggests a class of attentional cueing tasks that involve both neuromodulators and shows how their interactions may be part-antagonistic, part-synergistic.	Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of London; University College London	Yu, AJ (corresponding author), Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	feraina@gatsby.ucl.ac.uk		Dayan, Peter/0000-0003-3476-1839				AMMASSARITEULE M, 1991, BEHAV BRAIN RES, V45, P1, DOI 10.1016/S0166-4328(05)80174-3; ANDERSON CH, 1995, 19 INT WORKSH COND M; ASTONJONES G, 1981, J NEUROSCI, V1, P887; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Baxter MG, 1997, J NEUROSCI, V17, P5230; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bouret S, 2004, EUR J NEUROSCI, V20, P791, DOI 10.1111/j.1460-9568.2004.03526.x; BOWMAN EM, 1993, J NEUROPHYSIOL, V70, P431, DOI 10.1152/jn.1993.70.1.431; BROWN E, 2005, IN PRESS INT J BIFUR; Bucci DJ, 1998, J NEUROSCI, V18, P8038; Carpenter G. A., 1991, PATTERN RECOGNITION; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; CLARK CR, 1989, NEUROPSYCHOLOGIA, V27, P131, DOI 10.1016/0028-3932(89)90166-8; Clark J.J., 1990, DATA FUSION SENSORY; Clayton EC, 2004, J NEUROSCI, V24, P9914, DOI 10.1523/JNEUROSCI.2446-04.2004; Coull JT, 1997, EUR J NEUROSCI, V9, P589, DOI 10.1111/j.1460-9568.1997.tb01635.x; CURET O, 1987, J PHARMACOL EXP THER, V240, P327; Dayan P, 2003, IETE J RES, V49, P171, DOI 10.1080/03772063.2003.11416335; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; DONCHIN E, 1978, RELATED BRAIN POTENT, P1; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; DYONLAURENT C, 1993, EXP BRAIN RES, V96, P203; DYONLAURENT C, 1994, EXP BRAIN RES, V99, P259; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Ego-Stengel V, 2002, NEUROSCIENCE, V111, P275, DOI 10.1016/S0306-4522(02)00011-8; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; GREUEL JM, 1988, SCIENCE, V242, P74, DOI 10.1126/science.2902687; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Hasselmo ME, 1997, J NEUROPHYSIOL, V77, P3326, DOI 10.1152/jn.1997.77.6.3326; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Jaynes E.T., 2003, PROBABILITY THEORY L; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; JONES DNC, 1995, PSYCHOPHARMACOLOGY, V120, P142, DOI 10.1007/BF02246186; KAYE H, 1984, J EXP PSYCHOL ANIM B, V10, P90, DOI 10.1037/0097-7403.10.1.90; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Knill DC, 1996, PERCEPTION BAYESIAN; Kobayashi M, 2000, EUR J NEUROSCI, V12, P264, DOI 10.1046/j.1460-9568.2000.00917.x; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LEVIN BE, 1988, BRAIN RES, V443, P261, DOI 10.1016/0006-8993(88)91620-4; MACKAY DJC, 2003, INFORMATION THEORY; METHERATE R, 1990, SYNAPSE, V6, P133, DOI 10.1002/syn.890060204; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Missonnier P, 1999, INT J PSYCHOPHYSIOL, V33, P243, DOI 10.1016/S0167-8760(99)00059-8; O'Neill J, 2003, PHARMACOL BIOCHEM BE, V76, P301, DOI 10.1016/j.pbb.2003.08.006; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Phillips JM, 2000, PSYCHOPHARMACOLOGY, V150, P112, DOI 10.1007/s002130000437; Pineda JA, 1997, INT J PSYCHOPHYSIOL, V27, P223, DOI 10.1016/S0167-8760(97)00061-5; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Prendergast MA, 1998, PSYCHOPHARMACOLOGY, V136, P50, DOI 10.1007/s002130050538; Rajkowski J, 2004, J NEUROPHYSIOL, V92, P361, DOI 10.1152/jn.00673.2003; RAJKOWSKI J, 1994, SYNAPSE, V4, P162; Robbins Trevor W., 1995, P703; SARA SJ, 1991, PROG BRAIN RES, V88, P571; SARA SJ, 1995, P NATL ACAD SCI USA, V92, P6032, DOI 10.1073/pnas.92.13.6032; SARA SJ, 1989, ARCH GERONTOL GERIAT, P99; SARA SJ, 1994, BRAIN RES BULL, V35, P457, DOI 10.1016/0361-9230(94)90159-7; Sara SJ, 1998, CR ACAD SCI III-VIE, V321, P193, DOI 10.1016/S0764-4469(97)89821-6; SARA SJ, 1992, EXP BRAIN RES, V89, P125; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; TERRY AVJ, 2002, J PHARMACOL EXP THER, V301, P384; Turetsky BI, 2002, PSYCHOPHYSIOLOGY, V39, P147, DOI 10.1017/S0048577201392041; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; VANKOV A, 1995, EUR J NEUROSCI, V109, P903; VERLEGER R, 1994, PSYCHOPHYSIOLOGY, V31, P359, DOI 10.1111/j.1469-8986.1994.tb02444.x; VOYTKO ML, 1994, J NEUROSCI, V14, P167; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P315, DOI 10.1007/s002130050351; Yu A, 2005, ADV NEURAL INFORM PR, V17, P1577; Yu A. J., 2003, ADV NEURAL INF PROC, V15, P157; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8; Zaborszky L, 1997, NEUROSCIENCE, V79, P1051, DOI 10.1016/S0306-4522(97)00049-3; Zaborszky L, 2002, PROG BRAIN RES, V136, P359	88	994	1000	2	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					681	692		10.1016/j.neuron.2005.04.026	http://dx.doi.org/10.1016/j.neuron.2005.04.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944135	Green Submitted, Bronze			2022-12-28	WOS:000229294300018
J	Cheng, LC; Tavazoie, M; Doetsch, F				Cheng, LC; Tavazoie, M; Doetsch, F			Stem cells: From epigenetics to microRNAs	NEURON			English	Review							HISTONE DEACETYLASE ACTIVITY; NEURONAL DIFFERENTIATION; DNA METHYLATION; SONIC HEDGEHOG; EXPRESSION; BRAIN; MAINTENANCE; PATTERNS; IDENTITY		Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Doetsch, F (corresponding author), Columbia Univ, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.	fkd2101@columbia.edu						ABROS V, 2004, NATURE, V431, P350; BALLAS N, 2005, IN PRESS CELL, P121; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; GIRALDEZ AJ, 2005, SCIENCE; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KANEL O, 2005, GENE DEV, V19, P489; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Namihira M, 2004, FEBS LETT, V572, P184, DOI 10.1016/j.febslet.2004.07.029; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251	43	107	123	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					363	367		10.1016/j.neuron.2005.04.027	http://dx.doi.org/10.1016/j.neuron.2005.04.027			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882632	Bronze			2022-12-28	WOS:000229011400004
J	Konur, S; Ghosh, A				Konur, S; Ghosh, A			Calcium signaling and the control of dendritic development	NEURON			English	Review							RAT VISUAL-CORTEX; SPINE MORPHOGENESIS; NEUROTROPHIC FACTOR; NMDA RECEPTOR; MOLECULAR-MECHANISMS; CORTICAL DENDRITES; REARING COMPLEXITY; PYRAMIDAL NEURONS; BARREL CORTEX; BETA-CATENIN		Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	aghosh@ucsd.edu		Ultanir, Sila/0000-0001-5745-3957				Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COLEMAN PD, 1968, J ANAT, V102, P363; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gorski JA, 2003, J NEUROSCI, V23, P6856; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; Hering H, 2003, J NEUROSCI, V23, P11759; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Horch HW, 1999, NEURON, V23, P353; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jin X, 2003, J NEUROSCI, V23, P5662; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lohmann C, 2005, NAT NEUROSCI, V8, P305, DOI 10.1038/nn1406; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	62	177	180	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					401	405		10.1016/j.neuron.2005.04.022	http://dx.doi.org/10.1016/j.neuron.2005.04.022			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882639	Bronze			2022-12-28	WOS:000229011400011
J	Murai, KK; Pasquale, EB				Murai, KK; Pasquale, EB			New exchanges in Eph-dependent growth cone dynamics	NEURON			English	Editorial Material							RHO; RECEPTOR; GUIDANCE; COLLAPSE	The Eph receptor tyrosine kinases and their ephrin ligands play a pivotal role during axon pathfinding and neural circuitry formation. A prominent way in which Eph receptors sculpt cellular morphology is by remodeling the actin cytoskeleton and the surrounding plasma membrane through the regulation of Rho family GTPases. Two articles in this issue of Neuron (Sahin et al. and Cowan et al.) shed light on how Eph receptors recruit guanine nucleotide exchange factors for Rho family GTPases to modulate growth cone dynamics.	McGill Univ, Ctr Hlth, Montreal Gen Hosp, Ctr Res Neurosci,Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; Burnham Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	McGill University; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Murai, KK (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Ctr Res Neurosci,Dept Neurol & Neurosurg, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.							Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Jurney WM, 2002, J NEUROSCI, V22, P6019; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; PASQUALE EB, 2005, IN PRESS NAT REV MOL, V6; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017	15	24	28	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 21	2005	46	2					161	163		10.1016/j.neuron.2005.04.004	http://dx.doi.org/10.1016/j.neuron.2005.04.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848793	Bronze			2022-12-28	WOS:000228674800001
J	Billings, LM; Oddo, S; Green, KN; McGaugh, JL; LaFerla, FM				Billings, LM; Oddo, S; Green, KN; McGaugh, JL; LaFerla, FM			Intraneuronal A beta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; MEMORY CONSOLIDATION; AMYGDALA MODULATION; A-BETA-42 ACCUMULATION; HUMAN NEURONS; DOWN-SYNDROME; PLAQUES; DEMENTIA; IMPAIRMENT; BRAIN	Progressive memory loss and cognitive dysfunction are the hallmark clinical features of Alzheimer's disease (AD). Identifying the molecular triggers for the onset of AD-related cognitive decline presently requires the use of suitable animal models, such as the 3xTg-AD mice, which develop both amyloid and tangle pathology. Here, we characterize the onset of learning and memory deficits in this model. We report that 2-month-old, prepathologic mice are cognitively unimpaired. The earliest cognitive impairment manifests at 4 months as a deficit in long-term retention and correlates with the accumulation of intraneuronal AD in the hippocampus and amygdala. Plaque or tangle pathology is not apparent at this age, suggesting that they contribute to cognitive dysfunction at later time points. Clearance of the intraneuronal AD pathology by immunotherapy rescues the early cognitive deficits on a hippocampal-dependent task. Reemergence of the AD pathology again leads to cognitive deficits. This study strongly implicates intraneuronal AD in the onset of cognitive dysfunction.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferla@uci.edu		Oddo, Salvatore/0000-0001-7304-7430	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH012526, R56MH012526, R37MH012526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG024035] Funding Source: NIH RePORTER; NIA NIH HHS [F32 AG24035-01, AG0212982] Funding Source: Medline; NIMH NIH HHS [MH-12526] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Artero S, 2003, ACTA PSYCHIAT SCAND, V107, P390, DOI 10.1034/j.1600-0447.2003.00081.x; Blackwell AD, 2004, DEMENT GERIATR COGN, V17, P42, DOI 10.1159/000074081; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEUROBIOL AGING, V16, P705, DOI 10.1016/0197-4580(95)00082-P; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; ODDO S, 2005, IN PRESS P NATL ACAD, V43, P321; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Qi Y, 2003, BIOCHEMISTRY-US, V42, P1042, DOI 10.1021/bi0267590; Ralph MAL, 2003, BRAIN, V126, P2350, DOI 10.1093/brain/awg236; Roozendaal B, 1999, P NATL ACAD SCI USA, V96, P11642, DOI 10.1073/pnas.96.20.11642; SAMUEL W, 1994, ARCH NEUROL-CHICAGO, V51, P772, DOI 10.1001/archneur.1994.00540200048015; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tseng Bertrand P., 2004, Current Alzheimer Research, V1, P231, DOI 10.2174/1567205043332045; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	43	983	1030	3	71	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					675	688		10.1016/j.neuron.2005.01.040	http://dx.doi.org/10.1016/j.neuron.2005.01.040			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748844	Bronze			2022-12-28	WOS:000227446700008
J	Perlson, E; Hanz, S; Ben-Yaakov, K; Segal-Ruder, Y; Seger, R; Fainzilber, M				Perlson, E; Hanz, S; Ben-Yaakov, K; Segal-Ruder, Y; Seger, R; Fainzilber, M			Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve	NEURON			English	Article							INTERMEDIATE-FILAMENT NETWORKS; MICE LACKING VIMENTIN; IN-VIVO; NEURONAL DEVELOPMENT; SIGNALING PATHWAYS; MOLECULAR MOTORS; SODIUM-CHANNELS; PROTEIN-KINASES; AXON GROWTH; TRANSPORT	How are phosphorylated kinases transported over long intracellular distances, such as in the case of axon to cell body signaling after nerve injury? Here, we show that the MAP kinases Erk1 and Erk2 are phosphorylated in sciatic nerve axoplasm upon nerve injury, concomitantly with the production of soluble forms of the intermediate filament vimentin by local translation and calpain cleavage in axoplasm. Vimentin binds phosphorylated Erks (pErk), thus linking pErk to the dynein retrograde motor via direct binding of vimentin to importin P. Injury-induced Elk1 activation and neuronal regeneration are inhibited or delayed in dorsal root ganglion neurons from vimentin null mice, and in rats treated with a MEK inhibitor or with a peptide that prevents pErk-vimentin binding. Thus, soluble vimentin enables spatial translocation of pErk by importins and dynein in lesioned nerve.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Fainzilber, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	mike.fainzilber@weizmann.ac.il		Fainzilber, Mike/0000-0001-8173-8557; Perlson, Eran/0000-0001-6047-9613				Boyne LJ, 1996, INT J DEV NEUROSCI, V14, P739, DOI 10.1016/S0736-5748(96)00053-6; Clarke EJ, 2002, CURR BIOL, V12, pR596, DOI 10.1016/S0960-9822(02)01102-8; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dubey M, 2004, J NEUROSCI RES, V78, P245, DOI 10.1002/jnr.20146; Eckes B, 2000, J CELL SCI, V113, P2455; Gao Y, 2003, J NEUROSCI, V23, P11770; GIMENEZ YRM, 2000, GLIA, V31, P69, DOI DOI 10.1002/(SICI)1098-1136(200007)31:1<69::AID-GLIA70>3.0.C0;2-W; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hanz S, 2004, NEUROSCIENTIST, V10, P404, DOI 10.1177/1073858404267884; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011; Ho CL, 1998, J CELL SCI, V111, P1767; Houslay MD, 2003, BIOCHEM SOC T, V31, P1186; Howard MJ, 1999, NEUROSCIENCE, V93, P807, DOI 10.1016/S0306-4522(99)00195-5; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Inagaki N, 1997, J BIOL CHEM, V272, P25195, DOI 10.1074/jbc.272.40.25195; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Lalonde R, 2003, REV NEUROSCIENCE, V14, P369; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Mandolesi G, 2004, FASEB J, V18, P1934, DOI 10.1096/fj.04-1805fje; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Morris EJ, 2000, J CELL SCI, V113, P2433; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Perlson E, 2004, J NEUROBIOL, V58, P287, DOI 10.1002/neu.10316; Perlson E, 2004, MOL CELL PROTEOMICS, V3, P510, DOI 10.1074/mcp.M400004-MCP200; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; ROGERS KR, 1995, EUR J CELL BIOL, V66, P136; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; Smith DS, 1997, J NEUROSCI, V17, P646; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Sung YJ, 2004, J NEUROSCI, V24, P7583, DOI 10.1523/JNEUROSCI.1445-04.2004; TRAUB P, 1994, INT REV CYTOL, V154, P1, DOI 10.1016/S0074-7696(08)62198-1; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Weible MW, 2004, J NEUROBIOL, V58, P230, DOI 10.1002/neu.10318; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Wilsbacher JL, 2001, METHOD ENZYMOL, V332, P387; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yoo S, 2003, J NEUROSCI RES, V74, P541, DOI 10.1002/jnr.10771; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625	52	386	400	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					715	726		10.1016/j.neuron.2005.01.023	http://dx.doi.org/10.1016/j.neuron.2005.01.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748847	Bronze			2022-12-28	WOS:000227446700011
J	Zucker, RS				Zucker, RS			Minis: Whence and wherefore?	NEURON			English	Editorial Material							SPONTANEOUS TRANSMITTER RELEASE; MINIATURE SYNAPTIC EVENTS; TRANSMISSION; GLUTAMATE; SYNAPSES; VESICLES; CALCIUM; CA2+	In this issue of Neuron, Sara et al. find that spontaneously released miniature synaptic potentials arise from a pool of vesicles distinct from those released by neural activity. This modification of a basic tenet of the quantal hypothesis has important implications for the analysis of changes in synaptic transmission.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Mol & Cell Biol Dept, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zucker, RS (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343				Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; DELANEY KR, 1994, J NEUROSCI, V14, P5885; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; KATZ B, 1969, RELEASE NERUAL TRANS; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	17	29	29	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					482	484		10.1016/j.neuron.2005.02.003	http://dx.doi.org/10.1016/j.neuron.2005.02.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721234	Bronze			2022-12-28	WOS:000227099700003
J	Huang, YZ; Edwards, MJ; Rounis, E; Bhatia, KP; Rothwell, JC				Huang, YZ; Edwards, MJ; Rounis, E; Bhatia, KP; Rothwell, JC			Theta burst stimulation of the human motor cortex	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; REPETITIVE TMS; HIGH-FREQUENCY; DEPRESSION; EXCITABILITY; INDUCTION; PLASTICITY; SLICES	It has been 30 years since the discovery that repeated electrical stimulation of neural pathways can lead to long-term potentiation in hippocampal slices. With its relevance to processes such as learning and memory, the technique has produced a vast literature on mechanisms of synaptic plasticity in animal models. To date, the most promising method for transferring these methods to humans is repetitive transcranial magnetic stimulation (rTMS), a noninvasive method of stimulating neural pathways in the brain of conscious subjects through the intact scalp. However, effects on synaptic plasticity reported are often weak, highly variable between individuals, and rarely last longer than 30 min. Here we describe a very rapid method of conditioning the human motor cortex using rTMS that produces a controllable, consistent, long-lasting, and powerful effect on motor cortex physiology and behavior after an application period of only 20-190 s.	UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; Chang Gung Mem Hosp, Dept Neurol, Taipei 10507, Taiwan	University of London; University College London; Chang Gung Memorial Hospital	Rothwell, JC (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, Queen Sq, London WC1N 3BG, England.	j.rothwell@ion.ucl.ac.uk	Edwards, Mark J/F-1052-2012	Edwards, Mark J/0000-0002-8283-9015; Rothwell, John/0000-0003-1367-6467; Huang, Ying-Zu/0000-0002-8666-4013; Rounis, Elisabeth/0000-0002-1375-1001				CAPOCCHI G, 1992, BRAIN RES, V591, P332, DOI 10.1016/0006-8993(92)91715-Q; Chen R, 1998, J NEUROSCI, V18, P3443; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Evers S, 2001, NEUROREPORT, V12, P2915, DOI 10.1097/00001756-200109170-00032; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; Hadland KA, 2001, J COGNITIVE NEUROSCI, V13, P1097, DOI 10.1162/089892901753294392; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; Hausmann A, 2004, J NEUROL NEUROSUR PS, V75, P320; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P397; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Heusler P, 2000, EXP BRAIN RES, V135, P300, DOI 10.1007/s002210000530; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; HIRSCH JC, 1990, J PHYSIOL-LONDON, V427, P31, DOI 10.1113/jphysiol.1990.sp018159; Huang YZ, 2004, CLIN NEUROPHYSIOL, V115, P1069, DOI 10.1016/j.clinph.2003.12.026; Huemmeke M, 2002, EUR J NEUROSCI, V15, P1641, DOI 10.1046/j.1460-9568.2002.02002.x; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; Lee L, 2003, J NEUROSCI, V23, P5308; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Martin JLR, 2003, BRIT J PSYCHIAT, V182, P480, DOI 10.1192/bjp.182.6.480; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Reis J, 2002, EPILEPSIA, V43, P1149, DOI 10.1046/j.1528-1157.2002.09902.x; Ridding MC, 2003, CLIN NEUROPHYSIOL, V114, P1437, DOI 10.1016/S1388-2457(03)00115-9; Shen KZ, 2003, SYNAPSE, V50, P314, DOI 10.1002/syn.10274; Siebner HR, 2000, NEUROLOGY, V54, P956, DOI 10.1212/WNL.54.4.956; Siebner HR, 2003, BRAIN, V126, P2710, DOI 10.1093/brain/awg282; Sparing R, 2001, J CLIN NEUROPHYSIOL, V18, P326, DOI 10.1097/00004691-200107000-00004; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Takita M, 1999, EUR J NEUROSCI, V11, P4145, DOI 10.1046/j.1460-9568.1999.00870.x; Trepel C, 1998, CEREB CORTEX, V8, P719, DOI 10.1093/cercor/8.8.719; Vickery RM, 1997, J NEUROPHYSIOL, V78, P3039, DOI 10.1152/jn.1997.78.6.3039; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Ziemann U, 1998, J NEUROSCI, V18, P1115	36	2377	2474	13	216	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					201	206		10.1016/j.neuron.2004.12.033	http://dx.doi.org/10.1016/j.neuron.2004.12.033			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664172	Bronze			2022-12-28	WOS:000226451500007
J	Lou, H; Kim, SK; Zaitsev, E; Snell, CR; Lu, B; Loh, YP				Lou, H; Kim, SK; Zaitsev, E; Snell, CR; Lu, B; Loh, YP			Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase E	NEURON			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; SYNAPTIC MODULATION; PATHWAY; CELLS; PROOPIOMELANOCORTIN; IDENTIFICATION	Activity-dependent secretion of BDNF is important in mediating synaptic plasticity, but how it is achieved is unclear. Here we uncover a sorting motif receptor-mediated mechanism for regulated secretion of BDNF. X-ray crystal structure analysis revealed a putative sorting Motif, l(16)E(18)l(105)D(106), in BDNF, which when mutated at the acidic residues resulted in missorting of proBDNF to the constitutive pathway in AtT-20 cells. A V20E mutation to complete a similar motif in NGF redirected a significant proportion of it from the constitutive to the regulated pathway. Modeling and binding studies showed interaction of the acidic residues in the BDNF motif with two basic residues in the sorting receptor, carboxypeptidase E (CPE). S-35 labeling experiments demonstrated that activity dependent secretion of BDNF from cortical neurons was obliterated in CPE knockout mice. Thus, we have identified a mechanism whereby a specific Motif l(16)E(18)l(105)D(106) interacts with CPIE to sort proBDNF into regulated pathway vesicles for activity-dependent secretion.	NICHHD, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; NICHHD, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA; Medivir UK Ltd, Saffron Walden CB10 1XL, Essex, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Medivir	Loh, YP (corresponding author), NICHHD, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	lohp@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714, Z01HD000056] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BALSCHMIDT P, 1991, ACTA CRYSTALLOGR B, V47, P975, DOI 10.1107/S010876819100842X; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; CAWLEY NX, 2004, BEHAV DEICITS ENDOCR, V145, P5807; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cool DR, 1998, MOL CELL ENDOCRINOL, V139, P7, DOI 10.1016/S0303-7207(98)00081-1; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Dhanvantari S, 2003, MOL ENDOCRINOL, V17, P1856, DOI 10.1210/me.2002-0380; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Haubensak W, 1998, J CELL SCI, V111, P1483; Heymach JV, 1996, J BIOL CHEM, V271, P25430, DOI 10.1074/jbc.271.41.25430; Hibbert AP, 2003, J BIOL CHEM, V278, P48129, DOI 10.1074/jbc.M300961200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Loh YP, 2004, J MOL NEUROSCI, V22, P63, DOI 10.1385/JMN:22:1-2:63; LOH YP, 1988, FEBS LETT, V238, P142, DOI 10.1016/0014-5793(88)80244-8; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Luo XG, 2001, NEUROSCI RES, V39, P377, DOI 10.1016/S0168-0102(00)00238-8; MCDONALD NQ, 1991, J MOL BIOL, V219, P595, DOI 10.1016/0022-2836(91)90655-P; Michael GJ, 1997, J NEUROSCI, V17, P8476; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moller JC, 1998, J NEUROSCI RES, V51, P463, DOI 10.1002/(SICI)1097-4547(19980215)51:4<463::AID-JNR6>3.0.CO;2-A; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Normant E, 1998, ENDOCRINOLOGY, V139, P2137, DOI 10.1210/en.139.4.2137; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shen FS, 1999, NEUROPEPTIDES, V33, P276, DOI 10.1054/npep.1999.0045; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Wang LC, 2004, J NEUROENDOCRINOL, V16, P19, DOI 10.1111/j.1365-2826.2004.01110.x; Wu YJ, 2004, J NEUROSCI RES, V75, P825, DOI 10.1002/jnr.20048; Zhang CF, 1999, MOL ENDOCRINOL, V13, P527, DOI 10.1210/me.13.4.527; Zhang CF, 2003, BIOCHEM J, V369, P453, DOI 10.1042/BJ20020827	52	132	140	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					245	255		10.1016/j.neuron.2004.12.037	http://dx.doi.org/10.1016/j.neuron.2004.12.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664176	Bronze			2022-12-28	WOS:000226451500011
J	Xu, PX; Atkinson, R; Jones, DNM; Smith, DP				Xu, PX; Atkinson, R; Jones, DNM; Smith, DP			Drosophila OBP LUSH is required for activity of pheromone-sensitive neurons	NEURON			English	Article							ODORANT-BINDING-PROTEINS; CIS-VACCENYL ACETATE; ANTHERAEA-POLYPHEMUS; MOLECULAR-CLONING; MOTH; MELANOGASTER; FAMILY; SPECIFICITY; EXPRESSION	Odorant binding proteins (OBPs) are extracellular proteins localized to the chemosensory systems of most terrestrial species. OBPs are expressed by nonneuronal cells and secreted into the fluid bathing olfactory neuron dendrites. Several members have been shown to interact directly with odorants, but the significance of this is not clear. We show that the Drosophila OBP lush is completely devoid of evoked activity to the pheromone 11-cis vaccenyl acetate (VA), revealing that this binding protein is absolutely required for activation of pheromone-sensitive chemosensory neurons. lush mutants are also defective for pheromone-evoked behavior. Importantly, we identify a genetic interaction between lush and spontaneous activity in VA-sensitive neurons in the absence of pheromone. The defects in spontaneous activity and VA sensitivity are reversed by germline transformation with a lush transgene or by introducing recombinant LUSH protein into mutant sensilla. These studies directly link pheromone-induced behavior with OBP-dependent activation of a subset of olfactory neurons.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Pharmacol, Dallas, TX 75335 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Program Biomol Struct, Denver, CO 80262 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Smith, DP (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75335 USA.	dean.smith@utsouthwestern.edu	Jones, David N/C-5764-2013	Smith, Dean/0000-0002-4271-0436	NIAAA NIH HHS [R01 AA013618, R01 AA013618-05] Funding Source: Medline; NIDCD NIH HHS [R01 DC002539] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002539] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Galindo K, 2001, GENETICS, V159, P1059; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kaissling K.E., 1985, P173; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kim MS, 1998, GENETICS, V150, P711; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Leal WS, 1998, ANN NY ACAD SCI, V855, P301, DOI 10.1111/j.1749-6632.1998.tb10586.x; Maida R, 2000, EUR J BIOCHEM, V267, P2899, DOI 10.1046/j.1432-1327.2000.01303.x; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; RAMING K, 1989, FEBS LETT, V256, P215, DOI 10.1016/0014-5793(89)81751-X; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Shanbhag SR, 2001, MICROSC RES TECHNIQ, V55, P297, DOI 10.1002/jemt.1179; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STEINBRE.RA, 1971, Z ZELLFORSCH MIK ANA, V117, P570, DOI 10.1007/BF00330716; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; VANDERMEER RK, 1998, PHERMONE COMMUNICATI; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; VOGT RG, 1991, J NEUROSCI, V11, P2972; Vogt RG, 2003, INSECT PHEROMONE BIO, DOI 10.1016/B978-012107151-6/50016-5; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; WOODARD C, 1989, GENETICS, V123, P315; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885; Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7; ZIEGELBERGER G, 1995, EUR J BIOCHEM, V232, P706, DOI 10.1111/j.1432-1033.1995.tb20864.x	53	392	432	6	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					193	200		10.1016/j.neuron.2004.12.031	http://dx.doi.org/10.1016/j.neuron.2004.12.031			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664171	Bronze			2022-12-28	WOS:000226451500006
J	Lee, H; Simpson, GV; Logothetis, NK; Rainer, G				Lee, H; Simpson, GV; Logothetis, NK; Rainer, G			Phase locking of single neuron activity to theta oscillations during working memory in monkey extrastriate visual cortex	NEURON			English	Article							SHORT-TERM-MEMORY; PRIMATE PREFRONTAL CORTEX; GAMMA-BAND ACTIVITY; MNEMONIC PERSISTENT ACTIVITY; TASK; SYNCHRONIZATION; HUMANS; REPRESENTATION; PERFORMANCE; ASSOCIATION	Working memory has been linked to elevated single neuron discharge in monkeys and to oscillatory changes in the human EEG, but the relation between these effects has remained largely unexplored. We addressed this question by measuring local field potentials and single unit activity simultaneously from multiple electrodes placed in extrastriate visual cortex while monkeys were performing a working memory task. We describe a significant enhancement in theta band energy during the delay period. Theta oscillations had a systematic effect on single neuron activity, with neurons emitting more action potentials near their preferred angle of each theta cycle. Sample-selective delay activity was enhanced if only action potentials emitted near the preferred theta angle were considered. Our results suggest that extrastriate visual cortex is involved in short-term maintenance of information and that theta oscillations provide a mechanism for structuring the recurrent interaction between neurons in different brain regions that underlie working memory.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	Max Planck Society; University of California System; University of California San Francisco	Rainer, G (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	gregor.rainer@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Rainer, Gregor/B-5876-2012	Rainer, Gregor/0000-0002-5805-2220				Abeles M., 1982, LOCAL CORTICAL CIRCU; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; Funahashi S, 2002, REV NEUROSCIENCE, V13, P313; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Gundel Alexander, 1992, Brain Topography, V5, P17, DOI 10.1007/BF01129966; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kaiser J, 2003, NEUROIMAGE, V20, P816, DOI 10.1016/S1053-8119(03)00350-1; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; KUBOTA K, 1971, J NEUROPHYSIOL, V34, P337, DOI 10.1152/jn.1971.34.3.337; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lutzenberger W, 2002, J NEUROSCI, V22, P5630; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 2004, PLOS BIOL, V2, P275, DOI 10.1371/journal.pbio.0020044; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2002, NEUROSCIENTIST, V8, P6, DOI 10.1177/107385840200800104; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rols G, 2001, VISUAL NEUROSCI, V18, P527, DOI 10.1017/S0952523801184038; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; STARN CJ, 2002, INT J PSYCHOPHYSIOL, V46, P53; Tallon-Baudry C, 1999, VISUAL NEUROSCI, V16, P449, DOI 10.1017/S0952523899163065; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Worden MS, 2000, J NEUROSCI, V20	56	274	278	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					147	156		10.1016/j.neuron.2004.12.025	http://dx.doi.org/10.1016/j.neuron.2004.12.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629709	Bronze			2022-12-28	WOS:000226217100016
J	Livingstone, MS				Livingstone, MS			Directional inhibition: A new slant on an old question	NEURON			English	Editorial Material							CATS STRIATE CORTEX; RECEPTIVE-FIELDS; VISUAL-CORTEX; SIMPLE CELLS; ORIENTATION SELECTIVITY; SYNAPTIC POTENTIALS; AREA 17; GENICULATE; MOTION; INPUT	In this issue of Neuron, Priebe and Ferster describe the direction selectivity and spatiotemporal organization of excitatory and inhibitory inputs to direction-selective simple cells in cat visual cortex. Their most surprising finding is that inhibition shows the same preferred direction as excitation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Livingstone, MS (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.			Livingstone, Margaret/0000-0002-1950-0123				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Conway BR, 2003, J NEUROPHYSIOL, V89, P2726, DOI 10.1152/jn.00550.2002; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; FERSTER D, 1986, J NEUROSCI, V6, P1284; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	16	8	8	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					5	7		10.1016/j.neuron.2004.12.029	http://dx.doi.org/10.1016/j.neuron.2004.12.029			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629696	Bronze			2022-12-28	WOS:000226217100003
J	Mehta, MR				Mehta, MR			Role of rhythms in facilitating short-term memory	NEURON			English	Editorial Material							WORKING-MEMORY; THETA-OSCILLATIONS; CORTEX; TASK	Working memory tasks have been associated with the appearance of elevated single unit activity (SUA) in primate studies, and oscillatory activity in the EEG or the local field potential (LFP) in humans. The study by Lee et al. in this issue of Neuron provides novel insights regarding the relationship between SUA and UP rhythmicity in V4 during working memory tasks.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Mehta, MR (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.			Mehta, Mayank/0000-0003-2005-2468				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001	13	10	10	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					7	9		10.1016/j.neuron.2004.12.030	http://dx.doi.org/10.1016/j.neuron.2004.12.030			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629697	Bronze			2022-12-28	WOS:000226217100004
J	Chen, AI; de Nooij, JC; Jessell, TM				Chen, AI; de Nooij, JC; Jessell, TM			Graded activity of transcription factor Runx3 specifies the laminar termination pattern of sensory axons in the developing spinal cord	NEURON			English	Article							DORSAL-ROOT-GANGLIA; AFFERENT FIBER COLLATERALS; SOMATOTOPIC ORGANIZATION; CENTRAL PROJECTIONS; GENE-EXPRESSION; CHICKEN-EMBRYO; MOTOR-NEURONS; ETS PROTEIN; CAT; MORPHOLOGY	Different functional classes of dorsal root ganglion sensory neurons project their axons to distinct target zones within the developing spinal cord. To explore the mechanisms that link sensory neuron subtype identity and axonal projection pattern, we analyzed the roles of Runx and ETS transcription factors in the laminar targeting of sensory afferents. Gain- and loss-of-function studies in chick embryos reveal that the status of Runx3 expression is a major determinant of the dorso-ventral position of termination of proprioceptive and cutaneous sensory axons. In addition, the level of expression and/or activity of Runx3 in individual proprioceptive sensory neurons appears to specify whether their axons terminate in intermediate or ventral regions. Our findings suggest that the selectivity of Runx3 expression, and its level of activity, control sensory afferent targeting in the developing spinal cord.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu	Chen, Albert/E-7397-2014; Chen, Albert/AAH-9874-2020	Chen, Albert/0000-0001-5355-024X				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BROWN AG, 1979, J PHYSIOL-LONDON, V296, P215, DOI 10.1113/jphysiol.1979.sp013001; BROWN AG, 1978, J PHYSIOL-LONDON, V277, P15, DOI 10.1113/jphysiol.1978.sp012257; BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137; Brown AG, 1981, ORG SPINAL CORD; CARR VM, 1978, J COMP NEUROL, V182, P727; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; DAVIS BM, 1989, J COMP NEUROL, V279, P556, DOI 10.1002/cne.902790405; EIDE AL, 1995, J COMP NEUROL, V353, P247, DOI 10.1002/cne.903530207; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Fu SY, 2000, J NEUROBIOL, V45, P227, DOI 10.1002/1097-4695(200012)45:4<227::AID-NEU4>3.0.CO;2-N; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; HOHEISEL U, 1989, NEUROSCIENCE, V28, P495, DOI 10.1016/0306-4522(89)90195-4; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; LEE MT, 1988, J NEUROSCI, V8, P2530; Lefcort F, 1996, J NEUROSCI, V16, P3704; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; MU XJ, 1993, J NEUROSCI, V13, P4029; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Oakley RA, 2000, DEV BIOL, V224, P415, DOI 10.1006/dbio.2000.9804; Ozaki S, 1997, J COMP NEUROL, V380, P215; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Perrin JM, 2001, AMBUL PEDIATR, V1, P1; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; Watson AHD, 2001, J COMP NEUROL, V433, P335, DOI 10.1002/cne.1143; WILLIS WD, 1991, SENSORY MECH SPIAL; WOODBURY CJ, 1991, J COMP NEUROL, V314, P237, DOI 10.1002/cne.903140204; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	47	88	89	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					395	408		10.1016/j.neuron.2005.12.028	http://dx.doi.org/10.1016/j.neuron.2005.12.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446143	Bronze			2022-12-28	WOS:000235260900011
J	Bacci, A; Huguenard, JR				Bacci, A; Huguenard, JR			Enhancement of spike-timing precision by autaptic transmission in neocortical inhibitory interneurons	NEURON			English	Article							CAT VISUAL-CORTEX; RAT FRONTAL-CORTEX; IN-VIVO; RESPONSE VARIABILITY; FEEDFORWARD INHIBITION; GABAERGIC INTERNEURONS; CORTICAL-NEURONS; PYRAMIDAL CELLS; SYNAPTIC CONNECTIONS; HIPPOCAMPAL-NEURONS	In vivo studies suggest that precise firing of neurons is important for correct sensory representation. Principal neocortical neurons fire imprecisely when repeatedly activated by fixed sensory stimuli or current depolarizations. Here we show that in contrast to pyramidal neurons, firing in neocortical GABAergic fast-spiking (FS) interneurons is quite precise. FS interneurons are self-innervated by powerful GABAergic autaptic connections reliably activated after each spike, suggesting that autapses strongly regulate FS-cell spike timing. Indeed, blockade of autaptic transmission degraded temporal precision in multiple ways. Under these conditions, realistic dynamic-clamp hyperpolarizing autapses restored precision of spike timing, even in the presence of synaptic noise. Furthermore, firing precision was increased in pyramidal neurons by artificial GABAergic autaptic conductances, suggesting that tightly coupled synaptic feedback inhibition regulates spike timing in principal cells. Thus, well-timed inhibition, whether autaptic or synaptic, facilitates precise spike timing and promotes synchronized cortical network oscillations relevant to several behaviors.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Huguenard, JR (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	john.huguenard@stanford.edu	Huguenard, John/K-6429-2019; Huguenard, John/I-5016-2012	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bacci, Alberto/0000-0002-3355-5892	NINDS NIH HHS [NS39579] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039579] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bacci A, 2003, J NEUROSCI, V23, P9664; Bacci A, 2003, J NEUROSCI, V23, P859; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Butera RJ, 2001, IEEE T BIO-MED ENG, V48, P1460, DOI 10.1109/10.966605; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Dorval AD, 2001, ANN BIOMED ENG, V29, P897, DOI 10.1114/1.1408929; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Fuhrmann G, 2002, J NEUROPHYSIOL, V88, P761, DOI 10.1152/jn.2002.88.2.761; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Grothe B, 2000, CURR OPIN NEUROBIOL, V10, P467, DOI 10.1016/S0959-4388(00)00115-X; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Gur M, 1997, J NEUROSCI, V17, P2914; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Reinagel P, 2002, J NEUROSCI, V22, P6837; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stevens CF, 1995, CURR BIOL, V5, P1370, DOI 10.1016/S0960-9822(95)00273-9; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1997, J NEUROSCI, V17, P6352; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740	58	173	176	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					119	130		10.1016/j.neuron.2005.12.014	http://dx.doi.org/10.1016/j.neuron.2005.12.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387644	Bronze			2022-12-28	WOS:000236699300014
J	Horton, AC; Racz, B; Monson, EE; Lin, AL; Weinberg, RJ; Ehlers, MD				Horton, AC; Racz, B; Monson, EE; Lin, AL; Weinberg, RJ; Ehlers, MD			Polarized secretory trafficking directs cargo for asymmetric dendrite growth and morphogenesis	NEURON			English	Article							ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; GOLGI TRANSPORT; PROTEIN GRASP65; CELL-SURFACE; BREFELDIN-A; STACKING; INHIBITION; ORGANELLES; APPARATUS	Proper growth of dendrites is critical to the formation of neuronal circuits, but the cellular machinery that directs the addition of membrane components to generate dendritic architecture remains obscure. Here, we demonstrate that post-Golgi membrane trafficking is polarized toward longer dendrites of hippocampal pyramidal neurons in vitro and toward apical dendrites in vivo. Small Golgi outposts partition selectively into longer dendrites and are excluded from axons. In dendrites, Golgi outposts concentrate at branchpoints where they engage in post-Golgi trafficking. Within the cell body, the Golgi apparatus orients toward the longest dendrite, and this Golgi polarity precedes asymmetric dendrite growth. Manipulations that selectively block post-Golgi trafficking halt dendrite growth in developing neurons and cause a shrinkage of dendrites in mature pyramidal neurons. Further, disruption of Golgi polarity produces neurons with symmetric dendritic arbors lacking a single longest principal dendrite. These results define a novel polarized organization of neuronal secretory trafficking and demonstrate a mechanistic link between directed membrane trafficking and asymmetric dendrite growth.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Phys, Durham, NC 27710 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Neurosci Ctr, Chapel Hill, NC 27599 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Weinberg, Richard/AAC-1898-2020; Rácz, Bence/J-4220-2019	Rácz, Bence/0000-0002-1933-5332; Weinberg, Richard/0000-0001-9689-7278	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035527] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-35527] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; DASCHER C, 1994, J BIOL CHEM, V269, P1437; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Horton AC, 2003, J NEUROSCI, V23, P6188; Hu TH, 1999, MOL BIOL CELL, V10, P921, DOI 10.1091/mbc.10.4.921; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jareb M, 1997, J NEUROSCI, V17, P8955; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200	49	313	319	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					757	771		10.1016/j.neuron.2005.11.005	http://dx.doi.org/10.1016/j.neuron.2005.11.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337914	Bronze, Green Published			2022-12-28	WOS:000233927300015
J	DeWeese, MR; Hromadka, T; Zador, AM				DeWeese, MR; Hromadka, T; Zador, AM			Reliability and representational bandwidth in the auditory cortex	NEURON			English	Review							CORTICAL-NEURONS; UNIT RESPONSES; VISUAL-CORTEX; DYNAMIC SPECTRA; STRIATE CORTEX; NEURAL MODEL; SPIKE TRAINS; CAT; INFORMATION; VARIABILITY	It is unclear why there are so many more neurons in sensory cortex than in the sensory periphery. One possibility is that these "extra" neurons are used to overcome cortical noise and faithfully represent the acoustic stimulus. Another possibility is that even after overcoming cortical noise, there is "excess representational bandwidth" available and that this bandwidth is used to represent conjunctions of auditory and nonauditory information for computation. Here, we discuss recent data about neuronal reliability in auditory cortex showing that cortical noise may not be as high as was previously believed. Although at present, the data suggest that auditory cortex neurons can be more reliable than those in the visual cortex, we speculate that the principles governing cortical computation are universal and that visual and other cortical areas can also exploit strategies based on similarly high-fidelity activity.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136				ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Bair W, 1999, CURR OPIN NEUROBIOL, V9, P447, DOI 10.1016/S0959-4388(99)80067-1; Barbour DL, 2003, J NEUROSCI, V23, P7194, DOI 10.1523/JNEUROSCI.23-18-07194.2003; Berry MJ, 1998, J NEUROSCI, V18, P2200; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; Chimoto S, 2002, BRAIN RES, V934, P34, DOI 10.1016/S0006-8993(02)02316-8; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; DEAN AF, 1981, EXP BRAIN RES, V44, P437; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Edeline JM, 2001, EUR J NEUROSCI, V14, P1865, DOI 10.1046/j.0953-816x.2001.01821.x; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708, DOI 10.1152/jn.2000.83.5.2708; EVANS EF, 1964, J PHYSIOL-LONDON, V171, P476, DOI 10.1113/jphysiol.1964.sp007391; Fishbach A, 2003, J NEUROPHYSIOL, V90, P3663, DOI 10.1152/jn.00654.2003; Fishbach A, 2001, J NEUROPHYSIOL, V85, P2303, DOI 10.1152/jn.2001.85.6.2303; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; GOLDSTEIN MH, 1968, J ACOUST SOC AM, V43, P444, DOI 10.1121/1.1910851; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; Heil P, 2004, CURR OPIN NEUROBIOL, V14, P461, DOI 10.1016/j.conb.2004.07.002; HOCHERMAN S, 1976, BRAIN RES, V117, P51, DOI 10.1016/0006-8993(76)90555-2; Hopfield JJ, 2001, P NATL ACAD SCI USA, V98, P1282, DOI 10.1073/pnas.031567098; HUBEL DH, 1959, SCIENCE, V129, P1279, DOI 10.1126/science.129.3358.1279; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; King AJ, 2000, P NATL ACAD SCI USA, V97, P11821, DOI 10.1073/pnas.97.22.11821; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; O'Connor KN, 2005, J NEUROPHYSIOL, V94, P4051, DOI 10.1152/jn.00046.2005; Ohl FW, 2001, NATURE, V412, P733, DOI 10.1038/35089076; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; Sakai M, 2001, P NATL ACAD SCI USA, V98, P3507, DOI 10.1073/pnas.061021698; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stecker GC, 2003, BIOL CYBERN, V89, P341, DOI 10.1007/s00422-003-0439-1; Sukov W, 2001, J NEUROPHYSIOL, V85, P1235, DOI 10.1152/jn.2001.85.3.1235; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vapnik V., 1999, NATURE STAT LEARNING; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WHITFIEL.IC, 1965, J NEUROPHYSIOL, V28, P655, DOI 10.1152/jn.1965.28.4.655	56	25	25	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					479	488		10.1016/j.neuron.2005.10.016	http://dx.doi.org/10.1016/j.neuron.2005.10.016			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269364	Bronze			2022-12-28	WOS:000233250100008
J	Krahe, TE; Medina, AE; de Bittencourt-Navarrete, RE; Colello, RJ; Ramoa, AS				Krahe, TE; Medina, AE; de Bittencourt-Navarrete, RE; Colello, RJ; Ramoa, AS			Protein synthesis-independent plasticity mediates rapid and precise recovery of deprived eye responses	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; PRIMARY VISUAL-CORTEX; KITTEN STRIATE CORTEX; MONOCULAR DEPRIVATION; ORIENTATION SELECTIVITY; CRITICAL PERIOD; CORTICAL PLASTICITY; EXPERIENCE; FERRET; ORGANIZATION	Monocular deprivation (MD) for a few days during a critical period of development leads to loss of cortical responses to stimulation of the deprived eye. Despite the profound effects of MD on cortical function, optical imaging of intrinsic signals and single-unit recordings revealed that deprived eye responses and orientation selectivity recovered a few hours after restoration of normal binocular vision. Moreover, recovery of deprived eye responses was not dependent upon mRNA translation, but required cortical activity. Interestingly, this fast recovery and protein synthesis independence was restricted to the hemisphere contralateral to the previously deprived eye. Collectively, these results implicate a relatively simple mechanistic process in the reactivation of a latent set of connections following restoration of binocular vision and provide new insight into how recovery of cortical function can rapidly occur in response to changes in sensory experience.	Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA	Virginia Commonwealth University	Krahe, TE (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, 1101 E Marshall St, Richmond, VA 23298 USA.	tekrahe@vcu.edu	Krahe, Thomas E/H-1695-2013	Krahe, Thomas E/0000-0002-4686-9284; Medina, Alexandre/0000-0003-0517-7756	NATIONAL EYE INSTITUTE [R01EY011508] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11508] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Bailey CH, 2000, P NATL ACAD SCI USA, V97, P11581, DOI 10.1073/pnas.97.21.11581; BEAR MF, 1990, J NEUROSCI, V10, P909; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BURCHFIEL JL, 1981, BRAIN RES, V206, P479, DOI 10.1016/0006-8993(81)90551-5; Coppola DM, 2004, VISUAL NEUROSCI, V21, P39, DOI 10.1017/S0952523804041045; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; FAULKNER SD, 2005, IN PRESS CEREB CORTE; FRANK DA, 1994, CELL, V179, P5; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; GALAT A, 1992, BIOCHEMISTRY-US, V31, P2427, DOI 10.1021/bi00123a031; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 1998, J NEUROSCI, V18, P2108; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; Kind PC, 2002, NATURE, V416, P430, DOI 10.1038/416430a; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; KRATZ KE, 1976, J NEUROPHYSIOL, V39, P501, DOI 10.1152/jn.1976.39.3.501; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; Liao DS, 2002, J NEUROSCI, V22, P9015; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Medina AE, 2005, J NEUROPHYSIOL, V93, P1317, DOI 10.1152/jn.00714.2004; Medina AE, 2003, J NEUROSCI, V23, P10002; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mitchell DE, 2003, CURR BIOL, V13, P1704, DOI 10.1016/j.cub.2003.09.026; Mitchell DE, 1998, CURR BIOL, V8, P1179, DOI 10.1016/S0960-9822(07)00489-7; Mitchell DE, 2001, P NATL ACAD SCI USA, V98, P11662, DOI 10.1073/pnas.201392698; Moseley MJ, 1997, BRIT J OPHTHALMOL, V81, P956, DOI 10.1136/bjo.81.11.956; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; MUSTARI M, 1981, BRAIN RES, V211, P165, DOI 10.1016/0006-8993(81)90077-9; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OBRIG TG, 1971, J BIOL CHEM, V246, P174; OLSON CR, 1978, J NEUROPHYSIOL, V41, P65, DOI 10.1152/jn.1978.41.1.65; OLSON CR, 1975, J NEUROPHYSIOL, V38, P26, DOI 10.1152/jn.1975.38.1.26; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; REITER HO, 1986, EXP BRAIN RES, V65, P182; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; Rutstein RP, 1998, ANOMALIES BINOCULAR; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; White LE, 2001, VISUAL NEUROSCI, V18, P65, DOI 10.1017/S095252380118106X; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029	53	29	29	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					329	343		10.1016/j.neuron.2005.09.016	http://dx.doi.org/10.1016/j.neuron.2005.09.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242412	Bronze			2022-12-28	WOS:000232838700021
J	Perna, A; Tosetti, M; Montanaro, D; Morrone, MC				Perna, A; Tosetti, M; Montanaro, D; Morrone, MC			Neuronal mechanisms for illusory brightness perception in humans	NEURON			English	Article							PRIMARY VISUAL-CORTEX; HUMAN-VISION; NONHUMAN-PRIMATES; NEURAL DYNAMICS; HUMAN BRAIN; FILLING-IN; RESONANCE; AREAS; ATTENTION; 3D	Biological visual systems are extraordinarily capable of recovering the shape and brightness of objects from sparse and fragmentary information. Using functional magnetic imaging, we show that two associative areas of the dorsal pathway-in the caudal region of the intrapariatal sulcus and in the lateral occipital sulcus-respond specifically to the Craik-O'Brien-Cornsweet illusion generated by high-pass filtered edges. Other visual areas, including primary visual cortex, also respond strongly to the retinotopic location of the edge, but these areas respond equally well to a line of matched contrast and detectability, rather than specifically to the brightness illusion. The reconstruction of surface and/or its brightness seems to be achieved by associative areas from the information about visual features provided by the primary visual cortices, even where there is no physical difference in luminance.	CNR, Ist Neurosci, I-56127 Pisa, Italy; Scuola Normale Super Pisa, Pisa, Italy; Ist Sci Stella Maris, I-56100 Pisa, Italy; CNR, Ist Fisiol Clin, CREAS, I-56127 Pisa, Italy; Univ Vita Salute San Raffaele, I-20132 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; IRCCS Fondazione Stella Maris; Consiglio Nazionale delle Ricerche (CNR); Vita-Salute San Raffaele University	Morrone, MC (corresponding author), CNR, Ist Neurosci, Via Moruzzi 1, I-56127 Pisa, Italy.	concetta@in.cnr.it	Montanaro, Domenico/K-5938-2016; Tosetti, Michela/K-5749-2016; Morrone, Maria Concetta/C-6756-2014; Perna, Andrea/AAO-6594-2020; Montanaro, Domenico/AAB-9718-2022	Tosetti, Michela/0000-0002-2515-7560; Morrone, Maria Concetta/0000-0002-1025-0316; Perna, Andrea/0000-0001-8985-3920; Montanaro, Domenico/0000-0002-9895-7016				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; BURR DC, 1989, VISION RES, V29, P419, DOI 10.1016/0042-6989(89)90006-0; BURR DC, 1987, VISION RES, V27, P1903, DOI 10.1016/0042-6989(87)90056-3; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; CAMPBELL FW, 1978, J PHYSIOL-LONDON, V284, P193, DOI 10.1113/jphysiol.1978.sp012535; COHEN MA, 1984, PERCEPT PSYCHOPHYS, V36, P428, DOI 10.3758/BF03207497; CORNELISSE FW, 2003, J VISION, V3, pA57; CORNWEET TN, 1970, VISUAL PERCEPTION; Craik K. J. W., 1966, NATURE PSYCHOL; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Davey MP, 1998, VISION RES, V38, P2037, DOI 10.1016/S0042-6989(97)00329-5; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; GERRITS HJM, 1970, EXP BRAIN RES, V11, P411; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GROSSBERG S, 1988, PERCEPT PSYCHOPHYS, V43, P241, DOI 10.3758/BF03207869; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; KINGDOM F, 1992, VISION RES, V32, P1565, DOI 10.1016/0042-6989(92)90212-2; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; MacEvoy SP, 1998, NAT NEUROSCI, V1, P616, DOI 10.1038/2849; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marr D., 1982, VISION; MENDOLA J, 2003, FILLING IN PERCEPTUA, P38; Mendola JD, 1999, J NEUROSCI, V19, P8560; Moore C, 2001, NEURON, V29, P277, DOI 10.1016/S0896-6273(01)00197-0; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; OBRIEN V, 1958, J OPT SOC AM, V48, P112, DOI 10.1364/JOSA.48.000112; Press WA, 2001, VISION RES, V41, P1321, DOI 10.1016/S0042-6989(01)00074-8; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Ratliff F, 1972, Sci Am, V226, P91; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Sasaki Y, 2005, P NATL ACAD SCI USA, V102, P3159, DOI 10.1073/pnas.0500319102; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Taira M, 2001, NEUROIMAGE, V14, P959, DOI 10.1006/nimg.2001.0895; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; von der Heydt Rudiger., 2003, FILLING IN PERCEPTUA, P106, DOI DOI 10.1093/ACPROF:OSO/9780195140132.003.0006; WATT RJ, 1985, VISION RES, V25, P1661, DOI 10.1016/0042-6989(85)90138-5	47	50	50	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					645	651		10.1016/j.neuron.2005.07.012	http://dx.doi.org/10.1016/j.neuron.2005.07.012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129395	Bronze			2022-12-28	WOS:000231782700007
J	Schnee, ME; Lawton, DM; Furness, DN; Benke, TA; Ricci, AJ				Schnee, ME; Lawton, DM; Furness, DN; Benke, TA; Ricci, AJ			Auditory hair cell-afferent fiber synapses are specialized to operate at their best frequencies	NEURON			English	Article							RETINAL BIPOLAR CELLS; POST-SYNAPTIC POTENTIALS; PRESYNAPTIC ACTIVE ZONES; RIBBON SYNAPSE; NERVE-FIBERS; CA2+ CHANNELS; CALCIUM; TURTLE; EXOCYTOSIS; VESICLES	Auditory afferent fiber activity is driven by high-fidelity information transfer from the sensory hair cell. Presynaptic specializations, posited to maintain fidelity, are investigated at synapses with characteristic frequencies of 120 Hz and 320 Hz. Morphological data indicate that high-frequency cells have more synapses and higher vesicle density near dense bodies (DEls). Tracking vesicular release via capacitance changes identified three overlapping kinetic components of release corresponding to morphologically identified vesicle pools. High-frequency cells released faster; however, when normalized to release site number, low-frequency cells released faster, likely due to a greater Ca2+ load per synapse. The Ca2+-dependence of release was nonsaturating and independent of frequency, suggesting that release, not refilling, was rate limiting. A model of release derived from vesicle equilibration between morphologically defined pools reproduced the capacitance data, supporting a critical role in vesicle trafficking for DBs. The model suggests that presynaptic specializations enable synapses to operate most efficiently at their characteristic frequencies.	Louisiana State Univ, Ctr Neurosci, New Orleans, LA 70112 USA; Louisiana State Univ, Kresge Hearing Labs, New Orleans, LA 70112 USA; Univ Keele, MacKay Inst Commun & Neurosci, Keele ST5 5BG, Staffs, England; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	Louisiana State University System; Louisiana State University System; Keele University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ricci, AJ (corresponding author), Louisiana State Univ, Ctr Neurosci, New Orleans, LA 70112 USA.	aricci@lsuhsc.edu		ricci, anthony/0000-0002-1706-8904	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009913, R01DC003896] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01-DC03896, R01 DC009913] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adly MA, 1999, INVEST OPHTH VIS SCI, V40, P2165; Balkema GW, 2001, VISUAL NEUROSCI, V18, P789, DOI 10.1017/S0952523801185123; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; Eisen MD, 2004, J NEUROPHYSIOL, V91, P2422, DOI 10.1152/jn.01130.2003; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P193, DOI 10.1113/jphysiol.1978.sp012228; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P211, DOI 10.1113/jphysiol.1978.sp012229; GLEISNER L, 1973, ACTA OTO-LARYNGOL, V76, P199, DOI 10.3109/00016487309121500; Gomis A, 1999, J NEUROSCI, V19, P6309; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; HAMA K, 1977, J NEUROCYTOL, V6, P361, DOI 10.1007/BF01178223; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Johnson SL, 2002, PFLUG ARCH EUR J PHY, V443, P653, DOI 10.1007/s00424-001-0763-z; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14883, DOI 10.1073/pnas.94.26.14883; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lagnado L, 2003, CURR BIOL, V13, pR631, DOI 10.1016/S0960-9822(03)00566-9; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LIBERMAN MC, 1990, J COMP NEUROL, V301, P443, DOI 10.1002/cne.903010309; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; MartinezDunst C, 1997, J NEUROSCI, V17, P9133; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Nikolenko V, 2003, METHODS, V30, P3, DOI 10.1016/S1046-2023(03)00003-3; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Ricci AJ, 2000, J PHYSIOL-LONDON, V524, P423, DOI 10.1111/j.1469-7793.2000.00423.x; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rouze NC, 1998, J NEUROSCI, V18, P8614; Schnee ME, 2003, J PHYSIOL-LONDON, V549, P697, DOI 10.1113/jphysiol.2002.037481; SNEARY MG, 1988, J COMP NEUROL, V276, P588, DOI 10.1002/cne.902760411; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taylor AM, 2004, J COMPUT NEUROSCI, V16, P139, DOI 10.1023/B:JCNS.0000014107.16610.2e; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Tucker TR, 1996, J PHYSIOL-LONDON, V494, P613, DOI 10.1113/jphysiol.1996.sp021519; USUKURA J, 1987, CELL TISSUE RES, V247, P483, DOI 10.1007/BF00215740; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Youngs IJ, 2002, J PHYS D APPL PHYS, V35, P3127, DOI 10.1088/0022-3727/35/23/314; Zenisek D, 2003, J NEUROSCI, V23, P2538	52	91	95	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					243	254		10.1016/j.neuron.2005.06.004	http://dx.doi.org/10.1016/j.neuron.2005.06.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039566	Bronze			2022-12-28	WOS:000230693900011
J	Sokolov, S; Scheuer, T; Catterall, WA				Sokolov, S; Scheuer, T; Catterall, WA			Ion permeation through a voltage-sensitive gating pore in brain sodium channels having voltage sensor mutations	NEURON			English	Article							SHAKER K+ CHANNEL; POTASSIUM CHANNELS; ALPHA-SUBUNIT; MOLECULAR DETERMINANTS; FAST INACTIVATION; SENSING RESIDUES; SCORPION TOXIN; S4 SEGMENT; DOMAIN-II; MOVEMENT	Voltage-gated sodium channels activate in response to depolarization, but it is unknown whether the voltage-sensing arginines in their S4 segments pivot across the lipid bilayer as voltage sensor paddles or move through the protein in a gating pore. Here we report that mutation of pairs of arginine gating charges to glutamine induces cation permeation through a gating pore in domain 11 of the Na(v)1.2a channel. Mutation of R850 and R853 induces a K+-selective inward cationic current in the resting state that is blocked by activation. Remarkably, mutation of R853 and R856 causes an outward cationic current with the opposite gating polarity. These results support a model in which the IIS4 gating charges move through a narrow constriction in a gating pore in the sodium channel protein during gating. Paired substitutions of glutamine allow cation movement through the constriction when appropriately positioned by the gating movements of the S4 segment.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcaft@u.washington.edu			NINDS NIH HHS [R01 NS15751] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Creighton TE, 1994, PROTEINS STRUCTURE M; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mantegazza M, 2005, J NEUROSCI, V25, P3341, DOI 10.1523/JNEUROSCI.0104-05.2005; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Stefani E, 1998, METHOD ENZYMOL, V293, P300; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Yang NB, 1997, BIOPHYS J, V73, P2260, DOI 10.1016/S0006-3495(97)78258-4; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; YU FH, 2004, SCI STKE	37	102	103	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					183	189		10.1016/j.neuron.2005.06.012	http://dx.doi.org/10.1016/j.neuron.2005.06.012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039561	Bronze			2022-12-28	WOS:000230693900006
J	Stuber, GD; Wightman, RM; Carelli, RM				Stuber, GD; Wightman, RM; Carelli, RM			Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens	NEURON			English	Article							FREELY MOVING RATS; SEEKING BEHAVIOR; CAUDATE-PUTAMEN; REWARD; ADDICTION; INCREASES; SUBSTRATE; RELEASE; NEURONS; CUES	While Pavlovian and operant conditioning influence drug-seeking behavior, the role of rapid dopamine signaling in modulating these processes is unknown. During self-administration of cocaine, two dopaminergic signals, measured with 100 ms resolution, occurred immediately before and after the lever press (termed pre- and postresponse dopamine transients). Extinction of self-administration revealed that these two signals were functionally distinct. Preresponse transients, which could reflect the motivation to obtain the drug, did not decline during extinction. Remarkably, postresponse dopamine transients attenuated as extinction progressed, suggesting that they encode the learned association between environmental cues and cocaine. A third type of dopamine transient, not time locked to overt stimuli, decreased in frequency during extinction and correlated with calculated cocaine concentrations. These results show that dopamine release transients involved in different aspects of cocaine self-administration are highly plastic-differentially governed by motivation, learned associations linked with environmental stimuli, and the pharmacological actions of cocaine.	Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carelli, RM (corresponding author), Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA.	rcarelli@unc.edu	Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855	NIDA NIH HHS [DA015923, DA017318, DA10900] Funding Source: Medline; NINDS NIH HHS [T32 NS007431] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010900, R01DA017318, F31DA015923] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Carelli RM, 2000, BRAIN RES, V866, P44, DOI 10.1016/S0006-8993(00)02217-4; Carelli RM, 2004, NEUROPHARMACOLOGY, V47, P180, DOI 10.1016/j.neuropharm.2004.07.017; Carelli RM, 1996, J PHARMACOL EXP THER, V277, P385; Crombag HS, 2002, NEUROPSYCHOPHARMACOL, V27, P1006, DOI 10.1016/S0893-133X(02)00356-1; Di Ciano P, 2004, EUR J NEUROSCI, V19, P1661, DOI 10.1111/j.1460-9568.2004.03232.x; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Ito R, 2000, J NEUROSCI, V20, P7489; JONES SR, 1995, J PHARMACOL EXP THER, V274, P396; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; NICOLAYSEN LC, 1988, BRAIN RES, V456, P317, DOI 10.1016/0006-8993(88)90234-X; O'Brien C P, 1993, NIDA Res Monogr, V135, P71; PAN HT, 1991, J NEUROCHEM, V56, P1299, DOI 10.1111/j.1471-4159.1991.tb11425.x; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Phillips PEM, 2003, METH MOLEC MED, V79, P443; Phillips PEM, 2003, TRAC-TREND ANAL CHEM, V22, P509, DOI 10.1016/S0165-9936(03)00907-5; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schwarz AJ, 2004, NEUROIMAGE, V23, P296, DOI 10.1016/j.neuroimage.2004.05.001; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; Venton BJ, 2003, J NEUROCHEM, V84, P373, DOI 10.1046/j.1471-4159.2003.01527.x; Weiss F, 2001, NEUROPSYCHOPHARMACOL, V25, P361, DOI 10.1016/S0893-133X(01)00238-X; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; Wu Q, 2001, J NEUROSCI, V21, P6338, DOI 10.1523/JNEUROSCI.21-16-06338.2001	32	129	130	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					661	669		10.1016/j.neuron.2005.04.036	http://dx.doi.org/10.1016/j.neuron.2005.04.036			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944133	Green Published, Bronze			2022-12-28	WOS:000229294300016
J	Pelkey, KA; McBain, CJ				Pelkey, KA; McBain, CJ			How to dismantle a detonator synapse	NEURON			English	Editorial Material							MOSSY FIBER BOUTONS; RAT HIPPOCAMPUS; TARGETS; CELLS	Direct electrophysiological evaluation of ion channels in vertebrate presynaptic nerve terminals has been limited to synapses such as the neuromuscular junction and the giant calyx of Held. In this issue of Neuron, Engel and Jonas demonstrate that mossy fiber boutons have specialized voltage-gated Na+ channels that critically impact upon presynaptic Ca2+ influx by amplifying terminal invading action potentials.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pelkey, KA (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bldg 35, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acsady L, 1998, J NEUROSCI, V18, P3386; Bischofberger J, 2002, J NEUROSCI, V22, P10593; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Geiger JRP, 2002, PFLUG ARCH EUR J PHY, V443, P491, DOI 10.1007/s00424-001-0735-3; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; VONKITZING E, 1994, ADV SEC MESS PHOSPH, V29, P235	15	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 3	2005	45	3					327	329		10.1016/j.neuron.2005.01.018	http://dx.doi.org/10.1016/j.neuron.2005.01.018			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694316	Bronze			2022-12-28	WOS:000226787700002
J	Zylka, MJ; Rice, FL; Anderson, DJ				Zylka, MJ; Rice, FL; Anderson, DJ			Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd	NEURON			English	Article							GRIFFONIA-SIMPLICIFOLIA I; SUPERFICIAL DORSAL-HORN; PRIMARY SENSORY NEURONS; LECTIN-BINDING ANALYSIS; RAT SPINAL-CORD; MYSTACIAL PAD; COMPREHENSIVE IMMUNOFLUORESCENCE; IMMUNOCYTOCHEMICAL LOCALIZATION; DIFFERENTIAL DEPENDENCY; GENETIC APPROACH	The brain receives sensory input from diverse peripheral tissues, including the skin, the body's largest sensory organ. Using genetically encoded axonal tracers expressed from the Mrgprd locus, we identify a subpopulation of nonpeptidergic, nociceptive neurons that project exclusively to the skin, and to no other peripheral tissue examined. Surprisingly, Mrgprd(+) innervation is restricted to the epidermis and absent from specialized sensory structures. Furthermore, Mrgprd(+) fibers terminate in a specific layer of the epidermis, the stratum granulosum. This termination zone is distinct from that innervated by most CGRP(+) neurons, revealing that peptidergic and nonpeptidergic epidermal innervation is spatially segregated. The central projections deriving from these distinct epidermal innervation zones terminate in adjacent laminae in the dorsal spinal cord. Thus, afferent input from different layers of the epidermis is conveyed by topographically segregated sensory circuits, suggesting that at least some aspects of sensory information processing may be organized along labeled lines.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Albany Medical College; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol, 216-76, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034692] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34692] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bender E, 2002, P NATL ACAD SCI USA, V99, P8573, DOI 10.1073/pnas.122016499; Bennett DL, 1996, NEUROSCI LETT, V206, P33, DOI 10.1016/0304-3940(96)12418-6; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Guo A, 2001, EUR J NEUROSCI, V14, P293, DOI 10.1046/j.0953-816x.2001.01665.x; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MCNEILL DL, 1988, EXP NEUROL, V99, P699, DOI 10.1016/0014-4886(88)90186-0; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; Petruska JC, 1997, SOMATOSENS MOT RES, V14, P17, DOI 10.1080/08990229771187; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Rice FL, 1997, J COMP NEUROL, V385, P149; RICE FL, 1993, J COMP NEUROL, V337, P386, DOI 10.1002/cne.903370304; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P259, DOI 10.3109/07367228809144630; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Ulrich-Lai YM, 2001, AM J PHYSIOL-REG I, V280, pR137, DOI 10.1152/ajpregu.2001.280.1.R137; Wang HF, 1998, BRAIN RES, V811, P34, DOI 10.1016/S0006-8993(98)00916-0; Wang HF, 1998, NEUROSCIENCE, V87, P275, DOI 10.1016/S0306-4522(98)00061-X; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	42	464	470	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					17	25		10.1016/j.neuron.2004.12.015	http://dx.doi.org/10.1016/j.neuron.2004.12.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629699	Bronze			2022-12-28	WOS:000226217100006
J	Mann, EO; Paulsen, O				Mann, EO; Paulsen, O			Keeping inhibition timely	NEURON			English	Editorial Material							NETWORK OSCILLATIONS; GABA; INTERNEURONS; CORTEX	GABAergic interneurons play a key role in orchestrating cortical network oscillations. In this issue of Neuron, two studies (Bacci and Huguenard and Vida et al.) identify how networks of fast-spiking interneurons can enhance the regularity, precision, and robustness of their own rhythmicity via individual and collective self-innervation.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Oxford	Mann, EO (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Paulsen, Ole/ABB-4843-2020	Paulsen, Ole/0000-0002-2258-5455; Mann, Edward/0000-0002-2468-7148				Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Bacci A, 2003, J NEUROSCI, V23, P859; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Tamas G, 1997, J NEUROSCI, V17, P6352; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016	10	7	7	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 5	2006	49	1					8	9		10.1016/j.neuron.2005.12.015	http://dx.doi.org/10.1016/j.neuron.2005.12.015			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387634	Bronze			2022-12-28	WOS:000236699300004
J	Monani, UR				Monani, UR			Spinal muscular atrophy: A deficiency in a ubiquitous protein; a motor neuron-specific disease	NEURON			English	Review							DETERMINING GENE-PRODUCT; VALPROIC ACID INCREASES; SMN TUDOR DOMAIN; MOUSE MODEL; MESSENGER-RNA; SPLICING ENHANCER; SINGLE NUCLEOTIDE; ANIMAL-MODEL; SURVIVAL; EXPRESSION	Spinal muscularatrophy (SMA) is a neurodegenerative disease in humans and the most common genetic cause of infant mortality. The disease results in motor neuron loss and skeletal muscle atrophy. Despite a range of disease phenotypes, SMA is caused by mutations in a single gene, the Survival of Motor Neuron 1 (SMN1) gene. Recent advances have shed light on functions of the protein product of this gene and the pathophysiology of the disease, yet, fundamental questions remain. This review attempts to highlight some of the recent advances made in the understanding of the disease and how loss of the ubiquitously expressed survival of motor neurons (SMN) protein results in the SMA phenotype. Answers to some of the questions raised may ultimately result in a viable treatment for SMA.	Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA	Columbia University; Columbia University	Monani, UR (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.	um2105@columbia.edu						Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Barth S, 2003, J VIROL, V77, P5008, DOI 10.1128/JVI.77.8.5008-5013.2003; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Bassell GJ, 2004, CURR OPIN NEUROBIOL, V14, P574, DOI 10.1016/j.conb.2004.08.010; Bertrandy S, 1999, HUM MOL GENET, V8, P775, DOI 10.1093/hmg/8.5.775; Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Bromberg MB, 2002, MUSCLE NERVE, V25, P445, DOI 10.1002/mus.10050; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Cusco I, 2004, NEUROLOGY, V63, P146, DOI 10.1212/01.WNL.0000132634.48815.13; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Guettier-Sigrist S, 1998, J NEUROSCI RES, V53, P663, DOI 10.1002/(SICI)1097-4547(19980915)53:6<663::AID-JNR4>3.0.CO;2-3; Hannus S, 2000, HUM MOL GENET, V9, P663, DOI 10.1093/hmg/9.5.663; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Jones KW, 2001, J BIOL CHEM, V276, P38645, DOI 10.1074/jbc.M106161200; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kernochan LE, 2005, HUM MOL GENET, V14, P1171, DOI 10.1093/hmg/ddi130; Kerr DA, 2003, J NEUROSCI, V23, P5131; KOBAYASHI H, 1995, HUM MOL GENET, V4, P1213, DOI 10.1093/hmg/4.7.1213; Koirala S, 2003, J NEUROCYTOL, V32, P987, DOI 10.1023/B:NEUR.0000020637.71452.3c; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lesbordes JC, 2003, HUM MOL GENET, V12, P1233, DOI 10.1093/hmg/ddg143; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 1998, HUM MOL GENET, V7, P1269, DOI 10.1093/hmg/7.8.1269; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miguel-Aliaga I, 1999, HUM MOL GENET, V8, P2133, DOI 10.1093/hmg/8.12.2133; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; PEARN J, 1980, LANCET, V1, P919; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Tizzano EF, 1998, AM J PATHOL, V153, P355, DOI 10.1016/S0002-9440(10)65578-2; van der Vleuten AJW, 1998, EUR J HUM GENET, V6, P376, DOI 10.1038/sj.ejhg.5200229; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Viollet L, 2002, ANN NEUROL, V51, P585, DOI 10.1002/ana.10182; Vitte JM, 2004, AM J PATHOL, V165, P1731, DOI 10.1016/S0002-9440(10)63428-1; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Williams BY, 2000, FEBS LETT, V470, P207, DOI 10.1016/S0014-5793(00)01320-X; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2002, J VIROL, V76, P3892, DOI 10.1128/JVI.76.8.3892-3904.2002; Young PJ, 2002, J BIOL CHEM, V277, P2852, DOI 10.1074/jbc.M108769200; Zhang HLL, 2003, J NEUROSCI, V23, P6627	85	247	258	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					885	896		10.1016/j.neuron.2005.12.001	http://dx.doi.org/10.1016/j.neuron.2005.12.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364894	Bronze, Green Published			2022-12-28	WOS:000234301700005
J	Pape, HC				Pape, HC			GABAergic neurons: Gate masters of the amygdala, mastered by dopamine	NEURON			English	Editorial Material							BASOLATERAL AMYGDALA; LATERAL AMYGDALA; FEAR MEMORY; STRESS; INTERNEURONS; INHIBITION; MODULATION	A hyperdopaminergic state, such as stress, is associated with an increase in affective behavior. In this issue of Neuron, Marowsky and colleagues identify two clusters of paracapsular intercalated GABA neurons in amygdala slice preparations of GAD67-GFP mice. These GABA neurons mediate inhibition from cortical afferents to both the major input and output station of the amygdala, are inhibited during action of dopamine via D1 receptors, and are thus likely to represent important cellular players during dopaminergic disinhibition related to increased affective behavior.	Univ Munster, Dept Med, Inst Physiol 1, D-48149 Munster, Germany	University of Munster	Pape, HC (corresponding author), Univ Munster, Dept Med, Inst Physiol 1, D-48149 Munster, Germany.							Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Correll CM, 2005, BIOL PSYCHIAT, V58, P382, DOI 10.1016/j.biopsych.2005.04.009; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Manzanares PAR, 2005, J NEUROSCI, V25, P8725, DOI 10.1523/JNEUROSCI.2260-05.2005; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2000, J NEUROSCI, V20, P9034; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905	16	29	31	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					877	879		10.1016/j.neuron.2005.12.002	http://dx.doi.org/10.1016/j.neuron.2005.12.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364892	Bronze			2022-12-28	WOS:000234301700003
J	Amedi, A; Malach, R; Pascual-Leone, A				Amedi, A; Malach, R; Pascual-Leone, A			Negative BOLD differentiates visual imagery and perception	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY AUDITORY-CORTEX; HUMAN CEREBRAL-CORTEX; DEFAULT-MODE; HUMAN BRAIN; VOLUME MEASUREMENT; MENTAL-IMAGERY; ACTIVATION; FMRI; ATTENTION	Recent studies emphasize the overlap between the neural substrates of visual perception and visual imagery. However, the subjective experiences of imagining and seeing are clearly different. Here we demonstrate that deactivation of auditory cortex (and to some extent of somatosensory and subcortical visual structures) as measured by BOLD functional magnetic resonance imaging unequivocally differentiates visual imagery from visual perception. During visual imagery, auditory cortex deactivation negatively correlates with activation in visual cortex and with the score in the subjective vividness of visual imagery questionnaire (VVIQ). Perception of the world requires the merging of multisensory information so that, during seeing, information from other sensory systems modifies visual cortical activity and shapes experience. We suggest that pure visual imagery corresponds to the isolated activation of visual cortical areas with concurrent deactivation of "irrelevant" sensory processing that could disrupt the image created by our "mind's eye."	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Weizmann Institute of Science	Amedi, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA.	aamedi@bidmc.harvard.edu; apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; Amedi, Amir/0000-0001-5042-2533	NCRR NIH HHS [K24 RR018875] Funding Source: Medline; NEI NIH HHS [R01-EY-12091] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Baudewig J, 2000, MAGN RESON IMAGING, V18, P479, DOI 10.1016/S0730-725X(00)00122-3; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bestmann S, 2003, J MAGN RESON IMAGING, V17, P309, DOI 10.1002/jmri.10260; Bohning DE, 1998, INVEST RADIOL, V33, P336, DOI 10.1097/00004424-199806000-00004; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Horwitz Barry, 1994, Human Brain Mapping, V2, P112, DOI 10.1002/hbm.460020111; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; KAWASHIMA R, 1993, J CEREB BLOOD FLOW M, V13, pS502; Klein I, 2004, COGNITIVE BRAIN RES, V22, P26, DOI 10.1016/j.cogbrainres.2004.07.006; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Lambert S, 2004, COGNITIVE BRAIN RES, V20, P1; Laurienti PJ, 2004, J COGNITIVE NEUROSCI, V16, P1481, DOI 10.1162/0898929042568596; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Marx E, 2004, NEUROIMAGE, V21, P1818, DOI 10.1016/j.neuroimage.2003.12.026; MAZZIOTTA JC, 1982, NEUROLOGY, V32, P921, DOI 10.1212/WNL.32.9.921; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pascual-Leone A, 2001, ANN NY ACAD SCI, V930, P315, DOI 10.1111/j.1749-6632.2001.tb05741.x; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Renier L, 2005, NEUROIMAGE, V26, P573, DOI 10.1016/j.neuroimage.2005.01.047; Sathian K, 2001, OPTOMETRY VISION SCI, V78, P276, DOI 10.1097/00006324-200105000-00010; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Stein BE., 1993, MERGING SENSES; Talairach J., 1988, COPLANAR STEREOTAXIC; Wade AR, 2002, NEURON, V36, P993, DOI 10.1016/S0896-6273(02)01138-8; Weeks R, 2000, J NEUROSCI, V20, P2664; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251	65	162	167	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					859	872		10.1016/j.neuron.2005.10.032	http://dx.doi.org/10.1016/j.neuron.2005.10.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337922	Bronze			2022-12-28	WOS:000233927300023
J	Mazor, O; Laurent, G				Mazor, O; Laurent, G			Transient dynamics versus fixed points in odor representations by locust antennal lobe projection neurons	NEURON			English	Article							DISCRIMINATION; OSCILLATIONS; SEQUENCES; RESPONSES; CORTEX; CODE; INFORMATION; PERCEPTION; FEATURES; FLIGHT	Projection neurons (PNs) in the locust antennal lobe exhibit odor-specific dynamic responses. We studied a PN population, stimulated with five odorants and pulse durations between 0.3 and 10 s. Odor representations were characterized as time series of vectors of PN activity, constructed from the firing rates of all PNs in successive 50 ms time bins. Odor representations by the PN population can be described as trajectories in PN state space with three main phases: an on transient, lasting 1-2 s; a fixed point, stable for at least 8 s; and an off transient, lasting a few seconds as activity returns to baseline. Whereas all three phases are odor specific, optimal stimulus separation occurred during the transients rather than the fixed points. In addition, the PNs' own target neurons respond least when their PN-population input stabilized at a fixed point. Steady-state measures of activity thus seem inappropriate to understand the neural code in this system.	CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	laurentg@caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Mazor, Ofer/0000-0002-6860-7242	NCRR NIH HHS [P41RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Afraimovich VS, 2004, CHAOS, V14, P1123, DOI 10.1063/1.1819625; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; Daly KC, 2004, J NEUROPHYSIOL, V92, P236, DOI 10.1152/jn.01132.2003; DuchampViret P, 1996, NEUROSCIENCE, V74, P885, DOI 10.1016/0306-4522(96)00194-7; Dulac C, 1997, NEURON, V19, P477, DOI 10.1016/S0896-6273(00)80363-3; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; Freeman W.J., 2000, NEURODYNAMICS EXPLOR, DOI 10.1007/978-1-4471-0371-4; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Kanerva P., 1988, SPARSE DISTRIBUTED M; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leitch B, 1996, J COMP NEUROL, V372, P487; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Livermore A, 1996, J EXP PSYCHOL HUMAN, V22, P267, DOI 10.1037/0096-1523.22.2.267; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Menzel R., 1987, P310; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; PHILLIPS DP, 1985, HEARING RES, V19, P253, DOI 10.1016/0378-5955(85)90145-5; Pouget A, 1999, NEURAL COMPUT, V11, P85, DOI 10.1162/089976699300016818; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Slotnick B, 2002, J NEUROSCI, V22, P4205, DOI 10.1523/JNEUROSCI.22-10-04205.2002; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Vickers NJ, 1996, J COMP PHYSIOL A, V178, P831, DOI 10.1007/BF00225831; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	59	333	335	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					661	673		10.1016/j.neuron.2005.09.032	http://dx.doi.org/10.1016/j.neuron.2005.09.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301181	Bronze			2022-12-28	WOS:000233677300018
J	Fox, K; Wong, ROL				Fox, K; Wong, ROL			A comparison of experience-dependent plasticity in the visual and somatosensory systems	NEURON			English	Review							OCULAR DOMINANCE PLASTICITY; PROTEIN-KINASE-II; DENDRITIC SPINE STABILITY; LONG-TERM POTENTIATION; BARREL FIELD CORTEX; IN-VIVO; SYNAPTIC PLASTICITY; CRITICAL PERIOD; MONOCULAR DEPRIVATION; SENSORY DEPRIVATION	In the visual and somatosensory systems, maturation of neuronal circuits continues for days to weeks after sensory stimulation occurs. Deprivation of sensory input at various stages of development can induce physiological, and often structural, changes that modify the circuitry of these sensory systems. Recent studies also reveal a surprising degree of plasticity in the mature visual and somatosensory pathways. Here, we compare and contrast the effects of sensory experience on the connectivity and function of these pathways and discuss what is known to date concerning the structural, physiological, and molecular mechanisms underlying their plasticity.	Cardiff Univ, Cardiff Business Sch, Cardiff CF10 3US, S Glam, Wales; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Cardiff University; Washington University (WUSTL)	Fox, K (corresponding author), Cardiff Univ, Cardiff Business Sch, Museum Ave, Cardiff CF10 3US, S Glam, Wales.	foxkd@cf.ac.uk; wongr@pcg.wustl.edu	Fox, Kevin/E-8836-2010	Fox, Kevin/0000-0002-2563-112X	Medical Research Council [G0200413] Funding Source: Medline; MRC [G0200413] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ALTMANN L, 1987, J NEUROPHYSIOL, V58, P965, DOI 10.1152/jn.1987.58.5.965; Antonini A, 1999, J NEUROSCI, V19, P4388; Antonini A, 1996, J COMP NEUROL, V369, P64; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Bender KJ, 2003, J NEUROSCI, V23, P8759; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Fox K, 2002, PHILOS T ROY SOC B, V357, P1709, DOI 10.1098/rstb.2002.1169; Fox K, 1996, J PHYSIOLOGY-PARIS, V90, P263, DOI 10.1016/S0928-4257(97)81436-2; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Gordon JA, 1996, J NEUROSCI, V16, P3274; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hardingham N, 2003, J NEUROSCI, V23, P4428; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hensch TK, 1998, J NEUROSCI, V18, P2108; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Kossut M, 1999, NEUROSCIENCE, V92, P807, DOI 10.1016/S0306-4522(98)00722-2; LAW MI, 1980, P NATL ACAD SCI-BIOL, V77, P2314, DOI 10.1073/pnas.77.4.2314; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maravall M, 2004, CEREB CORTEX, V14, P655, DOI 10.1093/cercor/bhh026; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Morales B, 2002, J NEUROSCI, V22, P8084; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Ossipow V, 2004, MOL CELL NEUROSCI, V27, P70, DOI 10.1016/j.mcn.2004.05.003; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; Shen YS, 2005, J COMPUT NEUROSCI, V18, P25, DOI 10.1007/s10827-005-5475-5; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Silver MA, 2000, J COMP NEUROL, V422, P652, DOI 10.1002/1096-9861(20000710)422:4<652::AID-CNE11>3.0.CO;2-1; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Strack S, 1997, J NEUROCHEM, V68, P2119; Tailby C, 2005, P NATL ACAD SCI USA, V102, P4631, DOI 10.1073/pnas.0402747102; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; TIEMAN SB, 1995, DEV BRAIN RES, V84, P39; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; VALVERDE F, 1967, EXP BRAIN RES, V3, P337; VALVERDE F, 1971, BRAIN RES, V33, P1, DOI 10.1016/0006-8993(71)90302-7; Vees AM, 1998, J COMP NEUROL, V400, P110; Wallace H, 1999, J NEUROBIOL, V41, P58, DOI 10.1002/(SICI)1097-4695(199910)41:1<58::AID-NEU8>3.0.CO;2-F; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Waters J, 2003, J NEUROSCI, V23, P8558; Yang YP, 2005, NAT NEUROSCI, V8, P791, DOI 10.1038/nn1464; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	96	165	171	4	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					465	477		10.1016/j.neuron.2005.10.013	http://dx.doi.org/10.1016/j.neuron.2005.10.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269363	Bronze			2022-12-28	WOS:000233250100007
J	Dubois-Dalcq, M; Ffrench-Constant, C; Franklin, RJM				Dubois-Dalcq, M; Ffrench-Constant, C; Franklin, RJM			Enhancing central nervous system remyelination in multiple sclerosis	NEURON			English	Review							AUTOIMMUNE ENCEPHALOMYELITIS; CNS DEMYELINATION; REPAIR; MODEL; REEXPRESSION; MYELINATION; LESIONS	Recent studies on adult neural stem cells and the developmental biology of myelination have generated the expectation that neural precursors can repair the damaged central nervous system of multiple sclerosis patients where the endogenous remyelination process has failed. As a result, many laboratories are engaged in translational studies in which the goal is to design ways to promote remyelination and repair. Here we raise issues highlighted by prior experimental and human work that should be considered lest these studies become "lost in translation."	NINDS, NIH, Bethesda, MD 20892 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England; Univ Cambridge, Dept Vet Med, Cambridge CB2 1TN, England; Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Cambridge; University of Cambridge; University of Cambridge	Dubois-Dalcq, M (corresponding author), NINDS, NIH, Bethesda, MD 20892 USA.	dalcqm@mail.nih.gov; rjf1000@cam.ac.uk	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Franklin, Robin/0000-0001-6522-2104				Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Glaser T, 2004, FASEB J, V18, P112, DOI 10.1096/fj.04-1931fje; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pirko I, 2004, FASEB J, V18, P1577, DOI 10.1096/fj.04-2026fje; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Torregrossa P, 2004, J BIOL CHEM, V279, P30707, DOI 10.1074/jbc.M403935200; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014	25	94	101	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					9	12		10.1016/j.neuron.2005.09.004	http://dx.doi.org/10.1016/j.neuron.2005.09.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202704	Bronze			2022-12-28	WOS:000232625700004
J	Falk, J; Bechara, A; Fiore, R; Nawabi, H; Zhou, H; Hoyo-Becerra, C; Bozon, M; Rougon, G; Grumet, M; Puschel, AW; Sanes, JR; Castellani, V				Falk, J; Bechara, A; Fiore, R; Nawabi, H; Zhou, H; Hoyo-Becerra, C; Bozon, M; Rougon, G; Grumet, M; Puschel, AW; Sanes, JR; Castellani, V			Dual functional activity of semaphorin 3B is required for positioning the anterior commissure	NEURON			English	Article							FOCAL-ADHESION-KINASE; AXON GUIDANCE; NERVOUS-SYSTEM; NR-CAM; SECRETED SEMAPHORINS; GROWTH-CONE; IN-VIVO; RECEPTOR; NEUROPILIN-2; ATTRACTION	Chemorepulsion by semaphorins plays a critical role during the development of neuronal projections. Although semaphorin-induced chemoattraction has been reported in vitro, the contribution of this activity to axon pathfinding is still unclear. Using genetic and culture models, we provide evidence that both attraction and repulsion by Sema3B, a secreted semaphorin, are critical for the positioning of a major brain commissural projection, the anterior commissure (AC). NrCAM, an immunoglobulin superfamily adhesion molecule of the L1 subfamily, associates with neuropilin-2 and is a component of a receptor complex for Sema3B and Sema3F. Finally, we show that activation of the FAK/Src signaling cascade distinguishes Sema3B-mediated attractive from repulsive axonal responses of neurons forming the AC, revealing a mechanism underlying the dual activity of this guidance cue.	Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France; Inst Dev Biol, CNRS, UMR 6156, NMDA, F-13288 Marseille, France; Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany; Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, E-29071 Malaga, Spain; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); University of Munster; Universidad de Malaga; Washington University (WUSTL); Rutgers State University New Brunswick; Harvard University	Castellani, V (corresponding author), Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France.	castellani@cgmc.univ-lyon1.fr	castellani, valérie/H-3100-2017; Homaira, NAWABI/G-6145-2017; ROUGON, Genevieve/G-2578-2013; grumet, martin/ABC-6462-2020; Falk, Julien/G-9020-2017	castellani, valérie/0000-0001-9623-9312; Falk, Julien/0000-0001-8590-5615; ROUGON, Genevieve/0000-0003-1316-8200; NAWABI, Homaira/0000-0003-3155-2783				Atwal JK, 2003, J NEUROSCI, V23, P7602; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cummings DM, 1997, J NEUROBIOL, V32, P403; de Castro F, 1999, J NEUROSCI, V19, P4428; Faivre-Sarrailh C, 1999, J CELL SCI, V112, P3015; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Grumet M, 1997, CELL TISSUE RES, V290, P423, DOI 10.1007/s004410050949; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lustig M, 2001, J COMP NEUROL, V434, P13, DOI 10.1002/cne.1161; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; PIRESNETO MA, 1993, DEV BRAIN RES, V72, P59, DOI 10.1016/0165-3806(93)90159-8; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Sahay A, 2003, J NEUROSCI, V23, P6671; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	42	178	181	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					63	75		10.1016/j.neuron.2005.08.033	http://dx.doi.org/10.1016/j.neuron.2005.08.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202709	Bronze			2022-12-28	WOS:000232625700010
J	Kosik, KS; Krichevsky, AM				Kosik, KS; Krichevsky, AM			The elegance of the microRNAs: A neuronal perspective	NEURON			English	Review							EXPRESSION; MIRNA	As knowledge of microRNAs (miRNA) grows from a compendium of sequences to annotated functional data it has become increasingly clear that a highly significant segment of regulatory biology depends on these 22 nucleotide noncoding transcripts. The expression of many miRNAs in the nervous system, some with a high degree of temporal and spatial specificity, suggests that understanding miRNAs in the nervous system will yield rewarding neurobiological insights. High on the list of insights that microRNAs promise is a deeper understanding of the remarkable cellular diversity found among neurons. This review examines the interface between an emerging biology of miRNAs and their role in nervous systems.	Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of California System; University of California Santa Barbara; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu		Krichevsky, Anna/0000-0002-5080-5507				AMRBOS V, 2004, NATURE, V43, P350; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	25	125	133	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					779	782		10.1016/j.neuron.2005.08.019	http://dx.doi.org/10.1016/j.neuron.2005.08.019			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157272	Bronze			2022-12-28	WOS:000232085000005
J	Coussen, F; Perrais, D; Jaskolski, F; Sachidhanandam, S; Normand, E; Bockaert, J; Marin, P; Mulle, C				Coussen, F; Perrais, D; Jaskolski, F; Sachidhanandam, S; Normand, E; Bockaert, J; Marin, P; Mulle, C			Coassembly of two GluR6 Kainate receptor splice variants within a functional protein complex	NEURON			English	Article							MOSSY-FIBER SYNAPSES; NMDA RECEPTORS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; SUBUNIT COMPOSITION; SURFACE EXPRESSION; AMPA RECEPTORS; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; GLUTAMATE RECEPTORS	Kainate receptors (KAR) are composed of several distinct subunits and splice variants, but the functional relevance of this diversity remains largely unclear. Here we show that two splice variants of the GluR6 subunit, GIuR6a and GIuR6b, which differ in their C-terminal domains, do not show distinct functional properties, but coassemble as heteromers in vitro and in vivo. Using a proteomic approach combining affinity purification and MALDI-TOF mass spectrometry, we found that GluR6a and GIuR6b interact with two distinct subsets of cytosolic proteins mainly involved in W regulation of channel function and intracellular trafficking. Guided by these results, we provide evidence that the regulation of native KAR function by NMDA receptors depends on the heteromerization of GIuR6a and GIuR6b and interaction of calcineurin with GIuR6b. Thus, GIuR6a and GIuR6b bring in close proximity two separate subsets of interacting proteins that contribute to the fine regulation of KAR trafficking and function.	Univ Bordeaux 2, Inst Francois Magendie, CNRS, UMR 5091,Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France; Inserm U661, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Mulle, C (corresponding author), Univ Bordeaux 2, Inst Francois Magendie, CNRS, UMR 5091,Lab Physiol Cellulaire Synapse, Rue C St Saens, F-33077 Bordeaux, France.	mulle@u-bordeaux2.fr	Perrais, David/W-9360-2019	Perrais, David/0000-0002-5878-5408; Sachidhanandam, Shankar/0000-0002-9359-6653; Mulle, Christophe/0000-0003-2709-6615				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BERNARD V, 1992, J NEUROSCI, V12, P3591; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chazot PL, 1997, J NEUROCHEM, V69, P2138; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Cui CH, 1999, J NEUROSCI, V19, P8281; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Ghetti A, 2000, J NEUROSCI, V20, P2766; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Nourry Claire, 2003, Sci STKE, V2003, pRE7; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Ren Z, 2003, J BIOL CHEM, V278, P52700, DOI 10.1074/jbc.M309585200; Ren Z, 2003, J NEUROSCI, V23, P6608; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; WENTHOLD RJ, 1994, J BIOL CHEM, V269, P1332; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	65	67	72	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					555	566		10.1016/j.neuron.2005.06.033	http://dx.doi.org/10.1016/j.neuron.2005.06.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102538	Bronze			2022-12-28	WOS:000231411100012
J	Gardner, JL; Sun, P; Waggoner, RA; Ueno, K; Tanaka, K; Cheng, K				Gardner, JL; Sun, P; Waggoner, RA; Ueno, K; Tanaka, K; Cheng, K			Contrast adaptation and representation in human early visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; STRIATE CORTICAL-NEURONS; CEREBRAL BLOOD OXYGENATION; EXTRASTRIATE AREA V4; FUNCTIONAL MRI; RESPONSE AMPLITUDE; GAIN-CONTROL; SELECTIVE ADAPTATION; SYNAPTIC DEPRESSION; SPATIAL ATTENTION	The human visual system can distinguish variations in image contrast over a much larger range than measurements of the static relationship between contrast and response in visual cortex would suggest. This discrepancy may be explained if adaptation serves to recenter contrast response functions around the ambient contrast, yet experiments on humans have yet to report such an effect. By using event-related fMRl and a data-driven analysis approach, we found that contrast response functions in V1, V2, and V3 shift to approximately center on the adapting contrast. Furthermore, we discovered that, unlike earlier areas, human V4 (hV4) responds positively to contrast changes, whether increments or decrements, suggesting that hV4 does not faithfully represent contrast, but instead responds to salient changes. These findings suggest that the visual system discounts slow uninformative changes in contrast with adaptation, yet remains exquisitely sensitive to changes that may signal important events in the environment.	RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama 3510198, Japan; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Dept Psychol, New York, NY 10003 USA	RIKEN; New York University; New York University	Gardner, JL (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	justin@cns.nyu.edu	Sun, Pei/B-5191-2013; Ueno, Kenichi/A-9395-2014; Tanaka, Keiji/N-5917-2015; Waggoner, Allen/F-2654-2010; Cheng, Kang/A-6448-2016	Sun, Pei/0000-0003-4184-1079; Tanaka, Keiji/0000-0002-1910-3427; Waggoner, Allen/0000-0002-4921-7521; Gardner, Justin/0000-0003-2220-5050	NEI NIH HHS [F32 EY016260, F32 EY016260-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY016260] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adorjan P, 1999, REV NEUROSCIENCE, V10, P181; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ALLISON JD, 1993, VISUAL NEUROSCI, V10, P1129, DOI 10.1017/S0952523800010233; ANZAI A, 1995, VISUAL NEUROSCI, V12, P77, DOI 10.1017/S0952523800007331; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Bandettini PA, 1997, HUM BRAIN MAPP, V5, P93; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRAUN J, 1994, J NEUROSCI, V14, P554; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Chance FS, 1998, J NEUROSCI, V18, P4785; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEAN AF, 1983, VISION RES, V23, P249, DOI 10.1016/0042-6989(83)90113-X; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; FINLAYSON PG, 1995, EXP BRAIN RES, V106, P145; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GARDNER JL, 2005, P INT SOC MAGN RES M, V13, P25; GREENLEE MW, 1988, VISION RES, V28, P791, DOI 10.1016/0042-6989(88)90026-0; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kruger G, 1996, MAGNET RESON MED, V35, P797, DOI 10.1002/mrm.1910350602; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maas LC, 1997, MAGNET RESON MED, V37, P131, DOI 10.1002/mrm.1910370119; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; MCKEEFRY DJ, 1997, BRAIN, V120, P2299; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 2003, J NEUROSCI, V23, P3990; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1985, J NEUROPHYSIOL, V54, P668, DOI 10.1152/jn.1985.54.3.668; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SMIMAKIS SM, 1997, NATURE, V386, P69; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	76	146	148	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					607	620		10.1016/j.neuron.2005.07.016	http://dx.doi.org/10.1016/j.neuron.2005.07.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102542	Green Accepted, Bronze			2022-12-28	WOS:000231411100016
J	Palmer, CL; Lim, W; Hastie, PGR; Toward, M; Korolchuk, VI; Burbidge, SA; Banting, G; Collingridge, GL; Isaac, JTR; Henley, JM				Palmer, CL; Lim, W; Hastie, PGR; Toward, M; Korolchuk, VI; Burbidge, SA; Banting, G; Collingridge, GL; Isaac, JTR; Henley, JM			Hippocalcin functions as a calcium sensor in hippocampal LTD	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; TYROSINE MOTIFS; 2-HYBRID SYSTEM; CLATHRIN; PROTEIN; ENDOCYTOSIS; BINDING; BRAIN	It is not fully understood how NMDAR-dependent LTD causes Ca2+-dependent endocytosis of AMPARs. Here we show that the neuronal Ca2+ sensor hippocalcin binds the beta 2-adaptin subunit of the AP2 adaptor complex and that along with GluR2 these coimmunoprecipitate in a Ca2+-sensitive manner. Infusion of a truncated mutant of hippocalcin (HIP2-72) that lacks the Ca2+ binding domains prevents synaptically evoked LTD but has no effect on LTR These data indicate that the AP2-hippocalcin complex acts as a Ca2+ sensor that couples NMDAR-dependent activation to regulated endocytosis of AMPARs during LTD.	Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; GlaxoSmithKline Inc, Neurol Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; University of Bristol; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Henley, JM (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	j.m.henley@bris.ac.uk	Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020; Henley, Jeremy M/A-2776-2009	Collingridge, Graham L/0000-0002-9572-5359; Henley, Jeremy/0000-0003-3589-8335; Banting, George/0000-0001-8249-1621; Korolchuk, Viktor/0000-0002-4071-592X	Medical Research Council [G9532377, G9629038] Funding Source: Medline; Wellcome Trust [059917] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, Z01NS003011] Funding Source: NIH RePORTER; MRC [G9532377, G9629038] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Cupers P, 1997, BIOCHEM BIOPH RES CO, V236, P661, DOI 10.1006/bbrc.1997.7033; GRAY EG, 1962, J ANAT, V96, P79; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Hyun JK, 2000, MOL CELLS, V10, P669, DOI 10.1007/s100590000028; Ivings L, 2002, BIOCHEM J, V363, P599, DOI 10.1042/0264-6021:3630599; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; KAJIMOTO Y, 1993, J NEUROCHEM, V61, P1091, DOI 10.1111/j.1471-4159.1993.tb03624.x; KOBAYASHI M, 1993, BIOCHEM BIOPH RES CO, V196, P1017, DOI 10.1006/bbrc.1993.2351; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mercer EA, 2000, EMBO J, V19, P3597, DOI 10.1093/emboj/19.14.3597; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nishimune A, 1996, TRENDS NEUROSCI, V19, P261, DOI 10.1016/S0166-2236(96)40003-0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Perestenko P, 2003, BIOCHEM SOC T, V31, P880, DOI 10.1042/bst0310880; SAITOH S, 1993, NEUROSCI LETT, V157, P107, DOI 10.1016/0304-3940(93)90654-4; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200	40	105	110	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					487	494		10.1016/j.neuron.2005.06.014	http://dx.doi.org/10.1016/j.neuron.2005.06.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102532	Bronze, Green Accepted			2022-12-28	WOS:000231411100006
J	Lai, HC; Grabe, M; Jan, YN; Jan, LY				Lai, HC; Grabe, M; Jan, YN; Jan, LY			The S4 voltage sensor packs against the pore domain in the KAT1 voltage-gated potassium channel	NEURON			English	Article							DEPENDENT K+ CHANNEL; ION CHANNELS; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE SEGMENTS; FUNCTIONAL EXPRESSION; PACEMAKER CHANNELS; MOLECULAR-MOVEMENT; ESCHERICHIA-COLI; ELECTRIC-FIELD; GATING CHARGE	In voltage-gated ion channels, the S4 transmembrane segment responds to changes in membrane potential and controls channel opening. The local environment of S4 is still unknown, even regarding the basic question as to whether S4 is close to the pore domain. Relying on the ability of functional KAT1 channels to rescue potassium (K+) transport-deficient yeast, we have performed an unbiased mutagenesis screen aimed at determining whether S4 packs against S5 of the pore domain. Starting with semilethal mutations of surface-exposed S5 residues of the KAT1 pore domain, we have screened randomly mutagenized libraries of S4 or S1-S3 for second-site suppressors. Our study identifies two S4 residues that interact in a highly specific manner with two S5 residues in the middle of the membrane-spanning regions, supporting a model in which the S4 voltage sensor packs against the pore domain in the hyperpolarized, or "down," state of S4.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Sch Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA.	gkw@itsa.ucsf.edu	Grabe, Michael/B-3705-2009	Lai, Helen/0000-0003-4334-0243	NIGMS NIH HHS [GM08284] Funding Source: Medline; PHS HHS [R01] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; ASCHROFT FM, 2000, ION CHANNELS DIS; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; Brownlee C, 2002, CURR BIOL, V12, pR402, DOI 10.1016/S0960-9822(02)00886-2; CAO YW, 1995, J BIOL CHEM, V270, P17697, DOI 10.1074/jbc.270.30.17697; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gaymard F, 1998, CELL, V94, P647, DOI 10.1016/S0092-8674(00)81606-2; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; GRABE M, 2004, P NATL ACAD SCI USA, V102, P5020; Gulbis JM, 2004, CURR OPIN STRUC BIOL, V14, P440, DOI 10.1016/j.sbi.2004.06.008; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuruma A, 2000, AM J PHYSIOL-CELL PH, V279, pC1401, DOI 10.1152/ajpcell.2000.279.5.C1401; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Marten I, 1998, BIOPHYS J, V74, P2953, DOI 10.1016/S0006-3495(98)78002-6; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Mura CV, 2004, J MEMBRANE BIOL, V201, P157, DOI 10.1007/s00232-004-0713-8; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Ramon L, 2003, MOL MEMBR BIOL, V20, P19, DOI 10.1080/0968768021000057371; RASBAND WS, 1997, IMAGEJ COMPUTER PROG; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sands Z, 2005, CURR BIOL, V15, pR44, DOI 10.1016/j.cub.2004.12.050; Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SCHROEDER JI, 1994, ANNU REV BIOPH BIOM, V23, P441, DOI 10.1146/annurev.bb.23.060194.002301; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Shieh CC, 2000, PHARMACOL REV, V52, P557; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zei PC, 1998, J GEN PHYSIOL, V112, P679, DOI 10.1085/jgp.112.6.679	75	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					395	406		10.1016/j.neuron.2005.06.019	http://dx.doi.org/10.1016/j.neuron.2005.06.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055063	Bronze			2022-12-28	WOS:000231051900010
J	Verstreken, P; Ly, CV; Venken, KJT; Koh, TW; Zhou, Y; Bellen, HJ				Verstreken, P; Ly, CV; Venken, KJT; Koh, TW; Zhou, Y; Bellen, HJ			Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions	NEURON			English	Article							MOTOR-NERVE TERMINALS; LIGHT-CHAIN KINASE; TRANSMITTER RELEASE; AXONAL-TRANSPORT; NEUROTRANSMITTER RELEASE; REPETITIVE STIMULATION; SYMPATHETIC NEURONS; INTRACELLULAR CA2+; MYOSIN-II; SYNAPSES	In a forward screen for genes affecting neurotransmission in Drosophila, we identified mutations in dynamin-related protein (drp1). DRP1 is required for proper cellular distribution of mitochondria, and in mutant neurons, mitochondria are largely absent from synapses, thus providing a genetic tool to assess the role of mitochondria at synapses. Although resting Ca2+ is elevated at drp1 NMJs, basal synaptic properties are barely affected. However, during intense stimulation, mutants fail to maintain normal neurotransmission. Surprisingly, FM1-43 labeling indicates normal exo- and endocytosis, but a specific inability to mobilize reserve pool vesicles, which is partially rescued by exogenous ATP. Using a variety of drugs, we provide evidence that reserve pool recruitment depends on mitochondrial ATP production downstream of PKA signaling and that mitochondrial ATP limits myosin-propelled mobilization of reserve pool vesicles. Our data suggest a specific role for mitochondria in regulating synaptic strength.	Baylor Coll Med, Dept Mol & Humal Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Humal Genet, 1 Baylor Pl, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Verstreken, Patrik/AAC-7591-2022; Venken, Koen/B-9909-2013; Koh, Tong-Wey/M-3774-2013	Verstreken, Patrik/0000-0002-5073-5393; Venken, Koen/0000-0003-0741-4698; Koh, Tong-Wey/0000-0001-9136-3189; Bellen, Hugo/0000-0001-5992-5989				AIUCHI T, 1985, BIOCHIM BIOPHYS ACTA, V843, P20, DOI 10.1016/0304-4165(85)90044-3; ALNAES E, 1975, J PHYSIOL-LONDON, V248, P285, DOI 10.1113/jphysiol.1975.sp010974; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BELLEN HJ, 2000, DROSOPHILA PROTOCOLS, P175; Billups B, 2002, J NEUROSCI, V22, P5840; Bouchard R, 2003, PROG NEUROBIOL, V69, P391, DOI 10.1016/S0301-0082(03)00053-4; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Budd SL, 1996, J NEUROCHEM, V67, P2282; Calupca MA, 2001, J PHYSIOL-LONDON, V532, P217, DOI 10.1111/j.1469-7793.2001.0217g.x; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; FRIEL DD, 1994, J NEUROSCI, V14, P4007; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hurd DD, 1996, GENETICS, V144, P1075; JENSEN JR, 1991, BRAIN RES, V551, P311, DOI 10.1016/0006-8993(91)90947-T; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kann O, 2003, J NEUROPHYSIOL, V90, P613, DOI 10.1152/jn.00042.2003; Kidokoro Y, 2004, BRAIN RES REV, V47, P18, DOI 10.1016/j.brainresrev.2004.05.004; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, GENETICS, V138, P111; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; MAKISHIMA M, 1991, FEBS LETT, V287, P175, DOI 10.1016/0014-5793(91)80044-4; Mathews C.K., 1996, BIOCHEMISTRY; Medler K, 2002, J NEUROPHYSIOL, V87, P1426, DOI 10.1152/jn.00627.2001; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; MOLGO J, 1988, NEUROSCIENCE, V24, P695, DOI 10.1016/0306-4522(88)90362-4; Mozhayeva MG, 2004, J NEUROSCI, V24, P1680, DOI 10.1523/JNEUROSCI.3801-03.2004; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Parekh AB, 2003, NEWS PHYSIOL SCI, V18, P252, DOI 10.1152/nips.01458.2003; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rikhy R, 2003, GENETICS, V165, P1243; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Ryan TA, 1999, J NEUROSCI, V19, P1317; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; SANYAL S, 2004, GENETICS, V24, P4518; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Trotta N, 2004, J NEUROBIOL, V60, P328, DOI 10.1002/neu.20017; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; WERTH JL, 1994, J NEUROSCI, V14, P348; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; ZENGEL JE, 1994, J GEN PHYSIOL, V104, P337, DOI 10.1085/jgp.104.2.337; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5	73	597	605	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					365	378		10.1016/j.neuron.2005.06.018	http://dx.doi.org/10.1016/j.neuron.2005.06.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055061	Bronze			2022-12-28	WOS:000231051900008
J	Yu, H; Farley, BJ; Jin, DZ; Sur, M				Yu, H; Farley, BJ; Jin, DZ; Sur, M			The coordinated mapping of visual space and response features in visual cortex	NEURON			English	Article							OCULAR-DOMINANCE COLUMNS; ORIENTATION-PREFERENCE; SPATIAL-FREQUENCY; STRIATE-CORTEX; MAPS; ORGANIZATION; MACAQUE; TOPOGRAPHY; AREA-17; PATTERN	Whether general principles can explain the layouts of cortical maps remains unresolved. In primary visual cortex of ferret, the relationships between the maps of visual space and response features are predicted by a "dimension-reduction" model. The representation of visual space is anisotropic, with the elevation and azimuth axes having different magnification. This anisotropy is reflected in the orientation, ocular dominance, and spatial frequency domains, which are elongated such that their directions of rapid change, or high-gradient axes, are orthogonal to the high-gradient axis of the visual map. The feature maps are also strongly interdependent-their high-gradient regions avoid one another and intersect orthogonally where essential, so that overlap is minimized. Our results demonstrate a clear influence of the visual map on each feature map. In turn, the local representation of visual space is smooth, as predicted when many features are mapped within a cortical area.	MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sur, M (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msur@mit.edu	Jin, Dezhe/AAE-6788-2020	Farley, Brandon/0000-0002-9451-3653	NEI NIH HHS [EY07023] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAKER TI, 2005, IN PRESS J NEUROPHYS; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BAUER HU, 1995, NEURAL COMPUT, V7, P36, DOI 10.1162/neco.1995.7.1.36; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Buzas P, 2003, EUR J NEUROSCI, V18, P957, DOI 10.1046/j.1460-9568.2003.02808.x; CYNADER MS, 1987, J NEUROSCI, V7, P1401; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; ERWIN E, 1995, NEURAL COMPUT, V7, P425, DOI 10.1162/neco.1995.7.3.425; FLORENCE SL, 1992, VISUAL NEUROSCI, V8, P449, DOI 10.1017/S0952523800004958; Friedman RM, 2004, P NATL ACAD SCI USA, V101, P12724, DOI 10.1073/pnas.0404884101; Goodhill GJ, 1990, NETWORK-COMP NEURAL, V1, P41, DOI 10.1088/0954-898X/1/1/004; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KOHONEN T, 1982, BIOL CYBERN, V44, P135, DOI 10.1007/BF00317973; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; LEVAY S, 1985, J NEUROSCI, V5, P486; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; Mante V, 2003, CURR BIOL, V13, pR906, DOI 10.1016/j.cub.2003.11.010; MANTE V, 2005, IN PRESS J NEUROPHYS; Mrsic-Flogel T, 2003, CURR BIOL, V13, pR778, DOI 10.1016/j.cub.2003.09.022; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Rao SC, 1997, J COMP NEUROL, V387, P358; REDIES C, 1990, J NEUROSCI, V10, P2791; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sheth BR, 1996, SCIENCE, V274, P2110, DOI 10.1126/science.274.5295.2110; SUR M, 1981, SCIENCE, V212, P1059, DOI 10.1126/science.7233199; SWINDALE NV, 1991, BIOL CYBERN, V65, P415, DOI 10.1007/BF00204654; Swindale NV, 2004, NETWORK-COMP NEURAL, V15, P217, DOI 10.1088/0954-898X/15/4/001; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; WEBSTER MA, 1985, J OPT SOC AM A, V2, P1124, DOI 10.1364/JOSAA.2.001124; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; White LE, 2001, VISUAL NEUROSCI, V18, P65, DOI 10.1017/S095252380118106X; Wolf F, 1996, NATURE, V382, P306, DOI 10.1038/382306a0	46	86	89	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					267	280		10.1016/j.neuron.2005.06.011	http://dx.doi.org/10.1016/j.neuron.2005.06.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039568	Bronze			2022-12-28	WOS:000230693900013
J	Alonso, JM				Alonso, JM			Building better models of visual cortical receptive fields	NEURON			English	Editorial Material							COMPLEX CELLS; STRIATE CORTEX	Scientists usually study the receptive fields of visual cortical neurons by measuring responses to "optimal stimuli." In this issue of Neuron, Rust and colleagues have taken a promising alternative approach: build a receptive field model based on the cell responses to a stimulus subset and then use the model to predict responses to other stimuli.	SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	State University of New York (SUNY) System; SUNY Optometry	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA.							ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; CAJAL SRY, 1899, CAJAL CEREBRAL CORTE, P1; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Touryan J, 2002, J NEUROSCI, V22, P10811; VANSTEVENINCK RD, 1988, P ROY SOC LOND B BIO, V234, P269	12	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 16	2005	46	6					842	844		10.1016/j.neuron.2005.06.001	http://dx.doi.org/10.1016/j.neuron.2005.06.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953412	Bronze			2022-12-28	WOS:000229922500003
J	Flames, N; Marin, O				Flames, N; Marin, O			Developmental mechanisms underlying the generation of cortical interneuron diversity	NEURON			English	Review							MOUSE VISUAL-CORTEX; GABAERGIC NEURONS; CELL-MIGRATION; TANGENTIAL MIGRATION; GANGLIONIC EMINENCES; PARVALBUMIN; NEOCORTEX; ORIGIN; DIFFERENTIATION; SPECIFICATION		CSIC, Inst Neurociencias Alicante, Sant Joan dAlacant 03550, Spain; Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Marin, O (corresponding author), CSIC, Inst Neurociencias Alicante, Campus San Juan, Sant Joan dAlacant 03550, Spain.	o.marin@umh.es	Flames, Nuria/L-2290-2017; Marin, Oscar/F-3856-2012	Flames, Nuria/0000-0003-0961-0609; Marin, Oscar/0000-0001-6264-7027				Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Bellion A, 2003, CEREB CORTEX, V13, P203, DOI 10.1093/cercor/13.2.203; CAVANAGH ME, 1990, J COMP NEUROL, V297, P553, DOI 10.1002/cne.902970408; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fode C, 2000, GENE DEV, V14, P67; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Patz S, 2004, CEREB CORTEX, V14, P342, DOI 10.1093/cercor/bhg132; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; SOMOGYI P, 2005, J PHYSL, V5662, P9; SORIANO E, 1989, J COMP NEUROL, V281, P586, DOI 10.1002/cne.902810408; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yozu M, 2004, NEUROSCI RES, V49, P395, DOI 10.1016/j.neures.2004.05.005	34	80	83	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					377	381		10.1016/j.neuron.2005.04.020	http://dx.doi.org/10.1016/j.neuron.2005.04.020			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882635	Bronze			2022-12-28	WOS:000229011400007
J	Chenn, A				Chenn, A			The simple life (of cortical progenitors)	NEURON			English	Editorial Material							CELL-DIVISION; DROSOPHILA	Asymmetric cell division plays a major role in the generation of cell diversity during development. In this issue of Neuron, Sun and colleagues present evidence that the epidermal growth factor receptor is asymmetrically distributed in mitotic cerebral cortical precursors, and the resulting unequal inheritance generates offspring with different responsiveness to growth factor and unique cell fates.	Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Chenn, A (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.							Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Castaneda-Castellanos DR, 2004, NAT NEUROSCI, V7, P793, DOI 10.1038/nn0804-793; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Jan YN, 2000, CELL, V100, P599, DOI 10.1016/S0092-8674(00)80695-9; Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011; Perrimon N, 1997, CELL, V89, P13, DOI 10.1016/S0092-8674(00)80177-4; Perry A, 2004, CANCER, V101, P2318, DOI 10.1002/cncr.20625; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045	13	5	6	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					817	819		10.1016/j.neuron.2005.03.001	http://dx.doi.org/10.1016/j.neuron.2005.03.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797541	Bronze			2022-12-28	WOS:000228031300001
J	Cisek, P; Kalaska, JF				Cisek, P; Kalaska, JF			Neural correlates of reaching decisions in dorsal premotor cortex: Specification of multiple direction choices and final selection of action	NEURON			English	Article							PRIMATE MOTOR CORTEX; NEURONAL-ACTIVITY; PERCEPTUAL DECISION; SUPERIOR COLLICULUS; PREFRONTAL CORTEX; PRIOR INFORMATION; EYE FIELDS; MOVEMENT DIRECTION; ARM MOVEMENTS; CELL-ACTIVITY	We show that while a primate chooses between two reaching actions, its motor system first represents both options and later reflects selection between them. When two potential targets appeared, many (43%) task-related, directionally tuned cells in dorsal premotor cortex (PMd) discharged if one of the targets was near their preferred direction. At the population level, this generated two simultaneous sustained directional signals corresponding to the current reach options. After a subsequent nonspatial cue identified the correct target, the corresponding directional signal increased, and the signal for the rejected target was suppressed. The PMd population reliably predicted the monkey's response choice, including errors. This supports a planning model in which multiple reach options are initially specified and then gradually eliminated in a competition for overt execution, as more information accumulates.	Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Cisek, P (corresponding author), Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada.	paul.cisek@umontreal.ca	Cisek, Paul/H-2660-2012					Basso MA, 1998, J NEUROSCI, V18, P7519; Bastian A, 2003, EUR J NEUROSCI, V18, P2047, DOI 10.1046/j.1460-9568.2003.02906.x; Bastian A, 1998, NEUROREPORT, V9, P315, DOI 10.1097/00001756-199801260-00025; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; BULLOCK D, 1993, J COGNITIVE NEUROSCI, V5, P408, DOI 10.1162/jocn.1993.5.4.408; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cisek P, 2002, J NEUROPHYSIOL, V88, P1064, DOI 10.1152/jn.00995.2001; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Cisek P, 2001, BEHAV BRAIN SCI, V24, P36, DOI 10.1017/S0140525X0124391X; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Erlhagen W, 2002, PSYCHOL REV, V109, P545, DOI 10.1037//0033-295X.109.3.545; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Gibson J.J., 1986, ECOLOGICAL APPROACH; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lebedev MA, 2001, EUR J NEUROSCI, V13, P1002, DOI 10.1046/j.0953-816x.2001.01457.x; Matelli M, 1998, J COMP NEUROL, V402, P327; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rainer G, 1999, J NEUROSCI, V19, P5493; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; SALINAS E, 1995, J NEUROSCI, V15, P6461; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sergio LE, 2003, J NEUROPHYSIOL, V89, P212, DOI 10.1152/jn.00016.2002; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Tipper SP, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P223; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; VAADIA E, 1988, SOMATOSENS MOT RES, V6, P207, DOI 10.3109/08990228809144674; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Welsh TN, 1999, EXP BRAIN RES, V127, P207, DOI 10.1007/s002210050790; WISE SP, 1992, J NEUROPHYSIOL, V68, P969, DOI 10.1152/jn.1992.68.3.969; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	67	659	661	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					801	814		10.1016/j.neuron.2005.01.027	http://dx.doi.org/10.1016/j.neuron.2005.01.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748854	Bronze			2022-12-28	WOS:000227446700018
J	McBride, SMJ; Choi, CH; Wang, Y; Liebelt, D; Braunstein, E; Ferreiro, D; Sehgal, A; Siwicki, KK; Dockendorff, TC; Nguyen, HT; McDonald, TV; Jongens, TA				McBride, SMJ; Choi, CH; Wang, Y; Liebelt, D; Braunstein, E; Ferreiro, D; Sehgal, A; Siwicki, KK; Dockendorff, TC; Nguyen, HT; McDonald, TV; Jongens, TA			Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; MENTAL-RETARDATION PROTEIN; LONG-TERM-MEMORY; CONDITIONED COURTSHIP; MELANOGASTER; MUTANTS; MALES; GENE; ANTAGONIST; ACTIVATION	Fragile X syndrome is a leading heritable cause of mental retardation that results from the loss of FMR1 gene function. A Drosophila model for Fragile X syndrome, based on the loss of dfmr1 activity, exhibits phenotypes that bear similarity to Fragile X-related symptoms. Herein, we demonstrate that treatment with metabotropic glutamate receptor (mGluR) antagonists or lithium can rescue courtship and mushroom body defects observed in these flies. Furthermore, we demonstrate that dfmr1 mutants display cognitive deficits in experience-dependent modification of courtship behavior, and treatment with mGluR antagonists or lithium restores these memory defects. These findings implicate enhanced mGluR signaling as the underlying cause of the cognitive, as well as some of the behavioral and neuronal, phenotypes observed in the Drosophila Fragile X model. They also raise the possibility that compounds having similar effects on metabotropic glutamate receptors may ameliorate cognitive and behavioral defects observed in Fragile X patients.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Sect Mol Cardiol, Med Scientist Training Program, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Sect Mol Cardiol, Med Scientist Training Program, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Sect Mol Cardiol, Bronx, NY 10461 USA; Drexel Univ, Coll Med, Dept Pharmacol, MD PhD Program, Philadelphia, PA 19102 USA; Drexel Univ, Coll Med, Dept Physiol, MD PhD Program, Philadelphia, PA 19102 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; Miami Univ, Dept Zool, Oxford, OH 45056 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Drexel University; Drexel University; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Swarthmore College; University System of Ohio; Miami University	McBride, SMJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, Sect Mol Cardiol, Med Scientist Training Program, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	smcbride@aecom.yu.edu; jongens@mail.med.upenn.edu						ACKERMAN SL, 1986, J NEUROGENET, V3, P111, DOI 10.3109/01677068609106898; Bakker CE, 2003, CYTOGENET GENOME RES, V100, P111, DOI 10.1159/000072845; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.2307/2407002; BASTOCK M, 1955, BEHAVIOUR, V8, P86, DOI DOI 10.1163/156853955X00184; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; Cobb M, 1995, BEHAV PROCESS, V35, P35, DOI 10.1016/0376-6357(95)00052-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Fisch GS, 1999, AM J MED GENET, V83, P257, DOI 10.1002/(SICI)1096-8628(19990402)83:4<257::AID-AJMG5>3.0.CO;2-U; GAILEY DA, 1984, GENETICS, V106, P613; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hagerman R.J., 2002, FRAGILE X SYNDROME D; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HEISENBERG M, 1980, DEV NEUROBIOLOGY DRO, P373; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Parmentier ML, 1996, J NEUROSCI, V16, P6687; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pommier B, 2003, J NEUROCHEM, V85, P454, DOI 10.1046/j.1471-4159.2003.01690.x; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramaekers A, 2001, J COMP NEUROL, V438, P213, DOI 10.1002/cne.1310; Rasmussen K, 2004, NEUROPHARMACOLOGY, V46, P620, DOI 10.1016/j.neuropharm.2003.11.013; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sokal RR, 1995, BIOMETRY; Spooren WPJM, 2001, TRENDS PHARMACOL SCI, V22, P331, DOI 10.1016/S0165-6147(00)01694-1; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; VANSWINDEREN B, 1995, LEARN MEMORY, V2, P49, DOI 10.1101/lm.2.2.49; Villella A, 1996, GENETICS, V143, P331; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WrightTalamante C, 1996, AM J MED GENET, V64, P350, DOI 10.1002/(SICI)1096-8628(19960809)64:2<350::AID-AJMG23>3.0.CO;2-D; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	56	370	388	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					753	764		10.1016/j.neuron.2005.01.038	http://dx.doi.org/10.1016/j.neuron.2005.01.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748850	Bronze			2022-12-28	WOS:000227446700014
J	Yaron, A; Huang, PH; Cheng, HJ; Tessier-Lavigne, M				Yaron, A; Huang, PH; Cheng, HJ; Tessier-Lavigne, M			Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; AXON GUIDANCE; CAENORHABDITIS-ELEGANS; SECRETED SEMAPHORINS; OFF-TRACK; IN-VIVO; RECEPTOR; NEUROPILIN; GROWTH; 3A	The class 3 Semaphorins Sema3A and Sema3F are potent axonal repellents that cause repulsion by binding Neuropilin-1 and Neuropilin-2, respectively. Plexins are implicated as signaling coreceptors for the Neuropilins, but the identity of the Plexins that transduce Sema3A and Sema3F responses in vivo is uncertain. Here, we show that Plexin-A3 and -A4 are key determinants of these responses, through analysis of a Plexin-A3/Plexin-A4 double mutant mouse. Sensory and sympathetic neurons from the double mutant are insensitive to Sema3A and Sema3F in vitro, and defects in axonal projections in vivo correspond to those seen in Neuropilin-1 and -2 mutants. Interestingly, we found a differential requirement for these two Plexins: signaling via Neuropilin-1 is mediated principally by Plexin-A4, whereas signaling via Neuropilin-2 is mediated principally by Plexin-A3. Thus, Plexin-A3 and -A4 contribute to the specificity of axonal responses to class 3 Semaphorins.	Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA; Genentech Inc, San Francisco, CA USA; Univ Calif Davis, Ctr Neurosci, Sect Neurobiol Physiol & Behav, Div Biol Sci, Davis, CA 95616 USA; Univ Calif Davis, Dept Pathol & Lab Med, Sch Med, Davis, CA 95616 USA	Howard Hughes Medical Institute; Stanford University; Roche Holding; Genentech; University of California System; University of California Davis; University of California System; University of California Davis	Cheng, HJ (corresponding author), Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA.	hjcheng@ucdavis.edu; marctl@gene.com	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567; HUANG, PEI-HSIN/0000-0002-2414-1487				Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Brown CB, 2001, DEVELOPMENT, V128, P3071; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Chilton JK, 2003, DEV DYNAM, V228, P726, DOI 10.1002/dvdy.10396; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Dalpe G, 2004, DEVELOPMENT, V131, P2073, DOI 10.1242/dev.01063; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fujii T, 2002, DEVELOPMENT, V129, P2053; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Puschel AW, 2002, ADV EXP MED BIOL, V515, P71; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Sahay A, 2003, J NEUROSCI, V23, P6671; Schnorrer F, 2004, CURR BIOL, V14, pR19, DOI 10.1016/j.cub.2003.12.016; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8	49	179	181	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					513	523		10.1016/j.neuron.2005.01.013	http://dx.doi.org/10.1016/j.neuron.2005.01.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721238	Bronze			2022-12-28	WOS:000227099700008
J	Fanselow, EE; Connors, BW				Fanselow, EE; Connors, BW			Navigating a sensorimotor loop	NEURON			English	Editorial Material								Touch is an active process, but how do the body's somatic sensors influence its movement? In this issue of Neuron, Nguyen and Kleinfeld show that afferent activity from the whiskers on a rat's face trigger rapid and prolonged excitation of the motor neurons that drive movements of the same whiskers. Positive feedback through this sensorimotor loop may serve to optimize the interaction between sensors and stimuli.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Fanselow, EE (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.		Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157				Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8	8	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					329	330		10.1016/j.neuron.2005.01.022	http://dx.doi.org/10.1016/j.neuron.2005.01.022			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694317	Bronze			2022-12-28	WOS:000226787700003
J	Bean, BP				Bean, BP			The molecular machinery of resurgent sodium current revealed	NEURON			English	Editorial Material							PURKINJE NEURONS; INACTIVATION	Some TTX-sensitive sodium channels open transiently during recovery from inactivation, generating a resurgent" sodium current that flows immediately following action potentials. In this issue of Neuron, Grieco and colleagues present evidence that resurgent sodium current results from a novel form of inactivation in which the cytoplasmic tail of the beta4 subunit acts as a classic open-channel blocker.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Bean, BP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.							Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; Do MTH, 2004, J NEUROPHYSIOL, V92, P726, DOI 10.1152/jn.00186.2004; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Grieco TM, 2004, J NEUROSCI, V24, P35, DOI 10.1523/JNEUROSCI.3807-03.2004; Grieco TM, 2002, J NEUROSCI, V22, P3100, DOI 10.1523/JNEUROSCI.22-08-03100.2002; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Krzemien DM, 2000, J COMP NEUROL, V420, P70; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Smith MR, 1998, J NEUROSCI, V18, P6093; Yu FH, 2003, J NEUROSCI, V23, P7577	12	16	16	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					185	187		10.1016/j.neuron.2005.01.006	http://dx.doi.org/10.1016/j.neuron.2005.01.006			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664169	Bronze			2022-12-28	WOS:000226451500004
J	Miller, RH				Miller, RH			Dorsally derived oligodendrocytes come of age	NEURON			English	Editorial Material							SPINAL-CORD; CONNECTION; HEDGEHOG; LINEAGE; CELLS; CNS	While oligodendrocyte precursors have previously been localized to the ventral midline, two papers in this issue of Neuron (Cai et al. and Vallstedt et al.) provide compelling evidence for a second dorsal origin of oligodendrocyte precursors in the spinal cord and hindbrain. These cells share expression of the PDGF receptor and Olig2 with their ventral counterparts but differ in the requirement for Nkx6 and hedgehog signaling.	Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Miller, RH (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.							Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Noble M, 2004, DEV BIOL, V265, P33, DOI 10.1016/j.ydbio.2003.06.002; Orentas DM, 1996, DEV BIOL, V177, P43, DOI 10.1006/dbio.1996.0143; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	15	29	30	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					1	3		10.1016/j.neuron.2004.12.032	http://dx.doi.org/10.1016/j.neuron.2004.12.032			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629694	Bronze			2022-12-28	WOS:000226217100001
J	Ferrera, VP; Barborica, A				Ferrera, VP; Barborica, A			A flashing line can warp your mind	NEURON			English	Editorial Material							EYE-MOVEMENTS; MOTION; PREDICTION; MONKEY	Keeping pace with a constantly changing world requires the ability to make predictions about the future on a variety of timescales. A very basic example of this is the ability to predict the future location of a moving object in the brief time that it takes to perceive and respond to that object. In this issue of Neuron, experiments by Sundberg, Fallah, and Reynolds reveal a potential neural substrate for making short-range predictions about motion in visual area V4.	Columbia Univ, Dept Psychiat, Ctr Neurobiol & Behav, David Mahoney Ctr Brain & Behav Res, New York, NY 10032 USA	Columbia University	Ferrera, VP (corresponding author), Columbia Univ, Dept Psychiat, Ctr Neurobiol & Behav, David Mahoney Ctr Brain & Behav Res, New York, NY 10032 USA.		Barborica, Andrei/N-6204-2017	Barborica, Andrei/0000-0001-6783-3769; Ferrera, Vincent/0000-0002-6599-7740	NATIONAL EYE INSTITUTE [R24EY015634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059244] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY015634-01, R24 EY015634, R24 EY015634-04, R24 EY015634-02, R24 EY015634-03] Funding Source: Medline; NIMH NIH HHS [R01 MH059244] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; CAI R, 2001, J VISION, V1, pA127, DOI DOI 10.1167/1.3.127; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; GELLMAN RS, 1991, EXP BRAIN RES, V84, P660; KELLER E, 1990, EXP BRAIN RES, V80, P525; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Nijhawan R, 2002, TRENDS COGN SCI, V6, P387, DOI 10.1016/S1364-6613(02)01963-0; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; RON S, 1989, VISION RES, V29, P1103, DOI 10.1016/0042-6989(89)90059-X; SEGRAVES MA, 1987, J NEUROSCI, V7, P3040; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023	11	4	4	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 2	2006	49	3					327	329		10.1016/j.neuron.2006.01.012	http://dx.doi.org/10.1016/j.neuron.2006.01.012			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446136	Bronze			2022-12-28	WOS:000235260900004
J	de la Prida, LM; Huberfeld, G; Cohen, I; Miles, R				de la Prida, LM; Huberfeld, G; Cohen, I; Miles, R			Threshold behavior in the initiation of hippocampal population bursts	NEURON			English	Article							RECURRENT COLLATERAL SYNAPSES; SPONTANEOUS NETWORK ACTIVITY; EPILEPTIFORM BURSTS; IN-VITRO; FIRING PATTERNS; HIGH POTASSIUM; SPINAL-CORD/; RAT; NEURONS; SYNCHRONIZATION	Hippocampal population discharges such as sharp waves, epileptiform firing, and GDPs recur at long and variable intervals. The mechanisms for their precise timing are not well understood. Here, we show that population bursts in the disinhibited CA3 region are initiated at a threshold level of population firing after recovery from a previous event. Each population discharge follows an active buildup period when synaptic traffic and cell firing increase to threshold levels. Single-cell firing can advance burst onset by increasing population firing to suprathreshold values. Population synchrony is suppressed when threshold frequencies cannot be reached due to reduced cellular excitability or synaptic efficacy. Reducing synaptic strength reveals partially synchronous population bursts that are curtailed by GABA(B)-mediated conductances. Excitatory glutamatergic transmission and delayed GABA(B)-mediated signals have opposing feedback effects on CA3 cell firing and so determine threshold behavior for population synchrony.	Univ Paris 06, INSERM, U739, CHU Pitie Salpetriere, F-75013 Paris, France; Hosp Ramon y Cajal, E-28034 Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario Ramon y Cajal	de la Prida, LM (corresponding author), Univ Paris 06, INSERM, U739, CHU Pitie Salpetriere, F-75013 Paris, France.	liset.m.prida@hrc.es	de la Prida, Liset M/O-1342-2013	de la Prida, Liset M/0000-0002-0160-6472; Cohen, Ivan/0000-0001-6046-5289; Miles, Richard/0000-0001-7303-0233	NIMH NIH HHS [MH54671] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agmon A, 2003, J NEUROSCI, V23, P3658; ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; Ankri N, 1999, J NEUROSCI METH, V91, P83, DOI 10.1016/S0165-0270(99)00078-3; Aradi I, 2004, J NEUROSCI, V24, P9681, DOI 10.1523/JNEUROSCI.2800-04.2004; AYALA GF, 1973, BRAIN RES, V52, P1, DOI 10.1016/0006-8993(73)90647-1; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; CALVIN WH, 1972, BRAIN RES, V39, P71, DOI 10.1016/0006-8993(72)90786-X; CHAMBERLIN NL, 1990, J NEUROPHYSIOL, V64, P1000, DOI 10.1152/jn.1990.64.3.1000; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; COLOM LV, 1994, J NEUROPHYSIOL, V71, P1574, DOI 10.1152/jn.1994.71.4.1574; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 1999, J NEUROPHYSIOL, V82, P202, DOI 10.1152/jn.1999.82.1.202; de la Prida LM, 2000, NEUROSCIENCE, V97, P227, DOI 10.1016/S0306-4522(00)00029-4; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Grzywacz NM, 2000, VISUAL NEUROSCI, V17, P229, DOI 10.1017/S0952523800172050; HABLITZ JJ, 1984, J NEUROPHYSIOL, V51, P1011, DOI 10.1152/jn.1984.51.5.1011; IVES AE, 1990, NEUROSCI LETT, V112, P239, DOI 10.1016/0304-3940(90)90210-Z; Jack J, 1983, ELECT CURRENT FLOW E; JEFFERYS JGR, 1994, CURR OPIN NEUROL, V7, P113, DOI 10.1097/00019052-199404000-00007; KNOWLES WD, 1987, NEUROSCIENCE, V21, P441, DOI 10.1016/0306-4522(87)90134-5; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; LEUNG LWS, 1992, HIPPOCAMPUS, V2, P93, DOI 10.1002/hipo.450020202; Levy R, 2000, J NEUROSCI, V20, P7766; MASUKAWA LM, 1982, BRAIN RES, V242, P341, DOI 10.1016/0006-8993(82)90320-1; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; Staley KJ, 2001, J NEUROPHYSIOL, V86, P2736, DOI 10.1152/jn.2001.86.6.2736; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; Szucs A, 1998, J NEUROSCI METH, V81, P159, DOI 10.1016/S0165-0270(98)00033-8; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; TRAUB RD, 1990, J NEUROPHYSIOL, V64, P1009, DOI 10.1152/jn.1990.64.3.1009; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TRAUB RD, 1991, NEUROONAL NETWORKS H; Wenner P, 2001, J NEUROPHYSIOL, V86, P1481, DOI 10.1152/jn.2001.86.3.1481	51	133	135	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					131	142		10.1016/j.neuron.2005.10.034	http://dx.doi.org/10.1016/j.neuron.2005.10.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387645	Green Submitted, Bronze			2022-12-28	WOS:000236699300015
J	Koizumi, H; Tanaka, T; Gleeson, JG				Koizumi, H; Tanaka, T; Gleeson, JG			doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration	NEURON			English	Article							LISSENCEPHALY GENE; CALLOSAL AXONS; MOUSE; LIS1; EXPRESSION; MAP1B; MICE; TAU; CONNECTIONS; OUTGROWTH	The potential role of doublecortin (Dcx), encoding a microtubule-associated protein, in brain development has remained controversial. Humans with mutations show profound alterations in cortical lamination, whereas in mouse, RNAi-mediated knockdown but not germline knockout shows abnormal positioning of cortical neurons. Here, we report that the doublecortin-like kinase (Dclk) gene functions in a partially redundant pathway with Dcx in the formation of axonal projections across the midline and migration of cortical neurons. Dosage-dependent genetic effects were observed in both interhemispheric connectivity and migration of cortically and subcortically derived neurons. Surprisingly, RNAi-mediated knockdown of either gene results in similar migration defects. These results indicate the Dcx microtubule-associated protein family is required for proper neuronal migration and axonal wiring.	Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 93093 USA	University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 93093 USA.	jogleeson@ucsd.edu			NINDS NIH HHS [R01 NS041537, NS47101, NS42749, NS41537] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537, K02NS042749, P30NS047101] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; CHUNG WW, 1991, J COMP NEUROL, V314, P290, DOI 10.1002/cne.903140207; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dawson HN, 2001, J CELL SCI, V114, P1179; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; des Portes V, 1998, CELL, V92, P51; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; Edelman AM, 2005, J BIOL CHEM, V280, P8531, DOI 10.1074/jbc.M411027200; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gotz M, 2003, NAT NEUROSCI, V6, P1245, DOI 10.1038/nn1203-1245; GREGORY WA, 1988, J NEUROSCI, V8, P1728; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hedin-Pereira C, 1999, CEREB CORTEX, V9, P50, DOI 10.1093/cercor/9.1.50; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Lin PT, 2000, J NEUROSCI, V20, P9152; Matsumoto N, 1999, GENOMICS, V56, P179, DOI 10.1006/geno.1998.5673; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NORRIS CR, 1991, J NEUROSCI, V11, P3481; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Omori Y, 1998, J HUM GENET, V43, P169, DOI 10.1007/s100380050063; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; YORKE CH, 1975, J COMP NEUROL, V164, P233, DOI 10.1002/cne.901640206; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs	51	194	202	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					55	66		10.1016/j.neuron.2005.10.040	http://dx.doi.org/10.1016/j.neuron.2005.10.040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387639	Bronze			2022-12-28	WOS:000236699300009
J	Karpova, AY; Tervo, DGR; Gray, NW; Svoboda, K				Karpova, AY; Tervo, DGR; Gray, NW; Svoboda, K			Rapid and reversible chemical inactivation of synaptic transmission in genetically targeted neurons	NEURON			English	Article							GENE-EXPRESSION; IN-VIVO; DROSOPHILA; PROTEIN; DISRUPTION; RECEPTORS; CHANNEL; NEUROTRANSMISSION; SUPPRESSION; TRAFFICKING	Inducible and reversible silencing of selected neurons in vivo is critical to understanding the structure and dynamics of brain circuits. We have developed Molecules for Inactivation of Synaptic Transmission (MISTs) that can be genetically targeted to allow the reversible inactivation of neurotransmitter release. MISTs consist of modified presynaptic proteins that interfere with the synaptic vesicle cycle when crosslinked by small molecule "dimerizers." MISTs based on the vesicle proteins VAMP2/Synaptobrevin and Synaptophysin induced rapid (similar to 10 min) and reversible block of synaptic transmission in cultured neurons and brain slices. In transgenic mice expressing MISTs selectively in Purkinje neurons, administration of dimerizer reduced learning and performance of the rotarod behavior. MISTs allow for specific, inducible, and reversible lesions in neuronal circuits and may provide treatment of disorders associated with neuronal hyperactivity.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu		Gray, Noah/0000-0002-4672-7403				Abe K, 2003, INT REV NEUROBIOL, V55, P243, DOI 10.1016/S0074-7742(03)01011-0; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Amara JF, 1997, P NATL ACAD SCI USA, V94, P10618, DOI 10.1073/pnas.94.20.10618; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Bruijn LI, 2002, BIOTECHNIQUES, V32, P1112, DOI 10.2144/02325dd01; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Clackson T, 1997, CURR OPIN CHEM BIOL, V1, P210, DOI 10.1016/S1367-5931(97)80012-9; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hallett Mark, 2004, Adv Neurol, V94, P1; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Hogarth Penelope, 2003, Curr Neurol Neurosci Rep, V3, P279, DOI 10.1007/s11910-003-0003-3; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Jin LQ, 2000, NAT GENET, V26, P64, DOI 10.1038/79194; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lalonde R, 1996, NEUROBIOL LEARN MEM, V65, P113, DOI 10.1006/nlme.1996.0013; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Mallet VO, 2002, NAT BIOTECHNOL, V20, P1234, DOI 10.1038/nbt762; Marek KW, 2003, CURR OPIN NEUROBIOL, V13, P607, DOI 10.1016/j.conb.2003.09.001; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Rustay NR, 2003, BEHAV BRAIN RES, V141, P237, DOI 10.1016/S0166-4328(02)00376-5; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Sutherland ML, 1999, P NATL ACAD SCI USA, V96, P2451, DOI 10.1073/pnas.96.5.2451; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; White LJ, 2001, SOFTW TEST VERIF REL, V11, P1, DOI 10.1002/stvr.220; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	66	81	84	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					727	735		10.1016/j.neuron.2005.11.015	http://dx.doi.org/10.1016/j.neuron.2005.11.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337911	Bronze			2022-12-28	WOS:000233927300012
J	LeMasurier, M; Gillespie, PG				LeMasurier, M; Gillespie, PG			Hair-cell mechanotransduction and cochlear amplification	NEURON			English	Review							MECHANOELECTRICAL-TRANSDUCTION; TIP-LINK; MECHANICAL TRANSDUCTION; BUNDLE MOVEMENTS; MYOSIN-XVA; FAST ADAPTATION; GENE-PRODUCTS; MOTOR PROTEIN; CROSS-LINKS; STEREOCILIA	In the inner ear, sensory hair cells not only detect but also amplify the softest sounds, allowing us to hear over an extraordinarily wide intensity range. This amplification is frequency specific, giving rise to exquisite frequency discrimination. Hair cells detect sounds with their mechanotransduction apparatus, which is only now being dissected molecularly. Signal detection is not the only role of this molecular network; amplification of low-amplitude signals by hair bundles seems to be universal in hair cells. "Fast adaptation," the rapid closure of transduction channels following a mechanical stimulus, appears to be intimately involved in bundle-based amplification.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gillespp@ohsu.edu		Barr-Gillespie, Peter/0000-0002-9787-5860	NIDCD NIH HHS [DC003279, DC002368, DC005983, DC004571] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC002368, R01DC003279, R01DC004571] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Benser ME, 1996, J NEUROSCI, V16, P5629; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; BONBEKESY G, 1960, EXPT HEARTING; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; CHAN DK, 2005, IN PRESS BIOPHYS J, V89; CHEUNG EL, 2005, IN PRESS BIOPHYS J; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; DALLOS P, 1995, SCIENCE, V267, P2006, DOI 10.1126/science.7701325; Dallos P., 1996, COCHLEA, P1; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Etournay R, 2005, J CELL SCI, V118, P2891, DOI 10.1242/jcs.02424; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GEISLER CD, 1995, HEARING RES, V86, P132, DOI 10.1016/0378-5955(95)00064-B; GEISLER CD, 1993, HEARING RES, V68, P253, DOI 10.1016/0378-5955(93)90129-O; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Geleoc GSG, 2003, TRENDS NEUROSCI, V26, P115, DOI 10.1016/S0166-2236(03)00030-4; Gillespie PG, 2005, CURR OPIN NEUROBIOL, V15, P389, DOI 10.1016/j.conb.2005.06.007; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Holme RH, 2002, HEARING RES, V169, P13, DOI 10.1016/S0378-5955(02)00334-9; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1986, HEARING RES, V23, P93, DOI 10.1016/0378-5955(86)90178-4; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Howard J., 2001, MECH MOTOR PROTEINS; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; HUDSPETH AJ, 1979, P NATL ACAD SCI USA, V76, P1506, DOI 10.1073/pnas.76.3.1506; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Li HW, 2004, J COMP NEUROL, V468, P125, DOI 10.1002/cne.10944; Libby R T, 2000, Essays Biochem, V35, P159; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Lumpkin EA, 1997, P NATL ACAD SCI USA, V94, P10997, DOI 10.1073/pnas.94.20.10997; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Martin P, 2003, J NEUROSCI, V23, P4533; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Meyer J, 1998, J NEUROSCI, V18, P6748; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nicolson T, 2005, TRENDS NEUROSCI, V28, P140, DOI 10.1016/j.tins.2004.12.008; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V250, P217, DOI 10.1098/rspb.1992.0152; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Rzadzinska AK, 2005, HEARING RES, V208, P114, DOI 10.1016/j.heares.2005.05.008; SALT AN, 1989, AM J OTOLARYNG, V10, P371, DOI 10.1016/0196-0709(89)90030-6; Santos-Sacchi J, 2003, CURR OPIN NEUROBIOL, V13, P459, DOI 10.1016/S0959-4388(03)00100-4; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Slepecky NB, 1996, STRUCTURE MAMMALIAN; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; vonBekesy G., 1960, EXPT HEARING; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wood JD, 2004, JARO-J ASSOC RES OTO, V5, P99, DOI 10.1007/s10162-003-4022-1; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	120	154	160	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					403	415		10.1016/j.neuron.2005.10.017	http://dx.doi.org/10.1016/j.neuron.2005.10.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269359	Bronze			2022-12-28	WOS:000233250100003
J	Machold, R; Fishell, G				Machold, R; Fishell, G			Math1 is expressed in temporally discrete pools of cerebellar rhombic-lip neural progenitors	NEURON			English	Article							DEVELOPING NERVOUS-SYSTEM; SITE-SPECIFIC RECOMBINATION; GRANULE NEURONS; CRE RECOMBINASE; IN-VIVO; MOUSE; CELLS; PROJECTIONS; ACTIVATION; BOUNDARIES	We have utilized an in vivo-inducible genetic-fate-mapping strategy to permanently label cohorts of Math1-positive cells and their progeny that arise in the rhombic lip of the cerebellar primordium during embryogenesis. At stages prior to E12.5, with the exception of the deep cerebellar nuclei, we find that Math1 cells migrate out of the cerebellar primordium into the rostral hindbrain to populate specific nuclei that include cholinergic neurons of the mesopontine tegmental system. Moreover, analysis of Math1-null embryos shows that this gene is required for the formation of some of these nuclei. Around E12.5, granule cell precursors begin to be labeled: first, ones that give rise to granule cells that predominantly populate the anterior lobes of the adult cerebellum and later, those that populate progressing more caudally lobes until labeling of all granule cell precursors is complete by E17. Thus, we demonstrate that the cerebellar rhombic lip gives rise to multiple cell types within rhombomere 1.	NYU, Ctr Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Ctr Med, Dept Cell Biol, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University; New York University	Fishell, G (corresponding author), NYU, Ctr Med, Dev Genet Program, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu		Fishell, Gordon/0000-0002-9640-9278	NINDS NIH HHS [R01 NS032993-11] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032993] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Balaban CD, 2004, BRAIN RES, V996, P126, DOI 10.1016/j.brainres.2003.10.026; Bayer, 1997, RELATION ITS EVOLUTI; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gilthorpe JD, 2002, DEVELOPMENT, V129, P4719; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Helms AW, 2000, DEVELOPMENT, V127, P1185; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Kimmel RA, 2000, GENE DEV, V14, P1377; Koster RW, 2001, CURR BIOL, V11, P1858, DOI 10.1016/S0960-9822(01)00585-1; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lin JC, 2001, J NEUROSCI, V21, P159, DOI 10.1523/JNEUROSCI.21-01-00159.2001; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Nagy A., 2003, MANIPULATING MOUSE E; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; YEOMANS JS, 1995, NEUROPSYCHOPHARMACOL, V12, P3, DOI 10.1016/0893-133X(94)00054-4; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	35	394	396	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					17	24		10.1016/j.neuron.2005.08.028	http://dx.doi.org/10.1016/j.neuron.2005.08.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202705	Bronze			2022-12-28	WOS:000232625700006
J	Lisman, JE; Grace, AA				Lisman, JE; Grace, AA			The hippocampal-VTA loop: Controlling the entry of information into long-term memory	NEURON			English	Review							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; RECEPTOR MESSENGER-RNA; RAT-BRAIN; PROTEIN-SYNTHESIS; NOVELTY DETECTION; SPATIAL MEMORY; CA1 REGION; SYNAPTIC PLASTICITY; PROJECTION NEURONS	In this article we develop the concept that the hippocampus and the midbrain dopaminergic neurons of the ventral tegmental area (VTA) form a functional loop. Activation of the loop begins when the hippocampus detects newly arrived information that is not already stored in its long-term memory. The resulting novelty signal is conveyed through the subiculum, accumbens, and ventral pallidum to the VTA where it contributes (along with salience and goal information) to the novelty-dependent firing of these cells. In the upward arm of the loop, dopamine (DA) is released within the hippocampus; this produces an enhancement of LTP and learning. These findings support a model whereby the hippocampal-VTA loop regulates the entry of information into long-term memory.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	Brandeis University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lisman, JE (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA.	lisman@brandeis.edu		Grace, Anthony/0000-0003-1864-5504				Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Blaha CD, 1997, EUR J NEUROSCI, V9, P902, DOI 10.1111/j.1460-9568.1997.tb01441.x; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Brankack J, 1996, HIPPOCAMPUS, V6, P475, DOI 10.1002/(SICI)1098-1063(1996)6:5<475::AID-HIPO1>3.0.CO;2-I; BROUWER N, 1992, NEUROSCI LETT, V142, P223, DOI 10.1016/0304-3940(92)90378-K; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; CHROBAK JJ, 1993, J NEURAL TRANSM-GEN, V93, P123, DOI 10.1007/BF01245342; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c; FLICKER C, 1982, BRAIN RES REV, V4, P105, DOI 10.1016/0165-0173(82)90007-8; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; French SJ, 2003, NEUROSCIENCE, V119, P19, DOI 10.1016/S0306-4522(03)00150-7; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; GASBARRI A, 1994, BRAIN RES BULL, V33, P445, DOI 10.1016/0361-9230(94)90288-7; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; GINGRICH JA, 1992, NEUROCHEM INT, V20, pS9; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GOLDSMITH SK, 1994, HIPPOCAMPUS, V4, P354, DOI 10.1002/hipo.450040318; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; Gray JA, 1998, SCHIZOPHRENIA BULL, V24, P249, DOI 10.1093/oxfordjournals.schbul.a033324; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Hasselmo ME, 1997, BEHAV BRAIN RES, V89, P1, DOI 10.1016/S0166-4328(97)00048-X; Heckers S, 2004, AM J PSYCHIAT, V161, P2138, DOI 10.1176/appi.ajp.161.11.2138-a; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Honey RC, 1998, J NEUROSCI, V18, P2226; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; IUDICELLO JE, ACNP 43 ANN M SAN JU; Jenkins TA, 2004, NEUROSCIENCE, V124, P43, DOI 10.1016/j.neuroscience.2003.11.024; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; KEPECS A, 2002, ADV NEURAL INFORMATI, V14; Kilpatrick MR, 2000, NEUROSCIENCE, V96, P697, DOI 10.1016/S0306-4522(99)00578-3; Kitchigina V, 1997, EUR J NEUROSCI, V9, P41, DOI 10.1111/j.1460-9568.1997.tb01351.x; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; KOYAMA Y, 1994, NEUROSCIENCE, V63, P1021, DOI 10.1016/0306-4522(94)90569-X; LAURIER LG, 1994, MOL BRAIN RES, V25, P344, DOI 10.1016/0169-328X(94)90170-8; Lee I, 2005, BEHAV NEUROSCI, V119, P145, DOI 10.1037/0735-7044.119.1.145; Legault M, 2000, J NEUROSCI, V20, P1635; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Lodge D, 2005, SCHIZOPHRENIA BULL, V31, P304; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; MEADORWOODRUFF JH, 1992, NEUROSCI LETT, V145, P209, DOI 10.1016/0304-3940(92)90024-2; MENGOD G, 1992, NEUROCHEM INT, V20, pS33; MENNICKEN F, 1992, J NEURAL TRANSM-GEN, V87, P1, DOI 10.1007/BF01253106; Mitchell SN, 2000, EUR J PHARMACOL, V407, P131, DOI 10.1016/S0014-2999(00)00741-X; MOGENSON GJ, 1949, LIMBIC MOTOR CIRCUIT, P193; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; O'Donnell P, 1998, NEUROSCIENCE, V87, P823, DOI 10.1016/S0306-4522(98)00190-0; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; PACKARD MG, 1991, BEHAV NEUROSCI, V105, P295, DOI 10.1037/0735-7044.105.2.295; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; RUUSUVIRTA T, 1995, INT J PSYCHOPHYSIOL, V20, P41, DOI 10.1016/0167-8760(95)00025-N; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; SAKAGAMI H, 1994, MOL BRAIN RES, V25, P67, DOI 10.1016/0169-328X(94)90279-8; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SEMBA K, 1992, J COMP NEUROL, V323, P387, DOI 10.1002/cne.903230307; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; SOKOLOFF P, 1995, TRENDS PHARMACOL SCI, V16, P270, DOI 10.1016/S0165-6147(00)89044-6; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STEINFELS GF, 1983, BRAIN RES, V277, P150, DOI 10.1016/0006-8993(83)90917-4; Strange BA, 2001, HIPPOCAMPUS, V11, P690, DOI 10.1002/hipo.1084; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; SWANSON L, 1987, INTEGRATED SYSTEMS C, P125; Swanson-Park JL, 1999, NEUROSCIENCE, V92, P485, DOI 10.1016/S0306-4522(99)00010-X; Taepavarapruk P, 2000, PSYCHOPHARMACOLOGY, V151, P242, DOI 10.1007/s002130000376; Tseng KY, 2005, CEREB CORTEX, V15, P49, DOI 10.1093/cercor/bhh107; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; UZAKOV S, 2004, REINFORECEMENT HIPPO; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Vinogradova OS, 1984, HIPPOCAMPUS, P1; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wood DA, 2004, BEHAV BRAIN RES, V152, P59, DOI 10.1016/j.bbr.2003.09.038; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004; YANG CR, 1987, NEUROSCIENCE, V23, P1041, DOI 10.1016/0306-4522(87)90179-5; YOKOYAMA C, 1994, J COMP NEUROL, V344, P121, DOI 10.1002/cne.903440109	105	1300	1327	2	145	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 2	2005	46	5					703	713		10.1016/j.neuron.2005.05.002	http://dx.doi.org/10.1016/j.neuron.2005.05.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924857	Bronze			2022-12-28	WOS:000229689800005
J	Huang, Y; Man, HY; Sekine-Aizawa, Y; Han, YF; Juluri, K; Luo, HB; Cheah, J; Lowenstein, C; Huganir, RL; Snyder, SH				Huang, Y; Man, HY; Sekine-Aizawa, Y; Han, YF; Juluri, K; Luo, HB; Cheah, J; Lowenstein, C; Huganir, RL; Snyder, SH			S-nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors	NEURON			English	Article							LONG-TERM DEPRESSION; REFLECTION FLUORESCENCE MICROSCOPY; CULTURED HIPPOCAMPAL-NEURONS; NITRIC-OXIDE; SYNAPTIC PLASTICITY; ACTIVATION; NSF; GLUR2; TRAFFICKING; EXOCYTOSIS	Postsynaptic AMPA receptor (AMPAR) trafficking mediates some forms of synaptic plasticity that are modulated by NMDA receptor (NMDAR) activation and N-ethylmaleimide sensitive factor (NSF). We report that NSF is physiologically S-nitrosylated by endogenous, neuronally derived nitric oxide (NO). S-nitrosylation of NSF augments its binding to the AMPAR GluR2 subunit. Surface insertion of GluR2 in response to activation of synaptic NMDARs requires endogenous NO, acting selectively upon the binding of NSF to GluR2. Thus, AMPAR recycling elicited by NMDA neurotransmission is mediated by a cascade involving NMDA activation of neuronal NO synthase to form NO, leading to S-nitrosylation of NSF which is thereby activated, enabling it to bind to GluR2 and promote the receptor's surface expression.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@bs.jhmi.edu		Lowenstein, Charles/0000-0003-0485-7514	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00266, DA-00074] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2003, NEUROSCI RES, V47, P3, DOI 10.1016/S0168-0102(03)00160-3; Dingledine R, 1999, PHARMACOL REV, V51, P7; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Ishizuka Y, 2000, BRAIN RES, V862, P17, DOI 10.1016/S0006-8993(00)02061-8; Jaffrey SR, 2002, CHEM BIOL, V9, P1329, DOI 10.1016/S1074-5521(02)00293-4; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kim KA, 2002, J NEUROSCI RES, V69, P268, DOI 10.1002/jnr.10296; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Newman ME, 1998, J ECT, V14, P153; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Wilson M, 2003, NEURON, V37, P728, DOI 10.1016/S0896-6273(03)00121-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	42	137	140	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					533	540		10.1016/j.neuron.2005.03.028	http://dx.doi.org/10.1016/j.neuron.2005.03.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944123	Bronze			2022-12-28	WOS:000229294300006
J	Sallette, J; Pons, S; Devillers-Thiery, A; Soudant, M; de Carvalho, LP; Changeux, JP; Corringer, PJ				Sallette, J; Pons, S; Devillers-Thiery, A; Soudant, M; de Carvalho, LP; Changeux, JP; Corringer, PJ			Nicotine upregulates its own receptors through enhanced intracellular maturation	NEURON			English	Article							ACETYLCHOLINE-RECEPTORS; ENDOPLASMIC-RETICULUM; FUNCTIONAL-ACTIVITY; CHRONIC EXPOSURE; BINDING-SITES; SUBUNIT; EXPRESSION; CELLS; SH-SY5Y; BRAIN	Chronic exposure to nicotine elicits upregulation of high-affinity nicotinic receptors in the smoker's brain. To address the molecular mechanism of upregulation, we transfected HEK293 cells with human alpha 4 beta 2 receptors and traced the subunits throughout their intracellular biosynthesis, using metabolic labeling and immunoprecipitation techniques. We show that high-mannose glycosylated subunits mature and assemble into pentamers in the endoplasmic reticulum and that only pentameric receptors reach the cell surface following carbohydrate processing. Nicotine is shown to act inside the cell and to increase the amount of beta subunits immunoprecipitated by the conformation-dependent mAb290, indicating that nicotine enhances a critical step in the intracellular maturation of these receptors. This effect, which also takes place at concentrations of nicotine found in the blood of smokers upon expression of alpha 4 beta 2 in SH-SY5Y neuroblastoma cells, may play a crucial role in nicotine addiction and possibly implement a model of neural plasticity.	CNRS, URA, Inst Pasteur, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Changeux, JP (corresponding author), CNRS, URA, Inst Pasteur, 25 Rue Dr Roux, F-75724 Paris, France.	changeux@pasteur.fr; pjcorrin@pasteur.fr						Arroyo-Jimenez MD, 1999, J NEUROSCI, V19, P6475; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Breese CR, 2000, NEUROPSYCHOPHARMACOL, V23, P351, DOI 10.1016/S0893-133X(00)00121-4; Buisson B, 2002, TRENDS PHARMACOL SCI, V23, P130, DOI 10.1016/S0165-6147(00)01979-9; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fenster CP, 1999, J NEUROSCI, V19, P4804; Gopalakrishnan M, 1996, J PHARMACOL EXP THER, V276, P289; Gopalakrishnan M, 1997, MOL PHARMACOL, V52, P524, DOI 10.1124/mol.52.3.524; Grailhe R, 2004, EUR J NEUROSCI, V19, P855, DOI 10.1111/j.1460-9568.2004.03153.x; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Green WN, 1997, J BIOL CHEM, V272, P20945, DOI 10.1074/jbc.272.33.20945; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Harkness PC, 2002, J NEUROSCI, V22, P10172; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LINSTROM J, 1996, NEURONAL NICOTINE AC, P377; LUKAS RJ, 1993, MOL CELL NEUROSCI, V4, P1, DOI 10.1006/mcne.1993.1001; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MONTEGGIA LM, 1995, GENE, V155, P189, DOI 10.1016/0378-1119(94)00914-E; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nguyen HN, 2004, J NEUROCHEM, V90, P40, DOI 10.1111/j.1471-4159.2004.02482.x; Nguyen HN, 2003, J PHARMACOL EXP THER, V307, P1090, DOI 10.1124/jpet.103.056408; Peng X, 1997, MOL PHARMACOL, V51, P776, DOI 10.1124/mol.51.5.776; PENG X, 1994, MOL PHARMACOL, V46, P523; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Roth BL, 1998, DRUG ALCOHOL DEPEN, V51, P73, DOI 10.1016/S0376-8716(98)00067-2; ROWELL PP, 1990, J NEUROCHEM, V55, P2105, DOI 10.1111/j.1471-4159.1990.tb05802.x; Sallette J, 2004, J BIOL CHEM, V279, P18767, DOI 10.1074/jbc.M308260200; SMITH MM, 1987, J BIOL CHEM, V262, P4367; STRECKER A, 1994, EUR J BIOCHEM, V220, P1005, DOI 10.1111/j.1432-1033.1994.tb18705.x; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Warpman U, 1998, J NEUROCHEM, V70, P2028; Whiteaker P, 1998, MOL PHARMACOL, V53, P950; WHITING PJ, 1988, J NEUROSCI, V8, P3395	42	214	218	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					595	607		10.1016/j.neuron.2005.03.029	http://dx.doi.org/10.1016/j.neuron.2005.03.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944128	Bronze			2022-12-28	WOS:000229294300011
J	Fried, SI; Munch, TA; Werblin, FS				Fried, SI; Munch, TA; Werblin, FS			Directional selectivity is formed at multiple levels by laterally offset inhibition in the rabbit retina	NEURON			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RECEPTIVE-FIELDS; CHOLINERGIC NEURONS; BIPOLAR CELLS; ACETYLCHOLINE; RESPONSES; COMPUTATION; MECHANISMS; MORPHOLOGY	The excitatory and inhibitory inputs to directionally selective (DS) ganglion cells are themselves directionally selective. Directionality is achieved because excitation is reduced during null-direction movement along a GABAergic pathway. Inhibition is reduced during preferred-direction movement along a pathway that includes cholinergic synapses. Both excitation and inhibition are made directional by laterally offset inhibitory signals similar to the spatial offset of the direct inhibitory input to the DS cell dendrites. Thus, spatially offset lateral inhibition generates directionality at three different levels in the DS circuitry. We also found that for stimuli failing within the dendritic field, cholinergic input is delivered to the OFF but not the ON dendrites. Cholinergic pathways from outside the dendritic field reach both ON and OFF dendrites, but both of these pathways are normally inactivated by GABAergic synapses.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Werblin, FS (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 145 LSA, Berkeley, CA 94720 USA.	werblin@berkeley.edu	Fried, Shelley/S-7954-2016	Fried, Shelley/0000-0001-6456-8656; Munch, Thomas/0000-0002-8884-6961				Amthor FR, 1996, VISUAL NEUROSCI, V13, P303, DOI 10.1017/S0952523800007549; AMTHOR FR, 1984, BRAIN RES, V298, P187, DOI 10.1016/0006-8993(84)91167-3; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; Barlow H, 1996, NETWORK-COMP NEURAL, V7, P251, DOI 10.1088/0954-898X/7/2/004; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Brown SP, 1999, J COMP NEUROL, V408, P97; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chiao CC, 2003, NAT NEUROSCI, V6, P1251, DOI 10.1038/nn1147; Chiao CC, 2002, J NEUROSCI, V22, P10509; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2001, CURR OPIN NEUROBIOL, V11, P415, DOI 10.1016/S0959-4388(00)00228-2; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Grzywacz NM, 1998, J PHYSIOL-LONDON, V512, P575, DOI 10.1111/j.1469-7793.1998.575be.x; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; MILLER RF, 1983, P NATL ACAD SCI-BIOL, V80, P3069, DOI 10.1073/pnas.80.10.3069; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Reed BT, 2002, VISUAL NEUROSCI, V19, P427, DOI 10.1017/S0952523802194053; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1981, J COMP NEUROL, V199, P373, DOI 10.1002/cne.901990305; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; YANG G, 1994, J NEUROSCI, V14, P5267; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920	41	96	96	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					117	127		10.1016/j.neuron.2005.02.007	http://dx.doi.org/10.1016/j.neuron.2005.02.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820698	Bronze			2022-12-28	WOS:000228228600013
J	Nguyen, QT; Kleinfeld, D				Nguyen, QT; Kleinfeld, D			Positive feedback in a brainstem tactile sensorimotor loop	NEURON			English	Article							FACIAL NUCLEUS; MEMBRANE-PROPERTIES; HYPOGLOSSAL NUCLEI; SYNAPTIC RESPONSES; RAT; NEURONS; VIBRISSAE; WHISKING; CONNECTIONS; MOTONEURONS	The trigeminal loop in the brainstem comprises the innermost level of sensorimotor feedback in the rat vibrissa system. Anatomy suggests that this loop relays tactile information from the vibrissae to the motoneurons that control vibrissa movement. We demonstrate, using in vitro and in vivo recordings, that the trigeminal loop consists of excitatory pathways from vibrissa sensory inputs to vibrissa motoneurons in the facial nucleus. We further show that the trigeminal loop implements a rapidly depressing reflex that provides positive sensory feedback to the vibrissa musculature during simulated whisking and contact. On the basis of these findings, we propose that the trigeminal loop provides an enhancement of vibrissa muscle tone upon contact during active touch.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059867] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59867] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; Ahrens KF, 2002, P NATL ACAD SCI USA, V99, P15176, DOI 10.1073/pnas.222547199; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; BROWN AWS, 1974, J PHYSIOL-LONDON, V238, P387, DOI 10.1113/jphysiol.1974.sp010531; Cabanes C, 2002, J NEUROPHYSIOL, V87, P2398, DOI 10.1152/jn.2002.87.5.2398; Cajal S. Ry, 1909, HIST SYSTEME NERVEUX; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; Dauvergne C, 2001, NEUROSCI LETT, V311, P109, DOI 10.1016/S0304-3940(01)02150-4; DORFL J, 1982, J ANAT, V135, P147; Dumitru D, 1995, ELECTRODIAGNOSTIC ME; ERZURUMLU RS, 1979, J COMP NEUROL, V188, P75, DOI 10.1002/cne.901880107; EVINGER C, 1993, EXP BRAIN RES, V92, P507; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Filipkowski RK, 2001, NEUROSCIENCE, V106, P679, DOI 10.1016/S0306-4522(01)00310-4; FRIAUF E, 1986, J COMP NEUROL, V253, P231, DOI 10.1002/cne.902530209; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Guido W, 2001, DEV BRAIN RES, V132, P97, DOI 10.1016/S0165-3806(01)00283-8; Hallett M, 2002, NEUROLOGY, V59, P1306, DOI 10.1212/01.WNL.0000027361.73814.0E; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Holstege Gert, 1995, P257; JACQUIN MF, 1990, SOMATOSENS MOT RES, V7, P399, DOI 10.3109/08990229009144716; Kis Z, 2004, NEUROSCI LETT, V358, P223, DOI 10.1016/j.neulet.2004.01.037; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Lo FS, 1999, J NEUROPHYSIOL, V82, P2765, DOI 10.1152/jn.1999.82.5.2765; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Minnery BS, 2003, J NEUROPHYSIOL, V89, P40, DOI 10.1152/jn.00272.2002; Neimark MA, 2003, J NEUROSCI, V23, P6499; Nguyen QT, 2004, J PHYSIOL-LONDON, V556, P203, DOI 10.1113/jphysiol.2003.060087; Onodera K, 2000, J PHYSIOL-LONDON, V524, P503, DOI 10.1111/j.1469-7793.2000.00503.x; Rice FL, 1997, J COMP NEUROL, V385, P149; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; Schicatano EJ, 1997, J NEUROPHYSIOL, V77, P2842, DOI 10.1152/jn.1997.77.5.2842; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Voisin J, 2002, EXP BRAIN RES, V145, P251, DOI 10.1007/s00221-002-1118-5; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WINESKI LE, 1983, J ZOOL, V200, P261; Zerari-Mailly F, 2001, J COMP NEUROL, V429, P80, DOI 10.1002/1096-9861(20000101)429:1<80::AID-CNE7>3.0.CO;2-L; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	47	87	87	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					447	457		10.1016/j.neuron.2004.12.042	http://dx.doi.org/10.1016/j.neuron.2004.12.042			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694330	Bronze			2022-12-28	WOS:000226787700016
J	Hubbard, EM; Ramachandran, VS				Hubbard, EM; Ramachandran, VS			Neurocognitive mechanisms of synesthesia	NEURON			English	Review							COGNITIVE NEUROSCIENCE; INDIVIDUAL-DIFFERENCES; OBJECT-SUBSTITUTION; SPATIAL ATTENTION; COLORED-HEARING; VISUAL-CORTEX; SYNAESTHESIA; PERCEPTION; FORM; ACTIVATION	Synesthesia is a condition in which stimulation of one sensory modality causes unusual experiences in a second, unstimulated modality. Although long treated as a curiosity, recent research with a combination of phenomenological, behavioral, and neuroimaging methods has begun to identify the cognitive and neural basis of synesthesia. Here, we review this literature with an emphasis on grapheme-color synesthesia, in which viewing letters and numbers induces the perception of colors. We discuss both the substantial progress that has been made in the past fifteen years and some open questions. In particular, we focus on debates in the field relating to the neural basis of synesthesia, including the relationship between synesthesia and attention and the role of meaning in synesthetic colors. We propose that some, but probably not all, of these differences can be accounted for by differences in the synesthetes studied and discuss some methodological implications of these individual differences.	Univ Calif San Diego, Ctr Brain & Cognit, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hubbard, EM (corresponding author), CEA, Serv Hosp Frederic Joliot, INSERM, U562, 4 Pl Gen Leclerc, F-91401 Orsay, France.	edhubbard@gmail.com	Hubbard, Edward/N-2931-2019; Hubbard, Edward/C-1770-2012	Hubbard, Edward/0000-0002-2701-415X; 	NIMH NIH HHS [R01 MH 60474, F31 MH63585, F31 MH063585] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH063585, R01MH060474] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aleman A, 2001, NEUROREPORT, V12, P2827, DOI 10.1097/00001756-200109170-00015; Armel KC, 1999, NEUROCASE, V5, P293, DOI 10.1093/neucas/5.4.293; ASHER J, 2005, DIAGNOSING PHENOTYPI; Bailey M. E. S., 1997, SYNAESTHESIA CLASSIC, P182; Baron-Cohen S., 1997, SYNAESTHESIA CLASSIC; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Blake R., 2005, SYNESTHESIA PERSPECT, P47; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Borsook D, 1998, NEUROREPORT, V9, P1013, DOI 10.1097/00001756-199804200-00011; BOURMA H, 1970, NATURE, V226, P177; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Cytowic R. E., 1989, SYNAESTHESIA UNION S; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Dixon MJ, 2005, NEURON, V45, P821, DOI 10.1016/j.neuron.2005.03.007; EDQUIST J, 2005, IN PRESS CORTEX; Elias LJ, 2003, COGNITIVE BRAIN RES, V16, P232, DOI 10.1016/S0926-6410(02)00278-1; Enns JT, 1997, PSYCHOL SCI, V8, P135, DOI 10.1111/j.1467-9280.1997.tb00696.x; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Flournoy T, 1893, PHENOMENES SYNOPSIE; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Galton F., 1983, INQUIRY HUMAN FACULT; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Grossenbacher P. G., 1997, SYNAESTHESIA CLASSIC, P148; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Hubbard EM, 2003, J CONSCIOUSNESS STUD, V10, P77; HUBBARD EM, 2005, IN PRESS CORTEX; Hubbard TL, 1996, AM J PSYCHOL, V109, P219, DOI 10.2307/1423274; JANSARI AS, 2005, IN PRESS CORTEX; Kadosh RC, 2005, J COGNITIVE NEUROSCI, V17, P1766, DOI 10.1162/089892905774589181; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; KENNEDY H, 1997, SYNAESTHESIA CLASSIC, P243; Knoch D, 2005, COGNITIVE BRAIN RES, V25, P372, DOI 10.1016/j.cogbrainres.2005.05.005; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Laeng B, 2004, PSYCHOL SCI, V15, P277, DOI 10.1111/j.0956-7976.2004.00666.x; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LUPIANEZ JC, 2005, IN PRESS CORTEX; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MARKS LE, 1975, PSYCHOL BULL, V82, P303, DOI 10.1037/0033-2909.82.3.303; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Maurer D., 1997, SYNAESTHESIA CLASSIC, P224; MCCLELLAND JL, 1981, PSYCHOL REV, V89, P60; Mills CB, 1999, COGNITIVE NEUROPSYCH, V16, P181, DOI 10.1080/026432999380951; MILLS CB, 2005, IN PRESS CORTEX; MULVENNA C, 1908, J COGNITIVE NEUROS S, V16, P188; Myles KM, 2003, BRAIN COGNITION, V53, P342, DOI 10.1016/S0278-2626(03)00139-8; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Odgaard EC, 1999, PERCEPTION, V28, P651, DOI 10.1068/p2910; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; Pashler HE, 1998, PSYCHOL ATTENTION; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Ramachandran V, 2003, J CONSCIOUSNESS STUD, V10, P49; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rich AN, 2003, NEUROREPORT, V14, P1793, DOI 10.1097/00001756-200310060-00007; Rich AN, 2002, NAT REV NEUROSCI, V3, P43, DOI 10.1038/nrn702; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; ROBERTSON LC, 2005, SYNTHESIA PERSPECTIV; Rodman HR, 1997, CEREBR CORT, V12, P639; SAGIV N, 2005, IN PRESS CORTEX; SAGIV N, 2003, J COGNITIVE NEUROS S, V15, P153; Shanon B, 2002, J CONSCIOUSNESS STUD, V9, P3; Smilek D, 2002, NEUROCASE, V8, P338, DOI 10.1093/neucas/8.4.338; Smilek D, 2002, PSYCHOL SCI, V13, P548, DOI 10.1111/1467-9280.00496; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; SMILEK D, 2002, SYNERGISTIC UNDERSTA; SMILEK D, 2005, SYNESTHESIA PERSPECT, P74; SPELING JM, 2005, IN PRESS CORTEX; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; STEVEN MS, 2005, J COGNITIVE NEUROS S, V17, P216; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Treisman A., 2005, SYNESTHESIA PERSPECT, P239; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Wagar BM, 2002, BRAIN COGNITION, V48, P606, DOI 10.1006/brcg.2001.1426; Ward J, 2005, PERCEPTION, V34, P611, DOI 10.1068/p5250; Ward J, 2003, COGNITION, V89, P237, DOI 10.1016/S0010-0277(03)00122-7; WARD J, 2005, IN PRESS CORTEX; Weiss PH, 2001, CORTEX, V37, P750, DOI 10.1016/S0010-9452(08)70631-2; WEISS PH, 2005, IN PRESS NEUROIMAGE; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wollen KA, 1983, J MENT IMAG, V7, P83; [No title captured]	100	243	250	6	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					509	520		10.1016/j.neuron.2005.10.012	http://dx.doi.org/10.1016/j.neuron.2005.10.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	983RP	16269367	Bronze			2022-12-28	WOS:000233250100011
J	Awatramani, GB; Price, GD; Trussell, LO				Awatramani, GB; Price, GD; Trussell, LO			Modulation of transmitter release by presynaptic resting potential and background calcium levels	NEURON			English	Article							MOTOR NERVE TERMINALS; TERM SYNAPTIC PLASTICITY; RAT BRAIN-STEM; POSTTETANIC POTENTIATION; GIANT SYNAPSE; DEVELOPMENTAL REGULATION; IONOTROPIC RECEPTORS; BUFFER SATURATION; GLYCINE RECEPTORS; CHROMAFFIN CELLS	Activation of presynaptic ion channels alters the membrane potential of nerve terminals, leading to changes in transmitter release. To study the relationship between resting potential and exocytosis, we combined pre- and postsynaptic electrophysiological recordings with presynaptic Ca2+ measurements at the calyx of Held. Depolarization of the membrane potential to between -60 mV and -65 mV elicited P/Q-type Ca2+ currents of < 1 pA and increased intraterminal Ca2+ by < 100 nM. These small Ca2+ elevations were sufficient to enhance the probability of transmitter release up to 2-fold, with no effect on the readily releasable pool of vesicles. Moreover, the effects of mild depolarization on release had slow kinetics and were abolished by 1 mM intraterminal EGTA, suggesting that Ca2+ acted through a high-affinity binding site. Together, these studies suggest that control of resting potential is a powerful means for regulating synaptic function at mammalian synapses.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Trussell, LO (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Vollum Inst, Portland, OR 97239 USA.	trussell@ohsu.edu			NIDCD NIH HHS [DC04450] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004450] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Atluri PP, 1996, J NEUROSCI, V16, P5661; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brager DH, 2003, NAT NEUROSCI, V6, P551, DOI 10.1038/nn1067; BULLOCK TH, 1957, J GEN PHYSIOL, V40, P565, DOI 10.1085/jgp.40.4.565; Cattaert D, 1999, J NEUROSCI, V19, P6079, DOI 10.1523/JNEUROSCI.19-14-06079.1999; CHARLTON MP, 1977, BRAIN RES, V134, P367, DOI 10.1016/0006-8993(77)91081-2; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Chuhma N, 2002, J NEUROPHYSIOL, V87, P222, DOI 10.1152/jn.00235.2001; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DELANEY KR, 1994, J NEUROSCI, V14, P5885; DUCHEN MR, 1986, BRAIN RES, V379, P182, DOI 10.1016/0006-8993(86)90274-X; DUDEL J, 1971, PFLUG ARCH EUR J PHY, V324, P227, DOI 10.1007/BF00586421; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HUBBARD JI, 1968, J PHYSIOL-LONDON, V194, P381, DOI 10.1113/jphysiol.1968.sp008414; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Jackson MB, 2003, J NEUROSCI, V23, P1612; Jang IS, 2002, J PHYSIOL-LONDON, V541, P423, DOI 10.1113/jphysiol.2001.016535; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Khakh BS, 2000, J AUTONOM NERV SYST, V81, P110, DOI 10.1016/S0165-1838(00)00111-9; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V483, P79, DOI 10.1113/jphysiol.1995.sp020569; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Matveev V, 2002, BIOPHYS J, V83, P1368, DOI 10.1016/S0006-3495(02)73907-6; Matyushkin DP, 1995, GEN PHYSIOL BIOPHYS, V14, P369; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; NICHOLLS J, 1978, J PHYSIOL-LONDON, V281, P157, DOI 10.1113/jphysiol.1978.sp012414; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SHAPIRO E, 1980, P NATL ACAD SCI-BIOL, V77, P629, DOI 10.1073/pnas.77.1.629; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; TAKEUCHI A, 1961, J PHYSIOL-LONDON, V155, P46, DOI 10.1113/jphysiol.1961.sp006612; TAKEUCHI A, 1962, J GEN PHYSIOL, V45, P1181, DOI 10.1085/jgp.45.6.1181; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WOJTOWICZ JM, 1984, J NEUROPHYSIOL, V52, P99, DOI 10.1152/jn.1984.52.1.99; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; Ye JH, 2004, J NEUROSCI, V24, P8961, DOI 10.1523/JNEUROSCI.2016-04.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	59	196	201	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					109	121		10.1016/j.neuron.2005.08.038	http://dx.doi.org/10.1016/j.neuron.2005.08.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202712	Bronze			2022-12-28	WOS:000232625700013
J	Crowe, DA; Averbeck, BB; Chafee, MV; Georgopoulos, AP				Crowe, DA; Averbeck, BB; Chafee, MV; Georgopoulos, AP			Dynamics of parietal neural activity during spatial cognitive processing	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; MOTOR INTENTION ACTIVITY; POPULATION VECTOR; WORKING-MEMORY; RHESUS-MONKEY; CORTEX; ATTENTION; PLAN; REPRESENTATION; RESPONSES	Dynamic neural processing unrelated to changes in sensory input or motor output is likely to be a hallmark of cognitive operations. Here we show that neural representations of space in parietal cortex are dynamic while monkeys perform a spatial cognitive operation on a static visual stimulus. We recorded neural activity in area 7a during a visual maze task in which monkeys mentally followed a path without moving their eyes. We found that the direction of the followed path could be recovered from neuronal population activity. When the monkeys covertly processed a path that turned, the population representation of path direction shifted in the direction of the turn. This neural population dynamic took place during a period of unchanging visual input and showed characteristics of both serial and parallel processing. The data suggest that the dynamic evolution of parietal neuronal activity is associated with the progression of spatial cognitive operations.	Vet Adm Med Ctr, Brain Sci Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Georgopoulos, AP (corresponding author), Vet Adm Med Ctr, Brain Sci Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	omega@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017413] Funding Source: NIH RePORTER; NINDS NIH HHS [NS17413] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 2005, CEREB CORTEX, V15, P1393, DOI 10.1093/cercor/bhi021; Chafee MV, 2002, ARCH ITAL BIOL, V140, P247; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Crowe DA, 2004, CEREB CORTEX, V14, P23, DOI 10.1093/cercor/bhg088; Crowe DA, 2000, J COGNITIVE NEUROSCI, V12, P813, DOI 10.1162/089892900562426; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Houtkamp R, 2003, PERCEPT PSYCHOPHYS, V65, P1136, DOI 10.3758/BF03194840; JOLICOEUR P, 1986, MEM COGNITION, V14, P129, DOI 10.3758/BF03198373; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; MCCORMICK PA, 1991, MEM COGNITION, V19, P469, DOI 10.3758/BF03199570; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOUNTCASTLE VB, 1991, J NEUROSCI METH, V36, P77, DOI 10.1016/0165-0270(91)90140-U; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Roelfsema PR, 2000, VISION RES, V40, P1385, DOI 10.1016/S0042-6989(00)00004-3; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STEINMETZ MA, 1994, J NEUROPHYSIOL, V72, P1020, DOI 10.1152/jn.1994.72.2.1020; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Takeda K, 2004, CEREB CORTEX, V14, P1328, DOI 10.1093/cercor/bhh093; [No title captured]	32	35	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					885	891		10.1016/j.neuron.2005.08.005	http://dx.doi.org/10.1016/j.neuron.2005.08.005			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157282	Bronze			2022-12-28	WOS:000232085000015
J	Hernandez, PJ; Kelley, AE				Hernandez, PJ; Kelley, AE			Cracking addiction the second time around: Reconsolidation of drug-related memories	NEURON			English	Editorial Material							COCAINE-SEEKING BEHAVIOR; ACCUMBENS CORE; REACTIVATION; ACTIVATION; RETRIEVAL; BRAIN; SHELL	One of the greatest challenges in the understanding and treatment of addiction is cue-elicited relapse to drug use. The present findings of Miller and Marshall and Lee et al. reported in this issue of Neuron demonstrate that retrieved drug-related memories undergo reconsolidation and thus suggest that these maladaptive associations may be more labile than previously thought.	Univ Wisconsin, Madison Med Sch, Dept Psychiat, Madison, WI 53719 USA; Univ Wisconsin, Madison Med Sch, Neurosci Training Program, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, PJ (corresponding author), Univ Wisconsin, Madison Med Sch, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.							Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Ikemoto S, 2005, J NEUROSCI, V25, P5061, DOI 10.1523/JNEUROSCI.0892-05.2005; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Lattal KM, 2004, P NATL ACAD SCI USA, V101, P4667, DOI 10.1073/pnas.0306546101; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROUTTENBERG A, 1979, FED PROC, V38, P2446; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Thomas KL, 2003, EUR J NEUROSCI, V17, P1964, DOI 10.1046/j.1460-9568.2003.02617.x; Valjent E, 2000, J NEUROSCI, V20, P8701; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533	17	12	12	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					772	775		10.1016/j.neuron.2005.09.001	http://dx.doi.org/10.1016/j.neuron.2005.09.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157269	Bronze			2022-12-28	WOS:000232085000002
J	Stern, CE; Hasselmo, ME				Stern, CE; Hasselmo, ME			Less is more: How reduced activity reflects stronger recognition	NEURON			English	Editorial Material							MEMORY; FAMILIARITY; HIPPOCAMPAL; CORTEX	The mechanisms of recognition involve reductions of activity in the medial temporal lobe. This preview discusses recent fMRI and MEG data from Gonsalves et al. (this issue of Neuron) that provide some of the strongest evidence to date demonstrating that reduced medial temporal activity is correlated with stronger recognition of items in humans. This result provides an important test of theories of recognition memory function based on previous neuroimaging and unit recording data.	Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, Boston, MA 02215 USA	Boston University	Stern, CE (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, 64 Cummington St, Boston, MA 02215 USA.			Hasselmo, Michael/0000-0002-9925-6377				Bogacz R, 2003, HIPPOCAMPUS, V13, P494, DOI 10.1002/hipo.10093; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Sohal VS, 2000, NETWORK-COMP NEURAL, V11, P169, DOI 10.1088/0954-898X/11/3/301; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Weis S, 2004, NEUROREPORT, V15, P2729; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	10	3	3	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 1	2005	47	5					625	627		10.1016/j.neuron.2005.08.013	http://dx.doi.org/10.1016/j.neuron.2005.08.013			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129391	Bronze			2022-12-28	WOS:000231782700003
J	Forman, MS; Lee, VMY; Trojanowski, JQ				Forman, MS; Lee, VMY; Trojanowski, JQ			Nosology of Parkinson's disease: Looking for the way out of a quackmire	NEURON			English	Review							ALPHA-SYNUCLEIN; LEWY BODIES; MUTATIONS; GENE; DEMENTIA; FIBRILLIZATION; DIAGNOSIS; TAU	The discovery of SNCA mutations pathogenic for autosomal-dominant Lewy body Parkinson's disease (PD) in 1997 heralded a revolution in understanding the molecular and genetic basis of PD. Indeed, it now is clear that Lewy body PD is one of many neuro-degenerative parkinsonian disorders that result from nigrostriatal degeneration caused by diverse mechanisms. However, to capitalize on these new insights and facilitate efforts to improve the diagnosis and therapy of neurodegenerative movement disorders, it is timely to define a nosology for these diseases that is based on their genetic and molecular underpinnings, as proposed here.	Univ Penn, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania	Trojanowski, JQ (corresponding author), Univ Penn, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA.	trojanow@mail.med.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009215, P01AG011542, P01AG017586, P01AG014382, K08AG020073, P01AG014449, P30AG010124] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG09215, P30 AG10124, P01 AG17586, P01 AG14449, K08 AG20073, P01 AG11542, P01 AG14382] Funding Source: Medline; NINDS NIH HHS [NS044233] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Feany MB, 2004, NEW ENGL J MED, V351, P1937, DOI 10.1056/NEJMp048263; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LEWEY FH, 1912, HDB NEUROLOGIE, P920; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parkinson J, 1817, ESSAY SHAKING PALSY; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Welch K, 2003, TRENDS NEUROSCI, V26, P517, DOI 10.1016/j.tins.2003.08.001; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	26	71	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					479	482		10.1016/j.neuron.2005.07.021	http://dx.doi.org/10.1016/j.neuron.2005.07.021			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102530	Bronze			2022-12-28	WOS:000231411100004
J	Ryan, XZP; Alldritt, J; Svenningsson, P; Allen, PB; Wu, GY; Nairn, AC; Greengard, P				Ryan, XZP; Alldritt, J; Svenningsson, P; Allen, PB; Wu, GY; Nairn, AC; Greengard, P			The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ACTIN-BASED PLASTICITY; FILAMENT-BINDING PROTEIN; P70 S6 KINASE; SYNAPSE FORMATION; NMDA RECEPTOR; CELL-ADHESION; SMALL GTPASES; RAC; ACTIVATION	Neurabin and spinophilin are homologous protein phosphatase 1 and actin binding proteins that regulate dendritic spine function. A yeast two-hybrid analysis using the coiled-coil domain of neurabin revealed an interaction with Lfc, a Rho GEF. Lfc was highly expressed in brain, where it interacted with either neurabin or spinophilin. In neurons, Lfc was largely found in the shaft of dendrites in association with microtubules but translocated to spines upon neuronal stimulation. Moreover, expression of Lfc resulted in reduction in spine length and size. Both the translocation and the effect on spine morphology depended on the coiled-coil domain of Lfc. Coexpression of neurabin or spinophilin with Lfc resulted in their clustering together with F-actin, a process that depended on Rho activity. Thus, interaction between Lfc and neurabin/spinophilin selectively regulates Rho-dependent organization of F-actin in spines and is a link between the microtubule and F-actin cytoskeletons in dendrites.	Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Baylor College of Medicine; Rockefeller University; Yale University	Wu, GY (corresponding author), Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA.	gangyiw@bcm.tmc.edu; angus.nairn@yale.edu	Svenningsson, Per JL/K-5210-2014	Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044, R21DA017919] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10044, P01 DA010044, DA17919] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen PB, 1999, BIOCHEM SOC T, V27, P543, DOI 10.1042/bst0270543; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Blangy A, 2000, J CELL SCI, V113, P729; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buck KB, 2002, J NEUROSCI, V22, P9358; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Craig A. M, 1998, CULTURING NERVE CELL, P79; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Glaven JA, 1996, J BIOL CHEM, V271, P27374, DOI 10.1074/jbc.271.44.27374; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; Goslin K., 1998, CULTURING NERVE CELL, P339; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hering H, 2003, J NEUROSCI, V23, P11759; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Scott EK, 2003, J NEUROSCI, V23, P3118; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stephens DJ, 2000, BIOCHEM J, V345, P185, DOI 10.1042/0264-6021:3450185; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P27716, DOI 10.1074/jbc.M203365200; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; WANG CM, 1994, STRUCT ENG MECH, V2, P369; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WHITEHEAD I, 1995, J BIOL CHEM, V270, P18388, DOI 10.1074/jbc.270.31.18388; Wittmann T, 2001, J CELL SCI, V114, P3795; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	77	112	114	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					85	100		10.1016/j.neuron.2005.05.013	http://dx.doi.org/10.1016/j.neuron.2005.05.013			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996550	Bronze			2022-12-28	WOS:000230464000010
J	Travis, GH				Travis, GH			DISCO! Dissociation of cone opsins: the fast and noisy life of cones explained	NEURON			English	Editorial Material							PHOTOTRANSDUCTION; ADAPTATION; PROTEINS; ROD	Vertebrate retinas contain two types of photoreceptors. Rods are for vision in dim light, while cones provide high-speed color vision in bright light. In this issue of Neuron, Kefalov et al. present data to explain the reduced sensitivity and faster response kinetics of cones. They show that the chromophore dissociates from cone but not rod visual pigment, yielding apo-opsin. This apo-opsin activates the signaling cascade to desensitize cones and speed the photoresponse.	Univ Calif Los Angeles, Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.		Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493				Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Chen CKJ, 2002, ADV EXP MED BIOL, V514, P101; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122	9	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 16	2005	46	6					840	842		10.1016/j.neuron.2005.06.003	http://dx.doi.org/10.1016/j.neuron.2005.06.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953411	Bronze			2022-12-28	WOS:000229922500002
J	Speidel, D; Bruederle, CE; Enk, C; Voets, T; Varoqueaux, F; Reim, K; Becherer, U; Fornal, F; Ruggieri, S; Holighaus, Y; Weihe, E; Bruns, D; Brose, N; Rettig, J				Speidel, D; Bruederle, CE; Enk, C; Voets, T; Varoqueaux, F; Reim, K; Becherer, U; Fornal, F; Ruggieri, S; Holighaus, Y; Weihe, E; Bruns, D; Brose, N; Rettig, J			CAPS1 regulates catecholamine loading of large dense-core vesicles	NEURON			English	Article							CA2+-DEPENDENT ACTIVATOR PROTEIN; VESICULAR MONOAMINE TRANSPORTER; CHROMAFFIN CELLS; ENDOCRINE-CELLS; PLASMA-MEMBRANE; SECRETION; EXOCYTOSIS; RELEASE; GENE; MECHANISMS	CAPS1 is thought to play an essential role in mediating exocytosis from large dense-core vesicles (LDCVs). We generated CAPS1-deficient (KO) mice and studied exocytosis in a model system for Ca2+- dependent LDCV secretion, the adrenal chromaffin cell. Adult heterozygous CAPS1 KO cells display a gene dosage-dependent decrease of CAPS1 expression and a concomitant reduction in the number of docked vesicles and secretion. Embryonic homozygous CAPS1 KO cells show a strong reduction in the frequency of amperometrically detectable release events of transmitter-filled vesicles, while the total number of fusing vesicles, as judged by capacitance recordings or total internal reflection microscopy, remains unchanged. We conclude that CAPS1 is required for an essential step in the uptake or storage of catecholamines in LDCVs.	Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany; Univ Saarland, Physiolog Inst, D-66421 Homburg, Germany; Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Univ Pisa, Dept Human Morphol & Appl Biol, I-56126 Pisa, Italy; IRCCS Neuromed, Lab Neurobiol Movement Disorders, I-86077 Pozzilli, Isernia, Italy; Univ Marburg, Inst Anat & Zellbiol, Abt Mol Neurowissensch, D-35033 Marburg, Germany	Max Planck Society; Saarland University; Max Planck Society; University of Pisa; IRCCS Neuromed; Philipps University Marburg	Brose, N (corresponding author), Max Planck Inst Expt Med, Abt Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de; jrettig@uniklinik-saarland.de	Becherer, Ute/AGW-2576-2022; Voets, Thomas/AAD-4389-2019; Varoqueaux, Frederique/AAC-1834-2021; Becherer, Ute/F-6711-2010; Ruggieri, Stefano/G-7934-2011; Rettig, Jens/K-5103-2013; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Varoqueaux, Frederique/0000-0002-3614-3121; Becherer, Ute/0000-0001-6005-7517; Rettig, Jens/0000-0001-6160-3954; Voets, Thomas/0000-0001-5526-5821; FORNAI, FRANCESCO/0000-0002-3883-5084				Ahnert-Hilger G, 2004, REV PHYSIOL BIOCH P, V150, P140, DOI 10.1007/s10254-003-0020-2; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; AVERY L, 1993, GENETICS, V134, P454; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; DELATORRE JC, 1980, J NEUROSCI METH, V3, P1, DOI 10.1016/0165-0270(80)90029-1; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Fornai F, 2003, J NEUROSCI, V23, P8955; Gong LW, 2003, J NEUROSCI, V23, P7917; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Henry JP, 1998, NEUROCHEM INT, V32, P227, DOI 10.1016/S0197-0186(97)00092-2; Iwasa K, 1999, J VET MED SCI, V61, P621, DOI 10.1292/jvms.61.621; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Markoglou N, 2001, J BIOCHEM BIOPH METH, V48, P61, DOI 10.1016/S0165-022X(00)00142-1; Moser T, 1997, J NEUROSCI, V17, P2314; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Pahner I, 2002, EUR J CELL BIOL, V81, P449, DOI 10.1078/0171-9335-00269; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Peaston RT, 2004, ANN CLIN BIOCHEM, V41, P17, DOI 10.1258/000456304322664663; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Schonn JS, 2003, J NEUROCHEM, V84, P669, DOI 10.1046/j.1471-4159.2003.01561.x; SCHULDINER S, 1994, J NEUROCHEM, V62, P2067; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Tabares L, 2001, J BIOL CHEM, V276, P39974, DOI 10.1074/jbc.M106498200; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Wassenberg JJ, 2002, ANN NY ACAD SCI, V971, P201, DOI 10.1111/j.1749-6632.2002.tb04464.x; Weihe E, 2000, FASEB J, V14, P2435, DOI 10.1096/fj.00-0202rev; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730	48	87	91	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					75	88		10.1016/j.neuron.2005.02.019	http://dx.doi.org/10.1016/j.neuron.2005.02.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820695	Bronze, Green Published			2022-12-28	WOS:000228228600010
J	Zhou, FM; Liang, Y; Salas, R; Zhang, LF; De Biasi, M; Dani, JA				Zhou, FM; Liang, Y; Salas, R; Zhang, LF; De Biasi, M; Dani, JA			Corelease of dopamine and serotonin from striatal dopamine terminals	NEURON			English	Article							IN-VIVO MICRODIALYSIS; TRANSPORTER; RAT; RELEASE; MONOAMINE; NUCLEUS; MECHANISMS; FLUOXETINE; BEHAVIOR; NEURONS	The striatum receives rich dopaminergic and more moderate serotonergic innervation. After vesicular release, dopamine and serotonin (5-hydroxytryptamine, 5-HT) signaling is controlled by transporter-mediated reuptake. Dopamine is taken up by dopamine transporters (DATs), which are expressed at the highest density in the striatum. Although DATs also display a low affinity for 5-HT, that neurotransmitter is normally efficiently taken up by the 5-HT transporters. We found that when extracellular 5-HT is elevated by exogenous application or by using antidepressants (e.g., fluoxetine) to inhibit the 5-HT transporters, the extremely dense striatal DATs uptake 5-HT into dopamine terminals. Immunohistochemical results and measurements using fast cyclic voltammetry showed that elevated 5-HT is taken up by DATs into striatal dopamine terminals that subsequently release 5-HT and dopamine together. These results suggest that antidepressants that block serotonin transporters or other factors that elevate extracellular 5-HT alter the temporal and spatial relationship between dopamine and 5-HT signaling in the striatum.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	jdani@bcm.tmc.edu	Salas, Ramiro/A-9602-2015; De Biasi, Mariella/M-7646-2017	De Biasi, Mariella/0000-0002-0687-8872	NIDA NIH HHS [DA017173, DA09411] Funding Source: Medline; NIMH NIH HHS [MH67119] Funding Source: Medline; NINDS NIH HHS [R01 NS021229, NS048505, NS21229] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021229, R01NS021229, R01NS048505, R23NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017173, R01DA009411] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Bunin MA, 1998, J NEUROSCI, V18, P4854; Bymaster FP, 2002, PSYCHOPHARMACOLOGY, V160, P353, DOI 10.1007/s00213-001-0986-x; Cases O, 1998, J NEUROSCI, V18, P6914; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7; Descarries L, 2000, PROG BRAIN RES, V125, P27; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; FEUERSTEIN TJ, 1986, BRIT J PHARMACOL, V88, P677, DOI 10.1111/j.1476-5381.1986.tb10250.x; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Iravani MM, 1997, SYNAPSE, V25, P93; JACKSON BP, 1995, BRAIN RES, V674, P163, DOI 10.1016/0006-8993(95)00019-M; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Knobelman DA, 2000, J PHARMACOL EXP THER, V292, P1111; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Laasonen-Balk T, 1999, PSYCHOPHARMACOLOGY, V144, P282, DOI 10.1007/s002130051005; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McMahon LR, 2001, J NEUROSCI, V21, P7781, DOI 10.1523/JNEUROSCI.21-19-07781.2001; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Pickel VM, 1999, J NEUROSCI, V19, P7356, DOI 10.1523/JNEUROSCI.19-17-07356.1999; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; PRISTUPA ZB, 1994, MOL PHARMACOL, V45, P125; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Sesack SR, 1998, J NEUROSCI, V18, P2697; Sesack SR, 2002, HANDB EXP PHARM 1, P63; SHASKAN EG, 1970, J PHARMACOL EXP THER, V175, P404; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Smith TD, 2000, SYNAPSE, V38, P460, DOI 10.1002/1098-2396(20001215)38:4<460::AID-SYN11>3.0.CO;2-D; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; STERNBACH H, 1991, AM J PSYCHIAT, V148, P705; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; VANBOCKSTAELE EJ, 1993, J COMP NEUROL, V334, P603, DOI 10.1002/cne.903340408; WILLNER P, 2002, HANDB EXP PHARM 2, V154, P387; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Yelin Rodrigo, 2002, P313; Yuan J, 2002, J NEUROCHEM, V80, P960, DOI 10.1046/j.0022-3042.2002.00758.x; Zangen A, 2001, PSYCHOPHARMACOLOGY, V155, P434, DOI 10.1007/s002130100746; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	53	134	138	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					65	74		10.1016/j.neuron.2005.02.010	http://dx.doi.org/10.1016/j.neuron.2005.02.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820694	Bronze			2022-12-28	WOS:000228228600009
J	Lu, XF; Ashe, J				Lu, XF; Ashe, J			Anticipatory activity in primary motor cortex codes memorized movement sequences	NEURON			English	Article							CONTEXT-RECALL TASK; CORTICAL ACTIVITY; MULTIPLE MOVEMENTS; ARM MOVEMENTS; SINGLE-CELL; TEMPORAL ORGANIZATION; SEQUENTIAL MOVEMENT; NEURONAL-ACTIVITY; FINGER MOVEMENT; PREMOTOR CORTEX	Movement sequences, defined both by the component movements and by the serial order in which they are produced, are fundamental building blocks of motor behavior. The serial order of sequence production is strongly encoded in medial motor areas. It is not known to what extent sequences are further elaborated or encoded in primary motor cortex. Here, we describe cells in the primary motor cortex of the monkey that show anticipatory activity exclusively related to a specific memorized sequence of upcoming movements. In addition, the injection of muscimol, a GABA agonist, into motor cortex resulted in an increase in the error rate during sequence production, without concomitant effects on nonsequenced motor performance. Our results challenge the role of medial motor areas in the control of well-practiced movement sequences and suggest that motor cortex contains a complete apparatus for the planning and production of this complex behavior.	Vet Adm Med Ctr, Brain Sci Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ashe, J (corresponding author), Vet Adm Med Ctr, Brain Sci Ctr, Minneapolis, MN 55417 USA.	ashe@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042278] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42278] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; ASHE J, 1993, EXP BRAIN RES, V95, P118; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hatsopoulos NG, 2003, EXP BRAIN RES, V149, P478, DOI 10.1007/s00221-003-1385-9; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; KARNI A, 1995, NATURE, V377, P155; Kettner RE, 1996, EXP BRAIN RES, V112, P347, DOI 10.1007/BF00227941; Lashley KS., 1951, PROBLEM SERIAL ORDER, V21; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Lu XF, 1998, J NEUROPHYSIOL, V79, P2245, DOI 10.1152/jn.1998.79.5.2245; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; LURITO JT, 1991, EXP BRAIN RES, V87, P562; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PELLIZZER G, 1995, SCIENCE, V269, P702, DOI 10.1126/science.7624802; Schlag JD, 2002, NEURON, V34, P177, DOI 10.1016/S0896-6273(02)00668-2; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Taira M, 1996, EXP BRAIN RES, V109, P367; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462	37	91	94	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					967	973		10.1016/j.neuron.2005.01.036	http://dx.doi.org/10.1016/j.neuron.2005.01.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797556	Bronze			2022-12-28	WOS:000228031300016
J	Grudzinska, J; Schemm, R; Haeger, S; Nicke, A; Schmalzing, G; Betz, H; Laube, B				Grudzinska, J; Schemm, R; Haeger, S; Nicke, A; Schmalzing, G; Betz, H; Laube, B			The beta subunit determines the ligand binding properties of synaptic glycine receptors	NEURON			English	Article							D-ASPARTATE RECEPTOR; GATED ION CHANNELS; NICOTINIC ACETYLCHOLINE-RECEPTOR; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURES; AGONIST-BINDING; MESSENGER-RNAS; SPASTIC MOUSE; M3-M4 LOOP; RAT-BRAIN	Inhibitory glycine receptors (GlyRs) regulate motor coordination and sensory signal processing in spinal cord and other brain regions. GlyRs are pentameric proteins composed of membrane-spanning alpha and beta subunits. Here, site-directed mutagenesis combined with homology modeling based on the crystal structure of the acetylcholine binding protein identified key ligand binding residues of recombinant homooligomeric alpha1beta and heterooligomeric alpha1beta GlyRs. This disclosed two highly conserved, oppositely charged residues located on adjacent subunit interfaces as being crucial for agonist binding. In addition, the P subunit was found to determine the ligand binding properties of heterooligomeric GlyRs. Expression of an alp tandem construct and affinity purification of metabolically labeled GlyRs confirmed a subunit stoichionnetry of 2alpha3beta. Because the beta subunit anchors GlyRs at synaptic sites, our results have important implications for the biosynthesis, clustering, and pharmacology of synaptic GlyRs.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Rhein Westfal TH Aachen, Sch Med, Dept Mol Pharmacol, D-52074 Aachen, Germany	Max Planck Society; RWTH Aachen University	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de		Nicke, Annette/0000-0001-6798-505X				Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; BECKER CM, 1992, HDB EXPT PHARM, P539; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2003, RECEPTOR CHANNEL, V9, P353, DOI 10.3109/714041016; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chattipakorn SC, 2002, J NEUROPHYSIOL, V87, P1515, DOI 10.1152/jn.00365.2001; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2004, TRENDS NEUROSCI, V27, P337, DOI 10.1016/j.tins.2004.04.010; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; FUJITA M, 1991, BRAIN RES, V560, P23, DOI 10.1016/0006-8993(91)91210-R; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Hartenstein B, 1996, EMBO J, V15, P1275, DOI 10.1002/j.1460-2075.1996.tb00469.x; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2000, J PHYSIOL-LONDON, V522, P215, DOI 10.1111/j.1469-7793.2000.t01-1-00215.x; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Maksay G, 2003, J RECEPT SIG TRANSD, V23, P255, DOI 10.1081/RRS-120025568; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; PULLAN LM, 1992, NEUROSCI LETT, V148, P199, DOI 10.1016/0304-3940(92)90838-X; Racca C, 1997, J NEUROSCI, V17, P1691; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; Rees MI, 2002, HUM MOL GENET, V11, P853, DOI 10.1093/hmg/11.7.853; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; Schofield PR, 2002, ADV NEUROL, V89, P263; Singer JH, 2000, BRAIN RES BULL, V53, P553, DOI 10.1016/S0361-9230(00)00389-0; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; Wittekindt B, 2001, NEUROPHARMACOLOGY, V41, P753, DOI 10.1016/S0028-3908(01)00112-5; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	59	290	299	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					727	739		10.1016/j.neuron.2005.01.028	http://dx.doi.org/10.1016/j.neuron.2005.01.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748848	Bronze			2022-12-28	WOS:000227446700012
J	Schultz, J; Friston, KJ; O'Doherty, J; Wolpert, DM; Frith, CD				Schultz, J; Friston, KJ; O'Doherty, J; Wolpert, DM; Frith, CD			Activation in posterior superior temporal sulcus parallels parameter inducing the percept of animacy	NEURON			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; BIOLOGICAL MOTION; FUNCTIONAL MRI; NEURAL BASIS; HUMAN BRAIN; NEURONS; MOVEMENT; MACAQUE; OBJECT	An essential, evolutionarily stable feature of brain function is the detection of animate entities, and one of the main cues to identify them is their movement. We developed a model of a simple interaction between two objects, in which an increase of the correlation between their movements varied the amount of interactivity and animacy observers attributed to them. Functional magnetic resonance imaging revealed that activation in the posterior superior temporal sulcus and gyrus (pSTS/pSTG) increased in relation to the degree of correlated motion between the two objects. This activation increase was not different when subjects performed an explicit or implicit task while observing these interacting objects. These data suggest that the pSTS and pSTG play a role in the automatic identification of animate entities, by responding directly to an objective movement characteristic inducing the percept of animacy, such as the amount of interactivity between two moving objects.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Schultz, J (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	johannes.schultz@tuebingen.mpg.de	Friston, Karl/D-9230-2011; Schultz, Johannes/B-8613-2012; O'Doherty, John P/F-1204-2013; Frith, Chris D/A-2171-2009	Friston, Karl/0000-0001-7984-8909; Schultz, Johannes/0000-0003-4117-232X; Frith, Chris D/0000-0002-8665-0690; Wolpert, Daniel/0000-0003-2011-2790				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; BASSILI JN, 1976, J PERS SOC PSYCHOL, V33, P680; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Blythe P. W., 1999, SIMPLE HEURISTICS MA, P257; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Duvernoy HM, 1999, HUMAN BRAIN; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Johnson SC, 2003, PHILOS T R SOC B, V358, P549, DOI 10.1098/rstb.2002.1237; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; Nielsen JM, 1958, MEMORY AMNESIA; Opfer JE, 2002, COGNITION, V86, P97, DOI 10.1016/S0010-0277(02)00171-3; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; PERANI D, 1995, NEUROREPORT, V6, P1637, DOI 10.1097/00001756-199508000-00012; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Tremoulet PD, 2000, PERCEPTION, V29, P943, DOI 10.1068/p3101; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257	54	143	145	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					625	635		10.1016/j.neuron.2004.12.052	http://dx.doi.org/10.1016/j.neuron.2004.12.052			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721247	Bronze			2022-12-28	WOS:000227099700017
J	Grant, KA; Raible, DW; Piotrowski, T				Grant, KA; Raible, DW; Piotrowski, T			Regulation of latent sensory hair cell precursors by glia in the zebrafish lateral line	NEURON			English	Article							NEURAL-CREST; POSTEMBRYONIC DEVELOPMENT; CAGED FLUORESCEIN; NERVOUS-SYSTEM; SCHWANN-CELL; DANIO-RERIO; FATE; NEUROGENIN1; MUTATIONS; MIGRATION	The lateral line is a placodally derived mechanosensory organ in anamniotes that detects the movement of water. In zebrafish embryos, a migrating primordium deposits seven to nine clusters of sensory hair cells, or neuromasts, at intervals along the trunk. Post-embryonically, neuromasts continue to be added. We show that some secondary neuromasts arise from a pool of latent precursors that are deposited by the primordium between primary neuromasts. Interneuromast cells lie adjacent to the lateral line nerve and associated glia. These cells remain quiescent while they are juxtaposed with the glia; however, when they move away from the nerve they increase proliferation and form neuromasts. If glia are manually removed or genetically ablated by mutations in cis/sox10, hypersensitive (hps), or rowgain (rog), neuromasts precociously differentiate. Transplantation of wt glia into mutants rescues the appropriate temporal differentiation of interneuromast cells. Our studies reveal a role for glia in regulating sensory hair cell precursors.	NICHD, NIH, LMG, Bethesda, MD 20892 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Cell & Mol Biol Program, Seattle, WA 98195 USA; Univ Utah, Dept Anat & Neurobiol, Salt Lake City, UT 84132 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah	Raible, DW (corresponding author), NICHD, NIH, LMG, Bethesda, MD 20892 USA.	draible@u.washington.edu; piotrowski@neuro.utah.edu		Raible, David/0000-0002-5342-5841	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005987] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007183, 5 T32 HD07183-25] Funding Source: Medline; NIDCD NIH HHS [DC005987] Funding Source: Medline; NINDS NIH HHS [NS35833] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Blader P, 1997, DEVELOPMENT, V124, P4557; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; COLLAZO A, 1994, SCIENCE, V264, P426, DOI 10.1126/science.8153631; Cooper KL, 2003, DEV BIOL, V253, P200, DOI 10.1016/S0012-1606(02)00018-0; Cornell RA, 2002, DEVELOPMENT, V129, P2639; DUTTON K, 2001, DEVELOPMENT, V128, P2809; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Gompel N, 2001, DEVELOPMENT, V128, P387; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; HAECKEL E, 1875, JENA Z NATURWISS, V9, P401; HALL BK, 1990, CLEFT PALATE J, V27, P95, DOI 10.1597/1545-1569(1990)027<0095:EIICB>2.3.CO;2; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kos R, 2001, DEVELOPMENT, V128, P1467; Kozlowski DJ, 2000, METH MOL B, V135, P349; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Ledent V, 2002, DEVELOPMENT, V129, P597; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; NORTHCUTT RG, 1994, J COMP NEUROL, V340, P480, DOI 10.1002/cne.903400404; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Pichon F, 2004, EVOL DEV, V6, P187, DOI 10.1111/j.1525-142X.2004.04024.x; Piotrowski T, 1996, BRAIN BEHAV EVOLUT, V47, P55, DOI 10.1159/000113229; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; PLATT JB, 1896, Q J MICROSC SCI, V38, P485; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Raible DW, 1996, DEVELOPMENT, V122, P501; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Sahly I, 1999, DEV GENES EVOL, V209, P399, DOI 10.1007/s004270050270; Sapede D, 2002, DEVELOPMENT, V129, P605; Schulze F., 1861, ARCH ANAT PHYSL, V3, P759; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stone LS, 1935, P SOC EXP BIOL MED, V33, P80; Stone LS, 1922, J EXP ZOOL, V35, P421; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Whitfield TT, 1996, DEVELOPMENT, V123, P241; WINKLBAUER R, 1989, PROG NEUROBIOL, V32, P181, DOI 10.1016/0301-0082(89)90016-6; WOO K, 1995, DEVELOPMENT, V121, P2595	56	95	98	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					69	80		10.1016/j.neuron.2004.12.020	http://dx.doi.org/10.1016/j.neuron.2004.12.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629703	Bronze			2022-12-28	WOS:000226217100010
J	Kettunen, P; Kyriakatos, A; Hallen, K; El Manira, A				Kettunen, P; Kyriakatos, A; Hallen, K; El Manira, A			Neuromodulation via conditional release of endocannabinoids in the spinal locomotor network	NEURON			English	Article							ENDOGENOUS CANNABINOIDS; FICTIVE LOCOMOTION; RETROGRADE INHIBITION; PATTERN GENERATION; MOTOR-NEURONS; CORD INVITRO; LAMPREY; RECEPTORS; ACTIVATION; HIPPOCAMPUS	Endocannabinoids act as retrograde signals to modulate synaptic transmission. Little is known, however, about their significance in integrated network activity underlying motor behavior. We have examined the physiological effects of endocannabinoids in a neuronal network underlying locomotor behavior using the isolated lamprey spinal cord. Our results show that endocannabinoids are released during locomotor activity and participate in setting the baseline burst rate. They are released in response to mGluR1 activation and act as retrograde messengers. This conditional release of endocannabinoids can transform motoneurons and crossing interneurons into modulatory neurons by enabling them to regulate their inhibitory synaptic inputs and thus contribute to the modulation of the locomotor burst frequency. These results provide evidence that endocannabinoid retrograde signaling occurs within the locomotor network and contributes to motor pattern generation and regulation in the spinal cord.	Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden	Karolinska Institutet	El Manira, A (corresponding author), Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, S-17177 Stockholm, Sweden.	abdel.elmanira@neuro.ki.se	Kettunen, Petronella/AAF-7606-2019	Kettunen, Petronella/0000-0002-2510-3423; El Manira, Abdel/0000-0001-5920-9384				Alford S, 2003, NEUROSCIENTIST, V9, P217, DOI 10.1177/1073858403009003014; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Buchanan JT, 2001, PROG NEUROBIOL, V63, P441, DOI 10.1016/S0301-0082(00)00050-2; Cangiano L, 2003, J NEUROPHYSIOL, V89, P2931, DOI 10.1152/jn.01100.2002; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Clarac F, 2004, PROG BRAIN RES, V143, P57, DOI 10.1016/S0079-6123(03)43006-9; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; COHEN AH, 1984, BRAIN RES, V293, P164, DOI 10.1016/0006-8993(84)91464-1; COHEN AH, 1980, EXP BRAIN RES, V41, P11; Dale N, 1996, NATURE, V383, P259, DOI 10.1038/383259a0; Delgado-Lezama R, 1999, PROG BRAIN RES, V123, P57, DOI 10.1016/S0079-6123(08)62844-7; El Manira A, 2002, BRAIN RES REV, V40, P9, DOI 10.1016/S0165-0173(02)00184-4; ElManira A, 1997, J NEUROPHYSIOL, V78, P1334; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GRILLNER S, 1981, ACTA PHYSIOL SCAND, V113, P549, DOI 10.1111/j.1748-1716.1981.tb06937.x; Grillner S, 2002, BRAIN RES REV, V40, P92, DOI 10.1016/S0165-0173(02)00193-5; GRILLNER S, 1980, ACTA PHYSIOL SCAND, V110, P103, DOI 10.1111/j.1748-1716.1980.tb06637.x; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; Kettunen P, 2003, J NEUROPHYSIOL, V90, P2341, DOI 10.1152/jn.01132.2002; Kettunen P, 2002, J NEUROSCI, V22, P1868, DOI 10.1523/JNEUROSCI.22-05-01868.2002; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kim J, 2002, J NEUROSCI, V22, P10182; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Krieger P, 1996, J NEUROPHYSIOL, V76, P3834, DOI 10.1152/jn.1996.76.6.3834; Krieger P, 2000, J NEUROSCI, V20, P5382, DOI 10.1523/JNEUROSCI.20-14-05382.2000; Krieger P, 1998, EUR J NEUROSCI, V10, P3333, DOI 10.1046/j.1460-9568.1998.00337.x; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; MANGAN PS, 1994, J COMP PHYSIOL A, V175, P709, DOI 10.1007/BF00191843; MCPHERSON DR, 1994, J COMP PHYSIOL A, V175, P311; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Roberts A, 1995, J PHYSIOL-PARIS, V89, P241, DOI 10.1016/0928-4257(96)83640-0; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; Sillar KT, 1998, ANN NY ACAD SCI, V860, P318, DOI 10.1111/j.1749-6632.1998.tb09059.x; Sugiura T, 2002, PROSTAG LEUKOTR ESS, V66, P173, DOI 10.1054/plef.2001.0356; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	48	55	58	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					95	104		10.1016/j.neuron.2004.12.022	http://dx.doi.org/10.1016/j.neuron.2004.12.022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629705	Bronze			2022-12-28	WOS:000226217100012
J	Ryu, JB; Liu, LD; Wong, TP; Wu, DC; Burette, A; Weinberg, R; Wang, YT; Sheng, M				Ryu, JB; Liu, LD; Wong, TP; Wu, DC; Burette, A; Weinberg, R; Wang, YT; Sheng, M			A critical role for myosin IIB in dendritic spine morphology and synaptic function	NEURON			English	Article							HEAVY-CHAIN GENE; LIGHT-CHAIN; ACTIN; EXPRESSION; PLASTICITY; DYNAMICS; BLEBBISTATIN; INHIBITOR; RECEPTORS; MOTILITY	Dendritic spines show rapid motility and plastic morphology, which may mediate information storage in the brain. It is presently believed that polymerization/ depolymerization of actin is the primary determinant of spine motility and morphogenesis. Here, we show that myosin IIB, a molecular motor that binds and contracts actin filaments, is essential for normal spine morphology and dynamics and represents a distinct biophysical pathway to control spine size and shape. Myosin IIB is enriched in the postsynaptic density (PSD) of neurons. Pharmacologic or genetic inhibition of myosin IIB alters protrusive motility of spines, destabilizes their classical mushroom-head morphology, and impairs excitatory synaptic transmission. Thus, the structure and function of spines is regulated by an actin-based motor in addition to the polymerization state of actin.	MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, RIKEN,Nueorsci Res Ctr, Cambridge, MA 02139 USA; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, RIKEN,Nueorsci Res Ctr, Cambridge, MA 02139 USA.	msheng@mit.edu	Wang, Yu Tian/A-4729-2008; Weinberg, Richard/AAC-1898-2020; Wang, Yu Tian/J-8255-2015; Wu, Dong Chuan/O-3909-2015	Wong, Tak Pan/0000-0001-8611-4911; WU, DONG CHUAN/0000-0002-9539-5935; Liu, Lidong/0000-0002-7026-690X; Weinberg, Richard/0000-0001-9689-7278; Sheng, Morgan/0000-0002-8703-5366				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Amparan D, 2005, J NEUROCHEM, V92, P349, DOI 10.1111/j.1471-4159.2004.02869.x; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Dailey ME, 1996, J NEUROSCI, V16, P2983; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hering H, 2003, J NEUROSCI, V23, P11759; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; SUZUKI H, 1978, J BIOCHEM, V84, P1529, DOI 10.1093/oxfordjournals.jbchem.a132278; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; WATTS FZ, 1987, EMBO J, V6, P3499, DOI 10.1002/j.1460-2075.1987.tb02675.x; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	48	129	131	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					175	182		10.1016/j.neuron.2005.12.017	http://dx.doi.org/10.1016/j.neuron.2005.12.017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423692	Green Submitted, Bronze			2022-12-28	WOS:000234979900005
J	Prado, J; Clavagnier, S; Otzenberger, H; Scheiber, C; Kennedy, H; Perenin, MT				Prado, J; Clavagnier, S; Otzenberger, H; Scheiber, C; Kennedy, H; Perenin, MT			Two cortical systems for reaching in central and peripheral vision	NEURON			English	Article							EYE-HAND COORDINATION; POSTERIOR PARIETAL CORTEX; OPTIC ATAXIA; HUMAN INTRAPARIETAL; FUNCTIONAL-ANATOMY; VISUAL SPACE; MOVEMENTS; GAZE; TARGET; AREA	Parietal lesions in humans can produce a specific disruption of visually guided hand movement, termed optic ataxia. The fact that the deficit mainly occurs in peripheral vision suggests that reaching in foveal and extrafoveal vision rely on two different neural substrates. In the present study, we have directly tested this hypothesis by event-related fMRI in healthy subjects. Brain activity was measured when participants reached toward central or peripheral visual targets. Our results confirm the existence of two systems, differently modulated by the two conditions. Reaching in central vision involved a restricted network including the medial intraparietal sulcus (mIPS) and the caudal part of the dorsal premotor cortex (PMd). Reaching in peripheral vision activated in addition the parietooccipital junction (POJ) and a more rostral part of PMd. These results show that reaching to the peripheral visual field engages a more extensive cortical network than reaching to the central visual field.	INSERM, U371, Dept Cognit Neurosci, F-69675 Bron, France; Univ Lyon 1, Inst Federatif Neurosci IFR19, F-69675 Bron, France; CNRS, UMR 7004, Lab Neuroimagerie In Vivo, F-67085 Strasbourg, France; Univ Strasbourg, Fac Med, F-67085 Strasbourg, France; CNRS, UMR 5015, Inst Cognit Sci, F-69675 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS)	Prado, J (corresponding author), INSERM, U371, Dept Cognit Neurosci, F-69675 Bron, France.	jprado@isc.cnrs.fr; clavagnier@lyon.inserm.fr; perenin@lyon.inserm.fr	Kennedy, Henry/B-9636-2013; Prado, Jérôme/D-5581-2013; Scheiber, Christian/O-3259-2017	Kennedy, Henry/0000-0002-2796-7663; Prado, Jérôme/0000-0003-3548-5610; Clavagnier, Simon/0000-0002-1425-4584				Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Blouin J, 2002, EXP BRAIN RES, V144, P281, DOI 10.1007/s00221-002-1029-5; BLOUIN J, 1995, NEUROSCI LETT, V183, P187, DOI 10.1016/0304-3940(94)11147-B; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; Carey DP, 2002, PROG BRAIN RES, V140, P311; Carey DP, 1997, CORTEX, V33, P639, DOI 10.1016/S0010-9452(08)70722-6; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Dechent P, 2003, EUR J NEUROSCI, V17, P2201, DOI 10.1046/j.1460-9568.2003.02645.x; DEGRAAF JB, 1995, NEUROREPORT, V6, P1733, DOI 10.1097/00001756-199509000-00007; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Desmurget M, 2001, J NEUROSCI, V21, P2919, DOI 10.1523/JNEUROSCI.21-08-02919.2001; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; FISK JD, 1985, EXP BRAIN RES, V60, P159; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2003, EXP BRAIN RES, V152, P70, DOI 10.1007/s00221-003-1523-4; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Hoffmann A, 2000, MAGNET RESON MED, V44, P791, DOI 10.1002/1522-2594(200011)44:5<791::AID-MRM17>3.0.CO;2-2; Inoue K, 1998, J NEUROPHYSIOL, V79, P117, DOI 10.1152/jn.1998.79.1.117; Jackson SR, 2005, CURR BIOL, V15, P42, DOI 10.1016/S0960-9822(04)01046-2; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Kawashima R, 1996, NEUROREPORT, V7, P1253, DOI 10.1097/00001756-199605170-00006; Khan AZ, 2005, CEREB CORTEX, V15, P1547, DOI 10.1093/cercor/bhi033; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Matelli M, 1998, J COMP NEUROL, V402, P327; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Milner AD, 1999, P ROY SOC B-BIOL SCI, V266, P2225, DOI 10.1098/rspb.1999.0912; Neggers SFW, 1999, EXP BRAIN RES, V125, P97, DOI 10.1007/s002210050663; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Sailer U, 2000, EXP BRAIN RES, V134, P163, DOI 10.1007/s002210000457; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Donkelaar P, 2000, J NEUROPHYSIOL, V84, P1677, DOI 10.1152/jn.2000.84.3.1677; van Donkelaar P, 2000, EXP BRAIN RES, V133, P414, DOI 10.1007/s002210000422; van Donkelaar P, 2005, J MOTOR BEHAV, V37, P157, DOI 10.3200/JMBR.37.2.157-163; vanDonkelaar P, 1997, NEUROREPORT, V8, P2139, DOI 10.1097/00001756-199707070-00010; VERCHER JL, 1994, EXP BRAIN RES, V99, P507	55	242	245	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					849	858		10.1016/j.neuron.2005.10.010	http://dx.doi.org/10.1016/j.neuron.2005.10.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337921	Bronze			2022-12-28	WOS:000233927300022
J	Buchsbaum, BR; Olsen, RK; Koch, P; Berman, KF				Buchsbaum, BR; Olsen, RK; Koch, P; Berman, KF			Human dorsal and ventral auditory streams subserve rehearsal-based and echoic processes during verbal working memory	NEURON			English	Article							SHORT-TERM-MEMORY; PRECATEGORICAL ACOUSTIC STORAGE; POSITRON-EMISSION-TOMOGRAPHY; SUPERIOR TEMPORAL GYRUS; EVENT-RELATED FMRI; SPEECH-PERCEPTION; FUNCTIONAL NEUROANATOMY; SELECTIVE IMPAIRMENT; EPISODIC RETRIEVAL; EXECUTIVE CONTROL	To hear a sequence of words and repeat them requires sensory-motor processing and something more-temporary storage. We investigated neural mechanisms of verbal memory by using fMRI and a task designed to tease apart perceptually based ("echoic") memory from phonological-articulatory memory. Sets of two- or three-word pairs were presented bimodally, followed by a cue indicating from which modality (auditory or visual) items were to be retrieved and rehearsed over a delay. Although delay-period activation in the planum temporale (PT) was insensible to the source modality and showed sustained delay-period activity, the superior temporal gyrus (STG) activated more vigorously when the retrieved items had arrived to the auditory modality and showed transient delay-period activity. Functional connectivity analysis revealed two topographically distinct fronto-temporal circuits, with STG coactivating more strongly with ventrolateral prefrontal cortex and PT coactivating more strongly with dorsolateral prefrontal cortex. These argue for separate contributions of ventral and dorsal auditory streams in verbal working memory.	NIMH, Sect Integrat Neuroimaging, Clin Brain Disorders Branch,Dept Hlth & Human Ser, NIH,Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Buchsbaum, BR (corresponding author), NIMH, Sect Integrat Neuroimaging, Clin Brain Disorders Branch,Dept Hlth & Human Ser, NIH,Intramural Res Program, Bethesda, MD 20892 USA.	buchsbab@intra.nimh.nih.gov		Olsen, Rosanna/0000-0002-2918-4152	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Baddeley A.D., 1986, WORKING MEMORY THOUG; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BROADBENT DE, 1956, Q J EXP PSYCHOL, V8, P145, DOI 10.1080/17470215608416814; Buchsbaum BR, 2005, NEUROIMAGE, V24, P444, DOI 10.1016/j.neuroimage.2004.08.025; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; CROWDER RG, 1969, PERCEPT PSYCHOPHYS, V5, P365, DOI 10.3758/BF03210660; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Fiez JA, 1996, J NEUROSCI, V16, P808; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FRANKISH C, 1989, J EXP PSYCHOL LEARN, V15, P469, DOI 10.1037/0278-7393.15.3.469; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jonides J, 1998, J NEUROSCI, V18, P5026; Kraus N, 2005, TRENDS NEUROSCI, V28, P176, DOI 10.1016/j.tins.2005.02.003; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Loader C., 1999, LOCAL REGRESSION LIK; LU ZL, 1992, BRAIN RES, V572, P236, DOI 10.1016/0006-8993(92)90475-O; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Martin N, 2002, APHASIOLOGY, V16, P107, DOI 10.1080/02687040143000447; Milner A. D., 1995, VISUAL BRAIN ACTION; Mustovic H, 2003, NEUROIMAGE, V20, P429, DOI 10.1016/S1053-8119(03)00293-3; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; Pinheiro J, 2001, MIXED EFFECTS MODELS; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Postle BR, 2003, CORTEX, V39, P927, DOI 10.1016/S0010-9452(08)70871-2; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; Ramsay J.O., 1997, FUNCTIONAL DATA ANAL; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schubotz RI, 2003, NEUROIMAGE, V20, P173, DOI 10.1016/S1053-8119(03)00218-0; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHALLICE T, 1977, BRAIN LANG, V4, P479, DOI 10.1016/0093-934X(77)90040-2; SHIFFRIN RM, 1969, PSYCHOL REV, V76, P179, DOI 10.1037/h0027277; Stevens AA, 2004, COGNITIVE BRAIN RES, V18, P162, DOI 10.1016/j.cogbrainres.2003.10.008; Takayama Y, 2004, EUR NEUROL, V51, P115, DOI 10.1159/000076792; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; WATKINS MJ, 1973, J EXP PSYCHOL, V99, P226, DOI 10.1037/h0034651; WATKINS OC, 1980, J EXP PSYCHOL GEN, V109, P251, DOI 10.1037/0096-3445.109.3.251; WENICKE C, 1874, WERNICKES WORKS APHA, P91; Wilson M, 2001, PSYCHOL BULL, V127, P543, DOI 10.1037/0033-2909.127.4.543; Winkler I, 2005, EXP PSYCHOL, V52, P3, DOI 10.1027/1618-3169.52.1.3; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83	63	198	199	1	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 23	2005	48	4					687	697		10.1016/j.neuron.2005.09.029	http://dx.doi.org/10.1016/j.neuron.2005.09.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301183	Bronze			2022-12-28	WOS:000233677300020
J	Phelps, EA; LeDoux, JE				Phelps, EA; LeDoux, JE			Contributions of the amygdala to emotion processing: From animal models to human behavior	NEURON			English	Review							MEDIAL PREFRONTAL CORTEX; HUMAN-MEMORY CONSOLIDATION; FEAR-POTENTIATED STARTLE; CONDITIONED FEAR; LATERAL AMYGDALA; PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; TEMPORAL-LOBE; AFFECTIVE MODULATION; NEURONAL PLASTICITY	Research on the neural systems underlying emotion in animal models over the past two decades has implicated the amygdala in fear and other emotional processes. This work stimulated interest in pursuing the brain mechanisms of emotion in humans. Here, we review research on the role of the amygdala in emotional processes in both animal models and humans. The review is not exhaustive, but it highlights five major research topics that illustrate parallel roles for the amygdala in humans and other animals, including implicit emotional learning and memory, emotional modulation of memory, emotional influences on attention and perception, emotion and social behavior, and emotion inhibition and regulation.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Phelps, EA (corresponding author), NYU, Dept Psychol, 4-6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			NIMH NIH HHS [MH46516, MH62104, MH38774, MH067048, MH58911] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, R01MH062104, R01MH038774, R37MH038774, P50MH058911, K05MH067048] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R, 2000, LEARN MEMORY, V7, P180, DOI 10.1101/lm.7.3.180; AGGLETON JP, 1986, EMOTION THEORY RES E, V3, P281; Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2002, J COGNITIVE NEUROSCI, V14, P709, DOI 10.1162/08989290260138618; Anderson AK, 2003, J NEUROSCI, V23, P5627; ANDERSON AK, 2004, 16 ANN M AM PSYCH SO; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; [Anonymous], [No title captured]; Armony J.L., 1999, COGNITIVE NEUROSCIEN; Armony JL, 1997, TRENDS COGN SCI, V1, P28, DOI 10.1016/S1364-6613(97)01007-3; BACHEVALIER J, 1994, NEUROPSYCHOLOGIA, V32, P627, DOI 10.1016/0028-3932(94)90025-6; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BERLYNE DE, 1968, PSYCHON SCI, V13, P103, DOI 10.3758/BF03342431; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Booth JR, 2002, HUM BRAIN MAPP, V16, P251, DOI 10.1002/hbm.10054; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Canli T, 2000, J NEUROSCI, V20; CARRASCO M, 2004, NEUROBIOLOGY ATTENTI; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; CHIBA AA, 1995, J NEUROSCI, V15, P7315; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Davis M, 2002, BIOL PSYCHIAT, V52, P998, DOI 10.1016/S0006-3223(02)01507-X; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Delgado M. R., 2004, 11 ANN M COGN NEUR S; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Garcia R, 2002, REV NEUROSCIENCE, V13, P195; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Heberlein AS, 2004, P NATL ACAD SCI USA, V101, P7487, DOI 10.1073/pnas.0308220101; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Johnsrude IS, 2000, J NEUROSCI, V20, P2649; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; KAPP B S, 1992, P229; KEMPER TL, 1993, NEUROL CLIN, V11, P175, DOI 10.1016/S0733-8619(18)30176-2; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; KLEINSMITH LJ, 1963, J EXP PSYCHOL, V65, P190, DOI 10.1037/h0040288; KLING A S, 1992, P353; Kluaver H., 1937, AM J PHYSIOL, V119, P352; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lattal KM, 2004, BEHAV BRAIN RES, V153, P327, DOI 10.1016/j.bbr.2003.12.009; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux J. E., 1996, EMOTIONAL BRAIN; LeDoux J.E., 2002, SYNAPTIC SELF OUR BR; LEDOUX JE, 1984, J NEUROSCI, V4, P683; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Meunier M, 1999, EUR J NEUROSCI, V11, P4403, DOI 10.1046/j.1460-9568.1999.00854.x; Meunier M, 2002, EMOTION, V2, P147, DOI 10.1037//1528-3542.2.2.147; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Morgan MA, 2003, BEHAV BRAIN RES, V146, P121, DOI 10.1016/j.bbr.2003.09.021; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; ONO T, 1992, P167; Packard MG, 2001, CURR OPIN NEUROBIOL, V11, P752, DOI 10.1016/S0959-4388(01)00280-X; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; PHELPS EA, 2005, IN PRESS PSYCHOL; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Radwanska K, 2002, NEUROREPORT, V13, P2241, DOI 10.1097/00001756-200212030-00015; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Riccio DC, 2002, INTEGR PHYS BEH SCI, V37, P245, DOI 10.1007/BF02734247; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; ROLLS ET, 1999, BRAIN EMOTION; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; ROSVOLD HE, 1954, J COMP PHYSIOL PSYCH, V47, P173, DOI 10.1037/h0058870; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHACTER DL, 1996, NATURE, V380, P214; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Squire LR., 1999, MEMORY MIND MOL; Sullivan GM, 2004, NEUROSCIENCE, V128, P7, DOI 10.1016/j.neuroscience.2004.06.015; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Weinberger N. M., 1990, LEARNING COMPUTATION, P91; Weinberger Norman M., 1995, P1071; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Zola-Morgan S, 1991, Hippocampus, V1, P207, DOI 10.1002/hipo.450010208	169	2071	2114	10	477	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					175	187		10.1016/j.neuron.2005.09.025	http://dx.doi.org/10.1016/j.neuron.2005.09.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242399	Bronze, Green Published			2022-12-28	WOS:000232838700008
J	Calabrese, B; Halpain, S				Calabrese, B; Halpain, S			Essential role for the PKC target MARCKS in maintaining dendritic spine morphology	NEURON			English	Article							PROTEIN-KINASE-C; LONG-TERM DEPRESSION; ACTIN-BASED PLASTICITY; SUBSTRATE MARCKS; GLUTAMATE RECEPTORS; 87-KDA PROTEIN; RICH; PHOSPHORYLATION; EXPRESSION; ACTIVATION	Spine morphology is regulated by intracellular signals, like PKC, that affect cytoskeletal and membrane dynamics. We investigated the role of MARCKS (myristoylated, alanine-rich C-kinase substrate) in dendrites of 3-week-old hippocampal cultures. MARCKS associates with membranes via the combined action of myristoylation and a polybasic effector domain, which binds phospholipids and/or F-actin, unless phosphorylated by PKC. Knockdown of endogenous MARCKS using RNAi reduced spine density and size. PKC activation induced similar effects, which were prevented by expression of a nonphosphorylatable mutant. Moreover, expression of pseudophosphorylated MARCKS was, by itself, sufficient to induce spine loss and shrinkage, accompanied by reduced F-actin content. Nonphosphorylatable MARCKS caused spine elongation and increased the mobility of spine actin clusters. Surprisingly, it also decreased spine density via a novel mechanism of spine fusion, an effect that required the myristoylation sequence. Thus, MARCKS is a key factor in the maintenance of dendritic spines and contributes to PKC-dependent morphological plasticity.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Halpain, S (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	shelley@scripps.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037311] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH050861] Funding Source: Medline; NINDS NIH HHS [R01 NS037311, NS37311] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; BHAT NR, 1995, DEV NEUROSCI-BASEL, V17, P256, DOI 10.1159/000111294; Blackshear PJ, 1997, EXP NEUROL, V145, P46, DOI 10.1006/exnr.1997.6475; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Disatnik MH, 2002, J CELL SCI, V115, P2151; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Halpain S, 1998, J NEUROSCI, V18, P9835; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; Kim SS, 2002, J CELL SCI, V115, P2465; Kimura T, 2000, NEUROREPORT, V11, P869, DOI 10.1097/00001756-200003200-00042; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; McNamara RK, 1999, J CLIN PSYCHIAT, V60, P21; McNamara RK, 1999, J CLIN PSYCHIAT S2, V60, P113; Michaut MA, 2005, DEV BIOL, V280, P26, DOI 10.1016/j.ydbio.2005.01.006; Monfils MH, 2004, SYNAPSE, V53, P114, DOI 10.1002/syn.20039; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; OUIMET CC, 1990, J NEUROSCI, V10, P1683; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Pandey GN, 2003, J PSYCHIATR RES, V37, P421, DOI 10.1016/S0022-3956(03)00047-5; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Richards DA, 2004, J PHYSIOL-LONDON, V558, P503, DOI 10.1113/jphysiol.2004.062091; ROBINSON PJ, 1991, MOL NEUROBIOL, V5, P87, DOI 10.1007/BF02935541; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; Scarlett CO, 2003, DEV BRAIN RES, V144, P25, DOI 10.1016/S0165-3806(03)00155-x; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; Shiraishi Y, 2003, MOL CELL NEUROSCI, V22, P188, DOI 10.1016/S1044-7431(03)00037-X; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Swierczynski SL, 1996, J BIOL CHEM, V271, P23424, DOI 10.1074/jbc.271.38.23424; VACCARINO FM, 1991, J NEUROCHEM, V57, P391, DOI 10.1111/j.1471-4159.1991.tb03765.x; VERGHESE GM, 1994, J BIOL CHEM, V269, P9361; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; Wang L, 2001, J NEUROCHEM, V79, P816, DOI 10.1046/j.1471-4159.2001.00631.x; Wu J, 2004, NEUROSCIENCE, V123, P507, DOI 10.1016/j.neuroscience.2003.09.013; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	57	150	153	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					77	90		10.1016/j.neuron.2005.08.027	http://dx.doi.org/10.1016/j.neuron.2005.08.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202710	Bronze			2022-12-28	WOS:000232625700011
J	Li, N; Angelaki, DE				Li, N; Angelaki, DE			Updating visual space during motion in depth	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; STIMULATION-INDUCED PERTURBATIONS; POSTERIOR PARIETAL CORTEX; MEMORY-GUIDED SACCADES; HUMAN SPATIAL MEMORY; SMOOTH-PURSUIT; LINEAR DISPLACEMENT; 3-DIMENSIONAL SPACE; TARGETS; SIGNALS	Whether we are riding in a car or walking, our internal map of the environment must be continuously updated to maintain spatial constancy. Using a memory eye movement task, we examined whether nonhuman primates can keep track of changes in the distance of nearby objects when moved toward or away from them. We report that memory-guided eye movements take into account the change in distance traveled, illustrating that monkeys can update retinal disparity information in order to reconstruct three-dimensional visual space during motion in depth. This ability was compromised after destruction of the vestibular labyrinths, suggesting that the extraretinal signals needed for updating can arise from vestibular information signaling self-motion through space.	Washington Univ, Sch Med, Dept Neurobiol & Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Neurobiol & Biomed Engn, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu			NEI NIH HHS [EY12814] Funding Source: Medline; NIDCD NIH HHS [DC04260] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004260] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Angelaki DE, 2000, J NEUROPHYSIOL, V83, P1637, DOI 10.1152/jn.2000.83.3.1637; Angelaki DE, 1998, J NEUROPHYSIOL, V80, P680, DOI 10.1152/jn.1998.80.2.680; Baker JT, 2003, J NEUROPHYSIOL, V89, P2564, DOI 10.1152/jn.00610.2002; BERTHOZ A, 1995, SCIENCE, V269, P95, DOI 10.1126/science.7604286; Blohm G, 2005, J NEUROPHYSIOL, V93, P1510, DOI 10.1152/jn.00543.2004; Blohm G, 2003, J NEUROPHYSIOL, V89, P1423, DOI 10.1152/jn.00675.2002; Bloomberg J, 1988, Adv Otorhinolaryngol, V41, P71; COLBY CL, 1993, PROG BRAIN RES, V95, P307, DOI 10.1016/S0079-6123(08)60378-7; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Fukushima K, 2002, NATURE, V419, P157, DOI 10.1038/nature00953; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Gnadt JW, 1998, NEUROREPORT, V9, P233, DOI 10.1097/00001756-199801260-00011; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Herter TM, 1998, J NEUROPHYSIOL, V80, P2785, DOI 10.1152/jn.1998.80.5.2785; ISRAEL I, 1993, J NEUROPHYSIOL, V70, P1270, DOI 10.1152/jn.1993.70.3.1270; ISRAEL I, 1989, J NEUROPHYSIOL, V62, P247, DOI 10.1152/jn.1989.62.1.247; Israel I, 1999, NEUROREPORT, V10, P3479, DOI 10.1097/00001756-199911260-00003; Klier EM, 2005, J NEUROPHYSIOL, V94, P468, DOI 10.1152/jn.00700.2004; Li N, 2005, J NEUROPHYSIOL, V94, P722, DOI 10.1152/jn.01339.2004; MAXWELL JS, 1992, J NEUROPHYSIOL, V68, P1248, DOI 10.1152/jn.1992.68.4.1248; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; MCKENZIE A, 1986, J NEUROPHYSIOL, V56, P196, DOI 10.1152/jn.1986.56.1.196; Medendorp WP, 2003, J NEUROSCI, V23, P8135; Medendorp WP, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0006.2002; Newlands SD, 2001, EXP BRAIN RES, V140, P25, DOI 10.1007/s002210100810; OHTSUKA K, 1994, INVEST OPHTH VIS SCI, V35, P509; PELISSON D, 1989, EXP BRAIN RES, V78, P654; POGGIO GF, 1995, CEREB CORTEX, V5, P193, DOI 10.1093/cercor/5.3.193; Quaia C, 1998, NEURAL NETWORKS, V11, P1229, DOI 10.1016/S0893-6080(98)00069-0; SCHLAG J, 1990, J NEUROPHYSIOL, V64, P575, DOI 10.1152/jn.1990.64.2.575; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624; Zivotofsky AZ, 1996, J NEUROPHYSIOL, V76, P3617, DOI 10.1152/jn.1996.76.6.3617	41	26	26	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					149	158		10.1016/j.neuron.2005.08.021	http://dx.doi.org/10.1016/j.neuron.2005.08.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202715	Bronze			2022-12-28	WOS:000232625700016
J	Matus, A				Matus, A			MARCKS for maintenance in dendritic spines	NEURON			English	Editorial Material							ACTIN-BASED PLASTICITY; HIPPOCAMPUS; MOTILITY; RAFTS; RICH	Synapses in the brain must maintain a balance between learning-related plasticity and the stability necessary for reliable function. In this issue of Neuron, Calabrese and Halpain describe cell-transfection experiments implicating MARCKS, a protein that binds to both the cell surface and actin cytoskeleton, in the maintenance of dendritic spines.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Matus, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.							Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Hering H, 2003, J NEUROSCI, V23, P3262; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; McNamara RK, 2005, HIPPOCAMPUS, V15, P675, DOI 10.1002/hipo.20089; Richards DA, 2004, J PHYSIOL-LONDON, V558, P503, DOI 10.1113/jphysiol.2004.062091; SHEU FS, 1993, P NATL ACAD SCI USA, V90, P2705, DOI 10.1073/pnas.90.7.2705	12	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 6	2005	48	1					4	5		10.1016/j.neuron.2005.09.013	http://dx.doi.org/10.1016/j.neuron.2005.09.013			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202702	Bronze			2022-12-28	WOS:000232625700002
J	Beffert, U; Weeber, EJ; Durudas, A; Qiu, SF; Masiulis, I; Sweatt, JD; Li, WP; Adelmann, G; Frotscher, M; Hammer, RE; Herz, J				Beffert, U; Weeber, EJ; Durudas, A; Qiu, SF; Masiulis, I; Sweatt, JD; Li, WP; Adelmann, G; Frotscher, M; Hammer, RE; Herz, J			Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2	NEURON			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; CA3 NMDA RECEPTORS; TYROSINE PHOSPHORYLATION; BRAIN-DEVELOPMENT; BINDING DOMAIN; VLDL RECEPTOR; DISABLED 1; MOUSE; EXPRESSION	Apolipoprotein E receptor 2 (Apoer2), a member of the LDL receptor gene family, and its ligand Reelin control neuronal migration during brain development. Apoer2 is also essential for induction of long-term potentiation (LTP) in the adult brain. Here we show that Apoer2 is present in the postsynaptic densities of excitatory synapses where it forms a functional complex with NMDA receptors. Reelin signaling through Apoer2 markedly enhances LTP through a mechanism that requires the presence of amino acids encoded by an exon in the intracellular domain of Apoer2. This exon is alternatively spliced in an activity-dependent manner and is required for Reelin-induced tyrosine phosphorylation of NMDA receptor subunits. Mice constitutively lacking the exon perform poorly in learning and memory tasks. Thus, alternative splicing of Apoer2, a novel component of the NMDA receptor complex, controls the modulation of NMDA receptor activity, synaptic neurotransmission, and memory by Reelin.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Univ Freiburg, Zentrum Neurowissensch, Inst Anat & Zellbiol, D-79104 Freiburg, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Baylor College of Medicine; University of Freiburg	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu	Weeber, Edwin J/A-5396-2012	Hammer, Robert E./0000-0001-5487-7551; Sweatt, J. David/0000-0003-3567-485X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762, HL20948, HL63762] Funding Source: Medline; NIMH NIH HHS [MH57014] Funding Source: Medline; NINDS NIH HHS [NS43408] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Black D L, 2003, Prog Mol Subcell Biol, V31, P187; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Brandes C, 1997, GENOMICS, V42, P185, DOI 10.1006/geno.1997.4702; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Curran BP, 2003, NEUROSCIENCE, V118, P347, DOI 10.1016/S0306-4522(02)00941-7; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Drakew A, 1998, NEUROSCIENCE, V82, P1079; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Pesold C, 1999, P NATL ACAD SCI USA, V96, P3217, DOI 10.1073/pnas.96.6.3217; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200	42	353	376	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					567	579		10.1016/j.neuron.2005.07.007	http://dx.doi.org/10.1016/j.neuron.2005.07.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102539	Bronze			2022-12-28	WOS:000231411100013
J	Koekkoek, SKE; Yamaguchi, K; Milojkovic, BA; Dortland, BR; Ruigrok, TJH; Maex, R; De Graaf, W; Smit, AE; VanderWerf, F; Bakker, CE; Willemsen, R; Ikeda, T; Kakizawa, S; Onodera, K; Nelson, DL; Mientjes, E; Joosten, M; De Schutter, E; Oostra, BA; Ito, M; De Zeeuw, CI				Koekkoek, SKE; Yamaguchi, K; Milojkovic, BA; Dortland, BR; Ruigrok, TJH; Maex, R; De Graaf, W; Smit, AE; VanderWerf, F; Bakker, CE; Willemsen, R; Ikeda, T; Kakizawa, S; Onodera, K; Nelson, DL; Mientjes, E; Joosten, M; De Schutter, E; Oostra, BA; Ito, M; De Zeeuw, CI			Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome	NEURON			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM DEPRESSION; DENDRITIC SPINE; SYNAPSE ELIMINATION; CGG REPEAT; EXPRESSION; MOUSE; MICE; CORTEX; MODEL	Absence of functional FMRP causes Fragile X syndrome. Abnormalities in synaptic processes in the cerebral cortex and hippocampus contribute to cognitive deficits in Fragile X patients. So far, the potential roles of cerebellar deficits have not been investigated. Here, we demonstrate that both global and Purkinje cell-specific knockouts of Fmr1 show deficits in classical delay eyeblink conditioning in that the percentage of conditioned responses as well as their peak amplitude and peak velocity are reduced. Purkinje cells of these mice show elongated spines and enhanced LTD induction at the parallel fiber synapses that innervate these spines. Moreover, Fragile X patients display the same cerebellar deficits in eyeblink conditioning as the mutant mice. These data indicate that a lack of FMRP leads to cerebellar deficits at both the cellular and behavioral levels and raise the possibility that cerebellar dysfunctions can contribute to motor learning deficits in Fragile X patients.	Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Inst Clin Genet, NL-3000 DR Rotterdam, Netherlands; RIKEN, Lab Memory & Learning, Brain Sc Inst, Wako, Saitama 3510198, Japan; RIKEN, Lab Behav Genet, Brain Sc Inst, Wako, Saitama 3510198, Japan; Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; RIKEN; RIKEN; University of Antwerp; Baylor College of Medicine	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, POB 1738, NL-3000 DR Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	De Schutter, Erik/G-8460-2011; Maex, Reinoud/GSN-0965-2022	De Schutter, Erik/0000-0001-8618-5138; Maex, Reinoud/0000-0002-5543-8902	NICHD NIH HHS [5 R01 HD38038] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; BAKKER CE, 1994, CELL, V78, P23; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cesa R, 2003, J NEUROSCI, V23, P2363; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Coesmans M, 2003, ANN NEUROL, V53, P325, DOI 10.1002/ana.10451; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; De Zeeuw CI, 2004, SCIENCE, V304; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gruart A, 1997, PROG BRAIN RES, V114, P511; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Haasdijk ED, 2002, NEUROSCI LETT, V335, P29, DOI 10.1016/S0304-3940(02)01159-X; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Karachot L, 2001, J NEUROPHYSIOL, V86, P280, DOI 10.1152/jn.2001.86.1.280; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; LEINER HC, 1993, TRENDS NEUROSCI, V16, P444, DOI 10.1016/0166-2236(93)90072-T; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Miyata M, 1999, NEURON, V22, P763, DOI 10.1016/S0896-6273(00)80735-7; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Strata P, 2000, TRENDS NEUROSCI, V23, P198, DOI 10.1016/S0166-2236(00)01571-X; Teune TM, 2000, PROG BRAIN RES, V124, P141; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; VANPELT J, 1992, B MATH BIOL, V54, P759, DOI 10.1016/S0092-8240(05)80142-9; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vokaer M, 2002, NEUROLOGY, V58, P967, DOI 10.1212/WNL.58.6.967; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4	65	353	363	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					339	352		10.1016/j.neuron.2005.07.005	http://dx.doi.org/10.1016/j.neuron.2005.07.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055059	Green Published, Bronze			2022-12-28	WOS:000231051900006
J	McGowan, E; Pickford, F; Kim, J; Onstead, L; Eriksen, J; Yu, C; Skipper, L; Murphy, MP; Beard, J; Das, P; Jansen, K; DeLucia, M; Lin, WL; Dolios, G; Wang, R; Eckman, CB; Dickson, DW; Hutton, M; Hardy, J; Golde, T				McGowan, E; Pickford, F; Kim, J; Onstead, L; Eriksen, J; Yu, C; Skipper, L; Murphy, MP; Beard, J; Das, P; Jansen, K; DeLucia, M; Lin, WL; Dolios, G; Wang, R; Eckman, CB; Dickson, DW; Hutton, M; Hardy, J; Golde, T			A beta 42 is essential for parenchymal and vascular amyloid deposition in mice	NEURON			English	Article							FAMILIAL BRITISH DEMENTIA; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR-PROTEIN; APOLIPOPROTEIN-E; MEMORY DEFICITS; PEPTIDE; MUTANT; BRAIN	Considerable circumstantial evidence suggests that A beta 42 is the initiating molecule in Alzheimer's disease (AD) pathogenesis. However, the absolute requirement for A beta 42 for amyloid deposition has never been demonstrated in vivo. We have addressed this by developing transgenic models that express A beta 1-40 or A beta 1-42 in the absence of human amylold 0 protein precursor (APP) overexpression. Mice expressing high levels of A beta 1-40 do not develop overt amyloid pathology. In contrast, mice expressing lower levels of A beta 1-42 accumulate insoluble A beta 1-42 and develop compact amyloid plaques, congophilic amyloid angiopathy (CAA), and diffuse A beta deposits. When mice expressing A beta 1-42 are crossed with mutant APP (Tg2576) mice, there is also a massive increase in amyloid deposition. These data establish that A beta 1-42 is essential for amyloid deposition in the parenchyma and also in vessels.	Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	Mayo Clinic; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	McGowan, E (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	mcgowan.eileen@mayo.edu; golde.todd@mayo.edu	Hardy, John/C-2451-2009; Eriksen, Jason/A-8054-2008; Kim, Jungsu/A-1372-2009; Wang, Rong/A-8721-2009; Kim, Jungsu/F-2457-2012	Hardy, John/0000-0002-3122-0423; Eriksen, Jason/0000-0003-1549-4165; Kim, Jungsu/0000-0002-6931-8581; Skipper, Lisa/0000-0002-1524-9787; Dickson, Dennis W/0000-0001-7189-7917	NATIONAL CANCER INSTITUTE [R24CA088325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022595] Funding Source: NIH RePORTER; NCI NIH HHS [CA88325, R24 CA088325] Funding Source: Medline; NIA NIH HHS [R01 AG022595, R01 AG022595-02, R01 AG022595-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Ghiso J, 2000, ANN NY ACAD SCI, V920, P84; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lewis PA, 2001, BBA-MOL BASIS DIS, V1537, P58, DOI 10.1016/S0925-4439(01)00054-0; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Pype S, 2003, J NEUROCHEM, V84, P602, DOI 10.1046/j.1471-4159.2003.01556.x; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	39	449	466	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					191	199		10.1016/j.neuron.2005.06.030	http://dx.doi.org/10.1016/j.neuron.2005.06.030			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039562	Bronze, Green Accepted			2022-12-28	WOS:000230693900007
J	Sudhof, TC				Sudhof, TC			CAPS in search of a lost function	NEURON			English	Editorial Material							CORE VESICLE EXOCYTOSIS; PROTEIN; SECRETION; CHROMAFFIN; CELLS	(C) under bara(2+)-dependent (a) under bar ctivator (p) under bar rotein for (s) under bar ecretion (CAPS) is an evolutionarily conserved secretory protein that was previously thought to mediate Ca2+-triggered fusion of dense-core vesicles. In an elegant study of CAPS1-deficient mice, Speidel et al. (this issue of Neuron) now show that CAPS function may have been misunderstood. CAPS appears to act upstream of fusion in the biogenesis or maintenance of mature secretory vesicles, raising the possibility of a completely new type of function for an essential component of the secretory machinery.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, 6000 Harry Hines Blvd NA4-118, Dallas, TX 75390 USA.							Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; LIVIGSTONE D, 1991, THESIS U CAMBRIDGE C; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tabares L, 2001, J BIOL CHEM, V276, P39974, DOI 10.1074/jbc.M106498200; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9	11	7	9	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 7	2005	46	1					2	4		10.1016/j.neuron.2005.03.017	http://dx.doi.org/10.1016/j.neuron.2005.03.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820687	Bronze			2022-12-28	WOS:000228228600002
J	Sun, Y; Goderie, SK; Temple, S				Sun, Y; Goderie, SK; Temple, S			Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EPIDERMAL-GROWTH-FACTOR; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; DEVELOPING TELENCEPHALON; NEUROEPITHELIAL CELLS; CORTICAL NEUROGENESIS; SUBVENTRICULAR ZONE; ENDOCYTIC PROTEIN; BINDING-PROTEIN	It has been debated whether asymmetric distribution of cell surface receptors during mitosis could generate asymmetric cell divisions by yielding daughters with different environmental responsiveness and, thus, different fates. We have found that in mouse embryonic forebrain ventricular and subventricular zones, the EGFR can distribute asymmetrically during mitosis in vivo and in vitro. This occurs during divisions yielding two Nestin(+) progenitor cells, via an actindependent mechanism. The resulting sibling progenitor cells respond differently to EGFR ligand in terms of migration and proliferation. Moreover, they express different phenotypic markers: the EGFR(high) daughter usually has radial glial/astrocytic markers, while its EGFR(low) sister lacks them, indicating fate divergence. Lineage trees of cultured cortical glioblasts reveal repeated EGFR asymmetric distribution, and asymmetric divisions underlie formation of oligodendrocytes and astrocytes in clones. These data suggest that asymmetric EGFR distribution contributes to forebrain development by creating progenitors with different proliferative, migratory, and differentiation responses to ligand.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	Albany Medical College	Temple, S (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	temples@mail.amc.edu			NINDS NIH HHS [R37NS033529] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033529] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Bulgheresi S, 2001, J CELL SCI, V114, P3655; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Caric D, 2001, DEVELOPMENT, V128, P4203; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chojnacki A, 2004, J NEUROSCI, V24, P10888, DOI 10.1523/JNEUROSCI.3302-04.2004; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Kalyani AJ, 1999, J NEUROBIOL, V38, P207, DOI 10.1002/(SICI)1097-4695(19990205)38:2<207::AID-NEU4>3.0.CO;2-G; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kornblum HI, 1997, J COMP NEUROL, V380, P243, DOI 10.1002/(SICI)1096-9861(19970407)380:2<243::AID-CNE7>3.0.CO;2-3; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Liu Y, 2004, GLIA, V45, P67, DOI 10.1002/glia.10303; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Mai JK, 1998, EUR J NEUROSCI, V10, P746, DOI 10.1046/j.1460-9568.1998.00029.x; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Maric D, 2003, J NEUROSCI, V23, P240; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1; NAUBENSAK W, 2004, P NATL ACAD SCI USA, V101, P3196; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RIEDER CL, 1985, J HISTOCHEM CYTOCHEM, V33, P165, DOI 10.1177/33.2.3881520; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schools GP, 2003, J NEUROSCI RES, V73, P765, DOI 10.1002/jnr.10680; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shibata T, 1997, J NEUROSCI, V17, P9212; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SPANA EP, 1995, DEVELOPMENT, V121, P3489; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Walsh C, 1995, CIBA F SYMP, V193, P21; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Zerlin M, 2004, DEV BIOL, V270, P200, DOI 10.1016/j.ydbio.2004.02.024; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	57	162	166	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					873	886		10.1016/j.neuron.2005.01.045	http://dx.doi.org/10.1016/j.neuron.2005.01.045			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797549	Bronze			2022-12-28	WOS:000228031300009
J	Tao, HW; Poo, MM				Tao, HW; Poo, MM			Activity-dependent matching of excitatory and inhibitory inputs during refinement of visual receptive fields	NEURON			English	Article							DEVELOPING RETINOTECTAL SYNAPSES; PRIMARY AUDITORY-CORTEX; DIRECTION SELECTIVITY; CRITICAL-PERIOD; MAP FORMATION; NEURONS; ORIENTATION; PLASTICITY; XENOPUS; GABA	The receptive field (RF) of single visual neurons undergoes progressive refinement during development. It remains largely unknown how the excitatory and inhibitory inputs on single developing neurons are refined in a coordinated manner to allow the formation of functionally correct circuits. Using whole-cell voltage-clamp recording from Xenopus tectal neurons, we found that RFs determined by excitatory and inhibitory inputs in more mature tectal neurons are spatially matched, with each spot stimulus evoking balanced synaptic excitation and inhibition. This emerges during development through a gradual reduction in the RF size and a transition from disparate to matched topography of excitatory and inhibitory inputs to the tectal neurons. Altering normal spiking activity of tectal neurons by either blocking or elevating GABAA receptor activity significantly impeded the developmental reduction and topographic matching of RFs. Thus, appropriate inhibitory activity is essential for the coordinated refinement of excitatory and inhibitory connections.	Univ Calif Berkeley, Dept Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Tao, Huizhong W/HDM-9767-2022		NEI NIH HHS [EY015019, EY36999] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY015019] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; [Anonymous], [No title captured]; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BENARI Y, 2004, NAT REV NEUROSCI, V9, P728; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NAT NEUROSCI, V3, P303, DOI 10.1038/73849; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Holmgren CD, 2001, J NEUROSCI, V21, P8270; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAZAR G, 1973, J ANAT, V116, P347; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MUELLER AL, 1984, J NEUROSCI, V4, P860; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; PRINCE DA, 1984, ANN NEUROL, V16, pS59, DOI 10.1002/ana.410160710; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHMIDT JT, 1991, ANN NY ACAD SCI, V627, P385; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	52	113	114	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					829	836		10.1016/j.neuron.2005.01.046	http://dx.doi.org/10.1016/j.neuron.2005.01.046			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797545	Bronze			2022-12-28	WOS:000228031300005
J	Restrepo, D				Restrepo, D			The ins and outs of intracellular chloride in olfactory receptor neurons	NEURON			English	Editorial Material							TRANSDUCTION; CELLS; CHANNELS; CILIA	Stimulation of olfactory receptor neurons with odors culminates in opening of a ciliary Ca2+-activated CI-channel. Because intracellular Cl- ([CI-](i)) is above electrochemical equilibrium in these cells, the result is cell depolarization that triggers action potentials that carry information to the olfactory bulb. In this issue of Neuron, Reisert and coworkers use combined pharmacological and mouse genetic approaches to show that the transporter responsible for maintaining Cl- above electrochemical equilibrium is NKCC1, a Na+2CI-K+ cotransporter found in other tissues, including neurons.	Univ Colorado Denver, Dept Cell & Dev Biol, Neurosci Program, Aurora, CO 80045 USA; Univ Colorado Denver, Rocky Mt Taste & Smell Ctr, Sch Med, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Restrepo, D (corresponding author), Univ Colorado Denver, Dept Cell & Dev Biol, Neurosci Program, Aurora, CO 80045 USA.							Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reuter D, 1998, J NEUROSCI, V18, P6623; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429	10	12	13	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					481	482		10.1016/j.neuron.2005.02.002	http://dx.doi.org/10.1016/j.neuron.2005.02.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721233	Bronze			2022-12-28	WOS:000227099700002
J	Tomita, S; Stein, V; Stocker, TJ; Nicoll, RA; Bredt, DS				Tomita, S; Stein, V; Stocker, TJ; Nicoll, RA; Bredt, DS			Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; CHANNEL GAMMA-SUBUNIT; EXCITATORY SYNAPSES; KINASE-II; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; GLUR1 SUBUNIT; MUTANT MOUSE	Synaptic plasticity involves protein phosphorylation cascades that alter the density of AMPA-type glutamate receptors at excitatory synapses; however, the crucial phosphorylated substrates remain uncertain. Here, we show that the AMPA receptor-associated protein stargazin is quantitatively phosphorylated and that stargazin phosphorylation promotes synaptic trafficking of AMPA receptors. Synaptic NMDA receptor activity can induce both stargazin phosphorylation, via activation of CaMKII and PKC, and stargazin dephosphorylation, by activation of PP1 downstream of PP2B. At hippocampal synapses, long-term potentiation and long-term depression require stargazin phosphorylation and dephosphorylation, respectively. These results establish stargazin as a critical substrate in the bidirectional control of synaptic strength, which is thought to underlie aspects of learning and memory.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	bredt@itsa.ucsf.edu	Stein, Valentin/A-8025-2008	Stein, Valentin/0000-0003-1222-4928				Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GILL GN, 1990, MOL REPROD DEV, V27, P46, DOI 10.1002/mrd.1080270110; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche WK, 1996, NEURON, V16, P1179; Rousset M, 2001, J PHYSIOL-LONDON, V532, P583, DOI 10.1111/j.1469-7793.2001.0583e.x; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stein V, 2003, J NEUROSCI, V23, P5503; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	55	246	256	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					269	277		10.1016/j.neuron.2005.01.009	http://dx.doi.org/10.1016/j.neuron.2005.01.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664178	Bronze			2022-12-28	WOS:000226451500013
J	Wais, PE; Wixted, JT; Hopkins, RO; Squire, LR				Wais, PE; Wixted, JT; Hopkins, RO; Squire, LR			The hippocampus supports both the recollection and the familiarity components of recognition memory	NEURON			English	Article							TEMPORAL-LOBE DAMAGE; AMNESIC PATIENT; PROCESS MODEL; ITEM; RETRIEVAL; RECALL; ROCS; RATS	The receiver operating characteristic (ROC) has been used to investigate the component processes of recognition memory. Some studies with this technique have been taken to indicate that the hippocampus selectively supports the process of recollection, whereas adjacent cortex in the parahippocampal gyrus supports the process of familiarity. We analyzed ROC data from young adults, memory-impaired patients with limited hippocampal lesions, and age-matched controls. The shape of the ROC changed in similar ways from asymmetric to symmetric, as a function of the strength of memory (strong to weak) in both the young adults and the patients. Moreover, once overall memory strength was similar, the shape of the patient ROC was asymmetric and matched the control ROC. These results suggest that the component processes that determine the shape of the ROC are operative in the absence of the hippocampus, and they argue against the idea that the hippocampus selectively supports the recollection process.	Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Vet Affairs Med Ctr, La Jolla, CA 92161 USA; Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; Latter Day St Hosp, Dept Med, Div Pulm & Crit Care, Salt Lake City, UT 84143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Brigham Young University; Brigham Young University	Wixted, JT (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.	jwixted@ucsd.edu	Wixted, John/AAV-3458-2020	Wixted, John/0000-0001-6282-5479	NIMH NIH HHS [R01 MH024600] Funding Source: Medline; PHS HHS [24600] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH024600] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggleton JP, 2005, NEUROPSYCHOLOGIA, V43, P1810, DOI 10.1016/j.neuropsychologia.2005.01.019; Barbeau EJ, 2005, HIPPOCAMPUS, V15, P587, DOI 10.1002/hipo.20079; Bastin C, 2004, NEUROCASE, V10, P330, DOI 10.1080/13554790490507650; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Cipolotti L, 2006, NEUROPSYCHOLOGIA, V44, P489, DOI 10.1016/j.neuropsychologia.2005.05.014; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Glanzer M, 1999, J EXP PSYCHOL LEARN, V25, P500, DOI 10.1037/0278-7393.25.2.500; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; Heathcote A, 2003, J EXP PSYCHOL LEARN, V29, P1210, DOI 10.1037/0278-7393.29.6.1210; Hilford A, 2002, J EXP PSYCHOL GEN, V131, P494, DOI 10.1037//0096-3445.131.4.494; Macmillan NA., 1991, DETECTION THEORY USE; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; MANDLER G, 1974, MEM COGNITION, V2, P613, DOI 10.3758/BF03198129; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Mayes AR, 2002, HIPPOCAMPUS, V12, P325, DOI 10.1002/hipo.1111; OGILVIE JC, 1968, J MATH PSYCHOL, V5, P377, DOI 10.1016/0022-2496(68)90083-7; Qin JJ, 2001, J EXP PSYCHOL LEARN, V27, P1110, DOI 10.1037/0278-7393.27.4.1110; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Savage LM, 1999, DEV PSYCHOBIOL, V35, P318, DOI 10.1002/(SICI)1098-2302(199912)35:4<318::AID-DEV6>3.0.CO;2-8; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; Slotnick SD, 2005, MEM COGNITION, V33, P151, DOI 10.3758/BF03195305; Smith C, 2005, J NEUROSCI, V25, P10138, DOI 10.1523/JNEUROSCI.2731-05.2005; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525; Wixted JT, 2004, COGN AFFECT BEHAV NE, V4, P58, DOI 10.3758/CABN.4.1.58; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; Wixted JT, 2004, PSYCHOL REV, V111, P864, DOI 10.1037/0033-295x.111.4.864; YONELIAS A, 1998, NEUROPSYCHOLOGY, V12, P232; Yonelinas AP, 1997, MEM COGNITION, V25, P747, DOI 10.3758/BF03211318; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 1999, J EXP PSYCHOL LEARN, V25, P1415, DOI 10.1037/0278-7393.25.6.1415	32	185	189	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					459	466		10.1016/j.neuron.2005.12.020	http://dx.doi.org/10.1016/j.neuron.2005.12.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	011IF	16446148	Green Accepted, Bronze			2022-12-28	WOS:000235260900016
J	Burns, ME; Arshavsky, VY				Burns, ME; Arshavsky, VY			Beyond counting photons: Trials and trends in vertebrate visual transduction	NEURON			English	Review							CGMP-GATED CHANNEL; CYCLASE-ACTIVATING PROTEINS; PHOTORECEPTOR G-PROTEIN; GTPASE ACCELERATING PROTEIN; LEBER CONGENITAL AMAUROSIS; RETINAL-PIGMENT EPITHELIUM; COUPLED RECEPTOR KINASE; GUANYLATE-CYCLASE; CYCLIC-GMP; CRYSTAL-STRUCTURE	For over 30 years, photoreceptors have been an outstanding model system for elucidating basic principles in sensory transduction and G protein signaling. Recently, photoreceptors have become an equally attractive model for studying many facets of neuronal cell biology. The primary goal of this review is to illustrate this rapidly growing trend. We will highlight the areas of active research in photoreceptor biology that reveal how different specialized compartments of the cell cooperate in fulfilling its overall function: converting photon absorption into changes in neurotransmitter release. The same trend brings us closer to understanding how defects in photoreceptor signaling can lead to cell death and retinal degeneration.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	University of California System; University of California Davis; University of California System; University of California Davis; Duke University; Duke University	Burns, ME (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	meburns@ucdavis.edu; vadim.arshavsky@duke.edu			NEI NIH HHS [R01 EY014047, R01 EY014047-04, EY12859, EY10336, EY14047] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012859, R01EY010336, R01EY014047] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANANT JS, 1992, J BIOL CHEM, V267, P687; ANANT JS, 1992, BIOCHEM BIOPH RES CO, V183, P468, DOI 10.1016/0006-291X(92)90505-F; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; ATTWELL D, 1980, J PHYSIOL-LONDON, V309, P287, DOI 10.1113/jphysiol.1980.sp013509; Baker SA, 2004, REC ADV HUM BIOL, V10, P109; Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; BARLOW RB, 1972, HDB SENSORY PHYSL, P1; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Bauer PJ, 1996, J PHYSIOL-LONDON, V494, P675, DOI 10.1113/jphysiol.1996.sp021523; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BAYLOR DA, 1984, J PHYSIOL-LONDON, V354, P203, DOI 10.1113/jphysiol.1984.sp015372; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1977, J PHYSIOL-LONDON, V271, P391, DOI 10.1113/jphysiol.1977.sp012006; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; COLES JA, 1975, J PHYSIOL-LONDON, V247, P189, DOI 10.1113/jphysiol.1975.sp010927; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; DEGRIP WJ, 2000, MOL MECH VISUAL TRAN, P1, DOI DOI 10.1016/S1383-8121(00)80004-4; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; DERETIC D, 1995, J CELL SCI, V108, P215; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 2004, REC ADV HUM BIOL, V10, P29; DETWILER PB, 1980, J PHYSIOL-LONDON, V300, P213, DOI 10.1113/jphysiol.1980.sp013159; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DOWLING JE, 1972, J GEN PHYSIOL, V60, P698, DOI 10.1085/jgp.60.6.698; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FAIN GL, 1993, EXP EYE RES, V57, P335, DOI 10.1006/exer.1993.1132; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; FRANK RN, 1973, J BIOL CHEM, V248, P596; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187; GOLDSTEIN EB, 1973, VISION RES, V13, P527, DOI 10.1016/0042-6989(73)90022-9; GORODOVIKOVA EN, 1994, FEBS LETT, V353, P171, DOI 10.1016/0014-5793(94)01030-7; Govardovskii VI, 2000, J GEN PHYSIOL, V116, P791, DOI 10.1085/jgp.116.6.791; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Hamer RD, 2003, J GEN PHYSIOL, V122, P419, DOI 10.1085/jgp.200308832; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hecht S, 1937, PHYSIOL REV, V17, P239, DOI 10.1152/physrev.1937.17.2.239; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; HFOMANN KP, 2000, MOL MECH VISUAL TRAN, P91; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; HODGKIN AL, 1987, J PHYSIOL-LONDON, V391, P347, DOI 10.1113/jphysiol.1987.sp016742; Hofmann K. P., 2000, HDB BIOL PHYSICS, P91, DOI 10.1016/s1383-8121(00)80006-8; Horner TJ, 2005, J BIOL CHEM, V280, P28241, DOI 10.1074/jbc.M505117200; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; HUBBARD R, 1977, VISION RES, V17, P1247, DOI 10.1016/0042-6989(77)90111-0; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; INGLESE J, 1992, J BIOL CHEM, V267, P1422; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Keresztes G, 2003, MOL CELL NEUROSCI, V24, P687, DOI 10.1016/S1044-7431(03)00231-8; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; Korenbrot JI, 2002, ADV EXP MED BIOL, V514, P179; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; KRAFT TW, 1993, J PHYSIOL-LONDON, V464, P747, DOI 10.1113/jphysiol.1993.sp019661; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; KUHNE W, 1977, VISION RES, V17, P1269, DOI 10.1016/0042-6989(77)90114-6; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leconte L, 2000, INVEST OPHTH VIS SCI, V41, P917; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; Lem J, 2004, TRENDS MOL MED, V10, P150, DOI 10.1016/j.molmed.2004.02.009; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Liu XR, 1999, J NEUROSCI, V19, P6267; Luo WQ, 2004, J NEUROSCI, V24, P2623, DOI 10.1523/JNEUROSCI.5302-03.2004; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; MAKOUS W, 2001, VISUAL NEUROSCIENCES, P215; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Matthews HR, 1997, J GEN PHYSIOL, V109, P141, DOI 10.1085/jgp.109.2.141; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; MINKE B, 2000, MOL MECH VISUAL TRAN, P449; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NAKATANI K, 1995, J PHYSIOL-LONDON, V484, P69, DOI 10.1113/jphysiol.1995.sp020648; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Rebrik TI, 2000, J GEN PHYSIOL, V116, P521, DOI 10.1085/jgp.116.4.521; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reme C, 2005, INVEST OPHTH VIS SCI, V46, P2672, DOI 10.1167/iovs.04-1095; REME CE, 2005, OPHTHALMOL VIS SCI, V46, P2671; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Rodieck R.W., 1998, 1 STEPS SEEING; Saari JC, 2004, REC ADV HUM BIOL, V10, P301; Sampath AP, 2005, NEURON, V46, P413, DOI 10.1016/j.neuron.2005.04.006; SCHNAPF JL, 1982, NATURE, V296, P862, DOI 10.1038/296862a0; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schultze M., 1866, ARCH MICROSK ANAT, V2, P175, DOI DOI 10.1007/BF02962033; Shaaban SA, 1998, INVEST OPHTH VIS SCI, V39, P885; Shi G, 2004, REC ADV HUM BIOL, V10, P93; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Stiles W.S., 1932, EQUIVALENT ADAPTATIO, P194; Strissel KJ, 2005, J BIOL CHEM, V280, P29250, DOI 10.1074/jbc.M501789200; Sung CH, 2004, REC ADV HUM BIOL, V10, P65; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Thoreson WB, 1997, J NEUROPHYSIOL, V77, P2175, DOI 10.1152/jn.1997.77.4.2175; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Williams D. S., 2004, PHOTORECEPTOR CELL B; Williams DS, 2004, REC ADV HUM BIOL, V10, P397; WITKOVSKY P, 1988, BRAIN RES, V449, P332, DOI 10.1016/0006-8993(88)91048-7; WOLLMUTH LP, 1992, J GEN PHYSIOL, V100, P749, DOI 10.1085/jgp.100.5.749; Xu JW, 2005, J NEUROSCI, V25, P7660, DOI 10.1523/JNEUROSCI.1572-05.2005; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003; Zhu XM, 2002, MOL VIS, V8, P462; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	215	186	192	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					387	401		10.1016/j.neuron.2005.10.014	http://dx.doi.org/10.1016/j.neuron.2005.10.014			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269358	Bronze			2022-12-28	WOS:000233250100002
J	Mertens, I; Vandingenen, A; Johnson, EC; Shafer, OT; Li, W; Trigg, JS; De Loof, A; Schoofs, L; Taghert, PH				Mertens, I; Vandingenen, A; Johnson, EC; Shafer, OT; Li, W; Trigg, JS; De Loof, A; Schoofs, L; Taghert, PH			PDF receptor signaling in Drosophila contributes to both circadian and geotactic behaviors	NEURON			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; DIURETIC HORMONE-RECEPTOR; PIGMENT-DISPERSING FACTOR; PROTEIN-COUPLED RECEPTOR; CENTRAL-NERVOUS-SYSTEM; CLOCK NEURONS; GENE; NEUROPEPTIDE; MELANOGASTER; RHYTHMS	The neuropeptide Pigment-Dispersing Factor (PDF) is a principle transmitter regulating circadian locomotor rhythms in Drosophila. We have identified a Class II (secretin-related) G protein-coupled receptor (GPCR) that is specifically responsive to PDF and also to calcitonin-like peptides and to PACAP. In response to PDF, the PDF receptor (PDFR) elevates cAMP levels when expressed in HEK293 cells. As predicted by in vivo studies, cotransfection of Neurofibromatosis Factor 1 significantly improves coupling of PDFR to adenylate cyclase. pdfr mutant flies display increased circadian arrhythmicity, and also display altered geotaxis that is epistatic to that of pdf mutants. PDFR immunosignals are expressed by diverse neurons, but only by a small subset of circadian pacemakers. These data establish the first synapse within the Drosophila circadian neural circuit and underscore the importance of Class II peptide GPCR signaling in circadian neural systems.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Katholieke Univ Leuven, Lab Dev Physiol Genom & Proteom, B-3000 Louvain, Belgium	Washington University (WUSTL); KU Leuven	Taghert, PH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	taghertp@pcg.wustl.edu	schoofs, liliane/ABD-2943-2020; Mertens, Inge/N-9787-2018; Schoofs, Liliane/F-2815-2010	Mertens, Inge/0000-0002-4888-3485; Schoofs, Liliane/0000-0002-1673-432X	NIMH NIH HHS [MH067122] Funding Source: Medline; NINDS NIH HHS [NS56376, NS27149] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056376] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Burns DM, 2004, AM J PHYSIOL-CELL PH, V287, pC457, DOI 10.1152/ajpcell.00274.2003; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Dasgupta B, 2003, J NEUROSCI, V23, P8949; DeHaven W, 2004, J BIOL CHEM, V279, P40609, DOI 10.1074/jbc.M404743200; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hay DL, 2004, J MOL NEUROSCI, V22, P105, DOI 10.1385/JMN:22:1-2:105; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; Johnson EC, 2003, P NATL ACAD SCI USA, V100, P6198, DOI 10.1073/pnas.1030108100; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Nery LEM, 1997, COMP BIOCHEM PHYS A, V118, P1135, DOI 10.1016/S0300-9629(97)00045-5; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; PARK HT, 1993, BRAIN RES, V629, P335, DOI 10.1016/0006-8993(93)91342-P; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ruocco I, 2001, J COMP NEUROL, V432, P466, DOI 10.1002/cne.1114; Schneider NL, 2005, J NEUROSCI, V25, P5138, DOI 10.1523/JNEUROSCI.5138-A-04.2005; SKOFITSCH G, 1985, PEPTIDES, V6, P975, DOI 10.1016/0196-9781(85)90331-6; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Taghert PH, 2001, SEMIN CELL DEV BIOL, V12, P329, DOI 10.1006/scdb.2001.0260; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; USDIN TB, 1994, ENDOCRINOLOGY, V135, P2662, DOI 10.1210/en.135.6.2662; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; ZHONG Y, 1995, NEURON, V14, P527, DOI 10.1016/0896-6273(95)90309-7	36	245	248	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					213	219		10.1016/j.neuron.2005.09.009	http://dx.doi.org/10.1016/j.neuron.2005.09.009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242402	Bronze			2022-12-28	WOS:000232838700011
J	Wang, VY; Rose, MF; Zoghbi, HY				Wang, VY; Rose, MF; Zoghbi, HY			Math1 expression redefines the rhombic lip derivatives and reveals novel lineages within the brainstem and cerebellum	NEURON			English	Article							EXTRAMURAL MIGRATORY STREAM; PERIPHERAL NERVOUS-SYSTEM; PRECEREBELLAR NUCLEI; NEURONAL MIGRATION; COCHLEAR NUCLEUS; AUDITORY-SYSTEM; PRONEURAL GENE; GRANULE CELLS; RAT; MOUSE	The rhombic lip (RL) is an embryonic proliferative neuroepithelium that generates several groups of hind-brain neurons. However, the precise boundaries and derivatives of the RL have never been genetically identified. We use p-galactosidase expressed from the Math1 locus in Math1-heterozygous and Math1-null mice to track RL-derived cells and to evaluate their developmental requirements for Math1. We uncover a Math1-dependent rostral rhombic-lip migratory stream (RLS) that generates some neurons of the parabrachial, lateral lemniscal, and deep cerebellar nuclei, in addition to cerebellar granule neurons. A more caudal Math1-dependent cochlear extramural stream (CES) generates the ventral cochlear nucleus and cochlear granule neurons. Similarly, mossy-fiber precerebellar nuclei require Math1, whereas the inferior olive and locus coeruleus do not. We propose that Math1 expression delimits the extent of the rhombic lip and is required for the generation of the hind-brain superficial migratory streams, all of which contribute neurons to the proprioceptive/vestibular/auditory sensory network.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Rose, Matthew/0000-0002-1148-4130; Zoghbi, Huda/0000-0002-0700-3349				AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ALTMAN J, 1987, J COMP NEUROL, V257, P513, DOI 10.1002/cne.902570404; ALTMAN J, 1987, J COMP NEUROL, V257, P477, DOI 10.1002/cne.902570402; ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; ALTMAN J, 1987, J COMP NEUROL, V257, P490, DOI 10.1002/cne.902570403; ALTMAN J, 1987, J COMP NEUROL, V257, P529, DOI 10.1002/cne.902570405; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; Balaban CD, 2002, J NEUROPHYSIOL, V88, P3175, DOI 10.1152/jn.00499.2002; Bayer, 1997, RELATION ITS EVOLUTI; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; de Diego I, 2002, DEVELOPMENT, V129, P297; ELLENBERGER C, 1969, J COMP NEUROL, V137, P71, DOI 10.1002/cne.901370105; Essick CR, 1912, AM J ANAT, V13, P25, DOI 10.1002/aja.1000130103; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; Friede R.L., 1989, DEV NEUROPATHOLOGY; Funfschilling U, 2002, GENESIS, V33, P160, DOI 10.1002/gene.10104; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hirsch MR, 1998, DEVELOPMENT, V125, P599; His W., 1891, ABHANDLUNGEN KONI MP, V29, P1; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Ivanova A, 1998, DEV NEUROSCI-BASEL, V20, P495, DOI 10.1159/000017350; JACOBOWITZ DM, 1997, CHEMOARCHITECTONIC A; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jensen P, 2002, J NEUROSCI, V22, P8110; Kaufman M.H., 1992, ATLAS MOUSE DEV; Koster RW, 2001, CURR BIOL, V11, P1858, DOI 10.1016/S0960-9822(01)00585-1; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Lin JC, 2001, J NEUROSCI, V21, P159, DOI 10.1523/JNEUROSCI.21-01-00159.2001; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; MARTIN MR, 1981, J COMP NEUROL, V197, P169, DOI 10.1002/cne.901970113; Mathis L, 1997, DEVELOPMENT, V124, P4089; Millet S, 1996, DEVELOPMENT, V122, P3785; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Paxinos G, 1994, ATLAS DEV RAT NERVOU; PXINOS G, 1999, CHEMOARCHITECTONIC A; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Schambra UB, 1992, ATLAS PRENATAL MOUSE; TABERPIERCE E, 1975, BRAIN RES, V95, P503; TABERPIERCE E, 1967, J COMP NEUROL, V131, P27; TABERPIERCE E, 1966, J COMP NEUROL, V126, P219; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	51	373	377	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 6	2005	48	1					31	43		10.1016/j.neuron.2005.08.024	http://dx.doi.org/10.1016/j.neuron.2005.08.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202707	Bronze			2022-12-28	WOS:000232625700008
J	Wehr, M; Zador, AM				Wehr, M; Zador, AM			Synaptic mechanisms of forward suppression in rat auditory cortex	NEURON			English	Article							SHORT-TERM PLASTICITY; PRIMARY VISUAL-CORTEX; DIRECTION SELECTIVITY; CORTICAL-NEURONS; INHIBITION; SYNAPSES; DEPRESSION; REPRESENTATION; ORIENTATION; POTENTIALS	In the auditory cortex, brief sounds elicit a powerful suppression of responsiveness that can persist for hundreds of milliseconds. This forward suppression (sometimes also called forward masking) has usually been attributed to synaptic (GABAergic) inhibition. Here we have used whole-cell recordings in vivo to assess the role of synaptic inhibition in forward suppression in auditory cortex. We measured the excitatory and inhibitory synaptic conductances elicited by pairs of brief sounds presented at intervals from tens to hundreds of milliseconds. We find that inhibitory conductances rarely last longer than 50-100 ms, whereas spike responses and synaptic inputs remain suppressed for hundreds of milliseconds. We conclude that postsynaptic inhibition contributes to forward suppression for only the first 50-100 ms after a stimulus and that intracortical contributions to long-lasting suppression must involve other mechanisms, such as synaptic depression.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; [Anonymous], [No title captured]; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brosch M, 1999, J NEUROPHYSIOL, V82, P1542, DOI 10.1152/jn.1999.82.3.1542; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Carandini M, 2002, J NEUROSCI, V22, P10053; CastroAlamancos MA, 1997, REV NEUROSCIENCE, V8, P95; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; Denham SL, 2001, NATO SCI S A LIF SCI, V312, P281; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; EGGERMONT JJ, 1995, J NEUROPHYSIOL, V73, P227, DOI 10.1152/jn.1995.73.1.227; Eggermont JJ, 1999, J NEUROSCI, V19, P2780; FERSTER D, 1986, J NEUROSCI, V6, P1284; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; MACDONALD RL, 1989, J PHYSIOL-LONDON, V417, P483, DOI 10.1113/jphysiol.1989.sp017814; METHERATE R, 1994, J PHYSIOL-LONDON, V481, P331, DOI 10.1113/jphysiol.1994.sp020443; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore B. C. J., 1995, HEARING; NICOLL RA, 1975, NATURE, V258, P625, DOI 10.1038/258625a0; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Talbot MJ, 1996, J NEUROPHYSIOL, V76, P2120, DOI 10.1152/jn.1996.76.3.2120; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Varela JA, 1999, J NEUROSCI, V19, P4293; Varela JA, 1997, J NEUROSCI, V17, P7926; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; VOLKOV IO, 1992, EXP BRAIN RES, V91, P115; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	45	312	318	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 4	2005	47	3					437	445		10.1016/j.neuron.2005.06.009	http://dx.doi.org/10.1016/j.neuron.2005.06.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055066	Bronze			2022-12-28	WOS:000231051900013
J	Martinez-Trujillo, JC				Martinez-Trujillo, JC			Noncommutativity of eye rotations and the half-angle rule	NEURON			English	Editorial Material							NEURAL-CONTROL; PULLEYS; SYSTEM	In order to produce kinematically efficient behavior when dealing with the noncommutativity of rotations, the oculomotor system has developed strategies such as the half-angle rule. In this issue of Neuron, Ghasia and Angelaki demonstrate that during smooth pursuit eye movements the half-angle rule is implemented by the mechanical properties of the eye plant.	McGill Univ, Dept Physiol, Aerosp Med Res Unit, Montreal, PQ H3G 1Y6, Canada	McGill University	Martinez-Trujillo, JC (corresponding author), McGill Univ, Dept Physiol, Aerosp Med Res Unit, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Martinez-Trujillo, Julio C/M-2146-2015	Martinez-Trujillo, Julio C/0000-0003-3338-578X				Crawford JD, 2003, CURR OPIN NEUROBIOL, V13, P655, DOI 10.1016/j.conb.2003.10.009; CRAWFORD JD, 1994, J NEUROSCI, V14, P6911; DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125; Ghasia FF, 2005, NEURON, V47, P281, DOI 10.1016/j.neuron.2005.05.031; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P2179; Misslisch H, 2001, J NEUROPHYSIOL, V86, P1877, DOI 10.1152/jn.2001.86.4.1877; Quaia Christian, 2003, Strabismus, V11, P17, DOI 10.1076/stra.11.1.17.14088; SCHNABOLK C, 1994, J NEUROPHYSIOL, V71, P623, DOI 10.1152/jn.1994.71.2.623; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; Tweed DB, 1999, NATURE, V399, P261, DOI 10.1038/20441; Wong AMF, 2004, SURV OPHTHALMOL, V49, P563, DOI 10.1016/j.survophthal.2004.08.002	11	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					171	173		10.1016/j.neuron.2005.07.003	http://dx.doi.org/10.1016/j.neuron.2005.07.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039558	Bronze			2022-12-28	WOS:000230693900003
J	Inanobe, A; Furukawa, H; Gouaux, E				Inanobe, A; Furukawa, H; Gouaux, E			Mechanism of partial agonist action at the NR1 subunit of NMDA receptors	NEURON			English	Article							LIGAND-BINDING CORE; IONOTROPIC GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; ION-CHANNEL; 1-AMINOCYCLOBUTANE-1-CARBOXYLATE ACBC; TETRAMERIC STRUCTURE; GLYCINE; GLUR2; ACTIVATION	Partial agonists produce submaximal activation of ligand-gated ion channels. To address the question of partial agonist action at the NR1 subunit of the NMDA receptor, we performed crystallographic and electrophysiological studies with 1-aminocyclopropane-1-carboxylic acid (ACPC), 1-aminocyclobutane-l-carboxylic acid (ACBC), and 1-aminocyclopentane-1-carboxylic acid (cycloleucine), three compounds with incrementally larger carbocyclic rings. Whereas ACPC and ACBC partially activate the NMDA receptor by 80% and 42%, respectively, their cocrystal structures of the NR1 ligand binding core show the same degree of domain closure as found in the complex with glycine, a full agonist, illustrating that the NR1 subunit provides a new paradigm for partial agonist action that is distinct from that of the evolutionarily related GluR2, AMPA-sensitive receptor. Cycloleucine behaves as an antagonist and stabilizes an open-cleft conformation. The NR1-cycloleucine complex forms a dimer that is similar to the GluR2 dimer, thereby suggesting a conserved mode of subunit-subunit interaction in AMPA and NMDA receptors.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.	jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360				Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baron BM, 1996, J PHARMACOL EXP THER, V279, P62; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Danysz W, 1998, PHARMACOL REV, V50, P597; DeLano W.L, PYMOL MOL GRAPHICS S; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOOD WF, 1989, EUR J PHARMACOL, V161, P281, DOI 10.1016/0014-2999(89)90861-3; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2003, BIOCHEMISTRY-US, V42, P5201, DOI 10.1021/bi020632t; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kalbaugh TL, 2004, MOL PHARMACOL, V66, P209, DOI 10.1124/mol.66.2.209; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laube B, 1998, J NEUROSCI, V18, P2954; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NADLER V, 1988, EUR J PHARMACOL, V157, P115, DOI 10.1016/0014-2999(88)90478-5; Nahum-Levy R, 1999, MOL PHARMACOL, V56, P1207, DOI 10.1124/mol.56.6.1207; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sheinin A, 2001, NEUROPHARMACOLOGY, V41, P151, DOI 10.1016/S0028-3908(01)00073-9; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; WATSON GB, 1989, EUR J PHARMACOL, V167, P291, DOI 10.1016/0014-2999(89)90590-6; WATSON GB, 1990, NEUROPHARMACOLOGY, V29, P727, DOI 10.1016/0028-3908(90)90125-B; Zhang M, 2004, ACTA CRYSTALLOGR D, V60, P985, DOI 10.1107/S0907444904003786	59	155	159	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					71	84		10.1016/j.neuron.2005.05.022	http://dx.doi.org/10.1016/j.neuron.2005.05.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996549	Bronze			2022-12-28	WOS:000230464000009
J	Walters, CL; Cleck, JN; Kuo, YC; Blendy, JA				Walters, CL; Cleck, JN; Kuo, YC; Blendy, JA			mu-Opiloid receptor and CREB activation are required for nicotine reward	NEURON			English	Article							ELEMENT-BINDING PROTEIN; VENTRAL TEGMENTAL AREA; COCAINE-PAIRED ENVIRONMENT; REINFORCING PROPERTIES; TRANSCRIPTION FACTOR; SMOKING-CESSATION; CIGARETTE-SMOKING; GENE-EXPRESSION; FOS EXPRESSION; MET-ENKEPHALIN	Environmental cues associated with nicotine delivery are an important part of the stimulus that sustains smoking behavior and is often coupled with craving and relapse; however, the neuronal circuitry and molecular substrates underlying this process are still poorly understood. Exposure to an environment previously associated with rewarding properties of nicotine results in an increase of CREB phosphorylation similar to that seen following nicotine administration, and this response is absent in MOR-/- mice. Moreover, a single administration of an opioid receptor antagonist, naloxone, blocks both the conditioned molecular response (CREB phosphorylation) and the conditioned behavioral response (nicotine reward) in a place preference paradigm. Lastly, repeated nicotine administration results in increased expression of MORs. However, this effect, along with rewarding properties of nicotine, is blocked in mice with a targeted disruption in the CREB gene. Together, pharmacologic and genetic manipulations indicate that phosphorylation of CREB and upregulation of functional MORs are required for nicotine-conditioned reward.	Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Blendy, JA (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	blendy@pharm.med.upenn.edu		Blendy, Julie/0000-0003-1705-9001	NIDA NIH HHS [1F31 DA 015949, DA-11649-01A2] Funding Source: Medline; PHS HHS [P5084718] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011649, F31DA015949] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ACETO MD, 1993, EUR J PHARM-ENVIRON, V248, P333, DOI 10.1016/0926-6917(93)90009-F; Berrendero F, 2002, J NEUROSCI, V22, P10935; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; BROWN EE, 1992, J NEUROSCI, V12, P4112; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Caggiula AR, 2002, PHYSIOL BEHAV, V77, P683, DOI 10.1016/S0031-9384(02)00918-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORRIGALL WA, 1994, BRAIN RES, V653, P278, DOI 10.1016/0006-8993(94)90401-4; CORRIGALL WA, 1991, PSYCHOPHARMACOLOGY, V104, P171, DOI 10.1007/BF02244174; CORRIGALL WA, 1988, PSYCHOPHARMACOLOGY, V96, P29, DOI 10.1007/BF02431529; Covey LS, 1999, J ADDICT DIS, V18, P31, DOI 10.1300/J069v18n01_04; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; DAVENPORT KE, 1990, NEUROSCI LETT, V113, P40, DOI 10.1016/0304-3940(90)90491-Q; DHATT RK, 1995, J NEUROCHEM, V64, P1878; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Franklin TR, 2000, EUR J NEUROSCI, V12, P2097, DOI 10.1046/j.1460-9568.2000.00071.x; GUITART X, 1992, J NEUROCHEM, V58, P1168, DOI 10.1111/j.1471-4159.1992.tb09377.x; HOUDI AA, 1991, PEPTIDES, V12, P161, DOI 10.1016/0196-9781(91)90183-P; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Ise Y, 2000, PSYCHOPHARMACOLOGY, V151, P49, DOI 10.1007/s002130000482; KANO T, 1995, NEUROREPORT, V6, P2197, DOI 10.1097/00001756-199511000-00023; King AC, 2000, PHARMACOL BIOCHEM BE, V66, P563, DOI 10.1016/S0091-3057(00)00258-6; KONRADI C, 1994, J NEUROSCI, V14, P5623; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; Laviolette SR, 2003, PSYCHOPHARMACOLOGY, V166, P306, DOI 10.1007/s00213-002-1317-6; Laviolette SR, 2003, MOL PSYCHIATR, V8, P50, DOI 10.1038/sj.mp.4001197; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; MALIN DH, 1993, PSYCHOPHARMACOLOGY, V112, P339, DOI 10.1007/BF02244930; MARKS MJ, 1993, J PHARMACOL EXP THER, V266, P1268; MELLO NK, 1980, PSYCHOPHARMACOLOGY, V67, P45, DOI 10.1007/BF00427594; MIN BH, 1994, P NATL ACAD SCI USA, V91, P9081, DOI 10.1073/pnas.91.19.9081; Morgan MJ, 1999, BEHAV PHARMACOL, V10, P619, DOI 10.1097/00008877-199911000-00008; Mucha RF, 1999, PSYCHOPHARMACOLOGY, V147, P306, DOI 10.1007/s002130051172; NEMETHCOSLETT R, 1986, PSYCHOPHARMACOLOGY, V89, P261; NESTLER EJ, 1994, CELL, V79, P923, DOI 10.1016/0092-8674(94)90022-1; Pandey SC, 2001, J NEUROCHEM, V77, P943, DOI 10.1046/j.1471-4159.2001.00309.x; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PIERZCHALA K, 1987, PEPTIDES, V8, P1035, DOI 10.1016/0196-9781(87)90133-1; POMERLEAU OF, 1983, PSYCHOPHARMACOLOGY, V81, P61, DOI 10.1007/BF00439275; POMERLEAU OF, 1984, NEUROSCI BIOBEHAV R, V8, P503, DOI 10.1016/0149-7634(84)90007-1; Schroeder BE, 2002, BEHAV NEUROSCI, V116, P727, DOI 10.1037//0735-7044.116.4.727; Schroeder BE, 2001, NEUROSCIENCE, V105, P535, DOI 10.1016/S0306-4522(01)00221-4; Schroeder BE, 2000, SYNAPSE, V37, P146; SUTHERLAND G, 1995, PSYCHOPHARMACOLOGY, V120, P418, DOI 10.1007/BF02245813; Tanda GL, 1998, EUR J NEUROSCI, V10, P1179, DOI 10.1046/j.1460-9568.1998.00135.x; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Vaszar LT, 2002, RESPIRATION, V69, P381, DOI 10.1159/000064014; Walters CL, 2003, J NEUROCHEM, V87, P1237, DOI 10.1046/j.1471-4159.2003.02090.x; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Wewers ME, 1999, BRAIN RES, V822, P107, DOI 10.1016/S0006-8993(99)01095-1; WINDELL KL, 1996, J PHARMACOL EXP THER, V276, P306; Wong GY, 1999, ADDICTION, V94, P1227, DOI 10.1046/j.1360-0443.1999.948122713.x	59	164	169	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					933	943		10.1016/j.neuron.2005.05.005	http://dx.doi.org/10.1016/j.neuron.2005.05.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953421	Bronze			2022-12-28	WOS:000229922500012
J	Lin, WC; Dominguez, B; Yang, JF; Aryal, P; Brandon, EP; Gage, FH; Lee, KF				Lin, WC; Dominguez, B; Yang, JF; Aryal, P; Brandon, EP; Gage, FH; Lee, KF			Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism	NEURON			English	Article							CULTURED RAT MYOTUBES; TYROSINE-PHOSPHATASE; RECEPTOR CLUSTERS; GENETIC-EVIDENCE; GROWTH CONES; AGRIN; MUSCLE; PROTEIN; CDK5; EXPRESSION	Synapse formation requires interactions between pre- and postsynaptic cells to establish the connection of a presynaptic nerve terminal with the neurotransmitter receptor-rich postsynaptic apparatus. At developing vertebrate neuromuscular junctions, acetylcholine receptor (AChR) clusters of nascent postsynaptic apparatus are not apposed by presynaptic nerve terminals. Two opposing activities subsequently promote the formation of synapses: positive signals stabilize the innervated AChR clusters, whereas negative signals disperse those that are not innervated. Although the nerve-derived protein agrin has been suggested to be a positive signal, the negative signals remain elusive. Here, we show that cyclin-dependent kinase 5 (Cdk5) is activated by ACh agonists and is required for the ACh agonist-induced dispersion of the AChR clusters that have not been stabilized by agrin. Genetic elimination of Cdk5 or blocking ACh production prevents the dispersion of AChR clusters in agrin mutants. Therefore, we propose that ACh negatively regulates neuromuscular synapse formation through a Cdk5-dependent mechanism.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Lee, KF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	klee@salk.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044420, R21NS041994, R01NS047345] Funding Source: NIH RePORTER; NIA NIH HHS [AG104435] Funding Source: Medline; NICHD NIH HHS [HD34534] Funding Source: Medline; NINDS NIH HHS [NS44420, NS47345, NS41994] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; AVILA OL, 1989, J NEUROSCI, V9, P2902; Barber MJ, 1999, J NEUROSCI, V19, P9975; BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; Besset V, 1998, MOL REPROD DEV, V50, P18, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;18::AID-MRD3&gt;3.0.CO;2-#; Bezakova G, 2001, J CELL BIOL, V153, P1453, DOI 10.1083/jcb.153.7.1453; BLOCH RJ, 1979, J CELL BIOL, V82, P626, DOI 10.1083/jcb.82.3.626; BLOCH RJ, 1986, J NEUROSCI, V6, P691; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; Campagna JA, 1997, EUR J NEUROSCI, V9, P2269, DOI 10.1111/j.1460-9568.1997.tb01645.x; Chen JX, 2003, COMPUT SCI ENG, V5, P12, DOI 10.1109/MCISE.2003.1182957; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Dai ZS, 1998, J CELL BIOL, V141, P1613, DOI 10.1083/jcb.141.7.1613; DAVEY DF, 1986, J NEUROSCI, V6, P673; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FISCHBACH GD, 1980, J PHYSIOL-LONDON, V303, P125, DOI 10.1113/jphysiol.1980.sp013275; Fu AK, 2003, J NEUROCHEM, V87, P168; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; Lazzaro MA, 1997, J NEUROCHEM, V69, P348, DOI 10.1046/j.1471-4159.1997.69010348.x; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Liu F, 2001, P NATL ACAD SCI USA, V98, P11062, DOI 10.1073/pnas.191353898; Loeb JA, 2002, J NEUROSCI, V22, P2206, DOI 10.1523/JNEUROSCI.22-06-02206.2002; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; LUPA MT, 1989, J NEUROSCI, V9, P3937; Madhavan R, 2005, MOL CELL NEUROSCI, V28, P403, DOI 10.1016/j.mcn.2004.10.005; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OMalley JP, 1997, J CELL BIOL, V138, P159, DOI 10.1083/jcb.138.1.159; ROTZLER S, 1990, J CELL BIOL, V111, P655, DOI 10.1083/jcb.111.2.655; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; SHETTY KT, 1993, P NATL ACAD SCI USA, V90, P6844, DOI 10.1073/pnas.90.14.6844; SIEGELBAUM SA, 1984, DEV BIOL, V104, P366, DOI 10.1016/0012-1606(84)90092-7; Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tanowitz M, 1999, J NEUROSCI, V19, P9426; Tokuoka H, 2000, J CELL SCI, V113, P1059; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Trinidad JC, 2004, J BIOL CHEM, V279, P31622, DOI 10.1074/jbc.M400044200; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; Wells DG, 1999, P NATL ACAD SCI USA, V96, P1112, DOI 10.1073/pnas.96.3.1112; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; WOMBLE MD, 1986, AM J ANAT, V176, P191, DOI 10.1002/aja.1001760208; Wyatt RM, 2003, J NEUROCYTOL, V32, P777, DOI 10.1023/B:NEUR.0000020623.62043.33; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0	67	164	173	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					569	579		10.1016/j.neuron.2005.04.002	http://dx.doi.org/10.1016/j.neuron.2005.04.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944126	Bronze			2022-12-28	WOS:000229294300009
J	Hatton, CJ; Paoletti, P				Hatton, CJ; Paoletti, P			Modulation of triheteromeric NMDA receptors by N-terminal domain Ligands	NEURON			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; MOLECULAR CHARACTERIZATION; DEVELOPMENTAL-CHANGES; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURES; ZINC INHIBITION; BINDING DOMAIN; NR2A SUBUNIT; ACTIVATION	NMDA receptors (NMDARs) are heteromeric assemblies of NR1 and NR2(A-D) subunits with properties heavily influenced by the type of NF12 subunit incorporated. While NMDARs with only one type of NR2 subunit have been extensively characterized, little is known about receptors containing two different NR2 subunits, despite compelling evidence that such triheteromeric receptors exist in vivo. We used a point-mutation approach that allows isolation of recombinant triheteromeric NMDARs possessing two different NF12 N-terminal domains (NTDs). We show that in receptors associating the NR2A-NTD (sensing nanomolar Zn) and the NR2B-NTD (sensing ifenprodil), each NTD binding site retains selective high affinity for its ingand. However, each ligand produces only partial inhibition, and maximal inhibition requires occupancy of both NR2-NTDs by their respective ligands. Similarly, NR1/2A/2C receptors are inhibited by zinc with high potency but low efficacy. Therefore, interactions between homologous N-terminal domains determine the unique pharmacological properties of triheteromeric NIVIDARs.	Ecole Normale Super, CNRS, Neurobiol Lab, UMR 8544, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Paoletti, P (corresponding author), Ecole Normale Super, CNRS, Neurobiol Lab, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.	paoletti@biologie.ens.fr	Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				Anson LC, 1998, J NEUROSCI, V18, P581; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; Brickley SG, 2003, J NEUROSCI, V23, P4958; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Chazot PL, 1997, J NEUROCHEM, V69, P2138; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DIDIER M, 1995, NEUROREPORT, V6, P2255, DOI 10.1097/00001756-199511000-00036; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kew JNC, 1998, J NEUROSCI, V18, P1935; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Laube B, 1998, J NEUROSCI, V18, P2954; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Martell A. E., 1982, CRITICAL STABILITY C, V5; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mott DD, 1998, NAT NEUROSCI, V1, P659, DOI 10.1038/3661; Neugebauer R, 2003, BIOCHEM BIOPH RES CO, V305, P476, DOI 10.1016/S0006-291X(03)00768-X; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Sundstrom E, 1997, EXP NEUROL, V148, P407, DOI 10.1006/exnr.1997.6691; Tovar KR, 1999, J NEUROSCI, V19, P4180; WAFFORD KA, 1993, NEUROREPORT, V4, P1347, DOI 10.1097/00001756-199309150-00015; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x	54	190	198	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					261	274		10.1016/j.neuron.2005.03.005	http://dx.doi.org/10.1016/j.neuron.2005.03.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848804	Green Submitted, Bronze			2022-12-28	WOS:000228674800012
J	Bottjer, SW				Bottjer, SW			Timing and prediction: The code from basal ganglia to thalamus	NEURON			English	Editorial Material								When is an inhibitory synapse not inhibitory? In this issue of Neuron, Person and Perkel demonstrate that thalamic neurons can translate extrinsic GABAergic input from the basal ganglia into highly precise patterns of sustained spiking in a circuit that is essential for vocal learning in songbirds. Postinhibitory rebound serves as a mechanism that preserves precise spike timing information, enabling reliable propagation of activity throughout this pathway. The results have broad implications for basic mechanisms of functional processing in both thalamus and basal ganglia and serve to increase our understanding of how acoustic units of vocal sounds Eire transformed into motor gestures during the sensitive period for song learning.	Univ So Calif, Dept Biol, Los Angeles, CA 90089 USA	University of Southern California	Bottjer, SW (corresponding author), Univ So Calif, Dept Biol, 3641 Watt Way, Los Angeles, CA 90089 USA.							Bottjer SW, 2004, ANN NY ACAD SCI, V1016, P395, DOI 10.1196/annals.1298.037; Farries MA, 2002, J NEUROSCI, V22, P3776; Iyengar S, 2002, J NEUROSCI, V22, P946, DOI 10.1523/JNEUROSCI.22-03-00946.2002; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2002, J COMP PHYSIOL A, V188, P879, DOI 10.1007/s00359-002-0353-3; OLVECZKY BP, 2005, IN PRESS PLOS BIOL; Perkel DJ, 2004, ANN NY ACAD SCI, V1016, P736, DOI 10.1196/annals.1298.039; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Reiner A, 2004, J COMP NEUROL, V469, P239, DOI 10.1002/cne.11012; Troyer TW, 2001, CURR OPIN NEUROBIOL, V11, P721, DOI 10.1016/S0959-4388(01)00275-6	12	6	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					4	7		10.1016/j.neuron.2005.03.020	http://dx.doi.org/10.1016/j.neuron.2005.03.020			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820688	Bronze			2022-12-28	WOS:000228228600003
J	Brandish, PE; Su, M; Holder, DJ; Hodor, P; Szumiloski, J; Kleinhanz, RR; Forbes, JE; McWhorter, ME; Duenwald, SJ; Parrish, ML; Na, S; Liu, Y; Phillips, RL; Renger, JJ; Sankaranarayanan, S; Simon, AJ; Scolnick, EM				Brandish, PE; Su, M; Holder, DJ; Hodor, P; Szumiloski, J; Kleinhanz, RR; Forbes, JE; McWhorter, ME; Duenwald, SJ; Parrish, ML; Na, S; Liu, Y; Phillips, RL; Renger, JJ; Sankaranarayanan, S; Simon, AJ; Scolnick, EM			Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex	NEURON			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; BIPOLAR MOOD DISORDER; TRANSCRIPTION FACTOR; MESSENGER-RNA; BRAIN; TRIAL; PRAMIPEXOLE; LOCUS	Lithium inhibits inositol monophosphatase at therapeutically effective concentrations, and it has been hypothesized that depletion of brain inositol levels is an important chemical alteration for lithium's therapeutic efficacy in bipolar disorder. We have employed adult rat cortical slices as a model to investigate the gene regulatory consequences of inositol depletion effected by lithium using cytidine diphosphoryl-diacylglycerol as a functionally relevant biochemical marker to define treatment conditions. Genes coding for the neuropeptide hormone pituitary adenylate cyclase activating polypeptide (PACAP) and the enzyme that processes PACAP's precursor to the mature form, peptidylglycine alpha-amidating monooxygenase, were upregulated by inositol depletion. Previous work has shown that PACAP can increase tyrosine hydroxylase (TH) activity and dopamine release, and we found that the gene for GTP cyclohydrolase, which effectively regulates TH through synthesis of tetrahydrobiopterin, was also upregulated by inositol depletion. We propose that modulation of brain PACAP signaling might represent a new opportunity in the treatment of bipolar disorder.	Merck & Co Inc, West Point, PA 19486 USA; Rosetta Inpharmat LLC, Seattle, WA 98011 USA	Merck & Company; Merck & Company	Brandish, PE (corresponding author), Merck & Co Inc, West Point, PA 19486 USA.	philip_brandish@merck.com						ALLISON JH, 1971, NATURE-NEW BIOL, V233, P267, DOI 10.1038/newbio233267a0; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anderson ST, 1998, BRAIN RES, V790, P343, DOI 10.1016/S0006-8993(98)00176-0; ATACK JR, 1993, BRIT J PHARMACOL, V110, P809, DOI 10.1111/j.1476-5381.1993.tb13884.x; ATACK JR, 1992, J NEUROCHEM, V59, P1946, DOI 10.1111/j.1471-4159.1992.tb11031.x; BANKER G, 1998, CULTURING NERVE CELL; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Bonde C, 2002, NEUROSCI LETT, V327, P49, DOI 10.1016/S0304-3940(02)00382-8; Bowden CL, 2000, ARCH GEN PSYCHIAT, V57, P481, DOI 10.1001/archpsyc.57.5.481; Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392, DOI 10.1001/archpsyc.60.4.392; Chen G, 1998, J NEUROCHEM, V70, P1768; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dinan TG, 2002, BRIT MED J, V324, P989, DOI 10.1136/bmj.324.7344.989; GODFREY PP, 1989, BIOCHEM J, V258, P621, DOI 10.1042/bj2580621; Goldberg JF, 2004, AM J PSYCHIAT, V161, P564, DOI 10.1176/appi.ajp.161.3.564; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Gray SL, 2002, ENDOCRINOLOGY, V143, P3946, DOI 10.1210/en.2002-220401; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Hyland K, 2003, ANN NEUROL, V54, pS46, DOI 10.1002/ana.10695; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kawaguchi C, 2003, BIOCHEM BIOPH RES CO, V310, P169, DOI 10.1016/j.bbrc.2003.09.004; Kristensen BW, 2003, BRAIN RES, V964, P264, DOI 10.1016/S0006-8993(02)04080-5; Lenox RH, 2002, AM J MED GENET, V114, P391, DOI 10.1002/ajmg.10360; LENOX RH, 1998, TXB PSYCHOPHARMACOLO; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lubrich B, 1997, MOL PSYCHIATR, V2, P407, DOI 10.1038/sj.mp.4000267; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; McInnes LA, 2001, P NATL ACAD SCI USA, V98, P11485, DOI 10.1073/pnas.191519098; MIKKELSEN JD, 1994, NEUROSCI LETT, V171, P121, DOI 10.1016/0304-3940(94)90620-3; Mizushima K, 2000, GENOMICS, V69, P314, DOI 10.1006/geno.2000.6340; Moser A, 1999, NEUROPEPTIDES, V33, P492, DOI 10.1054/npep.1999.0768; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; O'Brien WT, 2004, J NEUROSCI, V24, P6791, DOI 10.1523/JNEUROSCI.4753-03.2004; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104; Pinhiero J.C., 2000, MIXED EFFECTS MODELS; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; SCHULLER HJ, 1995, FEBS LETT, V370, P149, DOI 10.1016/0014-5793(95)00818-T; Searle SR., 1992, VARIANCE COMPONENTS; SHANNON K, 2000, Patent No. 6132997; SHERMAN WR, 1986, FASEB J, V45, P2639; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; SMYTH GK, 2004, STAT APPL GENETICS M, V3; STUBBS EB, 1993, J NEUROCHEM, V60, P1292, DOI 10.1111/j.1471-4159.1993.tb03289.x; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Vaudry D, 2000, PHARMACOL REV, V52, P269; Wang L, 2001, J NEUROCHEM, V79, P816, DOI 10.1046/j.1471-4159.2001.00631.x; WEISSMAN MM, 1988, PSYCHOL MED, V18, P141, DOI 10.1017/S0033291700001975; WELSH DK, 1990, BIOL PSYCHIAT, V28, P117, DOI 10.1016/0006-3223(90)90629-G; Wilhelmi E, 2002, ATLA-ALTERN LAB ANIM, V30, P275, DOI 10.1177/026119290203000304; Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013	55	76	79	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					861	872		10.1016/j.neuron.2005.02.006	http://dx.doi.org/10.1016/j.neuron.2005.02.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797548	Bronze			2022-12-28	WOS:000228031300008
J	Engel, SA				Engel, SA			Adaptation of oriented and unoriented color-selective neurons in human visual areas	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; UNDERLYING CONTRAST ADAPTATION; MACAQUE STRIATE CORTEX; TEMPORAL CONTRAST; FUNCTIONAL MRI; CONE INPUTS; ORIENTATION; MONKEY; V2; MECHANISMS	Primary visual cortex contains at least two distinct populations of color-selective cells: neurons in one have circularly symmetric receptive fields and respond best to reddish and greenish light, while neurons in another have oriented receptive fields and a variety of color preferences. The relative prevalence and perceptual roles of the two kinds of neurons remain controversial, however. We used fMRI and a selective adaptation technique to measure responses attributable to these two populations. The technique revealed evidence of adaptation in both populations and indicated that they each produced strong signals in V1 and other human visual areas. The activity of both sets of neurons was also reflected in color appearance measurements made with the same stimuli. Thus, both oriented and unoriented color-selective cells in V1 are important components of the neural pathways that underlie perception of color.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Engel, SA (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1282A Franz Hall, Los Angeles, CA 90095 USA.	engel@psych.ucla.edu			NEI NIH HHS [EY11862] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011862, R55EY011862] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barnes J, 1999, NEUROREPORT, V10, P195, DOI 10.1097/00001756-199901180-00037; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Boynton GM, 2003, J NEUROSCI, V23, P8781; BRADLEY A, 1988, VISION RES, V28, P841, DOI 10.1016/0042-6989(88)90031-4; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Clifford CWG, 2003, J VISION, V3, P106, DOI 10.1167/3.2.1; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 1999, NEURON, V24, P893, DOI 10.1016/S0896-6273(00)81036-3; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; FLANAGAN P, 1990, VISION RES, V30, P768; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Kiper DC, 1997, VISUAL NEUROSCI, V14, P1061, DOI 10.1017/S0952523800011779; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3138, DOI 10.1152/jn.00957.1999; LENNIE P, 1990, J NEUROSCI, V10, P649; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; POIRSON AB, 1993, J OPT SOC AM A, V10, P2458, DOI 10.1364/JOSAA.10.002458; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Schluppeck Denis, 2002, J Vis, V2, P480, DOI 10.1167/2.6.5; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shipp S, 2002, VISUAL NEUROSCI, V19, P187, DOI 10.1017/S0952523802191164; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; THORELL LG, 1984, VISION RES, V24, P751, DOI 10.1016/0042-6989(84)90216-5; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721	52	73	74	2	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					613	623		10.1016/j.neuron.2005.01.014	http://dx.doi.org/10.1016/j.neuron.2005.01.014			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721246	Bronze			2022-12-28	WOS:000227099700016
J	Arlotta, P; Molyneaux, BJ; Chen, J; Inoue, J; Kominami, R; Macklis, JD				Arlotta, P; Molyneaux, BJ; Chen, J; Inoue, J; Kominami, R; Macklis, JD			Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo	NEURON			English	Article							ZINC-FINGER GENE; TRANSCRIPTIONAL REPRESSION; THALAMOCORTICAL AXONS; SUBCORTICAL TARGETS; BINDING PROTEIN-4; MOLECULAR-CLONING; SUBPLATE NEURONS; DEFICIENT MICE; COUP-TFI; EXPRESSION	Within the vertebrate nervous system, the presence of many different lineages of neurons and glia complicates the molecular characterization of single neuronal populations. In order to elucidate molecular mechanisms underlying the specification and development of corticospinal motor neurons (CSMN), we purified CSMN at distinct stages of development in vivo and compared their gene expression to two other pure populations of cortical projection neurons: callosal projection neurons and corticotectal projection neurons. We found genes that are potentially instructive for CSMN development, as well as genes that are excluded from CSMN and are restricted to other populations of neurons, even within the same cortical layer. Loss-of-function experiments in null mutant mice for Ctip2 (also known as Bcl1 1b), one of the newly characterized genes, demonstrate that it plays a critical role in the development of CSMN axonal projections to the spinal cord in vivo, confirming that we identified central genetic determinants of the CSMN population.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Stem Cell Inst, Boston, MA 02114 USA; Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata 9518122, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Niigata University	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	jeffrey_macklis@hms.harvard.edu	INOUE, Jun/O-7352-2016; Chen, Jinhui/A-7138-2009	INOUE, Jun/0000-0003-4145-3754; Chen, Jinhui/0000-0002-6864-7121; Molyneaux, Bradley/0000-0002-3377-1229				Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bayer S.A., 1991, NEOCORTICAL DEV; Becker T, 2002, MECH DEVELOP, V117, P75, DOI 10.1016/S0925-4773(02)00178-8; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; CAJAL SRY, 1928, RECUERDOS MI VIDA; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Coonan JR, 2001, J COMP NEUROL, V436, P248; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Fujimori KE, 2000, J COMP NEUROL, V417, P275, DOI 10.1002/(SICI)1096-9861(20000214)417:3<275::AID-CNE2>3.0.CO;2-7; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; GODEMENT P, 1987, DEVELOPMENT, V101, P697; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Huang ZY, 2003, MOL CELL BIOL, V23, P566, DOI 10.1128/MCB.23.2.566-578.2003; Inoue J, 2004, J OCUL PHARMACOL TH, V20, P1, DOI 10.1089/108076804772745419; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES EG, 1982, PROG BRAIN RES, V57, P361, DOI 10.1016/S0079-6123(08)64137-0; Kamme F, 2003, J NEUROSCI, V23, P3607; Kolle G, 2000, MECH DEVELOP, V90, P181, DOI 10.1016/S0925-4773(99)00248-8; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Liu Q, 2000, J NEUROSCI, V20, P7682; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; Mori JI, 2002, ENDOCRINOLOGY, V143, P1538, DOI 10.1210/en.143.4.1538; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Olson MF, 2003, CURR BIOL, V13, pR360, DOI 10.1016/S0960-9822(03)00277-X; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Polleux F, 2001, CEREB CORTEX, V11, P1027, DOI 10.1093/cercor/11.11.1027; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Rolf B, 2002, J NEUROSCI, V22, P8357; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; SANGAMESWARAN L, 1989, P NATL ACAD SCI USA, V86, P5651, DOI 10.1073/pnas.86.14.5651; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; SARIS CJM, 1987, J BIOL CHEM, V262, P10663; Segovia L, 1997, Mol Vis, V3, P9; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; STENVERS KL, 1994, J COMP NEUROL, V339, P91, DOI 10.1002/cne.903390109; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Sugimoto K, 1996, J BIOL CHEM, V271, P11548, DOI 10.1074/jbc.271.19.11548; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6; Zhou R, 2003, J ENDOCRINOL, V178, P177, DOI 10.1677/joe.0.1780177	57	778	789	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 20	2005	45	2					207	221		10.1016/j.neuron.2004.12.036	http://dx.doi.org/10.1016/j.neuron.2004.12.036			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664173	Bronze			2022-12-28	WOS:000226451500008
J	Sgaier, SK; Millet, S; Villanueva, MP; Berenshteyn, F; Song, C; Joyner, AL				Sgaier, SK; Millet, S; Villanueva, MP; Berenshteyn, F; Song, C; Joyner, AL			Morphogenetic and cellular movements that shape the mouse cerebellum: Insights from genetic fate mapping	NEURON			English	Article							SITE-SPECIFIC RECOMBINATION; MID-HINDBRAIN; RHOMBIC LIP; EXPRESSION; CELLS; PROGENITORS; TAMOXIFEN; REPLACEMENT; MIGRATION; PATTERNS	We used the cerebellum as a model to study the morphogenetic and cellular processes underlying the formation of elaborate brain structures from a simple neural tube, using an inducible genetic fate mapping approach in mouse. We demonstrate how a 90 rotation between embryonic days 9 and 12 converts the rostral-caudal axis of dorsal rhombomere 1 into the medial-lateral axis of the wing-like bilateral cerebellar primordium. With the appropriate use of promoters, we marked specific medial-lateral domains of the cerebellar primordium and derived a positional fate map of the murine cerebellum. We show that the adult medial cerebellum is produced by expansion, rather than fusion, of the thin medial primordium. Furthermore, ventricular-derived cells maintain their original medial-lateral coordinates into the adult, whereas rhombic lip-derived granule cells undergo lateral to medial posterior transverse migrations during foliation. Thus, we show that progressive changes in the axes of the cerebellum underlie its genesis.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; GenOway SA, F-69007 Lyon, France	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Joyner, AL (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	joyner@saturn.med.nyu.edu		Song, Christian/0000-0003-3807-3398				Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Altman J, 1997, DEV CEREBELLAR SYSTE; Bai CB, 2002, DEVELOPMENT, V129, P4753; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamre KM, 1997, DEVELOPMENT, V124, P4201; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hanks MC, 1998, DEVELOPMENT, V125, P4521; Helms AW, 1998, DEVELOPMENT, V125, P919; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Lin JC, 1999, DEV BIOL, V211, P177, DOI 10.1006/dbio.1999.9316; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; Mathis L, 1997, DEVELOPMENT, V124, P4089; Matise MP, 2000, PRACT APPROACH SER, V212, P101; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Millet S, 1996, DEVELOPMENT, V122, P3785; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; OTERO RA, 1993, J COMP NEUROL, V333, P597, DOI 10.1002/cne.903330411; Papaioannou V, 2000, PRACT APPROACH SER, V212, P133; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rosario CM, 1997, DEVELOPMENT, V124, P4213; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; Sidman R. L., 1982, HISTOL HISTOPATHOL, P3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	42	129	130	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					27	40		10.1016/S0896-6273(04)00802-5	http://dx.doi.org/10.1016/S0896-6273(04)00802-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629700	Bronze			2022-12-28	WOS:000226217100007
J	Bezdudnaya, T; Cano, M; Bereshpolova, Y; Stoelzel, CR; Alonso, JM; Swadlow, HA				Bezdudnaya, T; Cano, M; Bereshpolova, Y; Stoelzel, CR; Alonso, JM; Swadlow, HA			Thalamic burst mode and inattention in the awake LGNd	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; PRIMARY VISUAL-CORTEX; INFORMATION-PROCESSING STATES; AXONAL PROPERTIES; REFRACTIVE STATE; RESPONSE-MODES; RELAY NEURONS; IN-VIVO; EYE	Awake mammals are often inattentive in familiar environments, but must still respond appropriately to relevant visual stimulation. Such "inattentive vision" has received little study, perhaps due to difficulties in controlling eye position in this state. In rabbits, eye position is exceedingly stable in both alert and inattentive states. Here, we exploit this stability to examine temporal filtering of visual information in LGNd neurons as rabbits alternate between EEG-defined states. Within a single second of shifting from alert to an inattentive state, both peak temporal frequency and bandwidth were sharply reduced, and burst frequency increased dramatically. However, spatial dimensions of receptive field centers showed no significant state dependence. We conclude that extremely rapid and significant changes in temporal filtering and bursting occur in the LGNd as awake subjects shift between alert and inattentive states.	Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; SUNY Coll Optometry, Dept Sci Biol, New York, NY 10036 USA	University of Connecticut; State University of New York (SUNY) System; SUNY Optometry	Swadlow, HA (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	harvey.swadlow@uconn.edu	cano, monica/F-5833-2010		NEI NIH HHS [EY13788] Funding Source: Medline; NIMH NIH HHS [MH-64024] Funding Source: Medline; NATIONAL EYE INSTITUTE [R03EY013788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alitto HJ, 2005, J NEUROSCI, V25, P514, DOI 10.1523/JNEUROSCI.3369-04.2005; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; BARTLETT JR, 1973, EXP BRAIN RES, V18, P214; Carandini M, 1997, J NEUROSCI, V17, P8621; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; COLLEWIJN H, 1971, DOC OPHTHALMOL, V30, P205, DOI 10.1007/BF00142520; DEGRAAUW JG, 1977, PHYSIOL BEHAV, V21, P257; Denning KS, 2005, J NEUROSCI, V25, P3531, DOI 10.1523/JNEUROSCI.4417-04.2005; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; FULLER JH, 1981, BRAIN RES, V205, P363, DOI 10.1016/0006-8993(81)90346-2; FUNKE K, 1992, BRAIN RES, V573, P217, DOI 10.1016/0006-8993(92)90766-3; GLICKSTEIN M, 1970, SCIENCE, V168, P605, DOI 10.1126/science.168.3931.605; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Grubb MS, 2005, J NEUROPHYSIOL, V93, P3224, DOI 10.1152/jn.00445.2004; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; GUIDO W, 1995, VISUAL NEUROSCI, V12, P723, DOI 10.1017/S0952523800008993; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HUGHES A, 1978, VISION RES, V18, P1351, DOI 10.1016/0042-6989(78)90226-2; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Lotze M, 2000, VISION RES, V40, P3467, DOI 10.1016/S0042-6989(00)00175-9; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MAFFEI L, 1965, ARCH ITAL BIOL, V103, P596; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; MEYER DL, 1972, PFLUG ARCH EUR J PHY, V332, P80, DOI 10.1007/BF00603816; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; Prince JH., 1964, RABBIT EYE RES; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; REITBOECK HJ, 1983, J NEUROSCI METH, V8, P249, DOI 10.1016/0165-0270(83)90038-9; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rivadulla C, 2003, J PHYSIOL-LONDON, V553, P601, DOI 10.1113/jphysiol.2003.048561; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roge J, 2002, PERCEPT MOTOR SKILL, V95, P118; Sharma T, 2002, J PSYCHOPHARMACOL, V16, P183, DOI 10.1177/026988110201600210; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SINGER W, 1977, PHYSIOL REV, V57, P386, DOI 10.1152/physrev.1977.57.3.386; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; SNODDERLY DM, 1985, VISION RES, V25, P83, DOI 10.1016/0042-6989(85)90083-5; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Swadlow HA, 2005, J NEUROPHYSIOL, V93, P2959, DOI 10.1152/jn.01141.2004; Swadlow HA, 2002, J NEUROSCI, V22, P7766; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P168, DOI 10.1152/jn.1985.54.1.168; SWADLOW HA, 1987, J NEUROPHYSIOL, V57, P977, DOI 10.1152/jn.1987.57.4.977; UHLRICH DJ, 1995, J NEUROPHYSIOL, V73, P2428, DOI 10.1152/jn.1995.73.6.2428; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157	56	96	99	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					421	432		10.1016/j.neuron.2006.01.010	http://dx.doi.org/10.1016/j.neuron.2006.01.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446145	Bronze			2022-12-28	WOS:000235260900013
J	Kreiman, G; Hung, CP; Kraskov, A; Quiroga, RQ; Poggio, T; DiCarlo, JJ				Kreiman, G; Hung, CP; Kraskov, A; Quiroga, RQ; Poggio, T; DiCarlo, JJ			Object selectivity of local field potentials and spikes in the macaque inferior temporal cortex	NEURON			English	Article							INFEROTEMPORAL CORTEX; EVOKED-POTENTIALS; MONKEY; RECOGNITION; NEURONS; RESPONSES; REPRESENTATION; FEATURES; AREA; FACE	Local field potentials (LFPs) arise largely from dendritic activity over large brain regions and thus provide a measure of the input to and local processing within an area. We characterized LFPs and their relationship to spikes (multi and single unit) in monkey inferior temporal cortex (IT). LFP responses in IT to complex objects showed strong selectivity at 44% of the sites and tolerance to retinal position and size. The LFP preferences were poorly predicted by the spike preferences at the same site but were better explained by averaging spikes within similar to 3 mm. A comparison of separate sites suggests that selectivity is similar on a scale of similar to 800 mu m for spikes and similar to 5 mm for LFPs. These observations imply that inputs to IT neurons convey selectivity for complex shapes and that such input may have an underlying organization spanning several millimeters.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Ctr Biol & Computat Learning, Cambridge, MA 02139 USA; MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England; CALTECH, Div Biol, Pasadena, CA 91125 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Leicester; California Institute of Technology	Kreiman, G (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kreiman@mit.edu	Kraskov, Alexander/J-7964-2012	Kraskov, Alexander/0000-0002-3576-4719; Kreiman, Gabriel/0000-0003-3505-8475	Engineering and Physical Sciences Research Council [EP/D052254/1] Funding Source: researchfish; EPSRC [EP/D052254/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; Donchin O, 2001, EXP BRAIN RES, V140, P46, DOI 10.1007/s002210100784; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2133, DOI 10.1152/jn.1998.80.4.2133; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GOCHIN PM, 1991, EXP BRAIN RES, V84, P505; GROSS CG, 1994, CEREB CORTEX, V4, P455, DOI 10.1093/cercor/4.5.455; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Gustavsen K, 2003, CURR BIOL, V13, pR234, DOI 10.1016/S0960-9822(03)00159-3; HABERLY LB, 1973, J NEUROPHYSIOL, V36, P789, DOI 10.1152/jn.1973.36.4.789; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Juergens E, 1999, EXP BRAIN RES, V129, P247, DOI 10.1007/s002210050895; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayser C, 2004, CEREB CORTEX, V14, P881, DOI 10.1093/cercor/bhh047; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; KOCH C, 1999, BIOPHYSICS COMPUTATO; Kreiman G., 2004, Physics of Life Reviews, V1, P71, DOI 10.1016/j.plrev.2004.06.001; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MATHIESEN C, 2000, J PHYSL, V523, P2353; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; NAHM FKD, 1994, EXP BRAIN RES, V98, P401; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Press W. H., 1996, NUMERICAL RECIPES C; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; RICHMOND BJ, 1983, J NEUROPHYSIOL, V50, P1415, DOI 10.1152/jn.1983.50.6.1415; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; SATO T, 1980, EXP BRAIN RES, V38, P313; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665	48	227	228	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					433	445		10.1016/j.neuron.2005.12.019	http://dx.doi.org/10.1016/j.neuron.2005.12.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446146	Bronze			2022-12-28	WOS:000235260900014
J	Sherman, DL; Tait, S; Melrose, S; Johnson, R; Zonta, B; Court, FA; Macklin, WB; Meek, S; Smith, AJH; Cottrell, DF; Brophy, PJ				Sherman, DL; Tait, S; Melrose, S; Johnson, R; Zonta, B; Court, FA; Macklin, WB; Meek, S; Smith, AJH; Cottrell, DF; Brophy, PJ			Neurofascins are required to establish axonal domains for saltatory conduction	NEURON			English	Article							CELL-ADHESION MOLECULES; MYELINATED AXONS; ANKYRIN-G; INITIAL SEGMENTS; PROTEIN CASPR; NR-CAM; RANVIER; NODES; PERIAXIN; DIFFERENTIATION	Voltage-gated sodium channels are concentrated in myelinated nerves at the nodes of Ranvier flanked by paranodal axoglial junctions. Establishment of these essential nodal and paranodal domains is determined by myelin-forming glia, but the mechanisms are not clear. Here, we show that two isoforms of Neurofascin, Nfasc155 in glia and Nfasc186 in neurons, are required for the assembly of these specialized domains. In Neurofascin-null mice, neither paranodal adhesion junctions nor nodal complexes are formed. Transgenic expression of Nfasc155 in the myelinating glia of Nfasc(-/-) nerves rescues the axoglial adhesion complex by recruiting the axonal proteins Caspr and Contactin to the paranodes. However, in the absence of Nfasc186, sodium channels remain diffusely distributed along the axon. Our study shows that the two major Neurofascins play essential roles in assembling the nodal and paranodal domains of myelinated axons; therefore, they are essential for the transition to saltatory conduction in developing vertebrate nerves.	Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; Univ Edinburgh, Inst Stem Cell Res, Gene Targeting Lab, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh; Cleveland Clinic Foundation; University of Edinburgh	Brophy, PJ (corresponding author), Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland.	peter.brophy@ed.ac.uk	Court, Felipe/C-5911-2015	Court, Felipe/0000-0002-1384-2552; Court, Felipe/0000-0002-9394-7601	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025304] Funding Source: NIH RePORTER; Medical Research Council [G0301172, G0000221] Funding Source: Medline; Multiple Sclerosis Society [669] Funding Source: Medline; NINDS NIH HHS [R01 NS025304] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000221, G0301172] Funding Source: UKRI	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Multiple Sclerosis Society(National Multiple Sclerosis Society); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; Custer AW, 2003, J NEUROSCI, V23, P10032; DAVIDSON JM, 1993, J CELL BIOCHEM, P109; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Lambert S, 1997, J NEUROSCI, V17, P7025; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Ranvier LA, 1875, TRAITE TECHNIQUE HIS; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443	32	253	269	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					737	742		10.1016/j.neuron.2005.10.019	http://dx.doi.org/10.1016/j.neuron.2005.10.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337912	Bronze			2022-12-28	WOS:000233927300013
J	Aton, SJ; Herzog, ED				Aton, SJ; Herzog, ED			Come together, right...now: Synchronization of rhythms in a mammalian circadian clock	NEURON			English	Review							SUPRACHIASMATIC NUCLEUS; VPAC(2) RECEPTOR; PHASE-SHIFTS; OSCILLATORS; MOUSE; BRAIN; PACEMAKER; NEURONS; CELLS; VIP	In mammals, the suprachiasmatic nuclei (SCN) of the hypothalamus act as a dominant circadian pacemaker, coordinating rhythms throughout the body and regulating daily and seasonal changes in physiology and behavior. This review focuses on the mechanisms that mediate synchronization of circadian rhythms between SCN neurons. Understanding how these neurons communicate as a network of circadian oscillators has begun to shed light on the adaptability and dysfunction of the brain's master clock.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Herzog, ED (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	herzog@wustl.edu		Herzog, Erik/0000-0001-7209-5174; Aton, Sara/0000-0002-2921-0509	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH073302] Funding Source: NIH RePORTER; NIMH NIH HHS [F31 MH073302] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Antle MC, 2003, J BIOL RHYTHM, V18, P339, DOI 10.1177/0748730403253840; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Gonze D, 2005, BIOPHYS J, V89, P120, DOI 10.1529/biophysj.104.058388; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 2000, NEUROSCI LETT, V294, P113, DOI 10.1016/S0304-3940(00)01558-5; Itri J, 2003, J NEUROPHYSIOL, V90, P1589, DOI 10.1152/jn.00332.2003; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; McArthur AJ, 2000, J NEUROSCI, V20, P5496, DOI 10.1523/JNEUROSCI.20-14-05496.2000; Nagano M, 2003, J NEUROSCI, V23, P6141; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Schwartz WJ, 2001, J BIOL RHYTHM, V16, P302, DOI 10.1177/074873001129002024; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Takeuchi T, 2001, EUR J NEUROSCI, V14, P153, DOI 10.1046/j.0953-816x.2001.01620.x; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	37	198	206	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					531	534		10.1016/j.neuron.2005.11.001	http://dx.doi.org/10.1016/j.neuron.2005.11.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301169	Green Accepted, Bronze			2022-12-28	WOS:000233677300006
J	Kilgard, MP				Kilgard, MP			Cortical map reorganization without cholinergic modulation	NEURON			English	Editorial Material							PLASTICITY; PROJECTIONS	Acetylcholine has been shown to modulate many forms of cortical plasticity. New evidence indicates that reorganization of adult primary auditory cortex is still possible after removal of cholinergic inputs. This finding suggests that acetylcholine may act less as a gate and more as a gain control on cortical plasticity.	Univ Texas, Cognit & Neurosci Program, Sch Behav & Brain Sci, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Kilgard, MP (corresponding author), Univ Texas, Cognit & Neurosci Program, Sch Behav & Brain Sci, GR41, Richardson, TX 75083 USA.			Kilgard, Michael/0000-0002-6699-1818				Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Kamke MR, 2005, NEURON, V48, P675, DOI 10.1016/j.neuron.2005.09.014; Kilgard MP, 2002, BIOL CYBERN, V87, P333, DOI 10.1007/s00422-002-0352-z; McGaughy J, 2000, BEHAV BRAIN RES, V115, P251, DOI 10.1016/S0166-4328(00)00262-X; Richardson R T, 1991, Adv Exp Med Biol, V295, P233; Sarter M, 2002, EUR J NEUROSCI, V15, P1867, DOI 10.1046/j.1460-9568.2002.02004.x; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8	9	5	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					529	530		10.1016/j.neuron.2005.11.003	http://dx.doi.org/10.1016/j.neuron.2005.11.003			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301168	Bronze			2022-12-28	WOS:000233677300005
J	Miller, BT; D'Esposito, M				Miller, BT; D'Esposito, M			Searching for "the top" in top-down control	NEURON			English	Review							PREFRONTAL CORTEX; VISUAL-CORTEX; NEURAL MECHANISMS; WORKING-MEMORY; FUNCTIONAL MRI; ATTENTION; DYNAMICS; LATENCY; SIGNALS; TASK	Although numerous theoretical models implicate the prefrontal cortex (PFC) as a source of top-down control signals, empirical support is limited. In this review, we highlight direct evidence for this view of PFC function and discuss several lines of other supportive findings. Most evidence to-date is only suggestive due to methodological challenges in tracking the spatio-temporal dynamics of cortical networks. However, we discuss several promising approaches that could further our understanding of the role of the PFC in goal-directed behavior.	Univ Calif Berkeley, Helens Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Miller, BT (corresponding author), Univ Calif Berkeley, Helens Wills Neurosci Inst, Berkeley, CA 94720 USA.	btmiller@berkeley.edu						Bellgowan PSF, 2003, P NATL ACAD SCI USA, V100, P1415, DOI 10.1073/pnas.0337747100; Buckner RL, 2003, P NATL ACAD SCI USA, V100, P2177, DOI 10.1073/pnas.0630492100; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Druzgal TJ, 2003, J COGNITIVE NEUROSCI, V15, P771, DOI 10.1162/089892903322370708; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rowe JB, 2005, CEREB CORTEX, V15, P85, DOI 10.1093/cercor/bhh111; Sun FT, 2005, NEUROIMAGE, V28, P227, DOI 10.1016/j.neuroimage.2005.05.043; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372	22	205	210	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 23	2005	48	4					535	538		10.1016/j.neuron.2005.11.002	http://dx.doi.org/10.1016/j.neuron.2005.11.002			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301170	Bronze			2022-12-28	WOS:000233677300007
J	Zigman, M; Cayouette, M; Charalambous, C; Schleiffer, A; Hoeller, O; Dunican, D; McCudden, CR; Firnberg, N; Barres, BA; Siderovski, DP; Knoblich, JA				Zigman, M; Cayouette, M; Charalambous, C; Schleiffer, A; Hoeller, O; Dunican, D; McCudden, CR; Firnberg, N; Barres, BA; Siderovski, DP; Knoblich, JA			Mammalian inscuteable regulates spindle orientation and cell fate in the developing retina	NEURON			English	Article							DROSOPHILA NEUROBLASTS; ASYMMETRIC LOCALIZATION; DIVISION; PROTEIN; NEUROGENESIS; PINS; DIFFERENTIATION; IDENTIFICATION; INHERITANCE; VERTEBRATES	During mammalian neurogenesis, progenitor cells can divide with the mitotic spindle oriented parallel or perpendicular to the surface of the neuroepithelium. Perpendicular divisions are more likely to be asymmetric and generate one progenitor and one neuronal precursor. Whether the orientation of the mitotic spindle actually determines their asymmetric outcome is unclear. Here, we characterize a mammalian homolog of Inscuteable (mlnsc), a key regulator of spindle orientation in Drosophila. mlnsc is expressed temporally and spatially in a manner that suggests a role in orienting the mitotic spindle in the developing nervous system. Using retroviral RNAi in rat retinal explants, we show that downregulation of mlnsc inhibits vertical divisions. This results in enhanced proliferation, consistent with a higher frequency of symmetric divisions generating two proliferating cells. Our results suggest that the orientation of neural progenitor divisions is important for cell fate specification in the retina and determines their symmetric or asymmetric outcome.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; Med Univ Vienna, A-1090 Vienna, Austria; MRC, Cambridge CB2 2QH, England; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of North Carolina; University of North Carolina Chapel Hill	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Zigman, Mihaela/E-9430-2014; Siderovski, David Peter/AAA-9603-2019; Dunican, Dara/A-1208-2010	Knoblich, Juergen A/0000-0002-6751-3404; Siderovski, David Peter/0000-0002-0688-8210; Dunican, Dara/0000-0001-6563-8089; Zigman, Mihaela/0000-0001-8306-1922; Schleiffer, Alexander/0000-0001-6251-2747; McCudden, Christopher/0000-0002-4172-4641; Cayouette, Michel/0000-0003-4655-9048	NATIONAL EYE INSTITUTE [R01EY011310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533, R01GM062338] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11310] Funding Source: Medline; NIGMS NIH HHS [P01 GM065533, R01 GM062338] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DAVIDSON EH, 1991, DEVELOPMENT, V113, P1; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Irion U, 2004, CURR BIOL, V14, P138, DOI 10.1016/j.cub.2004.01.002; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Katoh M, 2003, INT J MOL MED, V11, P111; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; MARTIN AH, 1967, NATURE, V216, P1133, DOI 10.1038/2161133a0; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9	32	103	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					539	545		10.1016/j.neuron.2005.09.030	http://dx.doi.org/10.1016/j.neuron.2005.09.030			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301171	Green Published, Bronze			2022-12-28	WOS:000233677300008
J	Deisseroth, K; Malenka, RC				Deisseroth, K; Malenka, RC			GABA excitation in the adult brain: A mechanism for excitation-neurogenesis coupling	NEURON			English	Editorial Material							PROGENITOR CELLS; DENTATE GYRUS; SUBPOPULATION	The production of new neurons in the adult hippocampus is exquisitely regulated, and alterations in this process may underlie both normal and pathological hippocampal function. In this issue of Neuron, Tozuka et al. describe electrophysiological recordings that target proliferating progenitor cells in adult mouse hippocampal slices. They report that GABAergic synaptic inputs directly depolarize the proliferating progenitors, thereby activating molecular players that favor neuronal differentiation and providing a mechanism for direct excitation-neurogenesis coupling in vivo.	Stanford Univ, Sch Med, Dept Bioengn, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Sch Med, Dept Bioengn, Palo Alto, CA 94304 USA.							Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Fukuda S, 2003, J NEUROSCI, V23, P9357; Lehmann K, 2005, EUR J NEUROSCI, V21, P3205, DOI 10.1111/j.1460-9568.2005.04156.x; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002	13	22	23	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					775	777		10.1016/j.neuron.2005.08.029	http://dx.doi.org/10.1016/j.neuron.2005.08.029			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157270	Bronze			2022-12-28	WOS:000232085000003
J	Yi, JJ; Ehlers, MD				Yi, JJ; Ehlers, MD			Ubiquitin and protein turnover in synapse function	NEURON			English	Review							GLR-1 GLUTAMATE RECEPTORS; VENTRAL NERVE CORD; C-ELEGANS; PROTEASOME SYSTEM; DEGRADATION; ABUNDANCE; COMPLEX; ENDOCYTOSIS; PATHWAY; KINASE	Enduring modification of synapses is central to long-lasting neural circuit plasticity. Such adaptations include rapid posttranslational modification of existing synaptic proteins over periods of minutes and persisting changes in the abundance of synaptic proteins over hours to days. Recently, ubiquitination and protein degradation have emerged as additional mechanisms for modifying the function and molecular composition of synapses. These recent findings raise intriguing questions as to how enduring changes at synapses are accomplished in the face of robust, ongoing molecular turnover.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu		Yi, Jason/0000-0001-9648-9899				Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006	19	113	116	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					629	632		10.1016/j.neuron.2005.07.008	http://dx.doi.org/10.1016/j.neuron.2005.07.008			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129392	Bronze			2022-12-28	WOS:000231782700004
J	Rashid, T; Upton, AL; Blentic, A; Ciossek, T; Knoll, B; Thompson, ID; Drescher, U				Rashid, T; Upton, AL; Blentic, A; Ciossek, T; Knoll, B; Thompson, ID; Drescher, U			Opposing gradients of ephrin-As and EphA7 in the superior colliculus are essential for topographic mapping in the mammalian visual system	NEURON			English	Article							CONTROL AXON GROWTH; TYROSINE PHOSPHORYLATION; RETINOTECTAL MAP; FAMILY RECEPTORS; LIGANDS; EXPRESSION; GUIDANCE; KINASE; ARBORIZATION; ORGANIZATION	During development of the retinocollicular projection in mouse, retinal axons initially overshoot their future termination zones (TZs) in the superior colliculus (SC). The formation of TZs is initiated by interstitial branching at topographically appropriate positions. Ephrin-As are expressed in a decreasing posterior-to-anterior gradient in the SC, and they suppress branching posterior to future TZs. Here we investigate the role of an EphA7 gradient in the SC, which has the reverse orientation to the ephrin-A gradient. We find that in EphA7 mutant mice the retinocollicular map is disrupted, with nasal and temporal axons forming additional or extended TZs, respectively. In vitro, retinal axons are repelled from growing on EphA7-containing stripes. Our data support the idea that EphA7 is involved in suppressing branching anterior to future TZs. These findings suggest that opposing ephrin-A and EphA gradients are required for the proper development of the retinocollicular projection.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	University of London; King's College London; University of Oxford; Max Planck Society	Drescher, U (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, New Hunts House,Guys Hosp Campus, London SE1 1UL, England.	uwe.drescher@kcl.ac.uk	Thompson, Ian D/C-5785-2009; Drescher, Uwe/C-5438-2009	Drescher, Uwe/0000-0001-9725-7643	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brennan C, 1997, DEVELOPMENT, V124, P655; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; CIOSSEK T, 1995, ONCOGENE, V10, P97; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; FUJISAWA H, 1981, BRAIN RES, V206, P27, DOI 10.1016/0006-8993(81)90098-6; GIERER A, 1983, PROC R SOC SER B-BIO, V218, P77, DOI 10.1098/rspb.1983.0027; GIERER A, 1988, BIOL CYBERN, V59, P13, DOI 10.1007/BF00336886; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Goodhill GJ, 2000, NEURON, V25, P501, DOI 10.1016/S0896-6273(00)81051-X; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Knoll B, 2001, DEVELOPMENT, V128, P895; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Marin O, 2001, DEV BIOL, V234, P289, DOI 10.1006/dbio.2001.0268; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 1999, NEURON, V22, P636, DOI 10.1016/S0896-6273(00)80718-7; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; SIMON DK, 1992, J NEUROSCI, V12, P1212; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Takahashi H, 2003, DEVELOPMENT, V130, P5203, DOI 10.1242/dev.00724; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WALTER J, 1987, DEVELOPMENT, V101, P909; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wilkinson DG, 2000, CURR BIOL, V10, pR447, DOI 10.1016/S0960-9822(00)00530-3; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	60	125	127	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					57	69		10.1016/j.neuron.2005.05.030	http://dx.doi.org/10.1016/j.neuron.2005.05.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996548	Bronze			2022-12-28	WOS:000230464000008
J	Ceni, C; Barker, PA				Ceni, C; Barker, PA			Getting RIP'd stunts your growth	NEURON			English	Editorial Material							P75 NEUROTROPHIN RECEPTOR; AXONAL REGENERATION; FAMILY-MEMBER; APOPTOSIS; MYELIN; RHO	The p75 neurotrophin receptor (p75NTR) collaborates with the Nogo receptor (NgR) and LINGO-1 to activate RhoA in response to myelin-based growth inhibitors such as myelin-associated glycoprotein (MAG). In this issue of Neuron, Domeniconi et al., in a surprising turn, show that MAG induces intramembrane proteolysis (RIP) of p75NTR and find that p75NTR cleavage is required for MAG-induced RhoA activation and growth inhibition.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada	McGill University	Ceni, C (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.							Bhakar AL, 2003, J NEUROSCI, V23, P11373; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Majdan M, 1997, J NEUROSCI, V17, P6988; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	12	7	12	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 16	2005	46	6					839	840		10.1016/j.neuron.2005.06.002	http://dx.doi.org/10.1016/j.neuron.2005.06.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953410	Bronze			2022-12-28	WOS:000229922500001
J	Lin, SC; Huck, JHJ; Roberts, JDB; Macklin, WB; Somogyi, P; Bergles, DE				Lin, SC; Huck, JHJ; Roberts, JDB; Macklin, WB; Somogyi, P; Bergles, DE			Climbing fiber innervation of NG2-expressing glia in the mammalian cerebellum	NEURON			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; CENTRAL-NERVOUS-SYSTEM; SYNAPTICALLY RELEASED GLUTAMATE; PURKINJE-CELLS; PROGENITOR CELLS; GABAERGIC INTERNEURONS; SUBVENTRICULAR ZONE; RAT CEREBELLUM; ACID RECEPTORS; DEVELOPMENTAL FATES	The molecular layer of the cerebellar cortex is populated by glial progenitors that express ionotropic glutamate receptors and extend numerous processes among Purkinje cell dendrites. Here, we show that release of glutamate from climbing fiber (CF) axons produces AMPA receptor currents with rapid kinetics in these NG2-immunoreactive glial cells (NG2(+) cells) in cerebellar slices. NG2(+) cells may receive up to 70 discrete inputs from one CF and, unlike mature Purkinje cells, are often innervated by multiple CFs. Paired Purkinje cell-NG2(+) cell recordings show that one CF can innervate both cell types. CF boutons make direct synaptic junctions with NG2(+) cell processes, indicating that this rapid neuron-glia signaling occurs at discrete sites rather than through ectopic release at CF-Purkinje cell synapses. This robust activation of Ca2+-permeable AMPA receptors in NG2+ cells expands the influence of the olivocerebellar projection to this abundant class of glial progenitors.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Johns Hopkins University; Cleveland Clinic Foundation	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Huck, Jojanneke/B-1534-2013	Bergles, Dwight/0000-0002-7133-7378; Huck, Jojanneke/0000-0002-3853-8581	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025304] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS025304] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Cash S, 1996, SCIENCE, V272, P998, DOI 10.1126/science.272.5264.998; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; DESCLIN JC, 1976, ANAT EMBRYOL, V149, P87, DOI 10.1007/BF00315087; Diamond JS, 1997, J NEUROSCI, V17, P4672; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Dzubay JA, 1999, J NEUROSCI, V19, P5265; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Fortin M, 1998, NEUROSCI RES, V30, P155, DOI 10.1016/S0168-0102(97)00124-7; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; GALLO V, 1994, GLIA, V11, P94, DOI 10.1002/glia.440110204; Hall A, 1996, DEVELOPMENT, V122, P4085; HAMORI J, 1980, BRAIN RES, V186, P454, DOI 10.1016/0006-8993(80)90990-7; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Ichikawa R, 2002, J NEUROSCI, V22, P8487; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jorntell H, 2003, J NEUROSCI, V23, P9620; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Koutmani Y, 2004, EUR J NEUROSCI, V20, P2509, DOI 10.1111/j.1460-9568.2004.03724.x; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; LEVINE JM, 1987, J NEUROSCI, V7, P2711; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Lin SC, 2002, J NEUROCYTOL, V31, P537, DOI 10.1023/A:1025799816285; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; MARIANI J, 1981, J NEUROSCI, V1, P703, DOI 10.1523/JNEUROSCI.01-07-00703.1981; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Muller T, 1996, GLIA, V17, P274, DOI 10.1002/(SICI)1098-1136(199608)17:4<274::AID-GLIA2>3.0.CO;2-#; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Palay S. L., 1974, CEREBELLAR CORTEX CY; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; PENDE M, 1994, P NATL ACAD SCI USA, V91, P3215, DOI 10.1073/pnas.91.8.3215; Peters A, 2004, J NEUROCYTOL, V33, P345, DOI 10.1023/B:NEUR.0000044195.64009.27; Peters A., 1991, FINE STRUCTURE NERVO; RAMMES G, 1994, NEUROSCI LETT, V175, P21, DOI 10.1016/0304-3940(94)91068-5; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; Sugihara I, 1999, J COMP NEUROL, V414, P131; Tillet E, 1997, J BIOL CHEM, V272, P10769; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Ye P, 2003, J NEUROSCI, V23, P4401; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang L, 1996, J COMP NEUROL, V370, P536, DOI 10.1002/(SICI)1096-9861(19960708)370:4<536::AID-CNE9>3.0.CO;2-5	85	148	155	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					773	785		10.1016/j.neuron.2005.04.025	http://dx.doi.org/10.1016/j.neuron.2005.04.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924863	Bronze			2022-12-28	WOS:000229689800011
J	Stowers, L; Marton, TF				Stowers, L; Marton, TF			What is a pheromone? Mammalian pheromones reconsidered	NEURON			English	Review							VOMERONASAL ORGAN; SIGNALS; BEHAVIORS; MICE; MAIN; ODORANTS; TRP2	Pheromone communication is a two-component system: signaling pheromones and receiving sensory neurons. Currently, pheromones remain enigmatic bioactive compounds, as only a few have been identified, but classical bioassays have suggested that they are nonvolatile, activate vomeronasal sensory neurons, and regulate innate social behaviors and neuroendocrine release. Recent discoveries of potential pheromones reveal that they may be more structurally and functionally diverse than previously defined.	Univ Calif San Diego, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Stowers, L (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	stowers@scripps.edu	Stowers, Lisa/K-6137-2015	Stowers, Lisa/0000-0002-4403-1269				Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; BRUCE HM, 1959, NATURE, V184, P184; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; CUVIER M, 1811, ANN MUS HIST NAT PAR, V18, P412; Dorries KM, 1997, BRAIN BEHAV EVOLUT, V49, P53, DOI 10.1159/000112981; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; MARSDEN HM, 1964, SCIENCE, V144, P1469, DOI 10.1126/science.144.3625.1469; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; OCONNELL RJ, 1984, BEHAV NEUROSCI, V98, P1083, DOI 10.1037/0735-7044.98.6.1083; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039	19	69	71	3	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 2	2005	46	5					699	702		10.1016/j.neuron.2005.04.032	http://dx.doi.org/10.1016/j.neuron.2005.04.032			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924856	Bronze			2022-12-28	WOS:000229689800004
J	Choi, GB; Dong, HW; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Swanson, LW; Anderson, DJ				Choi, GB; Dong, HW; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Swanson, LW; Anderson, DJ			Lhx6 delineates a pathway mediating innate reproductive behaviors from the amygdala to the hypothalamus	NEURON			English	Article							POSTERIOR PARAVENTRICULAR THALAMUS; CEREBRAL HEMISPHERE REGULATION; INHIBIT MATERNAL-BEHAVIOR; CENTRAL-NERVOUS-SYSTEM; SYRIAN-HAMSTER BRAIN; MOTOR-NEURON POOL; C-FOS; DIFFERENTIAL PROJECTIONS; TRANSCRIPTIONAL CODES; SEX-DISCRIMINATION	In mammals, innate reproductive and defensive behaviors are mediated by anatomically segregated connections between the amygdala and hypothalamus. This anatomic segregation poses the problem of how the brain integrates activity in these circuits when faced with conflicting stimuli eliciting such mutually exclusive behaviors. Using genetically encoded and conventional axonal tracers, we have found that the transcription factor Lhx6 delineates the reproductive branch of this pathway. Other Lhx proteins mark neurons in amygdalar nuclei implicated in defense. We have traced parallel projections from the posterior medial amygdala, activated by reproductive or defensive olfactory stimuli, respectively, to a point of convergence in the ventromedial hypothalamus. The opposite neurotransmitter phenotypes of these convergent projections suggest a "gate control" mechanism for the inhibition of reproductive behaviors by threatening stimuli. Our data therefore identify a potential neural substrate for integrating the influences of conflicting behavioral cues and a transcription factor family that may contribute to the development of this substrate.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Regeneron Pharmaceut Inc, Tarrytown, NY USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Regeneron; University of Southern California; University of Southern California	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu		Murphy, Andrew/0000-0003-4152-4081	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH062825] Funding Source: NIH RePORTER; NIMH NIH HHS [R21MH62825] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bhatnagar S, 2003, PHARMACOL BIOCHEM BE, V76, P343, DOI 10.1016/j.pbb.2003.08.005; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Bressler SC, 1996, NEUROSCIENCE, V71, P1063, DOI 10.1016/0306-4522(95)00493-9; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Commons KG, 1999, BRAIN RES, V816, P58, DOI 10.1016/S0006-8993(98)01084-1; Coolen LM, 1998, J COMP NEUROL, V399, P189, DOI 10.1002/(SICI)1096-9861(19980921)399:2<189::AID-CNE4>3.0.CO;2-X; DAVIS BJ, 1978, BRAIN RES BULL, V3, P59, DOI 10.1016/0361-9230(78)90062-X; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Dong HW, 2004, J COMP NEUROL, V471, P396, DOI 10.1002/cne.20002; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; FERNANDEZFEWELL GD, 1994, J NEUROSCI, V14, P3643; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; GOMEZ DM, 1992, J COMP NEUROL, V317, P195, DOI 10.1002/cne.903170208; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Heeb MM, 1996, NEUROSCIENCE, V72, P1049, DOI 10.1016/0306-4522(95)00602-8; Inoue K, 2003, BLOOD CELL MOL DIS, V30, P157, DOI 10.1016/S1079-9796(03)00032-9; ITAYA SK, 1987, BRAIN RES, V409, P205, DOI 10.1016/0006-8993(87)90703-7; Jaferi A, 2003, PHYSIOL BEHAV, V78, P365, DOI 10.1016/S0031-9384(03)00014-3; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jongen-Relo AL, 2000, J NEUROSCI METH, V101, P9, DOI 10.1016/S0165-0270(00)00240-5; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Keverne EB, 2002, CELL, V108, P735, DOI 10.1016/S0092-8674(02)00687-6; KEVETTER GA, 1981, J COMP NEUROL, V197, P81, DOI 10.1002/cne.901970107; Klejbor I., 2003, Polish Journal of Veterinary Sciences, V6, P201; KollackWalker S, 1997, J NEUROBIOL, V32, P481, DOI 10.1002/(SICI)1097-4695(199705)32:5<481::AID-NEU4>3.0.CO;2-1; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; Kurumaji A, 2003, J NEURAL TRANSM, V110, P1161, DOI 10.1007/s00702-003-0023-9; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lieberoth Bettina C., 2003, Methods in Cell Science, V25, P65, DOI 10.1023/B:MICS.0000006848.57869.4c; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; MCCONNELL J, 1983, BRAIN RES, V272, P150, DOI 10.1016/0006-8993(83)90372-4; McGregor IS, 2004, J NEUROSCI, V24, P4134, DOI 10.1523/JNEUROSCI.0187-04.2004; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Numan M, 1997, ANN NY ACAD SCI, V807, P101, DOI 10.1111/j.1749-6632.1997.tb51915.x; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Remedios R, 2004, J NEUROSCI, V24, P6986, DOI 10.1523/JNEUROSCI.0001-04.2004; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; SEGOVIA S, 1993, BRAIN RES REV, V18, P51, DOI 10.1016/0165-0173(93)90007-M; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Sheehan T, 2001, NEUROSCIENCE, V106, P341, DOI 10.1016/S0306-4522(01)00286-X; Sheehan TP, 2000, BEHAV NEUROSCI, V114, P337, DOI 10.1037//0735-7044.114.2.337; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; WALL PD, 1980, PAIN RES PUBLICATION, V58, P205; Zirlinger M, 2003, GENES BRAIN BEHAV, V2, P282, DOI 10.1034/j.1601-183X.2003.00039.x; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698	64	350	356	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					647	660		10.1016/j.neuron.2005.04.011	http://dx.doi.org/10.1016/j.neuron.2005.04.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944132	Bronze			2022-12-28	WOS:000229294300015
J	Puchalla, JL; Schneidman, E; Harris, RA; Berry, MJ				Puchalla, JL; Schneidman, E; Harris, RA; Berry, MJ			Redundancy in the population code of the retina	NEURON			English	Article							GANGLION-CELLS; NATURAL IMAGES; MAMMALIAN RETINA; CAT RETINA; FUNCTIONAL ARCHITECTURE; VISUAL INFORMATION; RECEPTIVE-FIELDS; CORTICAL-NEURONS; RABBIT RETINA; SPIKE TRAINS	We have explored the manner in which the population of retinal ganglion cells collectively represent the visual world. Ganglion cells in the salamander were recorded simultaneously with a multielectrode array during stimulation with both artificial and natural visual stimuli, and the mutual information that single cells and pairs of cells conveyed about the stimulus was estimated. We found significant redundancy between cells spaced as far as 500 mu m apart. When we used standard methods for defining functional types, only ON-type and OFF-type cells emerged as truly independent information channels. Although the average redundancy between nearby cell pairs was moderate, each ganglion cell shared information with many neighbors, so that visual information was represented 10-fold within the ganglion cell population. This high degree of retinal redundancy suggests that design principles beyond coding efficiency may be important at the population level.	Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Berry, MJ (corresponding author), Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA.	berry@princeton.edu		schneidman, elad/0000-0001-8653-9848	NEI NIH HHS [R01 EY14196] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014196] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Balasubramanian V, 2002, NETWORK-COMP NEURAL, V13, P531, DOI 10.1088/0954-898X/13/4/306; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; Berry MJ, 1998, J NEUROSCI, V18, P2200; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Gat I., 1999, ADV NEURAL INFORM P, V11, P465; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Martignon L, 2000, NEURAL COMPUT, V12, P2621, DOI 10.1162/089976600300014872; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P249, DOI 10.1113/jphysiol.2004.063503; Pang JJ, 2002, J NEUROSCI, V22, P4693, DOI 10.1523/JNEUROSCI.22-11-04693.2002; Panzeri S, 2001, NEURAL COMPUT, V13, P1311, DOI 10.1162/08997660152002870; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Schneidman E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.238701; Schneidman E, 2003, J NEUROSCI, V23, P11539; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; Sterling P, 1998, SYNAPTIC ORG BRAIN; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; van Hateren JH, 2002, J NEUROSCI, V22, P9945; VANEY DI, 1994, J NEUROSCI, V14, P6301; VANHATEREN JH, 1992, BIOL CYBERN, V68, P23, DOI 10.1007/BF00203134; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000	56	154	154	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					493	504		10.1016/j.neuron.2005.03.026	http://dx.doi.org/10.1016/j.neuron.2005.03.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882648	Bronze			2022-12-28	WOS:000229011400020
J	Palanca, BJA; DeAngelis, GC				Palanca, BJA; DeAngelis, GC			Does neuronal synchrony underlie visual feature grouping?	NEURON			English	Article							TEMPORAL CORRELATION HYPOTHESIS; CROSS-CORRELATION ANALYSIS; CLASSICAL RECEPTIVE-FIELD; MONKEY STRIATE CORTEX; BINDING PROBLEM; AREA MT; OSCILLATORY RESPONSES; FEATURE INTEGRATION; MACAQUE MONKEY; CORTICAL AREAS	Previous research suggests that synchronous neural activity underlies perceptual grouping of visual image features. The generality of this mechanism is unclear, however, as previous studies have focused on pairs of neurons with overlapping or collinear receptive fields. By sampling more broadly and employing stimuli that contain partially occluded objects, we have conducted a more incisive test of the binding by synchrony hypothesis in area MT. We find that synchrony in spiking activity shows little dependence on feature grouping, whereas gamma band synchrony in field potentials can be significantly stronger when features are grouped. However, these changes in gamma band synchrony are small relative to the variability of synchrony across recording sites and do not provide a robust population signal for feature grouping. Moreover, these effects are reduced when stimulus differences nearby the receptive fields are eliminated using partial occlusion. Our findings suggest that synchrony does not constitute a general mechanism of visual feature binding.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	DeAngelis, GC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	gregd@cabernet.wusti.edu	Palanca, Ben Julian/AAW-4006-2021	Palanca, Ben Julian/0000-0001-7535-5701; DeAngelis, Gregory/0000-0002-1635-1273	NATIONAL EYE INSTITUTE [R01EY013644] Funding Source: NIH RePORTER; NEI NIH HHS [EY-013644] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bretzner F, 2001, EUR J NEUROSCI, V14, P1539, DOI 10.1046/j.0953-816x.2001.01776.x; Bretzner F, 2000, NEUROREPORT, V11, P1313, DOI 10.1097/00001756-200004270-00033; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brosch M, 1997, CEREB CORTEX, V7, P70, DOI 10.1093/cercor/7.1.70; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Freiwald WA, 1995, NEUROREPORT, V6, P2348, DOI 10.1097/00001756-199511270-00018; Frien A, 2000, EUR J NEUROSCI, V12, P1466, DOI 10.1046/j.1460-9568.2000.00026.x; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Ghose GM, 1999, NEURON, V24, P79, DOI 10.1016/S0896-6273(00)80823-5; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Golledge HDR, 2003, NEUROREPORT, V14, P1045, DOI 10.1097/00001756-200305230-00028; Golledge HDR, 1996, CURR BIOL, V6, P1092, DOI 10.1016/S0960-9822(02)70675-1; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Halliday D.M., 1999, TIME FREQUENCY DOMAI, P503, DOI DOI 10.1007/978-3-642-58552-4_18; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Kirk IJ, 2003, CORTEX, V39, P993, DOI 10.1016/S0010-9452(08)70874-8; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; KISVARDAY ZF, 1993, J COMP NEUROL, V327, P398, DOI 10.1002/cne.903270307; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SINGER W, 1997, COGNITIVE NEUROSCIEN, P91; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; TSO DY, 1986, J NEUROSCI, V6, P1160; Uka T, 2003, J NEUROSCI, V23, P3515; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X; Woelbern T, 2002, NEUROREPORT, V13, P1881, DOI 10.1097/00001756-200210280-00010; Wolfe JM, 1999, NEURON, V24, P11, DOI 10.1016/S0896-6273(00)80818-1	65	82	83	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					333	346		10.1016/j.neuron.2005.03.002	http://dx.doi.org/10.1016/j.neuron.2005.03.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848810	Bronze			2022-12-28	WOS:000228674800018
J	Borrelli, E				Borrelli, E			Without DJ-1, the D2 receptor doesn't play	NEURON			English	Editorial Material							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; DOPAMINE; NEURODEGENERATION; RECEPTORS; DEFICITS; INSIGHTS	Dopamine is an essential neuromodulator of the central nervous system whose activity is mediated through interaction with membrane receptors. Among these, the D2 receptor plays a pivotal role in regulating postsynaptic functions as well as dopamine synthesis and release from dopaminergic neurons. Parkinson's disease and parkinsonism are neurodegenerative diseases of dopaminergic neurons affecting the human brain. These diseases are clinically defined by a decrease in dopamine levels that manifest as motor impairements. In this issue of Neuron, Goldberg et al. report of an exciting link between the loss of function of DJ-1, a protein associated with familial parkinsonism, and D2 receptor activity.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-10142 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Borrelli, E (corresponding author), ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, 1,Rue L Fries, F-10142 Illkirch Graffenstaden, France.		Borrelli, Emiliana/M-8994-2018					Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bonifati V, 2004, J MOL MED, V82, P163, DOI 10.1007/s00109-003-0512-1; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572	10	3	4	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					479	481		10.1016/j.neuron.2005.02.004	http://dx.doi.org/10.1016/j.neuron.2005.02.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721232	Bronze			2022-12-28	WOS:000227099700001
J	Reisert, J; Lai, J; Yau, KW; Bradley, J				Reisert, J; Lai, J; Yau, KW; Bradley, J			Mechanism of the excitatory Cl- response in mouse olfactory receptor neurons	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; CHLORIDE CURRENT; SENSORY NEURONS; NA-K-2CL COTRANSPORTER; FUNCTIONAL EXPRESSION; INDUCED CURRENTS; TRANSGENIC MICE; CELLS; TRANSDUCTION; CILIA	In vertebrate olfactory receptor neurons (ORNs), the odorant-triggered receptor current flows through two distinct ion channels on the sensory cilia: Ca2+ influx through a cyclic nucleotide-gated (CNG) channel followed by CI- efflux through a Ca2+-activated anion channel. The excitatory CI- current amplifies the small CNG current and crucially depends on a high intracellular CI- concentration. We show here that a Na+-K+-2CI(-) cotransporter, NKCC1, is required for this CI- current, in that ORNs deficient in NKCC1 or incubated with an NKCC blocker (bumetanide) lack the CI- current. Surprisingly, immunocytochemistry indicates that NKCC1 is located on the somata and dendrites of ORNs rather than the cilia, where transduction occurs. This topography is remarkably similar to the situation in secretory epithelial cells, where basolateral CI- uptake and apical CI- efflux facilitate transepithelial fluid movement. Thus, a single functional architecture serves two entirely different purposes, probably underscoring the epithelial origin of the ORNs.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Reisert, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	jreisert@jhmi.edu; jbradley@jhu.edu		Bradley, Jonathan/0000-0002-6933-1153	NEI NIH HHS [R01 EY014596-01, R37 EY006837-15S1, R01 EY014596-03, R01 EY014596, R01 EY006837-18, R01 EY006837, R01 EY006837-17, R01 EY014596-02, R01 EY006837-16A1, R37 EY006837, R37 EY006837-15] Funding Source: Medline; NIDCD NIH HHS [DC 06904, R01 DC006904-01, R01 DC006904] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006837, R37EY006837, R01EY014596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Bradley J, 1997, J NEUROSCI, V17, P1993; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHIU D, 1988, CHEM SENSES, V13, P677; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; Evans RL, 2000, J BIOL CHEM, V275, P26720; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kaneko H, 2001, AM J PHYSIOL-CELL PH, V280, pC1387, DOI 10.1152/ajpcell.2001.280.6.C1387; Kaplan MR, 1996, J CLIN INVEST, V98, P723, DOI 10.1172/JCI118844; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; KURAHASHI T, 1994, CURR BIOL, V4, P256, DOI 10.1016/S0960-9822(00)00058-0; Laird JMA, 2004, NEUROSCI LETT, V361, P200, DOI 10.1016/j.neulet.2003.12.015; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; MATTHEWS HR, 1990, J PHYSL, V425, P20; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakamura T, 1997, NEUROSCI LETT, V237, P5, DOI 10.1016/S0304-3940(97)00794-5; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V534, P179, DOI 10.1111/j.1469-7793.2001.t01-1-00179.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Reuter D, 1998, J NEUROSCI, V18, P6623; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Sung KW, 2000, J NEUROSCI, V20, P7531; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; ZHAINAZAROV AB, 1995, J NEUROPHYSIOL, V74, P479, DOI 10.1152/jn.1995.74.1.479; Zhao H, 2001, CHEM SENSES, V26, P1110; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zhuo XL, 2001, ARCH BIOCHEM BIOPHYS, V391, P127, DOI 10.1006/abbi.2001.2410; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	48	132	140	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					553	561		10.1016/j.neuron.2005.01.012	http://dx.doi.org/10.1016/j.neuron.2005.01.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721241	Green Accepted, Bronze			2022-12-28	WOS:000227099700011
J	Salie, R; Niederkofler, V; Arber, S				Salie, R; Niederkofler, V; Arber, S			Patterning molecules: Multitasking in the nervous system	NEURON			English	Review							DROSOPHILA DERAILED RECEPTOR; AXON GUIDANCE; COMMISSURAL AXONS; NEURAL CREST; SPECIFICATION; REPULSION	Classical patterning molecules that were previously implicated in controlling cell fate choices in the nervous system have recently been shown to play additional roles in axon guidance and synaptogenesis. Bone morphogenetic proteins (BMPs), Sonic hedgehog (Shh), Writs, and fibroblast growth factors (FGFs) all participate in multiple acts of controlling neuronal circuit assembly. Depending on the cellular context, they can provide instructive signals at the growth cone or synapse or alternatively can elicit responses in the nucleus initiating transcriptional changes. Differences in signal transduction pathways may contribute to the diversity of the functional repertoire of these versatile molecules.	Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch		Arber, Silvia/0000-0002-6261-250X				Altmann CR, 2001, INT REV CYTOL, V203, P447; Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Irving C, 2002, DEVELOPMENT, V129, P5389, DOI 10.1242/dev.00117; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	20	34	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					189	192		10.1016/j.neuron.2005.01.002	http://dx.doi.org/10.1016/j.neuron.2005.01.002			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664170	Bronze			2022-12-28	WOS:000226451500005
J	Medina, JF; Carey, MR; Lisberger, SG				Medina, JF; Carey, MR; Lisberger, SG			The representation of time for motor learning	NEURON			English	Article							PURSUIT EYE-MOVEMENTS; HUMAN SMOOTH-PURSUIT; PURKINJE-CELL ACTIVITY; VESTIBULOOCULAR REFLEX; ADAPTIVE-CHANGES; DECISION-MAKING; NEURONS; MONKEY; RESPONSES; FLOCCULUS	We have identified factors that control precise motor timing by studying learning in smooth pursuit eye movements. Monkeys tracked a target that moved horizontally for a fixed time interval before changing direction through the addition of a vertical component of motion. After repeated presentations of the same target trajectory, infrequent probe trials of purely horizontal target motion evoked a vertical eye movement around the time when the change in target direction would have occurred. The pursuit system timed the vertical eye movement by keeping track of the duration of horizontal target motion and by measuring the distance the target traveled before changing direction, but not by learning the position in space where the target changed direction. We conclude that high temporal precision in motor output relies on multiple signals whose contributions to timing vary according to task requirements.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Intergrat Neurosci, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Medina, JF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.			Medina, Javier/0000-0001-8708-5315; Carey, Megan/0000-0002-4499-1657	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES GR, 1991, J PHYSIOL-LONDON, V439, P439, DOI 10.1113/jphysiol.1991.sp018675; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOMAN DK, 1992, VISION RES, V32, P675, DOI 10.1016/0042-6989(92)90184-K; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chou IH, 2004, J NEUROSCI, V24, P4124, DOI 10.1523/JNEUROSCI.0172-04.2004; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Fukushima K, 2000, J NEUROPHYSIOL, V83, P563, DOI 10.1152/jn.2000.83.1.563; Fukushima K, 1996, NEUROSCI RES, V25, P391; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; Heinen SJ, 1997, VISUAL NEUROSCI, V14, P853, DOI 10.1017/S0952523800011597; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kahlon M, 1996, J NEUROSCI, V16, P7270; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Karniel A, 2003, BIOL CYBERN, V89, P10, DOI 10.1007/s00422-003-0397-7; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; Martin TA, 2001, J NEUROPHYSIOL, V85, P2298, DOI 10.1152/jn.2001.85.5.2298; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McLaren IPL, 2002, ANIM LEARN BEHAV, V30, P177, DOI 10.3758/BF03192828; MIALL RC, 1992, NATO ASI SERIES D, P215; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Raymond JL, 1998, J NEUROSCI, V18, P9112; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Robinson FR, 2001, ANNU REV NEUROSCI, V24, P981, DOI 10.1146/annurev.neuro.24.1.981; Rushton SK, 1999, NAT NEUROSCI, V2, P186, DOI 10.1038/5750; SAKATA H, 1983, J NEUROPHYSIOL, V49, P1364, DOI 10.1152/jn.1983.49.6.1364; SCHNEIDERMAN N, 1964, J COMP PHYSIOL PSYCH, V57, P188, DOI 10.1037/h0043419; Schoner G, 2002, BRAIN COGNITION, V48, P31, DOI 10.1006/brcg.2001.1302; SCHWARTZ JD, 1994, VISUAL NEUROSCI, V11, P411, DOI 10.1017/S0952523800002352; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shafer JL, 2000, J NEUROPHYSIOL, V84, P88, DOI 10.1152/jn.2000.84.1.88; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Suh M, 2000, J NEUROPHYSIOL, V84, P1835, DOI 10.1152/jn.2000.84.4.1835; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; VANDENBERG AV, 1988, EXP BRAIN RES, V72, P95, DOI 10.1007/BF00248504; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WATERSTON JA, 1992, BRAIN, V115, P1343, DOI 10.1093/brain/115.5.1343; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wing AM, 2002, BRAIN COGNITION, V48, P7, DOI 10.1006/brcg.2001.1301; Wright BA, 1997, J NEUROSCI, V17, P3956	58	66	68	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					157	167		10.1016/j.neuron.2004.12.017	http://dx.doi.org/10.1016/j.neuron.2004.12.017			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629710	Bronze			2022-12-28	WOS:000226217100017
J	Meliza, CD; Dan, Y				Meliza, CD; Dan, Y			Receptive-field modification in rat visual cortex induced by paired visual stimulation and single-cell spiking	NEURON			English	Article							PRESYNAPTIC NEURONAL EXCITABILITY; DEPENDENT SYNAPTIC PLASTICITY; HIPPOCAMPAL SLICE CULTURES; MONOCULAR DEPRIVATION; CORTICAL PLASTICITY; PYRAMIDAL CELLS; STRIATE CORTEX; SPINY STELLATE; CONNECTIONS; SPECIFICITY	Experience-dependent plasticity of visual cortical receptive fields (RFs) involves synaptic modifications in the underlying neural circuits, but the site and mechanism of these modifications remain to be elucidated. Using in vivo whole-cell recordings, we show that pairing visual stimulation at a given retinal location with spiking of a single neuron in developing rat visual cortex induces rapid RF modifications. The time course of the response to the visual stimulus at the paired RF location is altered, with an enhancement of the response preceding the spike time and a reduction following the spike. Such bidirectional modification is consistent with spike timing-dependent plasticity. Response modification also occurs at nearby locations, the direction and magnitude of which are correlated with the change at the paired location. In addition, changes at unpaired locations show a negative correlation with the initial strength of the response, which may facilitate rapid modification of the spatial RF profile.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X; Meliza, C Daniel/0000-0002-9395-4369	NATIONAL EYE INSTITUTE [R01EY015180] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015180] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Fregnac Y, 1999, J NEUROBIOL, V41, P69; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Hebb Donald O., 1949, ORG BEHAV; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Li CY, 2004, NEURON, V41, P257, DOI 10.1016/S0896-6273(03)00847-X; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McLean J, 1998, VISUAL NEUROSCI, V15, P177, DOI 10.1017/S0952523898151143; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zilles Karl, 1995, P649	40	87	88	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					183	189		10.1016/j.neuron.2005.12.009	http://dx.doi.org/10.1016/j.neuron.2005.12.009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423693	Bronze			2022-12-28	WOS:000234979900006
J	Tu, DC; Zhang, DY; Demas, J; Slutsky, EB; Provencio, I; Holy, TE; Van Gelder, RN				Tu, DC; Zhang, DY; Demas, J; Slutsky, EB; Provencio, I; Holy, TE; Van Gelder, RN			Physiologic diversity and development of intrinsically photosensitive retinal ganglion cells	NEURON			English	Article							PHOTOPIGMENT MELANOPSIN; NON-CONE; NON-ROD; EXPRESSION; RESPONSES; PHOTORECEPTION; NETWORK; OPSIN; UNITS; MICE	Intrinsically photosensitive retinal ganglion cells (ipRGCs) mediate numerous nonvisual phenomena, including entrainment of the circadian clock to light-dark cycles, pupillary light responsiveness, and light-regulated hormone release. We have applied multielectrode array recording to characterize murine ipRGCs. We find that all ipRGC photosensitivity is melanopsin dependent. At least three populations of ipRGCs are present in the postnatal day 8 (P8) murine retina: slow onset, sensitive, fast off (type 1); slow onset, insensitive, slow off (type 11); and rapid onset, sensitive, very slow off (type 111). Recordings from adult rd/rd retinas reveal cells comparable to postnatal types 11 and 111. Recordings from early postnatal retinas demonstrate intrinsic light responses from PO. Early light responses are transient and insensitive but by P6 show increased photosensitivity and persistence. These results demonstrate that ipRGCs are the first light-sensitive cells in the retina and suggest previously unappreciated diversity in this cell population.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Uniformed Serv Univ Hlth Sci, Circadian Res Ctr, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Genet, Bethesda, MD 20814 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; University of Virginia	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	vangelder@vision.wustl.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Provencio, Ignacio/0000-0003-1175-920X; Demas, Jay/0000-0001-7678-1905	NATIONAL EYE INSTITUTE [T32EY013360, R01EY014988] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY13360, R01-EY14988] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Fahrenkrug J, 2004, NEUROREPORT, V15, P781, DOI 10.1097/00001756-200404090-00008; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hu EH, 2003, J NEUROSCI, V23, P6768; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; LEARD LE, 1994, NEUROREPORT, V5, P2683, DOI 10.1097/00001756-199412000-00069; Llamosas MM, 2000, DEV BRAIN RES, V120, P1, DOI 10.1016/S0165-3806(99)00175-3; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Peirson SN, 2004, MOL BRAIN RES, V123, P132, DOI 10.1016/j.molbrainres.2004.01.007; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PROVENCIO I, 2002, ASS RES VIS OPTH FOR; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; RATTO GM, 1991, NATURE, V351, P654, DOI 10.1038/351654a0; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Silverman B.W, 1986, DENSITY ESTIMATION; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; WEAVER DR, 1995, MOL BRAIN RES, V33, P136, DOI 10.1016/0169-328X(95)00117-B; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000	45	177	183	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					987	999		10.1016/j.neuron.2005.09.031	http://dx.doi.org/10.1016/j.neuron.2005.09.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364902	Bronze			2022-12-28	WOS:000234301700014
J	Fischer, A; Sananbenesi, F; Pang, PT; Lu, B; Tsai, LH				Fischer, A; Sananbenesi, F; Pang, PT; Lu, B; Tsai, LH			Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory	NEURON			English	Article							CDK5 ACTIVATOR P35; ALZHEIMERS-DISEASE; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; DENDRITIC SPINES; CONDITIONED FEAR; KINASE-ACTIVITY; NMDA RECEPTORS; HUMAN BRAIN; NEURODEGENERATION	While deregulation of cyclin-dependent kinase 5 (Cdk5) has been implicated in neurodegenerative diseases, its precise role in synaptic plasticity and memory remains elusive. Proteolytic cleavage of p35, a regulatory subunit of Cdk5, by calpain results in the generation of the truncated p25 protein, which causes hyperactivation of Cdk5. Using region-specific and inducible transgenic mice, we show that transiently increased p25 expression in the hippocampus enhanced long-term potentiation (LTP) and facilitated hippocampus-dependent memory. Moreover, p25 expression increased the number of dendritic spines and synapses. Importantly, enhanced memory achieved by a transient expression of p25 followed by its repression did not cause neurodegeneration. In contrast, prolonged p25 production caused severe cognitive deficits, which were accompanied by synaptic and neuronal loss and impaired LTP. Our data suggest a role for p25 in synaptic plasticity, synaptogenesis, learning, and memory and provide a model whereby deregulation of a plasticity factor can contribute to neurodegeneration.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; NIMH, Gene Cognit & Psychosis Program, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759; Fischer, Andre/0000-0001-8546-1161	Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [NS051874] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Arendt T, 2004, INT J DEV NEUROSCI, V22, P507, DOI 10.1016/j.ijdevneu.2004.07.007; Armstrong DM, 2003, CELL MOL NEUROBIOL, V23, P491, DOI 10.1023/A:1025063811290; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; COTMAN CW, 1988, ADV NEUROL, V47, P12; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2002, J NEUROSCI, V22, P3700; Fischer A, 2003, CNS NEUROL DISORD-DR, V2, P375, DOI 10.2174/1568007033482706; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Howell D, 2002, STAT METHODS PSYCHOL; KAPLAN MS, 1988, ARCH PHYS MED REHAB, V69, P984; Kerokoski P, 2004, NEUROSCI LETT, V368, P181, DOI 10.1016/j.neulet.2004.07.007; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patzke H, 2003, J NEUROSCI, V23, P2769; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rademakers R, 2005, NEUROBIOL AGING, V26, P1145, DOI 10.1016/j.neurobiolaging.2004.10.003; RAMONMOLINIER E, 1970, CONT RES METHODS NEU; Richardson JC, 2003, NEUROSCIENCE, V122, P213, DOI 10.1016/S0306-4522(03)00389-0; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheff S, 2003, NEUROCHEM RES, V28, P1625, DOI 10.1023/A:1026048619220; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tandon A, 2003, J NEUROCHEM, V86, P572, DOI 10.1046/j.1471-4159.2003.01865.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Weishaupt JH, 2003, MOL CELL NEUROSCI, V24, P489, DOI 10.1016/S1044-7431(03)00221-5; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146	58	215	240	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					825	838		10.1016/j.neuron.2005.10.033	http://dx.doi.org/10.1016/j.neuron.2005.10.033			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337919	Bronze			2022-12-28	WOS:000233927300020
J	Khalilov, I; Le van Quyen, M; Gozlan, H; Ben-Ari, Y				Khalilov, I; Le van Quyen, M; Gozlan, H; Ben-Ari, Y			Epileptogenic actions of GABA and fast oscillations in the developing hippocampus	NEURON			English	Article							GAMMA-FREQUENCY OSCILLATIONS; ICTAL EPILEPTIFORM ACTIVITY; SEIZURE-LIKE ACTIVITY; NETWORK OSCILLATIONS; EXCITATORY ACTIONS; GAP-JUNCTIONS; FAST RIPPLES; INTERNEURONS; RAT; MECHANISMS	GABA excites immature neurons and inhibits adult ones, but whether this contributes to seizures in the developing brain is not known. We now report that in the developing, but not the adult, hippocampus, seizures beget seizures only if GABAergic synapses are functional. In the immature hippocampus, seizures generated with functional GABAergic synapses include fast oscillations that are required to transform a naive network to an epileptic one: blocking GABA receptors prevents the long-lasting sequels of seizures. In contrast, in adult neurons, full blockade of GABA(A) receptors generates epileptogenic high-frequency seizures. Therefore, purely glutamatergic seizures are not epileptogenic in the developing hippocampus. We suggest that the density of glutamatergic synapses is not sufficient for epileptogenesis in immature neurons; excitatory GABAergic synapses are required for that purpose. We suggest that the synergistic actions of GABA and NMDA receptors trigger the cascades involved in epileptogenesis in the developing hippocampus.	INSERM, U29 Marseille, INMED, F-13273 Marseille, France; Hop La Pitie Salpetriere, CNRS,UPR 640, Neurodynam Grp, Cognit Neurosci & Brain Imaging Lab LENA, F-75651 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Ben-Ari, Y (corresponding author), INSERM, U29 Marseille, INMED, 163 Route Luminy, F-13273 Marseille, France.	ben-ari@inmed.univ-mrs.fr	Khalilov, Ilgam/B-5267-2015	Khalilov, Ilgam/0000-0002-9468-4778; Ben-Ari, Yehezkel/0000-0001-6208-8480				Avoli M, 2000, GABA IN THE NERVOUS SYSTEM: THE VIEW AT FIFTY YEARS, P293; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Borck C, 1999, J NEUROPHYSIOL, V82, P2130, DOI 10.1152/jn.1999.82.5.2130; Bracci E, 1999, J NEUROSCI, V19, P8104; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dzhala VI, 2004, J NEUROSCI, V24, P8896, DOI 10.1523/JNEUROSCI.3112-04.2004; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P65, DOI 10.1113/jphysiol.2004.077388; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; FISHER RS, 1992, J CLIN NEUROPHYSIOL, V9, P441; Fujiwara-Tsukamoto Y, 2003, NEUROSCIENCE, V119, P265, DOI 10.1016/S0306-4522(03)00102-7; Fukuda T, 2000, J NEUROSCI, V20, P1519; Gao XB, 1998, J NEUROPHYSIOL, V79, P716, DOI 10.1152/jn.1998.79.2.716; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; GOWERS WR, 2001, EPILEPSY OTHER CHRON; Gozlan H, 2003, CEREB CORTEX, V13, P684, DOI 10.1093/cercor/13.6.684; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; HOLMES GL, 1984, ARCH NEUROL-CHICAGO, V41, P853, DOI 10.1001/archneur.1984.04050190059014; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Isomura Y, 2003, J NEUROPHYSIOL, V90, P2752, DOI 10.1152/jn.00142.2003; Karnup S, 2001, J PHYSIOL-LONDON, V532, P713, DOI 10.1111/j.1469-7793.2001.0713e.x; Khalilov I, 1999, EUR J NEUROSCI, V11, P3468, DOI 10.1046/j.1460-9568.1999.00768.x; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Khalilov I, 1999, DEV NEUROSCI-BASEL, V21, P310, DOI 10.1159/000017380; Khazipov R, 1999, J NEUROPHYSIOL, V81, P921, DOI 10.1152/jn.1999.81.2.921; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Kohling R, 2000, J NEUROSCI, V20, P6820, DOI 10.1523/JNEUROSCI.20-18-06820.2000; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Quilichini PP, 2002, EUR J NEUROSCI, V16, P850, DOI 10.1046/j.1460-9568.2002.02143.x; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Ruusuvuori E, 2004, J NEUROSCI, V24, P2699, DOI 10.1523/JNEUROSCI.5176-03.2004; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; Thakor NV, 2004, ANNU REV BIOMED ENG, V6, P453, DOI 10.1146/annurev.bioeng.5.040202.121601; Traub RD, 2005, J NEUROPHYSIOL, V94, P1225, DOI 10.1152/jn.00069.2005; Traub RD, 1998, PROG NEUROBIOL, V55, P563, DOI 10.1016/S0301-0082(98)00020-3; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; TREMBLAY E, 1984, NEUROSCIENCE, V13, P1051, DOI 10.1016/0306-4522(84)90288-4; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Velazquez JLP, 1999, EUR J NEUROSCI, V11, P4110, DOI 10.1046/j.1460-9568.1999.00837.x; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149	62	121	144	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					787	796		10.1016/j.neuron.2005.09.026	http://dx.doi.org/10.1016/j.neuron.2005.09.026			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337916	Bronze			2022-12-28	WOS:000233927300017
J	Molyneaux, BJ; Arlotta, P; Hirata, T; Hibi, M; Macklis, JD				Molyneaux, BJ; Arlotta, P; Hirata, T; Hibi, M; Macklis, JD			Fezl is required for the birth and specification of corticospinal motor neurons	NEURON			English	Article							ZINC-FINGER GENE; CELL FATE SPECIFICATION; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-CORTEX; SUBVENTRICULAR ZONE; AREA IDENTITY; IN-VIVO; EXPRESSION; MOUSE; MIGRATION	The molecular mechanisms controlling the differentiation of neural progenitors into distinct subtypes of neurons during neocortical development are unknown. Here, we report that Fezl is required for the specification of corticospinal motor neurons and other subcerebral projection neurons, which are absent from Fezl null mutant neocortex. There is neither an increase in cell death in Fezl(-/-) cortex nor abnormalities in migration, indicating that the absence of subcerebral projection neurons is due to a failure in fate specification. In striking contrast, other neuronal populations in the same and other cortical layers are born normally. Overexpression of Fezl results in excess production of subcerebral projection neurons and arrested migration of these neurons in the germinal zone. These data indicate that Fezl plays a central role in the specification of corticospinal motor neurons and other subcerebral projection neurons, controlling early decisions regarding lineage-specific differentiation from neural progenitors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Stem Cell Inst, Boston, MA 02114 USA; RIKEN, Ctr Dev Biol, Lab Vertebrate Axis Format, Kobe, Hyogo, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; RIKEN	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	jeffrey_macklis@hms.harvard.edu	Hibi, Masahiko/I-6215-2014	Hibi, Masahiko/0000-0002-9142-4444; Molyneaux, Bradley/0000-0002-3377-1229	NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [NS45523, NS41590, NS49553] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049553, R01NS045523, R01NS041590, R37NS041590] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Desai AR, 2000, DEVELOPMENT, V127, P2863; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; FRABTZ GD, 1996, NEURON, V17, P55; Fujimori KE, 2000, J COMP NEUROL, V417, P275, DOI 10.1002/(SICI)1096-9861(20000214)417:3<275::AID-CNE2>3.0.CO;2-7; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Inoue J, 2004, J OCUL PHARMACOL TH, V20, P1, DOI 10.1089/108076804772745419; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lu J, 2005, EPILEPSY BEHAV, V7, P143, DOI 10.1016/j.yebeh.2005.05.001; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OUIMET CC, 1984, J NEUROSCI, V4, P111; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Polleux F, 2001, CEREB CORTEX, V11, P1027, DOI 10.1093/cercor/11.11.1027; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Syken J, 2003, P NATL ACAD SCI USA, V100, P13048, DOI 10.1073/pnas.1735415100; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	56	343	352	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					817	831		10.1016/j.neuron.2005.08.030	http://dx.doi.org/10.1016/j.neuron.2005.08.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157277	Bronze			2022-12-28	WOS:000232085000010
J	Lieberam, I; Agalliu, D; Nagasawa, T; Ericson, J; Jessell, TM				Lieberam, I; Agalliu, D; Nagasawa, T; Ericson, J; Jessell, TM			A Cxcl12-Cxcr4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons	NEURON			English	Article							LIM HOMEOBOX GENES; SPINAL-CORD; NEURON DIFFERENTIATION; ODORANT RECEPTORS; BRANCHIAL ARCHES; GUIDES AXONS; MICE LACKING; EXIT POINTS; GROWTH CONE; GUIDANCE	Motor neurons, alone among neurons in the vertebrate CNS, extend axons out of the neural tube to innervate peripheral targets. Two classes of motor neurons, termed vMNs and dMNs, extend axons out of the neural tube via ventral and dorsal exit points, respectively, in accord with their homeodomain transcription factor repertoire. Downstream of these transcriptional codes, the cell surface receptors that shape initial motor axon trajectories have not been identified. We show here that the chemokine receptor Cxcr4 is expressed on the axons of vMNs as they follow their ventral trajectory, whereas its ligand, Cxcl12, is expressed by mesenchymal cells surrounding the ventral neural tube. Genetic studies reveal that Cxcl12-Cxcr4 signaling directs the ventral trajectory of spinal vMNs. In its absence, these neurons adopt a dMN-like trajectory, despite preservation of their vMN transcriptional identity. Thus, the status of Cxcr4 signaling helps to determine the initial axonal trajectory of mammalian motor neurons.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Kyoto Univ, Dept Med Syst Control, Inst Frontier Med Sci, Kyoto 6068507, Japan; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Columbia University; Howard Hughes Medical Institute; Columbia University; Kyoto University; Karolinska Institutet	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	tmj1@columbia.edu	Lieberam, Ivo/C-5324-2009	Ericson, Johan/0000-0002-8019-7127; Lieberam, Ivo/0000-0003-3539-3054; Nagasawa, Takashi/0000-0002-1085-0960				Arakaki R, 1999, J VIROL, V73, P1719, DOI 10.1128/JVI.73.2.1719-1723.1999; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bruce LL, 1997, INT J DEV NEUROSCI, V15, P671, DOI 10.1016/S0736-5748(96)00120-7; Caton A, 2000, DEVELOPMENT, V127, P1751; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; GUTHRIE S, 1992, DEVELOPMENT, V114, P663; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jacob J, 2000, MOL CELL NEUROSCI, V16, P14, DOI 10.1006/mcne.2000.0855; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; LEBER SM, 1995, J NEUROSCI, V15, P1236; Li Q, 2005, J NEUROSCI, V25, P1711, DOI 10.1523/JNEUROSCI.4393-04.2005; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MOODY SA, 1983, J COMP NEUROL, V213, P327, DOI 10.1002/cne.902130308; Naeem A, 2002, J NEUROBIOL, V51, P101, DOI 10.1002/neu.10048; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pujol F, 2005, J CELL SCI, V118, P1071, DOI 10.1242/jcs.01694; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; Tran PB, 2003, J COMP NEUROL, V457, P1, DOI 10.1002/cne.10546; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WENTWORTH LE, 1984, J COMP NEUROL, V222, P81, DOI 10.1002/cne.902220108; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Zhang LQ, 2000, ANAT EMBRYOL, V201, P235, DOI 10.1007/s004290050314; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	56	128	130	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					667	679		10.1016/j.neuron.2005.08.011	http://dx.doi.org/10.1016/j.neuron.2005.08.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129397	Bronze			2022-12-28	WOS:000231782700009
J	Berridge, CW; Espana, RA				Berridge, CW; Espana, RA			Hypocretins: Waking, arousal, or action?	NEURON			English	Editorial Material							OREXIN; NARCOLEPSY	The role of hypocretin (orexin) neurotransmission in waking and arousal, though of intense interest, is poorly understood. In this issue of Neuron, Mileykovskiy et al., 2005 demonstrate that, in general, hypocretin neurons are minimally active during both sleep and quiet waking. In contrast, these neurons display robust activity during periods of alert and/or active waking.	Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Beth Israel Deaconess Medical Center	Berridge, CW (corresponding author), Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA.							Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Espana RA, 2003, NEUROSCIENCE, V121, P201, DOI 10.1016/S0306-4522(03)00334-8; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Winsky-Sommerer R, 2004, J NEUROSCI, V24, P11439, DOI 10.1523/JNEUROSCI.3459-04.2004; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Zeitzer JM, 2004, J PHYSIOL-LONDON, V557, P1045, DOI 10.1113/jphysiol.2004.061606	12	20	23	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					696	698		10.1016/j.neuron.2005.05.016	http://dx.doi.org/10.1016/j.neuron.2005.05.016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924855	Bronze			2022-12-28	WOS:000229689800003
J	Scherberger, H; Jarvis, MR; Andersen, RA				Scherberger, H; Jarvis, MR; Andersen, RA			Cortical local field potential encodes movement intentions in the posterior parietal cortex	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; SELECTIVE VISUAL-ATTENTION; NEURONAL OSCILLATIONS; ASSOCIATION CORTEX; MOTOR CORTEX; MONKEY; SYNCHRONIZATION; MACAQUE; MEMORY; SPACE	The cortical local field potential (LFP) is a summation signal of excitatory and inhibitory dendritic potentials that has recently become of increasing interest. We report that UP signals in the parietal reach region (PRR) of the posterior parietal cortex of macaque monkeys have temporal structure that varies with the type of planned or executed motor behavior. LFP signals from PRR provide better decode performance for reaches compared to saccades and have stronger coherency with simultaneously recorded spiking activity during the planning of reach movements than during saccade planning. UP signals predict the animal's behavioral state (e.g., planning a reach or saccade) and the direction of the currently planned movement from single-trial information. This new evidence provides further support for a role of the parietal cortex in movement planning and the potential application of LFP signals for a brain-machine interface.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Scherberger, H (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	hjs@ini.phys.ethz.ch		Scherberger, Hansjorg/0000-0001-6593-2800				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 2004, P 26 ANN INT C IEEE; Andersen RA, 2003, VISUAL NEUROSCIENCES, P1324; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FROMM GH, 1964, ELECTROEN CLIN NEURO, V17, P520, DOI 10.1016/0013-4694(64)90182-8; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDBERG ME, 1990, COLD SPRING HARB SYM, V55, P729; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; ISCHER NI, 1993, STAT ANAL CIRCULAR D; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; *NAT RES COUNC EE, 2003, GUID CAR US MAMM NEU; PERCIVAL DB, 1993, SPECTRAL ANAL PHYSL; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Scherberger H, 2003, J NEUROSCI METH, V130, P1, DOI 10.1016/S0165-0270(03)00190-0; Scherberger H, 2003, J NEUROPHYSIOL, V89, P1456, DOI 10.1152/jn.00883.2002; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Siegel M, 2003, J NEUROSCI, V23, P4251; Snyder LH, 2000, J NEUROPHYSIOL, V83, P1099, DOI 10.1152/jn.2000.83.2.1099; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Zar JH., 1999, BIOSTAT ANAL, V663rd	46	246	260	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					347	354		10.1016/j.neuron.2005.03.004	http://dx.doi.org/10.1016/j.neuron.2005.03.004			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848811	Bronze			2022-12-28	WOS:000228674800019
J	Liu, TS; Pestilli, F; Carrasco, M				Liu, TS; Pestilli, F; Carrasco, M			Transient attention enhances perceptual performance and fMRI response in human visual cortex	NEURON			English	Article							SELECTIVE ATTENTION; CONTRAST SENSITIVITY; REFLEXIVE ATTENTION; NEURAL MECHANISMS; CORTICAL AREAS; BRAIN ACTIVITY; STRIATE; MODULATION; COMPONENTS; MT	When a visual stimulus suddenly appears, it captures attention, producing a transient improvement of performance on basic visual tasks. We investigate the effect of transient attention on stimulus representations in early visual areas using rapid event-related fMRI. Participants discriminated the orientation of one of two gratings preceded or followed by a non-predictive peripheral cue. Compared to control conditions, precueing the target location improved performance and produced a larger fMRI response in corresponding retinotopic areas. This enhancement progressively increased from striate to extrastriate areas. Control conditions indicated that the enhanced fMRI response was not due to sensory summation of cue and target signals. Thus, an uninformative precue increases both perceptual performance and the concomitant stimulus-evoked activity in early visual areas. These results provide evidence regarding the retinotopically specific neural correlate for the effects of transient attention on early vision.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Carrasco, M (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	marisa.carrasco@nyu.edu	Pestilli, Franco/J-5236-2012; Liu, Taosheng/K-9148-2013	Pestilli, Franco/0000-0002-2469-0494; Liu, Taosheng/0000-0002-9768-0393	NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016200] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2004, VISION RES, V44, P1351, DOI 10.1016/j.visres.2003.11.026; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GOBEL J, 2005, IN PRESS PSYCHOL SCI; Handy TC, 2003, NAT NEUROSCI, V6, P421, DOI 10.1038/nn1031; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 1998, PSYCHOL SCI, V9, P441, DOI 10.1111/1467-9280.00083; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1999, PERCEPT PSYCHOPHYS, V61, P1424, DOI 10.3758/BF03206191; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Mayfrank L., 1987, EYE MOVEMENTS PHYSL, P37, DOI DOI 10.1167/4.12.12; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; NACHMIAS J, 1967, J OPT SOC AM, V57, P421, DOI 10.1364/JOSA.57.000421; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Noesselt T, 2002, NEURON, V35, P575, DOI 10.1016/S0896-6273(02)00781-X; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PESTILLI F, 2005, IN PRESS VISION RES; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SERENCES JT, 2005, IN PRESS PSYCHOL SCI; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Solomon JA, 1997, J OPT SOC AM A, V14, P2443, DOI 10.1364/JOSAA.14.002443; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; WANDELL BA, 2005, IN PRESS PHILOS T B; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	60	142	144	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					469	477		10.1016/j.neuron.2004.12.039	http://dx.doi.org/10.1016/j.neuron.2004.12.039			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694332	Green Accepted, Bronze			2022-12-28	WOS:000226787700018
J	Tombola, F; Pathak, MM; Isacoff, EY				Tombola, F; Pathak, MM; Isacoff, EY			Voltage-sensing arginines in a potassium channel permeate and occlude cation-selective pores	NEURON			English	Article							SHAKER K+ CHANNEL; CHARGE MOVEMENT; MOLECULAR-BASIS; GATING CHARGE; S4 SEGMENT; TRANSMEMBRANE SEGMENTS; SENSOR; INACTIVATION; MODELS; DOMAIN	Voltage-gated ion channels sense voltage by shuttling arginine residues located in the S4 segment across the membrane electric field. The molecular pathway for this arginine permeation is not understood, nor is the filtering mechanism that permits passage of charged arginines but excludes solution ions. We find that substituting the first S4 arginine with smaller amino acids opens a high-conductance pathway for solution cations in the Shaker K+ channel at rest. The cationic current does not flow through the central K+ pore and is influenced by mutation of a conserved residue in S2, suggesting that it flows through a protein pathway within the voltage-sensing domain. The current can be carried by guanidinium ions, suggesting that this is the pathway for transmembrane arginine permeation. We propose that when S4 moves it ratchets between conformations in which one arginine after another occupies and occludes to ions the narrowest part of this pathway.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	eisacoff@socrates.berkeley.edu	Tombola, Francesco/C-7311-2011; Tombola, Francesco/ABA-6002-2020; isacoff, ehud/AAP-1459-2020	Tombola, Francesco/0000-0002-9315-0352; Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS35549, R01 NS035549-08] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Goldstein SAN, 1996, NEURON, V16, P717, DOI 10.1016/S0896-6273(00)80092-6; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lecar H, 2003, BIOPHYS J, V85, P2854, DOI 10.1016/S0006-3495(03)74708-0; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Wang MH, 1999, J PHYSIOL-LONDON, V521, P315, DOI 10.1111/j.1469-7793.1999.00315.x; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	39	212	216	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					379	388		10.1016/j.neuron.2004.12.047	http://dx.doi.org/10.1016/j.neuron.2004.12.047			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694325	Bronze			2022-12-28	WOS:000226787700011
J	Mazzoni, EO; Desplan, C; Blau, J				Mazzoni, EO; Desplan, C; Blau, J			Circadian pacemaker neurons transmit and modulate visual information to control a rapid behavioral response	NEURON			English	Article							DROSOPHILA-MELANOGASTER; CHOLINE-ACETYLTRANSFERASE; GENETIC-ANALYSIS; NERVOUS-SYSTEM; CLOCK NEURONS; OPTIC-NERVE; PERIOD GENE; EXPRESSION; RHYTHMS; CRYPTOCHROME	Circadian pacemaker neurons contain a molecular clock that oscillates with a period of similar to24 hr, controlling circadian rhythms of behavior. Pacemaker neurons respond to visual system inputs for clock resetting, but, unlike other neurons, have not been reported to transmit rapid signals to their targets. Here we show that pacemaker neurons are required to mediate a rapid behavior. The Drosophila larval visual system, Bolwig's organ (BO), projects to larval pacemaker neurons to entrain their clock. BO also mediates larval photophobic behavior. We found that ablation or electrical silencing of larval pacemaker neurons abolished light avoidance. Thus, circadian pacemaker neurons receive input from BO not only to reset the clock but also to transmit rapid photophobic signals. Furthermore, as clock gene mutations also affect photophobicity, the pacemaker neurons modulate the sensitivity of larvae to light, generating a circadian rhythm in visual sensitivity.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Blau, J (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	justin.blau@nyu.edu		mazzoni, esteban/0000-0001-8994-681X; Desplan, Claude/0000-0002-6914-1413	NATIONAL EYE INSTITUTE [R01EY013010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911] Funding Source: NIH RePORTER; NEI NIH HHS [EY013010] Funding Source: Medline; NIGMS NIH HHS [GM063911] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; BARLOW RB, 1977, SCIENCE, V197, P86, DOI 10.1126/science.867057; BATTELLE BA, 2002, CELL, V15, P345; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cooke JP, 2003, ATHEROSCLEROSIS SUPP, V4, P53, DOI 10.1016/S1567-5688(03)00034-5; Dettman RW, 2001, GENETICS, V158, P253; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; GORCZYCA MG, 1987, J NEUROSCI, V7, P1361; Han DD, 2000, DEVELOPMENT, V127, P573; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 2000, J BIOL RHYTHM, V15, P13, DOI 10.1177/074873040001500103; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Malpel S, 2004, J BIOL RHYTHM, V19, P10, DOI 10.1177/0748730403260621; Malpel S, 2002, DEVELOPMENT, V129, P1443; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Ousley A, 1998, GENETICS, V148, P815; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Tosini G, 2002, CELL TISSUE RES, V309, P119, DOI 10.1007/s00441-002-0578-z; Wegener C, 2004, J NEUROPHYSIOL, V91, P912, DOI 10.1152/jn.00678.2003; YASUYAMA K, 1995, CELL TISSUE RES, V282, P193, DOI 10.1007/BF00319111	41	119	122	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					293	300		10.1016/j.neuron.2004.12.038	http://dx.doi.org/10.1016/j.neuron.2004.12.038			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664180	Bronze			2022-12-28	WOS:000226451500015
J	Humeau, Y; Herry, C; Kemp, N; Shaban, H; Fourcaudot, E; Bissiere, S; Luthi, A				Humeau, Y; Herry, C; Kemp, N; Shaban, H; Fourcaudot, E; Bissiere, S; Luthi, A			Dendritic spine heterogeneity determines afferent-specific Hebbian plasticity in the amygdala	NEURON			English	Article							LONG-TERM POTENTIATION; GATED CALCIUM-CHANNELS; LATERAL AMYGDALA; ELECTROPHYSIOLOGICAL PROPERTIES; ASSOCIATIVE PLASTICITY; SYNAPTIC PLASTICITY; CORTICAL INPUTS; NMDA RECEPTORS; FEAR MEMORY; NEURONS	Functional compartmentalization of dendrites is thought to underlie afferent-specific integration of neural activity in laminar brain structures. Here we show that in the lateral nucleus of the amygdala (LA), an area lacking apparent laminar organization, thalamic and cortical afferents converge on the same dendrites, contacting neighboring but morphologically and functionally distinct spine types. Large spines contacted by thalamic afferents exhibited larger Ca2+ transients during action potential backpropagation than did small spines contacted by cortical afferents. Accordingly, induction of Hebbian plasticity, dependent on postsynaptic spikes, was restricted to thalamic afferents. This synapse-specific effect involved activation of R-type voltage-dependent Ca2+ channels preferentially located at thalamic inputs. These results indicate that afferent-specific mechanisms of postsynaptic, associative Hebbian plasticity in LA projection neurons depend on local, spine-specific morphological and molecular properties, rather than global differences between dendritic compartments.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; CNRS, UPR2356, F-67084 Strasbourg, France; Univ Basel, Bioctr, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Basel	Luthi, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch	shaban, Hamdy/C-1939-2014; Herry, Cyril/AAP-9902-2020; Shaban, Hamdy/ABD-5617-2021	shaban, Hamdy/0000-0003-3760-6113; Herry, Cyril/0000-0003-2973-0843; Shaban, Hamdy/0000-0003-3760-6113				Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cain CK, 2002, J NEUROSCI, V22, P9113; CARLSEN J, 1988, BRAIN RES, V441, P377, DOI 10.1016/0006-8993(88)91418-7; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Farb CR, 1999, SYNAPSE, V33, P218, DOI 10.1002/(SICI)1098-2396(19990901)33:3<218::AID-SYN6>3.0.CO;2-1; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heinbockel T, 2000, J NEUROSCI, V20; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Isomura Y, 2002, J NEUROPHYSIOL, V87, P1169, DOI 10.1152/jn.00536.2001; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kubota M, 2001, BIOCHEM BIOPH RES CO, V282, P242, DOI 10.1006/bbrc.2001.4572; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Magee J. C., 1999, DENDRITES, P139; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Mainen Z. F., 1999, DENDRITES, P310; Majewska A, 2000, J NEUROSCI, V20, P1722; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Morgan SL, 2001, J NEUROPHYSIOL, V86, P1289, DOI 10.1152/jn.2001.86.3.1289; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Normann C, 2000, J NEUROSCI, V20, P8290, DOI 10.1523/JNEUROSCI.20-22-08290.2000; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; PARE D, 1995, J NEUROPHYSIOL, V74, P1179, DOI 10.1152/jn.1995.74.3.1179; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Smith Y, 2000, J COMP NEUROL, V416, P496; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Wilson SM, 2000, J NEUROSCI, V20, P8566; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	63	110	112	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					119	131		10.1016/j.neuron.2004.12.019	http://dx.doi.org/10.1016/j.neuron.2004.12.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629707	Bronze			2022-12-28	WOS:000226217100014
J	Harata, NC; Choi, S; Pyle, JL; Aravanis, AM; Tsien, RW				Harata, NC; Choi, S; Pyle, JL; Aravanis, AM; Tsien, RW			Frequency-dependent kinetics and prevalence of kiss-and-run and reuse at hippocampal synapses studied with novel quenching methods	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE ENDOCYTOSIS; NERVE-TERMINALS; EXOCYTOSIS; MEMBRANE; RELEASE; FUSION; TRANSMISSION; TRANSMITTER; NEURONS	The kinetics of exo-endocytotic recycling could restrict information transfer at central synapses if neurotransmission were entirely reliant on classical full-collapse fusion. Nonclassical fusion retrieval by kiss-and-run would be kinetically advantageous but remains controversial. We used a hydrophilic quencher, bromophenol blue (BPB), to help detect nonclassical events. Upon stimulation, extracellular BPB entered synaptic vesicles and quenched FM1-43 fluorescence, indicating retention of FM dye beyond first fusion. BPB also quenched fluorescence of VAMP (synaptobrevin-2)-EGFP, thus indicating the timing of first fusion of vesicles in the total recycling pool. Comparison with FM dye destaining revealed that kiss-and-run strongly prevailed over full-collapse fusion at low frequency, giving way to a near-even balance at high frequency. Quickening of kiss-and-run vesicle reuse was also observed at higher frequency in the average single vesicle fluorescence response. Kiss-and-run and reuse could enable hippocampal nerve terminals to conserve scarce vesicular resources when responding to widely varying input patterns.	Stanford Univ, Sch Med, Stanford, CA 94305 USA; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Stanford University; Seoul National University (SNU)	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Harata, N. Charles/0000-0003-3287-4549	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64070] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; An S, 2004, CURR OPIN NEUROBIOL, V14, P522, DOI 10.1016/j.conb.2004.08.008; Aravanis AM, 2003, NEUROPHARMACOLOGY, V45, P797, DOI 10.1016/S0028-3908(03)00310-1; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HEUSER JE, 1989, Q J EXP PHYSIOL CMS, V74, P1051, DOI 10.1113/expphysiol.1989.sp003333; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kavalali ET, 1999, PHILOS T ROY SOC B, V354, P337, DOI 10.1098/rstb.1999.0385; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Ryan TA, 2003, P NATL ACAD SCI USA, V100, P2171, DOI 10.1073/pnas.0530260100; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	47	128	133	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					243	256		10.1016/j.neuron.2005.12.018	http://dx.doi.org/10.1016/j.neuron.2005.12.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423698	Bronze			2022-12-28	WOS:000234979900011
J	Sullivan, JM				Sullivan, JM			Synaptic vesicles caught kissing again	NEURON			English	Editorial Material							HIPPOCAMPAL SYNAPSES; EXOCYTOSIS; TERMINALS; KINETICS; MODES	In this issue of Neuron, Harata et al. use a novel quenching technique to provide compelling evidence that kiss-and-run is the dominant mode of vesicle fusion at hippocampal synapses and that the prevalence of kiss-and-run can be modulated by stimulus frequency. The increased incidence of kiss-and-run at lower frequencies may ensure that vesicles are available for use during periods of high demand.	Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sullivan, JM (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.							Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697	13	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 19	2006	49	2					167	168		10.1016/j.neuron.2006.01.003	http://dx.doi.org/10.1016/j.neuron.2006.01.003			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423688	Bronze			2022-12-28	WOS:000234979900001
J	Cookson, MR; Clarimon, J				Cookson, MR; Clarimon, J			Dystonia and the nuclear envelope	NEURON			English	Editorial Material							TORSINA; MOVEMENT; PROTEIN	Mutations in torsinA cause dominantly inherited early-onset torsion dystonia in humans. In this issue of Neuron, Goodchild et al. show that torsinA knockout and knockin mice have similar phenotypes, which suggests that the mutant torsinA allele causes disease because it has decreased function. The experiments also highlight the possible role of nuclear envelope dynamics in maintaining normal neuronal function.	NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.		Cookson, Mark/AAW-2516-2021	Cookson, Mark/0000-0002-1058-3831; Clarimon, Jordi/0000-0002-6824-6942	NATIONAL INSTITUTE ON AGING [ZIAAG000953, Z01AG000953] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bragg DC, 2004, NEUROSCIENCE, V125, P651, DOI 10.1016/j.neuroscience.2004.01.053; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Bressman SB, 2000, NEUROLOGY, V54, P1746, DOI 10.1212/WNL.54.9.1746; Clarimon J, 2005, ANN NEUROL, V57, P765, DOI 10.1002/ana.20485; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Klein C, 2005, J INHERIT METAB DIS, V28, P425, DOI 10.1007/s10545-005-7495-8; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40	13	11	11	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					875	877		10.1016/j.neuron.2005.12.006	http://dx.doi.org/10.1016/j.neuron.2005.12.006			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364891	Bronze			2022-12-28	WOS:000234301700002
J	Kamke, MR; Brown, M; Irvine, DRF				Kamke, MR; Brown, M; Irvine, DRF			Basal forebrain cholinergic input is not essential for lesion-induced plasticity in mature auditory cortex	NEURON			English	Article							PARTIAL COCHLEAR LESIONS; CORTICAL PLASTICITY; ADULT CATS; NUCLEUS BASALIS; CORTICOFUGAL MODULATION; TONOTOPIC ORGANIZATION; FREQUENCY ORGANIZATION; SOMATOSENSORY CORTEX; INFERIOR COLLICULUS; SYSTEM	The putative role of the basal forebrain cholinergic system in mediating lesion-induced plasticity in topographic cortical representations was investigated. Cholinergic immunolesions were combined with unilateral restricted cochlear lesions in adult cats, demonstrating the consequence of cholinergic depletion on lesion-induced plasticity in primary auditory cortex (AI). Immunolesions almost eliminated the cholinergic input to AI, while cochlear lesions produced broad high-frequency hearing losses. The results demonstrate that the near elimination of cholinergic input does not disrupt reorganization of the tonotopic representation of the lesioned (contralateral) cochlea in AI and does not affect the normal representation of the unlesioned (ipsilateral) cochlea. It is concluded that cholinergic basal forebrain input to AI is not essential for the occurrence of lesion-induced plasticity in AI.	Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia	Monash University	Kamke, MR (corresponding author), Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia.	Marc.Kamke@med.monash.edu.au	Irvine, Dexter R/F-7474-2011; Kamke, Marc/J-4059-2014	Kamke, Marc/0000-0003-0248-9682; Irvine, Dexter/0000-0002-4397-947X				Avendano C, 1996, J CHEM NEUROANAT, V11, P113, DOI 10.1016/0891-0618(96)00132-9; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; Berman AL, 1982, THALAMUS BASAL TELEN; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CALFORD MB, 1993, NEUROSCIENCE, V55, P953, DOI 10.1016/0306-4522(93)90310-C; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Dupont E, 2002, BRAIN RES, V926, P51, DOI 10.1016/S0006-8993(01)03293-0; Edeline JM, 2003, EXP BRAIN RES, V153, P554, DOI 10.1007/s00221-003-1608-0; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GU Q, 1993, EUR J NEUROSCI, V5, P475, DOI 10.1111/j.1460-9568.1993.tb00514.x; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Irvine DRF, 2003, J COMP NEUROL, V467, P354, DOI 10.1002/cne.10921; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; Kaas J. H., 2001, MUTABLE BRAIN, P165; KAAS JH, 2000, NEW COGNITIVE NEUROS, P223; Kakigi A, 2000, AUDIOLOGY, V39, P153; Kamke MR, 2005, HEARING RES, V206, P89, DOI 10.1016/j.heares.2004.12.014; Kamke MR, 2003, J COMP NEUROL, V459, P355, DOI 10.1002/cne.10586; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura F, 2000, NEUROSCI RES, V38, P19, DOI 10.1016/S0168-0102(00)00151-6; Mercado E, 2001, NEUROREPORT, V12, P2283, DOI 10.1097/00001756-200107200-00047; Rajan R, 1998, J COMP NEUROL, V399, P35; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; Rajan R, 1996, AUDITORY SYSTEM PLASTICITY AND REGENERATION, P224; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; SCHWABER MK, 1993, AM J OTOL, V14, P252; Snyder RL, 2002, J NEUROPHYSIOL, V87, P434, DOI 10.1152/jn.00937.2000; STICHEL CC, 1987, J COMP NEUROL, V258, P91, DOI 10.1002/cne.902580107; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; TAGO H, 1986, J HISTOCHEM CYTOCHEM, V34, P1431, DOI 10.1177/34.11.2430009; WEBSTER HH, 1991, SOMATOSENS MOT RES, V8, P327, DOI 10.3109/08990229109144756; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wiley RG, 1997, ANN NY ACAD SCI, V835, P20, DOI 10.1111/j.1749-6632.1997.tb48615.x; WILLIAMSON BP, 1993, NLGI SPOKESMAN, V57, P329; Wrenn CC, 1998, INT J DEV NEUROSCI, V16, P595, DOI 10.1016/S0736-5748(98)00071-9; Yan J, 2005, EUR J NEUROSCI, V21, P563, DOI 10.1111/j.1460-9568.2005.03878.x	44	33	35	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 23	2005	48	4					675	686		10.1016/j.neuron.2005.09.014	http://dx.doi.org/10.1016/j.neuron.2005.09.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301182	Bronze			2022-12-28	WOS:000233677300019
J	Miller, JP				Miller, JP			A rose by any other code	NEURON			English	Editorial Material								In this issue of Neuron, Mazor and Laurent demonstrate that the internal representation of an odor in the antennal lobe of locusts is broadly distributed across the population of projection neurons and is formatted in a manner that requires deciphering of response transients rather than steady-state activity patterns.	Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Miller, JP (corresponding author), Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA.							Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Afraimovich VS, 2004, CHAOS, V14, P1123, DOI 10.1063/1.1819625; Dulac C, 1997, NEURON, V19, P477, DOI 10.1016/S0896-6273(00)80363-3; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					527	529		10.1016/j.neuron.2005.11.006	http://dx.doi.org/10.1016/j.neuron.2005.11.006			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301167	Bronze			2022-12-28	WOS:000233677300004
J	Torii, M; Levitt, P				Torii, M; Levitt, P			Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism	NEURON			English	Article							EMBRYONIC MOUSE-BRAIN; SOMATOSENSORY CORTEX; MUTANT MICE; THALAMIC INNERVATION; GENE-EXPRESSION; CEREBRAL-CORTEX; VISUAL-CORTEX; AREA IDENTITY; LAMINAR FATE; PROJECTIONS	Molecular mechanisms generating the topographic organization of corticothalamic (CT) circuits, which comprise more than three-quarters of the synaptic inputs onto sensory relay neurons, and their interdependence with thalamocortical (TC) axon development are unknown. Using in utero electroporation-mediated gene transfer, we show that EphA7-mediated signaling on neocortical axons controls the within-nucleus topography of CT projections in the thalamus. Notably, CT axons that misexpress EphA7 do not shift the relative positioning of their pathway within the subcortical telencephalon (ST), indicating that they do not depend upon EphA7/ephrin-A signaling in the ST for establishing this topography. Moreover, misexpression of cortical EphA7 results in disrupted topography of CT projections, but unchanged inter- and intra-areal topography of TC projections. Our results support a model in which EphA/ephrin-A signaling controls independently the precision with which CT and TC projections develop, yet is essential for establishing their topographic reciprocity.	Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University	Levitt, P (corresponding author), Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA.	pat.levitt@vanderbilt.edu			NICHD NIH HHS [P30HD15052] Funding Source: Medline; NIMH NIH HHS [MH45507] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045507, R01MH045507] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams NC, 1997, EUR J NEUROSCI, V9, P204, DOI 10.1111/j.1460-9568.1997.tb01391.x; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Alloway KD, 2003, BRAIN RES, V968, P54, DOI 10.1016/S0006-8993(02)04265-8; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CARVELL GE, 1987, J COMP NEUROL, V265, P409, DOI 10.1002/cne.902650309; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; FABRI M, 1991, BRAIN RES, V538, P351, DOI 10.1016/0006-8993(91)90455-5; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Frassoni C, 1995, DEV BRAIN RES, V90, P111, DOI 10.1016/0165-3806(96)83491-2; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Janis LS, 1999, J NEUROSCI, V19, P4962; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Korematsu K, 1997, DEV DYNAM, V208, P178, DOI 10.1002/(SICI)1097-0177(199702)208:2<178::AID-AJA5>3.0.CO;2-F; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Lozsadi DA, 1996, EUR J NEUROSCI, V8, P2416, DOI 10.1111/j.1460-9568.1996.tb01205.x; Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; MITROFANIS J, 1993, TRENDS NEUROSCI, V16, P240, DOI 10.1016/0166-2236(93)90163-G; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Mui SH, 2002, DEVELOPMENT, V129, P797; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOTHIAS F, 1988, BRAIN RES, V447, P169, DOI 10.1016/0006-8993(88)90980-8; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Shimogori T, 2005, J NEUROSCI, V25, P6550, DOI 10.1523/JNEUROSCI.0453-05.2005; Skaliora I, 1998, EUR J NEUROSCI, V10, P1215, DOI 10.1046/j.1460-9568.1998.00128.x; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 1999, J NEUROSCI, V19, P10357; Temereanca S, 2004, NEURON, V41, P639, DOI 10.1016/S0896-6273(04)00046-7; Torii MA, 1999, DEVELOPMENT, V126, P443; Uziel D, 2002, J NEUROSCI, V22, P9352; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	62	76	78	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					563	575		10.1016/j.neuron.2005.09.021	http://dx.doi.org/10.1016/j.neuron.2005.09.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301174	Bronze			2022-12-28	WOS:000233677300011
J	Dakin, S; Frith, U				Dakin, S; Frith, U			Vagaries of visual perception in autism	NEURON			English	Review							BIOLOGICAL MOTION PERCEPTION; HIGH-FUNCTIONING PERSONS; RECEPTIVE-FIELDS; EYE GAZE; CHILDREN; INTEGRATION; INDIVIDUALS; STIMULI; INFORMATION; SENSITIVITY	Three classes of perceptual phenomena have repeatedly been associated with autism spectrum disorder (ASD): superior processing of fine detail (local structure), either inferior processing of overall/global structure or an ability to ignore disruptive global/contextual information, and impaired motion perception. This review evaluates the quality of the evidence bearing on these three phenomena. We argue that while superior local processing has been robustly demonstrated, conclusions about global processing cannot be definitively drawn from the experiments to date, which have generally not precluded observers using more local cues. Perception of moving stimuli is impaired in ASD, but explanations in terms of magnocellular/dorsal deficits do not appear to be sufficient. We suggest that abnormalities in the superior temporal sulcus (STS) may provide a neural basis for the range of motion-processing deficits observed in ASD, including biological motion perception. Such an explanation may also provide a link between perceptual abnormalities and specific deficits in social cognition associated with autism.	UCL, Inst Ophthalmol, London EC1V 9EL, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Dakin, S (corresponding author), UCL, Inst Ophthalmol, Bath St, London EC1V 9EL, England.	s.dakin@ucl.ac.uk	Frith, Uta/C-1757-2008; Dakin, Steven C/B-7610-2008	Frith, Uta/0000-0002-9063-4466; Dakin, Steven C/0000-0002-3548-9104				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Allen HA, 2000, VISION RES, V40, P735, DOI 10.1016/S0042-6989(99)00223-0; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; BADCOCK JC, 1990, PERCEPTION, V19, P617, DOI 10.1068/p190617; Barlow H, 1997, J NEUROSCI, V17, P7954; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Bertone A, 2003, J COGNITIVE NEUROSCI, V15, P218, DOI 10.1162/089892903321208150; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Brosnan MJ, 2004, J CHILD PSYCHOL PSYC, V45, P459, DOI 10.1111/j.1469-7610.2004.00237.x; BURACK JA, 1994, J ABNORM PSYCHOL, V103, P535, DOI 10.1037/0021-843X.103.3.535; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Dakin SC, 2005, VISION RES, V45, P3027, DOI 10.1016/j.visres.2005.07.037; Derrington AM, 2004, ANNU REV PSYCHOL, V55, P181, DOI 10.1146/annurev.psych.55.090902.141903; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Foxton JM, 2003, BRAIN, V126, P2703, DOI 10.1093/brain/awg274; FRITH U, 1993, SCI AM, V268, P108, DOI 10.1038/scientificamerican0693-108; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gepner B, 2002, TRENDS COGN SCI, V6, P455, DOI 10.1016/S1364-6613(02)02004-1; Gepner B, 2002, J AUTISM DEV DISORD, V32, P231, DOI 10.1023/A:1015410015859; GEPNER B, 1995, NEUROREPORT, V6, P1211, DOI 10.1097/00001756-199505300-00034; Gerland G., 1996, REAL PERSON LIFE OUT; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grandin T., 1986, EMERGENCE LABELED AU; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; HAPPE F, 2006, IN PRESS J AUTISM DE; Happe FGE, 1996, J CHILD PSYCHOL PSYC, V37, P873, DOI 10.1111/j.1469-7610.1996.tb01483.x; Heaton P, 1998, MUSIC PERCEPT, V15, P291; Heaton P, 2003, J CHILD PSYCHOL PSYC, V44, P543, DOI 10.1111/1469-7610.00143; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jarrold C, 2005, DEVELOPMENTAL SCI, V8, P344, DOI 10.1111/j.1467-7687.2005.00422.x; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; LAGASSE LL, 1993, PERCEPT PSYCHOPHYS, V53, P89, DOI 10.3758/BF03211718; Leekam SR, 1998, J CHILD PSYCHOL PSYC, V39, P951, DOI 10.1017/S0021963098003035; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; Michels L, 2005, NEUROREPORT, V16, P1037, DOI 10.1097/00001756-200507130-00002; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; MOORE DG, 1992, BR J DEV PSYCHOL, V15, P401; Motter BC, 2002, J VISION, V2, p274a, DOI DOI 10.1167/2.7.274; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1111/1469-7610.00693; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P203, DOI 10.1111/1469-7610.00433; Mottron L, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P131; Mottron L, 2003, J CHILD PSYCHOL PSYC, V44, P904, DOI 10.1111/1469-7610.00174; MOTTRON L, 1993, BRAIN COGNITION, V23, P279, DOI 10.1006/brcg.1993.1060; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P743, DOI 10.1111/1469-7610.00490; MOTTRON L, 2006, IN PRESS J AUTISM DE; NAVON D, 1976, J EXP PSYCHOL HUMAN, V2, P130, DOI 10.1037/0096-1523.2.1.130; NEWSOME WT, 1986, J NEUROPHYSIOL, V55, P1340, DOI 10.1152/jn.1986.55.6.1340; NISHIDA S, 1995, VISION RES, V35, P477, DOI 10.1016/0042-6989(94)00144-B; NISHIDA S, 1992, VISION RES, V32, P1635, DOI 10.1016/0042-6989(92)90156-D; Noguchi Y, 2005, CEREB CORTEX, V15, P1592, DOI 10.1093/cercor/bhi037; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; OZONOFF S, 1994, J CHILD PSYCHOL PSYC, V35, P1015, DOI 10.1111/j.1469-7610.1994.tb01807.x; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P765, DOI 10.1111/1469-7610.00375; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Polyak S. L., 1941, RETINA-J RET VIT DIS; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rinehart NJ, 2000, J CHILD PSYCHOL PSYC, V41, P769, DOI 10.1017/S002196309900596X; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Ropar D, 1999, J CHILD PSYCHOL PSYC, V40, P1283, DOI 10.1017/S0021963099004667; Ropar D, 2001, J CHILD PSYCHOL PSYC, V42, P539, DOI 10.1017/S002196300100717X; SEKULER AB, 1994, PERCEPTION, V23, P529, DOI 10.1068/p230529; Servos P, 2002, CEREB CORTEX, V12, P772, DOI 10.1093/cercor/12.7.772; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; SPENCER M, 1984, NATURE, V309, P404, DOI 10.1038/309404b0; Stuart GW, 2001, VISION RES, V41, P3205, DOI 10.1016/S0042-6989(01)00176-6; Talcott JB, 2000, NEUROPSYCHOLOGIA, V38, P935, DOI 10.1016/S0028-3932(00)00020-8; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Waiter GD, 2004, NEUROIMAGE, V22, P619, DOI 10.1016/j.neuroimage.2004.02.029; WATT RJ, 1987, J OPT SOC AM A, V4, P2006, DOI 10.1364/JOSAA.4.002006; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386	96	503	507	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					497	507		10.1016/j.neuron.2005.10.018	http://dx.doi.org/10.1016/j.neuron.2005.10.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	983RP	16269366	Bronze			2022-12-28	WOS:000233250100010
J	Zelano, C; Sobel, N				Zelano, C; Sobel, N			Humans as an animal model for systems-level organization of olfaction	NEURON			English	Review							ANTERIOR PIRIFORM CORTEX; PRIMATE ORBITOFRONTAL CORTEX; SMELL IDENTIFICATION TEST; TEMPORAL LOBECTOMY; DISCRIMINATION ABILITY; PREFRONTAL CORTEX; GLOMERULAR LAYER; RECEPTOR NEURONS; ODOR-INTENSITY; NEURAL REPRESENTATIONS	The past 15 years have seen significant advances in the study of olfaction, with particular emphasis on elucidating the molecular building blocks of the sensory process. However, much of the systems-level organization of olfaction remains unexplored. Here, we provide an overview at this level, highlighting results obtained from studying humans, whom we think provide an underutilized, yet critical, animal model for olfaction.	Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zelano, C (corresponding author), Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA.	zelano@socrates.berkeley.edu; nsobel@berkeley.edu		Sobel, Noam/0000-0002-3232-9391	NIDCD NIH HHS [DC006915, DC005958] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005958, R01DC006915] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abele M, 2003, J NEUROL, V250, P1453, DOI 10.1007/s00415-003-0248-4; Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; ADRIAN ED, 1950, BRIT MED BULL, V6, P330, DOI 10.1093/oxfordjournals.bmb.a073625; Amoore JE, 1983, J APPL TOXICOL, V3, P272, DOI 10.1002/jat.2550030603; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; BERGLUND B, 1973, SCAND J PSYCHOL, V14, P131, DOI 10.1111/j.1467-9450.1973.tb00104.x; BROCA P, 1861, B SOC ANTHROPOL PAR, V2, P235; BROWN KS, 1968, HUM BIOL, V40, P456; BROWN R, 1966, J VERB LEARN VERB BE, V5, P325, DOI 10.1016/S0022-5371(66)80040-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; BUCK LB, 1995, CELL, V83, P349, DOI 10.1016/0092-8674(95)90110-8; CAIN WS, 1977, SCIENCE, V195, P796, DOI 10.1126/science.836592; CAIN WS, 1991, J EXP PSYCHOL HUMAN, V17, P382, DOI 10.1037/0096-1523.17.2.382; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Cerf-Ducastel B, 2003, BRAIN RES, V986, P39, DOI 10.1016/S0006-8993(03)03168-8; Chaput MA, 2000, CHEM SENSES, V25, P695, DOI 10.1093/chemse/25.6.695; CINELLI AR, 1987, BRAIN RES BULL, V19, P651, DOI 10.1016/0361-9230(87)90051-7; Cleland TA, 2003, HDB OLFACTION GUSTAT, P165, DOI DOI 10.1201/9780203911457.CH8; Connelly T, 2003, J NEUROL NEUROSUR PS, V74, P1435, DOI 10.1136/jnnp.74.10.1435; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; Damm M, 2002, CHEM SENSES, V27, P831, DOI 10.1093/chemse/27.9.831; Datiche F, 1996, J COMP NEUROL, V376, P265; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; DEWIJK RA, 1994, PERCEPT PSYCHOPHYS, V56, P12, DOI 10.3758/BF03211686; Djordjevic J, 2004, PSYCHOL SCI, V15, P143, DOI 10.1111/j.0956-7976.2004.01503001.x; Doty R. L., 2003, Handbook of olfaction and gustation, P345; DOTY RL, 1975, PERCEPT PSYCHOPHYS, V17, P492, DOI 10.3758/BF03203300; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Dravnieks A., 1985, ATLAS ODOR CHARACTER; Duchamp-Viret P, 2005, J NEUROBIOL, V65, P97, DOI 10.1002/neu.20177; DuchampViret P, 1997, PROG NEUROBIOL, V53, P561, DOI 10.1016/S0301-0082(97)00049-X; Egger V, 2003, J NEUROSCI, V23, P7551; EICHENBAUM H, 1983, BRAIN, V106, P459, DOI 10.1093/brain/106.2.459; ESKENAZI B, 1983, NEUROPSYCHOLOGIA, V21, P365, DOI 10.1016/0028-3932(83)90023-4; ESKENAZI B, 1986, NEUROPSYCHOLOGIA, V24, P553, DOI 10.1016/0028-3932(86)90099-0; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Ferdon S, 2003, NEUROIMAGE, V20, P12, DOI 10.1016/S1053-8119(03)00276-3; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; GESTELAND RC, 1965, J PHYSIOL-LONDON, V181, P525, DOI 10.1113/jphysiol.1965.sp007781; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gomez G, 2000, J NEUROSCI RES, V62, P737, DOI 10.1002/1097-4547(20001201)62:5<737::AID-JNR14>3.0.CO;2-A; Gomez G, 2005, CHEM SENSES, V30, P317, DOI 10.1093/chemse/bji026; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Gottfried JA, 2002, J NEUROSCI, V22, P10819; GRAZIADEI PPC, 1983, AM J OTOLARYNG, V4, P228, DOI 10.1016/S0196-0709(83)80063-5; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hahn CG, 2005, J COMP NEUROL, V483, P154, DOI 10.1002/cne.20424; Hahn CG, 2005, AM J PSYCHIAT, V162, P616, DOI 10.1176/appi.ajp.162.3.616; Hamann S, 2002, NEUROREPORT, V13, P15, DOI 10.1097/00001756-200201210-00008; HASELTON FR, 1988, J APPL PHYSIOL, V64, P2575, DOI 10.1152/jappl.1988.64.6.2575; Henkin R I, 1977, Trans Am Neurol Assoc, V102, P146; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Homewood J, 2001, BIOL PSYCHOL, V58, P65, DOI 10.1016/S0301-0511(01)00097-7; Hornung DE, 2001, RHINOLOGY, V39, P84; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; HOSOYA Y, 1937, J MED SCI, V5; HUGHES JR, 1970, ELECTROEN CLIN NEURO, V28, P97; Hummel T, 1996, BRAIN RES, V717, P160, DOI 10.1016/0006-8993(96)00094-7; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Jafek BW, 2002, CHEM SENSES, V27, P623, DOI 10.1093/chemse/27.7.623; Johnson BA, 1999, J COMP NEUROL, V409, P529; Johnson BA, 2000, J COMP NEUROL, V426, P330, DOI 10.1002/1096-9861(20001016)426:2<330::AID-CNE12>3.0.CO;2-5; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; JONESGOTMAN M, 1993, BRAIN COGNITION, V22, P182, DOI 10.1006/brcg.1993.1033; Kareken DA, 2004, NEUROIMAGE, V22, P456, DOI 10.1016/j.neuroimage.2004.01.008; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Keller A, 2004, NAT NEUROSCI, V7, P337, DOI 10.1038/nn1215; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; Keyhani K, 1997, J THEOR BIOL, V186, P279, DOI 10.1006/jtbi.1996.0347; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kurtz DB, 2004, CHEM SENSES, V29, P763, DOI 10.1093/chemse/bjh079; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Laska M, 2005, EXP BRAIN RES, V160, P302, DOI 10.1007/s00221-004-2012-0; Laska M, 1999, CHEM SENSES, V24, P161, DOI 10.1093/chemse/24.2.161; Laska M, 1997, CHEM SENSES, V22, P457, DOI 10.1093/chemse/22.4.457; Laska M, 2000, CHEM SENSES, V25, P189, DOI 10.1093/chemse/25.2.189; Laurent G, 1996, J NEUROSCI, V16, P3837; LAWLESS H, 1977, J EXP PSYCHOL-HUM L, V3, P52, DOI 10.1037/0278-7393.3.1.52; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; LEOPOLD DA, 1988, LARYNGOSCOPE, V98, P1232; Leopold DA, 2000, LARYNGOSCOPE, V110, P417, DOI 10.1097/00005537-200003000-00016; Levy LM, 1997, J COMPUT ASSIST TOMO, V21, P849, DOI 10.1097/00004728-199711000-00002; Linschoten MR, 2001, PERCEPT PSYCHOPHYS, V63, P1330, DOI 10.3758/BF03194546; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; LOVELL MA, 1982, ARCH OTOLARYNGOL, V108, P247; Lu XCM, 1998, NEUROSCIENCE, V84, P849, DOI 10.1016/S0306-4522(97)00520-4; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Macfarlane A, 1975, Ciba Found Symp, P103; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Mai J.K., 1997, ATLAS HUMAN BRAIN; Mainland JD, 2005, J NEUROSCI, V25, P6362, DOI 10.1523/JNEUROSCI.0920-05.2005; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mamlouk AM, 2003, NEUROCOMPUTING, V52-4, P591, DOI 10.1016/S0925-2312(02)00805-6; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Mori Kensaku, 1994, Seminars in Cell Biology, V5, P65, DOI 10.1006/scel.1994.1009; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; MOZELL MM, 1966, J GEN PHYSIOL, V50, P25, DOI 10.1085/jgp.50.1.25; MOZELL MM, 1973, SCIENCE, V181, P1247, DOI 10.1126/science.181.4106.1247; MOZELL MM, 1991, CHEM SENSES, V16, P631, DOI 10.1093/chemse/16.6.631; MUELLER CG, 1951, J GEN PHYSIOL, V34, P463, DOI 10.1085/jgp.34.4.463; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; MURPHY C, 1977, SENS PROCESS, V1, P204; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; OTTOSON D, 1956, ACTA PHYSL SCAND S, V35, P122; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Populin LC, 2005, J NEUROSCI, V25, P5903, DOI 10.1523/JNEUROSCI.1147-05.2005; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; PORTER RH, 1983, PHYSIOL BEHAV, V30, P151, DOI 10.1016/0031-9384(83)90051-3; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; PRICE JL, 1975, J COMP NEUROL, V162, P321, DOI 10.1002/cne.901620304; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; PRICE JL, 1987, NEUROBIOLOGY TASTE S; Radil T, 1998, ANN NY ACAD SCI, V855, P641, DOI 10.1111/j.1749-6632.1998.tb10638.x; RAUSCH R, 1977, CORTEX, V13, P445, DOI 10.1016/S0010-9452(77)80024-5; Rawson NE, 1997, J NEUROPHYSIOL, V77, P1606, DOI 10.1152/jn.1997.77.3.1606; Rawson NE, 2002, MICROSC RES TECHNIQ, V58, P142, DOI 10.1002/jemt.10132; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1982, DOI 10.1152/jn.1996.75.5.1982; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rousseaux M, 1996, STROKE, V27, P2328, DOI 10.1161/01.STR.27.12.2328; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; Royet JP, 2000, J NEUROSCI, V20, P7752; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; SATO T, 1994, J NEUROPHYSIOL, V72, P2980, DOI 10.1152/jn.1994.72.6.2980; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; SCHIFFMAN S, 1977, CHEM SENS FLAV, V2, P375, DOI 10.1093/chemse/2.3.375; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; SCHNEIDER RA, 1967, PHYSIOL BEHAV, V2, P305, DOI 10.1016/0031-9384(67)90084-4; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; SCHOON GAA, 1994, FORENSIC SCI INT, V69, P111, DOI 10.1016/0379-0738(94)90247-X; Scott JW, 1996, J NEUROPHYSIOL, V75, P2036, DOI 10.1152/jn.1996.75.5.2036; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Settles GS, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P323; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Shipley MT, 1996, J NEUROBIOL, V30, P123; Slotnick B, 2004, J NEUROSCI, V24, P9195, DOI 10.1523/JNEUROSCI.1936-04.2004; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Sobel N, 1998, J NEUROSCI, V18, P8990; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 1999, NATURE, V402, P35, DOI 10.1038/46944; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; STEVENS JC, 1988, CHEM SENSES, V13, P643, DOI 10.1093/chemse/13.4.643; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; TURNER BH, 1978, J COMP NEUROL, V177, P381, DOI 10.1002/cne.901770303; VONBEKESY G, 1964, J APPL PHYSIOL, V19, P369, DOI 10.1152/jappl.1964.19.3.369; Walker JC, 2003, CHEM SENSES, V28, P817, DOI 10.1093/chemse/bjg075; Wang J, 2005, J GERONTOL A-BIOL, V60, P510, DOI 10.1093/gerona/60.4.510; Wang LW, 2004, J PHYSIOL-LONDON, V554, P236, DOI 10.1113/jphysiol.2003.054726; Wells DL, 2000, PERCEPTION, V29, P111, DOI 10.1068/p2938; WHISMAN ML, 1978, ENVIRON SCI TECHNOL, V12, P1285, DOI 10.1021/es60147a003; Wiesmann M, 2001, NEUROIMAG CLIN N AM, V11, P237; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson DA, 1999, PHYSIOL BEHAV, V66, P41, DOI 10.1016/S0031-9384(98)00269-8; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yee KK, 2001, PHYSIOL BEHAV, V72, P705, DOI 10.1016/S0031-9384(01)00428-0; Yoshida M, 1984, B FS ENG CHUO U, V27, P343; Yousem DM, 1997, RADIOLOGY, V204, P833, DOI 10.1148/radiology.204.3.9280268; Yousem DM, 1998, ANN NY ACAD SCI, V855, P546, DOI 10.1111/j.1749-6632.1998.tb10624.x; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; ZATORRE RJ, 1991, BRAIN, V114, P71; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033; Zochowski MR, 2005, J NEUROPHYSIOL, V94, P2667, DOI 10.1152/jn.00328.2005; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	216	70	71	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					431	454		10.1016/j.neuron.2005.10.009	http://dx.doi.org/10.1016/j.neuron.2005.10.009			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269361	Bronze			2022-12-28	WOS:000233250100005
J	Gabernet, L; Jadhav, SP; Feldman, DE; Carandini, M; Scanziani, M				Gabernet, L; Jadhav, SP; Feldman, DE; Carandini, M; Scanziani, M			Somatosensory integration controlled by dynamic thalamocortical feed-forward inhibition	NEURON			English	Article							RAT BARREL CORTEX; CAT VISUAL-CORTEX; SYNAPTIC CONNECTIONS; PYRAMIDAL CELLS; SPINY STELLATE; LAYER 4; WHISKER DEFLECTIONS; RECEPTIVE-FIELDS; AUDITORY-CORTEX; NEURONS	The temporal features of tactile stimuli are faithfully represented by the activity of neurons in the somatosensory cortex. However, the cellular mechanisms that enable cortical neurons to report accurate temporal information are not known. Here, we show that in the rodent barrel cortex, the temporal window for integration of thalamic inputs is under the control of thalamocortical feed-forward inhibition and can vary from 1 to 10 ms. A single thalamic fiber can trigger feed-forward inhibition and contacts both excitatory and inhibitory cortical neurons. The dynamics of feed-forward inhibition exceed those of each individual synapse in the circuit and are captured by a simple disynaptic model of the thalamocortical projection. The variations in the integration window produce changes in the temporal precision of cortical responses to whisker stimulation. Hence, feed-forward inhibitory circuits, classically known to sharpen spatial contrast of tactile inputs, also increase the temporal resolution in the somatosensory cortex.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	University of Zurich; University of California System; University of California San Diego; The Smith-Kettlewell Eye Research Institute	Scanziani, M (corresponding author), Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland.	massimo@ucsd.edu	Jadhav, Shantanu/H-6654-2013; Carandini, Matteo/C-1922-2008; Carandini, Matteo/ABD-8296-2021	Jadhav, Shantanu/0000-0001-5821-0551; Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; gabernet, laetitia/0000-0001-5306-169X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071401, R01MH070058] Funding Source: NIH RePORTER; NIMH NIH HHS [MH71401, MH70058] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; Berger T, 2003, CEREB CORTEX, V13, P274, DOI 10.1093/cercor/13.3.274; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Bruno RM, 2002, J NEUROSCI, V22, P10966; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P396, DOI 10.1113/jphysiol.1955.sp005414; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FOX K, 1992, J NEUROSCI, V12, P1826; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1996, J NEUROSCI, V16, P6567; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; KELLER A, 1995, SYNAPTIC ORG BARREL, V11; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Laaris N, 2000, J NEUROSCI, V20, P1529; Lavallee P, 2004, J NEUROSCI, V24, P6098, DOI 10.1523/JNEUROSCI.0973-04.2004; LLOYD DPC, 1946, J NEUROPHYSIOL, V9, P421, DOI 10.1152/jn.1946.9.6.421; LONDON JA, 1989, J NEUROSCI, V9, P2182; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; MOUNTCASTLE VB, 1968, MED PHYSL, V2; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; PHILLIPS JR, 1988, P NATL ACAD SCI USA, V85, P1317, DOI 10.1073/pnas.85.4.1317; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Shimegi S, 1999, J NEUROSCI, V19, P10164; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	59	430	432	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					315	327		10.1016/j.neuron.2005.09.022	http://dx.doi.org/10.1016/j.neuron.2005.09.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242411	Bronze			2022-12-28	WOS:000232838700020
J	Wingate, R				Wingate, R			Math-map(ic)s	NEURON			English	Editorial Material							RHOMBIC LIP; GENE	In this issue of Neuron, Wang et al. and Machold and Fishell present contrasting molecular fate maps of Math1, which redefine the derivatives of the embryonic rhombic lip and offer a conceptual overhaul of cerebellar and precerebellar development. These fate maps identify a common developmental thread linking diverse, functionally associated neurons and reveal an exquisite temporal organization in cell production within a precise spatially defined region of neuroepithelium.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Wingate, R (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England.		Wingate, Richard JT/C-5341-2009	Wingate, Richard JT/0000-0002-1662-6097				Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; Funfschilling U, 2002, GENESIS, V33, P160, DOI 10.1002/gene.10104; HARKMARK W, 1954, ASPECTS CEREBELLAR A, P264; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Sherrington C, 1906, INTEGRATIVE ACTION N; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X	12	37	37	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 6	2005	48	1					1	4		10.1016/j.neuron.2005.09.012	http://dx.doi.org/10.1016/j.neuron.2005.09.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202701	Bronze			2022-12-28	WOS:000232625700001
J	Bonci, A; Hopf, FW				Bonci, A; Hopf, FW			The dopamine D2 receptor: New surprises from an old friend	NEURON			English	Review							PROTEIN-COUPLED RECEPTORS; NUCLEUS-ACCUMBENS NEURONS; DEPRESSION; DESENSITIZATION; SCHIZOPHRENIA; NEUROBIOLOGY; INHIBITION; ADDICTION	Drugs acting at dopamine D2 receptors (D2R) are commonly used to alleviate symptoms produced by diseases such as Parkinson's disease, schizophrenia, and depression. A limitation to the use of these drugs is that they sometimes afflict patients with severe side effects. This review discusses recent evidence for several proteins that represent novel mediators of the downstream consequences of D2R activation, since selective targeting of particular D2R-mediated signaling pathways could lead to the development of improved treatments for these devastating diseases.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Oakland, CA 94608 USA; Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Bonci, A (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Oakland, CA 94608 USA.	bonci@itsa.ucsf.edu						BARTLETT SE, 2005, IN PRESS P NATL ACAD; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Dailly E, 2004, FUND CLIN PHARMACOL, V18, P601, DOI 10.1111/j.1472-8206.2004.00287.x; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Hopf FW, 2005, J NEUROSCI, V25, P985, DOI 10.1523/JNEUROSCI.3099-04.2005; Hopf FW, 2003, J NEUROSCI, V23, P5079; Jeanneteau F, 2004, MOL BIOL CELL, V15, P4926, DOI 10.1091/mbc.E04-04-0285; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kabbani N, 2002, J NEUROSCI, V22, P8476; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Ralph RJ, 1999, J NEUROSCI, V19, P4627; Seeman P, 2005, P NATL ACAD SCI USA, V102, P3513, DOI 10.1073/pnas.0409766102; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004	24	73	73	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 4	2005	47	3					335	338		10.1016/j.neuron.2005.07.015	http://dx.doi.org/10.1016/j.neuron.2005.07.015			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055058	Bronze			2022-12-28	WOS:000231051900005
J	Domeniconi, M; Zampieri, N; Spencer, T; Hilaire, M; Mellado, W; Chao, MV; Filbin, MT				Domeniconi, M; Zampieri, N; Spencer, T; Hilaire, M; Mellado, W; Chao, MV; Filbin, MT			MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; GROWTH-FACTOR RECEPTOR; AXONAL REGENERATION; NOGO RECEPTOR; INTRACELLULAR DOMAIN; GAMMA-SECRETASE; FAMILY-MEMBER; RHO; COMPLEX; INTERACTS	The three known inhibitors of axonal regeneration present in myelin-MAG, Nogo, and OMgp-all interact with the same receptor complex to effect inhibition via protein kinase C (PKC)-dependent activation of the small GTPase Rho. The transducing component of this receptor complex is the p75 neurotrophin receptor. Here we show that MAG binding to cerebellar neurons induces alpha- and then gamma-secretase proteolytic cleavage of p75, in a protein kinase C-dependent manner, and that this cleavage is necessary for both activation of Rho and inhibition of neurite outgrowth.	CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Cell Biol & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA	City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, 695 Pk Ave, New York, NY 10021 USA.	filbin@genectr.hunter.cuny.edu	Spencer, Tim/AAK-2094-2020	Chao, Moses/0000-0002-6969-3744; Zampieri, Niccolo/0000-0002-2228-9453	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R56NS021072, U54NS041073] Funding Source: NIH RePORTER; NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS21072, NS41073] Funding Source: Medline; DS NIH HHS [NINDS NS 37060] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DS NIH HHS		Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Dergham P, 2002, J NEUROSCI, V22, P6570; DISTEFANO PS, 1988, P NATL ACAD SCI USA, V85, P270, DOI 10.1073/pnas.85.1.270; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; GROB PM, 1985, J BIOL CHEM, V260, P8044; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Majdan M, 1997, J NEUROSCI, V17, P6988; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	37	144	151	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					849	855		10.1016/j.neuron.2005.05.029	http://dx.doi.org/10.1016/j.neuron.2005.05.029			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953414	Bronze			2022-12-28	WOS:000229922500005
J	Petrovic, P; Dietrich, T; Fransson, P; Andersson, J; Carlsson, K; Ingvar, M				Petrovic, P; Dietrich, T; Fransson, P; Andersson, J; Carlsson, K; Ingvar, M			Placebo in emotional processing - Induced expectations of anxiety relief activate a generalized modulatory network	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; REWARD ANTICIPATION; PREFRONTAL CORTEX; NEURAL RESPONSES; PAIN; BRAIN; EXPECTANCY; ANALGESIA; FMRI; PERCEPTION	Placebo analgesia and reward processing share several features. For instance, expectations have a strong influence on the subsequent emotional experience of both. Recent imaging data indicate similarities in the underlying neuronal network. We hypothesized that placebo analgesia is a special case of reward processing and that placebo treatment could modulate emotional perception in the same way as does pain perception. The behavioral part of this study indicates that placebo treatment has an effect on how subjects perceive unpleasant pictures. Furthermore, event-related fMRI demonstrated that the same modulatory network, including the rostral anterior cingulate cortex and the lateral orbitofrontal cortex, is involved in both emotional placebo and placebo analgesia. These effects were correlated with the reported placebo effect and were predicted by the amount of treatment expectation induced on a previous day. Thus, the placebo effect may be considered to be a general process of modulation induced by the subjects' expectations.	Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Cognit Neurophysiol Res Grp R2 01, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Petrovic, P (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Cognit Neurophysiol Res Grp R2 01, S-17176 Stockholm, Sweden.	predrag.petrovic@cns.ki.se	Fransson, Peter/M-5679-2014; Petrovic, Predrag/AAS-6736-2020	Fransson, Peter/0000-0002-1305-9875; Petrovic, Predrag/0000-0002-5536-945X; Ingvar, Martin/0000-0002-9041-5714				Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Geday J, 2003, NEUROIMAGE, V18, P675, DOI 10.1016/S1053-8119(02)00038-1; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hsieh JC, 1999, NEUROSCI LETT, V262, P61, DOI 10.1016/S0304-3940(99)00060-9; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Kaasinen V, 2004, EUR J NEUROSCI, V19, P2352, DOI 10.1111/j.1460-9568.2004.03310.x; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Kringelbach ML, 2003, NEUROIMAGE, V20, P1371, DOI 10.1016/S1053-8119(03)00393-8; Lang PJ, 1995, INT AFFECTIVE PICTUR; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Liberzon I, 2002, P NATL ACAD SCI USA, V99, P7084, DOI 10.1073/pnas.102174799; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; Mellers BA, 2000, PSYCHOL BULL, V126, P910, DOI 10.1037/0033-2909.126.6.910; MELZACK R, 1968, P423; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; PRICE D, 1999, PSYCHOL MECH PAIN AN, P155; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Schoenbaum G, 2001, LEARN MEMORY, V8, P134, DOI 10.1101/lm.39901; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Ueda K, 2003, NEUROREPORT, V14, P51, DOI 10.1097/00001756-200301200-00010; Vase L, 2004, PROG PAIN RES MANAG, V29, P207; Vogt B., 1993, NEUROBIOLOGY CINGULA, P313; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1989, PAIN, V38, P109, DOI 10.1016/0304-3959(89)90080-8; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; WALL PD, 1999, TXB PAIN, P1419; Zubieta JK, 2003, ARCH GEN PSYCHIAT, V60, P1145, DOI 10.1001/archpsyc.60.11.1145	65	297	300	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					957	969		10.1016/j.neuron.2005.05.023	http://dx.doi.org/10.1016/j.neuron.2005.05.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953423	Bronze			2022-12-28	WOS:000229922500014
J	Hubbard, EM; Arman, AC; Ramachandran, VS; Boynton, GM				Hubbard, EM; Arman, AC; Ramachandran, VS; Boynton, GM			Individual differences among grapheme-color synesthetes: Brain-behavior correlations	NEURON			English	Article							PERCEPTION; SYNAESTHESIA; FORM; NUMBER; CORTEX; SPECIALIZATION; RETINOTOPY; ACTIVATION; SIMILARITY; RESOLUTION	Grapheme-color synesthetes experience specific colors associated with specific number or letter characters. To determine the neural locus of this condition, we compared behavioral and fMR1 responses in six grapheme-color synesthetes to control subjects. In our behavioral experiments, we found that a subject's synesthetic experience can aid in texture segregation (experiment 1) and reduce the effects of crowding (experiment 2). For synesthetes, graphemes produced larger fMR1 responses in color-selective area human V4 than for control subjects (experiment 3). Importantly, we found a correlation within subjects between the behavioral and fMR1 results; subjects with better performance on the behavioral experiments showed larger fMR1 responses in early retinotopic visual areas (V1, V2, V3, and hV4). These results suggest that grapheme-color synesthesia is the result of crossactivation between grapheme-selective and colorselective brain areas. The correlation between the behavioral and fMR1 results suggests that graphemecolor synesthetes may constitute a heterogeneous group.	Salk Inst Biol Studies, Syst Neurobiol Lab B, La Jolla, CA 92037 USA; Univ Calif San Diego, Ctr Brain & Cognit, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Hubbard, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab B, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edhubbard@gmail.com	Hubbard, Edward/N-2931-2019; Hubbard, Edward/C-1770-2012	Hubbard, Edward/0000-0002-2701-415X; 	NATIONAL EYE INSTITUTE [R01EY012925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH063585, R01MH060474] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY12925] Funding Source: Medline; NIMH NIH HHS [R01 MH 60474, F31 MH63585, F31 MH063585] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aleman A, 2001, NEUROREPORT, V12, P2827, DOI 10.1097/00001756-200109170-00015; Armel KC, 1999, NEUROCASE, V5, P293, DOI 10.1093/neucas/5.4.293; Baron-Cohen S., 1997, SYNAESTHESIA CLASSIC; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; Barrett NA, 2001, HUM BRAIN MAPP, V13, P213, DOI 10.1002/hbm.1034.abs; BECK J, 1966, PERCEPT PSYCHOPHYS, V1, P300, DOI 10.3758/BF03215792; Blake R., 2005, SYNESTHESIA PERSPECT, P47; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BOYNTON RM, 1968, SCIENCE, V161, P366, DOI 10.1126/science.161.3839.366; BOYNTON RM, 1988, ANNU REV PSYCHOL, V39, P69, DOI 10.1146/annurev.ps.39.020188.000441; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; CHURCHLAND PS, 2002, BRAIN WISIE STUDIES; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Crick F., 1994, ASTONISHING HYPOTHES; Cytowic R. E., 2002, SYNAESTHESIA UNION S; DAY S, 2005, SYNESTHESIA PERSPECT, P11; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Galton F., 1983, INQUIRY HUMAN FACULT; Gray JA, 2002, J CONSCIOUSNESS STUD, V9, P5; GRAY JA, 1997, POSSIBLE IMPLICATION, P173; Grossenbacher P. G., 1997, SYNAESTHESIA CLASSIC, P148; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Hubbard EM, 2003, J CONSCIOUSNESS STUD, V10, P77; HUBBARD EM, 2005, IN PRESS CORTEX; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; KENNEDY H, 1997, SYNAESTHESIA CLASSIC, P243; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; Laeng B, 2004, PSYCHOL SCI, V15, P277, DOI 10.1111/j.0956-7976.2004.00666.x; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Polk TA, 2002, J COGNITIVE NEUROSCI, V14, P145, DOI 10.1162/089892902317236803; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rich AN, 2002, NAT REV NEUROSCI, V3, P43, DOI 10.1038/nrn702; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Robertson LC, 2005, SYNESTHESIA PERSPECT; Rodman HR, 1997, CEREBR CORT, V12, P639; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SAGIV N, 2003, J COGNITIVE NEUROS S, V15, P153; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; SMILEK D, 2002, PSYCHE, V8, P475; SMILEK D, 2005, SYNESTHESIA PERSPECT, P74; Treisman A., 2005, SYNESTHESIA PERSPECT, P239; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Wagar BM, 2002, BRAIN COGNITION, V48, P606, DOI 10.1006/brcg.2001.1426; Weiss PH, 2001, CORTEX, V37, P750, DOI 10.1016/S0010-9452(08)70631-2; WOLFE JM, 1992, VISION RES, V32, P757, DOI 10.1016/0042-6989(92)90190-T; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669	72	242	245	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					975	985		10.1016/j.neuron.2005.02.008	http://dx.doi.org/10.1016/j.neuron.2005.02.008			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	911UO	15797557	Bronze			2022-12-28	WOS:000228031300017
J	Culham, JC				Culham, JC			Turn the other cheek: Viewpoint aftereffects for faces and objects	NEURON			English	Editorial Material									Univ Western Ontario, Social Sci Ctr, Dept Psychol, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Culham, JC (corresponding author), Univ Western Ontario, Social Sci Ctr, Dept Psychol, London, ON N6A 5C2, Canada.		Culham, Jody C./A-9863-2013	Culham, Jody C./0000-0003-0754-2999				Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974	5	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					644	645		10.1016/j.neuron.2005.02.020	http://dx.doi.org/10.1016/j.neuron.2005.02.020			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748839	Bronze			2022-12-28	WOS:000227446700003
J	Bagley, EE; Gerke, MB; Vaughan, CW; Hack, SP; Christie, MJ				Bagley, EE; Gerke, MB; Vaughan, CW; Hack, SP; Christie, MJ			GABA transporter currents activated by protein kinase a excite midbrain neurons during opioid withdrawal	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; PERIAQUEDUCTAL GRAY NEURONS; ROSTRAL VENTROMEDIAL MEDULLA; LOCUS-COERULEUS NEURONS; IN-VITRO; OPIATE WITHDRAWAL; ADENYLYL-CYCLASE; GLUTAMATE TRANSPORTERS; POTASSIUM CONDUCTANCE; MORPHINE-WITHDRAWAL	Adaptations in neurons of the midbrain periaqueductal gray (PAG) induced by chronic morphine treatment mediate expression of many signs of opioid withdrawal. The abnormally elevated action potential rate of opioid-sensitive PAG neurons is a likely cellular mechanism for withdrawal expression. We report here that opioid withdrawal in vitro induced an opioid-sensitive cation current that was mediated by the GABA transporter-1 (GAT-1) and required activation of protein kinase A (PKA) for its expression. Inhibition of GAT-1 or PKA also prevented withdrawal-induced hyperexcitation of PAG neurons. Our findings indicate that GAT-1 currents can directly increase the action potential rates of neurons and that GAT-1 may be a target for therapy to alleviate opioid-withdrawal symptoms.	Univ Sydney, Pain Management Res Inst, Royal N Shore Hosp, Sydney, NSW 2006, Australia	Royal North Shore Hospital; University of Sydney	Bagley, EE (corresponding author), Univ Sydney, Pain Management Res Inst, Royal N Shore Hosp, Sydney, NSW 2006, Australia.	bagleye@med.usyd.edu.au	Christie, MacDonald J/F-4724-2013	Christie, MacDonald J/0000-0002-0622-609X; Vaughan, Christopher/0000-0003-4314-7689; Bagley, Elena/0000-0002-3167-0707	NIDA NIH HHS [DA 12926-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012926] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; BARABAN SC, 1995, BRAIN RES, V676, P245, DOI 10.1016/0006-8993(95)00097-A; Barakat L, 2002, J NEUROPHYSIOL, V88, P1407, DOI 10.1152/jn.2002.88.3.1407; Barbaresi P, 2001, J COMP NEUROL, V429, P337, DOI 10.1002/1096-9861(20000108)429:2<337::AID-CNE12>3.0.CO;2-Z; Beckman ML, 1998, J NEUROSCI, V18, P6103; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; Bellchambers CE, 1998, NEUROSCIENCE, V83, P517, DOI 10.1016/S0306-4522(97)00399-0; Boczan J, 2004, J BIOL CHEM, V279, P18911, DOI 10.1074/jbc.M400496200; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; Cammack JN, 1996, P NATL ACAD SCI USA, V93, P723, DOI 10.1073/pnas.93.2.723; CAMMACK JN, 1993, J PHYSIOL-LONDON, V472, P81, DOI 10.1113/jphysiol.1993.sp019938; Chieng B, 1996, J NEUROSCI, V16, P7128; CHIENG B, 1994, BRIT J PHARMACOL, V113, P121, DOI 10.1111/j.1476-5381.1994.tb16183.x; COLLIER HOJ, 1974, NATURE, V248, P24, DOI 10.1038/248024a0; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; FEDYNYSHYN JP, 1989, FEBS LETT, V253, P23, DOI 10.1016/0014-5793(89)80921-4; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hack SP, 2003, NEUROPHARMACOLOGY, V45, P575, DOI 10.1016/S0028-3908(03)00205-3; Haghparast A, 1998, BRAIN RES, V814, P71, DOI 10.1016/S0006-8993(98)01029-4; Himmelsbach CK, 1943, FED PROC, V2, P201; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; INGRAM SL, 1994, NEURON, V13, P179, DOI 10.1016/0896-6273(94)90468-5; Ingram SL, 1998, J NEUROSCI, V18, P10269; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Ivanov A, 2001, J NEUROPHYSIOL, V85, P2388, DOI 10.1152/jn.2001.85.6.2388; Kalyuzhny AE, 1998, J COMP NEUROL, V392, P528; KOGAN JH, 1992, EUR J PHARMACOL, V211, P47, DOI 10.1016/0014-2999(92)90261-2; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; MALCHOW RP, 1990, P NATL ACAD SCI USA, V87, P8945, DOI 10.1073/pnas.87.22.8945; MALDONADO R, 1995, N-S ARCH PHARMACOL, V352, P565; Mao JR, 2002, J NEUROSCI, V22, P8312; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; NESTLER EJ, 1988, MOL PHARMACOL, V33, P127; NORTH RA, 1985, J PHYSIOL-LONDON, V364, P265, DOI 10.1113/jphysiol.1985.sp015743; Osborne PB, 1996, J PHYSIOL-LONDON, V490, P383, DOI 10.1113/jphysiol.1996.sp021152; Ozawa T, 2001, BRAIN RES, V905, P254, DOI 10.1016/S0006-8993(01)02536-7; Punch LJ, 1997, J NEUROSCI, V17, P8520; Quick MW, 2002, P NATL ACAD SCI USA, V99, P5686, DOI 10.1073/pnas.082712899; Risso S, 1996, J PHYSIOL-LONDON, V490, P691, DOI 10.1113/jphysiol.1996.sp021178; Schoffelmeer ANM, 2000, J NEUROSCI, V20, P3496, DOI 10.1523/JNEUROSCI.20-09-03496.2000; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SHEN KZ, 1992, J PHYSIOL-LONDON, V455, P471, DOI 10.1113/jphysiol.1992.sp019312; STINUS L, 1990, NEUROSCIENCE, V37, P767, DOI 10.1016/0306-4522(90)90106-E; SUZDAK PD, 1992, EUR J PHARMACOL, V224, P189, DOI 10.1016/0014-2999(92)90804-D; Svoboda KR, 1998, J NEUROSCI, V18, P7084; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; VAUGHAN CW, 2003, BRIT J PHARMACOL, V139, P392; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299	54	60	60	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 3	2005	45	3					433	445		10.1016/j.neuron.2004.12.049	http://dx.doi.org/10.1016/j.neuron.2004.12.049			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694329	Bronze			2022-12-28	WOS:000226787700015
J	Shao, ZH; Browning, JL; Lee, XH; Scott, ML; Shulga-Morskaya, S; Allaire, N; Thill, G; Levesque, M; Sah, D; McCoy, JM; Murray, B; Jung, V; Pepinsky, RB; Mi, S				Shao, ZH; Browning, JL; Lee, XH; Scott, ML; Shulga-Morskaya, S; Allaire, N; Thill, G; Levesque, M; Sah, D; McCoy, JM; Murray, B; Jung, V; Pepinsky, RB; Mi, S			TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration	NEURON			English	Article							CELL-DEATH; SUPERFAMILY; TNFRSF19; EDAR; MICE; CNS	Myelin-associated inhibitory factors (MAIFs) are inhibitors of CNS axonal regeneration following injury. The Nogo receptor complex, composed of the Nogo66 receptor 1 (NgR1), neurotrophin p75 receptor (p75), and LINGO-1, represses axon regeneration upon binding to these myelin components. The limited expression of p75 to certain types of neurons and its temporal expression during development prompted speculation that other receptors are involved in the NgR1 complex. Here, we show that an orphan receptor in the TNF family called TAJ, broadly expressed in postnatal and adult neurons, binds to NgR1 and can replace p75 in the p75/NgR1/LINGO-1 complex to activate RhoA in the presence of myelin inhibitors. In vitro exogenously added TAJ reversed neurite outgrowth caused by MAIFs. Neurons from Taj-deficient mice were more resistant to the suppressive action of the myelin inhibitors. Given the limited expression of p75, the discovery of TAJ function is an important step for understanding the regulation of axonal regeneration.	Biogen Inc, Dept Discovery Biol, Cambridge, MA 02142 USA	Biogen	Mi, S (corresponding author), Biogen Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com		Browning, Jeffrey/0000-0001-9168-5233				BROWNING JL, 1995, J IMMUNOL, V154, P33; CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189; Copray S, 2004, J NEUROIMMUNOL, V148, P41, DOI 10.1016/j.jneuroim.2003.11.008; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Hisaoka T, 2003, DEV BRAIN RES, V143, P105, DOI 10.1016/S0165-3806(03)00101-9; Hu SM, 1999, GENOMICS, V62, P103, DOI 10.1006/geno.1999.5979; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Rabizadeh S, 2003, CYTOKINE GROWTH F R, V14, P225, DOI 10.1016/S1359-6101(03)00018-2; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994	19	319	355	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					353	359		10.1016/j.neuron.2004.12.050	http://dx.doi.org/10.1016/j.neuron.2004.12.050			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694322	Bronze			2022-12-28	WOS:000226787700008
J	Wang, HG; Lu, FM; Jin, L; Udo, H; Kandel, ER; de Vente, J; Walter, U; Lohmann, SM; Hawkins, RD; Antonova, I				Wang, HG; Lu, FM; Jin, L; Udo, H; Kandel, ER; de Vente, J; Walter, U; Lohmann, SM; Hawkins, RD; Antonova, I			Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; ELEMENT-DEPENDENT TRANSCRIPTION; LATE-PHASE LTP; TERM POTENTIATION; GUANYLYL CYCLASE; DENDRITIC SPINE; NMDA RECEPTOR; SMOOTH-MUSCLE; CGMP; KINASE	Recent results suggest that long-lasting potentiation at hippocampal synapses involves the rapid formation of clusters or puncta of presynaptic as well as postsynaptic proteins, both of which are blocked by antagonists of NMDA receptors and an inhibitor of actin polymerization. We have investigated whether the increase in puncta involves retrograde signaling through the NO-cGMP-cGK pathway and also examined the possible roles of two classes of molecules that regulate the actin cytoskeleton: Ena/VASP proteins and Rho GTPases. Our results suggest that NO, cGMP, cGK, actin, and Rho GTPases including RhoA play important roles in the potentiation and act directly in both the presynaptic and postsynaptic neurons, where they contribute to the increase in puncta of synaptic proteins. cGK phosphorylates synaptic VASP during the potentiation, whereas Rho GTPases act both in parallel and upstream of cGMP, in part by maintaining the synaptic localization of soluble guanylyl cyclase.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA; Kavli Inst Brain Sci, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Limburg, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Hasselt University; Maastricht University; University of Wurzburg	Hawkins, RD (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	rdh1@columbia.edu	Walter, ulrich/W-2478-2017	Walter, ulrich/0000-0001-6784-2307	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50733] Funding Source: Medline; NINDS NIH HHS [NS45108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Arancio O, 2001, J NEUROSCI, V21, P143, DOI 10.1523/JNEUROSCI.21-01-00143.2001; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Blackshaw S, 2003, NEUROSCIENCE, V119, P979, DOI 10.1016/S0306-4522(03)00217-3; Bon CLM, 2003, J NEUROSCI, V23, P1941; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Burette A, 2002, J NEUROSCI, V22, P8961; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; DEVENTE J, 1988, BRAIN RES, V446, P387, DOI 10.1016/0006-8993(88)90900-6; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; Hawkins RD, 1996, NEURON, V16, P465, DOI 10.1016/S0896-6273(00)80064-1; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hindley S, 1997, J NEUROSCI RES, V47, P427; Kim CH, 1999, J NEUROSCI, V19, P4314; Kingston PA, 1996, P NATL ACAD SCI USA, V93, P10440, DOI 10.1073/pnas.93.19.10440; Kleppisch T, 1999, J NEUROSCI, V19, P48, DOI 10.1523/JNEUROSCI.19-01-00048.1999; Kleppisch T, 2003, J NEUROSCI, V23, P6005, DOI 10.1523/JNEUROSCI.23-14-06005.2003; Korey CA, 2000, J NEUROBIOL, V44, P184, DOI 10.1002/1097-4695(200008)44:2<184::AID-NEU8>3.0.CO;2-N; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Leamey CA, 2001, J NEUROSCI, V21, P3871, DOI 10.1523/JNEUROSCI.21-11-03871.2001; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lu YF, 2002, J NEUROPHYSIOL, V88, P1270, DOI 10.1152/jn.2002.88.3.1270; Lu YF, 1999, J NEUROSCI, V19, P10250; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARKERT T, 1995, J CLIN INVEST, V96, P822, DOI 10.1172/JCI118128; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; MONTFORT P, 2002, J NEUROSCI, V22, P10116; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; POPOV S, 1992, J NEUROSCI, V12, P77; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schmidt H, 2002, J CELL BIOL, V159, P489, DOI 10.1083/jcb.200207058; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Son H, 1998, LEARN MEMORY, V5, P231; Stanton PK, 2003, J NEUROSCI, V23, P5936; Tanaka J, 1997, GLIA, V19, P286; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; WENDLAND B, 1994, P NATL ACAD SCI USA, V91, P2151, DOI 10.1073/pnas.91.6.2151; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	80	167	172	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					389	403		10.1016/j.neuron.2005.01.011	http://dx.doi.org/10.1016/j.neuron.2005.01.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694326	Bronze			2022-12-28	WOS:000226787700012
J	Martinez-Conde, S; Macknik, SL; Troncoso, XG; Dyar, TA				Martinez-Conde, S; Macknik, SL; Troncoso, XG; Dyar, TA			Microsaccades counteract visual fading during fixation	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; FILLING-IN; IMAGE; ORIENTATION; SPECIFICITY; VISIBILITY; ATTENTION; RESPONSES; NEURONS; VISION	Our eyes move continually, even while we fixate our gaze on an object. If fixational eye movements are counteracted, our perception of stationary objects fades completely, due to neural adaptation. Some studies have suggested that fixational microsaccades refresh retinal images, thereby preventing adaptation and fading. However, other studies disagree, and so the role of microsaccades remains unclear. Here, we correlate visibility during fixation to the occurrence of microsaccades. We asked subjects to indicate when Troxler fading of a peripheral target occurs, while simultaneously recording their eye movements with high precision. We found that before a fading period, the probability, rate, and magnitude of microsaccades decreased. Before transitions toward visibility, the probability, rate, and magnitude of microsaccades increased. These results reveal a direct link between suppression of microsaccades and fading and suggest a causal relationship between microsaccade production and target visibility during fixation.	Barrow Neurol Inst, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	smart@neuralcorrelate.com	Macknik, Stephen L./H-7704-2019	Macknik, Stephen L./0000-0002-3143-9230; Troncoso, Xoana/0000-0001-7343-1272				Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Carpenter RHS, 1988, MOVEMENTS EYES; Clarke F.J.J., 1961, OPT ACTA, V8, P121, DOI [10.1080/713826370, DOI 10.1080/713826370]; CLARKE FJJ, 1962, VISION RES, V2, P53, DOI 10.1016/0042-6989(62)90063-9; Clarke FJJ., 1957, OPT ACTA, V4, P69, DOI 10.1080/713826067; Clarke FJJ, 1960, OPTICA ACTA INT J OP, V7, P219, DOI 10.1080/713826335; CLOWES M B, 1962, Optom Wkly, V9, P65; CUNITZ RJ, 1969, VISION RES, V9, P683, DOI 10.1016/0042-6989(69)90125-4; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; DITCHBURN RW, 1959, J PHYSIOL-LONDON, V145, P98, DOI 10.1113/jphysiol.1959.sp006130; DRYSDALE AE, 1975, VISION RES, V15, P813, DOI 10.1016/0042-6989(75)90259-X; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Engbert R, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P103, DOI 10.1016/B978-044451020-4/50007-4; Fiorentini A., 1966, ATTI FOND GIORGIO RO, V21; GERRITS HJM, 1970, VISION RES, V10, P1443, DOI 10.1016/0042-6989(70)90094-5; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; KOWLER E, 1979, VISION RES, V19, P105, DOI 10.1016/0042-6989(79)90129-9; KOWLER E, 1980, VISION RES, V20, P273, DOI 10.1016/0042-6989(80)90113-3; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; Magnussen S, 2001, VISION RES, V41, P2961, DOI 10.1016/S0042-6989(01)00178-X; Malinov IV, 2000, VISION RES, V40, P2083, DOI 10.1016/S0042-6989(00)00063-8; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2002, P NATL ACAD SCI USA, V99, P13920, DOI 10.1073/pnas.212500599; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; NACHMIAS J, 1961, J OPT SOC AM, V51, P761, DOI 10.1364/JOSA.51.000761; PRITCHARD R, 1961, SCI AM, V204, P72, DOI 10.1038/scientificamerican0661-72; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; RIGGS LA, 1952, J OPT SOC AM, V42, P872; Rolfs M, 2004, PSYCHOL SCI, V15, P705, DOI 10.1111/j.0956-7976.2004.00744.x; SABRIN HW, 1983, PERCEPT PSYCHOPHYS, V34, P155, DOI 10.3758/BF03211341; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHIETING S, 1987, VISION RES, V27, P277, DOI 10.1016/0042-6989(87)90190-8; SHARPE CR, 1972, J PHYSIOL-LONDON, V222, P113, DOI 10.1113/jphysiol.1972.sp009790; SKAVENSKI AA, 1979, VISION RES, V19, P675, DOI 10.1016/0042-6989(79)90243-8; SPILLMANN L, 1992, VISION RES, V32, P1941, DOI 10.1016/0042-6989(92)90053-L; Spillmann L., 2003, FILLING IN PERCEPTUA, P81, DOI DOI 10.1093/ACPROF:OSO/9780195140132.003.0005; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; Steinman RM, 2003, SPATIAL VISION, V16, P225, DOI 10.1163/156856803322467509; STEINMAN RM, 1980, VISION RES, V20, P415, DOI 10.1016/0042-6989(80)90032-2; STEINMAN RM, 1975, BASIC MECH OCULAR MO; Sturzel F, 2001, VISION RES, V41, P2969, DOI 10.1016/S0042-6989(01)00172-9; TROXLER D, 1804, OPHTHALMOLOGISCHE BI; Tse PU, 2004, PSYCHOL SCI, V15, P708, DOI 10.1111/j.0956-7976.2004.00745.x; Tse PU, 2002, VISION RES, V42, P1663, DOI 10.1016/S0042-6989(02)00076-7; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; van Dam LCJ, 2005, VISION RES, V45, P2417, DOI 10.1016/j.visres.2005.03.013; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	53	316	323	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					297	305		10.1016/j.neuron.2005.11.033	http://dx.doi.org/10.1016/j.neuron.2005.11.033			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423702	Bronze			2022-12-28	WOS:000234979900015
J	Weimer, JM; Anton, ES				Weimer, JM; Anton, ES			Doubling up on microtubule stabilizers: Synergistic functions of doublecortin-like kinase and doublecortin in the developing cerebral cortex	NEURON			English	Editorial Material							NEURONAL MIGRATION; PROTEIN; NEOCORTEX; LIS1	Dynamic regulation of neuronal cytoskeletal machinery in response to extracellular cues enables distinct changes in neuronal development in the cerebral cortex. In this issue of Neuron, three related studies on doublecortin-like kinase, a microtubule-associated protein related to doublecortin, by Shu et al., Koizumi et al., and Deuel et al., provide evidence that doublecortin-like kinase is essential for proper neurogenesis, neuronal migration, and axonal wiring.	Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Weimer, JM (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA.							Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Silverman MA, 1999, J BIOL CHEM, V274, P2631, DOI 10.1074/jbc.274.5.2631; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Vreugdenhil E, 2001, MOL BRAIN RES, V94, P67, DOI 10.1016/S0169-328X(01)00213-3	16	23	23	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					3	4		10.1016/j.neuron.2005.12.016	http://dx.doi.org/10.1016/j.neuron.2005.12.016			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387632	Bronze			2022-12-28	WOS:000236699300002
J	Hensch, TK				Hensch, TK			Recovery in the blink of an eye	NEURON			English	Editorial Material							MONOCULAR DEPRIVATION; VISUAL-CORTEX; CAT	Sensory deprivation sheds light on cortical plasticity mechanisms, but recovery of lost brain function may bear the greatest clinical relevance. Ramoa and colleagues now find that binocular recovery from monocular occlusion can be extraordinarily rapid, independent of protein synthesis, and precise. Reactivation of latent connections may then reverse amblyopia.	RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan	RIKEN	Hensch, TK (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Hensch, Takao/L-4182-2019					Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; HENSCH TK, 2005, IN PRESS NAT REV NEU; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; Kind PC, 2002, NATURE, V416, P430, DOI 10.1038/416430a; Krahe TE, 2005, NEURON, V48, P329, DOI 10.1016/j.neuron.2005.09.016; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; MALACH R, 1984, J NEUROPHYSIOL, V51, P538, DOI 10.1152/jn.1984.51.3.538; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	11	4	4	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					166	168		10.1016/j.neuron.2005.10.007	http://dx.doi.org/10.1016/j.neuron.2005.10.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242396	Bronze			2022-12-28	WOS:000232838700005
J	Porter, J; Anand, T; Johnson, B; Khan, RM; Sobel, N				Porter, J; Anand, T; Johnson, B; Khan, RM; Sobel, N			Brain mechanisms for extracting spatial information from smell	NEURON			English	Article							HUMAN OLFACTORY CORTEX; FALSE DISCOVERY RATE; TRIGEMINAL NERVE; ODORS; ACTIVATION; FMRI; NOSTRIL; RAT; DISCRIMINATION; LOCALIZATION	Forty years ago, von Bekesy demonstrated that the spatial source of an odorant is determined by comparing input across nostrils, but it is unknown how this comparison is effected in the brain. To address this, we delivered odorants to the left or right of the nose, and contrasted olfactory left versus right localization with olfactory identification during brain imaging. We found nostril-specific responses in primary olfactory cortex that were predictive of the accuracy of left versus right localization, thus providing a neural substrate for the behavior described by von Bdkdsy. Additionally, left versus right localization preferentially engaged a portion of the superior temporal gyrus previously implicated in visual and auditory localization, suggesting that localization information extracted from smell was then processed in a convergent brain system for spatial representation of multisensory inputs.	Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Bioengn Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Porter, J (corresponding author), Univ Calif Berkeley, Program Biophys, Berkeley, CA 94720 USA.	jessiep@calmail.berkeley.edu; nsobel@socrates.berkeley.edu		Sobel, Noam/0000-0002-3232-9391	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006915] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC006915-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACKERMAN D, 1990, NATURAL HIST SENSESS; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bensafi M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P259; BOJSENMOLLER F, 1975, J COMP NEUROL, V159, P245, DOI 10.1002/cne.901590206; BOUVET JF, 1987, NEUROSCI LETT, V77, P181, DOI 10.1016/0304-3940(87)90583-0; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Djordjevic J, 2005, NEUROIMAGE, V24, P791, DOI 10.1016/j.neuroimage.2004.09.035; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DOTY RL, 1995, NEUROL DIS, V32, P821; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Gottfried JA, 2002, J NEUROSCI, V22, P10819; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; HUMMEL T, 1992, ELECTROEN CLIN NEURO, V84, P192, DOI 10.1016/0168-5597(92)90025-7; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mai J.K., 1997, ATLAS HUMAN BRAIN; Marchini J, 2004, NEUROIMAGE, V22, P1203, DOI 10.1016/j.neuroimage.2004.03.030; Masago Ryoko, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P7, DOI 10.2114/jpa.20.7; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; NEGUS SV, 1958, COMP ANATOMY PHYSL N; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Price J.L., 1987, P179; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; PRINCIPATO JJ, 1970, ARCHIV OTOLARYNGOL, V91, P71; Radil T, 1998, ANN NY ACAD SCI, V855, P641, DOI 10.1111/j.1749-6632.1998.tb10638.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; Sabri M, 2005, NEUROIMAGE, V25, P969, DOI 10.1016/j.neuroimage.2004.12.033; Savic I, 2000, CHEM SENSES, V25, P517, DOI 10.1093/chemse/25.5.517; Savic I, 2000, NEUROREPORT, V11, P2861, DOI 10.1097/00001756-200009110-00007; Savic I, 2002, HUM BRAIN MAPP, V17, P17, DOI 10.1002/hbm.10045; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Schaefer ML, 2002, J COMP NEUROL, V444, P221, DOI 10.1002/cne.10143; SCHNEIDER RA, 1967, PHYSIOL BEHAV, V2, P305, DOI 10.1016/0031-9384(67)90084-4; Settles GS, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P323; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Sobel N, 1999, NATURE, V402, P35, DOI 10.1038/46944; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spence C, 2001, Q J EXP PSYCHOL-A, V54, P775, DOI 10.1080/02724980042000480; STODDART DM, 1979, EXPERIENTIA, V35, P1456, DOI 10.1007/BF01962780; STONE H, 1970, BRAIN RES, V21, P138, DOI 10.1016/0006-8993(70)90030-2; STONE H, 1968, EXP NEUROL, V21, P11, DOI 10.1016/0014-4886(68)90029-0; THESEN A, 1993, J EXP BIOL, V180, P247; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VONBEKESY G, 1964, J APPL PHYSIOL, V19, P369, DOI 10.1152/jappl.1964.19.3.369; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Wilson DA, 1999, PHYSIOL BEHAV, V66, P41, DOI 10.1016/S0031-9384(98)00269-8; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; ZATORRE RJ, 1990, PERCEPT PSYCHOPHYS, V47, P526, DOI 10.3758/BF03203105; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368	70	115	116	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					581	592		10.1016/j.neuron.2005.06.028	http://dx.doi.org/10.1016/j.neuron.2005.06.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102540	Bronze			2022-12-28	WOS:000231411100014
J	Mukamel, EA; Schnitzer, MJ				Mukamel, EA; Schnitzer, MJ			Retinal coding of visual scenes - Repetitive and redundant too?	NEURON			English	Editorial Material							GANGLION-CELLS; INFORMATION	Visual information reaches the brain by way of a fine cable, the optic nerve. The million or so axons in the optic nerve represent an information bottleneck in the visua pathway-where the fewest number of neurons convey the visual scene. It has long been thought that to make the most of the optic nerve's limited capacity the retina may encode visual information in an optimally efficient manner. In this issue of Neuron, Puchalla et al. report a test of this hypothesis using multiolectrode recordings from retinal ganglion cells stimulated with movies of natural scenes. The authors find substantial redundancy in the retinal code and estimate that there is an similar to 10-fold overrepresentation of visual information.	Stanford Univ, Dept Phys, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, James H Clark Ctr Biomed Engn & Sci, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Mukamel, EA (corresponding author), Stanford Univ, Dept Phys, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.			Mukamel, Eran/0000-0003-3203-9535				Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Shannon C.E., 1963, MATH THEORY COMMUNIC; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	11	4	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					357	359		10.1016/j.neuron.2005.04.018	http://dx.doi.org/10.1016/j.neuron.2005.04.018			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882630	Bronze			2022-12-28	WOS:000229011400002
J	Brambilla, D; Chapman, D; Greene, R				Brambilla, D; Chapman, D; Greene, R			Adenosine mediation of presynaptic feedback inhibition of glutamate release	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL SYNAPSES; EXTRACELLULAR ADENOSINE; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; PYRAMIDAL CELLS; NMDA RECEPTORS; NEURONS; POOL; ACTIVATION	Conditions of increased metabolic demand relative to metabolite availability are associated with increased extracellular adenosine in CNS tissue. Synaptic activation of postsynaptic NIVIDA receptors on neurons of the cholinergic brainstern arousal center can increase sufficient extracellular adenosine to act on presynaptic All adenosine receptors (AlADRs) of glutamate terminals, reducing release from the readily releasable pool. The time course of the adenosine response to an increase in glutamate release is slow (tau > 10 min), consistent with the role of adenosine as a fatigue factor that inhibits the activity of cholinergic arousal centers to reduce arousal.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Greene, R (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robertw.greene@utsouthwestern.edu	Shin, Jung Hoon/C-9566-2012; Brambilla, Dario/F-3126-2012	Brambilla, Dario/0000-0002-4838-482X	NIMH NIH HHS [5 R01 MH067777-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067777] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arrigoni E, 2001, J NEUROSCI, V21, P1076, DOI 10.1523/JNEUROSCI.21-03-01076.2001; Biber K, 1997, J NEUROSCI, V17, P4956; CRAIG CG, 1993, J NEUROCHEM, V60, P1073, DOI 10.1111/j.1471-4159.1993.tb03256.x; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; FREDHOLM BB, 1988, TRENDS PHARMACOL SCI, V9, P130, DOI 10.1016/0165-6147(88)90194-0; GOODMAN RR, 1983, SCIENCE, V220, P967, DOI 10.1126/science.6302841; GREENE RW, 1991, PROG NEUROBIOL, V36, P329, DOI 10.1016/0301-0082(91)90005-L; HAAS HL, 1984, PFLUG ARCH EUR J PHY, V402, P244, DOI 10.1007/BF00585506; Harvey J, 1997, J NEUROSCI, V17, P5271; Hausser M, 1997, J NEUROSCI, V17, P7606; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huston JP, 1996, NEUROSCIENCE, V73, P99, DOI 10.1016/0306-4522(96)00021-8; LUEBKE JI, 1993, J NEUROPHYSIOL, V70, P2128, DOI 10.1152/jn.1993.70.5.2128; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MCILWAIN H, 1986, J NEUROBIOL, V17, P39, DOI 10.1002/neu.480170105; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; POLI A, 1991, J NEUROCHEM, V57, P298, DOI 10.1111/j.1471-4159.1991.tb02128.x; Porkka-Heiskanen T, 2000, NEUROSCIENCE, V99, P507, DOI 10.1016/S0306-4522(00)00220-7; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Portas CM, 1997, NEUROSCIENCE, V79, P225, DOI 10.1016/S0306-4522(96)00640-9; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RAINNIE DG, 1994, SCIENCE, V263, P689, DOI 10.1126/science.8303279; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; RIVKEES SA, 1995, BRAIN RES, V677, P193, DOI 10.1016/0006-8993(95)00062-U; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Searl TJ, 2003, J PHYSIOL-LONDON, V553, P445, DOI 10.1113/jphysiol.2003.051300; Silinsky EM, 2004, J PHYSIOL-LONDON, V558, P389, DOI 10.1113/jphysiol.2004.061457; STERIADE M, 1990, J NEUROSCI, V10, P2541; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; WHITE TD, 1993, DRUG DEVELOP RES, V28, P406, DOI 10.1002/ddr.430280340; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; ZIMMERMANN H, 1995, ADENOSINE AND ADENINE NUCLEOTIDES: FROM MOLECULAR BIOLOGY TO INTEGRATIVE PHYSIOLOGY, P179	42	50	56	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					275	283		10.1016/j.neuron.2005.03.016	http://dx.doi.org/10.1016/j.neuron.2005.03.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848805	Bronze			2022-12-28	WOS:000228674800013
J	Cowan, CW; Shao, YR; Sahin, M; Shamah, SM; Lin, MZ; Greer, PL; Gao, S; Griffith, EC; Brugge, JS; Greenberg, ME				Cowan, CW; Shao, YR; Sahin, M; Shamah, SM; Lin, MZ; Greer, PL; Gao, S; Griffith, EC; Brugge, JS; Greenberg, ME			Vav family GEFs link activated Ephs to endocytosis and axon guidance	NEURON			English	Article							RECEPTOR TYROSINE KINASE; NUCLEOTIDE EXCHANGE FACTOR; GROWTH CONE COLLAPSE; GANGLION-CELL AXONS; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT ACTIVATION; LIGAND ACTIVATION; GDP/GTP EXCHANGE; PHOSPHORYLATION; PROTEINS	Ephrin signaling through Eph receptor tyrosine kinases can promote attraction or repulsion of axonal growth cones during development. However, the mechanisms that determine whether Eph signaling promotes attraction or repulsion are not known. We show here that the Rho family GEF Vav2 plays a key role in this process. We find that, during axon guidance, ephrin binding to Ephs triggers Vav-dependent endocytosis of the ligand-receptor complex, thus converting an initially adhesive interaction into a repulsive event. In the absence of Vav proteins, ephrin-Eph endocytosis is blocked, leading to defects in growth cone collapse in vitro and significant defects in the ipsilateral retinogeniculate projections in vivo. These findings suggest an important role for Vav family GEFs as regulators of ligand-receptor endocytosis and determinants of repulsive signaling during axon guidance.	Harvard Univ, Sch Med, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Neurobiol Program, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu	Cowan, Christopher W/I-2497-2014; SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953; Lin, Michael/0000-0002-0492-1961; Griffith, Eric/0000-0003-0428-3215	NHLBI NIH HHS [HL059561] Funding Source: Medline; NICHD NIH HHS [HD18655, K08 HD01384] Funding Source: Medline; NINDS NIH HHS [NS43855, R01 NS045500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Chauvet N, 2003, MOL CELL NEUROSCI, V22, P467, DOI 10.1016/S1044-7431(03)00030-7; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DAVIS A, 1994, SCIENCE, V264, P839, DOI 10.1126/science.8171338; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Ellis C, 1996, ONCOGENE, V12, P1727; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Marignani PA, 2001, J CELL BIOL, V154, P177, DOI 10.1083/jcb.200103134; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; PANDEY A, 1994, J BIOL CHEM, V269, P30154; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; PANDEY A, 1995, J BIOL CHEM, V270, P19201, DOI 10.1074/jbc.270.33.19201; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; STRITTMATTER RG, 2000, J CELL BIOL, V149, P411; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tamas P, 2001, CELL SIGNAL, V13, P475, DOI 10.1016/S0898-6568(01)00172-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Walkenhorst J, 2000, MOL CELL NEUROSCI, V16, P365, DOI 10.1006/mcne.2000.0878; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	66	185	190	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					205	217		10.1016/j.neuron.2005.03.019	http://dx.doi.org/10.1016/j.neuron.2005.03.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848800	Bronze			2022-12-28	WOS:000228674800008
J	Juttner, R; More, MI; Das, D; Babich, A; Meier, J; Henning, M; Erdmann, B; Muller, EC; Otto, A; Grantyn, R; Rathjen, FG				Juttner, R; More, MI; Das, D; Babich, A; Meier, J; Henning, M; Erdmann, B; Muller, EC; Otto, A; Grantyn, R; Rathjen, FG			Impaired synapse function during postnatal development in the absence of CALEB, an EGF-like protein processed by neuronal activity	NEURON			English	Article							CLASS-I MHC; AMPA RECEPTORS; NEUROGLYCAN-C; CHONDROITIN SULFATE; TENASCIN-C; PLASTICITY; EXPRESSION; RELEASE; FAMILY; MEMBER	In an attempt to characterize the molecular components by which electric activity influences the development of synapses, we searched for cell surface proteins modulated by calcium influx and glutamate receptor activity. Here, we report that neuronal depolarization facilitates the conversion of CALEB, which results in a truncated transmembrane form with an exposed EGF domain. To characterize the role of CALEB in synapse development, synaptic features were investigated in slices of the colliculus superior from CALEBdeficient mice. In the absence of CALEB, the number of synapses and their morphological characteristics remained unchanged. However, in CALEB-deficient mice, synapses displayed higher paired-pulse ratios, less depression during prolonged repetitive activation, a lower rate of spontaneous postsynaptic currents, and a lower release probability at early but not mature postnatal stages. Our findings indicate that CALEB provides a molecular basis for maintaining normal release probability at early developmental stages.	Max Delbruck Cent, D-13092 Berlin, Germany; Humboldt Univ Med Sch, Charite, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rathjen, FG (corresponding author), Max Delbruck Cent, Robert Rossle Str 10, D-13092 Berlin, Germany.	rathjen@mdc-berlin.de	Jüttner, Rene/G-4327-2011; Das, Debashish/ABB-4272-2020	Jüttner, Rene/0000-0003-3565-0698; Das, Debashish/0000-0002-9171-656X; More, Margret/0000-0002-3672-521X; Meier, Jochen/0000-0001-5574-3336				Aono S, 2000, J BIOL CHEM, V275, P337, DOI 10.1074/jbc.275.1.337; Aono S, 2004, J BIOL CHEM, V279, P46536, DOI 10.1074/jbc.M403263200; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Dumoulin A, 1999, J CELL SCI, V112, P811; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Grantyn R, 2004, METH NE FRO NEUROSCI, P173; Han B, 1999, J BIOL CHEM, V274, P26407, DOI 10.1074/jbc.274.37.26407; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ishizaki H, 2000, P NATL ACAD SCI USA, V97, P11587, DOI 10.1073/pnas.97.21.11587; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Juttner R, 2001, EUR J NEUROSCI, V13, P2088, DOI 10.1046/j.0953-816x.2001.01587.x; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kinugasa Y, 2004, BIOCHEM BIOPH RES CO, V321, P1045, DOI 10.1016/j.bbrc.2004.07.066; Kirischuk S, 2005, J PHYSIOL-LONDON, V563, P795, DOI 10.1113/jphysiol.2004.081216; Kirov SA, 1999, J NEUROSCI, V19, P2876; Konietzko U, 1999, EMBO J, V18, P3359, DOI 10.1093/emboj/18.12.3359; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; McCormick DA, 1999, SCIENCE, V285, P541, DOI 10.1126/science.285.5427.541; Meier J, 2004, J PHYSIOL-LONDON, V559, P355, DOI 10.1113/jphysiol.2004.066233; Meier J, 2003, MOL CELL NEUROSCI, V23, P600, DOI 10.1016/S1044-7431(03)00079-4; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schumacher S, 2003, J NEUROCHEM, V87, P1213, DOI 10.1046/j.1471-4159.2003.02112.x; Schumacher S, 2001, J BIOL CHEM, V276, P7337, DOI 10.1074/jbc.M007234200; Schumacher S, 1997, J CELL BIOL, V136, P895, DOI 10.1083/jcb.136.4.895; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Tsui CC, 1996, J NEUROSCI, V16, P2463; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yasuda Y, 1998, NEUROSCI RES, V32, P313, DOI 10.1016/S0168-0102(98)00098-4	58	33	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					233	245		10.1016/j.neuron.2005.02.027	http://dx.doi.org/10.1016/j.neuron.2005.02.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848802	Bronze			2022-12-28	WOS:000228674800010
J	Saddoris, MP; Gallagher, M; Schoenbaum, G				Saddoris, MP; Gallagher, M; Schoenbaum, G			Rapid associative encoding in basolateral amygdala depends on connections with orbitofrontal cortex	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; AUDITORY SECONDARY REINFORCEMENT; FRONTAL-CORTEX; RHESUS-MONKEYS; CONDITIONED REINFORCEMENT; LIMBIC CONNECTIONS; NEURONAL-ACTIVITY; ALERT MONKEY; LESIONS; DISCRIMINATION	Certain goal-directed behaviors depend upon interactions between basolateral amygdala (ABL) and orbitofrontal cortex (OFC). Here we describe neurophysiological evidence of this cooperative function. We recorded from ABL in intact and OFC-lesioned rats during learning of odor discrimination problems and reversals. During learning, rats with ipsilateral OFC lesions exhibited a marked decline in the proportion of ABL neurons that fired differentially during cue sampling both before and after reversal and in the proportion of neurons that reversed odor preference when the odor-outcome associations were reversed. This decline appeared to reflect a loss of rapid flexibility in cue selectivity that characterized activity in intact rats. In addition, lesioned rats had fewer neurons that fired in anticipation of the predicted outcome during a delay period after responding but before outcome delivery. These findings support a role for OFC in facilitating the encoding of information about expected outcomes in ABL.	Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Saddoris, MP (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, 3400 N Charles St,25 Ames Hall, Baltimore, MD 21218 USA.	saddoris@jhu.edu; schoenbg@schoenbaumlab.org						ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; BAXER MG, 2000, AMYGDALA FUNCTIONAL, P545; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 1999, J NEUROSCI, V19, P5473; Blundell P, 2001, J NEUROSCI, V21, P9018, DOI 10.1523/JNEUROSCI.21-22-09018.2001; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Cousens GA, 2003, INTEGR PHYS BEH SCI, V38, P272, DOI 10.1007/BF02688858; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gallagher M, 1999, ANN NY ACAD SCI, V877, P397, DOI 10.1111/j.1749-6632.1999.tb09279.x; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Hatfield T, 1996, J NEUROSCI, V16, P5256; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; KRETTEK JE, 1977, J COMP NEUROL, V172, P225; Malkova L, 1997, J NEUROSCI, V17, P6011; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; MCDANNALD MA, 2005, IN PRESS J NEUROSCI; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pears A, 2003, J NEUROSCI, V23, P11189; Pears A, 2001, BRAIN COGNITION, V47, P44; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; SANGHERA MK, 1979, EXP NEUROL, V63, P610, DOI 10.1016/0014-4886(79)90175-4; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; TRAPOLD MA, 1970, LEARN MOTIV, V1, P129, DOI 10.1016/0023-9690(70)90079-2; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009	52	174	178	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					321	331		10.1016/j.neuron.2005.02.018	http://dx.doi.org/10.1016/j.neuron.2005.02.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848809	Bronze			2022-12-28	WOS:000228674800017
J	Grieco, TM; Malhotra, JD; Chen, C; Isom, LL; Raman, IM				Grieco, TM; Malhotra, JD; Chen, C; Isom, LL; Raman, IM			Open-channel block by the cytoplasmic tail of sodium channel beta 4 as a mechanism for resurgent sodium current	NEURON			English	Article							AUXILIARY SUBUNIT; PURKINJE NEURONS; FUNCTIONAL EXPRESSION; INACTIVATION; VOLTAGE; MODULATION; MICE; RESTORATION; ACTIVATION; CONTACTIN	Voltage-gated sodium channels with "resurgent" kinetics are specialized for high-frequency firing. The alpha subunits interact with a blocking protein that binds open channels upon depolarization and unbinds upon repolarization, producing resurgent sodium current. By limiting classical inactivation, the cycle of block and unblock shortens refractory periods. To characterize the blocker in Purkinje neurons, we briefly exposed inside-out patches to substrate-specific proteases. Trypsin and chymotrypsin each removed resurgent current, consistent with established roles for positively charged and hydrophobic/aromatic groups in blocking sodium channels. In Purkinje cells, the only known sodium channel-associated subunit that has a cytoplasmic sequence with several positive charges and clustered hydrophobic/aromatic residues is beta4 (KKLITFILKKT REK; beta4(154-167)). After enzymatic removal of block, beta4(154-167) fully reconstituted resurgent current, whereas scrambled or point-mutated peptides were ineffective. In CA3 pyramidal neurons, which lack beta4 and endogenous block, beta4(154-167) generated resurgent current. Thus, 134 may be the endogenous open-channel blocker responsible for resurgent kinetics.	Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	Northwestern University; Northwestern University; University of Michigan System; University of Michigan	Raman, IM (corresponding author), Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA.	i-raman@northwestern.edu		Isom, Lori/0000-0002-9479-6729; Grieco-Calub, Tina M./0000-0001-8699-5990	NIMH NIH HHS [MH59980] Funding Source: Medline; NINDS NIH HHS [F31 NS045483, NS39395] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS045483, R01NS039395] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afshari FS, 2004, J NEUROPHYSIOL, V92, P2831, DOI 10.1152/jn.00261.2004; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; CAHALAN MD, 1979, BIOPHYS J, V27, P57, DOI 10.1016/S0006-3495(79)85202-9; Cantrell AR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-17-j0003.1999; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Do MTH, 2004, J NEUROPHYSIOL, V92, P726, DOI 10.1152/jn.00186.2004; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Eaholtz G, 1999, J GEN PHYSIOL, V113, P279, DOI 10.1085/jgp.113.2.279; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Grieco TM, 2004, J NEUROSCI, V24, P35, DOI 10.1523/JNEUROSCI.3807-03.2004; Grieco TM, 2002, J NEUROSCI, V22, P3100, DOI 10.1523/JNEUROSCI.22-08-03100.2002; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kazen-Gillespie KA, 2000, J BIOL CHEM, V275, P1079, DOI 10.1074/jbc.275.2.1079; KELLENBERGER S, 1909, J GEN PHYSIOL, V109, P589; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; OLEARY ME, 1994, J GEN PHYSIOL, V104, P507, DOI 10.1085/jgp.104.3.507; PAN F, 1999, J NEUROSCI, V17, P4517; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; REGAN LJ, 1991, J NEUROSCI, V11, P2259; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Smith MR, 1998, J NEUROSCI, V18, P6093; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tang LH, 1996, J GEN PHYSIOL, V108, P89, DOI 10.1085/jgp.108.2.89; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; WANG GK, 1993, MOL PHARMACOL, V44, P667; YEH JZ, 1977, J GEN PHYSIOL, V69, P293, DOI 10.1085/jgp.69.3.293; Yu FH, 2003, J NEUROSCI, V23, P7577; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAMPONI GW, 1994, BIOPHYS J, V67, P1040, DOI 10.1016/S0006-3495(94)80569-7	45	179	182	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					233	244		10.1016/j.neuron.2004.12.035	http://dx.doi.org/10.1016/j.neuron.2004.12.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664175	Bronze			2022-12-28	WOS:000226451500010
J	Sun, YE; Wu, H				Sun, YE; Wu, H			The ups and downs of BDNF in Rett syndrome	NEURON			English	Editorial Material							CPG-BINDING PROTEIN-2; MOUSE MODEL; MECP2; MICE	Rett syndrome (RTT) is an X-linked postnatal neurodevelopmental disorder, which is primarily caused by mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2). A number of MeCP2 target genes have been identified, including the neurotrophic factor BDNF; however, the functional relevance of these targets has not been established. In this issue of Neuron, Chang et al. provide the first in vivo evidence for a functional interaction between BDNF and MeCP2.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Inst Neuropsychiat, Dept Mol & Med Pharmacol, Los Angeles, CA 91301 USA	University of California System; University of California Los Angeles	Sun, YE (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Inst Neuropsychiat, Dept Mol & Med Pharmacol, 635 Charles E Young Dr S, Los Angeles, CA 91301 USA.		Wu, Hao/G-4145-2013	Wu, Hao/0000-0002-1256-6891; Wu, Hao/0000-0003-4395-6929				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899	13	29	33	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 2	2006	49	3					321	323		10.1016/j.neuron.2006.01.014	http://dx.doi.org/10.1016/j.neuron.2006.01.014			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446133	Bronze			2022-12-28	WOS:000235260900001
J	Boucard, AA; Chubykin, AA; Comoletti, D; Taylor, P; Sudhof, TC				Boucard, AA; Chubykin, AA; Comoletti, D; Taylor, P; Sudhof, TC			A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins	NEURON			English	Article							RECEPTOR; GENES; DYSTROGLYCAN; SYNAPSES; MOLECULE; LIGAND	Previous studies suggested that postsynaptic neuroligins form a trans-synaptic complex with presynaptic beta-neurexins, but not with presynaptic alpha-rieurexins. Unexpectedly, we now find that neuroligins also bind alpha-neurexins and that alpha- and beta-neurexin binding by neuroligin 1 is regulated by alternative splicing of neuroligin 1 (at splice site B) and of neurexins (at splice site 4). In neuroligin 1, splice site B is a master switch that determines alpha-neurexin binding but leaves beta-neurexin binding largely unaffected, whereas alternative splicing of neurexins modulates neuroligin binding. Moreover, neuroligin 1 splice variants with distinct neurexin binding properties differentially regulate synaptogenesis: neuroligin 1 that binds only beta-neurexins potently stimulates synapse formation, whereas neuroligin 1 that binds to both alpha- and beta-neurexins more effectively promotes synapse expansion. These findings suggest that neuroligin binding to alpha- and beta-neurexins mediates trans-synaptic cell adhesion but has distinct effects on synapse formation, indicating that expression of different neuroligin and neurexin isoforms specifies a trans-synaptic signaling code.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, 6000 Harry Hines Blvd NA4-118, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Boucard, Antony/ABA-9769-2020; Boucard, Antony/CAJ-3093-2022	Chubykin, Alexander/0000-0001-8224-9296; BOUCARD, Antony Jr/0000-0002-5538-0464	NIMH NIH HHS [R37 MH52804-08] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hoffman RC, 2004, BIOCHEMISTRY-US, V43, P1496, DOI 10.1021/bi035278t; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	30	344	359	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					229	236		10.1016/j.neuron.2005.08.026	http://dx.doi.org/10.1016/j.neuron.2005.08.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242404	Bronze			2022-12-28	WOS:000232838700013
J	Braz, JM; Nassar, MA; Wood, JN; Basbaum, AI				Braz, JM; Nassar, MA; Wood, JN; Basbaum, AI			Parallel "pain" pathways arise from subpopulation of primary afferent nociceptor	NEURON			English	Article							SPINAL-CORD; SUBSTANTIA GELATINOSA; DORSAL-HORN; ANTEROGRADE TRANSPORT; GENETIC APPROACH; GLOBUS-PALLIDUS; BRAIN-STEM; NEURONS; RAT; PROJECTIONS	A major unanswered question concerning "pain" circuitry is the extent to which different populations of primary afferent nociceptor engage the same or different ascending pathways. In the present study, we followed the transneuronal transport of a genetically expressed lectin tracer, wheat germ agglutinin, in Na(v)1.8-expressing nociceptors of the nonpeptide class. We found that interneurons of lamina II are at the origin of the major ascending circuits targeted by the nonpeptide nociceptors. These interneurons contact lamina V projection neurons, which in turn predominantly target fourth-order neurons in the amygdala, hypothalamus, bed nucleus of the stria terminalis, and to a remarkable extent, the globus pallidus. These circuits differ greatly from the lamina I-based projection that is targeted by the peptide class of nociceptors. Our results indicate that parallel, perhaps independent pain pathways arise from different nociceptor classes and that motor as well as limbic targets predominate in the circuits that originate from the nonpeptide population.	Univ Calif San Francisco, Dept Anat & Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; UCL, Mol Nocicept Grp, Dept Biol, London WC1E 6BT, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; University College London	Braz, JM (corresponding author), Univ Calif San Francisco, Dept Anat & Physiol, San Francisco, CA 94143 USA.	bjoao@phy.ucsf.edu	Braz, Joao/A-8102-2009		Medical Research Council [G9717869] Funding Source: Medline; NIDCR NIH HHS [DE-08973] Funding Source: Medline; NINDS NIH HHS [NS-14627] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9717869] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008973, P50DE008973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014627, R37NS014627] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbadie C, 1999, P NATL ACAD SCI USA, V96, P260, DOI 10.1073/pnas.96.1.260; BASBAUM AI, 2000, PRINCIPLES NEURAL SC, P472; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473, DOI 10.1152/jn.1990.63.3.473; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; BURSTEIN R, 1987, J NEUROSCI, V7, P4159; BURSTEIN R, 1993, J COMP NEUROL, V335, P469, DOI 10.1002/cne.903350402; CARTLON SM, 1988, J COMP NEUROL, V276, P527; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; CHUDLER EH, 1993, J NEUROPHYSIOL, V69, P1890, DOI 10.1152/jn.1993.69.6.1890; CLIFFER KD, 1991, J NEUROSCI, V11, P852; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; FRANKLIN BJ, 1997, MOUSE BRAIN STEREO; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; Gerke MB, 2004, NEUROSCIENCE, V127, P165, DOI 10.1016/j.neuroscience.2004.05.008; GOBEL S, 1979, BRAIN RES, V175, P335, DOI 10.1016/0006-8993(79)91012-6; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; Jasmin L, 1997, J NEUROSCI, V17, P3751; LIGHT AR, 1988, J COMP NEUROL, V267, P172, DOI 10.1002/cne.902670203; Nakano K, 2000, BRAIN DEV-JPN, V22, pS5; Newman HM, 1996, J COMP NEUROL, V365, P640, DOI 10.1002/(SICI)1096-9861(19960219)365:4<640::AID-CNE10>3.0.CO;2-L; Pukall CF, 2005, PAIN, V115, P118, DOI 10.1016/j.pain.2005.02.020; RETHELYI M, 1969, EXP BRAIN RES, V7, P258; Ruskin DN, 1997, NEUROSCIENCE, V81, P79, DOI 10.1016/S0306-4522(97)00113-9; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; SZENTOGOTHAI J., 1964, PROGR BRAIN RES, V11, P155; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	36	219	225	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					787	793		10.1016/j.neuron.2005.08.015	http://dx.doi.org/10.1016/j.neuron.2005.08.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157274	Bronze			2022-12-28	WOS:000232085000007
J	Boynton, GM				Boynton, GM			Contrast gain in the brain	NEURON			English	Editorial Material							ADAPTATION		Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Boynton, GM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Barlow H, 1997, SCIENCE, V276, P913, DOI 10.1126/science.276.5314.913; CAMPBELL FW, 1968, J PHYSL, V197, P221; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; Fine I, 2002, VISION RES, V42, P191, DOI 10.1016/S0042-6989(01)00266-8; Gardner JL, 2005, NEURON, V47, P607, DOI 10.1016/j.neuron.2005.07.016; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Seiffert AE, 2003, CEREB CORTEX, V13, P340, DOI 10.1093/cercor/13.4.340; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906	9	5	5	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 18	2005	47	4					476	477		10.1016/j.neuron.2005.08.003	http://dx.doi.org/10.1016/j.neuron.2005.08.003			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102529	Bronze			2022-12-28	WOS:000231411100003
J	Franks, KM; Isaacson, JS				Franks, KM; Isaacson, JS			Synapse-specific downregulation of NMDA receptors by early experience: A critical period for plasticity of sensory input to olfactory cortex	NEURON			English	Article							LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; PIRIFORM CORTEX; SILENT SYNAPSES; THALAMOCORTICAL SYNAPSES; POSTNATAL-DEVELOPMENT; AMPA RECEPTORS; BARREL CORTEX; MEMORY; TRANSMISSION	Olfaction is required at birth for survival; however, little is known about the maturation of olfactory cortical circuits. Here we show that in vivo sensory experience mediates the development of excitatory transmission in pyramidal neurons of rat olfactory cortex. We find a postnatal critical period during which there is an experience-dependent increase in the contribution of AMPARs versus NMDARs to transmission at primary sensory synapses but not associational inputs. The shift in receptors underlying transmission is mediated by a strong activity-dependent downregulation of NMDARs and modest increase in AMPARs. Sensory activity leads to a loss of "silent" NMDAR-only synapses and an increase in threshold for inducing long-term plasticity. These results indicate the importance of early olfactory experience in the establishment of cortical circuits and could reflect mechanisms governing early olfactory "imprinting."	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.	jisaacson@ucsd.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004682] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC04682] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Best AR, 2003, BRAIN RES, V961, P81, DOI 10.1016/S0006-8993(02)03847-7; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cummings DM, 1997, EXP NEUROL, V148, P360, DOI 10.1006/exnr.1997.6660; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Erisir A, 2003, J NEUROSCI, V23, P5208; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fiske BK, 2001, J COMP NEUROL, V431, P311; Groc L, 2002, J NEUROSCI, V22, P5552; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JUNG MW, 1990, SYNAPSE, V6, P279, DOI 10.1002/syn.890060307; KANTER ED, 1993, J NEUROSCI, V13, P2477, DOI 10.1523/JNEUROSCI.13-06-02477.1993; KANTER ED, 1990, BRAIN RES, V525, P175, DOI 10.1016/0006-8993(90)91337-G; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LEON M, 1992, ANNU REV PSYCHOL, V43, P377; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Mower GD, 2003, MOL BRAIN RES, V119, P19, DOI 10.1016/j.molbrainres.2003.08.007; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Patil MM, 1998, J NEUROPHYSIOL, V80, P2467, DOI 10.1152/jn.1998.80.5.2467; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; Rumpel S, 2004, J NEUROPHYSIOL, V91, P1097, DOI 10.1152/jn.00443.2003; Rumpel S, 1998, J NEUROSCI, V18, P8863; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; TANG AC, 1994, BRAIN RES, V659, P75, DOI 10.1016/0006-8993(94)90865-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 2000, BRAIN RES, V853, P317, DOI 10.1016/S0006-8993(99)02287-8; WOOLSEY TA, 1976, J COMP NEUROL, V170, P53, DOI 10.1002/cne.901700105; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	62	106	107	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					101	114		10.1016/j.neuron.2005.05.024	http://dx.doi.org/10.1016/j.neuron.2005.05.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996551	Bronze			2022-12-28	WOS:000230464000011
J	Pelkey, KA; Lavezzari, G; Racca, C; Roche, KW; McBain, CJ				Pelkey, KA; Lavezzari, G; Racca, C; Roche, KW; McBain, CJ			MGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; FIBER-INTERNEURON SYNAPSES; TARGET-SPECIFIC EXPRESSION; HIPPOCAMPAL INTERNEURONS; RAT HIPPOCAMPUS; SYNAPTIC PLASTICITY; TRANSMISSION; NEURONS; ACTIVATION	Plasticity of feedforward inhibition in the hippocampal mossy fiber (MF) pathway can dramatically influence dentate gyrus-CA3 dialog. Interestingly, MF inputs to CA3 stratum lucidum interneurons (SLINs) undergo long-term depression (LTD) following high-frequency stimulation (HFS), in contrast to IVIF-pyramid (PYR) synapses, where long-term potentiation (LTP) occurs. Furthermore, activity-induced potentiation of IVIF-SLIN transmission has not previously been observed. Here we report that metabotropic glutamate receptor subtype 7 (mGluR7) is a metaplastic switch at MF-SLIN synapses, whose activation and surface expression governs the direction of plasticity. In naive slices, mGIuR7 activation during HFS generates MF-SLIN LTD, depressing presynaptic release through a PKC-dependent mechanism. Following agonist exposure, mGIuR7 undergoes internalization, unmasking the ability of IVIF-SLIN synapses to undergo presynaptic potentiation in response to the same HFS that induces LTD in naive slices. Thus, selective mGIuR7 targeting to MF terminals contacting SLINs and not PYRs provides cell target-specific plasticity and bidirectional control of feedforward inhibition.	NICHHD, Lab Cellular & Synaptic Neurophysiol, NIH, Bethesda, MD 20892 USA; NINDS, NIH, Bethesda, MD 20892 USA; Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Leeds	Pelkey, KA (corresponding author), NICHHD, Lab Cellular & Synaptic Neurophysiol, NIH, Bldg 35, Bethesda, MD 20892 USA.	pelkeyk2@mail.nih.gov; mcbainc@mail.nih.gov	Roche, Katherine/W-9893-2019	Roche, Katherine/0000-0001-7282-6539	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994, Z01NS002994] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dev KK, 2000, J NEUROSCI, V20, P7252; Doherty J, 1998, J NEUROPHYSIOL, V79, P2903, DOI 10.1152/jn.1998.79.6.2903; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Hay M, 2000, J MEMBRANE BIOL, V178, P195, DOI 10.1007/s002320010027; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Losonczy A, 2003, J NEUROPHYSIOL, V89, P1910, DOI 10.1152/jn.00842.2002; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Mundell SJ, 2003, J NEUROCHEM, V84, P294, DOI 10.1046/j.1471-4159.2003.01515.x; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Perroy J, 2000, J NEUROSCI, V20, P7896; Perroy J, 2002, J BIOL CHEM, V277, P1223, DOI 10.1074/jbc.M109141200; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; Walker HC, 2002, NEURON, V35, P161, DOI 10.1016/S0896-6273(02)00734-1; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180	54	148	151	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					89	102		10.1016/j.neuron.2005.02.011	http://dx.doi.org/10.1016/j.neuron.2005.02.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820696	Bronze			2022-12-28	WOS:000228228600011
J	Pozas, E; Ibanez, CF				Pozas, E; Ibanez, CF			GDNF and GFR alpha 1 promote differentiation and tangential migration of cortical GABAergic neurons	NEURON			English	Article							ENTERIC NERVOUS-SYSTEM; MEDIAL GANGLIONIC EMINENCE; MICE LACKING; INTERNEURON MIGRATION; NEUROTROPHIC FACTOR; CELL-MIGRATION; SECRETED SEMAPHORINS; RECEPTOR; EXPRESSION; NEOCORTEX	Cortical GABAergic neurons are generated in the ventral telencephalon and migrate dorsally into the cortex following a tangential path. GDNF signaling via GFRalpha1 was found to promote the differentiation of ventral precursors into GABAergic cells, enhancing their neuronal morphology and motility. GDNF stimulated axonal growth in cortical GABAergic neurons and acted as a potent chemoattractant of GABAergic cells. These effects required GFRalpha1 but neither RET nor NCAM, the two transmembrane signaling receptors known for GDNF. Mutant mice lacking GDNF or GFRalpha1, but neither RET nor NCAM, showed reduced numbers of GABAergic cells in the cerebral cortex and hippocampus. We conclude that one of the normal functions of GDNF signaling via GFRalpha1 in the developing brain is to promote the differentiation and migration of cortical GABAergic neurons. The lack of involvement of RET or NCAM in these processes suggests the existence of additional transmembrane effectors for GDNF.	Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Pozas, E (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Sect, Scheeles Vag 1, S-17177 Stockholm, Sweden.	esther.pozas.pulido@neuro.ki.se; ibanez@neuro.ki.se						Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Brundin P, 2002, BRAIN, V125, P2149, DOI 10.1093/brain/awf217; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Danzer SC, 2002, J NEUROSCI, V22, P9754; Del Rio JA, 2000, CEREB CORTEX, V10, P784, DOI 10.1093/cercor/10.8.784; Denaxa M, 2001, DEVELOPMENT, V128, P4635; Enomoto H, 2004, NEURON, V44, P623, DOI 10.1016/j.neuron.2004.10.032; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; FONSECA M, 1995, J COMP NEUROL, V361, P177, DOI 10.1002/cne.903610114; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Gorski JA, 2003, J NEUROSCI, V23, P6856; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Horch HW, 1999, NEURON, V23, P353; Jacobowitz D.M, 1998, CHEMOARCHITECTONIC A; Jimenez D, 2002, J NEUROCYTOL, V31, P719, DOI 10.1023/A:1025751914372; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Messer CJ, 2000, NEURON, V26, P247, DOI 10.1016/S0896-6273(00)81154-X; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Olson L, 1997, TRENDS NEUROSCI, V20, P277, DOI 10.1016/S0166-2236(97)01098-9; Pappas IS, 1997, EXP NEUROL, V144, P302, DOI 10.1006/exnr.1997.6411; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204; Pascual M, 2004, MOL CELL NEUROSCI, V26, P24, DOI 10.1016/j.mcn.2003.12.008; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Polleux F, 2002, DEVELOPMENT, V129, P3147; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Pozas E, 1997, J NEUROBIOL, V33, P232, DOI 10.1002/(SICI)1097-4695(199709)33:3<232::AID-NEU3>3.3.CO;2-Y; Pozas E, 2001, MOL CELL NEUROSCI, V18, P26, DOI 10.1006/mcne.2001.0999; RAKIC P, 1972, J COMP NEUROL, V146, P335, DOI 10.1002/cne.901460304; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Wichterle H, 2003, P NATL ACAD SCI USA, V100, P727, DOI 10.1073/pnas.242721899; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	64	151	158	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					701	713		10.1016/j.neuron.2005.01.043	http://dx.doi.org/10.1016/j.neuron.2005.01.043			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748846	Bronze			2022-12-28	WOS:000227446700010
J	Coolen, MW; van Loo, KMJ; van Bakel, NNHM; Pulford, DJ; Serneels, L; de Strooper, B; Ellenbroek, BA; Cools, AR; Martens, GJM				Coolen, MW; van Loo, KMJ; van Bakel, NNHM; Pulford, DJ; Serneels, L; de Strooper, B; Ellenbroek, BA; Cools, AR; Martens, GJM			Gene dosage effect on gamma-secretase component Aph-1b in a rat model for neurodevelopmental disorders	NEURON			English	Article							P75 NEUROTROPHIN RECEPTOR; WISTAR RATS; APOMORPHINE SUSCEPTIBILITY; DOPAMINE RESPONSIVENESS; ANIMAL-MODELS; PRESENILIN; EXPRESSION; NICASTRIN; CLEAVAGE; PROTEIN	A combination of genetic factors and early life events is thought to determine the vulnerability of an individual to develop a complex neurodevelopmental disorder like schizophrenia. Pharmacogenetically selected, apomorphine-susceptible Wistar rats (APO-SUS) display a number of behavioral and pathophysiological features reminiscent of such disorders. Here, we report microarray analyses revealing in APO-SUS rats, relative to their counterpart APO-UNSUS rats, a reduced expression of Aph-1b, a component of the,gamma-secretase enzyme complex that is involved in multiple (neuro)developmental signaling pathways. The reduced expression is due to a duplicon-based genomic rearrangement event resulting in an Aph-1b dosage imbalance. The expression levels of the other, gamma-secretase components were not affected. However gamma-secretase cleavage activity was significantly changed, and the APO-SUS/-UNSUS Aph-1b genotypes segregated with a number of behavioral phenotypes. Thus, a subtle imbalance in the expression of a single, developmentally important protein may be sufficient to cause a complex phenotype.	Radboud Univ Nijmegen, Dept Mol Anim Physiol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; Radboud Univ Nijmegen, Inst Neurosci, NL-6525 GA Nijmegen, Netherlands; Organon Res Labs Ltd, Target Discovery, Newhouse ML1 5SH, Lanark, Scotland; Katholieke Univ Leuven VIB, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; Radboud Univ Nijmegen, Dept Psychoneuropharmacol, NIN, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Merck & Company; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Radboud University Nijmegen	Martens, GJM (corresponding author), Radboud Univ Nijmegen, Dept Mol Anim Physiol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands.	g.martens@ncmls.ru.nl	van Bakel, Nick/A-3187-2013; Martens, Gerard JM/D-1925-2010; Ellenbroek, Bart/C-4570-2012; De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019	Ellenbroek, Bart/0000-0003-1996-4873; De Strooper, Bart/0000-0001-5455-5819; Martens, Gerard/0000-0003-1761-4570; Serneels, Lutgarde/0000-0002-5463-4231; Coolen, Marcel/0000-0002-8188-8480				CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Cools A.R., 2002, BIOL PSYCHIAT, P1333; COOLS AR, 1993, BEHAV BRAIN RES, V55, P213, DOI 10.1016/0166-4328(93)90117-9; COOLS AR, 1990, BRAIN RES BULL, V24, P49, DOI 10.1016/0361-9230(90)90288-B; COOLS AR, 1988, NEUROBIOLOGICAL APPR, P15; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Degen SB, 2004, BEHAV BRAIN RES, V154, P107, DOI 10.1016/j.bbr.2004.01.025; ELLENBROEK BA, 1995, J NEUROSCI, V15, P7604; Ellenbroek BA, 2002, BEHAV GENET, V32, P349, DOI 10.1023/A:1020214322065; Ellenbroek BA, 1998, SCHIZOPHR RES, V30, P251, DOI 10.1016/S0920-9964(97)00149-7; Ellenbroek BA, 2000, PSYCHOPHARMACOLOGY, V148, P124, DOI 10.1007/s002130050033; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kavelaars A, 1997, J NEUROSCI, V17, P2580; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; MULDERS WHAM, 1995, BRAIN RES, V689, P61, DOI 10.1016/0006-8993(95)00546-3; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Rots NY, 1996, DEV BRAIN RES, V92, P164, DOI 10.1016/0165-3806(95)00214-6; ROTS NY, 1995, J NEUROENDOCRINOL, V7, P153, DOI 10.1111/j.1365-2826.1995.tb00678.x; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41	29	31	34	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 17	2005	45	4					497	503		10.1016/j.neuron.2004.12.054	http://dx.doi.org/10.1016/j.neuron.2004.12.054			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721236	Bronze			2022-12-28	WOS:000227099700006
J	Goldberg, AL				Goldberg, AL			Nobel committee tags ubiquitin for distinction	NEURON			English	Editorial Material							DEPENDENT PROTEOLYTIC SYSTEM; INTRACELLULAR PROTEIN DEGRADATION; MOLECULAR-WEIGHT PROTEASES; HEAT-STABLE POLYPEPTIDE; SKELETAL-MUSCLE ATROPHY; ESCHERICHIA-COLI; RABBIT RETICULOCYTES; ABNORMAL PROTEINS; BACTERIAL-CELLS; QUALITY CONTROL		Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu						ADAMS J, 2004, PROTEASOME INHIBITOR; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; CHUNG CH, 1993, SCIENCE, V262, P372, DOI 10.1126/science.8211156; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; CIECHANOVER A, 2004, IN PRESS NAT REV MOL; Cook MA, 2004, CURR BIOL, V14, pR11, DOI 10.1016/j.cub.2003.12.013; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DESAUTELS M, 1982, P NATL ACAD SCI-BIOL, V79, P1869, DOI 10.1073/pnas.79.6.1869; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; Ehlers MD, 2004, TRENDS NEUROSCI, V27, P3, DOI 10.1016/j.tins.2003.10.015; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; GOLDBERG AL, 1972, P NATL ACAD SCI USA, V69, P422, DOI 10.1073/pnas.69.2.422; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; GOLDBERG AL, 1975, INTRACELLULAR PROTEI, P17; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Guardavaccaro D, 2004, ONCOGENE, V23, P2037, DOI 10.1038/sj.onc.1207413; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Holler D, 2004, BIOCHEM PHARMACOL, V67, P1013, DOI 10.1016/j.bcp.2004.01.003; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JOHNSTON JA, 2004, PROG NEUROBIOL, V675, P1; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Krek W, 2000, NAT CELL BIOL, V2, pE121, DOI 10.1038/35017129; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martin SJ, 2004, NAT CELL BIOL, V6, P804, DOI 10.1038/ncb0904-804; Mizushima N, 2003, INT J BIOCHEM CELL B, V35, P553, DOI 10.1016/S1357-2725(02)00343-6; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sakamoto KM, 2002, MOL GENET METAB, V77, P44, DOI 10.1016/S1096-7192(02)00146-4; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHIMKE RT, 1970, ANNU REV BIOCHEM, V39, P929, DOI 10.1146/annurev.bi.39.070170.004433; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; TANAKA K, 1983, J CELL BIOL, V96, P1580, DOI 10.1083/jcb.96.6.1580; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529	75	31	34	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					339	344		10.1016/j.neuron.2005.01.019	http://dx.doi.org/10.1016/j.neuron.2005.01.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694320	Bronze			2022-12-28	WOS:000226787700006
J	Park, JB; Yiu, G; Kaneko, S; Wang, J; Chang, JF; He, ZG				Park, JB; Yiu, G; Kaneko, S; Wang, J; Chang, JF; He, ZG			A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors	NEURON			English	Article							TUMOR-NECROSIS-FACTOR; OPTIC-NERVE REGENERATION; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; NEUROTROPHIN RECEPTOR; SIGNALING PATHWAY; AXON REGENERATION; SENSORY NEURONS; GLYCOPROTEIN; EXPRESSION	A major obstacle for successful axon regeneration in the adult central nervous system (CNS) arises from inhibitory molecules in CNS myelin, which signal through a common receptor complex on neurons consisting of the ligand-binding Nogo-66 receptor (NgR) and two transmembrane coreceptors, p75 and LINGO-1. However, p75 expression is only detectable in sub-populations of mature neurons, raising the question of how these inhibitory signals are transduced in neurons lacking p75. In this study, we demonstrate that TROY (also known as TAJ), a TNF receptor family member selectively expressed in the adult nervous system, can form a functional receptor complex with NgR and LINGO-1 to mediate cellular responses to myelin inhibitors. Also, both overexpressing a dominant-negative TROY or presence of a soluble TROY protein can efficiently block neuronal response to myelin inhibitors. Our results implicate TROY in mediating myelin inhibition, offering new insights into the molecular mechanisms of regeneration failure in the adult nervous system.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	He, ZG (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	Yiu, Glenn/AAF-2858-2020	Yiu, Glenn/0000-0003-3061-3310				Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ma MH, 2004, J COMP NEUROL, V474, P469, DOI 10.1002/cne.20149; Matysiak M, 2002, BRAIN, V125, P2469, DOI 10.1093/brain/awf254; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Niederost B, 2002, J NEUROSCI, V22, P10368; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; RENNO T, 1995, J IMMUNOL, V154, P944; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006	42	319	360	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					345	351		10.1016/j.neuron.2004.12.040	http://dx.doi.org/10.1016/j.neuron.2004.12.040			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694321	Bronze			2022-12-28	WOS:000226787700007
J	Hashimotodani, Y; Ohno-Shosaku, T; Tsubokawa, H; Ogata, H; Emoto, K; Maejima, T; Araishi, K; Shin, HS; Kano, M				Hashimotodani, Y; Ohno-Shosaku, T; Tsubokawa, H; Ogata, H; Emoto, K; Maejima, T; Araishi, K; Shin, HS; Kano, M			Phospholipase C beta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal	NEURON			English	Article							DEPOLARIZED POSTSYNAPTIC NEURONS; LIVER PLASMA-MEMBRANES; METABOTROPIC GLUTAMATE; ENDOGENOUS CANNABINOIDS; INOSITOL 1,4,5-TRISPHOSPHATE; RECEPTOR REGULATION; CALCIUM; ACTIVATION; RELEASE; CELLS	Endocannabinoids mediate retrograde signal and modulate transmission efficacy at various central synapses. Although endocannabinoid release is induced by either depolarization or activation of G(q/11)-coupled receptors, it is markedly enhanced by the coincidence of depolarization and receptor activation. Here we report that this coincidence is detected by phospholipase Cbeta1 (PLCbeta1) in hippocampal neurons. By measuring cannabinoid-sensitive synaptic currents, we found that the receptor-driven endocannabinoid release was dependent on physiological levels of intracellular Call concentration ([Ca2+]i), and markedly enhanced by depolarization-induced [Call]i elevation. Furthermore, we measured PLC activity in intact neurons by using exogenous TRPC6 channel as a biosensor for the PLC product diacylglycerol and found that the receptor-driven PLC activation exhibited similar [Calli dependence to that of endocannabinoid release. Neither endocannabinoid release nor PLC activation was induced by receptor activation in PLCbeta1 knockout mice. We therefore conclude that PLCbeta1 serves as a coincidence detector through its Call dependency for endocannabinoid release in hippocampal neurons.	Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan; Tohoku Univ, Grad Sch Informat Sci, Lab Life Fluctuomat, Sendai, Miyagi 9808579, Japan; Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; Kobe Univ, Grad Sch Med, Div Cell Biol, Kobe, Hyogo 6500017, Japan; Korea Inst Sci & Technol, Ctr Calcium & Learning, Natl Creat Res Initit, Seoul 136791, South Korea	Kanazawa University; Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kobe University; Korea Institute of Science & Technology (KIST)	Kano, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan.	mkano@med.kanazawa-u.ac.jp	Ohno-Shosaku, Takako/C-3250-2015; Hashimotodani, Yuki/W-4690-2018; Ogata, Hidenori/GXN-3776-2022	Hashimotodani, Yuki/0000-0001-6723-2736; Ogata, Hidenori/0000-0001-8932-9731; Kano, Masanobu/0000-0002-0725-3292				Alger BE, 2002, PROG NEUROBIOL, V68, P247; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; COLE AE, 1984, J PHYSIOL-LONDON, V352, P173, DOI 10.1113/jphysiol.1984.sp015285; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; CREPEL V, 1994, J NEUROPHYSIOL, V72, P1561, DOI 10.1152/jn.1994.72.4.1561; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; DELRIO E, 1994, J NEUROCHEM, V63, P535; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FISHER SK, 1989, MOL PHARMACOL, V35, P195; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Gee CE, 2003, J PHYSIOL-LONDON, V546, P655, DOI 10.1113/jphysiol.2002.032961; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Irving AJ, 1998, J PHYSIOL-LONDON, V511, P747, DOI 10.1111/j.1469-7793.1998.747bg.x; Kano M, 2002, MOL PSYCHIATR, V7, P234, DOI 10.1038/sj.mp.4000999; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kim J, 2002, J NEUROSCI, V22, P10182; KONNERTH A, 1996, COINCEDENCE DETECTIO; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Masgrau R, 2001, EUR J NEUROSCI, V13, P248, DOI 10.1046/j.0953-816X.2000.01384.x; Masgrau R, 2000, J NEUROCHEM, V74, P818, DOI 10.1046/j.1471-4159.2000.740818.x; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; Nakahara N, 2000, REFR SCI T, V2000, P1; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2003, EUR J NEUROSCI, V18, P109, DOI 10.1046/j.1460-9568.2003.02732.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; SMITH CD, 1986, SCIENCE, V232, P97, DOI 10.1126/science.3006254; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; TAYLOR SJ, 1987, BIOCHEM J, V248, P791, DOI 10.1042/bj2480791; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; UHING RJ, 1986, J BIOL CHEM, V261, P2140; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Zhang L, 2001, J BIOL CHEM, V276, P13331, DOI 10.1074/jbc.M008914200; J NEUROSCI, V20, P8365	73	240	249	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					257	268		10.1016/j.neuron.2005.01.004	http://dx.doi.org/10.1016/j.neuron.2005.01.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664177	Bronze, Green Submitted			2022-12-28	WOS:000226451500012
J	Peirson, S; Foster, RG				Peirson, S; Foster, RG			Melanopsin: Another way of signaling light	NEURON			English	Review							RETINAL GANGLION-CELLS; PROTEIN-COUPLED RECEPTORS; HIDDEN MARKOV-MODELS; NON-CONE; NON-ROD; OCULAR PHOTORECEPTION; VISUAL TRANSDUCTION; CIRCADIAN RESPONSES; ACTION SPECTRUM; PHOTOPIGMENT	A subset of melanopsin-expressing retinal ganglion cells has been identified to be directly photosensitive (pRGCs), modulating a range of behavioral and physiological responses to light. Recent expression studies of melanopsin have provided compelling evidence that melanopsin is the photopigment of the pRGCs. However, the mechanism by which melanopsin tranduces light information remains an open question. This review discusses the signaling pathways that may underlie melanopsin-dependent phototransduction in native pRGCs, as well as the many exciting challenges ahead.	Charing Cross Hosp, Imperial Coll London, Fac Med, Dept Cellular & Mol Neurosci,Div Neurosci & Menta, London W6 8RF, England	Imperial College London	Peirson, S (corresponding author), Charing Cross Hosp, Imperial Coll London, Fac Med, Dept Cellular & Mol Neurosci,Div Neurosci & Menta, London W6 8RF, England.	s.peirson@imperial.ac.uk; r.foster@imperial.ac.uk	Peirson, Stuart/A-6768-2012	FOSTER, RUSSELL/0000-0001-6055-2067	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alexander SPH, 2004, BRIT J PHARMACOL, V141, pS1; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; BRIDGES CDB, 1959, NATURE, V184, P1727, DOI 10.1038/1841727a0; Broeck JV, 2001, ARCH INSECT BIOCHEM, V48, P1, DOI 10.1002/arch.1054; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; David-Gray ZK, 1998, NAT NEUROSCI, V1, P655, DOI 10.1038/3656; David-Gray ZK, 2002, EUR J NEUROSCI, V16, P1186, DOI 10.1046/j.1460-9568.2002.02161.x; David-Gray ZK, 1999, FEBS LETT, V461, P343, DOI 10.1016/S0014-5793(99)01455-6; DeCoursey PJ, 1989, CIRCADIAN CLOCKS ECO, P187; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; FOSTER RG, 1993, J BIOL RHYTHM, V8, pS17; Foster RG, 2002, CURR BIOL, V12, pR543, DOI 10.1016/S0960-9822(02)01047-3; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Foster RG, 2001, PHILOS T R SOC B, V356, P1779, DOI 10.1098/rstb.2001.0962; Foster Russell G., 2003, Novartis Foundation Symposium, V253, P3; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hunt DM, 2001, J EXP BIOL, V204, P3333; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; Lin S W, 1999, Novartis Found Symp, V224, P124; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Ma JX, 1999, FEBS LETT, V452, P199, DOI 10.1016/S0014-5793(99)00606-7; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Miyashita Y, 2001, ZOOL SCI, V18, P671, DOI 10.2108/zsj.18.671; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; NELSON DE, 1991, BRAIN RES, V554, P272, DOI 10.1016/0006-8993(91)90200-F; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; Peirson SN, 2005, METHOD ENZYMOL, V393, P697, DOI 10.1016/S0076-6879(05)93037-1; Pepe IM, 2001, PROG RETIN EYE RES, V20, P733, DOI 10.1016/S1350-9462(01)00013-1; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; PROVENCIO I, 1994, VISION RES, V34, P1799, DOI 10.1016/0042-6989(94)90304-2; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; ROBINSON SR, 1991, DEV MAMMALIAN RETINA; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Sgourakis NG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-104; Sgourakis NG, 2005, BIOINFORMATICS, V21, P4101, DOI 10.1093/bioinformatics/bti679; Sreekumar KR, 2004, BIOINFORMATICS, V20, P3490, DOI 10.1093/bioinformatics/bth434; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Van Gelder RN, 2003, TRENDS NEUROSCI, V26, P458, DOI 10.1016/S0166-2236(03)00211-X; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Van Gelder Russell N, 2003, Novartis Found Symp, V253, P31; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Yabuki Y, 2005, NUCLEIC ACIDS RES, V33, pW148, DOI 10.1093/nar/gki495; Yeagle PL, 2003, BIOCHEMISTRY-US, V42, P1365, DOI 10.1021/bi0270539	84	94	102	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					331	339		10.1016/j.neuron.2006.01.006	http://dx.doi.org/10.1016/j.neuron.2006.01.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446137	Bronze			2022-12-28	WOS:000235260900005
J	Sawamura, H; Orban, GA; Vogels, R				Sawamura, H; Orban, GA; Vogels, R			Selectivity of neuronal adaptation does not match response selectivity: A single-cell study of the fMRI adaptation paradigm	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; TERM MOTION ADAPTATION; MACAQUE AREA MT; INFEROTEMPORAL CORTEX; RECOGNITION MEMORY; RECEPTIVE-FIELDS; VISUAL-MOTION; OBJECT SHAPE; ANTERIOR; REPRESENTATION	fMRI-based adaptation paradigms (fMR-A) have been used to infer neuronal stimulus selectivities in humans. Inferring neuronal selectivities from fMR-A, however, requires an understanding of the relationship between the stimulus selectivity of neuronal adaptation and responses. We studied this relationship by recording single cells in macaque inferior temporal (IT)cortex, an area that shows fMRI adaptation. Repetition of identical object images reduced the responsiveness of single IT neurons. Presentation of an image to which the neuron was unresponsive did not alter the response to a subsequent image that activated the neuron. Successive presentation of two different images to which the neuron responded similarly produced adaptation, but less so than the repeated presentation of an image. The neuronal adaptation at the single-cell level showed a greater degree of stimulus selectivity than the responses. This complicates the interpretation of fMR-A paradigms when inferring neuronal selectivity.	Catholic Univ Louvain, Sch Med, Lab Neuro Psychofysiol, B-3000 Louvain, Belgium	Universite Catholique Louvain	Vogels, R (corresponding author), Catholic Univ Louvain, Sch Med, Lab Neuro Psychofysiol, Campus Gasthuisberg, B-3000 Louvain, Belgium.	rufin.vogels@med.kuleuven.be		Orban, Guy/0000-0002-8179-9584				Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Boynton GM, 2003, J NEUROSCI, V23, P8781; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; FAHY FL, 1993, EXP BRAIN RES, V96, P457; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1967, J NEUROPHYSIOL, V30, P833, DOI 10.1152/jn.1967.30.4.833; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MILLER EK, 1993, J NEUROSCI, V13, P1460; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P370, DOI 10.1152/jn.2002.88.1.370; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; RICHES IP, 1991, J NEUROSCI, V11, P1763; Ringo JL, 1996, BEHAV BRAIN RES, V76, P191, DOI 10.1016/0166-4328(95)00197-2; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P3120; SOBOTKA S, 1993, EXP BRAIN RES, V96, P28, DOI 10.1007/BF00230436; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6	57	249	249	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					307	318		10.1016/j.neuron.2005.11.028	http://dx.doi.org/10.1016/j.neuron.2005.11.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423703	Bronze			2022-12-28	WOS:000234979900016
J	Badre, D; Poldrack, RA; Pare-Blagoev, EJ; Insler, RZ; Wagner, AD				Badre, D; Poldrack, RA; Pare-Blagoev, EJ; Insler, RZ; Wagner, AD			Dissociable controlled retrieval and generalized selection mechanisms in ventrolateral prefrontal cortex	NEURON			English	Article							NEUROPSYCHOLOGICAL TEST; MEMORY RETRIEVAL; FRONTAL LESIONS; SEMANTIC MEMORY; WORKING-MEMORY; COMPETITION; BRAIN; MRI	How does ventrolateral prefrontal cortex (VLPFC) control mnemonic processing? Alternative models propose that VLPFC guides top-down (controlled) retrieval of knowledge from long-term stores or selects goal-relevant products of retrieval from among competitors. A paucity of evidence supports a retrieval/selection distinction, raising the possibility that these models reduce to a common mechanism. Here, four manipulations varied semantic control demands during fMRI: judgment specificity, cue-target-associative strength, competitor dominance, and number of competitors. Factor analysis revealed evidence for a meta-factor that accounted for common behavioral variance across manipulations and for functional variance in left mid-VLPFC. These data support a generalized control process that selects relevant knowledge from among competitors. By contrast, left anterior VLPFC and middle temporal cortex were sensitive to cue-target-associative strength, but not competition, consistent with a control process that retrieves knowledge stored in lateral temporal cortex. Distinct PFC mechanisms mediate top-down retrieval and postretrieval selection.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA; Martinos Ctr Biomed Imaging, Charlestown, MA USA	Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University	Badre, D (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	badred@mit.edu; wagner@psych.stanford.edu		Wagner, Anthony/0000-0003-0624-4543				Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; BADRE D, 2005, IN PRESS CEREB CORTE; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Brass M, 2004, J NEUROSCI, V24, P8847, DOI 10.1523/JNEUROSCI.2513-04.2004; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; DEMB JB, 1995, J NEUROSCI, V15, P5870; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; DOBBINS IG, 2005, IN PRESS CEREB CORTE; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gold BT, 2005, CEREB CORTEX, V15, P1438, DOI 10.1093/cercor/bhi024; HARRIS CW, 1967, PSYCHOMETRIKA, V32, P363, DOI 10.1007/BF02289652; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; KAPUR S, 1994, NEUROREPORT, V5, P2193, DOI 10.1097/00001756-199410270-00051; Kohler S, 2004, J COGNITIVE NEUROSCI, V16, P178, DOI 10.1162/089892904322984490; Kucera H., 1967, COMPUTATIONAL ANAL P; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Metzler C, 2001, NEUROPSYCHOLOGY, V15, P315, DOI 10.1037//0894-4105.15.3.315; MILHAM MP, 2001, ANNU REV NEUROSCI, V24, P167; Miller EK, 1996, J NEUROSCI, V16, P5154; MOSS HE, 2005, IN PRESS CEREB CORTE; Moss Helen, 1996, BIRKBECK WORD ASS NO; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Noppeney U, 2004, NEUROIMAGE, V22, P164, DOI 10.1016/j.neuroimage.2003.12.010; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Postman L., 1970, NORMS WORD ASS; Shimamura Arthur P., 1995, P803; Sohn MH, 2003, P NATL ACAD SCI USA, V100, P7412, DOI 10.1073/pnas.0832374100; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Swick D, 1996, NEUROPSYCHOLOGIA, V34, P1019, DOI 10.1016/0028-3932(96)00011-5; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Zhang JX, 2004, NEUROIMAGE, V23, P975, DOI 10.1016/j.neuroimage.2004.07.008	54	678	687	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					907	918		10.1016/j.neuron.2005.07.023	http://dx.doi.org/10.1016/j.neuron.2005.07.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157284	Bronze			2022-12-28	WOS:000232085000017
J	Gundlfinger, A; Schmitz, D				Gundlfinger, A; Schmitz, D			Inactivity sets XL synapses in motion	NEURON			English	Editorial Material							SYNAPTIC PLASTICITY; NEURONS; LTP	Neurons adapt their synaptic responses to the activity of the underlying network. In this issue of Neuron, Thiagarajan and colleagues report on specific subcellular mechanisms of homeostasis after prolonged neuronal inactivity. The results have important implications not only for neuronal homeostasis but also for further understanding of metaplasticity.	Univ Med Berlin, Neurosci Res Ctr Charite, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gundlfinger, A (corresponding author), Univ Med Berlin, Neurosci Res Ctr Charite, Schumannstr 20-21, D-10117 Berlin, Germany.			Schmitz, Dietmar/0000-0003-2741-5241				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103	10	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 1	2005	47	5					623	625		10.1016/j.neuron.2005.08.018	http://dx.doi.org/10.1016/j.neuron.2005.08.018			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129390	Bronze			2022-12-28	WOS:000231782700002
J	Small, DM; Gerber, JC; Mak, YE; Hummel, T				Small, DM; Gerber, JC; Mak, YE; Hummel, T			Differential neural responses evoked by orthonasal versus retronasal odorant perception in humans	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; HUMAN ORBITOFRONTAL CORTEX; HUMAN AMYGDALA; SPATIOTEMPORAL ANALYSIS; GUSTATORY STIMULATION; EMOTIONAL RESPONSES; REWARD; TASTE; BRAIN; ACTIVATION	Odors perceived through the mouth (retronasally) as flavor are referred to the oral cavity, whereas odors perceived through the nose (orthonasally) are referred to the external world. We delivered vaporized odorants via the orthonasal and retronasal routes and measured brain response with fMRI. Comparison of retronasal versus orthonasal delivery produced preferential activity in the mouth area at the base of the central sulcus, possibly reflecting olfactory referral to the mouth, associated with retronasal olfaction. Routes of delivery produced differential activation in the insula/operculum, thalamus, hippocampus, amygdala, and caudolateral orbitofrontal cortex in orthonasal > retronasal and in the perigenual cingulate and medial orbitofrontal cortex in retronasal > orthonasal in response to chocolate, but not lavender, butanol, or farnesol, so that an interaction of route and odorant may be inferred. These findings demonstrate differential neural recruitment depending upon the route of odorant administration and suggest that its effect is influenced by whether an odorant represents a food.	John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Dept Surg, Sch Med, New Haven, CT 06510 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Univ Dresden, Sch Med, Dept Neuroradiol, D-10307 Dresden, Germany; Univ Dresden, Sch Med, Smell & Taste Clin, D-10307 Dresden, Germany; Univ Dresden, Sch Med, Dept Otorhinolaryngol, D-10307 Dresden, Germany	Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Small, DM (corresponding author), John B Pierce Fdn Lab, 290 Congress Ave, New Haven, CT 06519 USA.	dsmall@jbpierce.org	Gerber, Johannes/U-4918-2019	Gerber, Johannes/0000-0001-7465-8700; Small, Dana/0000-0001-7363-1100	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006169] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03 DC006169-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Balleine BW, 2000, J NEUROSCI, V20, P8954; Baxter MG, 2000, J NEUROSCI, V20, P4311; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BINDRA D, 1978, BEHAV BRAIN SCI, V1, P41, DOI 10.1017/S0140525X00059380; Boling W, 2002, J NEUROSURG, V97, P388, DOI 10.3171/jns.2002.97.2.0388; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Chiavaras MM, 2000, J COMP NEUROL, V422, P35; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Frey S, 1999, EUR J NEUROSCI, V11, P2985, DOI 10.1046/j.1460-9568.1999.00738.x; Gallagher M, 2000, AMYGDALA FUNCTIONAL, P311; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Heilmann S, 2004, BEHAV NEUROSCI, V118, P412, DOI 10.1037/0735-7044.118.2.412; HEILMANN S, 2001, CHEM SENSES, V26, P1086; Holland PC, 2002, PHYSIOL BEHAV, V76, P117, DOI 10.1016/S0031-9384(02)00688-1; HUMMEL T, 2005, IN PRESS FLAVOR FRAG; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; KINOMURA S, 1994, BRAIN RES, V659, P263, DOI 10.1016/0006-8993(94)90890-7; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; KOBAL G, 1981, ELECTROPHYSIOLOGISCH, P18; Kobayakawa T, 1996, NEUROSCI LETT, V212, P155, DOI 10.1016/0304-3940(96)12798-1; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Morris JS, 2001, J NEUROSCI, V21, P5304, DOI 10.1523/JNEUROSCI.21-14-05304.2001; MOZELL MM, 1969, ARCH OTOLARYNGOL, V90, P367; MOZELL MM, 1966, J GEN PHYSIOL, V50, P25, DOI 10.1085/jgp.50.1.25; MOZELL MM, 1973, SCIENCE, V181, P1247, DOI 10.1126/science.181.4106.1247; MURPHY C, 1977, SENS PROCESS, V1, P204; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Pardo JV, 1997, NEUROSCI LETT, V234, P23, DOI 10.1016/S0304-3940(97)00650-2; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Petrovich GD, 2002, J NEUROSCI, V22, P8748; Pierce J, 1996, CHEM SENSES, V21, P529, DOI 10.1093/chemse/21.5.529; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Royet JP, 2000, J NEUROSCI, V20, P7752; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Small DM, 2004, J NEUROPHYSIOL, V92, P1892, DOI 10.1152/jn.00050.2004; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; VOIROL E, 1986, LEBENSM WISS TECHNOL, V19, P316; WHITE NM, 1989, NEUROSCI BIOBEHAV R, V13, P181, DOI 10.1016/S0149-7634(89)80028-4; WISE RA, 1985, BEHAV BRAIN SCI, V8, P178, DOI 10.1017/S0140525X00020306; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	88	274	281	4	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					593	605		10.1016/j.neuron.2005.07.022	http://dx.doi.org/10.1016/j.neuron.2005.07.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102541	Bronze			2022-12-28	WOS:000231411100015
J	Rinner, O; Makhankov, YV; Biehlmaier, O; Neuhauss, SCF				Rinner, O; Makhankov, YV; Biehlmaier, O; Neuhauss, SCF			Knockdown of cone-specific kinase GRK7 in larval zebrafish leads to impaired cone response recovery and delayed dark adaptation	NEURON			English	Article							VISUAL PIGMENT PHOSPHORYLATION; COUPLED RECEPTOR KINASE; RHODOPSIN KINASE; BRACHYDANIO-RERIO; LIGHT ADAPTATION; WILD-TYPE; M-OPSIN; SENSITIVITY; VERTEBRATE; GENE	Phosphorylation of rhodopsin by rhodopsin kinase GRK1 is an important desensitization mechanism in scotopic vision. For cone vision GRK1 is not essential. However, cone opsin is phosphorylated following light stimulation. In cone-dominant animals as well as in humans, but not in rodents, GRK7, a cone-specific homolog of GRK1, has been identified in cone outer segments. To investigate the function of GRK7 in vivo, we cloned two orthologs of grk7 in zebrafish and knocked down gene expression of grk7a in zebrafish larvae by morpholino antisense nucleotides. Photoresponse recovery in Grk7a-deficient larvae was delayed in electroretinographic measurements, and temporal contrast sensitivity was reduced, particularly under bright-light conditions. These results show that function of a cone-specific kinase is essential for cone vision in the zebrafish retina and argue that pigment bleaching and spontaneous decay alone are not sufficient for light adaptation and rapid cone response inactivation.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland; ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Neuhauss, SCF (corresponding author), Univ Zurich, Inst Brain Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	neuhauss@hifo.unizh.ch	Neuhauss, Stephan/AAX-9915-2020	Neuhauss, Stephan/0000-0002-9615-480X; Biehlmaier, Oliver/0000-0003-0825-8500				Allwardt BA, 2001, J NEUROCYTOL, V30, P493, DOI 10.1023/A:1015689116620; Bilotta J, 2001, DEV DYNAM, V222, P564, DOI 10.1002/dvdy.1188; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; BRANCHEK T, 1984, J COMP NEUROL, V224, P116, DOI 10.1002/cne.902240110; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Chen CK, 2001, MOL VIS, V7, P305; Cideciyan AV, 2003, INVEST OPHTH VIS SCI, V44, P1268, DOI 10.1167/iovs.02-0494; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; CLARK DT, 1981, THESIS U OREGON EUGE; CRAFT CM, 1995, FEBS LETT, V362, P247, DOI 10.1016/0014-5793(95)00213-S; Dowling J. E., 1987, RETINA APPROACHABLE; Dryja TP, 2000, AM J OPHTHALMOL, V130, P547, DOI 10.1016/S0002-9394(00)00737-6; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; Efron Bradley., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P10102, DOI 10.1021/bi00495a013; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; KELLY DH, 1961, J OPT SOC AM, V51, P422, DOI 10.1364/JOSA.51.000422; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379; Liu P, 2005, J NEUROCHEM, V93, P135, DOI 10.1111/j.1471-4159.2004.03003.x; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; Makhankov YV, 2004, J NEUROSCI METH, V135, P205, DOI 10.1016/j.jneumeth.2003.12.015; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; Page-McCaw PS, 2004, NAT NEUROSCI, V7, P1329, DOI 10.1038/nn1344; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Rinner O, 2005, INVEST OPHTH VIS SCI, V46, P137, DOI 10.1167/iovs.04-0682; RUSHTON WAH, 1977, BIOPHYS STRUCT MECH, V3, P159, DOI 10.1007/BF00535812; Sakuma H, 1998, GENE, V224, P87, DOI 10.1016/S0378-1119(98)00510-1; SCHONTHALER HB, 2005, INPRESS DEV BIOL; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Simon J. L., 1985, BASIC RES METHODS SO; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; THISSE C, 1993, DEVELOPMENT, V119, P1203; Weiss E R, 1998, Mol Vis, V4, P27; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	57	70	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					231	242		10.1016/j.neuron.2005.06.010	http://dx.doi.org/10.1016/j.neuron.2005.06.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039565	Bronze			2022-12-28	WOS:000230693900010
J	Kim, MJ; Dunah, AW; Wang, YT; Sheng, M				Kim, MJ; Dunah, AW; Wang, YT; Sheng, M			Differential roles of NR2A- and NR2B-containing NMDA receptors in and AMPA receptor Ras-ERK signaling trafficking	NEURON			English	Article							GTPASE-ACTIVATING PROTEIN; D-ASPARTATE RECEPTORS; SYNAPTIC PLASTICITY; SUBUNIT COMPOSITION; NR2A SUBUNIT; KINASE-II; EXPRESSION; SYNGAP; SYNAPSES; LTP	NMDA receptors (NMDARs) control bidirectional synaptic plasticity by regulating postsynaptic AMPA receptors (AMPARs). Here we show that NMDAR activation can have differential effects on AMPAR trafficking, depending on the subunit composition of NMDARs. In mature cultured neurons, NR2A-NMDARs promote, whereas NR2B-NMDARs inhibit, the surface expression of GluR1, primarily by regulating its surface insertion. In mature neurons, NR2B is coupled to inhibition rather than activation of the Ras-ERK pathway, which drives surface delivery of GluR1. Moreover, the synaptic Ras GTPase activating protein (GAP) SynGAP is selectively associated with NR2B-NMDARs in brain and is required for inhibition of NMDAR-dependent ERK activation. Preferential coupling of NR2B to SynGAP could explain the subtype-specific function of NR2B-NMDARs in inhibition of Ras-ERK, removal of synaptic AMPARs, and weakening of synaptic transmission.	MIT, Howard Hughes Med Inst, RIKEN, Neurosci Res Ctr,Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Univ British Columbia, Hlth Sci Ctr, Vancouver, BC V6T 2B5, Canada; Vancouver Hosp, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Vancouver Hosp, Dept Med, Vancouver, BC V6T 2B5, Canada	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; University of British Columbia; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of British Columbia; University of British Columbia	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN, Neurosci Res Ctr,Picower Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Sheng, Morgan/0000-0002-8703-5366				Abe M, 2004, J NEUROSCI, V24, P7292, DOI 10.1523/JNEUROSCI.1261-04.2004; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; Blevins T, 1997, J NEUROCHEM, V69, P2345; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Flint AC, 1997, J NEUROSCI, V17, P2469; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Ito I, 1997, J PHYSIOL-LONDON, V500, P401, DOI 10.1113/jphysiol.1997.sp022030; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Li WD, 2001, J BIOL CHEM, V276, P21417, DOI 10.1074/jbc.M010744200; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	48	382	404	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					745	760		10.1016/j.neuron.2005.04.031	http://dx.doi.org/10.1016/j.neuron.2005.04.031			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924861	Bronze			2022-12-28	WOS:000229689800009
J	Alkema, MJ; Hunter-Ensor, M; Ringstad, N; Horvitz, HR				Alkema, MJ; Hunter-Ensor, M; Ringstad, N; Horvitz, HR			Tyramine functions independently of octopamine in the Caenorhabditis elegans nervous system	NEURON			English	Article							DOPAMINE-BETA-HYDROXYLASE; C-ELEGANS; DROSOPHILA-MELANOGASTER; GLUTAMATE-RECEPTOR; APIS-MELLIFERA; TRACE AMINE; LOCOMOTORY BEHAVIOR; REVERSAL FREQUENCY; SYNAPTIC VESICLES; GENE	Octopamine biosynthesis requires tyrosine decarboxylase to convert tyrosine into tyramine and tyramine P-hydroxylase to convert tyramine into octopamine. We identified and characterized a Caenorhabditis elegans tyrosine decarboxylase gene, tdc-1, and a tyramine P-hydroxylase gene, tbh-1. The TBH-1 protein is expressed in a subset of TDC-1 -expressing cells, indicating that C. elegans has tyraminergic cells that are distinct from its octoparninergic cells. tdc-1 mutants have behavioral defects not shared by tbh-1 mutants. We show that tyramine plays a specific role in the inhibition of egg laying, the modulation of reversal behavior, and the suppression of head oscillations in response to anterior touch. We propose a model for the neural circuit that coordinates locomotion and head oscillations in response to anterior touch. Our findings establish tyramine as a neurotransmitter in C. elegans, and we suggest that tyramine is a genuine neurotransmitter in other invertebrates and possibly in vertebrates as well.	MIT, Howard Hughes Med Inst, Dept Biol 68425, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol 68425, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024663, R37GM024663] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24663] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; Barron AB, 2002, J COMP PHYSIOL A, V188, P603, DOI 10.1007/s00359-002-0335-5; Barron G.L., 1977, NEMATODE DESTROYING, VI, P144; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blumenthal EM, 2003, AM J PHYSIOL-CELL PH, V284, pC718, DOI 10.1152/ajpcell.00359.2002; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Boulton A A, 1976, Adv Biochem Psychopharmacol, V15, P57; Branchek TA, 2003, CURR OPIN PHARMACOL, V3, P90, DOI 10.1016/S1471-4892(02)00028-0; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; BURRELL BD, 1995, J INSECT PHYSIOL, V41, P671, DOI 10.1016/0022-1910(95)00022-M; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatelin S, 2001, MOL BRAIN RES, V97, P149, DOI 10.1016/S0169-328X(01)00318-7; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; CROLL NA, 1978, J ZOOL, V184, P507; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Dong MQ, 2000, GENE DEV, V14, P2003; Donini A, 2004, J INSECT PHYSIOL, V50, P351, DOI 10.1016/j.jinsphys.2004.02.005; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; EATON JL, 1988, ANAL BIOCHEM, V172, P484, DOI 10.1016/0003-2697(88)90471-X; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hammer M, 1998, LEARN MEMORY, V5, P146; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; Lucas P, 2003, FEMS MICROBIOL LETT, V229, P65, DOI 10.1016/S0378-1097(03)00787-0; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; MULLER B, 1984, NEUROSCIENCE, V11, P733, DOI 10.1016/0306-4522(84)90056-3; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; NATHANSON JA, 1979, SCIENCE, V203, P65, DOI 10.1126/science.214856; NELSON DL, 1976, J PHARMACOL EXP THER, V196, P346; Newman AP, 1996, DEVELOPMENT, V122, P3617; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Ohta H, 2003, INSECT MOL BIOL, V12, P217, DOI 10.1046/j.1365-2583.2003.00404.x; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; ORCHARD I, 1985, J NEUROBIOL, V16, P171, DOI 10.1002/neu.480160303; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; PETTINGILL TM, 1991, J BIOL CHEM, V266, P16996; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Prasad BC, 1998, DEVELOPMENT, V125, P1561; RAND JB, 1984, GENETICS, V106, P227; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Rex E, 2002, J NEUROCHEM, V82, P1352, DOI 10.1046/j.1471-4159.2002.01065.x; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; SCHINKMANN K, 1992, J COMP NEUROL, V316, P251, DOI 10.1002/cne.903160209; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; STEVENSON PA, 1995, COMP BIOCHEM PHYS A, V110, P203, DOI 10.1016/0300-9629(94)00152-J; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRENT C, 1983, GENETICS, V104, P619; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; VANDENBROECK J, 1995, J NEUROCHEM, V64, P2387; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	85	236	249	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					247	260		10.1016/j.neuron.2005.02.024	http://dx.doi.org/10.1016/j.neuron.2005.02.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848803	Bronze			2022-12-28	WOS:000228674800011
J	Murakami, M; Kashiwadani, H; Kirino, Y; Mori, K				Murakami, M; Kashiwadani, H; Kirino, Y; Mori, K			State-dependent sensory gating in olfactory cortex	NEURON			English	Article							BASAL FOREBRAIN NEURONS; BRAIN-STEM; ODOR MAPS; THALAMOCORTICAL NEURONS; PIRIFORM CORTEX; SLEEP; STIMULATION; OSCILLATION; RESPONSES; THALAMUS	Sensory systems show behavioral state-dependent gating of information flow that largely depends on the thalamus. Here we examined whether the statedependent gating occurs in the central olfactory pathway that lacks a thalamic relay. In urethane-anesthetized rats, neocortical EEG showed a periodical alternation between two states: a slow-wave state (SWS) characterized by large and slow waves and a fast-wave state (FWS) characterized by faster waves. Single-unit recordings from olfactory cortex neurons showed robust spike responses to adequate odorants during FWS, whereas they showed only weak responses during SWS. The state-dependent change in odorant-evoked responses was observed in a majority of olfactory cortex neurons, but in only a small percentage of olfactory bulb neurons. These findings demonstrate a powerful state-dependent gating of odor information in the olfactory cortex that works in synchrony with the gating of other sensory systems. They suggest a state-dependent switchover of signal processing modes in the olfactory cortex.	Univ Tokyo, Dept Physiol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Pharmaceut Sci, Lab Neurobiophys, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Mori, K (corresponding author), Univ Tokyo, Dept Physiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moriken@m.u-tokyo.ac.jp	Kashiwadani, Hideki/R-3404-2019; Murakami, Masayoshi/AAM-8778-2020	Mori, Kensaku/0000-0001-7853-9370; MURAKAMI, MASAYOSHI/0000-0001-5511-1144				Balatoni B, 2003, BRAIN RES, V959, P304, DOI 10.1016/S0006-8993(02)03768-X; Carskadon MA, 2004, SLEEP, V27, P402; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; Detari L, 1997, EUR J NEUROSCI, V9, P1153, DOI 10.1111/j.1460-9568.1997.tb01469.x; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; Edeline JM, 2000, J NEUROPHYSIOL, V84, P934, DOI 10.1152/jn.2000.84.2.934; ELMANSARI M, 1989, EXP BRAIN RES, V76, P519, DOI 10.1007/BF00248908; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1222, DOI 10.1152/jn.1992.67.5.1222; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; Igarashi KM, 2005, J NEUROPHYSIOL, V93, P1007, DOI 10.1152/jn.00873.2004; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; KETCHUM KL, 1993, J NEUROPHYSIOL, V69, P248, DOI 10.1152/jn.1993.69.1.248; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Manns ID, 2000, J NEUROSCI, V20, P1505; MARIOTTI M, 1989, NEUROSCI LETT, V102, P70, DOI 10.1016/0304-3940(89)90309-1; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RASMUSSON DD, 1994, NEUROSCIENCE, V60, P665, DOI 10.1016/0306-4522(94)90495-2; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1997, THALAMUS, P536; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	47	140	142	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					285	296		10.1016/j.neuron.2005.02.025	http://dx.doi.org/10.1016/j.neuron.2005.02.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848806	Bronze			2022-12-28	WOS:000228674800014
J	Burke, SN; Chawla, MK; Penner, MR; Crowell, BE; Worley, PF; Barnes, CA; McNaughton, BL				Burke, SN; Chawla, MK; Penner, MR; Crowell, BE; Worley, PF; Barnes, CA; McNaughton, BL			Differential encoding of behavior and spatial context in deep and superficial layers of the neocortex	NEURON			English	Article							CONDITIONED TASTE-AVERSION; HIPPOCAMPAL ENSEMBLE CODE; PERIRHINAL CORTEX; NEURAL ACTIVITY; UNIT-ACTIVITY; MEMORY; RAT; NEURONS; COMPLEMENTARY; PROJECTIONS	Rodent hippocampal activity is correlated with spatial and behavioral context, but how context affects coding in association neocortex is not well understood. The cellular distribution of the neural activity-regulated immediate-early gene Arc was used to monitor the activity history of cells in CA1, and in deep and superficial layers of posterior parietal and gustatory cortices (which encode movement and taste, respectively), during two behavioral epochs in which spatial and behavioral context were independently manipulated while gustatory input was held constant. Under conditions in which the hippocampus strongly differentiated behavioral and spatial contexts, deep parietal and gustatory layers did not discriminate between spatial contexts, whereas superficial layers in both neocortical regions discriminated well. Deep parietal cells discriminated behavioral context, whereas deep gustatory cortex neurons encoded the two conditions identically. Increased context sensitivity of superficial neocortical layers, which receive more hippocampal outflow, may reflect a general principle of neocortical organization for memory retrieval.	Univ Arizona, Neural Syst Memory & Aging Div, Tucson, AZ 85724 USA; Johns Hopkins Sch Med, Dept Neurosci Neurol, Baltimore, MD 21205 USA	University of Arizona; Johns Hopkins University; Johns Hopkins Medicine	McNaughton, BL (corresponding author), Univ Arizona, Neural Syst Memory & Aging Div, Life Sci N Bldg,Room 384, Tucson, AZ 85724 USA.	bruce@nsma.arizona.edu	Burke, Sara N/I-5691-2019	Burke, Sara N/0000-0002-1773-1294	NIA NIH HHS [AG023309, AG09219, AG18230, AG007434] Funding Source: Medline; NIMH NIH HHS [MH046823] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046823, R37MH046823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023309, R01AG018230, R01AG009219] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amaral David G., 1995, P443; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DEACON TW, 1983, J COMP NEUROL, V220, P168, DOI 10.1002/cne.902200205; DUNN LT, 1988, BEHAV NEUROSCI, V102, P3, DOI 10.1037/0735-7044.102.1.3; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McIntyre DC, 1996, J COMP NEUROL, V369, P302, DOI 10.1002/(SICI)1096-9861(19960527)369:2<302::AID-CNE10>3.0.CO;2-J; McNaughton, 2003, SLEEP BRAIN PLASTICI, P225, DOI DOI 10.1093/ACPROF:OSO/9780198574002.003.0013; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; Murre JMJ, 1996, HIPPOCAMPUS, V6, P675, DOI 10.1002/(SICI)1098-1063(1996)6:6<675::AID-HIPO10>3.0.CO;2-Y; Norgren Ralph, 1995, P751; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Paller KA, 1997, MEMORY, V5, P73, DOI 10.1080/741941150; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; SWANSON LW, 1986, J NEUROSCI, V6, P3010; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YAMAMOTO T, 1995, NEUROSCI RES, V22, P31, DOI 10.1016/0168-0102(95)00875-T	51	60	62	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					667	674		10.1016/j.neuron.2005.01.042	http://dx.doi.org/10.1016/j.neuron.2005.01.042			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748843	Bronze			2022-12-28	WOS:000227446700007
J	Krukowski, AE; Stone, LS				Krukowski, AE; Stone, LS			Expansion of direction space around the cardinal axes revealed by smooth pursuit eye movements	NEURON			English	Article							CORTICAL AREAS MT; PERCEPTION FOLLOWING LESIONS; TEMPORAL VISUAL AREA; MOTION PERCEPTION; MST; DISCRIMINATION; OCULOMOTOR; DEFICITS; MICROSTIMULATION; ANISOTROPIES	It is well established that perceptual direction discrimination shows an oblique effect; thresholds are higher for motion along diagonal directions than for motion along cardinal directions. Here, we compare simultaneous direction judgments and pursuit responses for the same motion stimuli and find that both pursuit and perceptual thresholds show similar anisotropies. The pursuit oblique effect is robust under a wide range of experimental manipulations, being largely resistant to changes in trajectory (radial versus tangential motion), speed (10 versus 25 deg/s), directional uncertainty (blocked versus randomly interleaved), and cognitive state (tracking alone versus concurrent tracking and perceptual tasks). Our data show that the pursuit oblique effect is caused by an effective expansion of direction space surrounding the cardinal directions and the requisite compression of space for other directions. This expansion suggests that the directions around the cardinal directions are in some way overrepresented in the visual cortical pathways that drive both smooth pursuit and perception.	NASA, Ames Res Ctr, Human Factors Res & Technol Div, Moffett Field, CA 94035 USA; San Jose State Univ, Dept Psychol, San Jose, CA 95192 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California State University System; San Jose State University	Stone, LS (corresponding author), NASA, Ames Res Ctr, Human Factors Res & Technol Div, Moffett Field, CA 94035 USA.	lstone@mail.arc.nasa.gov						BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Barnes GR, 2002, PROG BRAIN RES, V140, P239; Beutter BR, 2000, VISUAL NEUROSCI, V17, P139, DOI 10.1017/S0952523800171147; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; Dassonville P, 2004, VISION RES, V44, P603, DOI 10.1016/j.visres.2003.10.017; Dobkins KR, 1998, PERCEPTION, V27, P681, DOI 10.1068/p270681; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Finney D.J., 1971, PROBIT ANAL; Ganel T, 2003, NATURE, V426, P664, DOI 10.1038/nature02156; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gros BL, 1998, J OPT SOC AM A, V15, P2003, DOI 10.1364/JOSAA.15.002003; HEELEY DW, 1992, VISION RES, V32, P97, DOI 10.1016/0042-6989(92)90117-2; Ilg UJ, 2004, NEURON, V43, P145, DOI 10.1016/j.neuron.2004.06.006; Ilg UJ, 2003, J NEUROPHYSIOL, V90, P1489, DOI 10.1152/jn.00272.2003; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Krauzlis RJ, 1999, TRENDS NEUROSCI, V22, P544, DOI 10.1016/S0166-2236(99)01464-2; Krauzlis RJ, 2001, VISUAL NEUROSCI, V18, P365, DOI 10.1017/S0952523801183033; Krukowski AE, 2003, J VISION, V3, P831, DOI 10.1167/3.11.16; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; Madelain L, 2003, J VISION, V3, P642, DOI 10.1167/3.11.1; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; NEWSOME WT, 1985, J NEUROSCI, V5, P825; PASTERNAK T, 1994, CEREB CORTEX, V4, P247, DOI 10.1093/cercor/4.3.247; PRESS WH, 1992, MODELING NUMERICAL R, P689; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Smeets JBJ, 2002, EXP BRAIN RES, V147, P135, DOI 10.1007/s00221-002-1185-7; STEINBACH MJ, 1976, VISION RES, V16, P1371, DOI 10.1016/0042-6989(76)90154-1; Stone LS, 2000, PERCEPTION, V29, P771, DOI 10.1068/p2979; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Stone LS, 2003, J VISION, V3, pI, DOI 10.1167/3.11.i; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X	41	44	45	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					315	323		10.1016/j.neuron.2005.01.005	http://dx.doi.org/10.1016/j.neuron.2005.01.005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664182	Bronze			2022-12-28	WOS:000226451500017
J	Hayden, BY; Gallant, JL				Hayden, BY; Gallant, JL			Time course of attention reveals different mechanisms for spatial and feature-based attention in area V4	NEURON			English	Article							VISUAL-ATTENTION; STRIATE CORTEX; EYE-MOVEMENTS; RESPONSES; NEURONS; SEARCH; COLOR; SELECTION; LOCATION; VISION	Attention can facilitate visual processing, emphasizing specific locations and highlighting stimuli containing specific features. To dissociate the mechanisms of spatial and feature-based attention, we compared the time course of visually evoked responses under different attention conditions. We recorded from single neurons in area V4 during a delayed match-to-sample task that controlled both spatial and feature-based attention. Neuronal responses increased when spatial attention was directed toward the receptive field and were modulated by the identity of the target of feature-based attention. Modulation by spatial attention was weaker during the early portion of the visual response and stronger during the later portion of the response. In contrast, modulation by feature-based attention was relatively constant throughout the response. It appears that stimulus onset transients disrupt spatial attention, but not feature attention. We conclude that spatial attention reflects a combination of stimulus-driven and goal-driven processes, while feature-based attention is purely goal driven.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Gallant, Jack L/C-4426-2011; Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281	NATIONAL EYE INSTITUTE [R01EY012241] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012241] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEAN AF, 1982, EXP BRAIN RES, V45, P456, DOI 10.1007/BF01208607; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DeValois R.L., 1990, SPATIAL VISION, V14; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; GATTASS R, 1990, BRAZ J MED BIOL RES, V23, P375; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamy D, 2001, EUR J COGN PSYCHOL, V13, P305, DOI 10.1080/09541440042000016; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1994, J NEUROSCI, V14, P2178; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Shih SI, 1996, J EXP PSYCHOL HUMAN, V22, P758, DOI 10.1037/0096-1523.22.3.758; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; TSAL Y, 1993, J EXP PSYCHOL HUMAN, V19, P131, DOI 10.1037/0096-1523.19.1.131; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002	33	99	101	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					637	643		10.1016/j.neuron.2005.07.020	http://dx.doi.org/10.1016/j.neuron.2005.07.020			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129394	Bronze			2022-12-28	WOS:000231782700006
J	Frank, MJ; Woroch, BS; Curran, T				Frank, MJ; Woroch, BS; Curran, T			Error-related negativity predicts reinforcement learning and conflict biases	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; REWARD PREDICTION; AVERAGE REFERENCE; DOPAMINE RELEASE; BRAIN POTENTIALS; NEURAL SYSTEM; BASAL GANGLIA; PERSONALITY; SEROTONIN	The error-related negativity (ERN) is an electrophysiological marker thought to reflect changes in dopamine when participants make errors in cognitive tasks. Our computational model further predicts that larger ERNs should be associated with better learning to avoid maladaptive responses. Here we show that participants who avoided negative events had larger ERNs than those who were biased to learn more from positive outcomes. We also tested for effects of response conflict on ERN magnitude. While there was no overall effect of conflict, positive learners had larger ERNs when having to choose among two good options (win/win decisions) compared with two bad options (lose/lose decisions), whereas negative learners exhibited the opposite pattern. These results demonstrate that the ERN predicts the degree to which participants are biased to learn more from their mistakes than their correct choices and clarify the extent to which it indexes decision conflict.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Frank, MJ (corresponding author), Univ Colorado, Dept Psychol, 345 UCB, Boulder, CO 80309 USA.	frankmj@psych.colorado.edu	Frank, Michael J/B-2979-2008		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069597, R01MH064812] Funding Source: NIH RePORTER; NIMH NIH HHS [MH069597-01, MH64812-01] Funding Source: Medline; PHS HHS [N00014-03-1-0428] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abrams KY, 2004, PSYCHIAT CLIN NEUROS, V58, P240, DOI 10.1111/j.1440-1819.2004.01226.x; Bates AT, 2004, J PSYCHIATR RES, V38, P347, DOI 10.1016/j.jpsychires.2003.11.002; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; EBLEN F, 1995, J NEUROSCI, V15, P5999; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fallgatter AJ, 2004, NEUROPSYCHOPHARMACOL, V29, P1506, DOI 10.1038/sj.npp.1300409; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; HACJAK G, 2004, BRAIN COGNITION, V56, P189; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Luu P, 2000, J EXP PSYCHOL GEN, V129, P43, DOI 10.1037//0096-3445.129.1.43; McGowan S, 2004, ARCH GEN PSYCHIAT, V61, P134, DOI 10.1001/archpsyc.61.2.134; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nocjar C, 2002, NEUROSCIENCE, V111, P163, DOI 10.1016/S0306-4522(01)00593-0; OREILLY RC, 2005, IN PRESS NEURAL COMP; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; PICTON TW, 1995, HDB NEUROPSYCHOLOGY, V10, P373; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Tucker DM, 2003, J ABNORM PSYCHOL, V112, P667, DOI 10.1037/0021-843X.112.4.667; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Ventura R, 2004, J NEUROCHEM, V89, P494, DOI 10.1111/j.1471-4159.2004.02342.x; Wu Q, 2002, J NEUROSCI, V22, P6272; Yasuda A, 2004, NEUROREPORT, V15, P2561, DOI 10.1097/00001756-200411150-00027; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	47	314	321	0	48	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 18	2005	47	4					495	501		10.1016/j.neuron.2005.06.020	http://dx.doi.org/10.1016/j.neuron.2005.06.020			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102533	Bronze			2022-12-28	WOS:000231411100007
J	Cavodeassi, F; Carreira-Barbosa, F; Young, RM; Concha, ML; Allende, ML; Houart, C; Tada, M; Wilson, SW				Cavodeassi, F; Carreira-Barbosa, F; Young, RM; Concha, ML; Allende, ML; Houart, C; Tada, M; Wilson, SW			Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5, and the Wnt/beta-catenin pathway	NEURON			English	Article							CONVERGENT EXTENSION MOVEMENTS; SIGNALING PATHWAY; BETA-CATENIN; MOLECULAR-MECHANISM; NEGATIVE REGULATOR; PRECHORDAL PLATE; XENOPUS; EXPRESSION; GENES; MORPHOGENESIS	During regional patterning of the anterior neural plate a medially positioned domain of cells is specified to adopt retinal identity. These eye field cells remain coherent as they undergo morphogenetic events distinct from other prospective forebrain domains. We show that two branches of the Wnt signaling pathway coordinate cell fate determination with cell behavior during eye field formation. Wnt/beta-catenin signaling antagonizes eye specification through the activity of Wnt8b and Fz8a. In contrast, Wnt-11 and Fz5 promote eye field development, at least in part, through local antagonism of Wnt/beta-catenin signaling. Additionally, Wnt11 regulates the behavior of eye field cells, promoting their cohesion. Together, these results allow us to postulate a model in which Wnt11 and Fz5 signaling promotes early eye development through the coordinated antagonism of signals that suppress retinal identity and promotion of coherence of eye field cells.	UCL, Dept Anat, London 6BT WC1, England; Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Neurociencias Integradas,Programa Anat & Biol, Santiago, Chile; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 9RT, England	University of London; University College London; Universidad de Chile; Universidad de Chile; University of London; King's College London	Wilson, SW (corresponding author), UCL, Dept Anat, Gower St, London 6BT WC1, England.	s.wilson@ucl.ac.uk	Houart, Corinne/B-5128-2009; Wilson, Stephen W/B-9404-2008; Cavodeassi, Florencia/K-4400-2014; Cavodeassi, Florencia/AAW-4688-2020; Zebrafish, UCL/A-3125-2009; Concha, Miguel/I-2551-2013; Young, Rodrigo M/A-9512-2016; Allende, Miguel L/C-5167-2008; Tada, Masazumi/A-1431-2009; Young, Rodrigo/AAM-9392-2020	Houart, Corinne/0000-0002-2062-3964; Wilson, Stephen W/0000-0002-8557-5940; Cavodeassi, Florencia/0000-0003-4609-6258; Cavodeassi, Florencia/0000-0003-4609-6258; Concha, Miguel/0000-0003-3353-9398; Young, Rodrigo M/0000-0001-5765-197X; Allende, Miguel L/0000-0002-2783-2152; Young, Rodrigo/0000-0001-5765-197X	Wellcome Trust [074376] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barth KA, 1999, DEVELOPMENT, V126, P4977; Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1; Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Chuang JC, 2002, BIOESSAYS, V24, P519, DOI 10.1002/bies.10097; Cooke JE, 2002, TRENDS NEUROSCI, V25, P260, DOI 10.1016/S0166-2236(02)02134-3; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hammerschmidt M, 2003, DEV DYNAM, V227, P128, DOI 10.1002/dvdy.10281; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim SH, 1998, MECH DEVELOP, V78, P193, DOI 10.1016/S0925-4773(98)00137-3; Kim SH, 2002, DEVELOPMENT, V129, P4443; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lekven AC, 2003, DEV BIOL, V254, P172, DOI 10.1016/S0012-1606(02)00044-1; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; MOON RT, 1993, DEV S, V120, P85; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rasmussen JT, 2001, P NATL ACAD SCI USA, V98, P3861, DOI 10.1073/pnas.071586298; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Sumanas S, 2001, MECH DEVELOP, V103, P133, DOI 10.1016/S0925-4773(01)00327-6; Tada M, 2000, DEVELOPMENT, V127, P2227; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; WOO K, 1995, DEVELOPMENT, V121, P2595; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8	58	150	154	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					43	56		10.1016/j.neuron.2005.05.026	http://dx.doi.org/10.1016/j.neuron.2005.05.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996547	Green Accepted, Bronze			2022-12-28	WOS:000230464000007
J	Agler, HL; Evans, J; Tay, LH; Anderson, MJ; Colecraft, HM; Yue, DT				Agler, HL; Evans, J; Tay, LH; Anderson, MJ; Colecraft, HM; Yue, DT			G protein-gated inhibitory module of N-type (Ca(V)2.2) Ca2+ channels	NEURON			English	Article							G-BETA-GAMMA; BULLFROG SYMPATHETIC NEURONS; DEPENDENT CALCIUM-CHANNEL; KINASE-C; ALPHA(1) SUBUNIT; ACETYLCHOLINE-RECEPTOR; SIGNAL-TRANSDUCTION; VOLTAGE DEPENDENCE; POTASSIUM CHANNEL; OPIOID RECEPTOR	Voltage-dependent G protein (Gp gamma) inhibition of N-type (Ca(v)2.2) channels supports presynaptic inhibition and represents a central paradigm of channel modulation. Still controversial are the proposed determinants for such modulation, which reside on the principal alpha(1B) channel subunit. These include the interdomain I-II loop (I-II), the carboxy tail (CT), and the amino terminus (NT). Here, we probed these determinants and related mechanisms, utilizing compound-state analysis with yeast two-hybrid and mammalian cell FRET assays of binding among channel segments and G proteins. Chimeric channels confirmed the unique importance of NT. Binding assays revealed selective interaction between NT and I-II elements. Coexpressing NT peptide with Gp gamma induced constitutive channel inhibition, suggesting that the NT domain constitutes a G protein-gated inhibitory module. Such inhibition was limited to NT regions interacting with I-II, and G-protein inhibition was abolished within (alpha(1B) channels lacking these NT regions. Thus, an NT module, acting via interactions with the I-II loop, appears fundamental to such modulation.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, CA2 Signals Labs, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu	Tuluc, Petronel/C-2527-2011					Agler HL, 2003, J GEN PHYSIOL, V121, P495, DOI 10.1085/jgp.200208770; ALLEN JB, 1995, TRENDS BIOCHEM SCI, V20, P511, DOI 10.1016/S0968-0004(00)89119-7; Artim DE, 2000, J NEUROPHYSIOL, V84, P2417, DOI 10.1152/jn.2000.84.5.2417; Bastiaens PIH, 1996, P NATL ACAD SCI USA, V93, P8407, DOI 10.1073/pnas.93.16.8407; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bliss Michael, 2007, WILLIAM OSLER LIFE M; BOLAND LM, 1993, J NEUROSCI, V13, P516; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; Brody DL, 1997, J PHYSIOL-LONDON, V499, P637, DOI 10.1113/jphysiol.1997.sp021956; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; *CLONT LAB, 1999, MATCHMAKER GAL4 2 HY, P1; Colecraft HM, 2000, J GEN PHYSIOL, V115, P175, DOI 10.1085/jgp.115.2.175; Colecraft HM, 2001, J NEUROSCI, V21, P1137; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Doering CJ, 2004, J BIOL CHEM, V279, P29709, DOI 10.1074/jbc.M308693200; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Dunlap K, 1997, NATURE, V385, P394, DOI 10.1038/385394a0; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Elmslie KS, 2003, J BIOENERG BIOMEMBR, V35, P477, DOI 10.1023/B:JOBB.0000008021.55853.18; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Garcia DE, 1998, J NEUROSCI, V18, P9163; GAUTAM N, 1990, P NATL ACAD SCI USA, V87, P7973, DOI 10.1073/pnas.87.20.7973; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Glantz S., 1990, PRIMER APPL REGRESSI; Hamid J, 1999, J BIOL CHEM, V274, P6195, DOI 10.1074/jbc.274.10.6195; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jones LP, 1999, BIOPHYS J, V76, P2530, DOI 10.1016/S0006-3495(99)77407-2; Jones LP, 1997, J PHYSIOL-LONDON, V498, P601, DOI 10.1113/jphysiol.1997.sp021886; Kaneko S, 1997, BRIT J PHARMACOL, V121, P806, DOI 10.1038/sj.bjp.0701181; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Li B, 2004, MOL PHARMACOL, V66, P761; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; McIntosh JM, 2001, TOXICON, V39, P1447, DOI 10.1016/S0041-0101(01)00145-3; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Page KM, 1998, J NEUROSCI, V18, P4815; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Penn RD, 2000, PAIN, V85, P291, DOI 10.1016/S0304-3959(99)00254-7; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; Simen AA, 2000, MOL PHARMACOL, V57, P1064; Smiley MM, 2004, ANESTHESIOLOGY, V101, P759, DOI 10.1097/00000542-200409000-00026; SUGIMOTO K, 1985, FEBS LETT, V191, P235, DOI 10.1016/0014-5793(85)80015-6; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Wei X, 1996, RECEPTOR CHANNEL, V4, P205; WEI XY, 1991, J BIOL CHEM, V266, P21943; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILDING TJ, 1995, J NEUROSCI, V15, P4124; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Young K, 1998, NAT BIOTECHNOL, V16, P946, DOI 10.1038/nbt1098-946; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 2004, NEURON, V41, P3, DOI 10.1016/S0896-6273(03)00846-8; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	73	64	66	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					891	904		10.1016/j.neuron.2005.05.011	http://dx.doi.org/10.1016/j.neuron.2005.05.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953418	Bronze			2022-12-28	WOS:000229922500009
J	Bremmer, F				Bremmer, F			What's next? Sequential movement encoding in primary motor cortex	NEURON			English	Editorial Material							TEMPORAL ORGANIZATION; MULTIPLE MOVEMENTS; SUPPLEMENTARY; AREAS; FMRI	Complex actions often can be decomposed into sequences of individual movements. Primate medial motor areas (SMA and pre-SMA) have been shown to be key players in the concert of such sequential actions. In this issue of Neuron, Lu and Ashe show for the first time that neurons in primate M1-the ultimate output stage of cortex-have anticipatory activity related to specific movement sequences. These findings challenge the traditional view of M1 as being a simple module for generating movements.	Univ Marburg, Dept Neurophysiol, D-35032 Marburg, Germany	Philipps University Marburg	Bremmer, F (corresponding author), Univ Marburg, Dept Neurophysiol, Renthof 7-202, D-35032 Marburg, Germany.		Bremmer, Frank/F-3268-2012	Bremmer, Frank/0000-0003-1597-7407				Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Dick J P, 1986, Mov Disord, V1, P255, DOI 10.1002/mds.870010405; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0	10	5	5	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 24	2005	45	6					819	821		10.1016/j.neuron.2005.03.006	http://dx.doi.org/10.1016/j.neuron.2005.03.006			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797542	Bronze			2022-12-28	WOS:000228031300002
J	Udo, H; Jin, I; Kim, JH; Li, HL; Youn, T; Hawkins, RD; Kandel, ER; Bailey, CH				Udo, H; Jin, I; Kim, JH; Li, HL; Youn, T; Hawkins, RD; Kandel, ER; Bailey, CH			Serotonin-induced regulation of the actin network for learning-related synaptic growth requires Cdc42, N-WASP, and PAK in Aplysia sensory neurons	NEURON			English	Article							LONG-TERM FACILITATION; STRUCTURAL-CHANGES; RHO GTPASES; DEPOLYMERIZING PROTEIN; P21-ACTIVATED KINASE; MEMORY; RAC; PLASTICITY; SYNAPSES; TARGET	Application of Clostridium difficile toxin B, an inhibitor of the Rho family of GTPases, at the Aplysia sensory to motor neuron synapse blocks long-term facilitation and the associated growth of new sensory neuron varicosities induced by repeated pulses of serotonin (5-HT). We have isolated cDNAs encoding Aplysia Rho, Rac, and Cdc42 and found that Rho and Rac had no effect but that overexpression in sensory neurons of a dominant-negative mutant of ApCdc42 or the CRIB domains of its downstream effectors PAK and N-WASP selectively reduces the long-term changes in synaptic strength and structure. FRET analysis indicates that 5-HT activates ApCdc42 in a subset of varicosities contacting the postsynaptic motor neuron and that this activation is dependent on the PI3K and PLC signaling pathways. The 5-HT-induced activation of ApCdc42 initiates reorganization of the presynaptic actin network leading to the outgrowth of filopodia, some of which are morphological precursors for the learning-related formation of new sensory neuron varicosities.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; Pohang Univ Sci & Technol, Dept Life Sci, Kyungbuk 790784, South Korea	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Kyushu University; Pohang University of Science & Technology (POSTECH)	Kandel, ER (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA.	erk5@columbia.edu	Li, Hsiu-Ling/C-3567-2011		NIMH NIH HHS [MH37134, MH26212] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH026212, R01MH037134] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hatada Y, 2000, J NEUROSCI, V20, part. no.; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KUKAZAWA Y, 2003, NEURON, V38, P447; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RAYPORT SG, 1986, J NEUROSCI, V6, P759; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	54	84	86	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					887	901		10.1016/j.neuron.2005.01.044	http://dx.doi.org/10.1016/j.neuron.2005.01.044			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797550	Bronze			2022-12-28	WOS:000228031300010
J	Duebel, J; Haverkamp, S; Schleich, W; Feng, GP; Augustine, GJ; Kuner, T; Euler, T				Duebel, J; Haverkamp, S; Schleich, W; Feng, GP; Augustine, GJ; Kuner, T; Euler, T			Two-photon imaging reveals somatodendritic chloride gradient in retinal ON-type bipolar cells expressing the biosensor clomeleon	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; GABA-INDUCED CURRENTS; RECEPTIVE-FIELD; INTRACELLULAR CHLORIDE; MAMMALIAN RETINA; HORIZONTAL CELLS; AMACRINE CELLS; MOUSE RETINA; HIPPOCAMPAL-NEURONS; TIGER SALAMANDER	A somatodendritic gradient of Cl- concentration ([Cl-](i)) has been postulated to generate GABA-evoked responses of different polarity in retinal bipolar cells, hyperpolarizing in OFF cells with low dendritic [Cl-](i), and depolarizing in ON cells with high dendritic [Cl-](i). As glutamate released by the photoreceptors depolarizes OFF cells and hyperpolarizes ON cells, the bipolars' antagonistic receptive field (RF) could be computed by simply integrating glutamatergic inputs from the RF center and GABAergic inputs from horizontal cells in the RF surround. Using ratiometric two-photon imaging of Clomeleon, a Cl- indicator transgenically expressed in ON bipolar cells, we found that dendritic [Cl-](i) exceeds somatic [Cl-](i) by up to 20 mM and that GABA application can lead to Cl- efflux (depolarization) in these dendrites. Blockers of Cl- transporters reduced the somatodendritic [Cl-](i) gradient. Hence, our results support the idea that ON bipolar cells employ a somatodendritic [Cl-](i) gradient to invert GABAergic horizontal cell input.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; Max Planck Inst Brain Res, Dept Neuroanat, D-60528 Frankfurt, Germany; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Max Planck Society; Max Planck Society; Max Planck Society; Duke University	Kuner, T (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, Jahnstr 29, D-69120 Heidelberg, Germany.	thomas.kuner@mpimf-heidelberg.mpg.de; teuler@mpimf-heidelberg.mpg.de	Augustine, George James/J-9228-2013; Feng, Guoping/Y-2827-2019	Euler, Thomas/0000-0002-4567-6966; Duebel, Jens/0000-0002-9906-5597	NIMH NIH HHS [MH073166] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073166] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKAIKE N, 1994, JPN J PHYSIOL, V44, pS113; Amos BJ, 1996, EXP PHYSIOL, V81, P261, DOI 10.1113/expphysiol.1996.sp003930; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Ballanyi Klaus, 1998, P291; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BERGLUND K, 2004, IMAGING NEUROSCIENCE; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Carolina V, 2005, VISION RES, V45, P2659, DOI 10.1016/j.visres.2005.03.020; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Dallwig R, 1999, PFLUG ARCH EUR J PHY, V437, P289, DOI 10.1007/s004240050782; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Enz R, 1996, J NEUROSCI, V16, P4479; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GREFERATH U, 1994, CELL TISSUE RES, V276, P295, DOI 10.1007/s004410050092; GRUNERT U, 1990, J COMP NEUROL, V297, P509, DOI 10.1002/cne.902970405; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; HARE WA, 1990, J PHYSIOL-LONDON, V421, P223, DOI 10.1113/jphysiol.1990.sp017942; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; Haugh-Scheidt L, 1998, EXP EYE RES, V66, P449, DOI 10.1006/exer.1997.0441; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Kamermans M, 2004, CURR OPIN NEUROBIOL, V14, P531, DOI 10.1016/j.conb.2004.08.016; KANEKO A, 1973, J PHYSIOL-LONDON, V235, P133, DOI 10.1113/jphysiol.1973.sp010381; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Luckermann M, 1997, J NEUROPHYSIOL, V77, P1844, DOI 10.1152/jn.1997.77.4.1844; MARIANI AP, 1984, NATURE, V308, P184, DOI 10.1038/308184a0; MILLER RF, 1983, VISION RES, V23, P399, DOI 10.1016/0042-6989(83)90087-1; MILLER RF, 1976, J GEN PHYSIOL, V67, P639, DOI 10.1085/jgp.67.6.639; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; PASTERNACK M, 1993, ACTA PHYSIOL SCAND, V148, P229, DOI 10.1111/j.1748-1716.1993.tb09553.x; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Protti DA, 1998, J NEUROSCI, V18, P3715; Satoh H, 2001, NEUROSCI LETT, V310, P161, DOI 10.1016/S0304-3940(01)02120-6; Schwartz EA, 2002, PHYSIOL REV, V82, P875, DOI 10.1152/physrev.00010.2002; STONE S, 1991, VISUAL NEUROSCI, V7, P363, DOI 10.1017/S0952523800004855; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; TOYODA J, 1982, J GEN PHYSIOL, V79, P131, DOI 10.1085/jgp.79.1.131; VARDI N, 1994, VISION RES, V34, P1235, DOI 10.1016/0042-6989(94)90198-8; Vardi N, 2000, J NEUROSCI, V20, P7657; Wachter RM, 1997, BIOCHEMISTRY-US, V36, P9759, DOI 10.1021/bi970563w; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P62, DOI 10.1085/jgp.63.1.62; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; YAMASHITA M, 1991, VISUAL NEUROSCI, V6, P399, DOI 10.1017/S0952523800006635; YANG XL, 1991, P NATL ACAD SCI USA, V88, P3310, DOI 10.1073/pnas.88.8.3310	61	129	133	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					81	94		10.1016/j.neuron.2005.10.035	http://dx.doi.org/10.1016/j.neuron.2005.10.035			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387641	Bronze			2022-12-28	WOS:000236699300011
J	O'Neill, J; Senior, T; Csicsvari, J				O'Neill, J; Senior, T; Csicsvari, J			Place-selective firing of CA1 pyramidal cells during sharp wave/ripple network patterns in exploratory behavior	NEURON			English	Article							HIPPOCAMPUS IN-VITRO; WAVE-RIPPLE COMPLEXES; INTACT HIPPOCAMPUS; RAT HIPPOCAMPUS; NEURONS; EXPERIENCE; OSCILLATIONS; MEMORY; SLEEP; MECHANISMS	We observed sharp wave/ripples (SWR) during exploration within brief (< 2.4 s) interruptions of or during theta oscillations. CA1 network responses of SWRs occurring during exploration (eSWR) and SWRs detected in waking immobility or sleep were similar. However, neuronal activity during eSWR was location dependent, and eSWR-related firing was stronger inside the place field than outside. The eSPW-related firing increase was stronger than the baseline increase inside compared to outside, suggesting a "supralinear" summation of eSWR and place-selective inputs. Pairs of cells with similar place fields and/or correlated firing during exploration showed stronger coactivation during eSWRs and subsequent sleep-SWRs. Sequential activation of place cells was not required for the reactivation of waking co-firing patterns; cell pairs with symmetrical cross-correlations still showed reactivated waking co-firing patterns during sleep-SWRs. We suggest that place-selective firing during eSWRs facilitates initial associations between cells with similar place fields that enable place-related ensemble patterns to recur during subsequent sleep-SWRs.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Csicsvari, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	jozsef.csicsvari@pharm.ox.ac.uk			MRC [MC_U138169944] Funding Source: UKRI; Medical Research Council [MC_U138169944] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		BENARDO LS, 1993, NEUROSCIENCE, V53, P11, DOI 10.1016/0306-4522(93)90280-S; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; DUTAR P, 1988, J NEUROSCI, V8, P4214; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HOUNSGAARD J, 1978, EXP NEUROL, V62, P787, DOI 10.1016/0014-4886(78)90284-4; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jarosiewicz B, 2004, J NEUROSCI, V24, P5070, DOI 10.1523/JNEUROSCI.5650-03.2004; Kamondi A, 1998, J NEUROSCI, V18, P3919; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LEUNG LS, 1979, J NEUROPHYSIOL, V42, P1571, DOI 10.1152/jn.1979.42.6.1571; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1987, J NEUROSCI, V7, P733; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Nimmrich V, 2005, J PHYSIOL-LONDON, V563, P663, DOI 10.1113/jphysiol.2004.079558; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V69, P532, DOI 10.1016/0013-4694(88)90165-4; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Traub RD, 2000, J NEUROSCI, V20, P2086; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; YLINEN A, 1995, J NEUROSCI, V15, P30; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	61	187	189	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					143	155		10.1016/j.neuron.2005.10.037	http://dx.doi.org/10.1016/j.neuron.2005.10.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387646	Bronze			2022-12-28	WOS:000236699300016
J	McGann, JP; Pirez, N; Gainey, MA; Muratore, C; Elias, AS; Wachowiak, M				McGann, JP; Pirez, N; Gainey, MA; Muratore, C; Elias, AS; Wachowiak, M			Odorant representations are modulated by intra- but not interglomerular presynaptic inhibition of olfactory sensory neurons	NEURON			English	Article							EXTERNAL TUFTED CELLS; BULB GLOMERULI; SYNAPTIC-TRANSMISSION; FUNCTIONAL-ORGANIZATION; RECIPROCAL SYNAPSES; NERVE-TERMINALS; INPUT; RAT; EXPRESSION; RELEASE	Input to the central nervous system from olfactory sensory neurons (OSNs) is modulated presynaptically. We investigated the functional organization of this inhibition and its role in odor coding by imaging neurotransmitter release from OSNs in slices and in vivo in mice expressing synaptopHluorin, an optical indicator of vesicle exocytosis. Release from OSNs was strongly suppressed by heterosynaptic, intraglomerular inhibition. In contrast, inhibitory connections between glomeruli mediated only weak lateral inhibition of OSN inputs in slices and did not do so in response to odorant stimulation in vivo. Blocking presynaptic inhibition in vivo increased the amplitude of odorant-evoked input to glomeruli but had little effect on spatial patterns of glomerular input. Thus, intraglomerular inhibition limits the strength of olfactory input to the CNS, whereas interglomerular inhibition plays little or no role. This organization allows for control of input sensitivity while maintaining the spatial maps of glomerular activity thought to encode odorant identity.	Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	McGann, JP (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	mcgann@bu.edu		Gainey, Melanie/0000-0002-4782-9647; Pirez, Nicolas/0000-0002-0463-0080	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006441, F32DC007258, R03DC004938] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC6441, F32 DC007258, DC4938, DC7258] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brenowitz S, 2001, J NEUROSCI, V21, P1857, DOI 10.1523/JNEUROSCI.21-06-01857.2001; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Cho JY, 1996, J COMP NEUROL, V369, P264; Duchamp-Viret P, 2000, NEUROSCIENCE, V97, P771, DOI 10.1016/S0306-4522(00)00055-5; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GETCHELL TV, 1975, J PHYSIOL-LONDON, V251, P523, DOI 10.1113/jphysiol.1975.sp011106; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Keller A, 1998, J NEUROSCI, V18, P2602; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ohliger-Frerking P, 2003, J NEUROSCI, V23, P4809; PINCHING AJ, 1971, J CELL SCI, V9, P379; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Toida K, 2000, NEUROSCIENCE, V101, P11, DOI 10.1016/S0306-4522(00)00356-0; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VUCINIC D, 2005, IN PRESS J NEUROPHYS, V30; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	40	137	139	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					1039	1053		10.1016/j.neuron.2005.10.031	http://dx.doi.org/10.1016/j.neuron.2005.10.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364906	Bronze			2022-12-28	WOS:000234301700018
J	Cang, JH; Renteria, RC; Kaneko, M; Liu, XR; Copenhagen, DR; Stryker, MP				Cang, JH; Renteria, RC; Kaneko, M; Liu, XR; Copenhagen, DR; Stryker, MP			Development of precise maps in visual cortex requires patterned spontaneous activity in the retina	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; NICOTINIC ACETYLCHOLINE-RECEPTOR; OCULAR DOMINANCE COLUMNS; EYE-SPECIFIC SEGREGATION; MICE LACKING; BETA-2 SUBUNIT; GANGLION-CELLS; SUPERIOR COLLICULUS; NEURONAL-ACTIVITY; MAMMALIAN RETINA	The visual cortex is organized into retinotopic maps that preserve an orderly representation of the visual world, achieved by topographically precise inputs from the lateral geniculate nucleus. We show here that geniculocortical mapping is imprecise when the waves of spontaneous activity in the retina during the first postnatal week are disrupted genetically. This anatomical mapping defect is present by postnatal day 8 and has functional consequences, as revealed by optical imaging and microelectrode recording in adults. Pharmacological disruption of these retinal waves during the first week phenocopies the mapping defect, confirming both the site and the timing of the disruption in neural activity responsible for the defect. Analysis shows that the geniculocortical miswiring is not a trivial or necessary consequence of the retinogeniculate defect. Our findings demonstrate that disrupting early spontaneous activity in the eye alters thalamic connections to the cortex.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831; Renteria, Rene/0000-0002-4490-0735	NEI NIH HHS [R37 EY002874-24S1, R37 EY002874] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bansal A, 2000, J NEUROSCI, V20, P7672; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Demas J, 2003, J NEUROSCI, V23, P2851; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FOX K, 1992, J NEUROSCI, V12, P1826; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Grubb MS, 2004, J NEUROSCI, V24, P8459, DOI 10.1523/JNEUROSCI.1527-04.2004; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; GUILLERY RW, 1979, J COMP NEUROL, V185, P623, DOI 10.1002/cne.901850404; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Huang K, 1985, Brain Res, V352, P213; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; KAAS JH, 1973, BRAIN RES, V59, P61, DOI 10.1016/0006-8993(73)90253-9; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; Krug K, 1998, J NEUROSCI, V18, P5766; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Xu W, 1999, J NEUROSCI, V19, P9298; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zoli M, 1998, J NEUROSCI, V18, P4461	50	219	220	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					797	809		10.1016/j.neuron.2005.09.015	http://dx.doi.org/10.1016/j.neuron.2005.09.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337917	Green Accepted, Bronze			2022-12-28	WOS:000233927300018
J	Li, HY; Waites, CL; Staal, RG; Dobryy, Y; Park, J; Sulzer, DL; Edwards, RH				Li, HY; Waites, CL; Staal, RG; Dobryy, Y; Park, J; Sulzer, DL; Edwards, RH			Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines	NEURON			English	Article							SYNAPTIC-LIKE MICROVESICLES; TERMINAL DOPAMINE RELEASE; VENTRAL TEGMENTAL AREA; DENSE CORE VESICLES; NERVE GROWTH-FACTOR; SUBSTANTIA-NIGRA; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; MEMBRANE-PROTEIN; TIME-COURSE	The release of monoamine neurotransmitters from cell bodies and dendrites has an important role in behavior, but the mechanism (vesicular or nonvesicular) has remained unclear. Because the location of vesicular monoamine transporter 2 (VMAT2) defines the secretory vesicles capable of monoamine release, we have studied its trafficking to assess the potential for monoamine release by exocytosis. In neuroendocrine PC12 cells, VMAT2 localizes exclusively to large dense-core vesicles (LDCVs), and we now show that cytoplasmic signals target VMAT2 directly to LDCVs within the biosynthetic pathway. In neurons, VMAT2 localizes to a population of vesicles that we now find undergo regulated exocytosis in dendrites. Although hippocampal neurons do not express typical LDCV proteins, transfected chromogranins A, B, and brain-derived neurotrophic factor (BDNF) colocalize with VMAT2. VMAT2 thus defines a population of secretory vesicles that mediate the activity-dependent somato-dendritic release of multiple retrograde signals involved in synaptic function, growth, and plasticity.	Univ Calif San Francisco, Sch Med, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Grad Program Cell Biol, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Grad Program Neurosci, 600 16th St, San Francisco, CA 94143 USA.	edwards@itsa.ucsf.edu		Staal, Roland/0000-0002-2857-2241	NIDA NIH HHS [DA10154] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adell A, 1998, BRIT J PHARMACOL, V125, P1361, DOI 10.1038/sj.bjp.0702206; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bergquist F, 2003, BRAIN RES, V973, P81, DOI 10.1016/S0006-8993(03)02555-1; Bergquist F, 2002, BRAIN RES, V950, P245, DOI 10.1016/S0006-8993(02)03047-0; Blagoveshchenskaya AD, 1999, J CELL BIOL, V145, P1419, DOI 10.1083/jcb.145.7.1419; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; Cragg SJ, 1997, J NEUROSCI, V17, P5738; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FISCHERCOLBRIE R, 1993, J NEUROCHEM, V60, P2312, DOI 10.1111/j.1471-4159.1993.tb03520.x; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gnegy ME, 2004, MOL PHARMACOL, V66, P137, DOI 10.1124/mol.66.1.137; Heymach JV, 1996, J BIOL CHEM, V271, P25430, DOI 10.1074/jbc.271.41.25430; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; HURTLEY SM, 1993, J CELL SCI, V106, P649; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; Modderman PW, 1998, BIOCHEM J, V336, P153, DOI 10.1042/bj3360153; Mowla SJ, 1999, J NEUROSCI, V19, P2069; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; PETER D, 1995, J NEUROSCI, V15, P6179; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pothos EN, 2000, J NEUROSCI, V20, P7297; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; SULZER D, 1995, J NEUROSCI, V15, P4102; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THURESONKLEIN A, 1983, NEUROSCIENCE, V10, P245, DOI 10.1016/0306-4522(83)90132-X; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; Travis ER, 1998, ANNU REV BIOPH BIOM, V27, P77, DOI 10.1146/annurev.biophys.27.1.77; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Wasmeier C, 2005, TRAFFIC, V6, P474, DOI 10.1111/j.1600-0854.2005.00292.x; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Zhang CF, 2003, BIOCHEM J, V369, P453, DOI 10.1042/BJ20020827; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	61	62	64	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					619	633		10.1016/j.neuron.2005.09.033	http://dx.doi.org/10.1016/j.neuron.2005.09.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301178	Bronze			2022-12-28	WOS:000233677300015
J	Barria, A; Malinow, R				Barria, A; Malinow, R			NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII	NEURON			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; PROTEIN-KINASE-II; RAT VISUAL-CORTEX; CRITICAL PERIOD; NR2B SUBUNIT; THALAMOCORTICAL SYNAPSES; DIFFERENTIAL ROLES; EPSILON-1 SUBUNIT; HIPPOCAMPAL LTP	Calcium entry through postsynaptic NMDA-Rs and subsequent activation of CaMKII trigger synaptic plasticity in many brain regions. Active CaMKII can bind to NMDA-Rs, but the physiological role of this interaction is not well understood. Here, we test if association between active CaMKII and synaptic NMDA-Rs is required for synaptic plasticity. Switching synaptic NR2B-containing NMDA-Rs that bind CaMKII with high affinity with those containing NR2A, a subunit with low affinity for CaMKII, dramatically reduces LTP. Expression of NR2A with mutations that increase association to active CaMKII recovers LTP. Finally, driving into synapses NR2B with mutations that reduce association to active CaMKII prevents LTP. Spontaneous activity-driven potentiation shows similar results. We conclude that association between active CaMKII and NR2B is required for different forms of synaptic enhancement. The switch from NR2B to NR2A content in synaptic NMDA-Rs normally observed in many brain regions may contribute to reduced plasticity by controlling the binding of active CaMKII.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Barria, A (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	barria@u.washington.edu						Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; Bliss TVP, 2003, PHILOS T ROY SOC B, V358, P607, DOI 10.1098/rstb.2003.1282; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Flint AC, 1997, J NEUROSCI, V17, P2469; ISHII T, 1993, J BIOL CHEM, V268, P2836; Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kohr G, 2003, J NEUROSCI, V23, P10791; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mayadevi M, 2002, BBA-PROTEINS PROTEOM, V1598, P40, DOI 10.1016/S0167-4838(02)00315-1; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	55	511	530	0	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					289	301		10.1016/j.neuron.2005.08.034	http://dx.doi.org/10.1016/j.neuron.2005.08.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242409	Bronze			2022-12-28	WOS:000232838700018
J	Hyun, S; Lee, Y; Hong, ST; Bang, S; Paik, D; Kang, JK; Shin, J; Lee, J; Jeon, K; Hwang, S; Bae, E; Kim, J				Hyun, S; Lee, Y; Hong, ST; Bang, S; Paik, D; Kang, JK; Shin, J; Lee, J; Jeon, K; Hwang, S; Bae, E; Kim, J			Drosophila GPCR Han is a receptor for the circadian clock neuropeptide PDF	NEURON			English	Article							GENE-EXPRESSION; RHYTHMS; TRANSCRIPTION; NEURONS; MELANOGASTER; SYSTEM; IDENTIFICATION; PEPTIDES; VRILLE; PERIOD	The pigment-dispersing factor (PDF) is a neuropeptide controlling circadian behavioral rhythms in Drosophila, but its receptor is not yet known. From a large-scale temperature preference behavior screen in Drosophila, we isolated a P insertion mutant that preferred different temperatures during the day and night. This mutation, which we named han, reduced the transcript level of CG13758. We found that Han was expressed specifically in 13 pairs of circadian clock neurons in the adult brain. han null files showed arrhythmic circadian behavior in constant darkness. The behavioral characteristics of han null mutants were similar to those of pdf null mutants. We also found that PDF binds specifically to S2 cells expressing Han, which results in the elevation of c AMP synthesis. Therefore, we herein propose that Han is a PDF receptor regulating circadian behavioral rhythm through coordination of activities of clock neurons.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; GenExel Inc, Korea Adv Inst Sci & Technol, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 373-1 Guseong Dong, Taejon 305701, South Korea.	kjaeseob@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021	Kang, Jongkyun/0000-0003-0259-110X; Paik, Donggi/0000-0003-1031-0371; Hong, Sung-Tae/0000-0001-5981-4859; Lee, Youngseok/0000-0003-0459-1138				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; ANDERSON MS, 1988, J NEUROSCI, V8, P242; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen B, 1998, GENETICS, V149, P157; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1998, CURR OPIN NEUROBIOL, V8, P652, DOI 10.1016/S0959-4388(98)80095-0; Leal SM, 2002, J NEUROBIOL, V50, P245, DOI 10.1002/neu.10030; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nakamoto H, 2000, MOL BRAIN RES, V76, P93, DOI 10.1016/S0169-328X(99)00335-6; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Brien MA, 1998, J EXP BIOL, V201, P193; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Preston CR, 1996, GENETICS, V144, P1623; RAO KR, 1993, ANN NY ACAD SCI, V680, P78, DOI 10.1111/j.1749-6632.1993.tb19676.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729	47	223	228	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					267	278		10.1016/j.neuron.2005.08.025	http://dx.doi.org/10.1016/j.neuron.2005.08.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242407	Bronze			2022-12-28	WOS:000232838700016
J	Karmarkar, U; Dan, Y				Karmarkar, U; Dan, Y			One circuit, two kinds of timing	NEURON			English	Editorial Material							VISUAL-CORTEX; PLASTICITY	In this issue of Neuron, Gabernet et al. report an elegant series of in vivo and in vitro experiments that dissect a disynaptic circuit dictating the dynamic transition of cortical spiking responses to whisker stimulation from coincidence detection to temporal integration.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Karmarkar, U (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.			Dan, Yang/0000-0002-3818-877X				Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004	8	0	0	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 20	2005	48	2					165	166		10.1016/j.neuron.2005.10.001	http://dx.doi.org/10.1016/j.neuron.2005.10.001			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242395	Bronze			2022-12-28	WOS:000232838700004
J	Tozuka, Y; Fukuda, S; Namba, T; Seki, T; Hisatsune, T				Tozuka, Y; Fukuda, S; Namba, T; Seki, T; Hisatsune, T			GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells	NEURON			English	Article							CORTICAL CIRCUIT FORMATION; GENERATED GRANULE CELLS; RADIAL GLIAL-CELLS; DENTATE GYRUS; PRECURSOR CELLS; PSA-NCAM; PROLIFERATING CELLS; GAMMA OSCILLATIONS; NEUROPEPTIDE-Y; GABA RELEASE	Hippocampal activity influences neurogenesis in the adult dentate gyrus; however, little is known about the involvement of the hippocampal circuitry in this process. In the subgranular zone of the adult dentate gyrus, neurogenesis involves a series of differentiation steps from radial glia-like stem/progenitor (type-1) cells, to transiently amplifying neuronal progenitor (type-2) cells, to postmitotic neurons. In this study, we conducted GFP-targeted recordings of progenitor cells in fresh hippocampal slices from nestin-GFP mice and found that neuronal progenitor (type-2) cells receive active direct neural inputs from the hippocampal circuitry. This input was GABAergic but not glutamatergic. The GABAergic inputs depolarized type-2 cells because of their elevated [Cl-](i). This excitation initiated an increase of [Ca2+](i) and the expression of NeuroD. A BrdU-pulse labeling study with GABA(A)-R agonists demonstrated the promotion of neuronal differentiation via this GABAergic excitation. Thus, it appears that GABAergic inputs to hippocampal progenitor cells promote activity-dependent neuronal differentiation.	Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; Juntendo Univ, Sch Med, Dept Anat, Tokyo 1138421, Japan	University of Tokyo; Juntendo University	Hisatsune, T (corresponding author), Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan.	hisatsune@k.u-tokyo.ac.jp	Hisatsune, Tatsuhiro/Q-7583-2019; Namba, Takashi/AAE-4439-2022; Namba, Takashi/ABF-4571-2020	Namba, Takashi/0000-0003-4875-666X				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Antonopoulos J, 1997, EUR J NEUROSCI, V9, P291, DOI 10.1111/j.1460-9568.1997.tb01399.x; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; BRAGIN A, 1995, J NEUROSCI, V15, P47; CAMERON HA, 1995, J NEUROSCI, V15, P4687; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Dougherty KD, 1999, J NEUROSCI, V19, P10140; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fukuda S, 2003, J NEUROSCI, V23, P9357; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x; Imura T, 2005, CEREB CORTEX, V15, P332, DOI 10.1093/cercor/bhh135; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Kamada M, 2004, EUR J NEUROSCI, V20, P2499, DOI 10.1111/j.1460-9568.2004.03721.x; Katona I, 1999, J NEUROSCI, V19, P4544; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; KNEISLER TB, 1995, HIPPOCAMPUS, V5, P151, DOI 10.1002/hipo.450050302; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Koketsu D, 2003, J NEUROSCI, V23, P937; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MATHERN GW, 1995, J NEUROSCI, V15, P3990; Matsuyama S, 1997, BRAIN RES, V761, P105, DOI 10.1016/S0006-8993(97)00318-1; Mayo W, 2005, NEUROBIOL AGING, V26, P103, DOI 10.1016/j.neurobiolaging.2004.03.013; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mott DD, 1997, J NEUROSCI, V17, P3990; Nacher J, 2001, EUR J NEUROSCI, V13, P512, DOI 10.1046/j.0953-816x.2000.01424.x; Nguyen L, 2003, J NEUROSCI, V23, P3278; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Okada H, 2003, CEREB CORTEX, V13, P749, DOI 10.1093/cercor/13.7.749; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Rosenblum K, 1999, HIPPOCAMPUS, V9, P491, DOI 10.1002/(SICI)1098-1063(1999)9:5<491::AID-HIPO1>3.3.CO;2-M; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seki T, 2002, J NEUROSCI RES, V69, P772, DOI 10.1002/jnr.10366; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yoshida M, 2004, J NEUROBIOL, V60, P166, DOI 10.1002/neu.20003; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	78	566	609	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					803	815		10.1016/j.neuron.2005.08.023	http://dx.doi.org/10.1016/j.neuron.2005.08.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157276	Bronze			2022-12-28	WOS:000232085000009
J	Eshed, Y; Feinberg, K; Poliak, S; Sabanay, H; Sarig-Nadir, O; Spiegel, I; Bermingham, JR; Peles, E				Eshed, Y; Feinberg, K; Poliak, S; Sabanay, H; Sarig-Nadir, O; Spiegel, I; Bermingham, JR; Peles, E			Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; SODIUM-CHANNEL DISTRIBUTION; BETA-IV-SPECTRIN; MYELINATED AXONS; ANKYRIN-BINDING; ADHESION MOLECULES; INITIAL SEGMENTS; K+ CHANNELS; PROTEIN; IDENTIFICATION	Accumulation of Na+ channels at the nodes of Ranvier is a prerequisite for saltatory conduction. In peripheral nerves, clustering of these channels along the axolemma is regulated by myelinating Schwarm cells through a yet unknown mechanism. We report the identification of gliomedin, a glial ligand for neurofascin and NrCAM, two axonal immunoglobulin cell adhesion molecules that are associated with Na+ channels at the nodes of Ranvier. Gliomedin is expressed by myelinating Schwann cells and accumulates at the edges of each myelin segment during development, where it aligns with the forming nodes. Eliminating the expression of gliomedin by RNAi, or the addition of a soluble extracellular domain of neurofascin to myelinating cultures, which caused the redistribution of gliomedin along the internodes, abolished node formation. Furthermore, a soluble gliomedin induced nodal-like clusters of Na+ channels in the absence of Schwarm cells. We propose that gliomedin provides a glial cue for the formation of peripheral nodes of Ranvier.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; McLaughlin Res Inst, Great Falls, MT 59405 USA	Weizmann Institute of Science; McLaughlin Research Institute for Biomedical Sciences, Inc.	Peles, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	peIes@weizmann.ac.il	Spiegel, Ivo/O-4025-2014	Spiegel, Ivo/0000-0003-0979-1358; Peles, Elior/0000-0002-3325-0597	NINDS NIH HHS [NS50220, R01 NS040751] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050220, R01NS040751] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arroyo EJ, 2004, J COMP NEUROL, V479, P424, DOI 10.1002/cne.20321; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Bermingham JR, 2002, J NEUROSCI, V22, P10217; BERTHOLD CH, 1983, J NEUROCYTOL, V12, P475, DOI 10.1007/BF01159386; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BLACK JA, 1988, GLIA, V1, P169, DOI 10.1002/glia.440010302; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carenini S, 1998, GLIA, V22, P213, DOI 10.1002/(SICI)1098-1136(199803)22:3<213::AID-GLIA1>3.0.CO;2-6; Ching W, 1999, J NEUROCYTOL, V28, P295, DOI 10.1023/A:1007053411667; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; Craner MJ, 2003, BRAIN, V126, P1552, DOI 10.1093/brain/awg153; Custer AW, 2003, J NEUROSCI, V23, P10032; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Gatto CL, 2003, J CELL BIOL, V162, P489, DOI 10.1083/jcb.200303039; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Goutebroze L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-29; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graveel CR, 2003, ONCOGENE, V22, P1730, DOI 10.1038/sj.onc.1206309; Hillier BJ, 2003, J CELL BIOL, V160, P597, DOI 10.1083/jcb.200210053; ICHIMURA T, 1991, J NEUROCYTOL, V20, P667, DOI 10.1007/BF01187068; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KOTICHA D, 2005, IN PRESS DEV BIOL; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Lambert S, 1997, J NEUROSCI, V17, P7025; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Mathis C, 2001, DEVELOPMENT, V128, P4881; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Mohler PJ, 2002, J CELL SCI, V115, P1565; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ohlmann A, 2003, GLIA, V43, P128, DOI 10.1002/glia.10233; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; RAINE CS, 1984, J NEUROCYTOL, V13, P21, DOI 10.1007/BF01148316; RAINE CS, 1982, J NEUROCYTOL, V11, P935, DOI 10.1007/BF01148309; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; Scherer SS, 2001, J NEUROSCI RES, V65, P150, DOI 10.1002/jnr.1138; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; TAOCHENG JH, 1983, DEV BRAIN RES, V9, P251, DOI 10.1016/0165-3806(83)90023-8; Tsuda H, 2002, NEURON, V33, P515, DOI 10.1016/S0896-6273(02)00590-1; Vabnick I, 1996, J NEUROSCI, V16, P4914; Vabnick I, 1997, J NEUROSCI RES, V50, P321; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655	70	237	251	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					215	229		10.1016/j.neuron.2005.06.026	http://dx.doi.org/10.1016/j.neuron.2005.06.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039564	Bronze			2022-12-28	WOS:000230693900009
J	Hoshino, M; Nakamura, S; Mori, K; Kawauchi, T; Terao, M; Nishimura, YV; Fukuda, A; Fuse, T; Matsuo, N; Sone, M; Watanabe, M; Bito, H; Terashima, T; Wright, CVE; Kawaguchi, Y; Nakao, K; Nabeshima, YI				Hoshino, M; Nakamura, S; Mori, K; Kawauchi, T; Terao, M; Nishimura, YV; Fukuda, A; Fuse, T; Matsuo, N; Sone, M; Watanabe, M; Bito, H; Terashima, T; Wright, CVE; Kawaguchi, Y; Nakao, K; Nabeshima, YI			Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTORS; KLOTHO GENE; CELL-DEATH; MOUSE; EXPRESSION; RAC1; GROWTH; STEF; IDENTIFICATION; PROLIFERATION	The molecular machinery governing glutamatergic-GABAergic neuronal subtype specification is unclear. Here we describe a cerebellar mutant, cerebelless, which lacks the entire cerebellar cortex in adults. The primary defect of the mutant brains was a specific inhibition of GABAergic neuron production from the cerebellar ventricular zone (VZ), resulting in secondary and complete loss of external germinal layer, pontine, and olivary nuclei during development. We identified the responsible gene, Ptf1a, whose expression was lost in the cerebellar VZ but was maintained in the pancreas in cerebelless. Lineage tracing revealed that two types of neural precursors exist in the cerebellar VZ: Ptf1a-expressing and -nonexpressing precursors, which generate GABAergic and glutamatergic neurons, respectively. Introduction of Ptf1a into glutamatergic neuron precursors in the dorsal telencephalon generated GABAergic neurons with representative morphological and migratory features. Our results suggest that Ptf1a is involved in driving neural precursors to differentiate into GABAergic neurons in the cerebellum.	Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Surg & Surg Basic Sci, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Kobe Univ, Grad Sch Med, Dept Neurosci, Div Anat & Neurobiol, Kobe, Hyogo 6500017, Japan; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Vanderbilt Dev Biol Program, Nashville, TN 37232 USA; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Kyoto University; Columbia University; Kobe University; Vanderbilt University; Hokkaido University; University of Tokyo	Hoshino, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan.	mikio@lmls.med.kyoto-u.ac.jp	WATANABE, Masahiko/A-4055-2012; Sone, Masaki/Q-9058-2019; Kawauchi, Takeshi/L-4770-2013; Mori, Kiyoshi/N-1267-2014; Watanabe, Masahiko/S-3614-2019; Matsuo, Naoki/B-9929-2008; Bito, Haruhiko/A-8635-2008	WATANABE, Masahiko/0000-0001-5037-7138; Kawauchi, Takeshi/0000-0002-8650-4474; Mori, Kiyoshi/0000-0002-7285-8351; Watanabe, Masahiko/0000-0001-5037-7138; Matsuo, Naoki/0000-0003-0988-4706; Bito, Haruhiko/0000-0001-6315-9594				ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Ang ESBC, 2003, J NEUROSCI, V23, P5805; BATINI C, 1992, J COMP NEUROL, V315, P74, DOI 10.1002/cne.903150106; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bennett MR, 2002, AUTON NEUROSCI-BASIC, V95, P1, DOI 10.1016/S1566-0702(01)00358-7; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Chu T, 2000, J NEUROBIOL, V43, P18, DOI 10.1002/(SICI)1097-4695(200004)43:1<18::AID-NEU2>3.0.CO;2-C; COLLINS P, 1995, GRAYS ANATOMY; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Fode C, 2000, GENE DEV, V14, P67; Goldowitz D, 2000, J NEUROSCI, V20, P4129; Gu GQ, 2002, DEVELOPMENT, V129, P2447; HECKROTH JA, 1994, J COMP NEUROL, V343, P173, DOI 10.1002/cne.903430113; Herrup K, 1996, DEV BRAIN RES, V96, P28, DOI 10.1016/0165-3806(96)00069-7; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Hoveyda N, 1999, J MED GENET, V36, P700; Jacobowitz D.M, 1998, CHEMOARCHITECTONIC A; Jankovski A, 1996, EUR J NEUROSCI, V8, P2308, DOI 10.1111/j.1460-9568.1996.tb01194.x; KANEKO T, 1989, NEUROSCIENCE, V32, P79, DOI 10.1016/0306-4522(89)90109-7; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Mathis L, 2003, DEV BIOL, V258, P20, DOI 10.1016/S0012-1606(03)00098-8; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Palay S. L., 1974, CEREBELLAR CORTEX CY; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; PIERCE E T, 1975, Brain Research, V95, P503, DOI 10.1016/0006-8993(75)90124-9; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Sellick GS, 2003, DIABETES, V52, P2636, DOI 10.2337/diabetes.52.10.2636; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Yoshizawa M, 2003, GENE EXPR PATTERNS, V3, P375, DOI 10.1016/S1567-133X(03)00002-4; Yoshizawa M, 2002, MECH DEVELOP, V113, P65, DOI 10.1016/S0925-4773(01)00650-5	53	352	357	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					201	213		10.1016/j.neuron.2005.06.007	http://dx.doi.org/10.1016/j.neuron.2005.06.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039563	Bronze			2022-12-28	WOS:000230693900008
J	Polo-Parada, L; Plattner, F; Bose, C; Landmesser, LT				Polo-Parada, L; Plattner, F; Bose, C; Landmesser, LT			NCAM 180 acting via a conserved C-terminal domain and MLCK is essential for effective transmission with repetitive stimulation	NEURON			English	Article							CELL-ADHESION MOLECULE; MYOSIN-II; SMOOTH-MUSCLE; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; PROTEINS; PHOSPHORYLATION; SEQUENCE; KINASES; VA	NCAM 180 isoform null neuromuscular junctions are unable to effectively mobilize and exocytose synaptic vesicles and thus exhibit periods of total transmission failure during high-frequency repetitive stimulation. We have identified a highly conserved C-terminal (KENESKA) domain on NCAM that is required to maintain effective transmission and demonstrate that it acts via a pathway involving MLCK and probably myosin light chain (MLC) and myosin II. By perfecting a method of introducing peptides into adult NMJs, we tested the hypothesized role of proteins in this pathway by competitive disruption of protein-protein interactions. The effects of KENESKA and other peptides on MLCK and MLC activation and on failures in both wild-type and NCAM 180 null junctions supported this pathway, and serine phosphorylation of KENESKA was critical. We propose that this pathway is required to replenish synaptic vesicles utilized during high levels of exocytosis by facilitating myosindriven delivery of synaptic vesicles to active zones or their subsequent exocytosis.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Landmesser, LT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	lynn.landmesser@case.edu		Polo-Parada, Luis/0000-0002-5221-6060; Plattner, Florian/0000-0002-3150-1866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019640, R01NS023678] Funding Source: NIH RePORTER; NINDS NIH HHS [NS19640, NS23678] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; Brown JR, 2004, J NEUROBIOL, V58, P175, DOI 10.1002/neu.10317; Brown ME, 2004, J NEUROBIOL, V58, P118, DOI 10.1002/neu.10285; Buttner B, 2003, BIOCHEM BIOPH RES CO, V310, P967, DOI 10.1016/j.bbrc.2003.09.105; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Evans LL, 1998, J CELL SCI, V111, P2055; Hinsby AM, 2004, FRONT BIOSCI-LANDMRK, V9, P2227, DOI 10.2741/1393; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Kabouridis PS, 2003, TRENDS BIOTECHNOL, V21, P498, DOI 10.1016/j.tibtech.2003.09.008; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KEMP BE, 1987, J BIOL CHEM, V262, P2542; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297; Kolkova K, 2000, J NEUROSCI, V20, P2238; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; MOCHIDA S, 1995, J PHYSIOLOGY-PARIS, V89, P83, DOI 10.1016/0928-4257(96)80555-9; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rose SD, 2003, J NEUROCHEM, V85, P287, DOI 10.1046/j.1471-4159.2003.01649.x; Rost B, 2000, METH MOL B, V143, P71; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Ryan TA, 1999, J NEUROSCI, V19, P1317; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; Schmidt JT, 2002, J NEUROBIOL, V52, P175, DOI 10.1002/neu.10083; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TANAKA M, 1995, EMBO J, V14, P2839, DOI 10.1002/j.1460-2075.1995.tb07283.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263	49	47	47	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					917	931		10.1016/j.neuron.2005.05.018	http://dx.doi.org/10.1016/j.neuron.2005.05.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953420	Bronze			2022-12-28	WOS:000229922500011
J	Melcher, D; Papathomas, TV; Vidnyanszky, Z				Melcher, D; Papathomas, TV; Vidnyanszky, Z			Implicit attentional selection of bound visual features	NEURON			English	Article							AREA V4; TEMPORAL INTEGRATION; BINDING PROBLEM; MOTION; COLOR; MACAQUE; OBJECT; MODULATION; SPACE; SENSITIVITY	Traditionally, research on visual attention has been focused on the processes involved in conscious, explicit selection of task-relevant sensory input. Recently, however, it has been shown that attending to a specific feature of an object automatically increases neural sensitivity to this feature throughout the visual field. Here we show that directing attention to a specific color of an object results in attentional modulation of the processing of task-irrelevant and not consciously perceived motion signals that are spatio-temporally associated with this color throughout the visual field. Such implicit cross-feature spreading of attention takes place according to the veridical physical associations between the color and motion signals, even under special circumstances when they are perceptually misbound. These results imply that the units of implicit attentional selection are spatio-temporally colocalized feature clusters that are automatically bound throughout the visual field.	Oxford Brookes Univ, Dept Psychol, Oxford OX3 0BP, England; San Raffaele Univ, Fac Psychol, Milan, Italy; Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA; Rutgers State Univ, Vis Res Lab, Piscataway, NJ 08854 USA; Semmelweis Univ, Hungarian Acad Sci, Neurobiol Res Grp, H-1094 Budapest, Hungary; Peter Pazmany Catholic Univ, Fac Informat Technol, H-1083 Budapest, Hungary	Oxford Brookes University; Vita-Salute San Raffaele University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Hungarian Academy of Sciences; Semmelweis University	Melcher, D (corresponding author), Oxford Brookes Univ, Dept Psychol, Oxford OX3 0BP, England.	dmelcher@brookes.ac.uk; vidnyanszky@ana.sote.hu	Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X	NATIONAL EYE INSTITUTE [R01EY013758] Funding Source: NIH RePORTER; NEI NIH HHS [EY 013758-01, R01 EY013758-03] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; CHENG K, 1994, J NEUROPHYSIOL, V71, P2269, DOI 10.1152/jn.1994.71.6.2269; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Duncan J., 1996, ATTENTION PERFORM, P549; FERRERA VP, 1994, J NEUROSCI, V14, P6171; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; Humphrey GK, 1998, CONSCIOUS COGN, V7, P494, DOI 10.1006/ccog.1998.0369; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Melcher D, 2004, VISION RES, V44, P1367, DOI 10.1016/j.visres.2003.11.023; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; MOTTER BC, 1994, J NEUROSCI, V14, P2178; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Pessoa L, 2003, J NEUROSCI, V23, P3990; Raymond JE, 1998, VISION RES, V38, P2863, DOI 10.1016/S0042-6989(98)00145-X; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Schoenfeld MA, 2003, P NATL ACAD SCI USA, V100, P11806, DOI 10.1073/pnas.1932820100; Sohn W, 2004, VISION RES, V44, P1437, DOI 10.1016/j.visres.2003.12.010; Treisman A, 1999, NEURON, V24, P105, DOI 10.1016/S0896-6273(00)80826-0; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wolfe JM, 1999, NEURON, V24, P11, DOI 10.1016/S0896-6273(00)80818-1; Wu DA, 2004, NATURE, V429, P262, DOI 10.1038/429262a; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	32	81	83	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					723	729		10.1016/j.neuron.2005.04.023	http://dx.doi.org/10.1016/j.neuron.2005.04.023			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924859	Green Published, Bronze			2022-12-28	WOS:000229689800007
J	Mileykovskiy, BY; Kiyashchenko, LI; Siegel, JM				Mileykovskiy, BY; Kiyashchenko, LI; Siegel, JM			Behavioral correlates of activity in identified hypocretin/orexin neurons	NEURON			English	Article							DORSAL RAPHE NUCLEUS; FREELY MOVING CATS; HYPOTHALAMIC AROUSAL SYSTEM; MEDIAL PREFRONTAL CORTEX; POWER SPECTRAL-ANALYSIS; SLEEP-WAKING DISCHARGE; VENTRAL TEGMENTAL AREA; OREXIN NEURONS; LOCUS-COERULEUS; RETICULAR-FORMATION	Micropipette recording with juxtacellular Neurobiotin ejection, linked micropipette-microwire recording, and antidromic and orthodromic activation from the ventral tegmental area and locus coeruleus were used to identify hypocretin (Hcrt) cells in anesthetized rats and develop criteria for identification of these cells in unanesthetized, unrestrained animals. We found that Hcrt cells have broad action potentials with elongated later positive deflections that distinguish them from adjacent antidromically identified cells. They are relatively inactive in quiet waking but are transiently activated during sensory stimulation. Hcrt cells are silent in slow wave sleep and tonic periods of REM sleep, with occasional burst discharge in phasic REM. Hcrt cells discharge in active waking and have moderate and approximately equal levels of activity during grooming and eating and maximal activity during exploratory behavior. Our findings suggest that these cells are activated during emotional and sensorimotor conditions similar to those that trigger cataplexy in narcoleptic animals.	Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Vet Adm Greater Los Angeles Healthcare Syst Sepul, North Hills, CA 91343 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Mileykovskiy, BY (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA.	bmileyko@ucla.edu; jsiegel@ucla.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH071350, R01MH064109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014610, R01NS014610] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH064109, MH071350, MH064109, R03 MH071350] Funding Source: Medline; NINDS NIH HHS [R37 NS014610, R01 NS014610, NS14610] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acuna-Goycolea C, 2004, J NEUROSCI, V24, P3013, DOI 10.1523/JNEUROSCI.5416-03.2004; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Baker TL, 1985, BRAIN MECH SLEEP, P199; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; BEYER C, 1971, BRAIN RES, V29, P213, DOI 10.1016/0006-8993(71)90029-1; Borland LM, 2004, J NEUROCHEM, V91, P220, DOI 10.1111/j.1471-4159.2004.02708.x; Brown RE, 2002, J NEUROSCI, V22, P8850; Brown RE, 2001, NEUROPHARMACOLOGY, V40, P457, DOI 10.1016/S0028-3908(00)00178-7; Burlet S, 2002, J NEUROSCI, V22, P2862, DOI 10.1523/JNEUROSCI.22-07-02862.2002; CESPUGLIO R, 1992, J SLEEP RES, V1, P150, DOI 10.1111/j.1365-2869.1992.tb00030.x; CESPUGLIO R, 1990, EXP BRAIN RES, V80, P121; CHANG AYW, 1995, SYNAPSE, V21, P149, DOI 10.1002/syn.890210208; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chu M, 2004, NEUROSCI RES, V49, P417, DOI 10.1016/j.neures.2004.05.001; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Eggermann E, 2003, J NEUROSCI, V23, P1557; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Espana RA, 2005, J COMP NEUROL, V481, P160, DOI 10.1002/cne.20369; Espana RA, 2003, NEUROSCIENCE, V121, P201, DOI 10.1016/S0306-4522(03)00334-8; Espana RA, 2001, NEUROSCIENCE, V106, P699, DOI 10.1016/S0306-4522(01)00319-0; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fadel J, 2002, J NEUROSCI, V22, P6742; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; FINDLAY ALR, 1969, J PHYSIOL-LONDON, V201, P237, DOI 10.1113/jphysiol.1969.sp008753; Fornal CA, 1996, BRAIN RES, V716, P123, DOI 10.1016/0006-8993(96)00006-6; Fu LY, 2004, J NEUROSCI, V24, P8741, DOI 10.1523/JNEUROSCI.2268-04.2004; GLOTZBACH SF, 1987, BRAIN RES, V419, P279, DOI 10.1016/0006-8993(87)90594-4; GUILLEMINAULT C, 1976, NARCOLEPSY, P125; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Horvath TL, 1999, J COMP NEUROL, V415, P145; HOUDOUIN F, 1991, BRAIN RES, V565, P48, DOI 10.1016/0006-8993(91)91735-J; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Izumi T, 1968, Seishin Shinkeigaku Zasshi, V70, P493; JACOBS BL, 1991, J CLIN PSYCHIAT, V52, P17; John J, 2004, NEURON, V42, P619, DOI 10.1016/S0896-6273(04)00247-8; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Korotkova TM, 2003, J NEUROSCI, V23, P7; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Lambe EK, 2003, NEURON, V40, P139, DOI 10.1016/S0896-6273(03)00598-1; LEE M, 2004, DISCHARGE IDENTIFIED; LEVITT DR, 1975, P NATL ACAD SCI USA, V72, P2819, DOI 10.1073/pnas.72.7.2819; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu RJ, 2002, J NEUROSCI, V22, P9453; LUOH HF, 1994, SYNAPSE, V16, P29, DOI 10.1002/syn.890160104; Mathe JM, 1999, NEUROPHARMACOLOGY, V38, P121, DOI 10.1016/S0028-3908(98)00163-4; MITLER MM, 1976, J AM VET MED ASSOC, V168, P1036; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; PARMEGGIANI PL, 1987, BRAIN RES, V415, P79, DOI 10.1016/0006-8993(87)90270-8; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; PORTAS CM, 1994, BRAIN RES, V648, P306, DOI 10.1016/0006-8993(94)91132-0; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SIEGEL JM, 1991, SCIENCE, V252, P1315, DOI 10.1126/science.1925546; SIEGEL JM, 1978, SCIENCE, V199, P207; SIEGEL JM, 1979, BRAIN RES REV, V1, P69, DOI 10.1016/0165-0173(79)90017-1; SIEGEL JM, 1983, J NEUROPHYSIOL, V50, P696, DOI 10.1152/jn.1983.50.3.696; Siegel JM, 2004, ANNU REV PSYCHOL, V55, P125, DOI 10.1146/annurev.psych.55.090902.141545; Siegel JM, 2000, SCI AM, V282, P76, DOI 10.1038/scientificamerican0100-76; Sinnamon HM, 1997, BEHAV BRAIN RES, V89, P289, DOI 10.1016/S0166-4328(97)00089-2; Soffin EM, 2002, NEUROPHARMACOLOGY, V42, P127, DOI 10.1016/S0028-3908(01)00156-3; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; Torterolo P, 2004, SLEEP, V27, P5; Torterolo P, 2003, SLEEP, V26, P25; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; VALENSTEIN ES, 1971, J PSYCHIATR RES, V8, P335, DOI 10.1016/0022-3956(71)90029-X; VALENSTEIN ES, 1970, PSYCHOL REV, V77, P16, DOI 10.1037/h0028581; Vanni-Mercier G, 2003, BEHAV BRAIN RES, V144, P227, DOI 10.1016/S0166-4328(03)00091-3; VANNIMERCIER G, 1984, CR ACAD SCI III-VIE, V298, P195; Veasey SC, 1997, NEUROSCIENCE, V79, P161, DOI 10.1016/S0306-4522(96)00673-2; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; YOSHIDA K, 2004, AFFERENTS OREXIN NEU	83	617	633	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					787	798		10.1016/j.neuron.2005.04.035	http://dx.doi.org/10.1016/j.neuron.2005.04.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924864	Bronze, Green Accepted			2022-12-28	WOS:000229689800012
J	Moulder, KL; Mennerick, S				Moulder, KL; Mennerick, S			Reluctant vesicles coaxed into the limelight	NEURON			English	Editorial Material							POOL	Synapses respond to brief, repetitive stimulation with synaptic depression when initial transmitter release probability is high. Vesicle depletion has been a long-standing hypothesis for depression, but results unexplained by the depletion hypothesis have been nagging. In this issue of Neuron, Xu and Wu show that, under some conditions, calcium current inactivation explains stimulus-dependent depression at the calyx of Held.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Moulder, KL (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.		Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664				Brody DL, 2000, J NEUROSCI, V20, P2480; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Thomson AM, 2003, J COMPUT NEUROSCI, V15, P159, DOI 10.1023/A:1025812808362; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	11	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					523	525		10.1016/j.neuron.2005.05.003	http://dx.doi.org/10.1016/j.neuron.2005.05.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944119	Bronze			2022-12-28	WOS:000229294300002
J	Shepherd, GM				Shepherd, GM			Perception without a thalamus: How does olfaction do it?	NEURON			English	Editorial Material							ORBITOFRONTAL CORTEX; NEURONAL CIRCUITRY; PREFRONTAL CORTEX; BULB; DISCRIMINATION; RECOGNITION; NETWORKS; ODORS; RATS	The olfactory system has generated considerable interest in recent years, mainly focused on receptor genes and early olfactory processing. In this issue of Neuron, Mori et al. focus centrally, providing evidence for slow- and fast-wave states in olfactory cortex that appear to gate the inflow of information underlying conscious smell perception.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Shepherd, GM (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.							BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HABERLY LB, 1985, CHEM SENSES, V10, P219, DOI 10.1093/chemse/10.2.219; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; MUAKAMI M, 2005, NEURON, V48, P285; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; PAGER J, 1974, PHYSIOL BEHAV, V12, P189, DOI 10.1016/0031-9384(74)90172-3; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Shepherd GM, 2005, CHEM SENSES, V30, pI3, DOI 10.1093/chemse/bjh085; SHEPHERD GM, 1991, OLFACTION, P3; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#	17	38	39	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					166	168		10.1016/j.neuron.2005.03.012	http://dx.doi.org/10.1016/j.neuron.2005.03.012			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848795	Bronze			2022-12-28	WOS:000228674800003
J	Dolen, G; Bear, MF				Dolen, G; Bear, MF			Courting a cure for Fragile X	NEURON			English	Editorial Material							MENTAL-RETARDATION; RECEPTORS		MIT, Dept Brain & Cognit Sci, Howard Hughes Med Inst, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Dolen, G (corresponding author), MIT, Dept Brain & Cognit Sci, Howard Hughes Med Inst, Picower Ctr Learning & Memory, E25-618, Cambridge, MA 02139 USA.		Dolen, Gul/J-3073-2015	Dolen, Gul/0000-0003-1780-995X; Bear, Mark/0000-0002-9903-2541	NIMH NIH HHS [F30 MH067431] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH067431] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Hagerman RJ, 2002, FRAGILE X SYNDROME; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Spooren WPJM, 2001, TRENDS PHARMACOL SCI, V22, P331, DOI 10.1016/S0165-6147(00)01694-1; Zhao WF, 2004, J NEUROSCI, V24, P76, DOI 10.1523/JNEUROSCI.4515-03.2004	10	26	32	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					642	644		10.1016/j.neuron.2005.02.021	http://dx.doi.org/10.1016/j.neuron.2005.02.021			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748838	Bronze			2022-12-28	WOS:000227446700002
J	Fang, F; He, S				Fang, F; He, S			Viewer-centered object representation in the human visual system revealed by viewpoint aftereffects	NEURON			English	Article							LATERAL OCCIPITAL COMPLEX; HUMAN EXTRASTRIATE CORTEX; 3-DIMENSIONAL OBJECTS; FUNCTIONAL-ORGANIZATION; RECOGNITION; ORIENTATION; ADAPTATION; FACES; SHAPE; REPETITION	Are there neurons representing specific views of objects in the human visual system? A visual selective adaptation method was used to address this question. After visual adaptation to an object viewed either 15 or 30 degrees from one side, when the same object was subsequently presented near the frontal view, the perceived viewing directions were biased in a direction opposite to that of the adapted viewpoint. This aftereffect can be obtained with spatially nonoverlapping adapting and test stimuli, and it depends on the global representation of the adapting stimuli. Viewpoint aftereffects were found within, but not across, categories of objects tested (faces, cars, wire-like objects). The magnitude of this aftereffect depends on the angular difference between the adapting and test viewing angles and grows with increasing duration of adaptation. These results support the existence of object-selective neurons tuned to specific viewing angles in the human visual system.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	sheng@umn.edu			NATIONAL EYE INSTITUTE [R01EY015261] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015261-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANSTIS SM, 1970, Q J EXP PSYCHOL, V22, P222, DOI 10.1080/00335557043000159; Bar M, 2001, J COGNITIVE NEUROSCI, V13, P793, DOI 10.1162/08989290152541458; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; BIEDERMAN I, 1987, PSYCHOL REV, V85, P249; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Boynton GM, 2003, J NEUROSCI, V23, P8781; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; EDELMAN S, 1992, VISION RES, V32, P2385, DOI 10.1016/0042-6989(92)90102-O; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FINKE RA, 1988, J EXP PSYCHOL LEARN, V14, P112, DOI 10.1037/0278-7393.14.1.112; Foster DH, 2002, P ROY SOC B-BIOL SCI, V269, P1939, DOI 10.1098/rspb.2002.2119; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kohler Wolfgang, 1944, PROC AMER PHIL SOC, V88, P269; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; MATHER G, 1998, MOTION AFTER EFFECT; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MITCHELL DE, 1976, VISION RES, V16, P609, DOI 10.1016/0042-6989(76)90007-9; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; PERRETT DI, 1987, TRENDS NEUROSCI, V10, P358, DOI 10.1016/0166-2236(87)90071-3; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Suzuki S, 2002, NEURON, V36, P143, DOI 10.1016/S0896-6273(02)00934-0; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Troje NF, 1999, PERCEPTION, V28, P483, DOI 10.1068/p2901; ULLMAN S, 1989, COGNITION, V32, P193, DOI 10.1016/0010-0277(89)90036-X; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665	45	130	134	0	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					793	800		10.1016/j.neuron.2005.01.037	http://dx.doi.org/10.1016/j.neuron.2005.01.037			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748853	Bronze			2022-12-28	WOS:000227446700017
J	Roitman, MF; Wheeler, RA; Carelli, RM				Roitman, MF; Wheeler, RA; Carelli, RM			Nucleus Accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output	NEURON			English	Article							REQUIRES PROTEIN-SYNTHESIS; VENTRAL STRIATUM; DOPAMINE; FOOD; MOTIVATION; COCAINE; SHELL; ACTIVATION; RECEPTORS; BEHAVIOR	The nucleus accumbens (NAc) is a key component of the brain's reward pathway, yet little is known of how NAc cells respond to primary rewarding or aversive stimuli. Here, naive rats received brief intraoral infusions of sucrose and quinine paired with cues in a classical conditioning paradigm while the electrophysiological activity of individual NAc neurons was recorded. NAc neurons (102) were typically inhibited by sucrose (39 of 52, 75%) or excited by quinine (30 of 40, 75%) infusions. Changes in firing rate were correlated with the oromotor response to intraoral infusions. Most taste-responsive neurons responded to only one of the stimuli. NAc neurons developed responses to the cues paired with sucrose and quinine. Thus, NAc neurons are innately tuned to rewarding and aversive stimuli and rapidly develop responses to predictive cues. The results indicate that the output of the NAc is very different when rats taste rewarding versus aversive stimuli.	Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Carelli, RM (corresponding author), Univ N Carolina, Dept Psychol, CB 3270, Chapel Hill, NC 27599 USA.	rcarelli@unc.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014339] Funding Source: NIH RePORTER; NIDA NIH HHS [DA14339] Funding Source: Medline; NINDS NIH HHS [NS11152] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Carelli RM, 2003, J NEUROSCI, V23, P11214; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Carelli RM, 2000, J NEUROSCI, V20, P4255; CARELLI RM, 1994, J NEUROSCI, V14, P7735; CHANG JY, 1994, J NEUROSCI, V14, P1224, DOI 10.1523/JNEUROSCI.14-03-01224.1994; de Borchgrave R, 2002, EXP BRAIN RES, V144, P50, DOI 10.1007/s00221-002-1031-y; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; KAPLAN JM, 1995, NEUROSCI BIOBEHAV R, V19, P89, DOI 10.1016/0149-7634(94)00023-T; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kelley AE, 1997, BEHAV BRAIN RES, V89, P107, DOI 10.1016/S0166-4328(97)00054-5; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nicola SM, 2004, J NEUROPHYSIOL, V91, P1840, DOI 10.1152/jn.00657.2003; Nicola SM, 2004, J NEUROPHYSIOL, V91, P1866, DOI 10.1152/jn.00658.2003; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; NICOLELIS MAL, 1999, CRC METH NEUROSCI S, P121; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pecina S, 2000, BRAIN RES, V863, P71, DOI 10.1016/S0006-8993(00)02102-8; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Reynolds SM, 2002, J NEUROSCI, V22, P7308; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Roop RG, 2002, SYNAPSE, V43, P223, DOI 10.1002/syn.10041; Salamone JD, 2003, J PHARMACOL EXP THER, V305, P1, DOI 10.1124/jpet.102.035063; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Schafe GE, 1996, BRAIN RES, V741, P109, DOI 10.1016/S0006-8993(96)00906-7; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Stratford TR, 1997, J NEUROSCI, V17, P4434; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; TRAVERS JB, 1986, BEHAV NEUROSCI, V100, P544, DOI 10.1037/0735-7044.100.4.544; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zhang M, 1997, PSYCHOPHARMACOLOGY, V132, P350, DOI 10.1007/s002130050355	44	309	312	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					587	597		10.1016/j.neuron.2004.12.055	http://dx.doi.org/10.1016/j.neuron.2004.12.055			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721244	Bronze, Green Published			2022-12-28	WOS:000227099700014
J	Priebe, NJ; Ferster, D				Priebe, NJ; Ferster, D			Direction selectivity of excitation and inhibition in simple cells of the cat primary visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY AUDITORY-CORTEX; STRIATE CORTEX; ORIENTATION SELECTIVITY; SYNAPTIC POTENTIALS; RECEPTIVE-FIELDS; CORTICAL-NEURONS; QUADRATURE SUBUNITS; CONTRAST INVARIANCE; LINEAR MECHANISMS	Direction selectivity in simple cells of primary visual cortex, defined from their spike responses, cannot be predicted using linear models. It has been suggested that the shunting inhibition evoked by visual stimulation is responsible for the nonlinear component of direction selectivity. Cortical inhibition would suppress a neuron's firing when stimuli move in the nonpreferred direction, but would allow responses to stimuli in the preferred direction. Models of direction selectivity based solely on input from the lateral geniculate nucleus, however, propose that the nonlinear response is caused by spike threshold. By extracting excitatory and inhibitory components of synaptic inputs from intracellular records obtained in vivo, we demonstrate that excitation and inhibition are tuned for the same direction, but differ in relative timing. Further, membrane potential responses combine in a linear fashion. Spike threshold, however, quantitatively accounts for the nonlinear component of direction selectivity, amplifying the direction selectivity of spike output relative to that of synaptic inputs.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Priebe, NJ (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	nico@northwestern.edu			NEI NIH HHS [EY-014499, EY-04726] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY014499, R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anderson JC, 1999, NAT NEUROSCI, V2, P820, DOI 10.1038/12194; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Baker CL, 2001, VISUAL NEUROSCI, V18, P465, DOI 10.1017/S0952523801183136; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Contreras D, 2003, J NEUROSCI, V23, P6936; Conway BR, 2003, J NEUROPHYSIOL, V89, P2726, DOI 10.1152/jn.00550.2002; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Emerson RC, 1997, VISUAL NEUROSCI, V14, P373, DOI 10.1017/S0952523800011494; Emerson RC, 1997, VISUAL NEUROSCI, V14, P357, DOI 10.1017/S0952523800011482; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GRZYWACZ NM, 1987, SYNAPSE, V1, P417, DOI 10.1002/syn.890010506; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rall W, 1964, NEURAL THEORY MODELI, P73; REICHARDT W, 1983, BIOL CYBERN, V46, P1, DOI 10.1007/BF00595226; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; Rieke F., 1997, SPIKES EXPLORING NEU; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; SAUL AB, 1995, VISUAL NEUROSCI, V12, P191, DOI 10.1017/S0952523800007872; Sokal R.R., 2012, BIOMETRY; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; Troyer TW, 1998, J NEUROSCI, V18, P5908; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	49	188	190	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					133	145		10.1016/j.neuron.2004.12.024	http://dx.doi.org/10.1016/j.neuron.2004.12.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629708	Bronze			2022-12-28	WOS:000226217100015
J	Dhillon, H; Zigman, JM; Ye, CP; Lee, CE; McGovern, RA; Tang, VS; Kenny, CD; Christiansen, LM; White, RD; Edelstein, EA; Coppari, R; Balthasar, N; Cowley, MA; Chua, S; Elmquist, JK; Lowelll, BB				Dhillon, H; Zigman, JM; Ye, CP; Lee, CE; McGovern, RA; Tang, VS; Kenny, CD; Christiansen, LM; White, RD; Edelstein, EA; Coppari, R; Balthasar, N; Cowley, MA; Chua, S; Elmquist, JK; Lowelll, BB			Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; ARCUATE NUCLEUS; POMC NEURONS; OBESITY; BRAIN; HYPOTHALAMUS; EXPRESSION	Leptin, an adipocyte-derived hormone, acts directly on the brain to control food intake and energy expenditure. An important question is the identity of first-order neurons initiating leptin's anti-obesity effects. A widely held view is that most, if not all, of leptin's effects are mediated by neurons located in the arcuate nucleus of the hypothalamus. However, leptin receptors (LEPRs) are expressed in other sites as well, including the ventromedial hypothalamus (VMH). The possible role of leptin acting in "nonarcuate" sites has largely been ignored. In the present study, we show that leptin depolarizes and increases the firing rate of steroidogenic factor-1 (SF1)-positive neurons in the VMH. We also show, by generating mice that lack LEPRs on SF1-positive neurons, that leptin action at this site plays an important role in reducing body weight and, of note, in resisting diet-induced obesity. These results reveal a critical role for leptin action on VMH neurons.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Program Neurosci, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Oregon Hlth & Sci Univ, Oregon Reg Primate Res Ctr, Div Neurosci, Portland, OR 97006 USA; Albert Einstein Coll Med, Dept Med, New York, NY 10461 USA; Albert Einstein Coll Med, Dept Neurosci, New York, NY 10461 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Oregon Health & Science University; Oregon National Primate Research Center; Yeshiva University; Yeshiva University	Elmquist, JK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, 99 Brookline Ave, Boston, MA 02215 USA.	jelmquis@bidmc.harvard.edu; blowell@bidmc.harvard.edu	Coppari, Roberto/B-4799-2014; Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; COPPARI, Roberto/0000-0003-1288-6948; Zigman, Jeffrey/0000-0003-3477-1295	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053301, P01DK056116, T32DK007516, F32DK064564, R37DK053301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK53301-07S2, 5T32DK07516, DK53301, 1F32DK64564-01, P01 DK56116] Funding Source: Medline; NIMH NIH HHS [MH61583] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dellovade TL, 2000, J COMP NEUROL, V423, P579, DOI 10.1002/1096-9861(20000807)423:4<579::AID-CNE4>3.0.CO;2-#; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 2000, FRONT HORM RES, V26, P21; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; GOLD RM, 1973, SCIENCE, V182, P488, DOI 10.1126/science.182.4111.488; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McMinn JE, 2004, MAMM GENOME, V15, P677, DOI 10.1007/s00335-004-2340-1; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Seeley RJ, 1999, ACTA PAEDIATR, V88, P58, DOI 10.1111/j.1651-2227.1999.tb14352.x; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	54	573	578	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					191	203		10.1016/j.neuron.2005.12.021	http://dx.doi.org/10.1016/j.neuron.2005.12.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423694	Bronze			2022-12-28	WOS:000234979900007
J	Adesnik, H; Nicoll, RA; England, PM				Adesnik, H; Nicoll, RA; England, PM			Photoinactivation of native AMPA receptors reveals their real-time trafficking	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; BINDING; REDISTRIBUTION; DEGRADATION; EXPRESSION; PLASTICITY; ANTIBODY; GLUR2; CELLS	AMPA receptors mediate the majority of the fast excitatory transmission in the central nervous system. Much evidence suggests that the fast trafficking of AMPA receptors into and out of the postsynaptic membrane underlies changes in synaptic strength thought to be necessary for higher cognitive functions such as learning and memory. Despite the abundance of research conducted in this area, a direct, real-time functional assay that measures the trafficking of native AMPA receptors has been lacking. Toward this aim, we use a photoreactive, irreversible antagonist of AMPA receptors, ANQX, to rapidly silence surface AMPA receptors and investigate directly the trafficking of native AMPA receptors in real time. We find that the most dynamic movement of AMPA receptors occurs by lateral movement across the surface of neurons. Fast cycling of surface AMPA receptors with receptors from internal stores does occur but exclusively at extra-synaptic somatic sites. The cycling of synaptic AMPA receptors only occurs on a much longer timescale with complete exchange requiring at least 16 hr. This cycling is not dependent on protein synthesis or action potential driven network activity. These data suggest a revised model of AMPA receptor trafficking wherein a large internal store of AMPA receptors exchanges rapidly with extrasynaptic somatic AMPA receptors, and these newly inserted AMPA receptors then travel laterally along dendrites to reside stably at synapses.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu; england@picasso.ucsf.edu						Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bouron A, 1997, FEBS LETT, V404, P221, DOI 10.1016/S0014-5793(97)00135-X; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chambers JJ, 2004, J AM CHEM SOC, V126, P13886, DOI 10.1021/ja048331p; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GRUNFELD C, 1984, P NATL ACAD SCI-BIOL, V81, P2508, DOI 10.1073/pnas.81.8.2508; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KLECKNER NW, 1989, MOL PHARMACOL, V36, P430; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Tovar KR, 2002, NEURON, V34, P253; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WEISSMAN AM, 1986, J CELL BIOL, V102, P951, DOI 10.1083/jcb.102.3.951; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	35	173	183	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					977	985		10.1016/j.neuron.2005.11.030	http://dx.doi.org/10.1016/j.neuron.2005.11.030			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364901	Bronze			2022-12-28	WOS:000234301700013
J	Cang, JH; Kaneko, M; Yamada, J; Woods, G; Stryker, MP; Feldheim, DA				Cang, JH; Kaneko, M; Yamada, J; Woods, G; Stryker, MP; Feldheim, DA			Ephrin-As guide the formation of functional maps in the visual cortex	NEURON			English	Article							THALAMOCORTICAL PROJECTIONS; GENE-TRANSFER; MULTIPLE ROLES; CORTICAL AREAS; RECEPTORS; NEOCORTEX; SPECIFICATION; EMX2; MECHANISMS; GUIDANCE	Ephrin-As and their receptors, EphAs, are expressed in the developing cortex where they may act to organize thalamic inputs. Here, we map the visual cortex (V1) in mice deficient for ephrin-A2, -A3, and -A5 functionally, using intrinsic signal optical imaging and microelectrode recording, and structurally, by anatomical tracing of thalamocortical projections. V1 is shifted medially, rotated, and compressed and its internal organization is degraded. Expressing ephrin-A5 ectopically by in utero electroporation in the lateral cortex shifts the map of V1 medially, and expression within V1 disrupts its internal organization. These findings indicate that interactions between gradients of EphA/ephrin-A in the cortex guide map formation, but that factors other than redundant ephrin-As are responsible for the remnant map. Together with earlier work on the retinogeniculate map, the current findings show that the same molecular interactions may operate at successive stages of the visual pathway to organize maps.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu; feldheim@biology.ucsc.edu		Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [EY02874, R01 EY014689, R37 EY002874, R01 EY002874, EY014689, R37 EY002874-24S1] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874, R01EY014689, R01EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hashimoto M, 2004, J NEUROSCI, V24, P286, DOI 10.1523/JNEUROSCI.2529-03.2004; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Molnar Z, 1998, J NEUROSCI, V18, P5723; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Shimogori T, 2005, J NEUROSCI, V25, P6550, DOI 10.1523/JNEUROSCI.0453-05.2005; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Uziel D, 2002, J NEUROSCI, V22, P9352; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	49	137	138	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					577	589		10.1016/j.neuron.2005.10.026	http://dx.doi.org/10.1016/j.neuron.2005.10.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301175	Bronze, Green Accepted			2022-12-28	WOS:000233677300012
J	Balannik, V; Menniti, FS; Paternain, AV; Lerma, J; Stern-Bach, Y				Balannik, V; Menniti, FS; Paternain, AV; Lerma, J; Stern-Bach, Y			Molecular mechanism of AMPA receptor noncompetitive antagonism	NEURON			English	Article							LIGAND-BINDING DOMAIN; GLUTAMATE-RECEPTOR; ION CHANNELS; HIPPOCAMPAL-NEURONS; FUNCTIONAL-CHARACTERIZATION; KAINATE RECEPTORS; TERMINAL DOMAIN; POINT MUTATION; DESENSITIZATION; CYCLOTHIAZIDE	AMPA-type glutamate receptors are specifically inhibited by the noncompetitive antagonists GYKI-53655 and CP-465,022, which act through sites and mechanisms that are not understood. Using receptor mutagenesis, we found that these antagonists bind at the interface between the S1 and S2 glutamate binding core and channel transmembrane domains, specifically interacting with S1-M1 and S2-M4 linkers, thereby disrupting the transduction of agonist binding into channel opening. We also found that the antagonists' affinity is higher for agonist-unbound receptors than for activated nondesensitized receptors, further depending on the level of S1 and S2 domain closure. These results provide evidence for substantial conformational changes in the S1-M1 and S2-M4 linkers following agonist binding and channel opening, offering a conceptual frame to account for noncompetitive antagonism of AMPA receptors.	Hebrew Univ Jerusalem, Hadassah Dent Sch, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel; CNS Discovery, Pfizer Global Res & Dev, Groton, CT 06340 USA; UMH, CSIC, Inst Neurosci Alicante, Alacant 03550, Spain	Hebrew University of Jerusalem; Pfizer; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Stern-Bach, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Dent Sch, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel.	yaelb@cc.huji.ac.il	Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199; Menniti, Frank/0000-0003-2612-9534				Abele R, 1999, BIOCHEMISTRY-US, V38, P10949, DOI 10.1021/bi982928y; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; De Luca Laura, 2003, Farmaco (Lausanne), V58, P107, DOI 10.1016/S0014-827X(02)00027-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Donevan SD, 1998, NEUROSCIENCE, V87, P615, DOI 10.1016/S0306-4522(98)00109-2; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Franciosi S, 2001, CELL MOL LIFE SCI, V58, P921, DOI 10.1007/PL00000911; Herin GA, 2004, EUR J PHARMACOL, V500, P101, DOI 10.1016/j.ejphar.2004.07.015; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Lazzaro JT, 2002, NEUROPHARMACOLOGY, V42, P143, DOI 10.1016/S0028-3908(01)00170-8; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McFeeters RL, 2004, FASEB J, V18, P428, DOI 10.1096/fj.03-0873rev; Menniti FS, 2000, MOL PHARMACOL, V58, P1310, DOI 10.1124/mol.58.6.1310; Minami K, 1998, J BIOL CHEM, V273, P8248, DOI 10.1074/jbc.273.14.8248; PALMER AJ, 1993, EUR J PHARM-MOLEC PH, V244, P193, DOI 10.1016/0922-4106(93)90027-7; Partin KM, 1996, MOL PHARMACOL, V49, P142; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Paternain AV, 2003, J NEUROSCI, V23, P8641; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Rammes G, 1998, NEUROPHARMACOLOGY, V37, P1299, DOI 10.1016/S0028-3908(98)00111-7; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Sobolevsky AI, 2002, BIOPHYS J, V83, P3304, DOI 10.1016/S0006-3495(02)75331-9; Solyom S, 2002, CURR PHARM DESIGN, V8, P913, DOI 10.2174/1381612024607081; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; TARNAWA I, 1992, ACTA PHYSIOL HUNG, V79, P163; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	48	87	89	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					279	288		10.1016/j.neuron.2005.09.024	http://dx.doi.org/10.1016/j.neuron.2005.09.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242408	Bronze			2022-12-28	WOS:000232838700017
J	Barco, A; Patterson, S; Alarcon, JM; Gromova, P; Mata-Roig, M; Morozov, A; Kandell, ER				Barco, A; Patterson, S; Alarcon, JM; Gromova, P; Mata-Roig, M; Morozov, A; Kandell, ER			Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture	NEURON			English	Article							LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; CLASS-I MHC; NEUROTROPHIC FACTOR; MOLECULAR-MECHANISMS; NEUROTRANSMITTER RELEASE; TRANSCRIPTION FACTOR; PRODYNORPHIN GENE; NMDA RECEPTOR; LATE-PHASE	Expression of VP16-CREB, a constitutively active form of CREB, in hippocampal neurons of the CA1 region lowers the threshold for eliciting the late, persistent phase of long-term potentiation (L-LTP) in the Schaffer collateral pathway. This VP16-CREB-mediated L-LTP differs from the conventional late phase of LTP in not being dependent on new transcription. This finding suggests that in the transgenic mice the mRNA transcript(s) encoding the protein(s) necessary for this form of L-LTP might already be present in CA1 neurons in the basal condition. We used highdensity oligonucleotide arrays to identify the mRNAs differentially expressed in the hippocampus of transgenic and wild-type mice. We then explored the contribution of the most prominent candidate genes revealed by our screening, namely prodynorphin, BDNF, and MHC class I molecules, to the facilitated LTP of VP16-CREB mice. We found that the overexpression of brain-derived neurotrophic factor accounts for an important component of this phenotype.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; Univ Miguel Hernandez, Inst Neurociencias Alicante, Alicante 03550, Spain; Univ Valencia, Fac Med, Unidad Cent Invest, Valencia 46010, Spain; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Valencia; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Barco, A (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	abarco@umh.es	Gener, Petra/AAD-5770-2019; Barco, Angel/C-3062-2008; Morcillo, Esteban/I-1552-2015; Roig, Manuel Mata/G-4338-2015; Barco, Angel/ABF-1864-2021	Barco, Angel/0000-0002-0653-3751; Morcillo, Esteban/0000-0003-4373-9457; Roig, Manuel Mata/0000-0002-1506-7983; Barco, Angel/0000-0002-0653-3751; Gener, Petra/0000-0002-2250-570X				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alder J, 2005, J NEUROSCI, V25, P3080, DOI 10.1523/JNEUROSCI.2970-04.2005; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/14728222.7.1.101; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CAUDLE RM, 1994, J NEUROSCI, V14, P5580; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; COLLINSHICOK J, 1994, MOL CELL BIOL, V14, P2837, DOI 10.1128/MCB.14.5.2837; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hayes VY, 1997, MOL BRAIN RES, V45, P189, DOI 10.1016/S0169-328X(96)00254-9; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Ishiguro N, 1998, J IMMUNOL, V160, P5907; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Manabe T, 2002, SCIENCE, V295, P1651, DOI 10.1126/science.1070163; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; Shieh PB, 1999, J NEUROBIOL, V41, P127, DOI 10.1002/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J; SHUKLA VK, 1994, TRENDS PHARMACOL SCI, V15, P420, DOI 10.1016/0165-6147(94)90091-4; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; TERMAN GW, 1994, J NEUROSCI, V14, P4740; Timmusk T, 1999, J BIOL CHEM, V274, P1078; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Tyler WJ, 2002, NEUROSCIENTIST, V8, P524, DOI 10.1177/1073858402238511; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P4; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	48	204	211	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					123	137		10.1016/j.neuron.2005.09.005	http://dx.doi.org/10.1016/j.neuron.2005.09.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202713	Bronze			2022-12-28	WOS:000232625700014
J	Prybylowski, K; Chang, K; Sans, N; Kan, LL; Vicini, S; Wenthold, RJ				Prybylowski, K; Chang, K; Sans, N; Kan, LL; Vicini, S; Wenthold, RJ			The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2	NEURON			English	Article							D-ASPARTATE RECEPTOR; MEDIATED TYROSINE PHOSPHORYLATION; LONG-TERM POTENTIATION; NR2B SUBUNIT; GLUTAMATE RECEPTORS; CORTICAL-NEURONS; TRAFFICKING; AMPA; ORGANIZATION; INHIBITION	The NMDA receptor (NMDAR) is a component of excitatory synapses and a key participant in synaptic plasticity. We investigated the role of two domains in the C terminus of the NR2B subunit-the PDZ binding domain and the clathrin adaptor protein (AP-2) binding motif-in the synaptic localization of NMDA receptors. NR2B subunits lacking functional PDZ binding are excluded from the synapse. Mutations in the AP-2 binding motif, YEKL, significantly increase the number of synaptic receptors and allow the synaptic localization of NR2B subunits lacking PDZ binding. Peptides corresponding to YEKL increase the synaptic response within minutes. In contrast, the NR2A subunit localizes to the synapse in the absence of PDZ binding and is not altered by mutations in its motif corresponding to YEKL of NR2B. This study identifies a dynamic regulation of synaptic NR2B-containing NMDARs through PDZ protein-mediated stabilization and AP-2-mediated internalization that is modulated by phosphorylation by Fyn kinase.	Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Georgetown University	Prybylowski, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Room 4148 Bldg 50, Bethesda, MD 20892 USA.	prybylow@nidcd.nih.gov	Sans, Nathalie/N-7008-2017	Sans, Nathalie/0000-0001-7658-2471; Vicini, Stefano/0000-0001-8671-5194	NIDCD NIH HHS [Z01 DC000003-17] Funding Source: Medline; NINDS NIH HHS [R01 NS047700, R01 NS047700-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Clark BA, 1997, J NEUROSCI, V17, P107, DOI 10.1523/JNEUROSCI.17-01-00107.1997; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Follesa P, 1996, J BIOL CHEM, V271, P13297, DOI 10.1074/jbc.271.23.13297; Guo W, 2002, J NEUROSCI, V22, P6208; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Townsend M, 2003, P NATL ACAD SCI USA, V100, P1340, DOI 10.1073/pnas.0335786100; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7	61	288	297	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					845	857		10.1016/j.neuron.2005.08.016	http://dx.doi.org/10.1016/j.neuron.2005.08.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157279	Green Accepted, Bronze			2022-12-28	WOS:000232085000012
J	Zylka, MJ				Zylka, MJ			Nonpeptidergic circuits feel your pain	NEURON			English	Editorial Material							PATHWAYS	Pain consists of both a sensory component and an affective component. In this issue of Neuron, Braz and colleagues genetically targeted the transneuronal tract tracer wheat germ agglutinin (WGA) to nonpeptidergic nociceptive neurons. They found that these neurons give rise to a specialized multisynaptic circuit that links pain signals in the periphery to limbic/affective regions of the brain.	Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; California Institute of Technology	Zylka, MJ (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA.							Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jasmin L, 1997, J NEUROSCI, V17, P3751; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Shimizu I, 2005, PAIN, V116, P96, DOI 10.1016/j.pain.2005.03.030; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	11	21	22	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					771	772		10.1016/j.neuron.2005.09.003	http://dx.doi.org/10.1016/j.neuron.2005.09.003			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157268	Bronze			2022-12-28	WOS:000232085000001
J	Egea, J; Nissen, UV; Dufour, A; Sahin, M; Greer, P; Kullander, K; Mrsic-Flogel, TD; Greenberg, ME; Kiehn, O; Vanderhaeghen, P; Klein, R				Egea, J; Nissen, UV; Dufour, A; Sahin, M; Greer, P; Kullander, K; Mrsic-Flogel, TD; Greenberg, ME; Kiehn, O; Vanderhaeghen, P; Klein, R			Regulation of EphA4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function	NEURON			English	Article							CENTRAL PATTERN GENERATORS; NEONATAL-RAT; SPINAL-CORD; THALAMOCORTICAL PROJECTIONS; TYROSINE KINASES; ACTIVATION; DOMAIN; MECHANISMS; ATTACHMENT; EPHRIN-B3	Signaling by receptor tyrosine kinases (RTKs) is mediated by their intrinsic kinase activity. Typically, kinase-activating mutations result in ligand-independent signaling and gain-of-function phenotypes. Like other RTKs, Ephs require kinase activity to signal, but signaling by Ephs in vitro also requires clustering by their membrane bound ephrin ligands. The relative importance of Eph kinase activity and clustering for in vivo functions is unknown. We find that knockin mice expressing a mutant form of EphA4 (EphA4(EE)), whose kinase is constitutively activated in the absence of ephrinB ligands, are deficient in the development of thalamocortical projections and some aspects of central pattern generator rhythmicity. Surprisingly, other functions of EphA4 were regulated normally by EphA4(EE), including midline axon guidance, hindlimb locomotion, in vitro growth cone collapse, and phosphorylation of ephexin1. These results suggest that signaling of Eph RTKs follows a multistep process of induced kinase activity and higher-order clustering different from RTKs responding to soluble ligands.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Univ Brussels, Inst Rech Interdisciplinaires Biol Humaine & Mol, B-1070 Brussels, Belgium; Harvard Univ, Sch Med, Dept Neurol, Childrens Hosp, Boston, MA 02115 USA; Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden	Max Planck Society; Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard Medical School; Uppsala University	Klein, R (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	rklein@neuro.mpg.de	kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019; Egea, Joaquim/AAT-1984-2021; SAHIN, MUSTAFA/I-8653-2019; Egea, Joaquim/A-7501-2010; Klein, Ruediger/C-6147-2008; Kiehn, Ole/C-4679-2008	SAHIN, MUSTAFA/0000-0001-7044-2953; Klein, Ruediger/0000-0002-3109-0163; Mrsic-Flogel, Tom/0000-0002-8947-408X; Vanderhaeghen, Pierre/0000-0001-7899-5720; Egea Navarro, Joaquim/0000-0002-1164-8377; Kiehn, Ole/0000-0002-5954-469X; Kullander, Klas/0000-0001-6418-5460	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045500] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bardelli A, 1998, P NATL ACAD SCI USA, V95, P14379, DOI 10.1073/pnas.95.24.14379; BECKER N, 1995, FEBS LETT, V368, P353, DOI 10.1016/0014-5793(95)00652-P; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Chen LI, 1997, J CELL BIOL, V137, P619, DOI 10.1083/jcb.137.3.619; Chiarugi P, 2004, ONCOGENE, V23, P3905, DOI 10.1038/sj.onc.1207508; Cowan CA, 2004, DEV BIOL, V271, P263, DOI 10.1016/j.ydbio.2004.03.026; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Irusta PM, 1998, EMBO J, V17, P6912, DOI 10.1093/emboj/17.23.6912; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Kremer E, 1997, J NEUROPHYSIOL, V77, P1155, DOI 10.1152/jn.1997.77.3.1155; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasini A, 1997, ONCOGENE, V15, P393, DOI 10.1038/sj.onc.1201199; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	41	99	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					515	528		10.1016/j.neuron.2005.06.029	http://dx.doi.org/10.1016/j.neuron.2005.06.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102535	Bronze			2022-12-28	WOS:000231411100009
J	Storm, EE; Tecott, LH				Storm, EE; Tecott, LH			Social circuits: Peptidergic regulation of mammalian social behavior	NEURON			English	Review							PARTNER PREFERENCE; MICROTUS-OCHROGASTER; PRAIRIE VOLES; OXYTOCIN; VASOPRESSIN; RECOGNITION; GENE; RATS; EXPRESSION; RELEASE	Mammals have developed patterns of social relationships that enhance the survival of individuals and maximize the reproductive success of species. Although social stimuli and social responses are highly complex, recent studies are providing substantial insights into their neural substrates. Neural pathways employing the nonapeptides vasopressin and oxytocin play a particularly prominent role both in social recognition and the expression of appropriate social responses. New insights into social neuroscience are discussed, along with the relevance of this rapidly developing field to human relationships and disease processes.	Univ Calif San Francisco, Sch Med, Dept Psychiat, Ctr Neurobiol & Psychiat,Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Tecott, LH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Psychiat, Ctr Neurobiol & Psychiat,Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	tecott@itsa.ucsf.edu						Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; Engelmann M, 1996, NEUROSCI BIOBEHAV R, V20, P341, DOI 10.1016/0149-7634(95)00059-3; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Wigger A, 2004, NEUROPSYCHOPHARMACOL, V29, P1, DOI 10.1038/sj.npp.1300290; WILLIAMS JR, 1994, J NEUROENDOCRINOL, V6, P247, DOI 10.1111/j.1365-2826.1994.tb00579.x; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Young LJ, 1997, BEHAV NEUROSCI, V111, P599, DOI 10.1037/0735-7044.111.3.599; Young WS, 1996, J NEUROENDOCRINOL, V8, P847, DOI 10.1046/j.1365-2826.1996.05266.x	27	55	56	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					483	486		10.1016/j.neuron.2005.08.004	http://dx.doi.org/10.1016/j.neuron.2005.08.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102531	Bronze			2022-12-28	WOS:000231411100005
J	Bae, BI; Xu, H; Igarashi, S; Fujimuro, M; Agrawal, N; Taya, Y; Hayward, SD; Moran, TH; Montell, C; Ross, CA; Snyder, SH; Sawa, A				Bae, BI; Xu, H; Igarashi, S; Fujimuro, M; Agrawal, N; Taya, Y; Hayward, SD; Moran, TH; Montell, C; Ross, CA; Snyder, SH; Sawa, A			p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; N-TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE PATHOGENESIS; TRANSCRIPTIONAL ACTIVATOR; NUCLEAR-LOCALIZATION; PREPULSE INHIBITION; STRIATAL CELLS	We present evidence for a specific role of p53 in the mitochondria-associated cellular dysfunction and behavioral abnormalities of Huntington's disease (HD). Mutant huntingtin (mHtt) with expanded polyglutamine (polyQ) binds to p53 and upregulates levels of nuclear p53 as well as p53 transcriptional activity in neuronal cultures. The augmentation is specific, as it occurs with mHtt but not mutant ataxin-1 with expanded polyQ. p53 levels are also increased in the brains of mHtt transgenic (mHtt-Tg) mice and HD patients. Perturbation of p53 by pifithrin-alpha, RNA interference, or genetic deletion prevents mitochondrial membrane depolarization and cytotoxicity in HD cells, as well as the decreased respiratory complex IV activity of mHtt-Tg mice. Genetic deletion of p53 suppresses neurodegeneration in mHtt-Tg flies and neurobehavioral abnormalities of mHtt-Tg mice. Our findings suggest that p53 links nuclear and mitochondrial pathologies characteristic of HD.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Natl Canc Ctr, Res Inst, Radiobiol Div, Tokyo 1040045, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Cancer Center - Japan	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	asawa1@jhmi.edu	Xu, Hong/H-9997-2016; Ross, Christopher A/H-8395-2013; Fujimuro, Masahiro/AAC-4727-2020; Montell, Craig/AAH-3357-2021	Xu, Hong/0000-0003-1049-1184; Montell, Craig/0000-0001-5637-1482; Fujimuro, Masahiro/0000-0002-5165-0789; BAE, BYOUNG-IL/0000-0002-9958-678X	NEI NIH HHS [EY08117] Funding Source: Medline; NIDA NIH HHS [DA-00266, DA-00074] Funding Source: Medline; NIMH NIH HHS [MH-069853] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; BEAL MF, 1993, J NEUROSCI, V13, P4181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; de Aguilar JLG, 2000, NEUROBIOL DIS, V7, P406, DOI 10.1006/nbdi.2000.0295; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Grunewald T, 1999, ANN NY ACAD SCI, V893, P203, DOI 10.1111/j.1749-6632.1999.tb07827.x; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hebb MO, 1999, J COMP NEUROL, V410, P99, DOI 10.1002/(SICI)1096-9861(19990719)410:1<99::AID-CNE9>3.0.CO;2-E; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jordan J, 1997, J NEUROSCI, V17, P1397; Kazemi-Esfarjani P, 2002, HUM MOL GENET, V11, P2657, DOI 10.1093/hmg/11.21.2657; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuntz C, 2000, EXP NEUROL, V165, P184, DOI 10.1006/exnr.2000.7464; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandir AS, 2002, J NEUROCHEM, V83, P186, DOI 10.1046/j.1471-4159.2002.01144.x; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; MIYASHITA T, 1995, CELL, V80, P293; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Morrison RS, 1996, J NEUROSCI, V16, P1337; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sang TK, 2005, HUM MOL GENET, V14, P357, DOI 10.1093/hmg/ddi032; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Sawa A, 2001, J MOL MED, V79, P375, DOI 10.1007/s001090100223; Schapira AHV, 1997, ANN NEUROL, V41, P141, DOI 10.1002/ana.410410203; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shahbazian MD, 2001, NEUROBIOL DIS, V8, P974, DOI 10.1006/nbdi.2001.0444; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	72	379	391	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 7	2005	47	1					29	41		10.1016/j.neuron.2005.06.005	http://dx.doi.org/10.1016/j.neuron.2005.06.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996546	Bronze			2022-12-28	WOS:000230464000006
J	Philpot, BD				Philpot, BD			Sniffing out NMDA receptors in the olfactory cortex	NEURON			English	Editorial Material							HOMEOSTATIC PLASTICITY; SILENT SYNAPSES	Selective olfactory learning is essential for survival in most newborn mammals. Findings by Franks and Isaacson in this issue of Neuron suggest that early olfactory learning might be selective, in part because olfactory experience downregulates NMDA receptors at primary inputs to the olfactory cortex.	Univ N Carolina, Dept Cell & Mol Physiol, Curriculum neurobiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Curriculum neurobiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.							Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Rumpel S, 1998, J NEUROSCI, V18, P8863; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1	8	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 7	2005	47	1					3	5		10.1016/j.neuron.2005.06.021	http://dx.doi.org/10.1016/j.neuron.2005.06.021			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996542	Bronze			2022-12-28	WOS:000230464000002
J	Jockusch, WJ; Praefcke, GJK; McMahon, HT; Lagnado, L				Jockusch, WJ; Praefcke, GJK; McMahon, HT; Lagnado, L			Clathrin-dependent and clathrin-independent retrieval of synaptic vesicles in retinal bipolar cells	NEURON			English	Article							FROG NEUROMUSCULAR JUNCTION; RIBBON SYNAPSE; HIPPOCAMPAL SYNAPSES; MEMBRANE RETRIEVAL; MEDIATED ENDOCYTOSIS; TRANSMITTER RELEASE; SH3 DOMAIN; DYNAMIN; AMPHIPHYSIN; EXOCYTOSIS	Synaptic vesicles can be retrieved rapidly or slowly, but the molecular basis of these kinetic differences has not been defined. We now show that substantially different sets of molecules mediate fast and slow endocytosis in the synaptic terminal of retinal bipolar cells. Capacitance measurements of membrane retrieval were made in terminals in which peptides and protein domains were introduced to disrupt known interactions of clathrin, the AP2 adaptor complex, and amphiphysin. All these manipulations caused a selective inhibition of the slow phase of membrane retrieval (time constant similar to 10 s), leaving the fast phase (similar to 1 s) intact. Slow endocytosis after strong stimulation was therefore dependent on the formation of clathrin-coated membrane. Fast endocytosis occurring after weaker stimuli retrieves vesicle membrane in a clathrin-independent manner. All compensatory endocytosis required GTP hydrolysis, but only a subset of released vesicles were primed for fast, clathrinindependent endocytosis.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmb.cam.ac.uk; ll1@mrc-lmb.cam.ac.uk		Praefcke, Gerrit/0000-0001-8818-1499				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; BLOOM GS, 1993, J CELL BIOL, V120, P467, DOI 10.1083/jcb.120.2.467; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Grabs D, 2000, EUR J NEUROSCI, V12, P1545, DOI 10.1046/j.1460-9568.2000.00043.x; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hosoya O, 2004, EUR J NEUROSCI, V19, P2179, DOI 10.1111/j.0953-816X.2004.03340.x; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Indyk L, 1998, METHOD ENZYMOL, V295, P350; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Morgan JR, 2002, NEUROMOL MED, V2, P101, DOI 10.1385/NMM:2:2:101; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Paillart C, 2003, J NEUROSCI, V23, P4092; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Sherry DM, 2005, J COMP NEUROL, V484, P440, DOI 10.1002/cne.20504; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yao PJ, 2002, J COMP NEUROL, V447, P152, DOI 10.1002/cne.10217; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	58	103	105	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					869	878		10.1016/j.neuron.2005.05.004	http://dx.doi.org/10.1016/j.neuron.2005.05.004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953416	Green Submitted, Bronze			2022-12-28	WOS:000229922500007
J	Paulson, HL; Miller, VM				Paulson, HL; Miller, VM			Breaks in coordination: DNA repair in inherited ataxia	NEURON			English	Review							DOUBLE-STRAND BREAKS; SPINOCEREBELLAR ATAXIA; PHOSPHODIESTERASE TDP1; ATM; TELANGIECTASIA; APRATAXIN; PROTEINS; MUTATION; HELICASE; XRCC1	Genetic defects in DNA repair are increasingly recognized as being able to cause degenerative ataxia syndromes. It remains a mystery, however, why disruption of a process fundamental to proliferating cells can be selectively toxic to postmitotic neurons. Recent studies now reveal that an ataxia gene, tyrosyl phosphodiesterase 1 (TDP1), repairs single-stranded DNA breaks in nondividing cells. Here we review the implications of this and other findings for a growing list of hereditary ataxias.	Univ Iowa, Dept Neurol, Iowa City, IA 52245 USA; Univ Iowa, Grad Program Genet, Carver Coll Med, Iowa City, IA 52245 USA	University of Iowa; University of Iowa	Paulson, HL (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52245 USA.	henry-paulson@uiowa.edu						Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Connelly JC, 2004, MOL CELL, V13, P307, DOI 10.1016/S1097-2765(04)00056-5; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0; Pandolfo Massimo, 2003, Semin Pediatr Neurol, V10, P163, DOI 10.1016/S1071-9091(03)00025-1; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170	21	22	22	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 16	2005	46	6					845	848		10.1016/j.neuron.2005.05.025	http://dx.doi.org/10.1016/j.neuron.2005.05.025			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953413	Bronze			2022-12-28	WOS:000229922500004
J	Haynes, JD; Driver, J; Rees, G				Haynes, JD; Driver, J; Rees, G			Visibility reflects dynamic changes of effective connectivity between V1 and fusiform cortex	NEURON			English	Article							PRIMARY VISUAL-CORTEX; HUMAN OCCIPITAL CORTEX; STRIATE CORTEX; HUMAN BRAIN; METACONTRAST MASKING; BACKWARD-MASKING; FEEDBACK CONNECTIONS; COGNITIVE-PROCESSES; DISTINCT MODES; MONKEY	Identifying the neural basis of visibility is central to understanding conscious visual perception. Visibility of basic features such as brightness is often thought to reflect activity in just early visual cortex. But here we show under metacontrast masking that fMRI activity in stimulus-driven areas of early visual cortex did not reflect parametric changes in the visibility of a brightness stimulus. The psychometric visibility function was instead correlated with activity in later visual regions plus parieto-frontal areas, and surprisingly, in representations of the unstimulated stimulus surround for primary visual cortex. Critically, decreased stimulus visibility was associated with a regionally-specific decoupling between early visual cortex and higher visual areas. This provides evidence that dynamic changes in effective connectivity can closely reflect visual perception.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; UCL, Neurol Inst, London WC1N 3BG, England; Otto Von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany	University of London; University College London; University of London; University College London; University of London; University College London; Otto von Guericke University	Haynes, JD (corresponding author), UCL, Inst Cognit Neurosci, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	haynes@fil.ion.ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008; Driver, Jon/A-4779-2010	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007; 	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BRIDGEMAN B, 1975, VISION RES, V15, P91, DOI 10.1016/0042-6989(75)90065-6; BRIDGEMAN B, 1980, BRAIN RES, V196, P347, DOI 10.1016/0006-8993(80)90400-X; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Formisano E, 2003, CURR OPIN NEUROBIOL, V13, P174, DOI 10.1016/S0959-4388(03)00044-8; Francis G, 2000, PSYCHOL REV, V107, P768, DOI 10.1037/0033-295X.107.4.768; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Green MF, 2005, J COGNITIVE NEUROSCI, V17, P13, DOI 10.1162/0898929052880011; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2003, J NEUROPHYSIOL, V89, P2655, DOI 10.1152/jn.00820.2002; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Macknik SL, 1999, P NATL ACAD SCI USA, V96, P15208, DOI 10.1073/pnas.96.26.15208; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; RAMACHANDRAN VS, 1995, NATURE, V373, P66, DOI 10.1038/373066a0; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; ROCKLAND KS, 1994, VISUAL NEUROSCI, V11, P579, DOI 10.1017/S0952523800002480; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; VAUGHAN HG, 1968, SCIENCE, V160, P207, DOI 10.1126/science.160.3824.207; vonderHeydt R, 1997, INVEST OPHTH VIS SCI, V38, P2146; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	57	137	142	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 2	2005	46	5					811	821		10.1016/j.neuron.2005.05.012	http://dx.doi.org/10.1016/j.neuron.2005.05.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924866	Bronze			2022-12-28	WOS:000229689800014
J	Tsai, LH; Gleeson, JG				Tsai, LH; Gleeson, JG			Nucleokinesis in neuronal migration	NEURON			English	Review							ADENOMATOUS POLYPOSIS-COLI; GRANULE CELL-MIGRATION; CYTOPLASMIC DYNEIN; C-ELEGANS; NUCLEAR MIGRATION; ASPERGILLUS-NIDULANS; MICROTUBULE ORGANIZATION; MICE LACKING; PROTEIN EB1; GENE		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02115 USA; Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, 77 Ave Louis Pasteur,Room 858C, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu; jogleeson@ucsd.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS037007, K02NS042749, R01NS041537] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 47101, NS 37007, NS 41537, NS 42749] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cockell MM, 2004, J CELL SCI, V117, P4571, DOI 10.1242/jcs.01344; Dawe AL, 2001, DEV GENES EVOL, V211, P434, DOI 10.1007/s004270100176; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Falkai P, 2000, BIOL PSYCHIAT, V47, P937, DOI 10.1016/S0006-3223(99)00250-4; Flint AC, 1997, CURR OPIN NEUROL, V10, P92, DOI 10.1097/00019052-199704000-00004; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Huisman SM, 2005, J CELL SCI, V118, P463, DOI 10.1242/jcs.01650; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KOMURO H, 1995, J NEUROSCI, V15, P1110; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; OAKLEY BR, 1980, CELL, V19, P255, DOI 10.1016/0092-8674(80)90407-9; OAKLEY BR, 1981, CELL, V24, P837, DOI 10.1016/0092-8674(81)90109-4; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PALMINI A, 1991, ANN NEUROL, V30, P741, DOI 10.1002/ana.410300602; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6	60	260	267	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					383	388		10.1016/j.neuron.2005.04.013	http://dx.doi.org/10.1016/j.neuron.2005.04.013			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882636	Bronze			2022-12-28	WOS:000229011400008
J	Dreier, L; Burbea, M; Kaplan, JM				Dreier, L; Burbea, M; Kaplan, JM			LIN-23-mediated degradation of beta-catenin regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of C elegans	NEURON			English	Article							UBIQUITIN LIGASE COMPLEX; I-KAPPA-B; HOX GENE LIN-39; CAENORHABDITIS-ELEGANS; ALPHA UBIQUITINATION; WINGLESS SIGNAL; SYNAPTIC GROWTH; CELL-ADHESION; WNT PATHWAY; PROTEIN	Ubiquitin-mediated protein degradation has been proposed to play an important role in regulating synaptic transmission. Here we show that LIN-23, the substrate binding subunit of a Skp1/Cullin/F Box (SCF) ubiquitin ligase, regulates the abundance of the glutamate receptor GLR-1 in the ventral nerve cord of C. elegans. Mutants lacking lin-23 had an increased abundance of GLR-1 in the ventral cord. The increase of GLR-1 was not caused by changes in the ubiquitination of GLR-1. Instead, SCFLIN-23 regulates GLR-1 through the P-catenin homolog BAR-1 and the TCF/Lef transcription factor homolog POP-1. We hypothesize that LIN-23-mediated degradation of BAR-1 P-catenin regulates the transcription of Wnt target genes, which in turn alter postsynaptic properties.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Kaplan, JM (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu			NINDS NIH HHS [F32 NS41705, NS32196] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032196, F32NS041705, R01NS032196] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Herman MA, 2001, DEVELOPMENT, V128, P581; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maloof JN, 1999, DEVELOPMENT, V126, P37; Maloof JN, 1998, DEVELOPMENT, V125, P181; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Natarajan L, 2001, GENETICS, V159, P159; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Okamoto M, 2000, EUR J NEUROSCI, V12, P3067, DOI 10.1046/j.1460-9568.2000.00200.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	79	76	84	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					51	64		10.1016/j.neuron.2004.12.058	http://dx.doi.org/10.1016/j.neuron.2004.12.058			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820693	Bronze			2022-12-28	WOS:000228228600008
J	Goldman, AL; van Naters, WV; Lessing, D; Warr, CG; Carlson, JR				Goldman, AL; van Naters, WV; Lessing, D; Warr, CG; Carlson, JR			Coexpression of two functional odor receptors in one neuron	NEURON			English	Article							OLFACTORY SENSORY MAP; DROSOPHILA-ANTENNA; SYSTEM; FLY; ORGANIZATION; INFORMATION; PROJECTIONS; EXPRESSION; MUTATION; ELEGANS	One of the most fundamental tenets in the field of olfaction is that each olfactory receptor neuron (ORN) expresses a single odorant receptor. However, the one receptor-one neuron principle is difficult to establish rigorously. Here we construct a receptor-to-neuron map for an entire olfactory organ in Drosophila and find that two receptor genes are coexpressed in one class of ORN. Both receptors are functional in an in vivo expression system, they are only 16% identical in amino acid sequence, and the genes that encode them are unlinked. Most importantly, their coexpression has been conserved for >45 million years. Expression of multiple odor receptors in a cell provides an additional degree of freedom for odor coding.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	van der Goes van Naters, Wynand/0000-0002-6808-0161; Warr, Coral/0000-0002-5289-3950	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729, R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC02174, R01 DC04729] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERGMAN CM, 2002, GENOME BIOL, V3, P147; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0	25	185	199	1	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 3	2005	45	5					661	666		10.1016/j.neuron.2005.01.025	http://dx.doi.org/10.1016/j.neuron.2005.01.025			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748842	Bronze			2022-12-28	WOS:000227446700006
J	Smith, WB; Starck, SR; Roberts, RW; Schuman, EM				Smith, WB; Starck, SR; Roberts, RW; Schuman, EM			Dopaminergic stimulation of local protein synthesis enhances surface expression of GluR1 and synaptic transmission in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS NEURONS; SILENT SYNAPSES; CA1 REGION; RECEPTOR STIMULATION; LATE-PHASE; SIGNALING PATHWAY; DENDRITIC SPINES; AMPA RECEPTORS; IN-VITRO	The use-dependent modification of synapses is strongly influenced by dopamine, a transmitter that participates in both the physiology and pathophysiology of animal behavior. In the hippocampus, dopaminergic signaling is thought to play a key role in protein synthesis-dependent forms of synaptic plasticity. The molecular mechanisms by which dopamine influences synaptic function, however, are not well understood. Using a GFP-based reporter, as well as a small-molecule reporter of endogenous protein synthesis, we show that dopamine D1/D5 receptor activation stimulates local protein synthesis in the dendrites of hippocampal neurons. We also identify the GluR1 subunit of AMPA receptors as one protein upregulated by dopamine receptor activation, with increased incorporation of surface GluR1 at synaptic sites. The insertion of new GluRs is accompanied by an increase in the frequency of miniature synaptic events. Together, these data suggest a local protein synthesis-dependent activation of previously silent synapses as a result of dopamine receptor stimulation.	CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; CALTECH, Div Chem 147 75, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Schuman, EM (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011					Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Beninger RJ, 1998, NEUROSCI BIOBEHAV R, V22, P335, DOI 10.1016/S0149-7634(97)00019-5; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bouron A, 1999, NEUROSCIENCE, V94, P1063, DOI 10.1016/S0306-4522(99)00352-8; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Castner SA, 2004, J NEUROSCI, V24, P1446, DOI 10.1523/JNEUROSCI.3987-03.2004; Chao SZ, 2002, J NEUROCHEM, V83, P704, DOI 10.1046/j.1471-4159.2002.01164.x; Chen L, 2002, J NEUROPHYSIOL, V87, P2324, DOI 10.1152/jn.2002.87.5.2324; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Doi N, 2002, GENOME RES, V12, P487, DOI 10.1101/gr.218802; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; Harvey J, 1997, J NEUROSCI, V17, P5271; HERBERG LJ, 1990, BEHAV BRAIN RES, V39, P230, DOI 10.1016/0166-4328(90)90029-E; Horton AC, 2003, J NEUROSCI, V23, P6188; Howland JG, 2002, J NEUROSCI, V22, P1137, DOI 10.1523/JNEUROSCI.22-03-01137.2002; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liu GS, 2003, CURR OPIN NEUROBIOL, V13, P324, DOI 10.1016/S0959-4388(03)00078-3; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Matthies H, 1997, NEUROREPORT, V8, P3533, DOI 10.1097/00001756-199711100-00023; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nemoto N, 1999, FEBS LETT, V462, P43, DOI 10.1016/S0014-5793(99)01474-X; Nguyen Peter V, 2002, Trends Neurosci, V25, P180, DOI 10.1016/S0166-2236(02)02166-5; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; Sanmarti-Vila L, 2000, BIOCHEM BIOPH RES CO, V275, P43, DOI 10.1006/bbrc.2000.3256; SCHOLUBBERS HG, 1984, EUR J BIOCHEM, V138, P101, DOI 10.1111/j.1432-1033.1984.tb07887.x; SIBLEY DR, 1982, LIFE SCI, V31, P637, DOI 10.1016/0024-3205(82)90764-0; Starck SR, 2004, CHEM BIOL, V11, P999, DOI 10.1016/j.chembiol.2004.05.011; Starck SR, 2002, RNA, V8, P890, DOI 10.1017/S1355838202022069; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; STEWARD O, 1982, J NEUROSCI, V2, P284; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Swanson-Park JL, 1999, NEUROSCIENCE, V92, P485, DOI 10.1016/S0306-4522(99)00010-X; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Torre ER, 1996, J NEUROSCI, V16, P5967; TORRE ER, 1992, J NEUROSCI, V12, P762; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; YUSTA B, 1988, J NEUROCHEM, V51, P1807, DOI 10.1111/j.1471-4159.1988.tb01162.x	61	193	194	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					765	779		10.1016/j.neuron.2005.01.015	http://dx.doi.org/10.1016/j.neuron.2005.01.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748851	Bronze			2022-12-28	WOS:000227446700015
J	Knutson, B; Adcock, RA				Knutson, B; Adcock, RA			Remembrance of rewards past	NEURON			English	Editorial Material							REGION	Using event-related fMRI, Wittmann and colleagues report in this issue of Neuron that reward value enhances cue memory and that this process is associated with midbrain modulation of hippocampal consolidation. We propose that their findings introduce a novel mechanism by which positive arousal induced by reward anticipation may promote memory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Knutson, B (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.		Adcock, R Alison/AAX-6649-2020	Adcock, R Alison/0000-0002-7859-5484; Knutson, Brian/0000-0002-7669-426X				Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Ebbinghaus Hermann, 1913, CONTRIBUTION EXPT PS; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; PROUST M, 1927, REMEMBRANCE THINGS P; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010	12	6	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					331	332		10.1016/j.neuron.2005.01.020	http://dx.doi.org/10.1016/j.neuron.2005.01.020			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694318	Bronze			2022-12-28	WOS:000226787700004
J	Zhong, JA; Pevny, L; Snider, WD				Zhong, JA; Pevny, L; Snider, WD			"Runx"ing towards sensory differentiation	NEURON			English	Editorial Material							NEURONS; EXPRESSION; AFFERENTS	Somatosensory stimuli are encoded by molecularly and anatomically diverse classes of dorsal root ganglia (DRG) neurons. In this issue of Neuron, three papers demonstrate that the Runx transcription factors, Runx1 and Runx3, respectively regulate the molecular identities and spinal terminations of TrkA(+) nociceptive neurons and TrkC(+) proprioceptive neurons. These findings emphasize the importance of intrinsic genetic programs in generating the diversity of DRG neurons and specifying the circuits into which they incorporate.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Zhong, JA (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.							Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; *GNF, 2003, SYM V 1 1 1 COMP PRO; Hall AK, 2001, DEV BIOL, V229, P263, DOI 10.1006/dbio.2000.9966; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	17	17	17	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 2	2006	49	3					325	327		10.1016/j.neuron.2006.01.013	http://dx.doi.org/10.1016/j.neuron.2006.01.013			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446135	Bronze			2022-12-28	WOS:000235260900003
J	Fiumelli, H; Cancedda, L; Poo, MM				Fiumelli, H; Cancedda, L; Poo, MM			Modulation of GABAergic transmission by activity via postsynaptic Ca2+-dependent regulation of KCC2 function	NEURON			English	Article							K-CL COTRANSPORTER; EXCITATORY ACTIONS; DEPENDENT DEPRESSION; CA2+ OSCILLATIONS; RAT HIPPOCAMPUS; DOWN-REGULATION; GABA RESPONSES; SYNAPSES; EXPRESSION; POTENTIATION	Activity-induced modification of GABAergic transmission contributes to the plasticity of neural circuits. In the present work we found that prolonged postsynaptic spiking of hippocampal neurons led to a shift in the reversal potential of GABA-induced Cl- currents (E-Cl) toward positive levels in a duration- and frequency-dependent manner. This effect was abolished by blocking cytosolic Ca2+ elevation and mimicked by releasing Ca2+, from internal stores. Activity- and Ca2+-induced Eel shifts were larger in mature neurons, which express the K-Cl cotransporter KCC2 at high levels, and inhibition of KCC2 occluded the shifts. Overexpression of KCC2 in young cultured neurons, which express lower levels of KCC2 and have a more positive Eel, resulted in hyperpolarized Eel similar to that of mature cells. Importantly, these young KCC2-expressing neurons became responsive to neuronal spiking and Ca2+ elevation by showing positive Eel shifts. Thus, repetitive postsynaptic spiking reduces the inhibitory action of GABA through a Ca2+-dependent downregulation of KCC2 function.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu		Cancedda, Laura/0000-0003-0566-057X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1981, NEUROSCIENCE, V6, P2445, DOI 10.1016/0306-4522(81)90091-9; Chudotvorova I, 2005, J PHYSIOL-LONDON, V566, P671, DOI 10.1113/jphysiol.2005.089821; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lee H, 2005, EUR J NEUROSCI, V21, P2593, DOI 10.1111/j.1460-9568.2005.04084.x; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LING DSF, 1995, BRAIN RES, V670, P142, DOI 10.1016/0006-8993(94)01298-V; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Owens DF, 1996, J NEUROSCI, V16, P6414; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Taketo M, 2004, BRAIN RES, V1016, P229, DOI 10.1016/j.brainres.2004.05.008; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Wan JJ, 1999, SCIENCE, V285, P1725, DOI 10.1126/science.285.5434.1725; Wang J, 2003, J NEUROSCI, V23, P826; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Zucchi R, 1997, PHARMACOL REV, V49, P1	38	165	171	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					773	786		10.1016/j.neuron.2005.10.025	http://dx.doi.org/10.1016/j.neuron.2005.10.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337915	Bronze			2022-12-28	WOS:000233927300016
J	Choi, SY; Borghuis, B; Rea, R; Levitan, ES; Sterling, P; Kramer, RH				Choi, SY; Borghuis, B; Rea, R; Levitan, ES; Sterling, P; Kramer, RH			Encoding light intensity by the cone photoreceptor synapse	NEURON			English	Article							TIGER SALAMANDER RETINA; HIPPOCAMPAL SYNAPSES; BIPOLAR CELLS; VERTEBRATE PHOTORECEPTORS; RIBBON SYNAPSE; GANGLION-CELLS; OUTPUT SYNAPSE; VESICLES; TRANSMISSION; SENSITIVITY	How cone synapses encode light intensity determines the precision of information transmission at the first synapse on the visual pathway. Although it is known that cone photoreceptors hyperpolarize to light over 4-5 log units of intensity, the relationship between light intensity and transmitter release at the cone synapse has not been determined. Here, we use two-photon microscopy to visualize release of the synaptic vesicle dye FM1-43 from cone terminals in the intact lizard retina, in response to different stimulus light intensities. We then employ electron microscopy to translate these measurements into vesicle release rates. We find that from darkness to bright light, release decreases from 49 to similar to 2 vesicles per 200 ms; therefore, cones compress their 10,000-fold operating range for phototransduction into a 25-fold range for synaptic vesicle release. Tonic release encodes ten distinguishable intensity levels, skewed to most finely represent bright light, assuming release obeys Poisson statistics.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kramer, RH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rhkramer@berkeley.edu			NEI NIH HHS [EY00828, EY015514] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000828, R01EY015514] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; ATTWELL D, 1982, J PHYSIOL-LONDON, V328, P259, DOI 10.1113/jphysiol.1982.sp014263; ATTWELL D, 1987, NATURE, V328, P522, DOI 10.1038/328522a0; BANKS MS, 1987, VISION RES, V27, P1915, DOI 10.1016/0042-6989(87)90057-5; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Berntson A, 2003, VISUAL NEUROSCI, V20, P621, DOI 10.1017/S0952523803206040; BOWEN RW, 1989, VISION RES, V29, P1501, DOI 10.1016/0042-6989(89)90134-X; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; DEMARCO PJ, 1994, VISUAL NEUROSCI, V11, P491, DOI 10.1017/S0952523800002418; Demb JB, 2004, J NEUROPHYSIOL, V92, P2510, DOI 10.1152/jn.00108.2004; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; HAYHOE MM, 1992, VISION RES, V32, P323, DOI 10.1016/0042-6989(92)90142-6; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PATEL AS, 1968, J OPT SOC AM, V58, P696, DOI 10.1364/JOSA.58.000696; Perlman I, 1998, PROG RETIN EYE RES, V17, P523, DOI 10.1016/S1350-9462(98)00005-6; Purves D, 2004, PSYCHOL REV, V111, P142, DOI 10.1037/0033-295X.111.1.142; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Rodieck R.W., 1998, 1 STEPS SEEING; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; WU SM, 1994, ANNU REV PHYSIOL, V56, P141; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	44	53	54	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					555	562		10.1016/j.neuron.2005.09.011	http://dx.doi.org/10.1016/j.neuron.2005.09.011			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301173	Bronze			2022-12-28	WOS:000233677300010
J	Zhao, MG; Toyoda, H; Lee, YS; Wu, LJ; Ko, SW; Zhang, XH; Jia, YH; Shum, F; Xu, H; Li, BM; Kaang, BK; Zhuo, M				Zhao, MG; Toyoda, H; Lee, YS; Wu, LJ; Ko, SW; Zhang, XH; Jia, YH; Shum, F; Xu, H; Li, BM; Kaang, BK; Zhuo, M			Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; D-ASPARTATE RECEPTORS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; FUNCTIONAL-PROPERTIES; GLUTAMATE RECEPTORS; GENETIC ENHANCEMENT; LATERAL AMYGDALA; CONDITIONED FEAR; TRANSGENIC MICE	Cortical plasticity is thought to be important for the establishment, consolidation, and retrieval of permanent memory. Hippocampal long-term potentiation (LTP), a cellular mechanism of learning and memory, requires the activation of glutamate N-methyl-D-aspartate (NMDA) receptors. In particular, it has been suggested that NR2A-containing NMDA receptors are involved in LTP induction, whereas NR2B-containing receptors are involved in LTD induction in the hippocampus. However, LTP in the prefrontal cortex is less well characterized than in the hippocampus. Here we report that the activation of the NR2B and NR2A subunits of the NMDA receptor is critical for the induction of cingulate LTP, regardless of the induction protocol. Furthermore, pharmacological or genetic blockade of the NR2B subunit in the cingulate cortex impaired the formation of early contextual fear memory. Our results demonstrate that the NR2B subunit of the NMDA receptor in the prefrontal cortex is critically involved in both LTP and contextual memory.	Fudan Univ, Inst Neurobiol, Lab Higher Brain Funct, Shanghai 200433, Peoples R China; Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 151742, South Korea	Fudan University; University of Toronto; Seoul National University (SNU)	Li, BM (corresponding author), Fudan Univ, Inst Neurobiol, Lab Higher Brain Funct, 220 Han Dan Rd, Shanghai 200433, Peoples R China.	bmli@fudan.edu.cn; min.zhuo@utoronto.ca	Zhuo, Min/A-2072-2008; Lee, Yong Seok/J-5587-2012; Wu, Long-Jun/E-2684-2012; Wu, Long-Jun/AAK-7113-2020	Zhuo, Min/0000-0001-9062-3241; Wu, Long-Jun/0000-0001-8019-3380; Zhao, Ming-gao/0000-0002-7539-3887; Toyoda, Hiroki/0000-0002-9907-7176	NINDS NIH HHS [NS42722] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042722] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrigoni E, 2004, BRIT J PHARMACOL, V142, P317, DOI 10.1038/sj.bjp.0705744; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Bast T, 2003, HIPPOCAMPUS, V13, P657, DOI 10.1002/hipo.10115; Bear M F, 1993, Curr Opin Neurobiol, V3, P197, DOI 10.1016/0959-4388(93)90210-P; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P235, DOI 10.1037/0735-7044.108.2.235; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gao YJ, 2004, PAIN, V110, P343, DOI 10.1016/j.pain.2004.04.030; Gewirtz JC, 1997, BEHAV NEUROSCI, V111, P712, DOI 10.1037/0735-7044.111.4.712; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Kohr G, 2003, J NEUROSCI, V23, P10791; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; LIU L, 2004, SCIENCE, V304, P121; Loftis JM, 2003, PHARMACOL THERAPEUT, V97, P55, DOI 10.1016/S0163-7258(02)00302-9; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Mallon AP, 2005, EXP BRAIN RES, V162, P374, DOI 10.1007/s00221-004-2193-6; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morgan MA, 1999, NEUROBIOL LEARN MEM, V72, P244, DOI 10.1006/nlme.1999.3907; Morrow BA, 1999, J NEUROSCI, V19, P5666; Munoz A, 1999, J COMP NEUROL, V407, P472, DOI 10.1002/(SICI)1096-9861(19990517)407:4<472::AID-CNE2>3.0.CO;2-2; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2003, J NEUROSCI, V23, P8402; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhuo M, 2002, DRUG DISCOV TODAY, V7, P259, DOI 10.1016/S1359-6446(01)02138-9	67	384	400	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					859	872		10.1016/j.neuron.2005.08.014	http://dx.doi.org/10.1016/j.neuron.2005.08.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157280	Bronze			2022-12-28	WOS:000232085000013
J	Taveggia, C; Zanazzi, G; Petrylak, A; Yano, H; Rosenbluth, J; Einheber, S; Xu, XR; Esper, RM; Loeb, JA; Shrager, P; Chao, MV; Falls, DL; Role, L; Salzer, JL				Taveggia, C; Zanazzi, G; Petrylak, A; Yano, H; Rosenbluth, J; Einheber, S; Xu, XR; Esper, RM; Loeb, JA; Shrager, P; Chao, MV; Falls, DL; Role, L; Salzer, JL			Neuregulin-1 type III determines the ensheathment fate of axons	NEURON			English	Article							SCHWANN-CELL MYELINATION; NEURON-DERIVED FACTOR; SIGNAL-REGULATED KINASE; PERIPHERAL-NERVE; PLASMA-MEMBRANE; PI 3-KINASE; EXPRESSION; RECEPTOR; GROWTH; HEREGULIN	The signals that determine whether axons are ensheathed or myelinated by Schwann cells have long been elusive. We now report that threshold levels of neuregulin-1 (NRG1) type III on axons determine their ensheathment fate. Ensheathed axons express low levels whereas myelinated fibers express high levels of NRG1 type III. Sensory neurons from NRG1 type III deficient mice are poorly ensheathed and fail to myelinate; lentiviral-mediated expression of NRG1 type III rescues these defects. Expression also converts the normally unmyelinated axons of sympathetic neurons to myelination. Nerve fibers of mice haploinsufficient for NRG1 type III are disproportionately unmyelinated, aberrantly ensheathed, and hypomyelinated, with reduced conduction velocities. Type III is the sole NRG1 isoform retained at the axon surface and activates PI 3-kinase, which is required for Schwann cell myelination. These results indicate that levels of NRG1 type III, independent of axon diameter, provide a key instructive signal that determines the ensheathment fate of axons.	NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA; NYU, Sch Med, Rusk Inst, New York, NY 10016 USA; CUNY Hunter Coll, Sch Hlth Sci, New York, NY 10010 USA; Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	New York University; New York University; New York University; New York University; New York University; New York University; City University of New York (CUNY) System; Hunter College (CUNY); University of Rochester; University of Rochester; Wayne State University; Wayne State University; Emory University; Columbia University	Salzer, JL (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1St Ave, New York, NY 10016 USA.	salzer@saturn.med.nyu.edu	Role, LW/Q-7371-2018; Taveggia, Carla/AAN-4784-2020; Messier, Claude/A-2322-2008	Role, LW/0000-0001-5851-212X; Messier, Claude/0000-0002-4791-1763; Salzer, James/0000-0001-9126-7197; Petrylak, Ashley/0000-0003-2972-7054; Chao, Moses/0000-0002-6969-3744	NINDS NIH HHS [R01 NS029071-17, R01 NS026001, R01 NS029071-13S1, NS29071, R01 NS029071-15, R01 NS017965, NS17965, R01 NS037475, NS051282, R01 NS029071, R01 NS029071-16, NS037475, NS26001, R01 NS051282, R01 NS029071-14, R01 NS029071-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051282, R01NS017965, R01NS037475, R01NS026001, R01NS029071] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; AGUAYO AJ, 1976, J NEUROCYTOL, V5, P565, DOI 10.1007/BF01175570; Auger KR, 2000, BIOCHEM BIOPH RES CO, V272, P822, DOI 10.1006/bbrc.2000.2806; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BRUNDEN KR, 1992, J NEUROSCI RES, V32, P507, DOI 10.1002/jnr.490320406; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cabedo H, 2002, J BIOL CHEM, V277, P19905, DOI 10.1074/jbc.M201587200; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; ESTRIDGE M, 1978, J CELL BIOL, V79, P138, DOI 10.1083/jcb.79.1.138; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fitzpatrick VD, 1998, FEBS LETT, V431, P102, DOI 10.1016/S0014-5793(98)00737-6; Frenzel KE, 2001, J NEUROCHEM, V77, P1; FRIEDE RL, 1972, J COMP NEUROL, V144, P233, DOI 10.1002/cne.901440207; FRIEDE RL, 1967, J COMP NEUROL, V130, P223, DOI 10.1002/cne.901300304; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; HILLARP NA, 1946, ACTA ANAT, V2, P17; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Hoke A, 2003, J NEUROSCI, V23, P561; JESSEN KR, 2003, MYELIN BIOL DISORDER, P329; Langley JN, 1903, J PHYSL, V30, P439; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Meyer D, 1997, DEVELOPMENT, V124, P3575; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Murinson BB, 2004, J NEUROPATH EXP NEUR, V63, P246, DOI 10.1093/jnen/63.3.246; Murphy P, 1996, DEVELOPMENT, V122, P2847; MURRAY MA, 1968, ANAT REC, V161, P337; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; OBREMSKI VJ, 1993, J NEUROCYTOL, V22, P102, DOI 10.1007/BF01181574; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Peters A., 1991, FINE STRUCTURE NERVO; Rosenbluth J, 2003, GLIA, V41, P318, DOI 10.1002/glia.10179; ROUFA D, 1986, J NEUROSCI, V6, P790; SCHERER SS, 1994, J NEUROSCI, V14, P1930; Schroering A, 1998, J BIOL CHEM, V273, P30643, DOI 10.1074/jbc.273.46.30643; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SIMPSON SA, 1945, J ANAT, V79, P48; SMITH KJ, 1982, J NEUROL SCI, V55, P231, DOI 10.1016/0022-510X(82)90103-4; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Spencer PS, 1978, PHYSL PATHOBIOLOGY A, P389; Vabnick I, 1999, J NEUROSCI, V19, P747; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; WEINBERG HJ, 1976, BRAIN RES, V113, P363, DOI 10.1016/0006-8993(76)90947-1; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	65	537	556	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					681	694		10.1016/j.neuron.2005.08.017	http://dx.doi.org/10.1016/j.neuron.2005.08.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129398	Green Accepted, Bronze			2022-12-28	WOS:000231782700010
J	Korn, H; Faber, DS				Korn, H; Faber, DS			The Mauthner cell half a century later: A neurobiological model for decision-making?	NEURON			English	Review							CENTRAL-NERVOUS-SYSTEM; LONG-TERM POTENTIATION; CENTRAL INHIBITORY SYNAPSE; STEM ESCAPE NETWORK; EXCITATORY POSTSYNAPTIC POTENTIALS; RETICULOSPINAL COMMAND NEURON; GAMMA-AMINOBUTYRIC-ACID; SINGLE CLUB ENDINGS; MIXED SYNAPSES; SPINAL-CORD	The Mauthner (M) cell is a critical element in a vital escape "reflex" triggered by abrupt or threatening events. Its properties at the molecular and synaptic levels, their various forms of plasticity, and the design of its networks, are all well adapted for this survival function. They guarantee that this behavior is appropriately unilateral, variable, and unpredictable. The M cell sets the behavioral threshold, and, acting in concert with other elements of the brainstem escape network, determines when, where, and how the escape is executed.	Inst Pasteur, CNRS, URA 2182, Lab Recepteurs & Cognit, F-75724 Paris, France; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yeshiva University; Albert Einstein College of Medicine	Korn, H (corresponding author), Inst Pasteur, CNRS, URA 2182, Lab Recepteurs & Cognit, 25 Rue Docteur Roux, F-75724 Paris, France.	hkorn@pasteur.fr						ANDERSEN P, 1990, PROG BRAIN RES, V83, P215; ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; ANKRI N, 1994, J NEUROSCI METH, V52, P87, DOI 10.1016/0165-0270(94)90060-4; Ankri N, 1999, J NEUROSCI METH, V91, P83, DOI 10.1016/S0165-0270(99)00078-3; BENNETT MVL, 1963, SCIENCE, V141, P262, DOI 10.1126/science.141.3577.262; Bodian D, 1937, J COMP NEUROL, V68, P117, DOI 10.1002/cne.900680106; BURNOD Y, 1989, P NATL ACAD SCI USA, V86, P352, DOI 10.1073/pnas.86.1.352; CAJAL SRY, 1908, TRAB LAB INVEST BIOL, V6, P1; CANFIELD JG, 1993, J COMP PHYSIOL A, V172, P611, DOI 10.1007/BF00213683; CANFIELD JG, 1990, NATURE, V347, P760, DOI 10.1038/347760a0; Canfield JG, 2003, BRAIN BEHAV EVOLUT, V61, P148, DOI 10.1159/000069751; Casagrand JL, 1999, J NEUROPHYSIOL, V82, P1422, DOI 10.1152/jn.1999.82.3.1422; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Curti S, 2004, J NEUROSCI, V24, P3999, DOI 10.1523/JNEUROSCI.0077-04.2004; David-Watine B, 1999, NEUROSCIENCE, V90, P303, DOI 10.1016/S0306-4522(98)00430-8; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Detwiler SR, 1933, J EXP ZOOL, V64, P415, DOI 10.1002/jez.1400640304; DIAMOND J, 1963, NATURE, V199, P773, DOI 10.1038/199773a0; DIAMOND J, 1973, J PHYSIOL-LONDON, V232, P113, DOI 10.1113/jphysiol.1973.sp010259; DIAMOND J, 1968, J PHYSIOL-LONDON, V194, P669, DOI 10.1113/jphysiol.1968.sp008432; DIDOMENICO R, 1988, BRAIN RES, V473, P15, DOI 10.1016/0006-8993(88)90310-1; Domenici P, 1997, MAR BIOL, V128, P29, DOI 10.1007/s002270050065; DOMENICI P, 1993, J EXP BIOL, V177, P253; Domenici P, 1997, J EXP BIOL, V200, P1165; DOMENICI P, 2002, ENCY ENV, V2, P708; Dudek FE, 1998, CELL BIOL INT, V22, P793, DOI 10.1006/cbir.1999.0397; EATON RC, 1977, J EXP BIOL, V66, P65; EATON RC, 1991, J EXP BIOL, V161, P469; EATON RC, 1985, ENVIRON BIOL FISH, V12, P265, DOI 10.1007/BF00005457; EATON RC, 1991, BRAIN BEHAV EVOLUT, V37, P272, DOI 10.1159/000114365; EATON RC, 1988, J NEUROSCI, V8, P2758; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; EATON RC, 1982, J COMP PHYSIOL, V145, P485, DOI 10.1007/BF00612814; EATON RC, 1984, J COMP PHYSIOL, V155, P813, DOI 10.1007/BF00611598; Eccles, 2013, PHYSL SYNAPSES; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; ELBERT T, 1994, PHYSIOL REV, V74, P1, DOI 10.1152/physrev.1994.74.1.1; FABER DS, 1988, P NATL ACAD SCI USA, V85, P8708, DOI 10.1073/pnas.85.22.8708; FABER DS, 1989, PHYSIOL REV, V69, P821, DOI 10.1152/physrev.1989.69.3.821; FABER DS, 1991, ANN NY ACAD SCI, V627, P151; FABER DS, 1986, NEUROSCIENCE, V19, P1037, DOI 10.1016/0306-4522(86)90120-X; FABER DS, 1985, P NATL ACAD SCI USA, V82, P3504, DOI 10.1073/pnas.82.10.3504; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; FABER DS, 1980, SCIENCE, V208, P612, DOI 10.1126/science.6245449; FABER DS, 1987, J NEUROSCI, V7, P807; FABER DS, 1991, BRAIN BEHAV EVOLUT, V37, P286, DOI 10.1159/000114366; FABER DS, 1973, SCIENCE, V179, P577, DOI 10.1126/science.179.4073.577; FABER DS, 1989, ANN NY ACAD SCI, V563, P11, DOI 10.1111/j.1749-6632.1989.tb42187.x; FABER DS, 1982, J NEUROPHYSIOL, V48, P654, DOI 10.1152/jn.1982.48.3.654; FABER DS, 1978, NEUROBIOLOGY MAUTHNE, P47; FATT P, 1953, J PHYSIOL-LONDON, V121, P374, DOI 10.1113/jphysiol.1953.sp004952; Faure P, 2001, CR ACAD SCI III-VIE, V324, P773, DOI 10.1016/S0764-4469(01)01377-4; Faure P, 1997, P NATL ACAD SCI USA, V94, P6506, DOI 10.1073/pnas.94.12.6506; Faure P, 2000, J NEUROPHYSIOL, V84, P3010, DOI 10.1152/jn.2000.84.6.3010; FAURE P, 1998, PHYSICA D, V94, P6506; FAURE P, 2003, HDB BRAIN THEORY NEU, P1130; FERNALD RD, 1975, NATURE, V258, P228, DOI 10.1038/258228a0; FETCHO JR, 1991, BRAIN BEHAV EVOLUT, V37, P298, DOI 10.1159/000114367; Fetcho JR, 1998, ANN NY ACAD SCI, V860, P333, DOI 10.1111/j.1749-6632.1998.tb09060.x; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; FOREMAN MB, 1993, J NEUROSCI, V13, P4101; FRANK K, 1959, IRE T MED ELECTRON, V6, P85, DOI 10.1109/IRET-ME.1959.5007923; Fregnac Y, 2003, J PHYSIOLOGY-PARIS, V97, P441, DOI 10.1016/j.jphysparis.2004.02.004; Fucile S, 1999, J PHYSIOL-LONDON, V517, P369, DOI 10.1111/j.1469-7793.1999.0369t.x; FUKAMI Y, 1965, J GEN PHYSIOL, V48, P581, DOI 10.1085/jgp.48.4.581; FURSHPAN EJ, 1964, SCIENCE, V144, P878, DOI 10.1126/science.144.3620.878; FURSHPAN EJ, 1962, J NEUROPHYSIOL, V25, P732, DOI 10.1152/jn.1962.25.6.732; Furukawa T, 1966, Prog Brain Res, V21, P44; FURUKAWA T, 1963, J NEUROPHYSIOL, V26, P759, DOI 10.1152/jn.1963.26.5.759; FURUKAWA T, 1963, J NEUROPHYSIOL, V26, P140, DOI 10.1152/jn.1963.26.1.140; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Glimcher PW, 2003, BRADFORD BOOKS, P1; Glimcher PW, 2002, NEURON, V36, P323, DOI 10.1016/S0896-6273(02)00962-5; GOTOW T, 1990, J COMP NEUROL, V292, P255, DOI 10.1002/cne.902920208; Granato M, 1996, DEVELOPMENT, V123, P399; Gray M, 2001, DEV BIOL, V237, P306, DOI 10.1006/dbio.2001.0381; HACKETT JT, 1983, NEUROSCIENCE, V8, P317, DOI 10.1016/0306-4522(83)90069-6; Haddon C, 1998, DEVELOPMENT, V125, P359; Hale ME, 2004, J NEUROSCI, V24, P3070, DOI 10.1523/JNEUROSCI.5624-03.2004; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Hatta K, 2001, NEUROSCIENCE, V103, P561, DOI 10.1016/S0306-4522(00)00570-4; Hatta K, 1999, P NATL ACAD SCI USA, V96, P12090, DOI 10.1073/pnas.96.21.12090; Hatta K, 1998, J COMP NEUROL, V395, P493; Heuser JE, 1977, HDB PHYSL, VI, P261; Imboden M, 2001, NEUROSCIENCE, V103, P811, DOI 10.1016/S0306-4522(00)00576-5; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANDEL ER, 1983, COLD SPRING HARB SYM, V48, P465; Katz B, 1969, SHERRINGTON LECT, VX; Kimmel CB, 1978, NEUROBIOLOGY MAUTHNE, P183; KORN H, 1994, ADV SEC MESS PHOSPH, V29, P301; Korn H, 2003, CR BIOL, V326, P787, DOI 10.1016/j.crvi.2003.09.011; KORN H, 1982, J NEUROPHYSIOL, V48, P679, DOI 10.1152/jn.1982.48.3.679; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; KORN H, 1987, P NATL ACAD SCI USA, V84, P5981, DOI 10.1073/pnas.84.16.5981; KORN H, 1975, J NEUROPHYSIOL, V38, P452, DOI 10.1152/jn.1975.38.2.452; Korn H, 1996, CURR OPIN NEUROBIOL, V6, P826, DOI 10.1016/S0959-4388(96)80034-1; KORN H, 1986, J NEUROPHYSIOL, V55, P402, DOI 10.1152/jn.1986.55.2.402; KORN H, 1976, SCIENCE, V194, P1166, DOI 10.1126/science.186868; KORN H, 1992, P NATL ACAD SCI USA, V89, P440, DOI 10.1073/pnas.89.1.440; KORN H, 1980, P NATL ACAD SCI-BIOL, V77, P6244, DOI 10.1073/pnas.77.10.6244; KORN H, 1998, CENTRAL SYNAPSES QUA, P37; KORN H, 1990, HDB CHEM NEUROANATOM, V8, P403; Kruk PJ, 1997, BIOPHYS J, V73, P2874, DOI 10.1016/S0006-3495(97)78316-4; Kullmann DM, 1999, PHILOS T ROY SOC B, V354, P395, DOI 10.1098/rstb.1999.0392; Kumar SS, 1999, J NEUROSCI, V19, P1620; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; LAND BR, 1980, P NATL ACAD SCI-BIOL, V77, P3736, DOI 10.1073/pnas.77.6.3736; LEE RKK, 1993, J COMP NEUROL, V329, P539, DOI 10.1002/cne.903290409; Legendre P, 1997, J NEUROPHYSIOL, V77, P2400, DOI 10.1152/jn.1997.77.5.2400; LEGENDRE P, 1994, EUR J NEUROSCI, V6, P1544, DOI 10.1111/j.1460-9568.1994.tb00545.x; LEGENDRE P, 1995, J NEUROPHYSIOL, V73, P2404, DOI 10.1152/jn.1995.73.6.2404; Leghissa Silvano, 1941, ARCH ZOOL ITAL, V29, P213; LIN JW, 1988, J NEUROSCI, V8, P1302; LIN JW, 1988, J NEUROSCI, V8, P1313; Liu KS, 2003, J NEUROSCI, V23, P8159; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; LLINAS R, 1965, J NEUROPHYSIOL, V28, P413, DOI 10.1152/jn.1965.28.2.413; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARTIN AR, 1977, HDB PHYSL          1, V1, P329; MARTY A, 1995, CURR OPIN NEUROBIOL, V5, P335, DOI 10.1016/0959-4388(95)80046-8; McLachlan E M, 1978, Int Rev Physiol, V17, P49; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; MINTZ I, 1989, SCIENCE, V245, P190, DOI 10.1126/science.2749257; MINTZ I, 1991, J NEUROSCI, V11, P3359; MODEL PG, 1978, BRAIN RES, V153, P135, DOI 10.1016/0006-8993(78)91135-6; MULLINS MC, 1993, CURR OPIN GENET DEV, V3, P648, DOI 10.1016/0959-437X(93)90102-U; NAKAJIMA Y, 1974, J COMP NEUROL, V156, P375, DOI 10.1002/cne.901560402; Nakayama H, 2004, J NEUROSCI, V24, P3199, DOI 10.1523/JNEUROSCI.4419-03.2004; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; NISSANOV J, 1989, AM ZOOL, V29, P103; Oda Y, 1998, NATURE, V394, P182, DOI 10.1038/28172; ODA Y, 1995, J NEUROPHYSIOL, V74, P1056, DOI 10.1152/jn.1995.74.3.1056; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Oppenheimer JM, 1942, J COMP NEUROL, V77, P577, DOI 10.1002/cne.900770305; OTTERSEN OP, 1988, BRAIN RES, V450, P342, DOI 10.1016/0006-8993(88)91573-9; PALAY SL, 1958, EXP CELL RES S, V5, P1634; Pereda A, 2003, J NEUROSCI, V23, P7489; PEREDA A, 1992, P NATL ACAD SCI USA, V89, P12088, DOI 10.1073/pnas.89.24.12088; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; Pereda AE, 2004, BRAIN RES REV, V47, P227, DOI 10.1016/j.brainresrev.2004.06.010; PEREDA AE, 1994, J NEUROSCI, V14, P3704; Peters A., 1991, FINE STRUCTURE NERVO; Preuss T, 2003, J NEUROSCI, V23, P5617; RAJENDRA S, 1995, TRENDS NEUROSCI, V18, P80; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P135, DOI 10.1113/jphysiol.1983.sp014885; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; ROBERTSON J, 1961, ANN NY ACAD SCI, V94, P339, DOI 10.1111/j.1749-6632.1961.tb35552.x; ROBERTSON JD, 1963, J CELL BIOL, V19, P159, DOI 10.1083/jcb.19.1.159; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCOTT JW, 1994, J COMP NEUROL, V339, P76, DOI 10.1002/cne.903390108; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Smith M, 2003, P NATL ACAD SCI USA, V100, P4849, DOI 10.1073/pnas.0734299100; STEFANELLI A, 1951, Q REV BIOL, V26, P17, DOI 10.1086/397880; SUR C, 1994, J NEUROSCI, V14, P576; SUR C, 1995, J COMP NEUROL, V351, P247, DOI 10.1002/cne.903510205; Svoboda KR, 1996, J NEUROSCI, V16, P843; SWISHER JE, 1967, J EXP ZOOL, V165, P433, DOI 10.1002/jez.1401650311; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; TRILLER A, 1982, J NEUROPHYSIOL, V48, P708, DOI 10.1152/jn.1982.48.3.708; TRILLER A, 1990, New Biologist, V2, P637; Triller A, 1997, NEUROSCIENCE, V80, P133, DOI 10.1016/S0306-4522(97)00092-4; TRILLER A, 1987, J CELL BIOL, V104, P947, DOI 10.1083/jcb.104.4.947; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; WALMSLEY B, 1988, J NEUROPHYSIOL, V60, P889, DOI 10.1152/jn.1988.60.3.889; WEBB PW, 1976, J EXP BIOL, V65, P157; WEIHS D, 1973, Biorheology, V10, P343; WERMAN R, 1969, COMP BIOCHEM PHYSIOL, V30, P997, DOI 10.1016/0010-406X(69)91038-X; WERNIG A, 1972, J PHYSIOL-LONDON, V226, P751, DOI 10.1113/jphysiol.1972.sp010007; WERNIG A, 1975, J PHYSIOL-LONDON, V244, P207, DOI 10.1113/jphysiol.1975.sp010792; WILL U, 1991, BRAIN BEHAV EVOLUT, V37, P317, DOI 10.1159/000114368; WILSON DM, 1959, SCIENCE, V129, P841, DOI 10.1126/science.129.3352.841; Wolszon LR, 1997, J NEUROPHYSIOL, V78, P2693, DOI 10.1152/jn.1997.78.5.2693; YANG XD, 1990, NATURE, V348, P542, DOI 10.1038/348542a0; YANG XD, 1991, P NATL ACAD SCI USA, V88, P4299, DOI 10.1073/pnas.88.10.4299; YASARGIL GM, 1968, NATURE, V220, P241, DOI 10.1038/220241a0; Zottoli S. J., 1978, NEUROBIOLOGY MAUTHNE, P13; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	185	287	302	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					13	28		10.1016/j.neuron.2005.05.019	http://dx.doi.org/10.1016/j.neuron.2005.05.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996545	Bronze			2022-12-28	WOS:000230464000005
J	Zatorre, RJ; Halpern, AR				Zatorre, RJ; Halpern, AR			Mental concerts: Musical imagery and auditory cortex	NEURON			English	Review							MINDS EAR; BRAIN; PERCEPTION; PIANISTS; SPEECH; SONGS	Most people intuitively understand what it means to "hear a tune in your head." Converging evidence now indicates that auditory cortical areas can be recruited even in the absence of sound and that this corresponds to the phenomenological experience of imagining music. We discuss these findings as well as some methodological challenges. We also consider the role of core versus belt areas in musical imagery, the relation between auditory and motor systems during imagery of music performance, and practical implications of this research.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Bucknell Univ, Lewisburg, PA 17837 USA	McGill University; Bucknell University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	robert.zatorre@mcgill.ca	Halpern, Andrea/B-7099-2009	Halpern, Andrea/0000-0001-6384-6490				Griffiths TD, 2000, BRAIN, V123, P2065, DOI 10.1093/brain/123.10.2065; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; HALPERN AR, 1988, J EXP PSYCHOL LEARN, V14, P434, DOI 10.1037/0278-7393.14.3.434; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; HIGHBEN Z, 2004, B COUNCIL RES MUSIC, V159, P58; HUMPHREYS JT, 1986, J RES MUSIC EDUC, V34, P192, DOI 10.2307/3344748; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144; Naito E, 2002, J NEUROSCI, V22, P3683; Pascual-Leone A, 2003, COGNITIVE NEUROSCIEN, P396, DOI DOI 10.1093/ACPROF:OSO/9780198525202.003.0026; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; Schurmann M, 2002, NEUROIMAGE, V16, P434, DOI 10.1006/nimg.2002.1098; SHEPARD RN, 1971, SCIENCE, V171, P791; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; ZATORRE RJ, 1993, NEUROPSYCHOLOGIA, V31, P221, DOI 10.1016/0028-3932(93)90086-F; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	21	225	229	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 7	2005	47	1					9	12		10.1016/j.neuron.2005.06.013	http://dx.doi.org/10.1016/j.neuron.2005.06.013			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996544	Green Published, Bronze			2022-12-28	WOS:000230464000004
J	Sigman, M; Pan, H; Yang, YH; Stern, E; Silbersweig, D; Gilbert, CD				Sigman, M; Pan, H; Yang, YH; Stern, E; Silbersweig, D; Gilbert, CD			Top-down reorganization of activity in the visual pathway after learning a shape identification task	NEURON			English	Article							LATERAL OCCIPITAL COMPLEX; INFERIOR TEMPORAL CORTEX; RECEPTIVE-FIELDS; NEURAL BASIS; TEXTURE-DISCRIMINATION; INFEROTEMPORAL CORTEX; OBJECT RECOGNITION; NEURONAL-ACTIVITY; CEREBRAL-CORTEX; VERNIER ACUITY	Learning in shape identification led to global changes in activation across the entire visual pathway, as revealed with whole-brain fMRI. Following extensive training in a shape identification task, brain activity associated with trained shapes relative to the untrained shapes showed: (1) an increased level of activity in retinotopic cortex (RC), (2) a decrease in activation of the lateral occipital cortex (LO), and (3) a decrease in the dorsal attentional network. In addition, RC activations became more correlated (and LO activation, less correlated) with performance. When comparing target-present and target-absent trials within the trained condition, we observed a similar decrease in the dorsal attentional network but not in the visual cortices. These findings indicate a large-scale reorganization of activity in the visual pathway as a result of learning, with the RC becoming more involved (and the LO, less involved) and that these changes are triggered in a top-down manner depending on the perceptual task performed.	Rockefeller Univ, New York, NY 10021 USA; CEA, Serv Hosp Frederic Joliot, INSERM, Unit Cognit Neuroimaging 562, F-91406 Orsay, France; Cornell Univ, Weill Med Coll, Dept Psychiat, Fucnt Neuroimaging Lab, New York, NY USA	Rockefeller University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Cornell University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	gilbert@rockefeller.edu	Stern, Emily/E-6035-2011	Pan, Hong/0000-0003-4513-7310; Sigman, Mariano/0000-0003-0589-0033	NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY007968, EY07968] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BARLOW H, 1989, COMP NEUR S, P54; BERARDI N, 1987, J PHYSIOL-LONDON, V384, P633, DOI 10.1113/jphysiol.1987.sp016474; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; FRACKOWIACK RS, 2004, HUMAN BRAIN FUNCTION; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hopf JM, 2004, NEUROIMAGE, V22, P574, DOI 10.1016/j.neuroimage.2004.01.031; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; McIntosh AR, 1998, J NEUROPHYSIOL, V80, P3148, DOI 10.1152/jn.1998.80.6.3148; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Schiltz C, 1999, NEUROIMAGE, V9, P46, DOI 10.1006/nimg.1998.0394; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Talairach P., 1988, STEREOTACTIC COPLANA; Tanaka K, 1996, NEURAL NETWORKS, V9, P1459, DOI 10.1016/S0893-6080(96)00045-7; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ullman S., 1996, HIGH LEVEL VISION OB	66	152	157	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					823	835		10.1016/j.neuron.2005.05.014	http://dx.doi.org/10.1016/j.neuron.2005.05.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924867	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000229689800015
J	de Araujo, IE; Rolls, ET; Velazco, MI; Margot, C; Cayeux, I				de Araujo, IE; Rolls, ET; Velazco, MI; Margot, C; Cayeux, I			Cognitive modulation of olfactory processing	NEURON			English	Article							ORBITOFRONTAL CORTEX; NEURONAL-ACTIVITY; HUMAN AMYGDALA; REPRESENTATIONS; INTENSITY; ATTENTION; HUNGER; MEMORY; ODORS; MODEL	We showed how cognitive, semantic information modulates olfactory representations in the brain by providing a visual word descriptor, "cheddar cheese" or "body odor," during the delivery of a test odor (isovaleric acid with cheddar cheese flavor) and also during the delivery of clean air. Clean air labeled "air" was used as a control. Subjects rated the affective value of the test odor as significantly more unpleasant when labeled "body odor" than when labeled "cheddar cheese." In an event-related fMRI design, we showed that the rostral anterior cingulate cortex (ACC)/medial orbitofrontal cortex (OFC) was significantly more activated by the test stimulus and by clean air when labeled "cheddar cheese" than when labeled "body odor," and the activations were correlated with the pleasantness ratings. This cognitive modulation was also found for the test odor (but not for the clean air) in the amygdala bilaterally.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; John Radcliffe Hosp, Ctr Funct Magnet Resonance Imaging, Oxford OX3 9DU, England; Firmenich Co, CH-1211 Geneva, Switzerland	University of Oxford; University of Oxford; Firmenich	Rolls, ET (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	edmund.rolls@psy.ox.ac.uk		De Araujo, Ivan/0000-0003-3081-3339; Rolls, Edmund/0000-0003-3025-1292				Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; CAIN WS, 1979, SCIENCE, V203, P467, DOI 10.1126/science.760202; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Deco G, 2004, VISION RES, V44, P621, DOI 10.1016/j.visres.2003.09.037; Deco G, 2003, EUR J NEUROSCI, V18, P2374, DOI 10.1046/j.1460-9568.2003.02956.x; DECO G, 2005, IN PRESS J NEUROPHYS, P94; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Morris JS, 2001, J NEUROSCI, V21, P5304, DOI 10.1523/JNEUROSCI.21-14-05304.2001; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ongur D, 1998, J COMP NEUROL, V401, P480; Rolls E. T., 2005, EMOTION EXPLAINED; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Rolls ET, 2002, COMPUTATIONAL NEUROS; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Thevenaz P, 2000, IEEE T MED IMAGING, V19, P739, DOI 10.1109/42.875199; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Wilson JL, 2002, NEUROIMAGE, V17, P967, DOI 10.1006/nimg.2002.1172; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368	36	366	369	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					671	679		10.1016/j.neuron.2005.04.021	http://dx.doi.org/10.1016/j.neuron.2005.04.021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944134	Bronze			2022-12-28	WOS:000229294300017
J	Pardossi-Piquard, R; Petit, A; Kawarai, T; Sunyach, C; da Costa, CA; Vincent, B; Ring, S; D'Adamio, L; Shen, J; Muller, U; Hyslop, PS; Checler, F				Pardossi-Piquard, R; Petit, A; Kawarai, T; Sunyach, C; da Costa, CA; Vincent, B; Ring, S; D'Adamio, L; Shen, J; Muller, U; Hyslop, PS; Checler, F			Presenilin-dependent transcriptional control of the A beta-degrading enzyme neprilysin by intracellular domains of beta APP and APLP	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; NEUTRAL ENDOPEPTIDASE-24.11; SIGNAL-TRANSDUCTION; CLEAVAGE; NOTCH; PEPTIDE; FE65	Amyloid beta-peptide (A beta), which plays a central role in Alzheimer's disease, is generated by presenilin-dependent gamma-secretase cleavage of beta-amyloid precursor protein (beta APP). We report that the presenilins (PS1 and PS2) also regulate A beta degradation. Presenilin-deficient cells fail to degrade A beta and have drastic reductions in the transcription, expression, and activity of neprilysin, a key A beta-degrading enzyme. Neprilysin activity and expression are also lowered by gamma-secretase inhibitors and by PS1/PS2 deficiency in mouse brain. Neprilysin activity is restored by transient expression of PS1 or PS2 and by expression of the amyloid intracellular domain (AICD), which is cogenerated with A beta, during gamma-secretase cleavage of PAPP. Neprilysin gene promoters are transactivated by AlCDs from APP-like proteins (APP, APLP1, and APLP2), but not by A beta or by the gamma-secretase cleavage products of Notch, N- or E- cadherins. The presenilin-dependent regulation of neprilysin, mediated by AICDs, provides a physiological means to modulate A beta levels with varying levels of gamma-secretase.	UNSA, CNRS, UMR6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Toronto, Dept Med, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Hlth Network, Toronto Western Hosp, Res Inst, Toronto, ON M5S 3H2, Canada; Univ Heidelberg, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; Albert Einstein Coll Med, New York, NY USA; Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy; Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ruprecht Karls University Heidelberg; Yeshiva University; University of Naples Federico II; Harvard University; Harvard Medical School	Checler, F (corresponding author), UNSA, CNRS, UMR6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Checler, Frederic/C-1241-2009; Kawarai, Toshitaka/C-2822-2013; Pardossi-Piquard, Raphaëlle/ABA-4472-2021; da Costa, Cristine Alves/G-8075-2011; Pardossi-Piquard, Raphaëlle/D-6263-2012	Checler, Frederic/0000-0003-2098-1750; Kawarai, Toshitaka/0000-0003-4547-8131; Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; da Costa, Cristine Alves/0000-0002-7777-005X; D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882; Petit-Paitel, Agnes/0000-0003-1138-9966; Vincent, Bruno/0000-0003-3876-2118				Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Ausubel F, 2002, SHORT PROTOCOLS MOL, V2; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; BURDICK D, 1992, J BIOL CHEM, V267, P546; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Checler F, 1999, MOL NEUROBIOL, V19, P255, DOI 10.1007/BF02821716; Checler F., 1993, TEC BEHAV N 2, P375; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Hauss-Wegrzyniak B, 2002, NEUROSCI LETT, V322, P75, DOI 10.1016/S0304-3940(02)00087-3; Heber S, 2000, J NEUROSCI, V20, P7951; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Ishimaru F, 1997, BLOOD, V89, P4136, DOI 10.1182/blood.V89.11.4136; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marr RA, 2003, J NEUROSCI, V23, P1992; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Pollack Scott J, 2005, Curr Opin Investig Drugs, V6, P35; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; SUDA H, 1973, J ANTIBIOT, V26, P621, DOI 10.7164/antibiotics.26.621; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Vincent B, 1996, J NEUROSCI, V16, P5049; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	60	284	292	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					541	554		10.1016/j.neuron.2005.04.008	http://dx.doi.org/10.1016/j.neuron.2005.04.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944124	Bronze, Green Published			2022-12-28	WOS:000229294300007
J	Fishell, G; Kriegstein, A				Fishell, G; Kriegstein, A			Cortical development: New concepts	NEURON			English	Editorial Material									Univ Calif San Francisco, Sch Med, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; NYU, Dept Cell Biol, New York, NY 10016 USA; NYU, Skirball Dev Genet Program, New York, NY 10016 USA	University of California System; University of California San Francisco; New York University; New York University	Kriegstein, A (corresponding author), Univ Calif San Francisco, Sch Med, Program Dev & Stem Cell Biol, 513 Parnassus Ave,HSW 1201,Campus Box 0515, San Francisco, CA 94143 USA.	kriegsteina@steincell.ucsf.edu		Fishell, Gordon/0000-0002-9640-9278					0	16	16	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					361	362		10.1016/j.neuron.2005.04.016	http://dx.doi.org/10.1016/j.neuron.2005.04.016			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882631	Bronze			2022-12-28	WOS:000229011400003
J	Gu, XF; Li, CJ; Wei, WZ; Lo, V; Gong, SC; Li, SH; Iwasato, T; Itohara, S; Li, XJ; Mody, I; Heintz, N; Yang, XW				Gu, XF; Li, CJ; Wei, WZ; Lo, V; Gong, SC; Li, SH; Iwasato, T; Itohara, S; Li, XJ; Mody, I; Heintz, N; Yang, XW			Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; CENTRAL-NERVOUS-SYSTEM; IT15 PROTEIN PRODUCT; R6/2 TRANSGENIC MICE; MOUSE MODEL; STRIATAL NEURONS; WIDESPREAD EXPRESSION; NUCLEAR-LOCALIZATION; TERMINAL FRAGMENTS; MOTOR DYSFUNCTION	Expanded polyglutamine (polyQ) proteins in Huntington's disease (HID) as well as other polyQ disorders are known to elicit a variety of intracellular toxicities, but it remains unclear whether polyQ proteins can elicit pathological cell-cell interactions which are critical to disease pathogenesis. To test this possibility, we have created conditional HD mice expressing a neuroplathogenic form of mutant huntingtin (mhtt-exon1) in discrete neuronal populations. We show that mhtt aggregation is a cell-autonomous process. However, progressive motor deficits and cortical neuropathology are only observed when mhtt expression is in multiple neuronal types, including cortical inter-neurons, but not when mhtt expression is restricted to cortical pyramidal neurons. We further demonstrate an early deficit in cortical inhibition, suggesting that pathological interactions between interneurons and pyramidal neurons may contribute to the cortical manifestation of HD. Our study provides genetic evidence that pathological cell-cell interactions elicited by neuroplathogenic forms of mhtt can critically contribute to cortical pathogenesis in a HD mouse model.	Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst,Ctr Neurobehav Genet, Neuropsychiat Inst,Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; Rockefeller University; Emory University; RIKEN	Yang, XW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst,Ctr Neurobehav Genet, Neuropsychiat Inst,Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989	NIA NIH HHS [AG19206] Funding Source: Medline; NINDS NIH HHS [NS049501, NS41669, NS04739] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS049501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; Cepeda C, 2003, J NEUROSCI RES, V72, P472, DOI 10.1002/jnr.10604; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Dalby NO, 2003, J NEUROPHYSIOL, V90, P786, DOI 10.1152/jn.00118.2003; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; FERRER I, 1994, NEURODEGENERATION, V3, P169; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gourfinkel-An I, 2003, J NEUROCHEM, V86, P1369, DOI 10.1046/j.1471-4159.2003.01916.x; Grunewald T, 1999, ANN NY ACAD SCI, V893, P203, DOI 10.1111/j.1749-6632.1999.tb07827.x; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kosinski CM, 1999, NEUROREPORT, V10, P3891, DOI 10.1097/00001756-199912160-00031; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Leavitt BR, 1999, SEMIN NEUROL, V19, P385, DOI 10.1055/s-2008-1040853; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled LB, 2002, TRENDS PHARMACOL SCI, V23, P32, DOI 10.1016/S0165-6147(00)01884-8; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nance MA, 2001, MENT RETARD DEV D R, V7, P153, DOI 10.1002/mrdd.1022; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ross CA, 2004, CELL, V118, P4, DOI 10.1016/j.cell.2004.06.022; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; SCHILLING G, 1995, HUM MOL GENET, V4, P1365, DOI 10.1093/hmg/4.8.1365; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wellington CL, 2002, J NEUROSCI, V22, P7862; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	70	184	185	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					433	444		10.1016/j.neuron.2005.03.025	http://dx.doi.org/10.1016/j.neuron.2005.03.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882643	Bronze			2022-12-28	WOS:000229011400015
J	Sara, Y; Virmani, T; Deak, F; Liu, XR; Kavalali, ET				Sara, Y; Virmani, T; Deak, F; Liu, XR; Kavalali, ET			An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission	NEURON			English	Article							READILY RELEASABLE POOL; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; ENDOCYTOSIS; MEMBRANE; ABSENCE; CA2+	Spontaneous synaptic vesicle fusion is a common property of all synapses. To trace the origin of spontaneously fused vesicles in hippocampal synapses, we tagged vesicles with fluorescent styryl dyes, antibodies against synaptotagmin-1, or horseradish peroxidase. We could show that synaptic vesicles recycle at rest, and after spontaneous exo-endocytosis, they populate a reluctantly releasable pool of limited size. Interestingly, vesicles in this spontaneously labeled pool were more likely to re-fuse spontaneously compared to vesicles labeled with activity. We found that blocking vesicle refilling at rest selectively depleted neurotransmitter from spontaneously fusing vesicles without significantly altering evoked transmission. Furthermore, in the absence of the vesicle SNARE protein synaptobrevin (VAMP), activity-dependent and spontaneously recycling vesicles could mix, suggesting a role for synaptobrevin in the separation of the two pools. Taken together these results suggest that spontaneously recycling vesicles and activity-dependent recycling vesicles originate from distinct pools with limited cross-talk with each other.	Univ Texas, Ctr Basic Neurosci, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Physiol, SW Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kavalali, ET (corresponding author), Univ Texas, Ctr Basic Neurosci, SW Med Ctr, Dallas, TX 75390 USA.	ege.kavalali@utsouthwestern.edu	Deak, Ferenc/AAE-4324-2019	Sara, Yildirim/0000-0003-1079-0782; Virmani, Tuhin/0000-0002-1826-2020	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068437, R01MH066198] Funding Source: NIH RePORTER; NIMH NIH HHS [MH066198, MH068437] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; COLMEUS C, 1982, PROC R SOC SER B-BIO, V215, P63, DOI 10.1098/rspb.1982.0028; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dittman JS, 1996, J NEUROSCI, V16, P1623; Frerking M, 1997, J NEUROPHYSIOL, V78, P1293, DOI 10.1152/jn.1997.78.3.1293; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; KATZ B, 1969, RELEASE NEURAL TRANS, V10; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; OTSU Y, 2003, SCI STKE, V211, DOI DOI 10.1126/ST5E.2112003PE54; Prange O, 1999, J NEUROSCI, V19, P6427; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; VanderKloot W, 1996, J PHYSIOL-LONDON, V492, P155, DOI 10.1113/jphysiol.1996.sp021297; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	38	293	297	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					563	573		10.1016/j.neuron.2004.12.056	http://dx.doi.org/10.1016/j.neuron.2004.12.056			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721242	Bronze			2022-12-28	WOS:000227099700012
J	Moradi, F; Koch, C; Shimojo, S				Moradi, F; Koch, C; Shimojo, S			Face adaptation depends on seeing the face	NEURON			English	Article							ORIENTATION-SELECTIVE ADAPTATION; BINOCULAR-RIVALRY SUPPRESSION; MOTION-INDUCED BLINDNESS; FACIAL EXPRESSIONS; VISUAL AWARENESS; ATTENTION; DISCRIMINATION; PERCEPTION; IMAGERY; OBJECTS	Retinal input that is suppressed from visual awareness can nevertheless produce measurable aftereffects, revealing neural processes that do not directly result in a conscious percept. We here report that the face identity-specific aftereffect requires a visible face; it is effectively cancelled by binocular suppression or by inattentional blindness of the inducing face. Conversely, the same suppression does not interfere with the orientation-specific aftereffect. Thus, the competition between incompatible or interfering visual inputs to reach awareness is resolved before those aspects of information that are exploited in face identification are processed. We also found that the face aftereffect remained intact when the visual distracters in the inattention experiment were replaced with auditory distracters. Thus, cross-modal or cognitive interference that does not affect the visibility of the face does not interfere with the face aftereffect. We conclude that adaptation to face identity depends on seeing the face.	CALTECH, Pasadena, CA 91125 USA; NTT Corp, Commun Sci Lab, Kanagawa 2430198, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Moradi, F (corresponding author), CALTECH, Pasadena, CA 91125 USA.	farshadm@caltech.edu		Koch, Christof/0000-0001-6482-8067				AGHDAEE SM, 2004, IN PRES PERCEPTION; Arnell KM, 2002, PSYCHON B REV, V9, P497, DOI 10.3758/BF03196305; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLANZ V, 1999, 1999 S INT 3D GRAPH, P187; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Boynton GM, 2004, NAT NEUROSCI, V7, P8, DOI 10.1038/nn0104-8; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; de Gelder B, 2000, BRAIN COGNITION, V44, P425, DOI 10.1006/brcg.1999.1203; DEHAAN EHF, 1992, CORTEX, V28, P77, DOI 10.1016/S0010-9452(13)80167-0; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Mack A., 1998, INATTENTIONAL BLINDN; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Montaser-Kouhsari L, 2004, PERCEPTION, V33, P249, DOI 10.1068/p5174; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; OSHEA RP, 1981, VISION RES, V21, P801, DOI 10.1016/0042-6989(81)90177-2; Paller KA, 2003, NEURON, V38, P507, DOI 10.1016/S0896-6273(03)00198-3; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Reddy L, 2004, J VISION, V4, P106, DOI 10.1167/4.2.4; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; WHITE KD, 1978, VISION RES, V18, P1201, DOI 10.1016/0042-6989(78)90105-0; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Young AW, 1996, NEUROPSYCHOLOGIA, V34, P31, DOI 10.1016/0028-3932(95)00062-3	35	130	133	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					169	175		10.1016/j.neuron.2004.12.018	http://dx.doi.org/10.1016/j.neuron.2004.12.018			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629711	Bronze			2022-12-28	WOS:000226217100018
J	Chen, CL; Broom, DC; Liu, Y; de Nooij, JC; Li, Z; Cen, CA; Samad, OA; Jessell, TM; Woolf, CJ; Ma, QF				Chen, CL; Broom, DC; Liu, Y; de Nooij, JC; Li, Z; Cen, CA; Samad, OA; Jessell, TM; Woolf, CJ; Ma, QF			Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain	NEURON			English	Article							PRIMARY AFFERENT NEURONS; MOLECULAR-MECHANISMS; GENE-EXPRESSION; MICE LACKING; RECEPTOR; CHANNEL; FAMILY; GANGLIA; ORGANIZATION; TERMINATION	In mammals, the perception of pain is initiated by the transduction of noxious stimuli through specialized ion channels and receptors expressed by nociceptive sensory neurons. The molecular mechanisms responsible for the specification of distinct sensory modality are, however, largely unknown. We show here that Runx1, a Runt domain transcription factor, is expressed in most nociceptors; during embryonic development but in adult mice, becomes restricted to nociceptors marked by expression of the neurotrophin receptor Ret. In these neurons, Runx1 regulates the expression of many ion channels and receptors, including TRP class thermal receptors, Na+-gated, ATP-gated, and H+-gated channels, the opioid receptor MOR, and Mrgpr class G protein coupled receptors. Runx1 also controls the lamina-specific innervation pattern of nociceptive afferents in the spinal cord. Moreover, mice lacking Runx1 exhibit specific defects in thermal and neuropathic pain. Thus, Runx1 coordinates the phenotype of a large cohort of nociceptors, a finding with implications for pain therapy.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Anaesthesia & Crit Care, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Columbia University; Howard Hughes Medical Institute; Dartmouth College	Ma, QF (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	qiufu_ma@dfci.harvard.edu	Woolf, Clifford/A-9784-2010; samad, omar/K-1921-2012	Liu, Yang/0000-0002-0396-3844				Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Eng SR, 2004, DEVELOPMENT, V131, P3859, DOI 10.1242/dev.01260; Gardell LR, 2003, NAT MED, V9, P1383, DOI 10.1038/nm944; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grazzini E, 2004, P NATL ACAD SCI USA, V101, P7175, DOI 10.1073/pnas.0307185101; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Lanjuin A, 2004, CURR OPIN NEUROBIOL, V14, P22, DOI 10.1016/j.conb.2004.01.006; Lei L, 2005, GENE DEV, V19, P1354, DOI 10.1101/gad.1227705; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lewin GR, 2004, CURR OPIN NEUROBIOL, V14, P443, DOI 10.1016/j.conb.2004.07.009; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Li JL, 1998, BRAIN RES, V794, P347, DOI 10.1016/S0006-8993(98)00332-1; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; Ma L, 2003, DEVELOPMENT, V130, P3525, DOI 10.1242/dev.00582; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McMahon SB, 2004, J NEUROBIOL, V61, P72, DOI 10.1002/neu.20093; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perl ER, 1998, NAT NEUROSCI, V1, P177, DOI 10.1038/624; PERL ER, 1984, HDB PHYSL NERVOUS SY, V1, P915; Potrebic S, 2003, J NEUROSCI, V23, P10988; Price DD, 2003, PAIN, V106, P215, DOI 10.1016/j.pain.2003.10.016; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reed RR, 2004, CELL, V116, P329, DOI 10.1016/S0092-8674(04)00047-9; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Theriault FM, 2004, P NATL ACAD SCI USA, V101, P10343, DOI 10.1073/pnas.0400768101; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Wood JN, 2004, GUT, V53, P9, DOI 10.1136/gut.2003.033423; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Woolf CJ, 2004, LIFE SCI, V74, P2605, DOI 10.1016/j.lfs.2004.01.003; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	68	238	244	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					365	377		10.1016/j.neuron.2005.10.036	http://dx.doi.org/10.1016/j.neuron.2005.10.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446141	Bronze			2022-12-28	WOS:000235260900009
J	Rosenbaum, EE; Hardie, RC; Colley, NJ				Rosenbaum, EE; Hardie, RC; Colley, NJ			Calnexin is essential for rhodopsin maturation, Ca2+ regulation, and photoreceptor cell survival	NEURON			English	Article							CYCLOPHILIN HOMOLOG NINAA; DROSOPHILA-MELANOGASTER; VISUAL TRANSDUCTION; QUALITY-CONTROL; IN-VIVO; ENDOPLASMIC-RETICULUM; RETINAL DEGENERATION; MOLECULAR CHAPERONE; PROTEIN; GENE	In sensory neurons, successful maturation of signaling molecules and regulation of Ca2+ are essential for cell function and survival. Here, we demonstrate a multifunctional role for calnexin as both a molecular chaperone uniquely required for rhodopsin maturation and a regulator of Ca2+ that enters photoreceptor cells during light stimulation. Mutations in Drosophila calnexin lead to severe defects in rhodopsin (Rh1) expression, whereas other photoreceptor cell proteins are expressed normally. Mutations in calnexin also impair the ability of photoreceptor cells to control cytosolic Ca2+ levels following activation of the light-sensitive TRP channels. Finally, mutations in calnexin lead to retinal degeneration that is enhanced by light, suggesting that calnexin's function as a Ca2+ buffer is important for photoreceptor cell survival. Our results illustrate a critical role for calnexin in Rh1 maturation and Ca2+ regulation and provide genetic evidence that defects in calnexin lead to retinal degeneration.	Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA; Univ Wisconsin, Dept Genet, Madison, WI 53792 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Colley, NJ (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA.	njcolley@wisc.edu		Hardie, Roger/0000-0001-5531-3264	Biotechnology and Biological Sciences Research Council [BB/D007585/1] Funding Source: Medline; NEI NIH HHS [R01 EY008768-12, R01 EY008768-18, R01 EY008768-12S1, R01 EY008768-11, R01 EY008768-13S1, R01 EY008768-10A1, R01 EY008768-17S1, R01 EY008768-17, R01 EY008768-13, R01 EY008768-15S1, R01 EY008768-16S1, EY08768, R01 EY008768-14A1, P30 EY016665, R01 EY008768-09, R01 EY008768, R01 EY008768-16, R01 EY008768-15, R01 EY008768-09S1] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY016665, R29EY008768, R01EY008768] Funding Source: NIH RePORTER; BBSRC [BB/D007585/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BAUMANN O, 1994, CELL TISSUE RES, V275, P225, DOI 10.1007/BF00319420; Brody T, 2002, MECH DEVELOP, V113, P41, DOI 10.1016/S0925-4773(02)00010-2; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Christodoulou S, 1997, GENE, V191, P143, DOI 10.1016/S0378-1119(97)00025-5; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellgaard L., 2003, CALRETICULIN, P19, DOI [10.1007/978-1-4419-9258-1_3, DOI 10.1007/978-1-4419-9258-1_3]; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Franceschini N., 1972, INFORMATION PROCESSI, P75; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Georgiev P, 2005, J CELL SCI, V118, P1373, DOI 10.1242/jcs.01712; Hardie RC, 1996, J NEUROSCI, V16, P2924; Hardie RC, 1996, CELL CALCIUM, V20, P315, DOI 10.1016/S0143-4160(96)90037-8; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, J EXP BIOL, V204, P3403; Haug-Collet K, 1999, J CELL BIOL, V147, P659, DOI 10.1083/jcb.147.3.659; Hong CS, 1996, GENETICS, V142, P879; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MONTELL C, 1987, J NEUROSCI, V7, P1558; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberwinkler J, 2000, P NATL ACAD SCI USA, V97, P8578, DOI 10.1073/pnas.97.15.8578; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; PADINJAT R, 2000, MOL CELL NEUROSCI, V15, P429; Pak WL, 2003, RECEPTOR CHANNEL, V9, P149, DOI 10.1080/10606820308242; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Postma M, 1999, BIOPHYS J, V77, P1811, DOI 10.1016/S0006-3495(99)77026-8; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Sung CH, 2000, INT REV CYTOL, V195, P215; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Webel R, 2000, J BIOL CHEM, V275, P24752, DOI 10.1074/jbc.M002668200	57	84	86	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					229	241		10.1016/j.neuron.2005.12.011	http://dx.doi.org/10.1016/j.neuron.2005.12.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423697	Green Accepted, Bronze			2022-12-28	WOS:000234979900010
J	Vervaeke, K; Hu, H; Graham, LJ; Storm, JF				Vervaeke, K; Hu, H; Graham, LJ; Storm, JF			Contrasting effects of the persistent Na+ current on neuronal excitability and spike timing	NEURON			English	Article							ACTION-POTENTIAL GENERATION; SODIUM CURRENT; PYRAMIDAL NEURONS; AFTER-HYPERPOLARIZATION; SMALL-CONDUCTANCE; K+ CHANNELS; RAT; AMPLIFICATION; PRECISION; EPSPS	The persistent Na+ current, /(NaP), is known to amplify subthreshold oscillations and synaptic potentials, but its impact on action potential generation remains enigmatic. Using computational modeling, whole-cell recording, and dynamic clamp of CA1 hippocampal pyramidal cells in brain slices, we examined how /(NaP) changes the transduction of excitatory current into action potentials. Model simulations predicted that /(NaP) increases afterhyperpolarizations, and, although it increases excitability by reducing rheobase, /(NaP) also reduces the gain in discharge frequency in response to depolarizing current (0 gain). These predictions were experimentally confirmed by using dynamic clamp, thus circumventing the longstanding problem that /(NaP) cannot be selectively blocked. Furthermore, we found that /(NaP) increased firing regularity in response to sustained depolarization, although it decreased spike time precision in response to single evoked EPSPs. Finally, model simulations demonstrated that /(NaP) increased the relative refractory period and decreased interspike-interval variability under conditions resembling an active network in vivo.	Univ Oslo, Dept Physiol, Inst Bascal Med, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Paris 05, Lab Neurophys & Physiol, CNRS UMR 8119, UFR Biomed, F-75006 Paris, France	University of Oslo; University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Storm, JF (corresponding author), Univ Oslo, Dept Physiol, Inst Bascal Med, PB 1103 Blindern, N-0317 Oslo, Norway.	jstorm@medisin.uio.no		Hu, Hua/0000-0001-8187-4735				ALZHEIMER C, 1993, J NEUROSCI, V13, P660; Andreasen M, 1999, J PHYSIOL-LONDON, V519, P85, DOI 10.1111/j.1469-7793.1999.0085o.x; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berry MJ, 1998, J NEUROSCI, V18, P2200; BORGGRAHAM L, 1999, CEREBRAL CORTEX, V12; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; FRENCH CR, 1985, NEUROSCI LETT, V56, P289, DOI 10.1016/0304-3940(85)90257-5; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Graham LJ, 2004, SURF HIPPO NEURON SI; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Hallworth NE, 2003, J NEUROSCI, V23, P7525; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hausser M, 2004, J NEUROSCI, V24, P9215, DOI 10.1523/JNEUROSCI.3375-04.2004; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; HOTSON JR, 1980, J NEUROPHYSIOL, V43, P409, DOI 10.1152/jn.1980.43.2.409; HOTSON JR, 1979, J NEUROPHYSIOL, V42, P889, DOI 10.1152/jn.1979.42.3.889; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Kay AR, 1998, J NEUROPHYSIOL, V80, P1167, DOI 10.1152/jn.1998.80.3.1167; Koch Christof, 1999, P1; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; Lien CC, 2003, J NEUROSCI, V23, P2058; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Magistretti J, 1999, J GEN PHYSIOL, V114, P491, DOI 10.1085/jgp.114.4.491; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pinto RD, 2001, J NEUROSCI METH, V108, P39, DOI 10.1016/S0165-0270(01)00368-5; Sah P, 1996, J NEUROSCI, V16, P4537; SAH P, 1988, J GEN PHYSIOL, V91, P373, DOI 10.1085/jgp.91.3.373; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; SKAUGEN E, 1979, ACTA PHYSIOL SCAND, V107, P343, DOI 10.1111/j.1748-1716.1979.tb06486.x; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1990, PROG BRAIN RES, V83, P161; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001	54	115	117	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					257	270		10.1016/j.neuron.2005.12.022	http://dx.doi.org/10.1016/j.neuron.2005.12.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423699	Bronze			2022-12-28	WOS:000234979900012
J	Schroeder, BE; Koo, EH				Schroeder, BE; Koo, EH			To think or not to think: Synaptic activity and A beta release	NEURON			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; PRESENILIN-1; SECRETASE; APP	Accumulation of P-amyloid protein (AP) in the extracellular space of the brain has been hypothesized to be a culprit in the pathogenesis of Alzheimer's disease. In this issue of Neuron, Cirrito et al. describe a series of experiments demonstrating that extracellular AP levels are directly modulated by neuronal and synaptic activity.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Schroeder, BE (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.							Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410	12	14	14	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					873	875		10.1016/j.neuron.2005.12.005	http://dx.doi.org/10.1016/j.neuron.2005.12.005			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364890	Bronze			2022-12-28	WOS:000234301700001
J	Tolias, AS; Sultan, F; Augath, M; Oeltermann, A; Tehovnik, EJ; Schiller, PH; Logothetis, NK				Tolias, AS; Sultan, F; Augath, M; Oeltermann, A; Tehovnik, EJ; Schiller, PH; Logothetis, NK			Mapping cortical activity elicited with electrical microstimulation using fMRI in the macaque	NEURON			English	Article							PYRAMIDAL TRACT CELLS; PRIMARY VISUAL-CORTEX; SUPERIOR TEMPORAL SULCUS; SACCADIC EYE-MOVEMENTS; STRIATE CORTEX; RHESUS-MONKEY; FRONTAL-CORTEX; INTRACORTICAL MICROSTIMULATION; INTRINSIC CONNECTIONS; AXONAL PROJECTIONS	Over the last two centuries, electrical microstimulation has been used to demonstrate causal links between neural activity and specific behaviors and cognitive functions. However, to establish these links it is imperative to characterize the cortical activity patterns that are elicited by stimulation locally around the electrode and in other functionally connected areas. We have developed a technique to record brain activity using the blood oxygen level dependent (BOLD) signal while applying electrical microstimulation to the primate brain. We find that the spread of activity around the electrode tip in macaque area V1 was larger than expected from calculations based on passive spread of current and therefore may reflect functional spread by way of horizontal connections. Consistent with this functional transynaptic spread we also obtained activation in expected projection sites in extrastriate visual areas, demonstrating the utility of our technique in uncovering in vivo functional connectivity maps.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Massachusetts Institute of Technology (MIT)	Tolias, AS (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	andreas.tolias@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019		NATIONAL EYE INSTITUTE [R01EY014884] Funding Source: NIH RePORTER; NEI NIH HHS [EY014884] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGNEW WF, 1986, EXP NEUROL, V92, P162, DOI 10.1016/0014-4886(86)90132-9; [Anonymous], 1901, ARCH ITAL BIOL; ASANUMA H, 1976, EXP BRAIN RES, V26, P443; ASANUMA H, 1973, EXP BRAIN RES, V16, P507, DOI 10.1007/BF00234477; Austin VC, 2003, MAGNET RESON MED, V49, P838, DOI 10.1002/mrm.10428; Bartlett JR, 2005, J NEUROPHYSIOL, V94, P3430, DOI 10.1152/jn.00406.2005; BEEBE X, 1988, IEEE T BIO-MED ENG, V35, P494, DOI 10.1109/10.2122; BLASDEL GG, 1985, J NEUROSCI, V5, P3350; Brecht M, 2004, J NEUROPHYSIOL, V92, P424, DOI 10.1152/jn.00639.2003; Brewer AA, 2002, J NEUROSCI, V22, P10416; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; BRUMMER SB, 1983, ANN NY ACAD SCI, V405, P159, DOI 10.1111/j.1749-6632.1983.tb31628.x; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DOBELLE WH, 1974, J PHYSIOL-LONDON, V243, P553, DOI 10.1113/jphysiol.1974.sp010766; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; DOTY RW, 1981, ELECT STIMULATION RE, P71; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FINLAY BL, 1976, J NEUROPHYSIOL, V39, P1352, DOI 10.1152/jn.1976.39.6.1352; FISKEN RA, 1973, BRAIN RES, V53, P208, DOI 10.1016/0006-8993(73)90782-8; FITZPATRICK D, 1985, J NEUROSCI, V5, P3329; FRITSCH G, 1870, CEREB CORTEX, P73; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; HENTALL ID, 1984, J NEUROPHYSIOL, V51, P968, DOI 10.1152/jn.1984.51.5.968; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P597, DOI 10.1113/jphysiol.1972.sp009817; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P637, DOI 10.1113/jphysiol.1975.sp011035; LI CL, 1976, EXP NEUROL, V50, P67, DOI 10.1016/0014-4886(76)90236-3; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MCILWAIN JT, 1982, J NEUROPHYSIOL, V47, P167, DOI 10.1152/jn.1982.47.2.167; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; Nowak LG, 1997, CEREBR CORT, V12, P205; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; PERKEL DJ, 1986, J COMP NEUROL, V253, P374, DOI 10.1002/cne.902530307; Peters A, 1996, J COMP NEUROL, V365, P232; PETERS A, 1991, J COMP NEUROL, V306, P1, DOI 10.1002/cne.903060102; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; ROBERTS WJ, 1973, ACTA PHYSIOL SCAND, V89, P384, DOI 10.1111/j.1748-1716.1973.tb05533.x; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; ROCKLAND KS, 1981, BRAIN RES, V212, P249, DOI 10.1016/0006-8993(81)90461-3; RONNER SF, 1981, CLIN NEUROPHYSIOL, V52, P375; Rushton D. N., 1978, Frontiers in Visual Science, P574; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schafer E., 1888, BRAIN, V11, P1; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SCHILLER PH, 1979, BRAIN RES, V179, P162, DOI 10.1016/0006-8993(79)90500-6; SCLOSSER MJ, 1999, NEUROSURG FOCUS, V6, P1; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; SIBLEY GNA, 1984, J PHYSIOL-LONDON, V354, P431, DOI 10.1113/jphysiol.1984.sp015386; Sincich LC, 2003, J NEUROSCI, V23, P5684; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; TEHOVNIK EJ, 1993, EXP BRAIN RES, V96, P430; Tehovnik EJ, 2005, J NEUROPHYSIOL, V93, P1, DOI 10.1152/jn.00736.2004; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; WOOSLEY CN, 1952, RES PUBL ASS NERV ME, V30, P328; YEOMANS J, 1995, BEHAV BRAIN RES, V67, P121, DOI 10.1016/0166-4328(94)00149-A; Yeomans J. S., 1990, PRINCIPLES BRAIN STI; YEOMANS JS, 1988, BRAIN RES REV, V13, P235, DOI 10.1016/0165-0173(88)90008-2; YUKIE M, 1985, BRAIN RES, V346, P383, DOI 10.1016/0006-8993(85)90875-3; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	78	196	198	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					901	911		10.1016/j.neuron.2005.11.034	http://dx.doi.org/10.1016/j.neuron.2005.11.034			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364895	Bronze, Green Published			2022-12-28	WOS:000234301700007
J	Jacobs, WB; Govoni, G; Ho, D; Atwal, JK; Barnabe-Heider, F; Keyes, WM; Mills, AA; Miller, FD; Kaplan, DR				Jacobs, WB; Govoni, G; Ho, D; Atwal, JK; Barnabe-Heider, F; Keyes, WM; Mills, AA; Miller, FD; Kaplan, DR			P63 is an essential proapoptotic protein during neural development	NEURON			English	Article							CYTOCHROME-C RELEASE; PROMOTES NEURONAL SURVIVAL; PROGRAMMED CELL-DEATH; P53 FAMILY; P53-DEPENDENT APOPTOSIS; SYMPATHETIC NEURONS; TUMOR-SUPPRESSOR; NERVOUS-SYSTEM; P73; BAX	The p53 family member p63 is required for nonneural development, but has no known role in the nervous system. Here, we define an essential proapoptotic role for p63 during naturally occurring neuronal death. Sympathetic neurons express full-length TAp63 during the developmental death period, and TAp63 levels increase following NGF withdrawal. Overexpression of TAp63 causes neuronal apoptosis in the presence of NGF, while cultured p63(-/-) neurons are resistant to apoptosis following NGF withdrawal. TAp63 is also essential in vivo, since embryonic p63(-/-) mice display a deficit in naturally occurring sympathetic neuron death. While both TAp63 and p53 induce similar apoptotic signaling proteins and require BAX expression and function for their effects, TAp63 induces neuronal death in the absence of p53, but p53 requires coincident p63 expression for its proapoptotic actions. Thus, p63 is essential for developmental neuronal death, likely functioning both on its own, and as an obligate proapoptotic partner for p53.	Univ Toronto, Hosp Sick Children, Canc Res Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dev Biol Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; Univ Toronto, Div Neurosurg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; McGill University; Cold Spring Harbor Laboratory	Kaplan, DR (corresponding author), Univ Toronto, Hosp Sick Children, Canc Res Program, Toronto, ON M5G 1X8, Canada.	dkaplan@sickkids.ca		Govoni, Gregory/0000-0002-4664-0834; Keyes, William M./0000-0002-8917-2268				Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; COGGESHALL RE, 1984, J NEUROSCI METH, V12, P125, DOI 10.1016/0165-0270(84)90011-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eilers A, 1998, J NEUROSCI, V18, P1713; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kirkland RA, 2002, J NEUROSCI, V22, P6480; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lee AF, 2004, J NEUROSCI, V24, P9174, DOI 10.1523/JNEUROSCI.1588-04.2004; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MIYASHITA T, 1995, CELL, V80, P293; Moll UM, 2004, MOL CANCER RES, V2, P371; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Senoo M, 2004, CANCER CELL, V6, P85, DOI 10.1016/j.ccr.2004.06.005; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Vogel KS, 1998, MOL CELL NEUROSCI, V11, P19, DOI 10.1006/mcne.1998.0670; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	48	93	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					743	756		10.1016/j.neuron.2005.10.027	http://dx.doi.org/10.1016/j.neuron.2005.10.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337913	Bronze			2022-12-28	WOS:000233927300014
J	Nicotera, P; Melino, G				Nicotera, P; Melino, G			Neurodevelopment on route p63	NEURON			English	Editorial Material							P53 HOMOLOG; P73; DEATH; DELTA-NP63-ALPHA; APOPTOSIS; CANCER; LIMB	All known members of the p53 gene family, including the two homologs p73 and p63, have multiple biological functions. In neurons, p53 and p73 are known to regulate cell death in the developing and adult nervous system. A report by Jacobs et al. in this issue of Neuron shows that the more ancestral member of this gene family, p63, is an essential proapoptotic protein during neuronal development.	Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	Nicotera, P (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg, Leicester LE1 9HN, Leics, England.							Barbieri CE, 2003, J BIOL CHEM, V278, P51408, DOI 10.1074/jbc.M309943200; Bernassola F, 2005, ONCOGENE, V24, P6982, DOI 10.1038/sj.onc.1208843; Billon N, 2004, DEVELOPMENT, V131, P1211, DOI 10.1242/dev.01035; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Wu GJ, 2003, CANCER RES, V63, P2351; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	15	8	8	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 8	2005	48	5					707	709		10.1016/j.neuron.2005.11.023	http://dx.doi.org/10.1016/j.neuron.2005.11.023			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337905	Bronze			2022-12-28	WOS:000233927300006
J	Miyawaki, A				Miyawaki, A			Innovations in the imaging of brain functions using fluorescent proteins	NEURON			English	Editorial Material							GENETICALLY ENCODED INDICATORS; MONOMERIC RED; NEURONAL-ACTIVITY; NEURAL ACTIVITY; ENERGY-TRANSFER; CA2+; DYNAMICS; PROBE; FRET; GFP	Fluorescence imaging has enabled us to decipher spatiotemporal information coded in complex tissues. Genetically encoded probes that enable fluorescence imaging of excitable cell activity have been constructed by fusing fluorescent proteins to functional proteins that are involved in physiological signaling. The probes are introduced into an intact organism and targeted to specific tissues, cell types, or subcellular compartments, thereby allowing specific signals to be extracted more efficiently than was previously possible. In this primer, I will describe how this approach has met neuroscientists' demands and desires.	RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Adv Technol Dev Grp, Wako, Saitama 3510198, Japan	RIKEN	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Adv Technol Dev Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235				Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Dela Cruz JM, 2004, P NATL ACAD SCI USA, V101, P16996, DOI 10.1073/pnas.0407733101; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guerrero G, 2002, BIOPHYS J, V83, P3607, DOI 10.1016/S0006-3495(02)75361-7; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Hell SW, 2004, CURR OPIN NEUROBIOL, V14, P599, DOI 10.1016/j.conb.2004.08.015; Helmchen F, 2002, CURR OPIN NEUROBIOL, V12, P593, DOI 10.1016/S0959-4388(02)00362-8; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kawano H, 2003, BIOCHEM BIOPH RES CO, V311, P592, DOI 10.1016/j.bbrc.2003.09.236; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LUKYANOV KA, 2005, IN PRESS NAT REV MOL; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; Marchant JS, 2001, NAT BIOTECHNOL, V19, P645, DOI 10.1038/90249; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; MIESENBOCK G, 1998, NATURE, V433, P741; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Mongin O, 2002, ORG LETT, V4, P719, DOI 10.1021/ol017150e; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Sasaki E, 2005, J AM CHEM SOC, V127, P3684, DOI 10.1021/ja042967z; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SHKROB MA, IN PRESS BIOCEM J; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Truong K, 2001, NAT STRUCT BIOL, V8, P1069, DOI 10.1038/nsb728; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Verkhusha VV, 2005, CHEM BIOL, V12, P279, DOI 10.1016/j.chembiol.2005.01.005; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zochowski M, 2000, BIOL BULL-US, V198, P1, DOI 10.2307/1542798	101	125	134	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					189	199		10.1016/j.neuron.2005.10.003	http://dx.doi.org/10.1016/j.neuron.2005.10.003			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242400	Bronze			2022-12-28	WOS:000232838700009
J	DeWeese, MR; Zador, AM				DeWeese, MR; Zador, AM			Neural gallops across auditory streams	NEURON			English	Editorial Material							CORTEX; SEPARATION; SEGREGATION; PERCEPTION; MONKEY; TASK	We continually rely on our ability to segregate the myriad sounds in our environment-phones ringing, people talking-into separate "auditory streams," each originating from a different source. In this issue of Neuron, Micheyl et al. provide the most direct evidence to date linking single-unit spiking responses from auditory cortex to the perception of distinct auditory streams.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	DeWeese, MR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Zador, Anthony/0000-0002-8431-9136				Barbour DL, 2003, J NEUROSCI, V23, P7194, DOI 10.1523/JNEUROSCI.23-18-07194.2003; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bregman A.S., 1990, AUDITORY SCENE ANAL; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; HOCHERMAN S, 1976, BRAIN RES, V117, P51, DOI 10.1016/0006-8993(76)90555-2; HUBEL DH, 1959, SCIENCE, V129, P1279, DOI 10.1126/science.129.3358.1279; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Zibulevsky M, 2001, NEURAL COMPUT, V13, P863, DOI 10.1162/089976601300014385	13	0	0	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 6	2005	48	1					5	7		10.1016/j.neuron.2005.09.010	http://dx.doi.org/10.1016/j.neuron.2005.09.010			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202703	Bronze			2022-12-28	WOS:000232625700003
J	Knaut, H; Blader, P; Strahle, U; Schier, AF				Knaut, H; Blader, P; Strahle, U; Schier, AF			Assembly of trigeminal sensory ganglia by chemokine signaling	NEURON			English	Article							GERM-CELL MIGRATION; LATERAL-LINE SYSTEM; NEURAL CREST; ZEBRAFISH EMBRYO; GENE-EXPRESSION; CRANIAL GANGLIA; RECEPTOR CXCR4; NEURONS; NEUROGENIN1; CADHERIN	Sensory neurons with related functions form ganglia, but how these precisely positioned clusters are assembled has been unclear. Here, we use the zebrafish trigeminal sensory ganglion as a model to address this question. We find that some trigeminal sensory neurons are born at the position where the ganglion is assembled, whereas others are born at a distance and have to migrate against opposing morphogenetic movements to reach the site of ganglion assembly. Loss of Cxcr4b-mediated chemokine signaling results in the formation of mispositioned ganglia. Conversely, ectopic sources of the chemokine SDF1a can attract sensory neurons. Transplantation experiments reveal that neuron-neuron interaction and the adhesion molecules E- and N-Cadherin also contribute to ganglion assembly. These results indicate that ganglion formation depends on the interplay of birthplace, chemokine attraction, cell-cell interaction, and cadherin-mediated adhesion.	NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Univ Toulouse 3, Ctr Dev Biol, F-31062 Toulouse, France; Forschungszentrum Karlsruhe, Inst Genet & Toxikol, D-76021 Karlsruhe, Germany	New York University; New York University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Helmholtz Association; Karlsruhe Institute of Technology	Knaut, H (corresponding author), NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	knaut@saturn.med.nyu.edu; schier@saturn.med.nyu.edu	Straehle, Uwe/K-7054-2013	Schier, Alexander Franz/0000-0001-7645-5325; Knaut, Holger/0000-0002-8399-8720; Blader, Patrick/0000-0003-3299-6108				Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Artinger KB, 1999, DEVELOPMENT, V126, P3969; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Blader P, 1997, DEVELOPMENT, V124, P4557; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; Carmany-Rampey A, 2001, CURR BIOL, V11, P1261, DOI 10.1016/S0960-9822(01)00353-0; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Cornell RA, 2002, DEVELOPMENT, V129, P2639; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; DAVIES AM, 1988, DEVELOPMENT, V103, P175; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Halloran MC, 2000, DEVELOPMENT, V127, P1953; HAMBURGER V, 1961, J EXP ZOOL, V148, P91, DOI 10.1002/jez.1401480202; Hernandez-Lagunas L, 2005, DEV BIOL, V278, P347, DOI 10.1016/j.ydbio.2004.11.014; Holley SA, 2000, GENE DEV, V14, P1678; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kerstetter AE, 2004, DEV DYNAM, V230, P137, DOI 10.1002/dvdy.20021; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kim CH, 1997, NEUROSCI LETT, V239, P113, DOI 10.1016/S0304-3940(97)00908-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein RS, 2001, DEVELOPMENT, V128, P1971; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lele Z, 2002, DEVELOPMENT, V129, P3281; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Liu Q, 2003, GENE EXPR PATTERNS, V3, P653, DOI 10.1016/S1567-133X(03)00109-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Meulemans D, 2002, DEVELOPMENT, V129, P4953; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Norton WHJ, 2000, MECH DEVELOP, V99, P149, DOI 10.1016/S0925-4773(00)00472-X; Ober EA, 1999, DEV BIOL, V215, P167, DOI 10.1006/dbio.1999.9455; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Romer AS., 1986, VERTEBRATE BODY; Roy S, 2004, CURR BIOL, V14, P1772, DOI 10.1016/j.cub.2004.09.046; Schimel D, 2003, ECOL APPL, V13, P1, DOI 10.1890/1051-0761(2003)013[0001:E]2.0.CO;2; Schlosser G, 2000, J COMP NEUROL, V418, P121; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; WILSON SW, 1991, DEVELOPMENT, V112, P723; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	64	70	73	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					653	666		10.1016/j.neuron.2005.07.014	http://dx.doi.org/10.1016/j.neuron.2005.07.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129396	Bronze			2022-12-28	WOS:000231782700008
J	D'Arcangelo, G				D'Arcangelo, G			Apoer2: A Reelin receptor to remember	NEURON			English	Editorial Material							LIPOPROTEIN RECEPTORS; VLDL RECEPTOR; NEURONS		Texas Childrens Hosp, Cain Fdn Labs, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Dept Neurosci, Houston, TX 77030 USA; Texas Childrens Hosp, Program Dev Biol & Translat Biol, Houston, TX 77030 USA; Texas Childrens Hosp, Program Mol Med, Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	D'Arcangelo, G (corresponding author), Texas Childrens Hosp, Cain Fdn Labs, Dept Pediat, Houston, TX 77030 USA.			D'Arcangelo, Gabriella/0000-0003-1575-1010				Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 2005, INT REV NEUROBIOLOGY, V71; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Martinez-Cerdeno V, 2002, CEREB CORTEX, V12, P1298, DOI 10.1093/cercor/12.12.1298; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200	10	47	49	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 18	2005	47	4					471	473		10.1016/j.neuron.2005.08.001	http://dx.doi.org/10.1016/j.neuron.2005.08.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102527	Bronze			2022-12-28	WOS:000231411100001
J	Gottfried, JA				Gottfried, JA			A truffle in the mouth is worth two in the bush: Odor localization in the human brain	NEURON			English	Editorial Material							OLFACTION; TASTE		Northwestern Univ, Dept Neurol, Cognit Neurol & Alzheimers Dis Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Gottfried, JA (corresponding author), Northwestern Univ, Dept Neurol, Cognit Neurol & Alzheimers Dis Ctr, Feinberg Sch Med, 320 E Super St, Chicago, IL 60611 USA.							Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; MURPHY C, 1977, SENS PROCESS, V1, P204; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; Radil T, 1998, ANN NY ACAD SCI, V855, P641, DOI 10.1111/j.1749-6632.1998.tb10638.x; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; VONBEKESY G, 1964, J APPL PHYSIOL, V19, P369, DOI 10.1152/jappl.1964.19.3.369; Wilson DA, 1999, PHYSIOL BEHAV, V66, P41, DOI 10.1016/S0031-9384(98)00269-8; Wilson DA, 1997, J NEUROPHYSIOL, V78, P160, DOI 10.1152/jn.1997.78.1.160	15	9	9	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 18	2005	47	4					473	476		10.1016/j.neuron.2005.08.002	http://dx.doi.org/10.1016/j.neuron.2005.08.002			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102528	Bronze			2022-12-28	WOS:000231411100002
J	Beierlein, M; Regehr, WG				Beierlein, M; Regehr, WG			Conventional synapses for unconventional cells	NEURON			English	Editorial Material							GLIAL-CELLS; RELEASE	Powerful synapses between climbing fibers (CF) and Purkinje cells are crucial to cerebellar motor learning. In this issue of Neuron, Lin and colleagues provide compelling evidence for the existence of direct synaptic contacts between CFs and NG2-expressing glia cells, adding to the intrigue of neuro-glial interactions.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beierlein, M (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Beierlein, Michael/0000-0003-2210-3118				Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; ECCLES J, 1964, NATURE, V203, P245, DOI 10.1038/203245a0; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Lin SC, 2002, J NEUROCYTOL, V31, P537, DOI 10.1023/A:1025799816285; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Marcaggi P, 2004, GLIA, V47, P217, DOI 10.1002/glia.20027; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Palay S.L., 1974, CEREBELLAR CORTEX	12	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					694	696		10.1016/j.neuron.2005.05.017	http://dx.doi.org/10.1016/j.neuron.2005.05.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924854	Bronze			2022-12-28	WOS:000229689800002
J	Nelson, AB; Gittis, AH; du Lac, S				Nelson, AB; Gittis, AH; du Lac, S			Decreases in CaMKII activity trigger persistent potentiation of intrinsic excitability in spontaneously firing vestibular nucleus neurons	NEURON			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; BRAIN-STEM NEURONS; AUTOPHOSPHORYLATION SITES; INHIBITORY AUTOPHOSPHORYLATION; HIPPOCAMPAL-NEURONS; SUBTHALAMIC NEURONS; CEREBELLAR NUCLEI; IONIC CURRENTS; SODIUM CURRENT	Calcium/calmodulin-dependent protein kinase II (CaMKII) has been described as a biochemical switch that is turned on by increases in intracellular calcium to mediate synaptic plasticity. Here, we show that reductions in CaMKII activity trigger persistent increases in intrinsic excitability. In spontaneously firing vestibular nucleus neurons, CaMKII activity is near maximal, and blockade of CaMKII activity increases excitability by reducing BK-type calcium-activated potassium currents. Firing rate potentiation, a form of plasticity in which synaptic inhibition induces long-lasting increases in excitability, is occluded by prior blockade of CaMKII and blocked by addition of constitutively active CaMKII. Reductions in CaMKII activity are necessary and sufficient to induce firing rate potentiation and may contribute to motor learning in the vestibulo-ocular reflex.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	du Lac, S (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sascha@salk.edu	Gittis, Aryn/I-6128-2016	Gittis, Aryn/0000-0002-3591-5775	NATIONAL EYE INSTITUTE [R01EY011027] Funding Source: NIH RePORTER; NEI NIH HHS [EY11027] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; ALKON DL, 1984, SCIENCE, V226, P1037, DOI 10.1126/science.6093258; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bennett BD, 1999, J NEUROSCI, V19, P5586; Bevan MD, 1999, J NEUROSCI, V19, P7617, DOI 10.1523/JNEUROSCI.19-17-07617.1999; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Cameron SA, 1997, NEUROREPORT, V8, P2595, DOI 10.1097/00001756-199707280-00035; Churn SB, 2000, P NATL ACAD SCI USA, V97, P5604, DOI 10.1073/pnas.080071697; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Darlington CL, 2002, EUR J NEUROSCI, V15, P1719, DOI 10.1046/j.1460-9568.2002.02024.x; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Fox K, 2003, CURR BIOL, V13, pR143, DOI 10.1016/S0960-9822(03)00077-0; FUCHS AF, 1975, J NEUROPHYSIOL, V38, P1140, DOI 10.1152/jn.1975.38.5.1140; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; JOHNSTON AR, 1994, J PHYSIOL-LONDON, V481, P61, DOI 10.1113/jphysiol.1994.sp020419; KURET J, 1985, J BIOL CHEM, V260, P6427; LAI Y, 1987, P NATL ACAD SCI USA, V84, P5710, DOI 10.1073/pnas.84.16.5710; LICKTEIG R, 1988, J BIOL CHEM, V263, P19232; LIN Y, 1993, CELL MOL NEUROBIOL, V13, P601, DOI 10.1007/BF00711560; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P928, DOI 10.1152/jn.1994.72.2.928; LISBERGER SG, 1988, SCIENCE, V242, P771, DOI 10.1126/science.3142040; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LOU LL, 1989, J NEUROSCI, V9, P2020; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; PARTSALIS AM, 1995, J NEUROPHYSIOL, V73, P615, DOI 10.1152/jn.1995.73.2.615; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PRECHT W, 1966, J NEUROPHYSIOL, V29, P996, DOI 10.1152/jn.1966.29.6.996; Raman IM, 2000, J NEUROSCI, V20, P9004; Sansom SC, 2000, AM J PHYSIOL-RENAL, V279, pF283, DOI 10.1152/ajprenal.2000.279.2.F283; Schulman H, 2004, J NEUROSCI, V24, P8399, DOI 10.1523/JNEUROSCI.3606-04.2004; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Sekirnjak C, 2002, J NEUROSCI, V22, P2083, DOI 10.1523/JNEUROSCI.22-06-02083.2002; SERAFIN M, 1991, EXP BRAIN RES, V84, P426, DOI 10.1007/BF00231465; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Yamanaka T, 2000, J PHYSIOL-LONDON, V523, P413, DOI 10.1111/j.1469-7793.2000.t01-1-00413.x; Yoshimura Y, 1999, FEBS LETT, V446, P239, DOI 10.1016/S0014-5793(99)00226-4; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	57	83	85	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					623	631		10.1016/j.neuron.2005.04.009	http://dx.doi.org/10.1016/j.neuron.2005.04.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944130	Bronze			2022-12-28	WOS:000229294300013
J	Campbell, K				Campbell, K			Cortical neuron specification: It has its time and place	NEURON			English	Review							MAMMALIAN TELENCEPHALON; SUBVENTRICULAR ZONE; TRANSCRIPTION FACTOR; CEREBRAL-CORTEX; LAYER NEURONS; RADIAL GLIA; EXPRESSION; PAX6; FATE; NEUROGENESIS		Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Campbell, K (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	kenneth.campbell@chmcc.org	Campbell, Kenneth/ABC-3570-2021					Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Desai AR, 2000, DEVELOPMENT, V127, P2863; Fode C, 2000, GENE DEV, V14, P67; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Land PW, 2003, CEREB CORTEX, V13, P921, DOI 10.1093/cercor/13.9.921; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Stenman J, 2003, DEVELOPMENT, V130, P1113, DOI 10.1242/dev.00328; Stoykova A, 2000, J NEUROSCI, V20, P8042; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Toresson H, 2000, DEVELOPMENT, V127, P4361; Viti J, 2003, J NEUROSCI, V23, P5919; Yun K, 2001, DEVELOPMENT, V128, P193; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	31	48	50	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					373	376		10.1016/j.neuron.2005.04.014	http://dx.doi.org/10.1016/j.neuron.2005.04.014			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882634	Bronze			2022-12-28	WOS:000229011400006
J	Soriano, E; del Rio, JA				Soriano, E; del Rio, JA			The cells of Cajal-Retzius: Still a mystery one century after	NEURON			English	Review							HUMAN HIPPOCAMPAL-FORMATION; MESSENGER-RNA EXPRESSION; RADIAL GLIAL SCAFFOLD; RAT CEREBRAL-CORTEX; NEURONAL MIGRATION; CORTICAL DEVELOPMENT; REELIN EXPRESSION; DENDRITIC SPINE; DOWN-REGULATION; MOUSE-BRAIN		Inst Recerca Biomed Barcelona, Barcelona 08028, Spain; Univ Barcelona, Dept Cell Biol, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Soriano, E (corresponding author), Inst Recerca Biomed Barcelona, Parc Cientif Barcelona, Barcelona 08028, Spain.	esoriano@pcb.ub.es	Del Rio Fernandez, Jose A/AAD-1121-2020; del rio, jose antonio/L-9232-2014; Soriano, Eduardo/AAB-3216-2019	del rio, jose antonio/0000-0002-5214-4909; Soriano, Eduardo/0000-0002-3204-9285				Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Abraham H, 2004, CEREB CORTEX, V14, P484, DOI 10.1093/cercor/bhh010; Abraham H, 2003, HIPPOCAMPUS, V13, P715, DOI 10.1002/hipo.10125; Aguilo A, 1999, J NEUROSCI, V19, P10856, DOI 10.1523/JNEUROSCI.19-24-10856.1999; Alcantara S, 1998, J NEUROSCI, V18, P7779; Beffert U, 2004, J NEUROSCI, V24, P1897, DOI 10.1523/JNEUROSCI.4084-03.2004; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Benardete EA, 2002, EPILEPSIA, V43, P970, DOI 10.1046/j.1528-1157.2002.40901.x; Boncinelli Edoardo, 2000, Novartis Foundation Symposium, V228, P53; Borrell V, 1999, J NEUROSCI, V19, P1345; Caviness V S Jr, 1982, Brain Res, V256, P293; Costa E, 2001, NEUROBIOL DIS, V8, P723, DOI 10.1006/nbdi.2001.0436; DAMANGELO G, 1999, NEURON, V24, P471; DAMANGELO G, 1995, NATURE, V374, P719; DEFLIO JA, 1995, CEREB CORTEX, V5, P13; DEFLIO JA, 1996, J NEUROSCI, V16, P6896; del Rio JA, 2002, EUR J NEUROSCI, V15, P1881, DOI 10.1046/j.1460-9568.2002.02027.x; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Eriksson SH, 2001, BRAIN, V124, P1350, DOI 10.1093/brain/124.7.1350; Fatemi SH, 2001, MOL PSYCHIATR, V6, P129, DOI 10.1038/sj.mp.4000129; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014; Gorski JA, 2002, J NEUROSCI, V22, P6309; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gressens P, 2000, PEDIATR RES, V48, P725, DOI 10.1203/00006450-200012000-00004; Haas CA, 2002, J NEUROSCI, V22, P5797; Halfter W, 2002, J NEUROSCI, V22, P6029; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Hering H, 2000, J COMP NEUROL, V424, P153, DOI 10.1002/1096-9861(20000814)424:1<153::AID-CNE11>3.0.CO;2-1; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Kilb W, 2002, NEUROSCIENCE, V112, P299, DOI 10.1016/S0306-4522(02)00071-4; Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299; Kuvbachieva A, 2004, EUR J NEUROSCI, V20, P603, DOI 10.1111/j.1460-9568.2004.03473.x; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; Lu SM, 2001, J NEUROPHYSIOL, V86, P2642, DOI 10.1152/jn.2001.86.5.2642; Luque JM, 2003, DEV BRAIN RES, V140, P195, DOI 10.1016/S0165-3806(02)00604-1; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Martinez-Galan JR, 2001, EUR J NEUROSCI, V13, P1147, DOI 10.1046/j.0953-816x.2001.01494.x; Marty S, 1996, J NEUROSCI, V16, P675; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Mienville JM, 1999, J NEUROSCI, V19, P1636; Noh JS, 2005, P NATL ACAD SCI USA, V102, P1749, DOI 10.1073/pnas.0409648102; Okabe A, 2004, NEUROSCIENCE, V123, P715, DOI 10.1016/j.neuroscience.2003.10.014; Perez-Garcia CG, 2004, EUR J NEUROSCI, V20, P2827, DOI 10.1111/j.1460-9568.2004.03733.x; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Radnikow G, 2002, J NEUROSCI, V22, P6908; Rakic S, 2003, CEREB CORTEX, V13, P1072, DOI 10.1093/cercor/13.10.1072; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; SCHMID RS, 2002, IN PRESS CEREB CORTE; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Soda T, 2003, J NEUROSCI, V23, P6272; Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Super H, 1998, J NEUROSCI, V18, P4616; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Veldic M, 2004, P NATL ACAD SCI USA, V101, P348, DOI 10.1073/pnas.2637013100; Weiss KH, 2003, J COMP NEUROL, V460, P56, DOI 10.1002/cne.10644; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001	79	178	186	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					389	394		10.1016/j.neuron.2005.04.019	http://dx.doi.org/10.1016/j.neuron.2005.04.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882637	Bronze			2022-12-28	WOS:000229011400009
J	Zuo, Y; Lin, A; Chang, P; Gan, WB				Zuo, Y; Lin, A; Chang, P; Gan, WB			Development of long-term dendritic spine stability in diverse regions of cerebral cortex	NEURON			English	Article							IN-VIVO; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; STRIATE CORTEX; VISUAL-CORTEX; ADULT CORTEX; LIVING MICE; SYNAPSES; SYNAPTOGENESIS; RAT	Synapse formation and elimination occur throughout life, but the magnitude of such changes at distinct developmental stages remains unclear. Using transgenic mice overexpressing yellow fluorescent protein and transcranial two-photon microscopy, we repeatedly imaged dendritic spines on the apical dendrites of layer 5 pyramidal neurons. In young adolescent mice (1-month-old), 13%-20% of spines were eliminated and 5%-8% formed over 2 weeks in barrel, motor, and frontal cortices, indicating a cortical-wide spine loss during this developmental period. As animals mature, there is also a substantial loss of dendritic filopodia involved in spinogenesis. In adult mice (4-6 months old), 3%-5% of spines were eliminated and formed over 2 weeks in various cortical regions. Over 18 months, only 26% of spines were eliminated and 19% formed in adult barrel cortex. Thus, after a concurrent loss of spines and spine precursors in diverse regions of young adolescent cortex, spines become stable and a majority of them can last throughout life.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst,Dept Physiol & Neurosci, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst,Dept Physiol & Neurosci, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu		Zuo, Yi/0000-0001-9020-0003				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dailey ME, 1996, J NEUROSCI, V16, P2983; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Grossman AW, 2002, PROG BRAIN RES, V138, P91, DOI 10.1016/S0079-6123(02)38073-7; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LUBKE J, 1989, DEV BRAIN RES, V45, P29, DOI 10.1016/0165-3806(89)90004-7; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Peters A, 1998, CEREB CORTEX, V8, P671, DOI 10.1093/cercor/8.8.671; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	32	469	479	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					181	189		10.1016/j.neuron.2005.04.001	http://dx.doi.org/10.1016/j.neuron.2005.04.001			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848798	Bronze			2022-12-28	WOS:000228674800006
J	Hoebeek, FE; Stahl, JS; van Alphen, AM; Schonewille, M; Luo, C; Rutteman, M; van den Maagdenberg, AMJM; Molenaar, R; Goossens, HHLM; Frens, MA; De Zeeuw, CI				Hoebeek, FE; Stahl, JS; van Alphen, AM; Schonewille, M; Luo, C; Rutteman, M; van den Maagdenberg, AMJM; Molenaar, R; Goossens, HHLM; Frens, MA; De Zeeuw, CI			Increased noise level of Purkinje cell activities minimizes impact of their modulation during sensorimotor control	NEURON			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; COMPLEX SPIKE ACTIVITY; CALCIUM-CHANNEL; P-TYPE; INTRINSIC EXCITABILITY; SYNAPTIC-TRANSMISSION; CEREBELLAR-ATAXIA; ALPHA(1A) SUBUNIT; NUCLEUS NEURONS; CA2+ CHANNELS	While firing rate is well established as a relevant parameter for encoding information exchanged between neurons, the significance of other parameters is more conjectural. Here, we show that regularity of neuronal spike activities affects sensorimotor processing in tottering mutants, which suffer from a mutation in P/Q-type voltage-gated calcium channels. While the modulation amplitude of the simple spike firing rate of their floccular Purkinje cells during optokinetic stimulation is indistinguishable from that of wild-types, the regularity of their firing is markedly disrupted. The gain and phase values of tottering's compensatory eye movements are indistinguishable from those of flocculectomized wild-types or from totterings with the flocculus treated with P/Q-type calcium channel blockers. Moreover, normal eye movements can be evoked in tottering when the flocculus is electrically stimulated with regular spike trains mimicking the firing pattern of normal simple spikes. This study demonstrates the importance of regularity of firing in Purkinje cells for neuronal information processing.	Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2333 AL Leiden, Netherlands; Radboud Univ Nijmegen, Dept Biophys, NL-6500 HB Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Case Western Reserve University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Hoebeek, FE (corresponding author), Erasmus MC, Dept Neurosci, Dr Molenwaterpl 50,POB 1738, NL-3000 DR Rotterdam, Netherlands.	f.hoebeek@erasmusmc.nl; c.dezeeuw@erasmusmc.nl	Schonewille, Martijn/E-6170-2013; Goossens, Jeroen/D-7311-2010	Goossens, Jeroen/0000-0001-5522-3437				Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Baloh RW, 1997, ANN NEUROL, V41, P8, DOI 10.1002/ana.410410105; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Buttner N, 1998, ARCH NEUROL-CHICAGO, V55, P1353, DOI 10.1001/archneur.55.10.1353; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Chacron MJ, 2003, NETWORK-COMP NEURAL, V14, P803, DOI 10.1088/0954-898X/14/4/010; Craig PJ, 1998, J COMP NEUROL, V397, P251; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 2004, SPR HDB AUD, P375; DEZEEUW CI, 1994, J COMP NEUROL, V349, P428, DOI 10.1002/cne.903490308; DEZEEUW CI, 1995, J NEUROPHYSIOL, V74, P2051, DOI 10.1152/jn.1995.74.5.2051; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Frazor RA, 2004, J NEUROPHYSIOL, V91, P2607, DOI 10.1152/jn.00858.2003; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; GRAF W, 1988, J NEUROPHYSIOL, V60, P2091, DOI 10.1152/jn.1988.60.6.2091; GREEN MC, 1962, J HERED, V53, P233, DOI 10.1093/oxfordjournals.jhered.a107180; HAMO H, 2003, NEUROLOGY, V61, P1748; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; JAARSMA D, 1992, HIPPOCAMPUS, V2, P143, DOI 10.1002/hipo.450020206; Knight YE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0002.2002; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; Leenders AGM, 2002, EUR J NEUROSCI, V15, P13, DOI 10.1046/j.0953-816x.2001.01839.x; Li ZZ, 1999, J NEUROPHYSIOL, V82, P188, DOI 10.1152/jn.1999.82.1.188; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Mar DJ, 1999, P NATL ACAD SCI USA, V96, P10450, DOI 10.1073/pnas.96.18.10450; Matsushita K, 2002, J NEUROSCI, V22, P4388, DOI 10.1523/JNEUROSCI.22-11-04388.2002; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; Qian J, 2001, J NEUROSCI, V21, P3721, DOI 10.1523/JNEUROSCI.21-11-03721.2001; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rieke F., 1997, SPIKES EXPLORING NEU; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; SATO Y, 1993, J NEUROPHYSIOL, V69, P1082, DOI 10.1152/jn.1993.69.4.1082; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; SHIELDS KG, IN PRESS NEUROSCIENC; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1396, DOI 10.1152/jn.1995.73.4.1396; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1383, DOI 10.1152/jn.1995.73.4.1383; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Steinmetz PN, 2001, BIOSYSTEMS, V62, P87, DOI 10.1016/S0303-2647(01)00139-3; Tiesinga PHE, 2002, NEURAL COMPUT, V14, P1629, DOI 10.1162/08997660260028647; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; VANDERSTEEN J, 1994, J NEUROPHYSIOL, V72, P31, DOI 10.1152/jn.1994.72.1.31; VANDERSTEEN J, 1995, VISION RES, V35, P3459, DOI 10.1016/0042-6989(95)00138-5; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WYLIE DR, 1995, J NEUROSCI, V15, P2875; Zee D S, 1983, Neurol Clin, V1, P909; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhou YD, 2003, J PHYSIOL-LONDON, V547, P497, DOI 10.1113/jphysiol.2002.033415; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	66	117	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					953	965		10.1016/j.neuron.2005.02.012	http://dx.doi.org/10.1016/j.neuron.2005.02.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797555	Bronze			2022-12-28	WOS:000228031300015
J	Zhang, XD; Gainetdinov, RR; Beaulieu, JM; Sotnikova, TD; Burch, LH; Williams, RB; Schwartz, DA; Krishnan, KRR; Caron, MG				Zhang, XD; Gainetdinov, RR; Beaulieu, JM; Sotnikova, TD; Burch, LH; Williams, RB; Schwartz, DA; Krishnan, KRR; Caron, MG			Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression	NEURON			English	Article							SEROTONIN; GENE; EXPRESSION; POLYMORPHISM; DISORDERS; TRAITS; MODELS; SYSTEM; LOCUS; TPH1	Dysregulation of central serotonin neurotransmission has been widely suspected as an important contributor to major depression. Here, we identify a (G1463A) single nucleotide polymorphism (SNP) in the rate-limiting enzyme of neuronal serotonin synthesis, human tryptophan hydroxylase-2 (hTPH2). The functional SNP in hTPH2 replaces the highly conserved Arg441 with His, which results in similar to80% loss of function in serotonin production when hTPH2 is expressed in PC12 cells. Strikingly, SNP analysis in a cohort of 87 patients with unipolar major depression revealed that nine patients carried the mutant (1463A) allele, while among 219 controls, three subjects carried this mutation. In addition, this functional SNP was not found in a cohort of 60 bipolar disorder patients. Identification of a loss-of-function mutation in hTPH2 suggests that defect in brain serotonin synthesis may represent an important risk factor for unipolar major depression.	Duke Univ, Med Ctr, Dept Cell Biol, Ctr Models Human Dis,Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Ctr Models Human Dis,Inst Genome Sci & Policy, Durham, NC 27710 USA.	caron002@mc.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Gainetdinov, Raul R/G-5875-2011; Sotnikova, Tatyana D/T-9992-2017	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; 	NCRR NIH HHS [M01RR30] Funding Source: Medline; NHLBI NIH HHS [P01HL36587] Funding Source: Medline; NIMH NIH HHS [MH60451, K05MH79482] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abkevich V, 2003, AM J HUM GENET, V73, P1271, DOI 10.1086/379978; Arango V, 2003, J PSYCHIATR RES, V37, P375, DOI 10.1016/S0022-3956(03)00048-7; Blier P, 2001, J PSYCHIATR NEUROSCI, V26, P37; Bonasera SJ, 2000, PHARMACOL THERAPEUT, V88, P133, DOI 10.1016/S0163-7258(00)00087-5; Bosworth HB, 2002, AM J GERIAT PSYCHIAT, V10, P551, DOI 10.1176/appi.ajgp.10.5.551; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gordon JA, 2004, ANNU REV NEUROSCI, V27, P193, DOI 10.1146/annurev.neuro.27.070203.144212; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Jiang GCT, 2000, J MOL BIOL, V302, P1005, DOI 10.1006/jmbi.2000.4097; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Malhotra AK, 2004, AM J PSYCHIAT, V161, P780, DOI 10.1176/appi.ajp.161.5.780; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Murphy DL, 2003, GENES BRAIN BEHAV, V2, P350, DOI 10.1046/j.1601-1848.2003.00049.x; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Pey AL, 2003, HUM MUTAT, V21, P370, DOI 10.1002/humu.10198; Quist JF, 2001, J AM ACAD CHILD PSY, V40, P253, DOI 10.1097/00004583-200102000-00022; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; YANG XJ, 1994, P NATL ACAD SCI USA, V91, P6659, DOI 10.1073/pnas.91.14.6659; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	35	360	387	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					11	16		10.1016/j.neuron.2004.12.014	http://dx.doi.org/10.1016/j.neuron.2004.12.014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629698	Bronze			2022-12-28	WOS:000226217100005
J	Takeda, M; Naya, Y; Fujimichi, R; Takeuchi, D; Miyashita, Y				Takeda, M; Naya, Y; Fujimichi, R; Takeuchi, D; Miyashita, Y			Active maintenance of associative mnemonic signal in monkey inferior temporal cortex	NEURON			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; INFEROTEMPORAL CORTEX; PREFRONTAL CORTEX; PERIRHINAL CORTEX; STIMULUS ASSOCIATION; PERSISTENT ACTIVITY; NEURONAL-ACTIVITY; PRIMATE; MACAQUE	We investigated the contribution of the inferior temporal (IT) cortical neurons to the active maintenance of internal representations. The activity of single neurons in the IT cortex was recorded while the monkeys performed a sequential-type associative memory task in which distractor stimuli interrupted the delay epoch between the cue and target (paired-associate) stimuli. For each neuron, information about each stimulus conveyed by the delay activity was estimated as a coefficient of multiple regression analysis. We found that target information derived from long-term memory (LTM) persisted despite the distractors. By contrast, cue information derived from the visual system was attenuated and frequently replaced by distractor information. These results suggest that LTM-derived information required for upcoming behavior is actively maintained in the IT neurons, whereas visually derived information tends to be updated irrespective of behavioral relevance.	Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019	Miyashita, Yasushi/0000-0003-3496-8637; Takeda, Masaki/0000-0002-2235-1624				Amit DJ, 2003, CEREB CORTEX, V13, P1139, DOI 10.1093/cercor/bhg103; Anderson J.R., 1995, COGNITIVE PSYCHOL IT, V4th; Buckley MJ, 1997, J NEUROPHYSIOL, V77, P587, DOI 10.1152/jn.1997.77.2.587; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; Fuster JM, 1995, MEMORY CEREBRAL CORT; Grunewald A, 2002, J NEUROSCI, V22, P6195; Gutnikov SA, 1997, EUR J NEUROSCI, V9, P1524, DOI 10.1111/j.1460-9568.1997.tb01507.x; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Jha Amishi P., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P517, DOI 10.3758/CABN.4.4.517; Law JR, 2005, J NEUROSCI, V25, P5720, DOI 10.1523/JNEUROSCI.4935-04.2005; Littell RC, 2002, SAS LINEAR MODELS; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Murray EA, 2001, CURR OPIN NEUROBIOL, V11, P188, DOI 10.1016/S0959-4388(00)00195-1; MURRAY EA, 1993, J NEUROSCI, V13, P4549; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Naya Y, 2003, EUR J NEUROSCI, V18, P2915, DOI 10.1111/j.1460-9568.2003.03020.x; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Postle BR, 2003, CORTEX, V39, P927, DOI 10.1016/S0010-9452(08)70871-2; Rainer G, 1999, J NEUROSCI, V19, P5493; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Ranganath C, 2004, J NEUROSCI, V24, P3917, DOI 10.1523/JNEUROSCI.5053-03.2004; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Rolls ET, 2002, COMPUTATIONAL NEUROS; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Yakovlev V, 1998, NAT NEUROSCI, V1, P310, DOI 10.1038/1131; Zar JH., 1999, BIOSTAT ANAL, V663rd	49	43	43	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					839	848		10.1016/j.neuron.2005.09.028	http://dx.doi.org/10.1016/j.neuron.2005.09.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337920	Bronze			2022-12-28	WOS:000233927300021
J	Guan, Z; Saraswati, S; Adolfsen, B; Littleton, JT				Guan, Z; Saraswati, S; Adolfsen, B; Littleton, JT			Genome-wide transcriptional changes associated with enhanced activity in the Drosophila nervous system	NEURON			English	Article							CAMP-RESPONSIVE ELEMENT; NEURONAL-ACTIVITY; PLASTICITY; PROTEIN; GENE; SYNAPTOTAGMIN; PHOSPHORYLATION; ORGANIZATION; CHANNELS; MUTATION	Neuronal plasticity is an important feature of the developing brain and requires neuronal circuits to reconfigure their functional connectivity depending upon activity patterns. To explore changes in neuronal function that occur downstream of altered activity, we performed an expression analysis in Drosophila mutants with acute or chronic alterations in neuronal activity. We find that seizure induction leads to an over-proliferation of synaptic connections, indicating that activity-dependent neuronal rewiring occurs in Drosophila. To analyze transcriptional recoding during altered neuronal activity, we performed genome-wide DNA microarray analysis following multiple seizure induction and recovery paradigms. Approximately 250 genes implicated in cell adhesion, membrane excitability, and cellular signaling are differentially regulated, including the Kek 2 neuronal cell adhesion protein, which, as we demonstrate, functions as a regulator of synaptic growth. These data identify a collection of activity-regulated transcripts that may link changes in neuronal firing patterns to transcription-dependent modulation of brain function, including activity-dependent synaptic rewiring.	MIT, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA; MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Northwell Health	Littleton, JT (corresponding author), MIT, Picower Inst Learning & Memory, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	troy@mit.edu		Littleton, J. Troy/0000-0001-5576-2887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043244] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS043244-03, R01 NS043244] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etter PD, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-39; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; GANETZKY B, 1986, ANNU REV GENET, V20, P13; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hoeffer CA, 2003, J NEUROSCI, V23, P6362; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MacLaren CM, 2004, DEV GENES EVOL, V214, P360, DOI 10.1007/s00427-004-0414-4; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; Musacchio M, 1996, DEV BIOL, V178, P63, DOI 10.1006/dbio.1996.0198; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Ono T, 2003, J NEUROSCI, V23, P5887; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; RAISMAN G, 1969, BRAIN RES, V14, P25, DOI 10.1016/0006-8993(69)90029-8; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Rikhy R, 2003, GENETICS, V165, P1243; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sone M, 2000, DEVELOPMENT, V127, P4157; Titus SA, 1997, J NEUROSCI, V17, P875; TSUKAHARA N, 1975, J NEUROPHYSIOL, V38, P1359, DOI 10.1152/jn.1975.38.6.1359; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wang P, 2004, J NEUROSCI, V24, P4518, DOI 10.1523/JNEUROSCI.0542-04.2004; Yoshihara M, 2003, CURR OPIN NEUROBIOL, V13, P315, DOI 10.1016/S0959-4388(03)00063-1; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; ZHANG HG, 1994, J PHYSIOL-LONDON, V479, P65, DOI 10.1113/jphysiol.1994.sp020278; Zhong Y, 2004, J NEUROSCI, V24, P1439, DOI 10.1523/JNEUROSCI.0740-02.2004; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	44	64	65	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					91	107		10.1016/j.neuron.2005.08.036	http://dx.doi.org/10.1016/j.neuron.2005.08.036			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202711	Bronze			2022-12-28	WOS:000232625700012
J	Micheyl, C; Tian, B; Carlyon, RP; Rauschecker, JP				Micheyl, C; Tian, B; Carlyon, RP; Rauschecker, JP			Perceptual organization of tone sequences in the auditory cortex of awake Macaques	NEURON			English	Article							STREAM SEGREGATION; SCENE ANALYSIS; ADAPTATION; SOUNDS; ATTENTION; MODEL	Acoustic sequences such as speech and music are generally perceived as coherent auditory "streams," which can be individually attended to and followed over time. Although the psychophysical stimulus parameters governing this "auditory streaming" are well established, the brain mechanisms underlying the formation of auditory streams remain largely unknown. In particular, an essential feature of the phenomenon, which corresponds to the fact that the segregation of sounds into streams typically takes several seconds to build up, remains unexplained. Here, we show that this and other major features of auditory-stream formation measured in humans using alternating-tone sequences can be quantitatively accounted for based on single-unit responses recorded in the primary auditory cortex (A1) of awake rhesus monkeys listening to the same sound sequences.	MIT, Elect Res Lab, Cambridge, MA 02139 USA; Georgetown Univ, Ctr Med, Georgetown Inst Cognit & Computat Sci, Dept Physiol & Biophys, Washington, DC 20007 USA; MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England	Massachusetts Institute of Technology (MIT); Georgetown University	Micheyl, C (corresponding author), MIT, Elect Res Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cmicheyl@mit.edu; rauschej@georgetown.edu	Rauschecker, Josef P/A-4120-2013; Carlyon, Robert p/A-5387-2010	Rauschecker, Josef P./0000-0003-4353-9084; Carlyon, Robert/0000-0002-6166-501X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005216, R01DC003489] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC05216, R01 DC003489] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alain C, 1998, NEUROREPORT, V9, P3537, DOI 10.1097/00001756-199810260-00037; ANSTIS S, 1985, VISION RES, V25, P1051, DOI 10.1016/0042-6989(85)90093-8; ANSTIS S, 1985, J EXP PSYCHOL HUMAN, V11, P257, DOI 10.1037/0096-1523.11.3.257; BEAUVOIS MW, 1991, Q J EXP PSYCHOL-A, V43, P517, DOI 10.1080/14640749108400985; Bee MA, 2004, J NEUROPHYSIOL, V92, P1088, DOI 10.1152/jn.00884.2003; BENSON DA, 1978, BRAIN RES, V159, P307, DOI 10.1016/0006-8993(78)90537-1; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1971, J EXP PSYCHOL, V89, P244, DOI 10.1037/h0031163; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; BROCH M, 1994, J NEUROPHYSIOL, V77, P923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fay RR, 1998, HEARING RES, V120, P69, DOI 10.1016/S0378-5955(98)00058-6; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Green DM, 1966, SIGNAL DETECTION THE; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; Hulse SH, 1997, J COMP PSYCHOL, V111, P3, DOI 10.1037/0735-7036.111.1.3; Hung J, 2001, EXP BRAIN RES, V140, P56, DOI 10.1007/s002210100783; Izumi A, 2002, COGNITION, V82, pB113, DOI 10.1016/S0010-0277(01)00161-5; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1771, DOI 10.1152/jn.1980.43.6.1771; Jones SJ, 1998, EVOKED POTENTIAL, V108, P131, DOI 10.1016/S0168-5597(97)00077-4; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kanwal JS, 2003, NETWORK-COMP NEURAL, V14, P413, DOI 10.1088/0954-898X/14/3/303; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MacDougall-Shackleton SA, 1998, J ACOUST SOC AM, V103, P3581, DOI 10.1121/1.423063; Macken WJ, 2003, J EXP PSYCHOL HUMAN, V29, P43, DOI 10.1037/0096-1523.29.1.43; McCabe SL, 1997, J ACOUST SOC AM, V101, P1611, DOI 10.1121/1.418176; Micheyl C, 2005, AUDITORY SIGNAL PROCESSINGP: PHYSIOLOGY, PSYCHOACOUSTICS, AND MODELS, P203; Miller CT, 2001, NAT NEUROSCI, V4, P783, DOI 10.1038/90481; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Petkov CI, 2003, J NEUROSCI, V23, P9155; PFINGST BE, 1993, J ACOUST SOC AM, V93, P2124, DOI 10.1121/1.406673; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sussman E, 1999, PSYCHOPHYSIOLOGY, V36, P22, DOI 10.1017/S0048577299971056; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004	55	219	221	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					139	148		10.1016/j.neuron.2005.08.039	http://dx.doi.org/10.1016/j.neuron.2005.08.039			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202714	Bronze			2022-12-28	WOS:000232625700015
J	Schoenbaum, G; Roesch, M				Schoenbaum, G; Roesch, M			Orbitofrontal cortex, associative learning, and expectancies	NEURON			English	Review							AUDITORY SECONDARY REINFORCEMENT; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; REWARD VALUE; LESIONS; COMPLEX; ACQUISITION; MOTIVATION; DEPENDS; ROLES	Orbitofrontal cortex is characterized by its unique pattern of connections with subcortical areas, such as basolateral amygdala. Here we distinguish between the critical role of these areas in associative learning and the pivotal contribution of OFC to the manipulation of this information to control behavior. This contribution reflects the ability of OFC to signal the desirability of expected outcomes, which requires the integration of associative information with information concerning internal states and goals in representational memory.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St, HSF-2 S251, Baltimore, MD 21201 USA.	schoenbg@schoenbaumlab.org			NIDA NIH HHS [R01 DA015718-03, R01-DA015718, R01 DA015718] Funding Source: Medline; NINDS NIH HHS [T32 NS007375, T32-NS07375] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arana FS, 2003, J NEUROSCI, V23, P9632; Bechara A, 1999, J NEUROSCI, V19, P5473; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cousens GA, 2003, INTEGR PHYS BEH SCI, V38, P272, DOI 10.1007/BF02688858; DICKINSON A, 1989, CONT LEARNING THEORI, P2790; Gallagher M, 1999, J NEUROSCI, V19, P6610; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hatfield T, 1996, J NEUROSCI, V16, P5256; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Malkova L, 1997, J NEUROSCI, V17, P6011; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Pears A, 2003, J NEUROSCI, V23, P11189; Pickens CL, 2003, J NEUROSCI, V23, P11078; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Setlow B, 2002, EUR J NEUROSCI, V15, P1841, DOI 10.1046/j.1460-9568.2002.02010.x; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	28	303	305	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					633	636		10.1016/j.neuron.2005.07.018	http://dx.doi.org/10.1016/j.neuron.2005.07.018			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129393	Green Accepted, Bronze			2022-12-28	WOS:000231782700005
J	Ghasia, FF; Angelaki, DE				Ghasia, FF; Angelaki, DE			Do motoneurons encode the noncommutativity of ocular rotations?	NEURON			English	Article							PURSUIT EYE-MOVEMENTS; LATERAL RECTUS MUSCLE; EXTRAOCULAR-MUSCLES; VESTIBULOOCULAR REFLEX; OCULOMOTOR SYSTEM; ABDUCENS NUCLEUS; LISTING LAW; DISCHARGE CHARACTERISTICS; QUANTITATIVE-ANALYSIS; 3-DIMENSIONAL EYE	As we look around, the orientation of our eyes depends on the order of the rotations that are carried out, a mathematical feature of rotatory motions known as noncommutativity. Theorists and experimentalists continue to debate how biological systems deal with this property when generating kinematically appropriate movements. Some believe that this is always done by neural commands to a simplified eye plant. Others have postulated that noncommutativity is implemented solely by the mechanical properties of the eyeball. Here we directly examined what the brain tells the muscles, by recording motoneuron activities as monkeys made eye movements. We found that vertical recti and superior/inferior oblique motoneurons, which drive sensory-generated torsional eye movements, do not modulate their firing rates according to the noncommutative-driven torsion during pursuit. We conclude that part of the solution for kinematically appropriate eye movements is found in the mechanical properties of the eyeball, although neural computations remain necessary and become increasingly important during head movements.	Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu			NATIONAL EYE INSTITUTE [R01EY012814, R01EY015271] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY12814, R01 EY015271, R01-EY15271] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angelaki DE, 2004, EUR J NEUROSCI, V19, P1, DOI 10.1111/j.1460-9568.2004.03068.x; Angelaki DE, 2003, J NEUROPHYSIOL, V89, P2685, DOI 10.1152/jn.01137.2002; Angelaki DE, 2003, J NEUROSCI, V23, P2971; Angelaki DE, 2003, J NEUROSCI, V23, P1104, DOI 10.1523/JNEUROSCI.23-04-01104.2003; Buttner-Ennever JA, 2002, CURR OPIN NEUROL, V15, P35, DOI 10.1097/00019052-200202000-00007; Buttner-Ennever JA, 2001, J COMP NEUROL, V438, P318, DOI 10.1002/cne.1318; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Crawford JD, 2003, CURR OPIN NEUROBIOL, V13, P655, DOI 10.1016/j.conb.2003.10.009; CRAWFORD JD, 1991, J NEUROPHYSIOL, V65, P407, DOI 10.1152/jn.1991.65.3.407; Crawford JD, 1997, J NEUROPHYSIOL, V78, P1447, DOI 10.1152/jn.1997.78.3.1447; DELACRUZ RR, 1989, EUR J NEUROSCI, V1, P288; DELGADOGARCIA JM, 1986, NEUROSCIENCE, V17, P929, DOI 10.1016/0306-4522(86)90072-2; DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125; Demer JL, 2000, INVEST OPHTH VIS SCI, V41, P1280; Demer JL, 2003, J NEUROPHYSIOL, V89, P2072, DOI 10.1152/jn.00636.2002; Dimitrova DM, 2003, J NEUROPHYSIOL, V90, P3809, DOI 10.1152/jn.00622.2003; FERMAN L, 1987, VISION RES, V27, P929, DOI 10.1016/0042-6989(87)90009-5; FUCHS AF, 1970, J NEUROPHYSIOL, V33, P382, DOI 10.1152/jn.1970.33.3.382; FUCHS AF, 1988, J NEUROPHYSIOL, V60, P1874, DOI 10.1152/jn.1988.60.6.1874; FUCHS AF, 1971, EXP BRAIN RES, V13, P78; Goldberg SJ, 1998, J NEUROSCI, V18, P10629; Goldberg SJ, 1999, PROG BRAIN RES, V123, P221, DOI 10.1016/S0079-6123(08)62859-9; Goldstein H, 2002, CLASSICAL MECH; HASLWANTER T, 1995, VISION RES, V35, P1727, DOI 10.1016/0042-6989(94)00257-M; Haslwanter T, 2002, ANN NY ACAD SCI, V956, P33, DOI 10.1111/j.1749-6632.2002.tb02806.x; HASLWANTER T, 1991, EXP BRAIN RES, V87, P470; Henn V, 1982, Hum Neurobiol, V1, P77; HENN V, 1973, J NEUROPHYSIOL, V36, P115, DOI 10.1152/jn.1973.36.1.115; HEPP K, 1985, VISION RES, V25, P493, DOI 10.1016/0042-6989(85)90151-8; Klier EM, 1998, J NEUROPHYSIOL, V80, P2274, DOI 10.1152/jn.1998.80.5.2274; KLIER EM, 2005, IN PRESS J NEUROPHYS; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P2179; MAYS LE, 1991, J NEUROPHYSIOL, V65, P1484, DOI 10.1152/jn.1991.65.6.1484; Medendorp WP, 2002, J NEUROPHYSIOL, V87, P295, DOI 10.1152/jn.00892.2000; MILLER JM, 1993, OPHTHALMOLOGY, V100, P475; MILLER JM, 1992, VISION RES, V32, P1099, DOI 10.1016/0042-6989(92)90010-G; MISSLISCH H, 1994, J NEUROPHYSIOL, V72, P2490, DOI 10.1152/jn.1994.72.5.2490; Misslisch H, 2001, J NEUROPHYSIOL, V86, P1877, DOI 10.1152/jn.2001.86.4.1877; Misslisch H, 2000, J NEUROPHYSIOL, V83, P3264, DOI 10.1152/jn.2000.83.6.3264; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; Porrill J, 2000, VISION RES, V40, P3743, DOI 10.1016/S0042-6989(00)00211-X; Precht W, 1979, Prog Brain Res, V50, P459, DOI 10.1016/S0079-6123(08)60845-6; Quaia C, 1998, J NEUROPHYSIOL, V79, P3197, DOI 10.1152/jn.1998.79.6.3197; Quaia Christian, 2003, Strabismus, V11, P17, DOI 10.1076/stra.11.1.17.14088; Raphan T, 1998, J NEUROPHYSIOL, V79, P2653, DOI 10.1152/jn.1998.79.5.2653; Robinson D A, 1972, Bibl Ophthalmol, V82, P7; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; SCHILLER PH, 1970, EXP BRAIN RES, V10, P347, DOI 10.1007/BF02324764; SKAVENSKI AA, 1973, J NEUROPHYSIOL, V36, P724, DOI 10.1152/jn.1973.36.4.724; Smith MA, 1998, J NEUROPHYSIOL, V80, P2295, DOI 10.1152/jn.1998.80.5.2295; Smith MA, 2005, J NEUROPHYSIOL, V93, P1742, DOI 10.1152/jn.00306.2004; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1383, DOI 10.1152/jn.1995.73.4.1383; SUZUKI Y, 1995, EXP BRAIN RES, V106, P215; Suzuki Y, 1999, EXP BRAIN RES, V126, P187, DOI 10.1007/s002210050728; Sylvestre PA, 1999, J NEUROPHYSIOL, V82, P2612, DOI 10.1152/jn.1999.82.5.2612; TWEED D, 1994, J NEUROPHYSIOL, V72, P1425, DOI 10.1152/jn.1994.72.3.1425; TWEED D, 1992, VISION RES, V32, P1225, DOI 10.1016/0042-6989(92)90217-7; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; TWEED D, 1990, VISION RES, V30, P111, DOI 10.1016/0042-6989(90)90131-4; Tweed D., 1997, 3 DIMENSIONAL KINEMA, P375; Tweed DB, 1999, NATURE, V399, P261, DOI 10.1038/20441; VILIS T, 1989, EXP BRAIN RES, V77, P1; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; WESTHEIMER G, 1957, J OPT SOC AM, V47, P967, DOI 10.1364/JOSA.47.000967; Zhou W, 1998, NATURE, V393, P692, DOI 10.1038/31489	65	50	51	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 21	2005	47	2					281	293		10.1016/j.neuron.2005.05.031	http://dx.doi.org/10.1016/j.neuron.2005.05.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039569	Bronze			2022-12-28	WOS:000230693900014
J	La Spada, AR; Morrison, RS				La Spada, AR; Morrison, RS			The power of the dark side: Huntington's disease protein and p53 form a deadly alliance	NEURON			English	Editorial Material							NEURONAL CELL-DEATH; TRANSGENIC MICE; TRANSCRIPTION; APOPTOSIS	A role for apoptotic mediators in neurodegenerative disease has long been considered, but the identity of the putative effectors and the basis of their actions in neurodegeneration remain ill-defined. Huntington's disease (HD) is a polyglutamine disorder whose pathogenesis likely involves mitochondrial dysfunction. In this issue of Neuron, Bae et al. present data implicating p53 in HD pathogenesis. This intriguing study may thus provide a link between nuclear transcription dysregulation and mitochondrial abnormalities in HD.	Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	La Spada, AR (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.		La Spada, Albert/AAG-8809-2020					Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; BEAL MF, 1993, J NEUROSCI, V13, P4181; Gilman CP, 2003, NEUROMOL MED, V3, P159, DOI 10.1385/NMM:3:3:159; Johnson MD, 1999, J NEUROSCI, V19, P2996; LaFerla FM, 1996, J CLIN INVEST, V98, P1626, DOI 10.1172/JCI118957; Martin LJ, 2000, NEUROBIOL DIS, V7, P613, DOI 10.1006/nbdi.2000.0314; Schuler M, 2005, TRENDS GENET, V21, P182, DOI 10.1016/j.tig.2005.01.001; Shahbazian MD, 2001, NEUROBIOL DIS, V8, P974, DOI 10.1006/nbdi.2001.0444; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	13	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 7	2005	47	1					1	3		10.1016/j.neuron.2005.06.023	http://dx.doi.org/10.1016/j.neuron.2005.06.023			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996541	Bronze			2022-12-28	WOS:000230464000001
J	Aktas, O; Smorodchenko, A; Brocke, S; Infante-Duarte, C; Topphoff, US; Vogt, J; Prozorovski, T; Meier, S; Osmanova, V; Pohl, E; Bechmann, I; Nitsch, R; Zipp, F				Aktas, O; Smorodchenko, A; Brocke, S; Infante-Duarte, C; Topphoff, US; Vogt, J; Prozorovski, T; Meier, S; Osmanova, V; Pohl, E; Bechmann, I; Nitsch, R; Zipp, F			Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL	NEURON			English	Article							APOPTOSIS-INDUCING LIGAND; HUMAN T-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; EFFECTOR-CELLS; AXONAL DAMAGE; HUMAN BRAIN; RECEPTOR; ENCEPHALOMYELITIS; EXPRESSION	Here, we provide evidence for a detrimental role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in neural death in T cell-induced experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Clinical severity and neuronal apoptosis in brainstem motor areas were substantially reduced upon brain-specific blockade of TRAIL after induction of EAE through adoptive transfer of encephalitogenic T cells. Furthermore, TRAIL-deficient myelin-specific lymphocytes showed reduced encephalitogenicity when transferred to wildtype mice. Conversely, intracerebral delivery of TRAIL to animals with EAE increased clinical deficits, while naive mice were not susceptible to TRAIL. Using organotypic slice cultures as a model for living brain tissue, we found that neurons were susceptible to TRAIL-mediated injury induced by encephalitogenic T cells. Thus, in addition to its known immunoregulatory effects, the death ligand TRAIL contributes to neural damage in the inflamed brain.	Humboldt Univ, Charite, Neurosci Res Ctr, Inst Neuroimmunol, D-10098 Berlin, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91120 Jerusalem, Israel; Humboldt Univ, Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-10098 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zipp, F (corresponding author), Humboldt Univ, Charite, Neurosci Res Ctr, Inst Neuroimmunol, Clara Zetkin Str 94, D-10098 Berlin, Germany.	frauke.zipp@charite.de	Smorodchenko, Alina/D-1880-2010; Nitsch, Robert/AAI-9129-2021; Vogt, Johannes/O-4289-2019; Pohl, Elena E./A-4025-2009; Aktas, Orhan/B-7623-2009; Smorodchenko, Alina/AAU-2854-2020; Smorodchenko, Alina/ABB-2411-2020; Zipp, Frauke/C-9968-2015; Vogt, Johannes/K-2278-2015	Pohl, Elena E./0000-0002-0604-5950; Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Vogt, Johannes/0000-0003-2439-8247; Smorodchenko, Alina/0000-0003-1415-1531; Infante Duarte, Carmen/0000-0003-3005-351X				Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Brocke Stefan, 1996, Methods (Orlando), V9, P458, DOI 10.1006/meth.1996.0053; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Cretney E, 2003, J EXP MED, V198, P491, DOI 10.1084/jem.20030634; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; Dorr J, 2002, J NEUROIMMUNOL, V122, P117, DOI 10.1016/S0165-5728(01)00450-7; Dorr J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0001.2002; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; FORD AL, 1995, J IMMUNOL, V154, P4309; Gimsa U, 2000, BRAIN PATHOL, V10, P365; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Hilliard B, 2001, J IMMUNOL, V166, P1314, DOI 10.4049/jimmunol.166.2.1314; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; LERANTH C, 1994, J NEUROSCI, V14, P4079; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Mack CL, 2003, J NEUROIMMUNOL, V144, P68, DOI 10.1016/j.jneuroim.2003.08.032; Mariani SM, 1998, EUR J IMMUNOL, V28, P1492, DOI 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Matysiak M, 2002, BRAIN, V125, P2469, DOI 10.1093/brain/awf254; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Miura Y, 2003, P NATL ACAD SCI USA, V100, P2777, DOI 10.1073/pnas.2628048100; Nitsch R, 2004, J NEUROSCI, V24, P2458, DOI 10.1523/JNEUROSCI.4703-03.2004; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; Okuda Y, 1998, J NEUROIMMUNOL, V81, P201, DOI 10.1016/S0165-5728(97)00180-X; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Qin JZ, 2001, NAT MED, V7, P385, DOI 10.1038/86401; Reijneveld JC, 1999, J NEURO-ONCOL, V42, P137, DOI 10.1023/A:1006237917632; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; SAEKI Y, 1992, P NATL ACAD SCI USA, V89, P6157, DOI 10.1073/pnas.89.13.6157; Schmaltz C, 2002, NAT MED, V8, P1433, DOI 10.1038/nm797; Schneider P, 2003, J BIOL CHEM, V278, P5444, DOI 10.1074/jbc.M210783200; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Steinbrecher A, 2001, J IMMUNOL, V166, P2041, DOI 10.4049/jimmunol.166.3.2041; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Wendling U, 2000, CELL DEATH DIFFER, V7, P637, DOI 10.1038/sj.cdd.4400692; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, CANCER RES, V59, P2770; Zamai L, 2000, BLOOD, V95, P3716; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zheng SJ, 2004, J CLIN INVEST, V113, P58, DOI 10.1172/JCI200419255; Zipp F, 1999, IMMUNOL TODAY, V20, P550, DOI 10.1016/S0167-5699(99)01545-5	63	174	183	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					421	432		10.1016/j.neuron.2005.03.018	http://dx.doi.org/10.1016/j.neuron.2005.03.018			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882642	Bronze, Green Accepted			2022-12-28	WOS:000229011400014
J	Degonda, N; Mondadori, CRA; Bosshardt, S; Schmidt, CF; Boesiger, P; Nitsch, RM; Hock, C; Henke, K				Degonda, N; Mondadori, CRA; Bosshardt, S; Schmidt, CF; Boesiger, P; Nitsch, RM; Hock, C; Henke, K			Implicit associative learning engages the hippocampus and interacts with explicit associative learning	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; EVENT-RELATED FMRI; RELATIONAL MEMORY; AMNESIC SUBJECTS; SEMANTIC MEMORY; RETRIEVAL; AWARENESS; SYSTEM; SENSE; PET	The hippocampus is crucial for conscious, explicit memory, but whether it is also involved in nonconscious, implicit memory is uncertain. We investigated with functional magnetic resonance imaging whether implicit learning engages the hippocampus and interacts with subsequent explicit learning. The presentation of subliminal faces-written profession pairs for implicit learning was followed by the explicit learning of supraliminal pairs composed of the same faces combined with written professions semantically incongruous to those presented subliminally (experiment 1), semantically congruous professions (experiment 2), or identical professions (experiment 3). We found that implicit face-profession learning interacted with explicit face-profession learning in all experiments, impairing the explicit retrieval of the associations. Hippocampal activity increased during the subliminal presentation of face-profession pairs versus face-nonword pairs and correlated with the later impairment of explicit retrieval. These findings suggest that implicit semantic associative learning engages the hippocampus and influences explicit memory.	Univ Zurich, Div Psychiat Res, Zurich, Switzerland; Univ Zurich, IBT, Zurich, Switzerland; ETH, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Henke, K (corresponding author), Univ Zurich, Div Psychiat Res, Zurich, Switzerland.	henke@bfi.unizh.ch						[Anonymous], 1998, NEURAL NETWORKS BRAI; BOWERS JS, 1990, J EXP PSYCHOL LEARN, V16, P404, DOI 10.1037/0278-7393.16.3.404; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CHEESMAN J, 1984, PERCEPT PSYCHOPHYS, V36, P387, DOI 10.3758/BF03202793; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; CORKIN S, 1968, NEUROPSYCHOLOGIA, V6, P225; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Devlin JT, 2002, NEUROPSYCHOLOGIA, V40, P54, DOI 10.1016/S0028-3932(01)00066-5; Dienes Z, 1997, PSYCHON B REV, V4, P3, DOI 10.3758/BF03210769; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; EBBINGHAUS H, 1992, GEDACHTNIS UNTERSUCH, P70; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Grabowski TJ, 2001, HUM BRAIN MAPP, V13, P199, DOI 10.1002/hbm.1033; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Greene AJ, 2001, MEM COGNITION, V29, P893, DOI 10.3758/BF03196418; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henke K, 2003, NEUROPSYCHOLOGIA, V41, P863, DOI 10.1016/S0028-3932(03)00035-6; Henke K, 2003, CONSCIOUS COGN, V12, P31, DOI 10.1016/S1053-8100(02)00006-5; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; KAYSER A, 1985, HEADS; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Mayes AR, 1998, BEHAV NEUROL, V11, P163; McIntosh AR, 2003, J NEUROSCI, V23, P6520; McKone E, 1997, MEM COGNITION, V25, P352, DOI 10.3758/BF03211291; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Musen G., 1993, NEUROPSYCHOLOGY, V7, P119, DOI DOI 10.1037/0894-4105.7.2.119; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Reilly RC, 2000, HIPPOCAMPUS, V10, P389, DOI 10.1002/1098-1063(2000)10:4<389::AID-HIPO5>3.0.CO;2-P; Perani D, 1999, BRAIN, V122, P2337, DOI 10.1093/brain/122.12.2337; Pilgrim LK, 2002, NEUROIMAGE, V16, P713, DOI 10.1006/nimg.2002.1105; Preibisch C, 2003, NEUROIMAGE, V19, P412, DOI 10.1016/S1053-8119(03)00080-6; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rajaram S, 2000, NEUROPSYCHOLOGY, V14, P427, DOI 10.1037//0894-4105.14.3.427; Rajaram S, 2000, J MEM LANG, V43, P291, DOI 10.1006/jmla.2000.2733; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Savage GR, 2002, NEUROPSYCHOLOGIA, V40, P302, DOI 10.1016/S0028-3932(01)00092-6; Schacter DL, 1998, NEUROBIOL LEARN MEM, V70, P284, DOI 10.1006/nlme.1998.3854; Schacter DL, 1998, SCIENCE, V280, P59, DOI 10.1126/science.280.5360.59; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schmidt CF, 2005, NEUROIMAGE, V25, P625, DOI 10.1016/j.neuroimage.2004.12.002; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; Weiger M, 2000, MAGNET RESON MED, V43, P177, DOI 10.1002/(SICI)1522-2594(200002)43:2<177::AID-MRM3>3.0.CO;2-1; Willingham DB, 1997, PSYCHON B REV, V4, P587; Yang JJ, 2003, NEUROPSYCHOLOGIA, V41, P818, DOI 10.1016/S0028-3932(02)00289-0	63	90	91	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					505	520		10.1016/j.neuron.2005.02.030	http://dx.doi.org/10.1016/j.neuron.2005.02.030			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	924WL	15882649	Bronze			2022-12-28	WOS:000229011400021
J	Bokor, H; Frere, SGA; Eyre, MD; Slezia, A; Ulbert, I; Luthi, A; Acsady, L				Bokor, H; Frere, SGA; Eyre, MD; Slezia, A; Ulbert, I; Luthi, A; Acsady, L			Selective GABAergic control of higher-order thalamic relays	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; ANTERIOR PRETECTAL NUCLEUS; ELECTRON-MICROSCOPIC ANALYSIS; GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC ACID; CENTRAL-NERVOUS-SYSTEM; RETICULAR NUCLEUS; ZONA INCERTA; SYNAPTIC INPUT; A-LAMINAE	GABAergic signaling is central to the function of the thalamus and has been traditionally attributed primarily to the nucleus reticularis thalami (nRT). Here we present a GABAergic pathway, distinct from the nRT, that exerts a powerful inhibitory effect selectively in higher-order thalamic relays of the rat. Axons originating in the anterior pretectal nucleus (APT) innervated the proximal dendrites of relay cells via large GABAergic terminals with multiple release sites. Stimulation of the APT in an in vitro slice preparation revealed a GABA(A) receptor-mediated, monosynaptic IPSC in relay cells. Activation of presumed single APT fibers induced rebound burst firing in relay cells. Different APT neurons recorded in vivo displayed fast bursting, tonic, or rhythmic firing. Our data suggest that selective extrareticular GABAergic control of relay cell activity will result in effective, state-dependent gating of thalamocortical information transfer in higher-order but not in first-order relays.	Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary; Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland; Hungarian Acad Sci, Inst Psychol, H-1068 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Basel; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Acsady, L (corresponding author), Hungarian Acad Sci, Inst Expt Med, POB 67, H-1450 Budapest, Hungary.	acsady@koki.hu	Acsady, Laszlo/C-7773-2014; Luthi, Anita/ABE-1411-2021; Ulbert, Istvan/F-2213-2010	Acsady, Laszlo/0000-0002-0679-2980; Slezia, Andrea/0000-0002-4528-3169; Luthi, Anita/0000-0002-4954-4143; Eyre, Mark/0000-0001-9102-2894	Wellcome Trust [067573] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; Bartho P, 2002, EUR J NEUROSCI, V16, P999, DOI 10.1046/j.1460-9568.2002.02157.x; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8; BERMAN N, 1977, J COMP NEUROL, V174, P227, DOI 10.1002/cne.901740204; CADUSSEAU J, 1991, NEUROSCI RES, V12, P83, DOI 10.1016/0168-0102(91)90102-5; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CUCCHIARO JB, 1991, J COMP NEUROL, V310, P316, DOI 10.1002/cne.903100304; CUCCHIARO JB, 1993, J COMP NEUROL, V334, P618, DOI 10.1002/cne.903340409; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; FOSTER GA, 1989, NEUROSCIENCE, V29, P685, DOI 10.1016/0306-4522(89)90141-3; GRAHAM J, 1981, NEUROSCI LETT, V26, P209, DOI 10.1016/0304-3940(81)90134-8; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109; HOOGLAND PV, 1991, EXP BRAIN RES, V87, P159, DOI 10.1007/BF00228517; Huguenard JR, 1998, J SLEEP RES, V7, P24, DOI 10.1046/j.1365-2869.7.s1.5.x; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; JOURDAIN A, 1989, BRAIN RES, V505, P55, DOI 10.1016/0006-8993(89)90115-7; Kenigfest NB, 2000, J COMP NEUROL, V426, P31, DOI 10.1002/1096-9861(20001009)426:1<31::AID-CNE3>3.0.CO;2-S; Kim U, 1998, J NEUROSCI, V18, P9500; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LIU XB, 1995, J COMP NEUROL, V352, P187, DOI 10.1002/cne.903520203; LLINAS R, 1997, COHERENT OSCILLATION, P501; LUBKE J, 1993, J COMP NEUROL, V329, P458, DOI 10.1002/cne.903290404; Magistretti J, 1996, TRENDS NEUROSCI, V19, P530, DOI 10.1016/S0166-2236(96)40004-2; May PJ, 1997, NEUROSCIENCE, V77, P1091, DOI 10.1016/S0306-4522(96)00535-0; MONTERO VM, 1981, NEUROSCIENCE, V6, P2561, DOI 10.1016/0306-4522(81)90102-0; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; ROBERTSON RT, 1983, EXP BRAIN RES, V51, P157; Schiff ND, 2002, NEUROL RES, V24, P116, DOI 10.1179/016164102101199576; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2004, TRENDS NEUROSCI, V27, P670, DOI 10.1016/j.tins.2004.08.003; SOMOGYI P, 1985, J HISTOCHEM CYTOCHEM, V33, P240, DOI 10.1177/33.3.2579123; Steriade M, 2004, NEURON, V41, P493, DOI 10.1016/S0896-6273(04)00076-5; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS, VI; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; TERENZI MG, 1995, BRAIN RES, V701, P183, DOI 10.1016/0006-8993(95)01001-8; Trageser JC, 2004, J NEUROSCI, V24, P8911, DOI 10.1523/JNEUROSCI.3218-04.2004; Veinante P, 1999, J NEUROSCI, V19, P5085; Vidnyanszky Z, 1996, EXP BRAIN RES, V109, P63; Wang ST, 2002, NEUROSCI LETT, V323, P141, DOI 10.1016/S0304-3940(01)02533-2; Ward R, 2002, NAT NEUROSCI, V5, P99, DOI 10.1038/nn794; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003	57	102	104	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					929	940		10.1016/j.neuron.2005.01.048	http://dx.doi.org/10.1016/j.neuron.2005.01.048			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797553	Bronze			2022-12-28	WOS:000228031300013
J	Dixon, MJ; Smilek, D				Dixon, MJ; Smilek, D			The importance of individual differences in grapheme-color synesthesia	NEURON			English	Editorial Material							SYNAESTHESIA	In this issue of Neuron, Hubbard et al. show individual differences in how grapheme-color synesthetes perform on cognitive tasks. Importantly, these behavioral differences were correlated with fMRI measures. Such individual differences have important ramifications for synesthesia research. If individual differences are ignored, then synesthesia research will be characterized by erroneous conclusions and failures to replicate.	Univ Waterloo, Synaesthesia Res Ctr, Waterloo, ON N2L 3G1, Canada; Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Dixon, MJ (corresponding author), Univ Waterloo, Synaesthesia Res Ctr, Waterloo, ON N2L 3G1, Canada.							Blake R., 2005, SYNESTHESIA PERSPECT, P47; Cytowic R. E., 2002, SYNESTHESIA UNION SE; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; EMERSON LJ, 2005, MIXED SIGNALS; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; SMILEK D, 2002, PSYCHE, V8	12	40	40	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 24	2005	45	6					821	823		10.1016/j.neuron.2005.03.007	http://dx.doi.org/10.1016/j.neuron.2005.03.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797543	Bronze			2022-12-28	WOS:000228031300003
J	Fusi, S; Drew, PJ; Abbott, LF				Fusi, S; Drew, PJ; Abbott, LF			Cascade models of synaptically stored memories	NEURON			English	Article							LONG-TERM POTENTIATION; RECOGNITION MEMORY; PROTEIN-SYNTHESIS; INDUCTION; PLASTICITY; REVERSAL; LTP; METAPLASTICITY; CONSOLIDATION; FACILITATION	Storing memories of ongoing, everyday experiences requires a high degree of plasticity, but retaining these memories demands protection against changes induced by further activity and experience. Models in which memories are stored through switch-like transitions in synaptic efficacy are good at storing but bad at retaining memories if these transitions are likely, and they are poor at storage but good at retention if they are unlikely. We construct and study a model in which each synapse has a cascade of states with different levels of plasticity, connected by metaplastic transitions. This cascade model combines high levels of memory storage with long retention times and significantly outperforms alternative models. As a result, we suggest that memory storage requires synapses with multiple states exhibiting dynamics over a wide range of timescales, and we suggest experimental tests of this hypothesis.	Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland	Brandeis University; Brandeis University; University of Bern	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA.	abboft@brandeis.edu	Drew, Patrick J/L-7808-2018; Fusi, Stefano/E-9109-2011	Drew, Patrick J/0000-0002-7483-7378; Fusi, Stefano/0000-0002-3035-6652	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016455] Funding Source: NIH RePORTER; NIDA NIH HHS [DA016455] Funding Source: Medline; NIMH NIH HHS [MH58754] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham WC, 2002, J NEUROSCI, V22, P9626; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; AMIT DJ, 1992, NETWORK-COMP NEURAL, V3, P443, DOI 10.1088/0954-898X/3/4/008; AMIT DJ, 1994, NEURAL COMPUT, V6, P957, DOI 10.1162/neco.1994.6.5.957; Anderson RB, 2001, MEM COGNITION, V29, P1061, DOI 10.3758/BF03195767; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bogacz R, 2001, J COMPUT NEUROSCI, V10, P5, DOI 10.1023/A:1008925909305; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GROSSBERG S, 1982, PSYCHOL REV, V89, P529, DOI 10.1037/0033-295X.89.5.529; Hermitte G, 1999, NEUROBIOL LEARN MEM, V71, P34, DOI 10.1006/nlme.1998.3858; HETZ J, 1991, INTRO THEORY NEURAL; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; NICKERSON RS, 1965, CAN J PSYCHOLOGY, V19, P155, DOI 10.1037/h0082899; O'Dell T J, 1994, Learn Mem, V1, P129; PAVLIK RI, 2005, IN PRESS COGN SCI; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sanna PP, 2002, J NEUROSCI, V22, P3359; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; SHEPARD RN, 1967, J VERB LEARN VERB BE, V6, P156, DOI 10.1016/S0022-5371(67)80067-7; Simons DJ, 1996, PSYCHOL SCI, V7, P301, DOI 10.1111/j.1467-9280.1996.tb00378.x; STANDING L, 1970, PSYCHON SCI, V19, P73, DOI 10.3758/BF03337426; STANDING L, 1973, Q J EXP PSYCHOL, V25, P207, DOI 10.1080/14640747308400340; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P713, DOI 10.1142/S0217984990000891; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x; Woo NH, 2003, HIPPOCAMPUS, V13, P293, DOI 10.1002/hipo.10086; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xiao MY, 1996, EUR J NEUROSCI, V8, P1916, DOI 10.1111/j.1460-9568.1996.tb01335.x; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	52	316	322	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					599	611		10.1016/j.neuron.2005.02.001	http://dx.doi.org/10.1016/j.neuron.2005.02.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721245	Bronze			2022-12-28	WOS:000227099700015
J	Wang, T; Xu, H; Oberwinkler, J; Gu, YC; Hardie, RC; Montell, C				Wang, T; Xu, H; Oberwinkler, J; Gu, YC; Hardie, RC; Montell, C			Light activation, adaptation, and cell survival functions of the Na+/Ca2(+) exchanger CaIX	NEURON			English	Article							DROSOPHILA-NINAC KINASE; RETINAL DEGENERATION; MOLECULAR CHARACTERIZATION; CALMODULIN REGULATION; VISUAL TRANSDUCTION; NA+-CA2+ EXCHANGER; DOMAIN PROTEIN; CALCIUM INFLUX; PDZ PROTEIN; TRP GENE	In sensory neurons, Ca2+ entry is crucial for both activation and subsequent attenuation of signaling. Influx of Ca2+ is counterbalanced by Ca2+ extrusion, and Na+/Ca2+ exchange is the primary mode for rapid Ca2+ removal during and after sensory stimulation. However, the consequences on sensory signaling resulting from mutations in Na+/Ca2+ exchangers have not been described. Here, we report that mutations in the Drosophila Na+/Ca2+ exchanger calk have a profound effect on activity-dependent survival of photoreceptor cells. Loss of CalX activity resulted in a transient response to light, a dramatic decrease in signal amplification, and unusually rapid adaptation. Conversely, overexpression of CalX had reciprocal effects and greatly suppressed the retinal degeneration caused by constitutive activity of the TRP channel. These results illustrate the critical role of Ca2+ for proper signaling and provide genetic evidence that Ca2+ overload is responsible for a form of retinal degeneration resulting from defects in the TRIP channel.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Saarland, Inst Pharmakol & Toxikol, D-66421 Homburg, Germany	Johns Hopkins University; University of Cambridge; Saarland University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Xu, Hong/H-9997-2016; Montell, Craig/AAH-3357-2021	Xu, Hong/0000-0003-1049-1184; Montell, Craig/0000-0001-5637-1482; gu, yuchun/0000-0002-7558-0447; Wang, Tao/0000-0002-2395-3483; Oberwinkler, Johannes/0000-0002-8541-3626; Xu, Hong/0000-0002-1423-1809; Hardie, Roger/0000-0001-5531-3264	NEI NIH HHS [EY08117, EY10852] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010852, R01EY008117] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Arnon A, 1997, P NATL ACAD SCI USA, V94, P5894, DOI 10.1073/pnas.94.11.5894; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1995, J NEUROSCI, V15, P889; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; Haug-Collet K, 1999, J CELL BIOL, V147, P659, DOI 10.1083/jcb.147.3.659; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; MATSUMOTO E, 1988, CELL TISSUE RES, V252, P293; MINKE B, 1984, VISION RES, V24, P109, DOI 10.1016/0042-6989(84)90095-6; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberwinkler J, 2000, P NATL ACAD SCI USA, V97, P8578, DOI 10.1073/pnas.97.15.8578; OBERWINKLER J, 2000, THESIS U GRONINGEN G; ODAY PM, 1991, ANN NY ACAD SCI, V639, P285, DOI 10.1111/j.1749-6632.1991.tb17317.x; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pak WL, 2003, RECEPTOR CHANNEL, V9, P149, DOI 10.1080/10606820308242; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Ruknudin A, 1997, AM J PHYSIOL-CELL PH, V273, pC257, DOI 10.1152/ajpcell.1997.273.1.C257; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Schwarzer A, 2000, J BIOL CHEM, V275, P13448, DOI 10.1074/jbc.275.18.13448; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Smith DP, 1996, CURR OPIN NEUROBIOL, V6, P500, DOI 10.1016/S0959-4388(96)80056-0; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Winkfein RJ, 2004, CELL CALCIUM, V36, P147, DOI 10.1016/j.ceca.2004.01.021; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Yoon J, 2000, J NEUROSCI, V20, P649, DOI 10.1523/JNEUROSCI.20-02-00649.2000	59	98	98	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					367	378		10.1016/j.neuron.2004.12.046	http://dx.doi.org/10.1016/j.neuron.2004.12.046			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694324	Bronze			2022-12-28	WOS:000226787700010
J	Gottfried, JA; Winston, JS; Dolan, RJ				Gottfried, JA; Winston, JS; Dolan, RJ			Dissociable codes of odor quality and odorant structure in human piriform cortex	NEURON			English	Article							OLFACTORY DISCRIMINATION ABILITY; INFERIOR TEMPORAL CORTEX; CROSS-ADAPTATION; ORBITOFRONTAL CORTEX; NEURAL REPRESENTATIONS; RECOGNITION MEMORY; ALIPHATIC-ALCOHOLS; GLOMERULAR LAYER; SELF-ADAPTATION; PERCEPTION	The relationship between odorant structure and odor quality has been a focus of olfactory research for 100 years, although no systematic correlations are yet apparent. Animal studies suggest that topographical representations of odorant structure in olfactory bulb form the perceptual basis of odor quality. Whether central olfactory regions are similarly organized is unclear. Using an olfactory version of fMRI cross-adaptation, we measured neural responses in primary olfactory (piriform) cortex as subjects smelled pairs of odorants systematically differing in quality and molecular functional group (as one critical attribute of odorant structure). Our results indicate a double dissociation in piriform cortex, whereby posterior regions encode quality (but not structure) and anterior regions encode structure (but not quality). The presence of structure-based codes suggests fidelity of sensory information arising from olfactory bulb. In turn, quality-based codes are independent of any simple structural configuration, implying that synthetic mechanisms may underlie our experience of smell.	Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Dept Neurol, Chicago, IL 60611 USA; Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	Northwestern University; Feinberg School of Medicine; University of London; University College London	Gottfried, JA (corresponding author), Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Dept Neurol, 320 E Super St, Chicago, IL 60611 USA.	j-gottfried@northwestern.edu	Winston, Joel/F-6180-2010	Winston, Joel/0000-0002-3957-0612; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMOORE JE, 1972, MOL BASIS ODOR; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Arctander S, 1994, PERFUME FLAVOR CHEM; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CAIN WS, 1992, CHEM SENSES, V17, P481, DOI 10.1093/chemse/17.5.481; CAIN WS, 1970, PERCEPT PSYCHOPHYS, V7, P271, DOI 10.3758/BF03210163; CATTARELLI M, 1988, BRAIN RES, V442, P180, DOI 10.1016/0006-8993(88)91449-7; Counet C, 2002, J AGR FOOD CHEM, V50, P2385, DOI 10.1021/jf0114177; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dravnieks A., 1985, ATLAS ODOR CHARACTER; ENGEN T, 1963, AM J PSYCHOL, V76, P96, DOI 10.2307/1420004; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Henning, 1916, DER GERUCH; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; Laska M, 2000, CHEM SENSES, V25, P189, DOI 10.1093/chemse/25.2.189; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; MacDonald MK, 1922, AM J PSYCHOL, V33, P535, DOI 10.2307/1413549; Mai J.K., 1997, ATLAS HUMAN BRAIN; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Menager I, 2004, J AGR FOOD CHEM, V52, P1248, DOI 10.1021/jf0350919; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Moncrieff R.W., 1967, CHEM SENSES, V3rd; MONCRIEFF RW, 1956, J PHYSIOL-LONDON, V133, P301, DOI 10.1113/jphysiol.1956.sp005587; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; OCONNELL RJ, 1994, CHEM SENSES, V19, P197, DOI 10.1093/chemse/19.3.197; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Pierce JD, 1996, CHEM SENSES, V21, P223, DOI 10.1093/chemse/21.2.223; POLAK EH, 1973, J THEOR BIOL, V245, P175; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Stevenson RJ, 2001, LEARN MOTIV, V32, P154, DOI 10.1006/lmot.2000.1070; Sullivan R.M., 2003, HDB OLFACTION GESTAT, P181; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; TODRANK J, 1991, CHEM SENSES, V16, P467, DOI 10.1093/chemse/16.5.467; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Wise PM, 2000, CHEM SENSES, V25, P429, DOI 10.1093/chemse/25.4.429; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506; Zwaardemaker H, 1895, PHYSL GERUCHS	61	141	146	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					467	479		10.1016/j.neuron.2006.01.007	http://dx.doi.org/10.1016/j.neuron.2006.01.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446149	Green Submitted, Bronze			2022-12-28	WOS:000235260900017
J	Sundberg, KA; Fallah, M; Reynolds, JH				Sundberg, KA; Fallah, M; Reynolds, JH			A motion-dependent distortion of retinotopy in area V4	NEURON			English	Article							SPATIAL RELATIONSHIP; EYE-MOVEMENTS; ADAPTATION; INTEGRATION; EXTRAPOLATION; FIELDS; MT; RESPONSES; DYNAMICS; POSITION	When one element in an apparent motion sequence differs in color from the others, it is perceived as shifted along the motion trajectory. We examined whether V4 neurons encode the physical or perceived location of this "flashed" element by recording neuronal responses while monkeys viewed these stimuli. The retinotopic locus of V4 activity evoked by the flashed element shifted along the motion trajectory. The magnitude of the shift is consistent with the perceptual shift in humans viewing identical stimuli. This retinotopic distortion depended on the presence of a flashed element but was observed for both color-selective and non-color-selective neurons. The distortion was undiminished when the flashed element terminated the sequence, a condition that reduced the perceptual shift in humans. These findings are consistent with a Bayesian model of localization in which perceived location is derived from position signals optimally integrated across visual areas.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Sundberg, KA (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sundberg@salk.edu	Fallah, Mazyar/ABH-9906-2020	Fallah, Mazyar/0000-0001-5979-3955	NATIONAL EYE INSTITUTE [R01EY013802] Funding Source: NIH RePORTER; NEI NIH HHS [1R01EY13802-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Brenner E, 2001, VISION RES, V41, P2253, DOI 10.1016/S0042-6989(01)00018-9; CAI R, 2001, J VISION, V1, pA127, DOI DOI 10.1167/1.3.127; Cai RH, 2000, EXP BRAIN RES, V135, P275, DOI 10.1007/s002210000549; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Fu YX, 2004, J NEUROSCI, V24, P2165, DOI 10.1523/JNEUROSCI.5145-03.2004; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Groh JM, 1997, J NEUROSCI, V17, P4312; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jancke D, 1999, J NEUROSCI, V19, P9016, DOI 10.1523/JNEUROSCI.19-20-09016.1999; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; Knill DC, 1996, PERCEPTION BAYESIAN; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kondo H, 2000, NEUROSCI RES, V36, P27, DOI 10.1016/S0168-0102(99)00104-2; Krekelberg B, 2000, VISION RES, V40, P201, DOI 10.1016/S0042-6989(99)00168-6; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Shim WM, 2005, VISION RES, V45, P3253, DOI 10.1016/j.visres.2005.05.029; SPARKS DL, 1976, BRAIN RES, V113, P21, DOI 10.1016/0006-8993(76)90003-2; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Vreven D, 2005, PERCEPTION, V34, P31, DOI 10.1068/p5371; Whitney D, 2003, SCIENCE, V302, P878, DOI 10.1126/science.1087839; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659	38	54	54	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					447	457		10.1016/j.neuron.2005.12.023	http://dx.doi.org/10.1016/j.neuron.2005.12.023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446147	Bronze, Green Submitted			2022-12-28	WOS:000235260900015
J	Brincat, SL; Connor, CE				Brincat, SL; Connor, CE			Dynamic shape synthesis in posterior inferotemporal cortex	NEURON			English	Article							VISUAL-CORTEX; AREA MT; MACAQUE; NEURONS; REPRESENTATION; RESPONSES; FEATURES; FACE; RECOGNITION; SELECTIVITY	How does the brain synthesize low-level neural signals for simple shape parts into coherent representations of complete objects? Here, we present evidence for a dynamic process of object part integration in macaque posterior inferotemporal cortex (IT). Immediately after stimulus onset, neural responses carried information about individual object parts (simple contour fragments) only. Subsequently, information about specific multipart configurations emerged, building gradually over the course of similar to 60 ms, producing a sparser and more explicit representation of object shape. We show that this gradual transformation can be explained by a recurrent network process that effectively compares parts signals across neurons to generate inferences about multipart shape configurations.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	connor@jhu.edu						Arguin M, 2000, VISION RES, V40, P3099, DOI 10.1016/S0042-6989(00)00155-3; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Bullier J, 2001, PROG BRAIN RES, V134, P193; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Dayan P, 2001, COMPUTATIONAL NEUROS; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Movshon A, 1985, PATTERN RECOGN, V54, P117; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pugh MC, 2000, J COMPUT NEUROSCI, V8, P143, DOI 10.1023/A:1008921231855; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Ringach DL, 1996, VISION RES, V36, P3037, DOI 10.1016/0042-6989(96)00062-4; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Rolls ET, 1990, NETWORK-COMP NEURAL, V1, P407, DOI 10.1088/0954-898X/1/4/002; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	38	132	132	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					17	24		10.1016/j.neuron.2005.11.026	http://dx.doi.org/10.1016/j.neuron.2005.11.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387636	Bronze			2022-12-28	WOS:000236699300006
J	Arimura, N; Kaibuchi, K				Arimura, N; Kaibuchi, K			Key regulators in neuronal polarity	NEURON			English	Review							CULTURED HIPPOCAMPAL-NEURONS; AXON FORMATION; CELL POLARITY; CRMP-2; COMPLEX; SPECIFICATION; ESTABLISHMENT; GSK-3-BETA; TRANSPORT; PHOSPHORYLATION	Neurons are highly polarized cells, most of which develop a single axon and several dendrites. These two compartments acquire specific characteristics that enable neurons to transmit intercellular signals from several dendrites to an axon. A wealth of recent studies has shown that PI 3-kinase, Rho family GTPases, the Par complex, and cytoskeleton-related proteins participate in the initial events of neuronal polarization. Here, we review the role of polarity-regulating molecules and the potential mechanisms underlying the specification of an axon and dendrites.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan	Nagoya University	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp						Baas PW, 2004, J NEUROBIOL, V58, P3, DOI 10.1002/neu.10281; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Esch T, 1999, J NEUROSCI, V19, P6417; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Rolls MM, 2004, NAT NEUROSCI, V7, P1293, DOI 10.1038/nn1346; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; YOSHIMURA T, 2005, IN PRESS BIOCH BIOPH	32	112	117	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					881	884		10.1016/j.neuron.2005.11.007	http://dx.doi.org/10.1016/j.neuron.2005.11.007			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364893	Bronze			2022-12-28	WOS:000234301700004
J	Dulla, CG; Dobelis, P; Pearson, T; Frenguelli, BG; Staley, KJ; Masino, SA				Dulla, CG; Dobelis, P; Pearson, T; Frenguelli, BG; Staley, KJ; Masino, SA			Adenosine and ATP link P-CO2 to cortical excitability via pH	NEURON			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICE; CENTRAL-NERVOUS-SYSTEM; CA3 NETWORK ACTIVITY; METHYL-D-ASPARTATE; SYNAPTIC-TRANSMISSION; P2X RECEPTORS; EPILEPTIFORM ACTIVITY; SEROTONERGIC NEURONS; CARBON-DIOXIDE	In addition to affecting respiration and vascular tone, deviations from normal CO2 alter pH, consciousness, and seizure propensity. Outside the brainstem, however, the mechanisms by which CO2 levels modify neuronal function are unknown. In the hippocampal slice preparation, increasing CO2, and thus decreasing pH, increased the extracellular concentration of the endogenous neuromodulator adenosine and inhibited excitatory synaptic transmission. These effects involve adenosine A(1) and ATP receptors and depend on decreased extracellular pH. In contrast, decreasing CO2 levels reduced extracellular adenosine concentration and increased neuronal excitability via adenosine A, receptors, ATP receptors, and ecto-ATPase. Based on these studies, we propose that CO2-induced changes in neuronal function arise from a pH-dependent modulation of adenosine and ATP levels. These findings demonstrate a mechanism for the bidirectional effects Of CO2 on neuronal excitability in the forebrain.	Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Dundee, Div Pathol & Neurosci, Inst Neurosci, Ninewells Hosp, Dundee DD1 9SY, Scotland; Trinity Coll, Program Neurosci, Hartford, CT 06106 USA; Trinity Coll, Dept Psychol, Hartford, CT 06106 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Dundee; Trinity College; Trinity College	Staley, KJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Program Neurosci, 4200 E 9th Ave, Denver, CO 80262 USA.	kevin.staley@uchsc.edu	Frenguelli, Bruno/C-5007-2015	Frenguelli, Bruno/0000-0001-7214-3172; Dulla, Chris/0000-0002-6560-6535	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029173] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029173-13, R01 NS029173, R01 NS029173-10, R01 NS029173-12, R01 NS029173-11, R01 NS029173-09A1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ACHENBACHNG J, 1994, J CLIN NEUROPHYSIOL, V11, P220, DOI 10.1097/00004691-199403000-00007; ADAMS DJ, 1981, NEUROLOGY, V31, P1175, DOI 10.1212/WNL.31.9.1175; Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; Almeida T, 2003, NEUROSCIENCE, V122, P111, DOI 10.1016/S0306-4522(03)00523-2; ARAM JA, 1987, NEUROSCI LETT, V83, P345, DOI 10.1016/0304-3940(87)90112-1; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; BALESTRINO M, 1988, J PHYSIOL-LONDON, V396, P247, DOI 10.1113/jphysiol.1988.sp016961; Bao Yinghui, 2000, Chin J Traumatol, V3, P210; Boison D, 2002, EPILEPSIA, V43, P788, DOI 10.1046/j.1528-1157.2002.33001.x; Bradley SR, 2002, NAT NEUROSCI, V5, P401, DOI 10.1038/nn848; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Capps R T, 1968, Clin Anesth, V3, P122; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cunha RA, 1998, J NEUROSCI, V18, P1987; Dale N, 1998, J PHYSIOL-LONDON, V511, P265, DOI 10.1111/j.1469-7793.1998.265bi.x; Dale N, 2000, J PHYSIOL-LONDON, V526, P143, DOI 10.1111/j.1469-7793.2000.00143.x; Datto C, 2002, J ECT, V18, P118, DOI 10.1097/00124509-200209000-00002; Drakulich DA, 2004, EUR J PHARMACOL, V485, P137, DOI 10.1016/j.ejphar.2003.11.056; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Dunwiddie T V, 1999, Adv Neurol, V79, P1001; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; FUJIWARA N, 1992, BRAIN RES, V572, P335, DOI 10.1016/0006-8993(92)90496-V; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; GU JG, 1995, J NEUROCHEM, V64, P2105; Guaranha MSB, 2005, EPILEPSIA, V46, P69, DOI 10.1111/j.0013-9580.2005.11104.x; Huguenard J R, 1999, Adv Neurol, V79, P991; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KARURI AR, 1993, BRIT J CANCER, V68, P1080, DOI 10.1038/bjc.1993.485; Khakh BS, 2003, J NEUROSCI, V23, P7426; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Lee J, 1996, BRAIN RES, V706, P210, DOI 10.1016/0006-8993(95)01214-1; MACVICAR BA, 1982, BRAIN RES, V242, P341; Malva JO, 2003, NEUROCHEM RES, V28, P1501, DOI 10.1023/A:1025618324593; Masino SA, 1999, J NEUROSCI, V19, P1932; Mendoza-Fernandez V, 2000, J PHARMACOL EXP THER, V293, P172; MILEY CE, 1977, ARCH NEUROL-CHICAGO, V34, P371, DOI 10.1001/archneur.1977.00500180065014; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; NAGY AK, 1986, J NEUROCHEM, V47, P976; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; Pankratov Y, 1999, PROG BRAIN RES, V120, P237; Pankratov YV, 2002, J NEUROSCI, V22, P8363; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pearson T, 2001, J NEUROSCI, V21, P2298, DOI 10.1523/JNEUROSCI.21-07-02298.2001; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; Thummler S, 2000, J NEUROPHYSIOL, V83, P1787, DOI 10.1152/jn.2000.83.4.1787; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wirrell EC, 1996, EPILEPSIA, V37, P459, DOI 10.1111/j.1528-1157.1996.tb00592.x; Yoshioka K, 2002, FEBS LETT, V531, P299, DOI 10.1016/S0014-5793(02)03540-8; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; ZIGANSHIN AU, 1994, DRUG DEVELOP RES, V32, P134, DOI 10.1002/ddr.430320303; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	67	132	136	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1011	1023		10.1016/j.neuron.2005.11.009	http://dx.doi.org/10.1016/j.neuron.2005.11.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364904	Green Accepted, Bronze			2022-12-28	WOS:000234301700016
J	Marowsky, A; Yanagawa, Y; Obata, K; Vogt, KE				Marowsky, A; Yanagawa, Y; Obata, K; Vogt, KE			A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function	NEURON			English	Article							ANTAGONIST SCH 23390; GREEN FLUORESCENT PROTEIN; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; POTENTIATED STARTLE; LATERAL AMYGDALA; CONDITIONED FEAR; ACOUSTIC STARTLE; RAT AMYGDALA; IN-VIVO	The amygdala is under inhibitory control from the cortex through the activation of local GABAergic interneurons. This inhibition is greatly diminished during heightened emotional states due to dopamine release. However, dopamine excites most amygdala interneurons, suggesting that this dopaminergic gate may be mediated by an unknown subpopulation of interneurons. We hypothesized that this gate is mediated by paracapsular intercalated cells, a subset of interneurons that are innervated by both cortical and mesolimbic dopaminergic afferents. Using transgenic mice that express GFP in GABAergic interneurons, we show that paracapsular cells form a network surrounding the basolateral complex of the amygdala. We found that they provide feedforward inhibition into the basolateral and the central amygdala. Dopamine hyperpolarized paracapsular cells through D1 receptors and substantially suppressed their excitability, resulting in a disinhibition of the basolateral and central nuclei. Suppression of the paracapsular system by dopamine provides a compelling neural mechanism for the increased affective behavior observed during stress or other hyperdopaminergic states.	Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Japan Sci & Technol Corp, SORST, Kawaguchi, Japan; RIKEN, Brain Sci Inst, Neuronal Circuit Mechanisms Res Grp, Wako, Saitama 35101, Japan	University of Zurich; Gunma University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); RIKEN	Vogt, KE (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	kvogt@pharma.unizh.ch		Vogt, Kaspar/0000-0002-0859-876X				Alheid George F., 1995, P495; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Asan E, 1998, Adv Anat Embryol Cell Biol, V142, P1; Berretta S, 2005, NEUROSCIENCE, V132, P943, DOI 10.1016/j.neuroscience.2005.01.020; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Borowski TB, 1998, BEHAV NEUROSCI, V112, P952, DOI 10.1037/0735-7044.112.4.952; Collins DR, 1999, EUR J NEUROSCI, V11, P3441, DOI 10.1046/j.1460-9568.1999.00763.x; Correll CM, 2005, BIOL PSYCHIAT, V58, P382, DOI 10.1016/j.biopsych.2005.04.009; de la Mora MP, 2005, NEUROSCI LETT, V377, P101, DOI 10.1016/j.neulet.2004.11.079; Freedman LJ, 2000, J COMP NEUROL, V421, P172; Fuxe K, 2003, NEUROSCIENCE, V119, P733, DOI 10.1016/S0306-4522(03)00148-9; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Inoue T, 2000, PHARMACOL BIOCHEM BE, V66, P573, DOI 10.1016/S0091-3057(00)00254-9; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; KRONER S, 2004, J NEUROPHYSIOL, V843, P1; Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9; Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEGALLASALLE G, 1978, BRAIN RES, V155, P397, DOI 10.1016/0006-8993(78)91037-5; Leonard SK, 2003, SYNAPSE, V50, P320, DOI 10.1002/syn.10272; Loretan K, 2004, NEUROPHARMACOLOGY, V47, P631, DOI 10.1016/j.neuropharm.2004.07.015; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; Meloni EG, 1999, PSYCHOPHARMACOLOGY, V144, P373, DOI 10.1007/s002130051020; MILLHOUSE OE, 1986, J COMP NEUROL, V247, P246, DOI 10.1002/cne.902470209; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Nicola SM, 1996, J NEUROSCI, V16, P1591; PachecoCano MT, 1996, EXP BRAIN RES, V110, P205; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; Pare D, 2003, ANN NY ACAD SCI, V985, P78; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Royer S, 1999, J NEUROSCI, V19, P10575; Royer S, 2000, J NEUROSCI, V20, P9034; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Smith Y, 2000, J COMP NEUROL, V416, P496; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taylor SF, 2002, SCHIZOPHR RES, V58, P159, DOI 10.1016/S0920-9964(01)00403-0; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Yokoyama M, 2005, NEUROSCI LETT, V379, P37, DOI 10.1016/j.neulet.2004.12.047; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349	60	231	242	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					1025	1037		10.1016/j.neuron.2005.10.029	http://dx.doi.org/10.1016/j.neuron.2005.10.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364905	Bronze			2022-12-28	WOS:000234301700017
J	Chotard, C; Leung, W; Salecker, I				Chotard, C; Leung, W; Salecker, I			glial cells missing and gcm2 cell autonomously regulate both glial and neuronal development in the visual system of Drosophila	NEURON			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; ZINC-FINGER PROTEIN; DNA-BINDING DOMAIN; RETINAL AXONS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ECTOPIC EXPRESSION; OPTIC GANGLION; EGF RECEPTOR; DIFFERENTIATION	The transcription factors Glial cells missing (Gcm) and Gcm2 are known to play a crucial role in promoting glial-cell differentiation during Drosophila embryogenesis. Our findings reveal a central function for gcm genes in regulating neuronal development in the postembryonic visual system. We demonstrate that Gcm and Gcm2 are expressed in both glial and neuronal precursors within the optic lobe. Removal of gcm and gcm2 function shows that the two genes act redundantly and are required for the formation of a subset of glial cells. They also cell-autonomously control the differentiation and proliferation of specific neurons. We show that the transcriptional regulator Dachshund acts downstream of gcm genes and is required to make lamina precursor cells and lamina neurons competent for neuronal differentiation through regulation of epidermal growth factor receptor levels. Our findings further suggest that gcm genes regulate neurogenesis through collaboration with the Hedgehog-signaling pathway.	Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research	Salecker, I (corresponding author), Natl Inst Med Res, Div Mol Neurobiol, Ridgeway, London NW7 1AA, England.	isaleck@nimr.mrc.ac.uk	Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763	Medical Research Council [MC_U117581332] Funding Source: Medline; MRC [MC_U117581332] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Akiyama-Oda Y, 1998, DEV GENES EVOL, V208, P578, DOI 10.1007/s004270050217; Akiyama-Oda Y, 1999, DEVELOPMENT, V126, P1967; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Bello B, 1998, DEVELOPMENT, V125, P2193; Bernardoni R, 1997, DEV BIOL, V191, P118; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Dearborn R, 2004, DEVELOPMENT, V131, P2291, DOI 10.1242/dev.01111; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Fichelson P, 2003, DEVELOPMENT, V130, P123, DOI 10.1242/dev.00198; GLESEN K, 1997, DEVELOPMENT, V124, P2307; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hashemothosseini S, 2004, J CELL BIOL, V166, P765, DOI 10.1083/jcb.200406097; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ito K, 1997, DEVELOPMENT, V124, P761; Iwasaki Y, 2003, DEVELOPMENT, V130, P6027, DOI 10.1242/dev.00822; Jones BW, 2005, DEV BIOL, V278, P265, DOI 10.1016/j.ydbio.2004.11.022; Jones BW, 2004, DEV BIOL, V266, P374, DOI 10.1016/j.ydbio.2003.10.013; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Jones BW, 2001, BIOESSAYS, V23, P877, DOI 10.1002/bies.1129; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lillien L, 1998, MOL CELL NEUROSCI, V10, P296, DOI 10.1006/mcne.1997.0659; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; MARDON G, 1994, DEVELOPMENT, V120, P3473; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Nait-Oumesmar B, 2002, DEVELOPMENT, V129, P3957; Newsome TP, 2000, DEVELOPMENT, V127, P851; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Perez SE, 1996, MECH DEVELOP, V59, P11, DOI 10.1016/0925-4773(96)00556-4; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Ragone G, 2003, DEV BIOL, V255, P138, DOI 10.1016/S0012-1606(02)00081-7; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Sepp KJ, 1999, GENETICS, V151, P1093; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Soustelle L, 2004, DEVELOPMENT, V131, P4521, DOI 10.1242/dev.01290; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Tavsanli BC, 2004, DEV BIOL, V272, P231, DOI 10.1016/j.ydbio.2004.05.005; Van De Bor V, 2000, DEVELOPMENT, V127, P3735; Vincent S, 1996, DEVELOPMENT, V122, P131; Wallace K, 2000, GENESIS, V26, P77, DOI 10.1002/(SICI)1526-968X(200001)26:1<77::AID-GENE10>3.3.CO;2-I; Wegner M, 2001, TRENDS GENET, V17, P286, DOI 10.1016/S0168-9525(01)02275-2; WINBERG ML, 1992, DEVELOPMENT, V115, P903; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	69	101	102	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					237	251		10.1016/j.neuron.2005.09.019	http://dx.doi.org/10.1016/j.neuron.2005.09.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242405	Bronze			2022-12-28	WOS:000232838700014
J	Kumar, A; Choi, KH; Renthal, W; Tsankova, NM; Theobald, DEH; Truong, HT; Russo, SJ; LaPlant, Q; Sasaki, TS; Whistler, KN; Neve, RL; Self, DW; Nestler, EJ				Kumar, A; Choi, KH; Renthal, W; Tsankova, NM; Theobald, DEH; Truong, HT; Russo, SJ; LaPlant, Q; Sasaki, TS; Whistler, KN; Neve, RL; Self, DW; Nestler, EJ			Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum	NEURON			English	Article							CHRONIC ELECTROCONVULSIVE SEIZURES; HISTONE DEACETYLASE INHIBITORS; CYCLIN-DEPENDENT KINASE-5; EARLY GENE-EXPRESSION; DELTA-FOSB; TRANSCRIPTION FACTOR; NUCLEUS-ACCUMBENS; C-FOS; HUNTINGTONS-DISEASE; SEEKING BEHAVIOR	Given that cocaine induces neuroadaptations through regulation of gene expression, we investigated whether chromatin remodeling at specific gene promoters may be a key mechanism. We show that cocaine induces specific histone modifications at different gene promoters in striaturn, a major neural substrate for cocaine's behavioral effects. At the cFos promoter, H4 hyperacetylation is seen within 30 min of a single cocaine injection, whereas no histone modifications were seen with chronic cocaine, consistent with cocaine's ability to induce cFos acutely, but not chronically. In contrast, at the BDNF and Cdk5 promoters, genes that are induced by chronic, but not acute, cocaine, H3 hyperacetylation was observed with chronic cocaine only. Delta FosB, a cocaine-induced transcription factor, appears to mediate this regulation of the Cdk5 gene. Furthermore, modulating histone deacetylase activity alters locomotor and rewarding responses to cocaine. Thus, chromatin remodeling is an important regulatory mechanism underlying cocaine-induced neural and behavioral plasticity.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; McLean Hosp, Belmont, MA 02178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University; McLean Hospital	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Russo, Scott/R-7107-2019; Kumar, Arvind/B-6094-2009	Russo, Scott/0000-0002-6470-1805; Kumar, Arvind/0000-0003-2879-3826; Renthal, William/0000-0003-0206-2101				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Andersson M, 2001, J NEUROSCI, V21, P9930, DOI 10.1523/JNEUROSCI.21-24-09930.2001; Ang E, 2001, J NEUROCHEM, V79, P221, DOI 10.1046/j.1471-4159.2001.00563.x; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Chen JS, 2000, J NEUROSCI, V20, P8965; Chen JS, 1997, J NEUROSCI, V17, P4933; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Colby CR, 2003, J NEUROSCI, V23, P2488; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; DAUNAIS JB, 1993, NEUROREPORT, V4, P543, DOI 10.1097/00001756-199305000-00020; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Grimm JW, 2003, J NEUROSCI, V23, P742; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Huang YF, 2002, J NEUROSCI, V22, P8422; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson KD, 2002, METHODS, V26, P27, DOI 10.1016/S1046-2023(02)00005-1; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kalivas Peter W, 2004, Curr Psychiatry Rep, V6, P347, DOI 10.1007/s11920-004-0021-0; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Mattson MP, 2003, AGEING RES REV, V2, P329, DOI 10.1016/S1568-1637(03)00013-8; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; PERSICO AM, 1993, MOL BRAIN RES, V20, P91, DOI 10.1016/0169-328X(93)90113-4; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; Zeitlin SG, 2001, J CELL SCI, V114, P653	61	590	622	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					303	314		10.1016/j.neuron.2005.09.023	http://dx.doi.org/10.1016/j.neuron.2005.09.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242410	Bronze			2022-12-28	WOS:000232838700019
J	Bielsky, IF; Hu, SB; Ren, XH; Terwilliger, EF; Young, LJ				Bielsky, IF; Hu, SB; Ren, XH; Terwilliger, EF; Young, LJ			The V1a vasopressin receptor is necessary and sufficient for normal social recognition: A gene replacement study	NEURON			English	Article							ANXIETY-RELATED BEHAVIOR; LATERAL SEPTAL VASOPRESSIN; PAIR-BOND FORMATION; AGGRESSIVE-BEHAVIOR; PATERNAL BEHAVIOR; RAT-BRAIN; OXYTOCIN; MEMORY; BINDING; ANTAGONIST	Vasopressin modulates many social and nonsocial behaviors, including emotionality. We have previously reported that male mice with a null mutation in the V1a receptor (V1aR) exhibit a profound impairment in social recognition and changes in anxiety-like behavior. Using site-specific injections of a V1aR-specific antagonist, we demonstrate that the lateral septum, but not the medial amygdala, is critical for social recognition. Reexpressing V1aR in the lateral septum of V1aR knockout mice (V1aRKO) using a viral vector resulted in a complete rescue of social recognition. Furthermore, overexpression of the V1aR in the lateral septum of wild-type (wt) mice resulted in a potentiation of social recognition behavior and a mild increase in anxiety-related behavior. These results demonstrate that the V1aR in the lateral septum plays a critical role in the neural processing of social stimuli required for complex social behavior.	Emory Univ, Dept Psychiat, Atlanta, GA 30329 USA; Emory Univ, Ctr Behav Neurosci, Atlanta, GA 30329 USA; NIMH, Clin Neuroendocrinol Branch, NIH, Bethesda, MD 20892 USA; Harvard Univ, Inst Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Bielsky, IF (corresponding author), Emory Univ, Dept Psychiat, Atlanta, GA 30329 USA.	alanwithisa@yahoo.com	Young, Larry/HGE-5031-2022		NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH070112, R01MH056897, R29MH056897, K02MH064692, R01MH056538] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00165] Funding Source: Medline; NIMH NIH HHS [MH070112, MH056538, MH64692, MH56897] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DG, 2003, NEUROPSYCHOLOGIA, V41, P516, DOI 10.1016/S0028-3932(03)00004-6; Appenrodt E, 1998, PHYSIOL BEHAV, V64, P543, DOI 10.1016/S0031-9384(98)00119-X; Bamshad M, 1996, J COMP NEUROL, V369, P252; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BLUTHE RM, 1990, BRAIN RES, V535, P301, DOI 10.1016/0006-8993(90)91613-L; Boccia MM, 1998, NEUROBIOL LEARN MEM, V69, P136, DOI 10.1006/nlme.1997.3817; Chu J, 1998, HORM BEHAV, V34, P248, DOI 10.1006/hbeh.1998.1479; CLARKE A, 1982, PHARMACOL BIOCHEM BE, V17, P623, DOI 10.1016/0091-3057(82)90334-3; Daenen EWPM, 2002, BEHAV BRAIN RES, V136, P571, DOI 10.1016/S0166-4328(02)00223-1; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; DANTZER R, 1988, BRAIN RES, V457, P143, DOI 10.1016/0006-8993(88)90066-2; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Engelmann M, 1996, NEUROSCI BIOBEHAV R, V20, P341, DOI 10.1016/0149-7634(95)00059-3; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Everts HGJ, 1997, BRAIN RES, V760, P1, DOI 10.1016/S0006-8993(97)00269-2; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FERRIS CF, 1984, SCIENCE, V224, P521, DOI 10.1126/science.6538700; FERRIS CF, 1986, PHYSIOL BEHAV, V38, P135, DOI 10.1016/0031-9384(86)90143-5; Goodson JL, 1999, J NEUROENDOCRINOL, V11, P19; GREIDANUS TBV, 1983, PHARMACOL THERAPEUT, V20, P437; Greidanus TBV, 1996, BRAIN RES, V713, P153, DOI 10.1016/0006-8993(95)01505-1; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Hu SB, 2003, J NEUROIMMUNOL, V135, P72, DOI 10.1016/S0165-5728(02)00442-3; JOHNSON AE, 1993, BRAIN RES, V622, P9, DOI 10.1016/0006-8993(93)90795-O; Lai WS, 2002, PHYSIOL BEHAV, V76, P225, DOI 10.1016/S0031-9384(02)00721-7; Landgraf R, 1998, PROG BRAIN RES, V119, P201; Landgraf R, 2003, EUR J NEUROSCI, V18, P403, DOI 10.1046/j.1460-9568.2003.02750.x; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; LEMOAL M, 1987, NEUROSCI LETT, V77, P353, DOI 10.1016/0304-3940(87)90527-1; Liebsch G, 1996, NEUROSCI LETT, V217, P101, DOI 10.1016/0304-3940(96)13069-X; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Nair HP, 2002, METHODS, V28, P195, DOI 10.1016/S1046-2023(02)00223-2; Packard MG, 2004, NEUROBIOL LEARN MEM, V82, P243, DOI 10.1016/j.nlm.2004.06.008; Parker KJ, 2001, HORM BEHAV, V39, P285, DOI 10.1006/hbeh.2001.1655; Parker KJ, 2001, BEHAV NEUROSCI, V115, P1341, DOI 10.1037/0735-7044.115.6.1341; Peel AL, 1997, GENE THER, V4, P16, DOI 10.1038/sj.gt.3300358; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Sheehan Teige, 2000, P175; Stemmelin J, 2005, NEUROPSYCHOPHARMACOL, V30, P35, DOI 10.1038/sj.npp.1300562; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; Wigger A, 2004, NEUROPSYCHOPHARMACOL, V29, P1, DOI 10.1038/sj.npp.1300290; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wotjak CT, 1996, J NEUROSCI, V16, P7725; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 1997, BEHAV NEUROSCI, V111, P599, DOI 10.1037/0735-7044.111.3.599	60	275	284	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					503	513		10.1016/j.neuron.2005.06.031	http://dx.doi.org/10.1016/j.neuron.2005.06.031			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102534	Bronze			2022-12-28	WOS:000231411100008
J	Yuan, Q; Lin, FJ; Zheng, XZ; Sehgal, A				Yuan, Q; Lin, FJ; Zheng, XZ; Sehgal, A			Serotonin modulates circadian entrainment in Drosophila	NEURON			English	Article							SUPRACHIASMATIC NUCLEUS; EXPRESSION PATTERNS; BEHAVIORAL RHYTHMS; LIGHT RESPONSE; CLOCK; PROTEIN; MELANOGASTER; NEURONS; TIMELESS; PERIOD	Entrainment of the Drosophila circadian clock to light involves the light-induced degradation of the clock protein timeless (TIM). We show here that this entrainment mechanism is inhibited by serotonin, acting through the Drosophila serotonin receptor 1B (d5-HT1B). d5-HT1B is expressed in clock neurons, and alterations of its levels affect molecular and behavioral responses of the clock to light. Effects of d5-HT1B are synergistic with a mutation in the circadian photoreceptor cryptochrome (CRY) and are mediated by SHAGGY (SGG), Drosophila glycogen synthase kinase 3 beta (GSK3 beta), which phosphorylates TIM. Levels of serotonin are decreased in flies maintained in extended constant darkness, suggesting that modulation of the clock by serotonin may vary under different environmental conditions. These data identify a molecular connection between serotonin signaling and the central clock component TIM and suggest a homeostatic mechanism for the regulation of circadian photosensitivity in Drosophila.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu	Yuan, Quan/E-7688-2013					Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Albert PR, 2001, TRENDS ENDOCRIN MET, V12, P453, DOI 10.1016/S1043-2760(01)00498-2; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; Boutrel B, 2002, J NEUROSCI, V22, P4686, DOI 10.1523/JNEUROSCI.22-11-04686.2002; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Cymborowski B, 1998, PHYSIOL ENTOMOL, V23, P25, DOI 10.1046/j.1365-3032.1998.2310025.x; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dudley TE, 1998, J NEUROSCI, V18, P5045; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Garabette ML, 2000, BRIT J PHARMACOL, V131, P1569, DOI 10.1038/sj.bjp.0703753; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Glass JD, 2003, J NEUROSCI, V23, P7451; Hall JC, 2000, CURR OPIN NEUROBIOL, V10, P456, DOI 10.1016/S0959-4388(00)00117-3; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Iwahana E, 2004, EUR J NEUROSCI, V19, P2281, DOI 10.1111/j.0953-816X.2004.03322.x; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Meinertzhagen IA, 1999, MICROSC RES TECHNIQ, V45, P96, DOI 10.1002/(SICI)1097-0029(19990415)45:2<96::AID-JEMT4>3.0.CO;2-L; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Nagayama H, 1997, BRAIN RES, V756, P92, DOI 10.1016/S0006-8993(97)00121-2; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Page T.L., 1987, Journal of Biological Rhythms, V2, P23, DOI 10.1177/074873048700200103; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Pickard GE, 1997, BIOL CELL, V89, P513, DOI 10.1016/S0248-4900(98)80007-5; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Saifullah ASM, 2002, J EXP BIOL, V205, P1305; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Shafer OT, 2002, J NEUROSCI, V22, P5946; Smart CM, 2001, NEUROSCI LETT, V305, P33, DOI 10.1016/S0304-3940(01)01797-9; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, J NEUROSCI, V17, P676; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; WINFREE AT, 1972, J COMP PHYSIOL, V77, P418, DOI 10.1007/BF00694944; Wulbeck C, 2005, GENETICS, V169, P751, DOI 10.1534/genetics.104.036244; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	54	177	185	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					115	127		10.1016/j.neuron.2005.05.027	http://dx.doi.org/10.1016/j.neuron.2005.05.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996552	Bronze			2022-12-28	WOS:000230464000012
J	Nair, KS; Hanson, SM; Mendez, A; Gurevich, EV; Kennedy, MJ; Shestopalov, VI; VlshnivetskLy, SA; Chen, J; Hurley, JB; Gurevich, VV; Slepak, VZ				Nair, KS; Hanson, SM; Mendez, A; Gurevich, EV; Kennedy, MJ; Shestopalov, VI; VlshnivetskLy, SA; Chen, J; Hurley, JB; Gurevich, VV; Slepak, VZ			Light-dependent redistribution of arrestin in vertebrate rods is an energy-independent process governed by protein-protein interactions	NEURON			English	Article							VISUAL ARRESTIN; RHODOPSIN PHOSPHORYLATION; MULTIPLE PHOSPHORYLATION; PHOTORECEPTOR CELLS; S-ANTIGEN; BINDING; TRANSLOCATION; SELECTIVITY; ADAPTATION; TRANSDUCIN	In rod photoreceptors, arrestin localizes to the outer segment (OS) in the light and to the inner segment (IS) in the dark. Here, we demonstrate that redistribution of arrestin between these compartments can proceed in ATP-depleted photoreceptors. Translocation of transducin from the IS to the OS also does not require energy, but depletion of ATP or GTP inhibits its reverse movement. A sustained presence of activated rhodopsin is required for sequestering arrestin in the OS, and the rate of arrestin relocalization to the OS is determined by the amount and the phosphorylation status of photolyzed rhodopsin. Interaction of arrestin with microtubules is increased in the dark. Mutations that enhance arrestin-microtubule binding attenuate arrestin translocation to the OS. These results indicate that the distribution of arrestin in rods is controlled by its dynamic interactions with rhodopsin in the OS and microtubules in the IS and that its movement occurs by simple diffusion.	Univ Miami, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Miami, Neurosci Program, Miami, FL 33136 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of Miami; University of Miami; Vanderbilt University; University of Southern California; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gurevich, VV (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	vsevolod.gurevich@vanderbilt.edu; v.slepak@miami.edu	Gurevich, Vsevolod/A-3236-2008; Méndez, Ana/F-9729-2016	Gurevich, Vsevolod/0000-0002-3950-5351; Méndez, Ana/0000-0001-6393-1644; Shestopalov, Valery/0000-0002-1568-6637	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012982, R01EY011500, P30EY008126, R01EY012155, F32EY006641, R01EY006641, R01EY012703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK058404, P30DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060019, R01GM063097, T32GM007628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH062651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045117] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485, P30 CA068485] Funding Source: Medline; NEI NIH HHS [EY 06641, EY012703, R01 EY012703, EY08126, EY012155, P30 EY008126, F32 EY006641, R01 EY006641, R01 EY012155, R01 EY012982-04, EY11500, R01 EY012982, R01 EY011500] Funding Source: Medline; NICHD NIH HHS [P30 HD015052, HD15052] Funding Source: Medline; NIDDK NIH HHS [P60 DK020593, DK20593, DK58404, P30 DK058404, P30 DK020593] Funding Source: Medline; NIGMS NIH HHS [R01 GM060019, GM 060019, R01 GM060019-03, GM07628, R01 GM060019-03S1, R01 GM060019-02S1, R01 GM060019-05, R01 GM063097, T32 GM007628, GM63097] Funding Source: Medline; NIMH NIH HHS [MH62651] Funding Source: Medline; NINDS NIH HHS [R01 NS045117, NS45117] Funding Source: Medline; PHS HHS [NEI 012982] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARSHAVSKY VY, 2003, SCI STKE; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; EBREY TG, 1968, VISION RES, V8, P965, DOI 10.1016/0042-6989(68)90071-0; Eckmiller MS, 2000, VISUAL NEUROSCI, V17, P711, DOI 10.1017/S0952523800175054; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HAGINS WA, 1956, NATURE, V177, P989, DOI 10.1038/177989b0; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; HOFMANN KP, 1983, BIOCHIM BIOPHYS ACTA, V725, P60, DOI 10.1016/0005-2728(83)90224-4; HURLEY JB, 1977, NATURE, V270, P540, DOI 10.1038/270540a0; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Lee KA, 2002, PROTEIN SCI, V11, P862, DOI 10.1110/ps.3870102; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; MANGINI NJ, 1994, VISUAL NEUROSCI, V11, P561, DOI 10.1017/S0952523800002467; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2003, J NEUROSCI, V23, P3124; Nair KS, 2004, J BIOL CHEM, V279, P41240, DOI 10.1074/jbc.M406768200; NIR I, 1993, EXP EYE RES, V57, P307, DOI 10.1006/exer.1993.1129; PALCZEWSKI K, 1991, FEBS LETT, V295, P195, DOI 10.1016/0014-5793(91)81416-6; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; PUIG J, 1995, FEBS LETT, V362, P185, DOI 10.1016/0014-5793(95)00225-X; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang HB, 2003, MOL VIS, V9, P231	38	137	140	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					555	567		10.1016/j.neuron.2005.03.023	http://dx.doi.org/10.1016/j.neuron.2005.03.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944125	Green Accepted, Bronze			2022-12-28	WOS:000229294300008
J	Levitt, P				Levitt, P			Developmental neurobiology and clinical disorders: I lost in translation?	NEURON			English	Review							X MENTAL-RETARDATION; CORTICAL DENDRITE DEVELOPMENT; FRAGILE-X; GENE-EXPRESSION; INTERNEURON DEVELOPMENT; SYNAPTIC PLASTICITY; BRAIN-DEVELOPMENT; AUTISM; SCHIZOPHRENIA; NEURONS		Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA	Vanderbilt University	Levitt, P (corresponding author), Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA.	pat.levitt@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD15052] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abbeduto L, 2001, MENT RETARD DEV D R, V7, P45, DOI 10.1002/1098-2779(200102)7:1<45::AID-MRDD1007>3.0.CO;2-H; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Antonarakis SE, 1998, NAT GENET, V19, P106, DOI 10.1038/450; Ashwood Paul, 2004, Clin Dev Immunol, V11, P165, DOI 10.1080/10446670410001722096; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bourgeois JP, 1997, ACTA PAEDIATR, V86, P27; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Caballero IM, 2005, HUM MOL GENET, V14, pR19, DOI 10.1093/hmg/ddi102; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Chez Michael G, 2004, Semin Pediatr Neurol, V11, P229, DOI 10.1016/j.spen.2004.07.007; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; CHUBYKIN AA, 2005, IN PRESS J BIOL CHEM; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Darnell JC, 2004, MENT RETARD DEV D R, V10, P49, DOI 10.1002/mrdd.20008; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Dolen G, 2005, NEURON, V45, P642, DOI 10.1016/j.neuron.2005.02.021; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Flames N, 2005, NEURON, V46, P377, DOI 10.1016/j.neuron.2005.04.020; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gottesman II, 2005, ANNU REV PSYCHOL, V56, P263, DOI 10.1146/annurev.psych.56.091103.070208; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Guerrini Renzo, 2003, Paediatr Drugs, V5, P647, DOI 10.2165/00148581-200305100-00001; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Hessl D, 2004, MENT RETARD DEV D R, V10, P17, DOI 10.1002/mrdd.20004; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Koshibu K, 2005, J NEUROSCI, V25, P3870, DOI 10.1523/JNEUROSCI.0175-05.2005; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lin SC, 2004, GLIA, V47, P290, DOI 10.1002/glia.20060; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lipska BK, 2004, J PSYCHIATR NEUROSCI, V29, P282; Malow BA, 2004, MENT RETARD DEV D R, V10, P122, DOI 10.1002/mrdd.20023; MANJI HK, 2003, SCI STKE, P49; McAllister AK, 2002, NEURON, V33, P2, DOI 10.1016/S0896-6273(01)00577-3; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Minshew N J, 1997, J Int Neuropsychol Soc, V3, P303; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Miyazaki K, 2004, BRAIN DEV-JPN, V26, P292, DOI 10.1016/S0387-7604(03)00168-2; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nakahara H, 2004, P NATL ACAD SCI USA, V101, P7170, DOI 10.1073/pnas.0401196101; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1978, POSTGRAD MED J, V54, P25; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Selemon LD, 2001, SCHIZOPHRENIA BULL, V27, P349, DOI 10.1093/oxfordjournals.schbul.a006881; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Shirts Brian H, 2004, Curr Psychiatry Rep, V6, P303, DOI 10.1007/s11920-004-0081-1; Spence Sarah J, 2004, Semin Pediatr Neurol, V11, P186, DOI 10.1016/j.spen.2004.07.002; Spence Sarah J, 2004, Semin Pediatr Neurol, V11, P196, DOI 10.1016/j.spen.2004.07.003; Swann JW, 2004, MENT RETARD DEV D R, V10, P96, DOI 10.1002/mrdd.20018; Tuchman R, 2003, NEUROL CLIN, V21, P915, DOI 10.1016/S0733-8619(03)00011-2; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Vawter MP, 2001, BRAIN RES BULL, V55, P641, DOI 10.1016/S0361-9230(01)00522-6; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9	87	23	26	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					407	412		10.1016/j.neuron.2005.04.015	http://dx.doi.org/10.1016/j.neuron.2005.04.015			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882640	Bronze			2022-12-28	WOS:000229011400012
J	Sauman, I; Briscoe, AD; Zhu, HS; Shi, DD; Froy, O; Stalleicken, J; Yuan, Q; Casselman, A; Reppert, SM				Sauman, I; Briscoe, AD; Zhu, HS; Shi, DD; Froy, O; Stalleicken, J; Yuan, Q; Casselman, A; Reppert, SM			Connecting the navigational clock to sun compass input in monarch butterfly brain	NEURON			English	Article							CIRCADIAN CLOCK; POLARIZATION; CRYPTOCHROME; ORIENTATION; ULTRAVIOLET; MECHANISMS; SEQUENCE; OPSINS; PHOTORECEPTOR; LOCALIZATION	Migratory monarch butterflies (Danaus plexippus) use a time-compensated sun compass to navigate to their overwintering grounds in Mexico. Although polarized light: is one of the celestial cues used for orientation, the spectral content (color) of that light has not been fully explored. We cloned the cDNAs of three visual pigment-encoding opsins (ultraviolet [UV], blue, and long wavelength) and found that all three are expressed uniformly in main retina. The photoreceptors of the polarization-specialized dorsal rim area, on the other hand, are monochromatic for the UV opsin. Behavioral studies support the importance of polarized UV light for flight orientation. Next, we used clock protein expression patterns to identify the location of a ci-cadian clock in the dorsolateral protocerebrum of butterfly brain. To provide a link between the clock and the sun compass, we identified a CRYPTOCHROME-staining neural pathway that likely connects the circadian clock to polarized light input entering brain.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Acad Sci Czech Republ, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Comparat & Evolutionary Physiol Grp, Irvine, CA 92697 USA; Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, VW Nachwuchsgrp Anim Invest, D-26111 Oldenburg, Germany	University of Massachusetts System; University of Massachusetts Worcester; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of California System; University of California Irvine; Carl von Ossietzky Universitat Oldenburg	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	Steven.Reppert@umassmed.edu	Briscoe, Adriana/E-8963-2010; Froy, Oren/C-3550-2009; Sauman, Ivo/H-2071-2014	Briscoe, Adriana/0000-0001-8514-4983; Sauman, Ivo/0000-0002-3576-3222	NINDS NIH HHS [R01 NS047141] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barta A, 2004, J THEOR BIOL, V226, P429, DOI 10.1016/j.jtbi.2003.09.017; Batschelet E., 1981, CIRCULAR STAT BIOL; BRINES ML, 1979, SCIENCE, V206, P571, DOI 10.1126/science.206.4418.571; Briscoe A, 1999, AM ZOOL, V39, p134A; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2003, J COMP NEUROL, V458, P334, DOI 10.1002/cne.10582; Briscoe AD, 2001, MOL BIOL EVOL, V18, P2270, DOI 10.1093/oxfordjournals.molbev.a003773; Brower LP, 1996, J EXP BIOL, V199, P93; EDRICH W, 1979, J COMP PHYSIOL, V134, P151, DOI 10.1007/BF00610473; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; Herman WS, 2001, P ROY SOC B-BIOL SCI, V268, P2509, DOI 10.1098/rspb.2001.1765; HYATT MB, 1993, THESIS U PITTSBURGH; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; Kumar S, 2001, GENETICS, V158, P1321; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; LAMPEL J, 2005, IN PRESS CELL TISSUE; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Qi-Miao S, 2003, EUR J ENTOMOL, V100, P283, DOI 10.14411/eje.2003.044; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Sauman Ivo, 1999, Entomological Science, V2, P589; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Waterman T.H., 1981, HDB SENSORY PHYSL, P281; Wehner R, 1997, EXS, V84, P145; Wehner R, 2001, J EXP BIOL, V204, P2589; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Wise S, 2002, J COMP NEUROL, V447, P366, DOI 10.1002/cne.10242; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711	49	133	137	5	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					457	467		10.1016/j.neuron.2005.03.014	http://dx.doi.org/10.1016/j.neuron.2005.03.014			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882645	Bronze			2022-12-28	WOS:000229011400017
J	Sulzer, D; Edwards, RH				Sulzer, D; Edwards, RH			Antidepressants and the monoamine masquerade	NEURON			English	Editorial Material							SEROTONIN; TRANSPORTERS; DOPAMINE; SENSITIVITY; MECHANISM; OXIDASE; BRAIN	Neurotransmitter transporters have long been known to recognize related compounds as substrates, resulting in the accumulation and release of so-called "false transmitters." In this issue of Neuron, Zhou et al. show that when serotonin levels are elevated by inhibition of either serotonin reuptake or of mono amine oxidase, dopamine neurons accumulate serotonin. The results suggest that release of serotonin by dopamine neurons may contribute to the effects of multiple major classes of antidepressants.	Columbia Univ, Dept Neurol, New York State Psychiat Inst, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York State Psychiat Inst, New York, NY 10032 USA; Columbia Univ, Dept Neurosci, New York State Psychiat Inst, New York, NY 10032 USA; Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, Sch Med, San Francisco, CA 94143 USA	Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, New York State Psychiat Inst, New York, NY 10032 USA.							BLACKWELL B, 1965, LANCET, V1, P938; Cases O, 1998, J NEUROSCI, V18, P6914; ERICKSON JD, 1993, J NEUROCHEM, V61, P2314, DOI 10.1111/j.1471-4159.1993.tb07476.x; GU H, 1994, J BIOL CHEM, V269, P7124; HUGHES FB, 1959, J PHARMACOL EXP THER, V127, P96; HUGHES FB, 1958, EXPERIENTIA, V14, P178, DOI 10.1007/BF02158651; KOPIN IJ, 1968, ANNU REV PHARMACOLOG, V8, P377, DOI 10.1146/annurev.pa.08.040168.002113; PETER D, 1994, J BIOL CHEM, V269, P7231; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; VANHATALO S, 1995, NEUROSCI RES, V22, P367, DOI 10.1016/0168-0102(95)00913-E; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9; Zhou FM, 2005, NEURON, V46, P65, DOI 10.1016/j.neuron.2005.02.010	12	13	13	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 7	2005	46	1					1	2		10.1016/j.neuron.2005.03.013	http://dx.doi.org/10.1016/j.neuron.2005.03.013			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820686	Bronze			2022-12-28	WOS:000228228600001
J	Touryan, J; Felsen, G; Dan, Y				Touryan, J; Felsen, G; Dan, Y			Spatial structure of complex cell receptive fields measured with natural images	NEURON			English	Article							CAT STRIATE CORTEX; VISUAL CORTICAL-NEURONS; INFORMATION-TRANSMISSION; NEURAL RESPONSES; V1 NEURONS; STATISTICS; ORGANIZATION; SEQUENCES; STIMULI; MONKEY	Neuronal receptive fields (RFs) play crucial roles in visual processing. While the linear RFs of early neurons have been well studied, RFs of cortical complex cells are nonlinear and therefore difficult to characterize, especially in the context of natural stimuli. In this study, we used a nonlinear technique to compute the RFs of complex cells from their responses to natural images. We found that each RF is well described by a small number of subunits, which are oriented, localized, and bandpass. These subunits contribute to neuronal responses in a contrast-dependent, polarity invariant manner, and they can largely predict the orientation and spatial frequency tuning of the cell. Although the RIF structures measured with natural images were similar to those measured with random stimuli, natural images were more effective for driving complex cells, thus facilitating rapid identification of the subunits. The subunit RF model provides a useful basis for understanding cortical processing of natural stimuli.	Univ Calif Berkeley, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Touryan, Jonathan/AAA-7108-2019	Touryan, Jonathan/0000-0001-7343-7869; Dan, Yang/0000-0002-3818-877X	NATIONAL EYE INSTITUTE [R01EY012561] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY12561] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; GASKA JP, 1994, VISUAL NEUROSCI, V11, P805, DOI 10.1017/S0952523800003102; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lau B, 2002, P NATL ACAD SCI USA, V99, P8974, DOI 10.1073/pnas.122173799; LEHKY SR, 1992, J NEUROSCI, V12, P3568; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; Mechler F, 2002, J NEUROSCI, V22, P6129; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Prenger R, 2004, NEURAL NETWORKS, V17, P663, DOI 10.1016/j.neunet.2004.03.008; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Rust NC, 2004, NEUROCOMPUTING, V58, P793, DOI 10.1016/j.neucom.2004.01.128; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smyth D, 2003, J NEUROSCI, V23, P4746; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1244, DOI 10.1152/jn.1985.53.5.1244; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Thomson MGA, 2001, NETWORK-COMP NEURAL, V12, P271, DOI 10.1088/0954-898X/12/3/303; Touryan J, 2002, J NEUROSCI, V22, P10811; Touryan J, 2001, CURR OPIN NEUROBIOL, V11, P443, DOI 10.1016/S0959-4388(00)00232-4; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; WIENER N, 1958, NONLINEAR PROBLEMS R	50	146	146	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					781	791		10.1016/j.neuron.2005.01.029	http://dx.doi.org/10.1016/j.neuron.2005.01.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748852	Bronze			2022-12-28	WOS:000227446700016
J	Brenowitz, SD; Regehr, WG				Brenowitz, SD; Regehr, WG			Associative short-term synaptic plasticity mediated by endocannabinoids	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; ENDOGENOUS CANNABINOIDS; RETROGRADE INHIBITION; DENDRITIC SPINES; CALCIUM-RELEASE; SYNAPSES; ACTIVATION; NEURONS; BRAIN	Associative learning is important on rapid timescales, but no suitable form of short-term plasticity has been identified that is both associative and synapse specific. Here, we assess whether endocannabinoids can mediate such plasticity. In the cerebellum, bursts of parallel fiber (PF) activity evoke endocannabinoid release from Purkinje cell dendrites that results in retrograde synaptic inhibition lasting seconds. We find that the powerful climbing fiber (CF) to Purkinje cell synapse regulates this inhibition. Compared to PF stimulation alone, coactivation of PF and CF synapses greatly enhanced endocannabinoid-mediated inhibition of PF synapses. Retrograde inhibition was restricted to PFs activated within several hundred milliseconds of CF activation. This associative plasticity reflects two aspects of calcium-dependent endocannabinoid release. First, PF-mediated activation of metabotropic glutamate receptors locally reduced the dendritic calcium levels required for endocannabinoid release. Second, CF and PF coactivation evoked localized supralinear dendritic calcium signals. Thus, endocannabinoids mediate transient associative synaptic plasticity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wregehr@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044396, F32NS046842] Funding Source: NIH RePORTER; NINDS NIH HHS [NS046842, NS044396] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Alger BE, 2002, PROG NEUROBIOL, V68, P247; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Brunel N, 2003, CEREB CORTEX, V13, P1151, DOI 10.1093/cercor/bhg096; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; ECCLES JC, 1966, EXP BRAIN RES, V1, P82; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glanz SA, 2002, PRIMER BIOSTATISTICS; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; KAWATO M, 1992, BIOL CYBERN, V68, P95, DOI 10.1007/BF00201431; Kettner RE, 2002, ANN NY ACAD SCI, V978, P455, DOI 10.1111/j.1749-6632.2002.tb07587.x; Kettner RE, 1997, J NEUROPHYSIOL, V77, P2115, DOI 10.1152/jn.1997.77.4.2115; Kim J, 2002, J NEUROSCI, V22, P10182; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Sandberg A, 2003, NETWORK-COMP NEURAL, V14, P789, DOI 10.1088/0954-898X/14/4/309; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schwarz C, 2001, J NEUROPHYSIOL, V86, P2489, DOI 10.1152/jn.2001.86.5.2489; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Widrow B., 1985, ADAPTIVE SIGNAL PROC; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	57	119	124	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					419	431		10.1016/j.neuron.2004.12.045	http://dx.doi.org/10.1016/j.neuron.2004.12.045			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694328	Bronze			2022-12-28	WOS:000226787700014
J	Wittmann, BC; Schott, BH; Guderian, S; Frey, JU; Heinze, HJ; Duzel, E				Wittmann, BC; Schott, BH; Guderian, S; Frey, JU; Heinze, HJ; Duzel, E			Reward-related fMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation	NEURON			English	Article							SYNAPTIC PLASTICITY; BRAIN ACTIVITY; CA1 REGION; ACETYLCHOLINE-RELEASE; PROTEIN-SYNTHESIS; NEURONAL-ACTIVITY; SPATIAL MEMORY; NOVELTY; POTENTIATION; ANTICIPATION	Long-term potentiation in the hippocampus can be enhanced and prolonged by dopaminergic inputs from midbrain structures such as the substantia nigra. This improved synaptic plasticity is hypothesized to be associated with better memory consolidation in the hippocampus. We used a condition that reliably elicits a dopaminergic response, reward anticipation, to study the relationship between activity of dopaminergic midbrain areas and hippocampal long-term memory in healthy adults. Pictures of object drawings that predicted monetary reward were associated with stronger fMRI activity in reward-related brain areas, including the substantia nigra, compared with non-reward-predicting pictures. Three weeks later, recollection and source memory were better for reward-predicting than for non-reward-predicting pictures. FMRI activity in the hippocampus and the midbrain was higher for reward-predicting pictures that were later recognized compared with later forgotten Pictures. These data are consistent with the hypothesis that activation of dopaminergic midbrain regions enhances hippocampus-dependent memory formation, possibly by enhancing consolidation.	Otto Von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Ctr Adv Imaging, D-39120 Magdeburg, Germany; Leibniz Neurobiol, D-39118 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Duzel, E (corresponding author), Otto Von Guericke Univ, Dept Neurol 2, Leipziger Str 44, D-39120 Magdeburg, Germany.	emrah.duezel@medizin.uni-magdeburg.de	Schott, Björn H/U-5626-2017; Duzel, Emrah/A-1794-2010; Schott, Björn H/B-9369-2012; Wittmann, Bianca/C-1931-2008	Schott, Björn H/0000-0002-8237-4481; Wittmann, Bianca/0000-0002-2583-3311; Duzel, Emrah/0000-0002-0139-5388				Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Backman L, 2000, AM J PSYCHIAT, V157, P635; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Canli T, 2000, J NEUROSCI, V20; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Eckert T, 2004, NEUROIMAGE, V21, P229, DOI 10.1016/j.neuroimage.2003.08.028; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; HERSI AI, 1995, NEUROSCIENCE, V69, P1067, DOI 10.1016/0306-4522(95)00319-E; Holscher C, 2003, BEHAV BRAIN RES, V142, P181, DOI 10.1016/S0166-4328(02)00422-9; Honey G, 2004, TRENDS PHARMACOL SCI, V25, P366, DOI 10.1016/j.tips.2004.05.009; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kemppainen N, 2003, EUR J NEUROSCI, V18, P149, DOI 10.1046/j.1460-9568.2003.02716.x; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schroder N, 2003, SYNAPSE, V49, P89, DOI 10.1002/syn.10210; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; Straube T, 2003, NEUROSCI LETT, V344, P5, DOI 10.1016/S0304-3940(03)00349-5; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Talairach J., 1988, COPLANAR STEREOTAXIC; Tracey I, 2001, J CLIN PHARMACOL, p21S; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Umegaki H, 2001, NEUROSCIENCE, V103, P27, DOI 10.1016/S0306-4522(00)00542-X; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wan HM, 1999, J NEUROSCI, V19, P1142; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	56	482	488	4	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					459	467		10.1016/j.neuron.2005.01.010	http://dx.doi.org/10.1016/j.neuron.2005.01.010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694331	Bronze			2022-12-28	WOS:000226787700017
J	Dougherty, JD; Geschwind, DH				Dougherty, JD; Geschwind, DH			Progress in realizing the promise of microarrays in systems neurobiology	NEURON			English	Editorial Material							GENE-EXPRESSION PATTERNS; DNA MICROARRAY; HYBRIDIZATION; BRAIN	The power of microarrays in neuroscience has been challenged by the cellular heterogeneity and complexity of the central nervous system. In this issue of Neuron, Arlotta, Molyneaux, and colleagues have developed a technique combining retrograde labeling, flow cytometry, and microarrays to purify and molecularly characterize a specific population of neurons from the brain, focusing here on cortical projection neurons. We discuss these findings and the implications of this development for both systems and molecular neuroscience.	Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Program Neurogenet,Neurol Dept, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Interdept Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dougherty, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Program Neurogenet,Neurol Dept, Los Angeles, CA 90095 USA.			Dougherty, Joseph/0000-0002-6385-3997				Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; DeRisi J, 1996, NAT GENET, V14, P457; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0	12	18	19	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 20	2005	45	2					183	185		10.1016/j.neuron.2005.01.007	http://dx.doi.org/10.1016/j.neuron.2005.01.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664168	Bronze			2022-12-28	WOS:000226451500003
J	Lyles, V; Zhao, YL; Martin, KC				Lyles, V; Zhao, YL; Martin, KC			Synapse formation and mRNA localization in cultured Aplysia neurons	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; LONG-TERM FACILITATION; SENSORY NEURONS; PLASTICITY; EXPRESSION; TARGET; SYNAPTOGENESIS; CONNECTIONS; MECHANISMS; DENDRITES	mRNA localization and regulated translation provide a means of spatially restricting gene expression within neurons during axon guidance and long-term synaptic plasticity. Here we show that synapse formation specifically alters the localization of the mRNA encoding sensorin, a peptide neurotransmitter with neurotrophin-like properties. In isolated Aplysia sensory neurons, which do not form chemical synapses, sensorin mRNA is diffusively distributed throughout distal neurites. Upon contact with a target motor neuron, sensorin mRNA rapidly concentrates at synapses. This redistribution only occurs in the presence of a target motor neuron and parallels the distribution of sensorin protein. Reduction of sensorin mRNA, but not protein, with dsRNA inhibits synapse formation. Our results indicate that synapse formation can alter mRNA localization within individual neurons. They further suggest that translation of a specific localized mRNA, encoding the neuropeptide sensorin, is required for synapse formation between sensory and motor neurons.	Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Indept Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martin, KC (corresponding author), Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu			NINDS NIH HHS [R01 NS045324] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Broadie KS, 2002, CURR OPIN NEUROBIOL, V12, P491, DOI 10.1016/S0959-4388(02)00359-8; BRUNET JF, 1991, SCIENCE, V252, P856, DOI 10.1126/science.1840700; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Conrad P, 1999, J NEUROBIOL, V39, P237, DOI 10.1002/(SICI)1097-4695(199905)39:2<237::AID-NEU8>3.3.CO;2-S; Coulson RL, 1997, J NEUROPHYSIOL, V77, P2316, DOI 10.1152/jn.1997.77.5.2316; DALE N, 1993, P NATL ACAD SCI USA, V90, P7163, DOI 10.1073/pnas.90.15.7163; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; HAWVER DB, 1993, J NEUROBIOL, V24, P368, DOI 10.1002/neu.480240309; Horton AC, 2003, J NEUROSCI, V23, P6188; Hu JY, 2004, NEURON, V43, P373, DOI 10.1016/j.neuron.2004.07.011; Hu JY, 2003, J NEUROSCI, V23, P1804; Hu JY, 2002, J NEUROSCI, V22, P2669, DOI 10.1523/JNEUROSCI.22-07-02669.2002; Jin YS, 2002, CURR OPIN NEUROBIOL, V12, P71, DOI 10.1016/S0959-4388(02)00292-1; Liu K, 2003, J NEUROBIOL, V56, P275, DOI 10.1002/neu.10242; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Moccia R, 2003, J NEUROSCI, V23, P9409; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Schacher S, 1999, J NEUROSCI, V19, P6338; Schacher S, 2002, J NEUROSCI, V22, P1831, DOI 10.1523/JNEUROSCI.22-05-01831.2002; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tongiorgi E, 2004, J NEUROSCI, V24, P6842, DOI 10.1523/JNEUROSCI.5471-03.2004; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	31	88	89	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					349	356		10.1016/j.neuron.2005.12.029	http://dx.doi.org/10.1016/j.neuron.2005.12.029			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446139	Bronze			2022-12-28	WOS:000235260900007
J	Grill-Spector, K				Grill-Spector, K			Selectivity of adaptation in single units: Implications for fMRI experiments	NEURON			English	Editorial Material							LATERAL OCCIPITAL COMPLEX; MECHANISMS; SHAPE	Understanding the neural basis of adaptation (repetition suppression) is critical for interpreting fMRI-adaptation experiments. Sawamura and colleagues provide a critical stepping-stone by elucidating the relation between neural adaptation and response selectivity. They find some cross-adaptation by two different stimuli that activate the same neuron.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Grill-Spector, K (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.			Grill-Spector, Kalanit/0000-0002-5404-9606				Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; GRILLSPECTOR K, 2006, IN PRESS TRENDS COGN; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; SAYRES R, 2005, IN PRESS J NEUROPHYS; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	15	44	45	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 19	2006	49	2					170	171		10.1016/j.neuron.2006.01.004	http://dx.doi.org/10.1016/j.neuron.2006.01.004			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423690	Bronze			2022-12-28	WOS:000234979900003
J	Krantz, DE				Krantz, DE			Vesicular monogamy?	NEURON			English	Editorial Material							GLUTAMATE TRANSPORTER; QUANTAL SIZE; RELEASE; EXPRESSION	Vesicular neurotransmitter transporters package transmitter into the lumen of synaptic vesicles for quantal release. However, the number of transporters that localize to each vesicle is not known. In this issue of Neuron, a study by Daniels et al. using the Drosophila neuromuscular junction and mutations of the vesicular glutamate transporter suggests that one transporter may suffice to fill each vesicle.	Univ Calif Los Angeles, David Geffen Sch Med, Gonda Ctr Genet & Neurosci Res, Dept Psychiat & Biobehav Sci,Hatos Ctr Neuropharm, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Gonda Ctr Genet & Neurosci Res, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Krantz, DE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Gonda Ctr Genet & Neurosci Res, Dept Psychiat & Biobehav Sci,Hatos Ctr Neuropharm, Room 3357C,695 Charles Young Dr, Los Angeles, CA 90095 USA.							Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Pothos EN, 2000, J NEUROSCI, V20, P7297; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	11	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					1	2		10.1016/j.neuron.2005.12.013	http://dx.doi.org/10.1016/j.neuron.2005.12.013			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387631	Bronze			2022-12-28	WOS:000236699300001
J	Vida, I; Bartos, M; Jonas, P				Vida, I; Bartos, M; Jonas, P			Shunting inhibition improves robustness of gamma oscillations in hippocampal interneuron networks by homogenizing firing rates	NEURON			English	Article							IN-VITRO; SYNAPTIC INHIBITION; EXCITATORY ACTIONS; BEHAVING RAT; K+ CHANNELS; SYNAPSES; NEURONS; GABA; FREQUENCY; VIVO	Networks of GABAergic neurons are key elements in the generation of gamma oscillations in the brain. Computational studies suggested that the emergence of coherent oscillations requires hyperpolarizing inhibition. Here, we show that GABA(A) receptor-mediated inhibition in mature interneurons of the hippocampal dentate gyrus is shunting rather than hyperpolarizing. Unexpectedly, when shunting inhibition is incorporated into a structured interneuron network model with fast and strong synapses, coherent oscillations emerge. In comparison to hyperpolarizing inhibition, networks with shunting inhibition show several advantages. First, oscillations are generated with smaller tonic excitatory drive. Second, network frequencies are tuned to the gamma band. Finally, robustness against heterogeneity in the excitatory drive is markedly improved. In single interneurons, shunting inhibition shortens the interspike interval for low levels of drive but prolongs it for high levels, leading to homogenization of neuronal firing rates. Thus, shunting inhibition may confer increased robustness to gamma oscillations in the brain.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Univ Freiburg, Inst Anat, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de	Vida, Imre/F-8275-2012	Vida, Imre/0000-0003-3214-2233; Jonas, Peter/0000-0001-5001-4804; Bartos, Marlene/0000-0001-9741-1946				ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bazhenov M, 1999, NAT NEUROSCI, V2, P168, DOI 10.1038/5729; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chavas J, 2003, J NEUROSCI, V23, P2019; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; ERMENTROUT GB, 1990, SIAM J APPL MATH, V50, P125, DOI 10.1137/0150009; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lamsa K, 2003, J NEUROPHYSIOL, V90, P1983, DOI 10.1152/jn.00060.2003; Lien CC, 2003, J NEUROSCI, V23, P2058; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Maex R, 2003, J NEUROSCI, V23, P10503; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; Meyer AH, 2002, J NEUROSCI, V22, P7055; NEITNER L, 2000, NEURAL COMPUT, V12, P1607; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SIK A, 1995, J NEUROSCI, V15, P6651; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stein V, 2003, NEURON, V37, P375, DOI 10.1016/S0896-6273(03)00056-4; Stiefel KM, 2005, J COMPUT NEUROSCI, V19, P71, DOI 10.1007/s10827-005-0188-3; Tiesinga PHE, 2000, NETWORK-COMP NEURAL, V11, P1, DOI 10.1088/0954-898X/11/1/301; Towers SK, 2002, J NEUROPHYSIOL, V87, P1165, DOI 10.1152/jn.00495.2001; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Traub RD, 1999, FAST OSCILLATIONS CO; van Hooft JA, 2000, J NEUROSCI, V20, P3544, DOI 10.1523/JNEUROSCI.20-10-03544.2000; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	61	247	253	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 5	2006	49	1					107	117		10.1016/j.neuron.2005.11.036	http://dx.doi.org/10.1016/j.neuron.2005.11.036			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	031IZ	16387643	Green Submitted, Bronze			2022-12-28	WOS:000236699300013
J	Levinson, JN; El-Husseini, A				Levinson, JN; El-Husseini, A			Building excitatory and inhibitory synapses: Balancing neuroligin partnerships	NEURON			English	Review							RECEPTOR TRAFFICKING; ADHESION MOLECULE; CA2+ CHANNELS; PSD-95; DIFFERENTIATION; TRANSMISSION; PLASTICITY; TERMINALS; SYNCAM	Processing of neural information is thought to occur by integration of excitatory and inhibitory synaptic inputs. As such, precise control mechanisms must exist to maintain an appropriate balance between each synapse type. Recent findings indicate that neuroligins and their synaptic binding partners modulate the development of both excitatory and inhibitory synapses. Here we highlight these findings and discuss a mechanism potentially involved in controlling the balance between excitation and inhibition.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	El-Husseini, A (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	alaa@interchange.ubc.ca						Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brunig I, 2002, J NEUROSCI, V22, P4805, DOI 10.1523/JNEUROSCI.22-12-04805.2002; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Gilbert M, 2001, GLIA, V34, P151, DOI 10.1002/glia.1050; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saghatelyan AK, 2004, MOL CELL NEUROSCI, V26, P191, DOI 10.1016/j.mcn.2004.01.008; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	26	109	113	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					171	174		10.1016/j.neuron.2005.09.017	http://dx.doi.org/10.1016/j.neuron.2005.09.017			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242398	Bronze			2022-12-28	WOS:000232838700007
J	Hand, R; Bortone, D; Mattar, P; Nguyen, L; Heng, JIT; Guerrier, S; Boutt, E; Peters, E; Barnes, AP; Parras, C; Schuurmans, C; Guillemot, F; Polleux, F				Hand, R; Bortone, D; Mattar, P; Nguyen, L; Heng, JIT; Guerrier, S; Boutt, E; Peters, E; Barnes, AP; Parras, C; Schuurmans, C; Guillemot, F; Polleux, F			Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex	NEURON			English	Article							RAT VISUAL-CORTEX; DEVELOPING CEREBRAL-CORTEX; PERIPHERAL NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; PRONEURAL GENE; TRANSCRIPTION FACTORS; CORTICAL DEVELOPMENT; SPECIFICATION; PROTEIN; GROWTH	The molecular mechanisms specifying the dendritic morphology of different neuronal subtypes are poorly understood. Here we demonstrate that the bHLH transcription factor Neurogenin2 (Ngn2) is both necessary and sufficient for specifying the dendritic morphology of pyramidal neurons in vivo by specifying the polarity of its leading process during the initiation of radial migration. The ability of Ngn2 to promote a polarized leading process outgrowth requires the phosphorylation of a single tyrosine residue at position 241, an event that is neither involved in Ngn2 direct transactivation properties nor its proneural function. Interestingly, the migration defect observed in the Ngn2 knockout mouse and in progenitors expressing the Ngn2(Y241F) mutation can be rescued by inhibiting the activity of the small-GTPase RhoA in cortical progenitors. Our results demonstrate that Ngn2 coordinates the acquisition of the radial migration properties and the unipolar dendritic morphology characterizing pyramidal neurons through molecular mechanisms distinct from those mediating its proneural activity.	Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ Calgary, Calgary, AB T2N 4N1, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of Calgary	Polleux, F (corresponding author), Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA.	polleux@med.unc.edu	Guillemot, Francois/AAV-1482-2021; Polleux, Franck/H-9948-2014; Parras, Carlos/G-6611-2017	Parras, Carlos/0000-0003-0248-1752; Mattar, Pierre/0000-0002-5708-6218; Heng, Julian Ik-Tsen/0000-0002-0378-7078; Barnes, Anthony/0000-0002-4598-9591; Nguyen, Laurent/0000-0002-8560-3008; Schuurmans, Carol/0000-0003-3567-0058; Polleux, Franck/0000-0003-4313-0481	NINDS NIH HHS [NS047701-01, P30 NS45892-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS047701] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bar I, 2000, TRENDS NEUROSCI, V23, P633, DOI 10.1016/S0166-2236(00)01675-1; BERRY M, 1965, J ANAT, V99, P691; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; des Portes V, 1998, CELL, V92, P51; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hasegawa H, 2004, J NEUROSCI, V24, P8711, DOI 10.1523/JNEUROSCI.3070-04.2004; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Katoh M, 2004, INT J MOL MED, V13, P749; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Megason SG, 2002, DEVELOPMENT, V129, P2087; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MOLLA R, 1986, J HIRNFORSCH, V27, P625; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Olenik C, 1999, MOL BRAIN RES, V70, P9, DOI 10.1016/S0169-328X(99)00121-7; Olson EC, 1998, MOL CELL NEUROSCI, V12, P281, DOI 10.1006/mcne.1998.0712; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; PETERS A, 1985, J COMP NEUROL, V238, P263, DOI 10.1002/cne.902380303; Polleux F, 1997, J COMP NEUROL, V385, P95; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; POLLEUX F, 2002, SCI STKE, pPL9; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Quan XJ, 2004, DEVELOPMENT, V131, P1679, DOI 10.1242/dev.01055; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Sharma A, 1999, MOL CELL BIOL, V19, P704; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Talikka M, 2002, DEV BIOL, V247, P137, DOI 10.1006/dbio.2002.0677; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941	74	259	265	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2005	48	1					45	62		10.1016/j.neuron.2005.08.032	http://dx.doi.org/10.1016/j.neuron.2005.08.032			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974XW	16202708	Green Published, Bronze			2022-12-28	WOS:000232625700009
J	Gonsalves, BD; Kahn, I; Curran, T; Norman, KA; Wagner, AD				Gonsalves, BD; Kahn, I; Curran, T; Norman, KA; Wagner, AD			Memory strength and repetition suppression: Multimodal imaging of medial temporal cortical contributions to recognition	NEURON			English	Article							REMEMBER-KNOW JUDGMENTS; PROCESS DISSOCIATION; BRAIN ACTIVITY; HIPPOCAMPAL DAMAGE; RETRIEVAL DYNAMICS; SEPARATE PROCESSES; PERIRHINAL CORTEX; ITEM RECOGNITION; FAMILIARITY; RECOLLECTION	Declarative memory permits an organism to recognize stimuli that have been previously encountered, discriminating them from those that are novel. One basis for recognition is item memory strength, which may support the perception of stimulus familiarity. Though the medial temporal lobes are known to be critical for declarative memory, at present the neural mechanisms supporting perceived differences in memory strength remain poorly specified. Here, functional MRI (fMRI) and anatomically constrained magneto-encephalography (MEG) indexed correlates of graded memory strength in the human brain, focusing on medial temporal cortex. fMRI revealed a decrease in medial temporal cortical activation that tracked parametric levels of perceived memory strength. Anatomically constrained MEG current estimates revealed that strength-dependent signal reductions onset within 150-300 ms. Memory strength appears to be rapidly signaled by medial temporal cortex through repetition suppression (activation reductions), providing a basis for the subjective perception of stimulus familiarity or novelty.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Boulder; Princeton University	Wagner, AD (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	wagner@psych.stanford.edu		Wagner, Anthony/0000-0003-0624-4543; Kahn, Itamar/0000-0002-1895-8677	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH065812, R01MH064812] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64812, F32MH65812] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Baxter MG, 2001, HIPPOCAMPUS, V11, P61, DOI 10.1002/1098-1063(2001)11:1<61::AID-HIPO1021>3.3.CO;2-Q; Bogacz R, 2003, HIPPOCAMPUS, V13, P494, DOI 10.1002/hipo.10093; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Curran T, 2003, PSYCHOPHYSIOLOGY, V40, P979, DOI 10.1111/1469-8986.00116; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; Duarte A, 2004, COGNITIVE BRAIN RES, V18, P255, DOI 10.1016/j.cogbrainres.2003.10.010; Dunn JC, 2004, PSYCHOL REV, V111, P524, DOI 10.1037/0033-295X.111.2.524; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Eldridge LL, 2002, PSYCHON B REV, V9, P139, DOI 10.3758/BF03196270; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Henson RNA, 2003, HIPPOCAMPUS, V13, P301, DOI 10.1002/hipo.10117; Hicks JL, 1999, PSYCHON B REV, V6, P117, DOI 10.3758/BF03210818; Hintzman DL, 1998, MEM COGNITION, V26, P449, DOI 10.3758/BF03201155; HINTZMAN DL, 1994, J MEM LANG, V33, P1, DOI 10.1006/jmla.1994.1001; Holdstock JS, 2002, HIPPOCAMPUS, V12, P341, DOI 10.1002/hipo.10011; Insausti R, 1998, AM J NEURORADIOL, V19, P659; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; McElree B, 1999, J EXP PSYCHOL LEARN, V25, P563, DOI 10.1037/0278-7393.25.3.563; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2000, J COGNITIVE NEUROSCI, V12, P664, DOI 10.1162/089892900562291; SMITH ME, 1986, ELECTROEN CLIN NEURO, V63, P145, DOI 10.1016/0013-4694(86)90008-8; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stark CEL, 2003, HIPPOCAMPUS, V13, P281, DOI 10.1002/hipo.10085; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Tsivilis D, 2003, HUM BRAIN MAPP, V19, P145, DOI 10.1002/hbm.10116; Tsivilis D, 2001, NEURON, V31, P497, DOI 10.1016/S0896-6273(01)00376-2; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; Weis S, 2004, NEUROREPORT, V15, P2729; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Yovel G, 2004, NEUROIMAGE, V21, P789, DOI 10.1016/j.neuroimage.2003.09.034; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	62	191	192	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					751	761		10.1016/j.neuron.2005.07.013	http://dx.doi.org/10.1016/j.neuron.2005.07.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	963DE	16129403	Bronze			2022-12-28	WOS:000231782700015
J	Kefalov, VJ; Estevez, ME; Kono, M; Goletz, PW; Crouch, RK; Cornwall, MC; Yau, KW				Kefalov, VJ; Estevez, ME; Kono, M; Goletz, PW; Crouch, RK; Cornwall, MC; Yau, KW			Breaking the covalent bond - A pigment property that contributes to desensitization in cones	NEURON			English	Article							RETINALDEHYDE-BINDING PROTEIN; ROD OUTER SEGMENTS; VISUAL-PIGMENT; ACTIVATES TRANSDUCTION; SENSITIVITY REGULATION; SALAMANDER RETINA; DARK-ADAPTATION; RHODOPSIN; PHOTORECEPTORS; PHOTOTRANSDUCTION	Retinal rod and cone pigments consist of an apoprotein, opsin, covalently linked to a chromophore, 11-cis retinal. Here we demonstrate that the formation of the covalent bond between opsin and 11-cis retinal is reversible in darkness in amphibian red cones, but essentially irreversible in red rods. This dissociation, apparently a general property of cone pigments, results in a surprisingly large amount of free opsin-about 10% of total opsin-in dark-adapted red cones. We attribute this significant level of free opsin to the low concentration of intracellular free 11-cis retinal, estimated to be only a tiny fraction (similar to 0.1 %) of the pigment content in red cones. With its constitutive transducin-stimulating activity, the free cone opsin produces an similar to 2-fold desensitization in red cones, equivalent to that produced by a steady light causing 500 photoisomerizations s(-1). Cone pigment dissociation therefore contributes to the sensitivity difference between rods and cones.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; Boston Univ, Sch Med, Dept Physiol, Boston, MA 02118 USA	Johns Hopkins University; Medical University of South Carolina; Boston University	Kefalov, VJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	vkefalov@jhmi.edu; kwyau@mail.jhmi.edu	Kono, Masahiro/AAT-2265-2021	Kono, Masahiro/0000-0001-7377-1664; Cornwall, M./0000-0002-0847-939X; Stabio, Maureen/0000-0002-2159-5301; Kefalov, Vladimir/0000-0002-1659-008X	NEI NIH HHS [R01 EY006837, EY 13748, R01 EY006837-18, R01 EY014596, R01 EY014596-03, R37 EY006837-15S1, R01 EY014596-01, R37 EY006837-15, EY 01157, R01 EY004939, R01 EY014596-02, F32 EY006837, NIH EY 06837, R01 EY006837-17, EY 04939, R37 EY006837, R01 EY006837-16A1, R01 EY013748, R01 EY001157] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-01, R01 DC006904] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013748, R01EY006837, F32EY006837, R01EY004939, R01EY001157, R37EY006837, R01EY014596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABRAHAMSON EW, 1974, EXP EYE RES, V18, P51, DOI 10.1016/0014-4835(74)90043-8; AZUMA K, 1980, PHOTOCHEM PHOTOBIOL, V32, P529, DOI 10.1111/j.1751-1097.1980.tb03799.x; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BROWN PK, 1963, J CELL BIOL, V19, P79, DOI 10.1083/jcb.19.1.79; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; CHEN JG, 1989, BIOPHYS J, V55, P725, DOI 10.1016/S0006-3495(89)82871-1; CHEN Y, 1994, BIOCHEMISTRY-US, V33, P10658, DOI 10.1021/bi00201a013; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1995, J GEN PHYSIOL, V106, P543, DOI 10.1085/jgp.106.3.543; Cornwall MC, 2000, METHOD ENZYMOL, V316, P224; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; Crabb JW, 1998, METH MOL B, V89, P91; CRESCITELLI F, 1984, VISION RES, V24, P1551, DOI 10.1016/S0042-6989(84)80004-8; Dartnell HJA, 1972, PHOTOCHEMISTRY VISIO, P122; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; DEFOE DM, 1983, INVEST OPHTH VIS SCI, V24, P1211; FUKADA Y, 1981, BIOCHIM BIOPHYS ACTA, V675, P195, DOI 10.1016/0304-4165(81)90226-9; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P3133, DOI 10.1021/bi00464a033; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Grimm C, 2000, INVEST OPHTH VIS SCI, V41, P3984; Harosi F. I, 1984, PHOTORECEPTORS, P41; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; HUBBARD R, 1958, P NATL ACAD SCI USA, V44, P130, DOI 10.1073/pnas.44.2.130; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; JONES GJ, 1993, J GEN PHYSIOL, V102, P483, DOI 10.1085/jgp.102.3.483; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; Leibrock CS, 1998, EYE, V12, P511, DOI 10.1038/eye.1998.139; LEVINE JS, 1985, VISUAL SYSTEM, P73; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; MacNichol E. F.  Jr., 1978, Frontiers in Visual Science, P194; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MATSUMOTO H, 1975, BIOCHIM BIOPHYS ACTA, V404, P300, DOI 10.1016/0304-4165(75)90337-2; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; NAKATANI K, 1989, J PHYSIOL-LONDON, V409, P525, DOI 10.1113/jphysiol.1989.sp017511; NUNN BJ, 1984, NATURE, V309, P264, DOI 10.1038/309264a0; OKADA D, 1989, PHOTOCHEM PHOTOBIOL, V49, P197, DOI 10.1111/j.1751-1097.1989.tb04096.x; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; OPRIAN DD, 1993, METH NEUROSCI, V15, P301; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Pepe IM, 2001, PROG RETIN EYE RES, V20, P733, DOI 10.1016/S1350-9462(01)00013-1; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; SAARI JC, 1987, J BIOL CHEM, V262, P7618; SHICHIDA Y, 1994, BIOCHEMISTRY-US, V33, P9040, DOI 10.1021/bi00197a002; Starace DM, 1997, J BIOL CHEM, V272, P1095, DOI 10.1074/jbc.272.2.1095; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	58	81	82	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					879	890		10.1016/j.neuron.2005.05.009	http://dx.doi.org/10.1016/j.neuron.2005.05.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953417	Green Accepted, Bronze			2022-12-28	WOS:000229922500008
J	Simerly, R				Simerly, R			Building neural choice points for love and war	NEURON			English	Editorial Material							TRANSCRIPTIONAL CODES; CIRCUITS; BEHAVIOR; AMYGDALA; GENES; BRAIN	The molecular specification of central circuits that coordinate expression of innate behaviors in response to specific sensory cues from the environment remains a puzzle. In this issue of Neuron, Choi, Dong, and colleagues used expression profiling and genetic axonal tracing to visualize a hypothalamic point of convergence for defensive and reproductive olfactory cues that may function as a gating mechanism for sensory activation of defensive responses over reproduction.	Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Simerly, R (corresponding author), Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA.							Canteras NS, 1997, BRAIN RES BULL, V44, P297, DOI 10.1016/S0361-9230(97)00141-X; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SIMERLY RB, 1990, TRENDS NEUROSCI, V13, P104, DOI 10.1016/0166-2236(90)90186-E; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Zirlinger M, 2003, GENES BRAIN BEHAV, V2, P282, DOI 10.1034/j.1601-183X.2003.00039.x; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	14	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					525	526		10.1016/j.neuron.2005.05.001	http://dx.doi.org/10.1016/j.neuron.2005.05.001			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944120	Bronze			2022-12-28	WOS:000229294300003
J	Clandinin, TR				Clandinin, TR			Surprising twists to exocyst function	NEURON			English	Editorial Material							COMPONENT SEC5; MEMBRANE; COMPLEX; MUTATIONS; DELIVERY; EFFECTOR; GTPASE	What do neurons use the exocyst complex for? In this issue of Neuron, using mutations in one exocyst component, Mehta et al. reach the surprising conclusion that exocyst function is divisible: different components play distinct roles. These studies also suggest that the exocyst may regulate membrane insertion of cell adhesion molecules required for synaptic partner choice.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, 299 W Campus Dr, Stanford, CA 94305 USA.							BERONJA S, 2005, IN PRESS J CELL BIOL; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Murthy M, 2004, DEVELOPMENT, V131, P377, DOI 10.1242/dev.00931; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Murthy M, 2005, J CELL SCI, V118, P1139, DOI 10.1242/jcs.01644; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	15	11	11	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					164	166		10.1016/j.neuron.2005.04.003	http://dx.doi.org/10.1016/j.neuron.2005.04.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848794	Bronze			2022-12-28	WOS:000228674800002
J	Sahin, M; Greer, PL; Lin, MZ; Poucher, H; Eberhart, J; Schmidt, S; Wright, TM; Shamah, SM; O'Connel, S; Cowan, CW; Hu, L; Goldberg, JL; Debant, A; Corfas, G; Krull, CE; Greenberg, ME				Sahin, M; Greer, PL; Lin, MZ; Poucher, H; Eberhart, J; Schmidt, S; Wright, TM; Shamah, SM; O'Connel, S; Cowan, CW; Hu, L; Goldberg, JL; Debant, A; Corfas, G; Krull, CE; Greenberg, ME			Eph-dependent tyrosine phosphorylation of ephexin1 modulates growth cone collapse	NEURON			English	Article							RETINAL AXON GUIDANCE; MOTOR-NEURONS; RHO; RECEPTORS; MORPHOGENESIS; PHOSPHATASE; ACTIVATION; MECHANISMS; COMPLEXES; EPHRINS	Ephs regulate growth cone repulsion, a process controlled by the actin cytoskeleton. The guanine nucleotide exchange factor (GEF) ephexinl interacts with EphA4 and has been suggested to mediate the effect of EphA on the activity of Rho GTPases, key regulators of the cytoskeleton and axon guidance. Using cultured ephexin1(-/-) mouse neurons and RNA interference in the chick, we report that ephexinl is required for normal axon outgrowth and ephrin-dependent axon repulsion. Ephexin1 becomes tyrosine phosphorylated in response to EphA signaling in neurons, and this phosphorylation event is required for growth cone collapse. Tyrosine phosphorylation of ephexinl enhances ephexinl's GEF activity toward RhoA while not altering its activity toward Rac1 or Cdc42, thus changing the balance of GTPase activities. These findings reveal that ephexinl plays a role in axon guidance and is regulated by a switch mechanism that is specifically tailored to control Eph-mediated growth cone collapse.	Harvard Univ, Sch Med, Neurol Program, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Missouri, Columbia, MO 65211 USA; Ctr Natl Rech Sci, Ctr Rech Biochim Macromol, FRE 2593, F-34293 Montpellier, France; Univ Miami, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Columbia; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Bascom Palmer Eye Institute; University of Miami	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Neurol Program, Childrens Hosp, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu	Cowan, Christopher W/I-2497-2014; SAHIN, MUSTAFA/I-8653-2019; Corfas, Gabriel/AAH-2378-2020	SAHIN, MUSTAFA/0000-0001-7044-2953; Corfas, Gabriel/0000-0001-5412-9473; Goldberg, Jeffrey/0000-0002-1390-7360; Lin, Michael/0000-0002-0492-1961	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884, R01NS045500] Funding Source: NIH RePORTER; NICHD NIH HHS [HD18655, K08 HD01384] Funding Source: Medline; NIMH NIH HHS [R01 MH59894] Funding Source: Medline; NINDS NIH HHS [NS45500, R01 NS045500, R01 NS35884] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jurney WM, 2002, J NEUROSCI, V22, P6019; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Krull CE, 2004, DEV DYNAM, V229, P433, DOI 10.1002/dvdy.10473; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sun QL, 2000, MOL CELL NEUROSCI, V16, P686, DOI 10.1006/mcne.2000.0893; VAN AL, 1997, GENE DEV, V11, P2295; van Horck FPG, 2004, CURR OPIN NEUROBIOL, V14, P61, DOI 10.1016/j.conb.2004.01.002; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Winning RS, 2002, DIFFERENTIATION, V70, P46, DOI 10.1046/j.1432-0436.2002.700105.x	24	184	194	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					191	204		10.1016/j.neuron.2005.01.030	http://dx.doi.org/10.1016/j.neuron.2005.01.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848799	Bronze			2022-12-28	WOS:000228674800007
J	Gardner, SM; Takamiya, K; Xia, J; Suh, JG; Johnson, R; Yu, S; Huganir, RL				Gardner, SM; Takamiya, K; Xia, J; Suh, JG; Johnson, R; Yu, S; Huganir, RL			Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF	NEURON			English	Article							LONG-TERM DEPRESSION; ETHYLMALEIMIDE-SENSITIVE FACTOR; DOMAIN-CONTAINING PROTEINS; KINASE-C-ALPHA; HIPPOCAMPAL-NEURONS; SYNAPTIC-TRANSMISSION; INWARD RECTIFICATION; DEPENDENT REGULATION; GLUTAMATE RECEPTORS; MEMBRANE CURVATURE	A recently described form of synaptic plasticity results in dynamic changes in the calcium permeability of synaptic AMPA receptors. Since the AMPA receptor GluR2 subunit confers calcium permeability, this plasticity is thought to occur through the dynamic exchange of synaptic GluR2-lacking and GluR2-containing receptors. To investigate the molecular mechanisms underlying this calcium-permeable (A) under bar MPA (r) under bar eceptor (p) under bar lasticity (CARP), we examined whether AMPA receptor exchange was mediated by subunit-specific protein-protein interactions. We found that two GluR2-interacting proteins, the PDZ domain-containing Protein interacting with (C) under bar (k) under bar inase (PICK1) and (N) under bar -ethy1maleimide (s) under bar ensitive (f) under bar usion protein (NSF), are specifically required for CARP. Furthermore, PICK1, but not NSF, regulates the formation of extrasynaptic plasma membrane pools of GluR2-containing receptors that may be laterally mobilized into synapses during CARP. These results demonstrate that PICK1 and NSF dynamically regulate the synaptic delivery of GluR2-containing receptors during CARP and thus regulate the calcium permeability of AMPA receptors at excitatory synapses.	Johns Hopkins Univ, Howard Hughes Med Inst, Dept Neurosci, Sch Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Dept Neurosci, Sch Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu	Suh, Jun Gyo/U-7198-2019; Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188; Takamiya, Kogo/0000-0001-7240-6307	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043061, R01NS036715] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36715, NS43061, R01 NS036715] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAUDE A, 1994, J NEUROSCI, V14, P2830; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V136, P224, DOI 10.1007/BF00519180; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	58	203	217	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					903	915		10.1016/j.neuron.2005.02.026	http://dx.doi.org/10.1016/j.neuron.2005.02.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797551	Bronze			2022-12-28	WOS:000228031300011
J	Vosshall, LB; Stensmyr, MC				Vosshall, LB; Stensmyr, MC			Wake up and smell the pheromones	NEURON			English	Editorial Material							BINDING PROTEIN; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; RECEPTOR; NEURONS	Odorant binding proteins (OBPs) are abundant proteins of unknown function expressed at high levels in insect and vertebrate chemosensory organs. In this issue of Neuron, Xu et al. show that Drosophila OBP76a is necessary for fruit flies to respond to the aggregation pheromone 11-cis vaccenyl acetate. The results suggest a mechanism by which this OBP is intimately involved in pheromone signal transduction.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; Rockefeller Univ, Lab Dev Biol & Neurogenet, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, Box 63, New York, NY 10021 USA.			Vosshall, Leslie/0000-0002-6060-8099; Stensmyr, Marcus/0000-0003-4009-9212				Kaissling KE, 1998, ANN NY ACAD SCI, V855, P320, DOI 10.1111/j.1749-6632.1998.tb10590.x; Kim MS, 1998, GENETICS, V150, P711; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950	8	12	13	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 20	2005	45	2					179	181		10.1016/j.neuron.2005.01.001	http://dx.doi.org/10.1016/j.neuron.2005.01.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664166	Bronze			2022-12-28	WOS:000226451500001
J	Marella, S; Fischler, W; Kong, P; Asgarian, S; Rueckert, E; Scott, K				Marella, S; Fischler, W; Kong, P; Asgarian, S; Rueckert, E; Scott, K			Imaging taste responses in the fly brain reveals a functional map of taste category and behavior	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; DROSOPHILA-MELANOGASTER; CAPSAICIN RECEPTOR; MAMMALIAN SWEET; NEURAL ACTIVITY; ODOR; CA2+; EXPRESSION; INDICATORS; NEURONS	The sense of taste allows animals to distinguish nutritious and toxic substances and elicits food acceptance or avoidance behaviors. In Drosophila, taste cells that contain the Gr5a receptor are necessary for acceptance behavior, and cells with the Gr66a receptor are necessary for avoidance. To determine the cellular substrates of taste behaviors, we monitored taste cell activity in vivo with the genetically encoded calcium indicator G-CaMP. These studies reveal that Gr5a cells selectively respond to sugars and Gr66a cells to bitter compounds. Flies are attracted to sugars and avoid bitter substances, suggesting that Gr5a cell activity is sufficient to mediate acceptance behavior and that Gr66a cell activation mediates avoidance. As a direct test of this hypothesis, we inducibly activated different taste neurons by expression of an exogenous ligand-gated ion channel and found that cellular activity is sufficient to drive taste behaviors. These studies demonstrate that taste cells are tuned by taste category and are hard-wired to taste behaviors.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Columbia University; Howard Hughes Medical Institute	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 291 Life Sci Addit, Berkeley, CA 94720 USA.	kscott@berkeley.edu		Fischler-Ruiz, Walter/0000-0003-3998-3588	NIDCD NIH HHS [R01 DC006252, 1R01DC006252-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Keller A, 2003, CURR OPIN NEUROBIOL, V13, P103, DOI 10.1016/S0959-4388(03)00011-4; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; POWER ME, 1948, J COMP NEUROL, V88, P347, DOI 10.1002/cne.900880303; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; RUBIN GM, 1985, TRENDS NEUROSCI, V8, P231, DOI 10.1016/0166-2236(85)90094-3; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Scott TR, 2000, PHYSIOL BEHAV, V69, P65, DOI 10.1016/S0031-9384(00)00189-X; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; Smith DV, 1999, CURR OPIN NEUROBIOL, V9, P427, DOI 10.1016/S0959-4388(99)80064-6; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	31	242	249	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					285	295		10.1016/j.neuron.2005.11.037	http://dx.doi.org/10.1016/j.neuron.2005.11.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423701	Bronze			2022-12-28	WOS:000234979900014
J	Huber, AB; Kania, A; Tran, TS; Gu, CH; Garcia, ND; Lieberam, I; Johnson, D; Jessell, TM; Ginty, DD; Kolodkin, AL				Huber, AB; Kania, A; Tran, TS; Gu, CH; Garcia, ND; Lieberam, I; Johnson, D; Jessell, TM; Ginty, DD; Kolodkin, AL			Distinct roles for secreted semaphorin signaling in spinal motor axon guidance	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; LIM HOMEOBOX GENES; CHICK HIND LIMB; EMBRYONIC CHICK; GROWTH CONE; POLYSIALIC ACID; DIFFERENTIAL EXPRESSION; NEURITE OUTGROWTH; DIFFERENT SUBSETS; SUBTYPE IDENTITY	Neuropilins, secreted semaphorin coreceptors, are expressed in discrete populations of spinal motor neurons, suggesting they provide critical guidance information for the establishment of functional motor circuitry. We show here that motor axon growth and guidance are impaired in the absence of Sema3A-Npn-1 signaling. Motor axons enter the limb precociously, showing that Sema3A controls the timing of motor axon in-growth to the limb. Lateral motor column (LMC) motor axons within spinal nerves are defasciculated as they grow toward the limb and converge in the plexus region. Medial and lateral LMC motor axons show dorso-ventral guidance defects in the forelimb. In contrast, Sema3F-Npn-2 signaling guides the axons of a medial subset of LMC neurons to the ventral limb, but plays no major role in regulating their fasciculation. Thus, Sema3A-Npn-1 and Sema3F-Npn-2 signaling control distinct steps of motor axon growth and guidance during the formation of spinal motor connections.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Inst Rech Clin Montreal, Neural Circuit Dev Lab, Montreal, PQ H2W 1R7, Canada; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Howard Hughes Medical Institute; Johns Hopkins University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Columbia University; Howard Hughes Medical Institute	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu; kolodkin@jhmi.edu	Lieberam, Ivo/C-5324-2009; Tran, Tracy/M-2173-2019	Lieberam, Ivo/0000-0003-3539-3054; Kania, Artur/0000-0002-5209-2520; Tran, Tracy/0000-0002-2179-5725	NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095825] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; DAVIS BM, 1989, J COMP NEUROL, V279, P556, DOI 10.1002/cne.902790405; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; GHOSH A, 1993, DEVELOPMENT, V117, P1031; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; Greene E.C., 1935, ANATOMY RAT, V27; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; HONIG MG, 1986, DEV BIOL, V118, P532, DOI 10.1016/0012-1606(86)90024-2; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1986, DEV BIOL, V118, P511, DOI 10.1016/0012-1606(86)90023-0; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; Sahay A, 2003, J NEUROSCI, V23, P6671; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TOSNEY KW, 1989, J EXP ZOOL, V251, P232, DOI 10.1002/jez.1402510211; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wang G, 1999, DEV BIOL, V208, P324, DOI 10.1006/dbio.1999.9212; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; Watanabe Y, 2004, DEVELOPMENT, V131, P681, DOI 10.1242/dev.00970; WHITELAW V, 1983, J NEUROSCI, V3, P1226; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	71	178	184	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					949	964		10.1016/j.neuron.2005.12.003	http://dx.doi.org/10.1016/j.neuron.2005.12.003			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364899	Bronze			2022-12-28	WOS:000234301700011
J	Bonini, NM; La Spada, AR				Bonini, NM; La Spada, AR			Silencing polyglutamine degeneration with RNAi	NEURON			English	Review							INDUCED NEURODEGENERATION; NEUROPATHOLOGY; ATAXIN-3; REPEAT; SIRNAS; MOTOR; MODEL; GENE	Nine dominantly inherited neurodegenerative diseases are caused by expansion of a CAG repeat encoding glutamine. An important development in the study of such "polyglutamine" diseases was the realization that merely shutting off expression of a disease-encoding transgene could arrest progression in animal models with significant disease pathology. Such studies opened the door to a powerful new therapeutic approach now being pioneered: silencing of the dominant disease allele by RNA-mediated interference (RNAi), for the arrest-and potential reversal-of the disease process.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu; laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020	Bonini, Nancy/0000-0003-0226-5291				Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Katsuno M, 2004, J MOL MED, V82, P298, DOI 10.1007/s00109-004-0530-7; Li Y, 2004, ANN NEUROL, V56, P124, DOI 10.1002/ana.20141; Limprasert P, 1996, HUM MOL GENET, V5, P207, DOI 10.1093/hmg/5.2.207; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Vande Velde C, 2005, NAT NEUROSCI, V8, P5, DOI 10.1038/nn0105-5; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	20	22	27	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					715	718		10.1016/j.neuron.2005.11.008	http://dx.doi.org/10.1016/j.neuron.2005.11.008			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337909	Bronze			2022-12-28	WOS:000233927300010
J	Tombola, F; Pathak, MM; Isacoff, EY				Tombola, F; Pathak, MM; Isacoff, EY			How far will you go to sense voltage?	NEURON			English	Review							DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; GATING-CHARGE; ION CHANNELS; PORE DOMAIN; S4 SEGMENT; ACTIVATION; DISPLACEMENT; MOVEMENT; MUTATIONS	Despite tremendous progress in the study of voltage-gated channels, the molecular mechanism underlying voltage sensing has remained a matter of debate. We review five new studies that make major progress in the field. The studies employ a battery of distinct approaches that have the common aim of measuring the motion of the voltage sensor. We interpret the results in light of the recent crystal structure of the mammalian potassium channel Kv1.2. We focus on the transmembrane movement of the voltage sensor as a key element to the detection of membrane potential and to the control of channel gating.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Padua	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Tombola, Francesco/ABA-6002-2020; isacoff, ehud/AAP-1459-2020; Tombola, Francesco/C-7311-2011	Tombola, Francesco/0000-0002-9315-0352; Isacoff, Ehud Y./0000-0003-4775-9359				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mathur R, 1997, J GEN PHYSIOL, V109, P191, DOI 10.1085/jgp.109.2.191; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468	29	53	56	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2005	48	5					719	725		10.1016/j.neuron.2005.11.024	http://dx.doi.org/10.1016/j.neuron.2005.11.024			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	993BI	16337910	Bronze			2022-12-28	WOS:000233927300011
J	Ache, BW; Young, JM				Ache, BW; Young, JM			Olfaction: Diverse species, conserved principles	NEURON			English	Review							ODORANT-BINDING-PROTEIN; MOTH MANDUCA-SEXTA; RECEPTOR NEURONS; CAENORHABDITIS-ELEGANS; PERIRECEPTOR EVENTS; PRESYNAPTIC INHIBITION; ADAPTIVE EVOLUTION; GENE SUPERFAMILY; MOLECULAR-BASIS; ANTENNAL LOBES	Olfaction is a vitally important sense for all animals. There are striking similarities between species in the organization of the olfactory pathway, from the nature of the odorant receptor proteins, to perireceptor processes, to the organization of the olfactory CNS, through odor-guided behavior and memory. These common features span a phylogenetically broad array of animals, implying that there is an optimal solution to the problem of detecting and discriminating odors.	Univ Florida, Ctr Smell & Taste, Dept Zool, Whitney Lab Marine Biosci, Gainesville, FL 32610 USA; Univ Florida, Ctr Smell & Taste, Dept Neurosci, Whitney Lab Marine Biosci, Gainesville, FL 32610 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center	Ache, BW (corresponding author), Univ Florida, Ctr Smell & Taste, Dept Zool, Whitney Lab Marine Biosci, Gainesville, FL 32610 USA.	bwa@whitney.ufl.edu			NIDCD NIH HHS [DC04209, DC05995, R01 DC004209, R01 DC005995, R01 DC004209-08] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209, R01DC005995] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACHE BW, 1991, SMELL TASTE HLTH DIS, P3; Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; BELLONCI G, 1883, ARCH ITAL BIOL, V3, P191; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; BJOSTAD LB, 1984, J CHEM ECOL, V10, P1309, DOI 10.1007/BF00988113; Bobkov YV, 2005, J NEUROPHYSIOL, V93, P1372, DOI 10.1152/jn.00990.2004; BOEKHOFF I, 1994, J NEUROSCI, V14, P3304; BOEKHOFF I, 1990, J COMP PHYSIOL B, V160, P99, DOI 10.1007/BF00258768; Briand L, 2002, BIOCHEMISTRY-US, V41, P7241, DOI 10.1021/bi015916c; BROWER LP, 1975, SCIENCE, V208, P753; BRUCH RC, 1989, CHEM SENSES, V1, P283; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Capaldi ED, 2004, BEHAV NEUROSCI, V118, P1400, DOI 10.1037/0735-7044.118.6.1400; CAPRIO J, 1977, NATURE, V266, P850, DOI 10.1038/266850a0; CARR WES, 1990, CHEM SENSES, V15, P181, DOI 10.1093/chemse/15.2.181; CARR WES, 1990, TRENDS NEUROSCI, V13, P212, DOI 10.1016/0166-2236(90)90162-4; CHASE R, 1986, CELL TISSUE RES, V246, P567, DOI 10.1007/BF00215198; CHASE R, 1985, ZOOMORPHOLOGY, V105, P60, DOI 10.1007/BF00312074; CHASE R, 1986, BRAIN RES, V384, P232, DOI 10.1016/0006-8993(86)91159-5; CHASE R, 1986, J COMP PHYSIOL A, V158, P375, DOI 10.1007/BF00603621; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CHRISTENSEN TA, 2000, NEUROBIOLOGY TASTE S, P201; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; Colbert HA, 1997, J NEUROSCI, V17, P8259; COOPERSMITH R, 1984, SCIENCE, V225, P849, DOI 10.1126/science.6474157; Dahl A.R., 1988, MOL NEUROBIOLGY OLFA, P51, DOI [10.1016/j.semcdb.2012.09.001, DOI 10.1016/J.SEMCDB.2012.09.001]; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Delaney KR, 1996, J NEUROSCI METH, V68, P193, DOI 10.1016/0165-0270(96)00069-6; Derby CD, 2000, PHYSIOL BEHAV, V69, P203, DOI 10.1016/S0031-9384(00)00202-X; DETHIER VG, 1987, P AM PHILOS SOC, V131, P159; DETHIER VG, 1981, P AM PHILOS SOC, V125, P460; DOVING KB, 1977, OLFACTION TASTE, V6, P175; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; Elmore T, 2003, J NEUROSCI, V23, P9906; Ermentrout B, 2004, J COMPUT NEUROSCI, V17, P365, DOI 10.1023/B:JCNS.0000044877.21949.44; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; GELPERIN A, 1975, SCIENCE, V189, P567, DOI 10.1126/science.1145215; GELPERIN A, 1986, TRENDS NEUROSCI, V9, P323, DOI 10.1016/0166-2236(86)90098-6; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Gelperin A, 1999, J EXP BIOL, V202, P1855; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; Greenspan RJ, 2005, CURR BIOL, V15, pR671, DOI 10.1016/j.cub.2005.08.018; GRIFF IC, 1995, CELL, V83, P407, DOI 10.1016/0092-8674(95)90118-3; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HUGHES AL, 1993, J MOL EVOL, V36, P249, DOI 10.1007/BF00160480; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; KAUER JS, 1977, J PHYSIOL-LONDON, V272, P495, DOI 10.1113/jphysiol.1977.sp012056; Kimura T, 1998, LEARN MEMORY, V4, P389, DOI 10.1101/lm.4.5.389; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; KUBIE J, 1975, J COMP PHYSIOL PSYCH, V89, P667, DOI 10.1037/h0077061; LAING DG, 1985, PHYSIOL BEHAV, V34, P569, DOI 10.1016/0031-9384(85)90050-2; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lazar J, 2002, BIOCHEMISTRY-US, V41, P11786, DOI 10.1021/bi0256734; LISON M, 1980, BRIT MED J, V281, P1676, DOI 10.1136/bmj.281.6256.1676; Loudon C, 2000, J EXP BIOL, V203, P2977; LUCERO MT, 1992, J EXP BIOL, V162, P231; Luu P, 2004, J NEUROSCI, V24, P10128, DOI 10.1523/JNEUROSCI.3117-04.2004; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MATSUMOTO SG, 1981, PROC R SOC SER B-BIO, V213, P249, DOI 10.1098/rspb.1981.0066; MCCLINTOCK TS, 1989, CHEM SENSES, V14, P637, DOI 10.1093/chemse/14.5.637; Meister M, 2001, J NEUROSCI, V21, P1351; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Munger SD, 2000, J BIOL CHEM, V275, P20450, DOI 10.1074/jbc.M001989200; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1990, CHEM SENSES, V15, P205, DOI 10.1093/chemse/15.2.205; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; PINCHING AJ, 1971, J CELL SCI, V9, P347; Quignon P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r80; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; RYBCZYNSKI R, 1989, J NEUROSCI, V9, P1341; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Sandeman DC, 1998, J EXP BIOL, V201, P1331; SANHUEZA M, 2000, J EXP BIOL, V203, P253; SCHMITT BC, 1979, SCIENCE, V205, P204, DOI 10.1126/science.205.4402.204; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; Shorey H. H, 2013, ANIMAL COMMUNICATION; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Stensmyr MC, 2005, CURR BIOL, V15, P116, DOI 10.1016/j.cub.2004.12.069; Steullet P, 2000, J NEUROSCI, V20, P3282, DOI 10.1523/JNEUROSCI.20-09-03282.2000; Stewart MR, 2005, GENETICS, V169, P1985, DOI 10.1534/genetics.104.035329; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; TANK DW, 1994, SCIENCE, V265, P1819, DOI 10.1126/science.265.5180.1819; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Thomas JH, 2005, P NATL ACAD SCI USA, V102, P4476, DOI 10.1073/pnas.0406469102; TOLBERT LP, 1981, PROC R SOC SER B-BIO, V213, P279, DOI 10.1098/rspb.1981.0067; TRAPIDOROSENTHAL HG, 1987, J NEUROCHEM, V49, P1174, DOI 10.1111/j.1471-4159.1987.tb10008.x; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VANDENBURG JG, 1983, PHEROMONES REPROD MA; Vickers NJ, 1998, J COMP NEUROL, V400, P35; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; VOGT RG, 1990, NATO ASI SERIES H, V39, P33; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2002, MICROSC RES TECHNIQ, V58, P365, DOI 10.1002/jemt.10144; Wachowiak M, 1997, J EXP BIOL, V200, P989; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; WHITTAKER RH, 1971, SCIENCE, V171, P757, DOI 10.1126/science.171.3973.757; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	154	387	396	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					417	430		10.1016/j.neuron.2005.10.022	http://dx.doi.org/10.1016/j.neuron.2005.10.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269360	Bronze			2022-12-28	WOS:000233250100004
J	Maren, S				Maren, S			Synaptic mechanisms of associative memory in the amygdala	NEURON			English	Review							LONG-TERM POTENTIATION; LATERAL AMYGDALA; BASOLATERAL AMYGDALA; CONDITIONAL FEAR; PLASTICITY; RATS; EXTINCTION; EXPRESSION; RECEPTORS; INDUCTION	Do associative learning and synaptic long-term potentiation (LTP) depend on the same cellular mechanisms? Recent work in the amygdala reveals that LTP and Pavlovian fear conditioning induce similar changes in postsynaptic AMPA-type glutamate receptors and that occluding these changes by viral-mediated overexpression of a dominant-negative GluR1 construct attenuates both LTP and fear memory in rats. Novel forms of presynaptic plasticity in the lateral nucleus may also contribute to fear memory formation, bolstering the connection between synaptic plasticity mechanisms and associative learning and memory.	Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Maren, S (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	maren@umich.edu	Maren, Stephen/B-6182-2014; Maren, Stephen/A-7091-2009	Maren, Stephen/0000-0002-9342-7411; Maren, Stephen/0000-0002-9342-7411	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065961] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH065961, R01MH050093] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Fu Y, 2005, J NEUROPHYSIOL, V93, P3012, DOI 10.1152/jn.00871.2004; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Goosens KA, 2004, EUR J NEUROSCI, V20, P537, DOI 10.1111/j.1460-9568.2004.03513.x; Heinbockel T, 2000, J NEUROSCI, V20; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin CH, 2003, J NEUROSCI, V23, P8310; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 1999, J NEUROSCI, V19, P8696; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; RODRIGUES SM, 2002, J NEUROSCI, V22, pU1; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002	25	235	244	5	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 15	2005	47	6					783	786		10.1016/j.neuron.2005.08.009	http://dx.doi.org/10.1016/j.neuron.2005.08.009			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157273	Green Published, Bronze			2022-12-28	WOS:000232085000006
J	Miller, CA; Marshall, JF				Miller, CA; Marshall, JF			Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory	NEURON			English	Article							SIGNAL-REGULATED KINASE; ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS CORE; SEEKING BEHAVIOR; SYNAPTIC PLASTICITY; CONSOLIDATION; AMYGDALA; PHOSPHORYLATION; CASCADE	Relapse into drug taking among addicts often depends on learned associations between drug-paired cues and the rewarding effects of these drugs, such as cocaine (COC). Memory for drug-paired cues resists extinction and contributes to the high rate of relapse; however, the molecular mechanisms underlying these associations are not understood. We show that COC-conditioned place preference (CPP) activates ERK, CREB, Elk-1, and Fos in the nucleus accumbens core (AcbC) but not shell. Intra-AcbC infusions of U0126, an inhibitor of the ERK kinase MEK, prevent both the activation of ERK, CREB, Elk-1, and Fos and retrieval of COC-CPP. When tested again 24 hr or 14 days after intra-AcbC infusions of U0126 or another MEK inhibitor, PD98059, CPP retrieval and concomitant protein activation were significantly attenuated. Together, these findings indicate the necessity of the AcbC ERK signaling pathway for drug-paired contextual cue memories and suggest that these strong memories can become susceptible to disruption by therapeutic agents.	Univ Calif Irvine, Dept Neurobiol & Behav, Ctr Neurobiol Learning & Memory, Irvine, CA 92627 USA	University of California System; University of California Irvine	Marshall, JF (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Ctr Neurobiol Learning & Memory, Irvine, CA 92627 USA.	jfmarsha@uci.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012204] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 12204] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Cammarota M, 2004, AN ACAD BRAS CIENC, V76, P573, DOI 10.1590/S0001-37652004000300011; Carelli RM, 2001, BRAIN RES, V907, P156, DOI 10.1016/S0006-8993(01)02604-X; Childress A, 1988, NIDA Res Monogr, V81, P74; Choe ES, 2001, J NEUROCHEM, V76, P401, DOI 10.1046/j.1471-4159.2001.00051.x; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fuchs RA, 2004, PSYCHOPHARMACOLOGY, V176, P459, DOI 10.1007/s00213-004-1895-6; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Hebert AE, 2004, J NEUROSCI, V24, P10111, DOI 10.1523/JNEUROSCI.3491-04.2004; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; KADDIS FG, 1995, BRAIN RES, V697, P76, DOI 10.1016/0006-8993(95)00786-P; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Koh MT, 2003, NEUROREPORT, V14, P405, DOI 10.1097/01.wnr.0000058519.74643.df; Lattal KM, 2004, P NATL ACAD SCI USA, V101, P4667, DOI 10.1073/pnas.0306546101; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Liao RM, 1998, CHINESE J PHYSIOL, V41, P85; Lindgren N, 2002, EUR J NEUROSCI, V15, P769, DOI 10.1046/j.1460-9568.2002.01901.x; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Miller CA, 2005, EUR J NEUROSCI, V21, P1385, DOI 10.1111/j.1460-9568.2005.03974.x; Miller CA, 2004, J NEUROSCI, V24, P6889, DOI 10.1523/JNEUROSCI.1685-04.2004; Mizoguchi H, 2004, MOL PHARMACOL, V65, P1293, DOI 10.1124/mol.65.5.1293; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Roberson ED, 1999, J NEUROSCI, V19, P4337; Schafe GE, 2000, J NEUROSCI, V20, P8177; Sellings LHL, 2003, J NEUROSCI, V23, P6295; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Valjent E, 2000, J NEUROSCI, V20, P8701; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; Winters BD, 2005, J NEUROSCI, V25, P4243, DOI 10.1523/JNEUROSCI.0480-05.2005; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004	45	355	367	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 15	2005	47	6					873	884		10.1016/j.neuron.2005.08.006	http://dx.doi.org/10.1016/j.neuron.2005.08.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157281	Bronze			2022-12-28	WOS:000232085000014
J	Miller, RJ; Tran, PB				Miller, RJ; Tran, PB			Chemokinetics	NEURON			English	Editorial Material							CXCR4; MIGRATION; RECEPTORS; SDF-1	How do migrating neural progenitor cells and growing axons know where to go? In this issue of Neuron, two papers (Knaut et al. and Lieberam et al.) demonstrate that activation of Cxcr4 chemokine receptors by the chemokine SDF1/Cxcl12 can direct both of these tasks.	Northwestern Univ, Feinberg Sch ed, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Miller, RJ (corresponding author), Northwestern Univ, Feinberg Sch ed, Dept Biol Chem & Mol Pharmacol, 303 E Chicago Ave, Chicago, IL 60611 USA.				NIDA NIH HHS [R01 DA013141-05, R01 DA013141] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013141] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Huising MO, 2003, TRENDS IMMUNOL, V24, P307, DOI 10.1016/S1471-4906(03)00120-0; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	12	12	12	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					621	623		10.1016/j.neuron.2005.08.012	http://dx.doi.org/10.1016/j.neuron.2005.08.012			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129389	Green Accepted, Bronze			2022-12-28	WOS:000231782700001
J	Bayer, HM; Glimcher, PW				Bayer, HM; Glimcher, PW			Midbrain dopamine neurons encode a quantitative reward prediction error signal	NEURON			English	Article							RESPONSES; DEPLETION; SEROTONIN; DECISION	The midbrain dopamine neurons are hypothesized to provide a physiological correlate of the reward prediction error signal required by current models of reinforcement learning. We examined the activity of single dopamine neurons during a task in which subjects learned by trial and error when to make an eye movement for a juice reward. We found that these neurons encoded the difference between the current reward and a weighted average of previous rewards, a reward prediction error, but only for outcomes that were better than expected. Thus, the firing rate of midbrain dopamine neurons is quantitatively predicted by theoretical descriptions of the reward prediction error signal used in reinforcement learning models for circumstances in which this signal has a positive value. We also found that the dopamine system continued to compute the reward prediction error even when the behavioral policy of the animal was only weakly influenced by this computation.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Columbia Univ, Ctr Decis Sci, New York, NY 10027 USA	New York University; Columbia University	Glimcher, PW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	glimcher@cns.nyu.edu		Bayer, Hannah/0000-0002-5644-4124; Glimcher, Paul/0000-0001-7872-3856	NATIONAL EYE INSTITUTE [R01EY010536] Funding Source: NIH RePORTER; NEI NIH HHS [EY-10536, R01 EY010536] Funding Source: Medline; NIMH NIH HHS [MH12790, F31 MH012790] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Al-Ruwaitea ASA, 1999, PSYCHOPHARMACOLOGY, V144, P264, DOI 10.1007/s002130051002; Bush Robert R., 1955, STOCHASTIC MODELS LE; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Deakin J.F.W., 1983, J PSYCHOPHARMACOL, V43, P563; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Handel A, 1997, J NEUROPHYSIOL, V78, P2164, DOI 10.1152/jn.1997.78.4.2164; Harrison AA, 1999, BEHAV BRAIN RES, V100, P99, DOI 10.1016/S0166-4328(98)00117-X; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rogers RD, 2003, NEUROPSYCHOPHARMACOL, V28, P153, DOI 10.1038/sj.npp.1300001; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	30	794	802	4	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					129	141		10.1016/j.neuron.2005.05.020	http://dx.doi.org/10.1016/j.neuron.2005.05.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996553	Green Accepted, Bronze			2022-12-28	WOS:000230464000013
J	Bayley, PJ; Gold, JJ; Hopkins, RO; Squire, LR				Bayley, PJ; Gold, JJ; Hopkins, RO; Squire, LR			The neuroanatomy of remote memory	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; RETROGRADE-AMNESIA; AUTOBIOGRAPHICAL MEMORY; SEMANTIC DEMENTIA; EPISODIC MEMORY; VISUAL-IMAGERY; DAMAGE; PATIENT; IMPAIRMENT; CONSOLIDATION	In humans and experimental animals, damage to the hippocampus or related medial temporal lobe structures severely impairs the formation of new memory but typically spares very remote memory. Questions remain about the importance of these structures for the storage and retrieval of remote autobiographical memory. We carried out a detailed volumetric analysis of structural brain images from eight memory-impaired patients. Five of the patients had damage limited mainly to the medial temporal lobe. These patients performed normally on tests of remote autobiographical memory. Three patients had medial temporal lobe damage plus significant additional damage to neocortex, and these patients were severely impaired. These findings account for previously reported differences in the recollective ability of memory-impaired patients and demonstrate that the ability to recollect remote autobiographical events depends not on the medial temporal lobe but on widely distributed neocortical areas, especially the frontal, lateral temporal, and occipital lobes.	Univ Calif San Diego, La Jolla, CA 92093 USA; Brigham Young Univ, Provo, UT 84602 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Vet Adm Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; Brigham Young University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Squire, LR (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	lsquire@ucsd.edu			NIMH NIH HHS [MH 24600, R01 MH024600] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH024600, R01MH024600] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Bayley PJ, 2003, NEURON, V38, P135, DOI 10.1016/S0896-6273(03)00156-9; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Corkin S, 1997, J NEUROSCI, V17, P3964; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CROVITZ HF, 1974, B PSYCHONOMIC SOC, V4, P517; DUVERNOY H, 1991, HUMAN BRAIN; Eslinger PJ, 1998, NEUROCASE, V4, P481, DOI 10.1093/neucas/4.6.481; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; FUJII T, 2000, HDB NEUROPSYCHOLOGY, P223; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; Goodglass H., 1983, BOSTON NAMING TEST; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; HAYMAN CAG, 1993, J COGNITIVE NEUROSCI, V5, P375, DOI 10.1162/jocn.1993.5.4.375; Heaps CM, 2001, J EXP PSYCHOL LEARN, V27, P920, DOI 10.1037//0278-7393.27.4.920; Hermann BP, 1999, NEUROPSYCHOLOGY, V13, P3, DOI 10.1037/0894-4105.13.1.3; Hirano M, 2002, J CLIN EXP NEUROPSYC, V24, P548, DOI 10.1076/jcen.24.4.548.1041; Hirano M, 1998, PERCEPT MOTOR SKILL, V87, P99, DOI 10.2466/pms.1998.87.1.99; Insausti R, 1998, MICROSC RES TECHNIQ, V43, P8, DOI 10.1002/(SICI)1097-0029(19981001)43:1<8::AID-JEMT2>3.0.CO;2-4; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Kapur N, 1999, PSYCHOL BULL, V125, P800, DOI 10.1037/0033-2909.125.6.800; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; KARTSOUNIS LD, 1995, J NEUROL NEUROSUR PS, V59, P95, DOI 10.1136/jnnp.59.1.95; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Kitchener EG, 1998, BRAIN, V121, P1313, DOI 10.1093/brain/121.7.1313; Kopelman MD, 2003, HIPPOCAMPUS, V13, P879, DOI 10.1002/hipo.10140; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Levy DA, 2004, P NATL ACAD SCI USA, V101, P6710, DOI 10.1073/pnas.0401679101; MACKINNON DF, 1989, PSYCHOBIOLOGY, V17, P247, DOI 10.1007/BF03337776; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Moscovitch M, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P331; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; OGDEN JA, 1993, NEUROPSYCHOLOGIA, V31, P571, DOI 10.1016/0028-3932(93)90053-3; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Reed JM, 1998, J NEUROSCI, V18, P3943; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Rosenbaum RS, 2004, NEUROPSYCHOLOGIA, V42, P1619, DOI 10.1016/j.neuropsychologia.2004.04.010; Rubin DC, 1998, P NATL ACAD SCI USA, V95, P5413, DOI 10.1073/pnas.95.9.5413; SAGAR HJ, 1985, ANN NY ACAD SCI, V444, P533, DOI 10.1111/j.1749-6632.1985.tb37637.x; Squire LR, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P691; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1990, J NEUROSCI, V10, P3106; Stark CEL, 2003, HIPPOCAMPUS, V13, P281, DOI 10.1002/hipo.10085; Stefanacci L, 2000, J NEUROSCI, V20, P7024, DOI 10.1523/JNEUROSCI.20-18-07024.2000; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Verfaellie M, 2000, NEUROPSYCHOLOGIA, V38, P1581, DOI 10.1016/S0028-3932(00)00073-7; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Wechsler D., 1945, WECHSLER MEMORY SCAL; WECHSLER D, 1981, WECHSLER AUDLT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII; Westmacott R, 2001, NEUROCASE, V7, P37, DOI 10.1093/neucas/7.1.37; WITTGEN BJ, 2004, NEURON, V44, P101; ZOLAMORGAN S, 1983, NEUROPSYCHOLOGIA, V21, P487, DOI 10.1016/0028-3932(83)90005-2; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	66	133	138	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					799	810		10.1016/j.neuron.2005.04.034	http://dx.doi.org/10.1016/j.neuron.2005.04.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924865	Green Accepted, Bronze			2022-12-28	WOS:000229689800013
J	Christie, JM; Bark, C; Hormuzdi, SG; Helbig, I; Monyer, H; Westbrook, GL				Christie, JM; Bark, C; Hormuzdi, SG; Helbig, I; Monyer, H; Westbrook, GL			Connexin36 mediates spike synchrony in olfactory bulb glomeruli	NEURON			English	Article							NEURONAL GAP-JUNCTIONS; CELL LATERAL DENDRITES; ELECTRICAL SYNAPSES; MITRAL CELLS; FREQUENCY OSCILLATIONS; RAT-BRAIN; EXPRESSION; NETWORK; INTERNEURONS; TRANSMISSION	Neuronal synchrony is important to network behavior in many brain regions. In the olfactory bulb, principal neurons (mitral cells) project apical dendrites to a common glomerulus where they receive a common input. Synchronized activity within a glomerulus depends on chemical transmission but mitral cells are also electrically coupled. We examined the role of connexin-mediated gap junctions in mitral cell coordinated activity. Electrical coupling as well as correlated spiking between mitral cells projecting to the same glomerulus was entirely absent in connexin36 (Cx36) knockout mice. Ultrastructural analysis of glomeruli confirmed that mitral-mitral cell gap junctions on distal apical dendrites contain Cx36. Coupled AMPA responses between mitral cell pairs were absent in the knockout, demonstrating that electrical coupling, not transmitter spillover, is responsible for synchronization. Our results indicate that Cx36-mediated gap junctions between mitral cells orchestrate rapid coordinated signaling via a novel form of electrochemical transmission.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Hosp Neurol, Dept Clin Neurobiol, Heidelberg, Germany; Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA	Oregon Health & Science University; Ruprecht Karls University Heidelberg; Oregon Health & Science University	Christie, JM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	christij@ohsu.edu	Helbig, Ingo/G-8467-2018; Helbig, Ingo/A-5544-2009	Helbig, Ingo/0000-0001-8486-0558; Christie, Jason/0000-0003-0276-2554; Monyer, Hannah/0000-0002-9332-5749	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026494, R29NS026494] Funding Source: NIH RePORTER; NIDCD NIH HHS [1F31-DC051224] Funding Source: Medline; NINDS NIH HHS [NS26494] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Alvarez VA, 2002, P NATL ACAD SCI USA, V99, P4032, DOI 10.1073/pnas.062716299; Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BISHOFBERGER J, 1997, J PHYSL, V504, P359; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Bozza TC, 2001, CURR BIOL, V11, pR687, DOI 10.1016/S0960-9822(01)00409-2; Cang JH, 2003, J NEUROSCI, V23, P4108; Carlson GC, 2000, J NEUROSCI, V20, P2011; Chao TI, 1997, J COMP NEUROL, V388, P191; Christie JM, 2003, J NEUROPHYSIOL, V89, P2466, DOI 10.1152/jn.00997.2002; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; De Zeeuw CI, 2003, J NEUROSCI, V23, P4700; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Degen J, 2004, J COMP NEUROL, V473, P511, DOI 10.1002/cne.20085; Devor A, 2002, J NEUROPHYSIOL, V87, P3048, DOI 10.1152/jn.2002.87.6.3048; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Feigenspan A, 2004, J NEUROSCI, V24, P3325, DOI 10.1523/JNEUROSCI.5598-03.2004; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; Hormuzdi SG, 2004, BBA-BIOMEMBRANES, V1662, P113, DOI 10.1016/j.bbamem.2003.10.023; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Kosaka T, 2004, NEUROSCI RES, V49, P373, DOI 10.1016/j.neures.2004.04.003; Kosaka T, 2003, NEUROSCI RES, V45, P189, DOI 10.1016/S0168-0102(02)00222-5; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Laurent G, 1996, J NEUROSCI, V16, P3837; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; Long MA, 2002, J NEUROSCI, V22, P10898; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Migliore M, 2005, J COMPUT NEUROSCI, V18, P151, DOI 10.1007/s10827-005-6556-1; Miragall F, 1996, NEUROSCI LETT, V216, P199, DOI 10.1016/0304-3940(96)13042-1; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Parenti R, 2000, NEUROREPORT, V11, P1497, DOI 10.1097/00001756-200005150-00027; PATERNOSTRO MA, 1995, DEV BRAIN RES, V84, P1; Pereda A, 2003, CELL COMMUN ADHES, V10, P419, DOI 10.1080/714040462; PEREDA AE, 1995, J NEUROSCI, V15, P5943; PINCHING AJ, 1971, J CELL SCI, V9, P347; Puopolo M, 2001, EUR J NEUROSCI, V13, P92, DOI 10.1046/j.1460-9568.2001.01365.x; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Smith M, 2003, P NATL ACAD SCI USA, V100, P4849, DOI 10.1073/pnas.0734299100; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Traub RD, 2003, P NATL ACAD SCI USA, V100, P1370, DOI 10.1073/pnas.0337529100; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Zhang CB, 2003, J COMP NEUROL, V459, P426, DOI 10.1002/cne.10617; Zhang CB, 2002, BRAIN RES, V929, P37, DOI 10.1016/S0006-8993(01)03372-8	66	120	125	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					761	772		10.1016/j.neuron.2005.04.030	http://dx.doi.org/10.1016/j.neuron.2005.04.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924862	Bronze			2022-12-28	WOS:000229689800010
J	Zufall, F				Zufall, F			Connexins and olfactory synchronicity: Toward the olfactory code	NEURON			English	Editorial Material							SYNCHRONIZATION; CELLS	A striking example of neuronal synchronization occurs in the mammalian main olfactory bulb where mitral cells that project to the same glomerular unit display highly synchronized spike activity. In this issue of Neuron, Christie et al. use mice deficient for the gap junction protein connexin36 (Cx36) to demonstrate that Cx36-mediated electrical coupling underlies such synchrony.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zufall, F (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St, Baltimore, MD 21201 USA.		Zufall, Frank/AAE-5290-2021	Zufall, Frank/0000-0002-4383-8618				Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Firestein S, 2005, NEURON, V45, P333, DOI 10.1016/j.neuron.2005.01.021; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Zhang CB, 2003, J COMP NEUROL, V459, P426, DOI 10.1002/cne.10617	11	3	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 2	2005	46	5					693	694		10.1016/j.neuron.2005.05.015	http://dx.doi.org/10.1016/j.neuron.2005.05.015			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934EN	15924853	Bronze			2022-12-28	WOS:000229689800001
J	Bazhenov, M; Stopfer, M; Sejnowski, TJ; Laurent, G				Bazhenov, M; Stopfer, M; Sejnowski, TJ; Laurent, G			Fast odor learning improves reliability of odor responses in the locust antennal lobe	NEURON			English	Article							ENCODING NEURAL ASSEMBLIES; ZEBRAFISH OLFACTORY-BULB; SYNAPTIC DEPRESSION; REPRESENTATIONS; DISCRIMINATION; OSCILLATIONS; NEURONS; SYNCHRONIZATION; INFORMATION; MECHANISMS	Recordings in the locust antennal lobe (AL) reveal activity-dependent, stimulus-specific changes in projection neuron (PN) and local neuron response patterns over repeated odor trials. During the first few trials, PN response intensity decreases, while spike time precision increases, and coherent oscillations, absent at first, quickly emerge. We examined this "fast odor learning" with a realistic computational model of the AL. Activity-dependent facilitation of AL inhibitory synapses was sufficient to simulate physiological recordings of fast learning. In addition, in experiment:; with noisy inputs, a network including synaptic facilitation of both inhibition and excitation responded with reliable spatiotemporal patterns from trial to trial despite the noise. A network lacking fast plasticity, however, responded with patterns that varied across trials, reflecting the input variability. Thus, our study suggests that fast olfactory learning results from stimulus-specific, activity-dependent synaptic facilitation and may improve the signal-to-noise ratio for repeatedly encountered odor stimuli.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; NICHD, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; CALTECH, Pasadena, CA 91125 USA	Salk Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego; California Institute of Technology	Bazhenov, M (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bazhenov@salk.edu	Sejnowski, Terrence/AAV-5558-2021; Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Stopfer, Mark/0000-0001-9200-1884	Howard Hughes Medical Institute Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008760] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008760] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; LAURENT G, 1993, J NEUROPHYSIOL, V69, P1484, DOI 10.1152/jn.1993.69.5.1484; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Mellon D, 1997, J COMP PHYSIOL A, V180, P553, DOI 10.1007/s003590050072; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Sloper J J, 1979, Philos Trans R Soc Lond B Biol Sci, V285, P124; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Traub R.D., 1991, NEURONAL NETWORKS HI; TRAUB RD, 1982, NEUROSCIENCE, V7, P1233, DOI 10.1016/0306-4522(82)91130-7; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vanderwolf CH, 2001, BRAIN RES, V892, P301, DOI 10.1016/S0006-8993(00)03263-7; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	38	58	59	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					483	492		10.1016/j.neuron.2005.03.022	http://dx.doi.org/10.1016/j.neuron.2005.03.022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882647	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000229011400019
J	Myers, CP; Lewcock, JW; Hanson, MG; Gosgnach, S; Aimone, JB; Gage, FH; Lee, KF; Landmesser, LT; Pfaff, SL				Myers, CP; Lewcock, JW; Hanson, MG; Gosgnach, S; Aimone, JB; Gage, FH; Lee, KF; Landmesser, LT; Pfaff, SL			Cholinergic input is required during embryonic development to mediate proper assembly of spinal locomotor circuits	NEURON			English	Article							CENTRAL PATTERN GENERATOR; PROGENITOR-CELL IDENTITY; LEFT-RIGHT COORDINATION; VENTRAL NEURAL-TUBE; IN-VITRO; CORD PREPARATION; NEONATAL RAT; TRANSCRIPTIONAL CODES; NEURONAL IDENTITY; RHYTHMIC ACTIVITY	Rhythmic limb movements are controlled by pattern-generating neurons within the ventral spinal cord, but little is known about how these locomotor circuits are assembled during development. At early stages of embryogenesis, motor neurons are spontaneously active, releasing acetylcholine that triggers the depolarization of adjacent cells in the spinal cord. To investigate whether acetylcholine-driven activity is required for assembly of the central pattern-generating (CPG) circuit, we studied mice lacking the choline acetyltransferase (ChAT) enzyme. Our studies show that a rhythmically active spinal circuit forms in ChAT mutants, but the duration of each cycle period is elongated, and right-left and flexor-extensor coordination are abnormal. In contrast, blocking acetylcholine receptors after the locomotor network is wired does not affect right-left or flexor-extensor coordination. These findings suggest that the cholinergic neurotransmitter pathway is involved in configuring the CPG during a transient period of development.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	Salk Institute; Salk Institute; Salk Institute; Salk Institute; Case Western Reserve University	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	pfaff@salk.edu	Aimone, James Bradley/H-4694-2016; Aimone, James B/C-7821-2011	Aimone, James Bradley/0000-0002-7361-253X; 	FOGARTY INTERNATIONAL CENTER [R03TW005563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009370, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; FIC NIH HHS [TW005563] Funding Source: Medline; NCI NIH HHS [T32 CA09370, P30 CA14195] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07198] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; Chub N, 1998, J NEUROSCI, V18, P294; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; ECCLES JC, 1954, J PHYSIOL-LONDON, V126, P524, DOI 10.1113/jphysiol.1954.sp005226; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Harrison RG, 1904, AM J ANAT, V3, P197, DOI 10.1002/aja.1000030206; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1338; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kjaerulff O, 1997, J NEUROSCI, V17, P9433; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Milner LD, 1999, J NEUROSCI, V19, P3007; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Nakayama K, 2002, J NEUROSCI, V22, P10388; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; O'Donovan MJ, 1998, ANN NY ACAD SCI, V860, P130; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; PANCHIN YV, 1991, J EXP BIOL, V161, P527; PERRINS R, 1995, J NEUROPHYSIOL, V73, P1013, DOI 10.1152/jn.1995.73.3.1013; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; Ritter A, 1999, J NEUROSCI, V19, P3457; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SERNAGOR E, 1995, J NEUROSCI, V15, P7452; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Wenner P, 1999, J NEUROSCI, V19, P7557, DOI 10.1523/JNEUROSCI.19-17-07557.1999; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Whelan PJ, 2003, J PHYSIOL-LONDON, V553, P695, DOI 10.1113/jphysiol.2003.046219; WINDHORST U, 1990, PROG NEUROBIOL, V35, P135, DOI 10.1016/0301-0082(90)90020-H	58	118	118	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					37	49		10.1016/j.neuron.2005.02.022	http://dx.doi.org/10.1016/j.neuron.2005.02.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820692	Bronze			2022-12-28	WOS:000228228600007
J	Wang, HB; Woolf, CJ				Wang, HB; Woolf, CJ			Pain TRPs	NEURON			English	Review							PRIMARY SENSORY NEURONS; TRANSDUCTION CHANNEL; THERMAL HYPERALGESIA; CAPSAICIN RECEPTOR; HEAT HYPERALGESIA; MICE LACKING; NOCICEPTION; ACTIVATION; SENSITIZATION; CALMODULIN	Transient receptor potential (TRIP) ion channels are molecular gateways in sensory systems, an interface between the environment and the nervous system. Several TRPs transduce thermal, chemical, and mechanical stimuli into inward currents, an essential first step for eliciting thermal and pain sensations. Precise regulation of the expression, localization, and function of the TRP channels is crucial for their sensory role in nociceptor terminals, particularly after inflammation, when they contribute to pain hypersensitivity by undergoing changes in translation and trafficking as well as diverse posttranslational modifications.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.	cwoolf@partners.org	Woolf, Clifford/A-9784-2010					Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Ferreira J, 2004, BRIT J PHARMACOL, V141, P787, DOI 10.1038/sj.bjp.0705546; Hu HJ, 2002, J NEUROSCI, V22, P7444; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Shu X, 2001, J NEUROPHYSIOL, V86, P2931, DOI 10.1152/jn.2001.86.6.2931; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	28	106	113	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					9	12		10.1016/j.neuron.2005.03.011	http://dx.doi.org/10.1016/j.neuron.2005.03.011			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820689	Bronze			2022-12-28	WOS:000228228600004
J	Kalivas, PW; Volkow, N; Seamans, J				Kalivas, PW; Volkow, N; Seamans, J			Unmanageable motivation in addiction: A pathology in prefrontal-accumbens glutamate transmission	NEURON			English	Review							COCAINE-INDUCED REINSTATEMENT; NUCLEUS-ACCUMBENS; SEEKING; RECEPTORS; DOPAMINE; CORTEX; ACTIVATION		Med Univ S Carolina, Dept Neurosci, Charleston, SC 29465 USA; NIDA, Bethesda, MD 20892 USA	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29465 USA.	kalivasp@musc.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550, Z01AA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Baptista MAS, 2004, J NEUROSCI, V24, P4723, DOI 10.1523/JNEUROSCI.0176-04.2004; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; Chandler LJ, 2003, PHARMACOL THERAPEUT, V99, P311, DOI 10.1016/S0163-7258(03)00096-2; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Dietrich D, 2002, NEUROPHARMACOLOGY, V42, P297, DOI 10.1016/S0028-3908(01)00193-9; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McBean GJ, 2002, TRENDS PHARMACOL SCI, V23, P299, DOI 10.1016/S0165-6147(02)02060-6; McFarland K, 2001, J NEUROSCI, V21, P8655; Moran MM, 2003, ANN NY ACAD SCI, V1003, P445, DOI 10.1196/annals.1300.048; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	23	466	478	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 3	2005	45	5					647	650		10.1016/j.neuron.2005.02.005	http://dx.doi.org/10.1016/j.neuron.2005.02.005			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	903SU	15748840	Bronze			2022-12-28	WOS:000227446700004
J	Firestein, S				Firestein, S			A Nobel nose: The 2004 Nobel prize in Physiology and Medicine	NEURON			English	Editorial Material							PUTATIVE PHEROMONE RECEPTORS; SENSITIVE ADENYLATE-CYCLASE; BETA-ADRENERGIC-RECEPTOR; ODORANT RECEPTORS; FUNCTIONAL EXPRESSION; MULTIGENE FAMILY; OLFACTORY-BULB; TASTE RECEPTORS; SENSORY MAP; NEURONS		Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	stuart@biology.columbia.edu						AMOORE JE, 1967, NATURE, V214, P1095, DOI 10.1038/2141095a0; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2004, CELL, V116, P117; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kauer J.S., 1987, P205; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; LETTVIN JY, 1965, COLD SPRING HARB SYM, V30, P217, DOI 10.1101/SQB.1965.030.01.024; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; REED RR, 1990, SOC GEN PHY, V45, P153; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; SCHWARTZ EA, 1985, ANNU REV NEUROSCI, V8, P339; SHEPHERD GM, 1975, NERVOUS SYSTEM, P207; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506; Zozulya S, 2001, GENOME BIOL, V2	57	13	14	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					333	338		10.1016/j.neuron.2005.01.021	http://dx.doi.org/10.1016/j.neuron.2005.01.021			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694319	Bronze			2022-12-28	WOS:000226787700005
J	Holtmaat, AJGD; Trachtenberg, JT; Wilbrecht, L; Shepherd, GM; Zhang, XQ; Knott, GW; Svoboda, K				Holtmaat, AJGD; Trachtenberg, JT; Wilbrecht, L; Shepherd, GM; Zhang, XQ; Knott, GW; Svoboda, K			Transient and persistent dendritic spines in the neocortex in vivo	NEURON			English	Article							RAT BARREL CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; CAT VISUAL-CORTEX; CRITICAL PERIOD; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; ADULT CORTEX; BRAIN-SLICES; SYNAPSES	Dendritic spines were imaged over days to months in the apical tufts of neocortical pyramidal neurons (layers 5 and 2/3) in vivo. A fraction of thin spines appeared and disappeared over a few days, while most thick spines persisted for months. In the somatosensory cortex, from postnatal day (PND) 16 to PND 25 spine retractions exceeded additions, resulting in a net loss of spines. The fraction of persistent spines (lifetime ! 8 days) grew gradually during development and into adulthood (PND 16-25,35%; PND 35-80,54%; PND 80-120, 66%; PND 175-225, 73%), providing evidence that synaptic circuits continue to stabilize even in the adult brain, long after the closure of known critical periods. In 6-month-old mice, spines turn over more slowly in visual compared to somatosensory cortex, possibly reflecting differences in the capacity for experience-dependent plasticity in these brain regions.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010; Wilbrecht, Linda/J-7988-2013	Holtmaat, Anthony/0000-0002-7577-0769; Knott, Graham W/0000-0002-2956-9052				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Barth AL, 2000, J NEUROSCI, V20, P4206; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; BRAINTENBERG V, 1991, ANATOMY CORTEX, V18; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; CHEN B, 2004, LONG TERM HIGH RESOL, P423; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dailey ME, 1996, J NEUROSCI, V16, P2983; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1992, J NEUROSCI, V12, P2685; JURASKA JM, 1982, J COMP NEUROL, V212, P208, DOI 10.1002/cne.902120210; KATZ LC, 1987, J NEUROSCI, V7, P1223; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LORENTE R, 1992, SOMATOSENS MOT RES, V9, P3; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maravall M, 2004, CEREB CORTEX, V14, P655, DOI 10.1093/cercor/bhh026; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Racca C, 2000, J NEUROSCI, V20, P2512; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SPACEK J, 1985, ANAT EMBRYOL, V171, P235, DOI 10.1007/BF00341418; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	64	803	823	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 20	2005	45	2					279	291		10.1016/j.neuron.2005.01.003	http://dx.doi.org/10.1016/j.neuron.2005.01.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	889OE	15664179	Bronze			2022-12-28	WOS:000226451500014
J	Cirrito, JR; Yamada, KA; Finn, MB; Sloviter, RS; Bales, KR; May, PC; Schoepp, DD; Paul, SM; Mennerick, S; Holtzman, DM				Cirrito, JR; Yamada, KA; Finn, MB; Sloviter, RS; Bales, KR; May, PC; Schoepp, DD; Paul, SM; Mennerick, S; Holtzman, DM			Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo	NEURON			English	Article							TRANSGENIC MOUSE MODEL; A-BETA; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PROTEIN-PRECURSOR; BRAIN; RELEASE; RAT; HIPPOCAMPUS; METABOLISM	Aggregation of the amyloid-beta (A beta) peptide in the extracellular space of the brain is central to Alzheimer's disease pathogenesis. A beta aggregation is concentration dependent and brain region specific. Utilizing in vivo microdialysis concurrently with field potential recordings, we demonstrate that A beta levels in the brain interstitial fluid are dynamically and directly influenced by synaptic activity on a timescale of minutes to hours. Using an acute brain slice model, we show that the rapid effects of synaptic activity on A beta levels are primarily related to synaptic vesicle exocytosis. These results suggest that synaptic activity may modulate a neurodegenerative disease process, in this case by influencing A beta metabolism and ultimately region-specific A beta deposition. The findings also have important implications for treatment development.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Univ Arizona, Dept Pharmacol, Tucson, AZ 85724 USA; Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Arizona; Eli Lilly	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.		Mennerick, Steven/O-2806-2017; Paul, Steve/ABE-5400-2020	Mennerick, Steven/0000-0003-0868-0664; 	NATIONAL INSTITUTE ON AGING [R37AG013956, P01AG011355, R01AG013956] Funding Source: NIH RePORTER; NIA NIH HHS [AG13956, AG11355] Funding Source: Medline; NIDA NIH HHS [DA70261] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Beach TG, 2001, NEUROSCI LETT, V310, P21, DOI 10.1016/S0304-3940(01)02076-6; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Cirrito JR, 2003, J NEUROSCI, V23, P8844; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Fryer JD, 2003, J NEUROSCI, V23, P7889; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hock C, 2003, AMYLOID, V10, P1, DOI 10.3109/13506120308995249; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Nilsen KE, 2005, EPILEPSIA, V46, P179, DOI 10.1111/j.0013-9580.2005.26004.x; Nitsch RM, 2000, ANN NEUROL, V48, P913, DOI 10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.3.CO;2-J; NITSCH RM, 1993, P NATL ACAD SCI USA, V90, P5191, DOI 10.1073/pnas.90.11.5191; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sheng JG, 2002, J NEUROSCI, V22, P9794; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200	38	863	894	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					913	922		10.1016/j.neuron.2005.10.028	http://dx.doi.org/10.1016/j.neuron.2005.10.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364896	Bronze			2022-12-28	WOS:000234301700008
J	Lear, BC; Lin, JM; Keath, JR; McGill, JJ; Raman, IM; Allada, R				Lear, BC; Lin, JM; Keath, JR; McGill, JJ; Raman, IM; Allada, R			The ion channel narrow abdomen is critical for neural output of the Drosophila circadian pacemaker	NEURON			English	Article							NERVOUS-SYSTEM; TIMELESS GENES; CLOCK GENES; NEURONS; PERIOD; NEUROPEPTIDE; EXPRESSION; RHYTHMS; BRAIN; MELANOGASTER	Circadian clocks consist of transcriptional feedback loops housed in interdependent pacemaker neurons. Yet little is known about the neuronal output components essential for rhythmic behavior. Drosophila mutants of a putative ion channel, narrow abdomen (na), exhibit poor circadian rhythms and suppressed daylight activity. We find that NA is expressed in pacemaker neurons and induced expression within circadian neurons is sufficient to rescue these mutant phenotypes. Selective na rescue in distinct pacemaker neurons influences rhythmicity and timing of behavior. Oscillations of the clock protein PERIOD are intact in na mutants, indicating an output role. Pore residues are required for robust rescue consistent with NA action as an ion channel. In na mutants, expression of potassium currents and the key neuropeptide PDF are elevated, the latter consistent with reduced release. These data implicate NA and the pacemaker neural network in controlling phase and rhythmicity.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu	Lear, Bridget/A-1350-2013					Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; Bahinski A, 1997, MOL CELL BIOCHEM, V166, P125, DOI 10.1023/A:1006847632410; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Christian SL, 2002, GENOMICS, V79, P635, DOI 10.1006/geno.2002.6765; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hall JC, 1998, J NEUROGENET, V12, P115, DOI 10.3109/01677069809108556; HARDIN PE, 1992, EMBO J, V11, P1; Helfrich-Forster C, 2003, MICROSC RES TECHNIQ, V62, P94, DOI 10.1002/jemt.10357; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; KRISHNAN KS, 1990, P NATL ACAD SCI USA, V87, P8632, DOI 10.1073/pnas.87.21.8632; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leibovitch BA, 1995, J NEUROGENET, V10, P1, DOI 10.3109/01677069509083455; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Sambrook J., 2001, MOL CLONING LAB MANU; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; TANG SQ, 1993, J BIOL CHEM, V268, P13026; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	44	84	85	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					965	976		10.1016/j.neuron.2005.10.030	http://dx.doi.org/10.1016/j.neuron.2005.10.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364900	Bronze			2022-12-28	WOS:000234301700012
J	Gao, J; Duan, B; Wang, DG; Deng, XH; Zhang, GY; Xu, L; Xu, TL				Gao, J; Duan, B; Wang, DG; Deng, XH; Zhang, GY; Xu, L; Xu, TL			Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death	NEURON			English	Article							PROTEIN-KINASE-II; SUBUNIT MESSENGER-RNAS; D-ASPARTATE RECEPTOR; CELL-DEATH; FOREBRAIN ISCHEMIA; GLUTAMATE NEUROTOXICITY; HIPPOCAMPAL SYNAPSES; GLUCOSE DEPRIVATION; NERVOUS-SYSTEM; NR2B SUBUNIT	Acid-sensing ion channels (ASICs) composed of ASIC1a subunit exhibit a high Ca2+ permeability and play important roles in synaptic plasticity and acid-induced cell death. Here, we show that ischemia enhances ASIC currents through the phosphorylation at Ser478 and Ser479 of ASIC1a, leading to exacerbated ischemic cell death. The phosphorylation is catalyzed by Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity, as a result of activation of NR2B-containing N-methyl-D-aspartate subtype of glutamate receptors (NMDARs) during ischemia. Furthermore, NR2B-specific antagonist, CaMKII inhibitor, or overexpression of mutated form of ASIC1a with Ser478 or Ser479 replaced by alanine (ASICla-S478A, ASIC1a-S479A) in cultured hippocampal neurons prevented ischemia-induced enhancement of ASIC currents, cytoplasmic Ca2+ elevation, as well as neuronal death. Thus, NMDAR-CaMKII cascade is functionally coupled to ASICs and contributes to acidotoxicity during ischemia. Specific blockade of NMDAR/CaMKII-ASIC coupling may reduce neuronal death after ischemia and other pathological conditions involving excessive glutamate release and acidosis.	Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Key Lab Neurobiol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; Univ Sci & Technol China, Hefei 230027, Peoples R China; Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Xuzhou 221002, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Lab Learning & Memory, Kunming 650223, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Xuzhou Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology	Xu, TL (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	tlxu@ion.ac.cn	Xu, Lin/T-5531-2017	Xu, Lin/0000-0002-2710-3507				ALLEN NJ, 2002, J PHYSL, V543, P52; ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BERECZKI D, 1993, METAB BRAIN DIS, V8, P125, DOI 10.1007/BF00996926; Biagini G, 2001, NEUROBIOL DIS, V8, P45, DOI 10.1006/nbdi.2000.0331; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHURN SB, 1992, J NEUROCHEM, V59, P1221, DOI 10.1111/j.1471-4159.1992.tb08431.x; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411, DOI 10.1113/jphysiol.1990.sp018074; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hajimohammadreza I, 1997, J NEUROCHEM, V69, P1006; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Johnson MB, 2001, J CEREBR BLOOD F MET, V21, P734, DOI 10.1097/00004647-200106000-00011; Katsura K, 1999, BRAIN RES, V849, P119, DOI 10.1016/S0006-8993(99)02072-7; Kawabata K, 2000, AM J PHYSIOL-HEART C, V278, pH1008, DOI 10.1152/ajpheart.2000.278.3.H1008; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Shamloo M, 2000, NEUROSCIENCE, V96, P665, DOI 10.1016/S0306-4522(99)00586-2; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SUZUKI T, 1994, J NEUROCHEM, V63, P1529, DOI 10.1046/j.1471-4159.1994.63041529.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YAMAMOTO H, 1992, J NEUROCHEM, V58, P1110, DOI 10.1111/j.1471-4159.1992.tb09369.x; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	50	253	277	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					635	646		10.1016/j.neuron.2005.10.011	http://dx.doi.org/10.1016/j.neuron.2005.10.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301179	Bronze			2022-12-28	WOS:000233677300016
J	Scott, K				Scott, K			Taste recognition: Food for thought	NEURON			English	Review							ODORANT RECEPTOR EXPRESSION; SWEET TASTE; BITTER TASTE; SENSORY PROJECTIONS; POSITIONAL CLONING; MAMMALIAN SWEET; SOLITARY TRACT; SOUR TASTE; DROSOPHILA; GENE	The ability to identify food that is nutrient-rich and avoid toxic substances is essential for an animal's survival. Although olfaction and vision contribute to food detection, the gustatory system acts as a final checkpoint control for food acceptance or rejection behavior. Recent studies with model organisms such as mice and Drosophila have identified candidate taste receptors and examined the logic of taste coding in the periphery. Despite differences in terms of gustatory anatomy and taste-receptor families, these gustatory systems share a basic organization that is different from other sensory systems. This review will summarize our current understanding of taste recognition in mammals and Drosophila, highlighting similarities and raising several as yet unanswered questions.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 291 Life Sci Addict, Berkeley, CA 94720 USA.	kscott@berkeley.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER; NIDCD NIH HHS [1R01DC006252-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACKERMAN D., 1991, NATURAL HIST SENSES; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2000, NEUROSCI LETT, V283, P61, DOI 10.1016/S0304-3940(00)00911-3; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Boughter JD, 1999, NEURON, V22, P213, DOI 10.1016/S0896-6273(00)81082-X; Breslin PAS, 1996, PERCEPT PSYCHOPHYS, V58, P327, DOI 10.3758/BF03206809; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; DeSimone JA, 2001, RESP PHYSIOL, V129, P231, DOI 10.1016/S0034-5687(01)00293-6; Dethier VG, 1976, HUNGRY FLY; Dotson CD, 2005, CHEM SENSES, V30, P593, DOI 10.1093/chemse/bji053; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gilbertson TA, 1998, CURR OPIN NEUROBIOL, V8, P447, DOI 10.1016/S0959-4388(98)80030-5; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Glendinning JI, 2005, CHEM SENSES, V30, P299, DOI 10.1093/chemse/bji025; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; HAMILTON RB, 1984, J COMP NEUROL, V222, P560, DOI 10.1002/cne.902220408; HAYAMA T, 1985, EXP BRAIN RES, V60, P235; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KINNAMON SC, 1988, J GEN PHYSIOL, V91, P351, DOI 10.1085/jgp.91.3.351; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kleyman TR, 1999, SEMIN NEPHROL, V19, P524; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Kunes Samuel, 1993, Current Opinion in Neurobiology, V3, P53, DOI 10.1016/0959-4388(93)90035-W; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Liu LJ, 2001, BRAIN RES, V923, P58, DOI 10.1016/S0006-8993(01)03190-0; Lyall V, 2005, CHEM SENSES, V30, pI42, DOI 10.1093/chemse/bjh104; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MIYAMOTO T, 1988, J PHYSIOL-LONDON, V405, P699, DOI 10.1113/jphysiol.1988.sp017356; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; NISSENBAUM JW, 1987, NEUROSCI BIOBEHAV R, V11, P187, DOI 10.1016/S0149-7634(87)80025-8; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Sclafani A, 2004, APPETITE, V43, P1, DOI 10.1016/j.appet.2004.03.007; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Smith DV, 1999, CURR OPIN NEUROBIOL, V9, P427, DOI 10.1016/S0959-4388(99)80064-6; Smith DV, 2001, SCI AM, V284, P32, DOI 10.1038/scientificamerican0301-32; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; TRAVERS JB, 1987, ANNU REV NEUROSCI, V10, P595, DOI 10.1146/annurev.ne.10.030187.003115; TRAVERS SP, 1991, J NEUROPHYSIOL, V65, P1372, DOI 10.1152/jn.1991.65.6.1372; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yamaguchi S, 2000, J NUTR, V130, p921S, DOI 10.1093/jn/130.4.921S; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	103	143	146	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2005	48	3					455	464		10.1016/j.neuron.2005.10.015	http://dx.doi.org/10.1016/j.neuron.2005.10.015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983RP	16269362	Bronze			2022-12-28	WOS:000233250100006
J	Messinger, A; Squire, LR; Zola, SM; Albright, TD				Messinger, A; Squire, LR; Zola, SM; Albright, TD			Neural correlates of knowledge: Stable representation of stimulus associations across variations in behavioral performance	NEURON			English	Article							INFERIOR TEMPORAL NEURONS; GUIDED VISUAL-SEARCH; PREFRONTAL CORTEX; RECEPTIVE-FIELDS; MEMORY-RETRIEVAL; EYE-MOVEMENT; TERM-MEMORY; MACAQUE; RESPONSES; ATTENTION	Behavioral responses to a sensory stimulus are often guided by associative memories. These associations remain intact even when other factors determine behavior. The substrates of associative memory should therefore be identifiable by neuronal responses that are independent of behavioral choices. We tested this hypothesis using a paired-associates task in which monkeys learned arbitrary associations between pairs of visual stimuli. We examined the activity of neurons in inferior temporal cortex as the animals prepared to choose a remembered stimulus from a visual display. The activity of some neurons (22%) depended on the monkey's behavioral choice; but for a novel class of neurons (54%), activity reflected the stimulus that the monkey was instructed to choose, regardless of the behavioral response. These neurons appear to represent memorized stimulus associations that are stable across variations in behavioral performance. In addition, many neurons (74%) were modulated by the spatial arrangement of the stimuli in the display.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, La Jolla, CA 92161 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego	Albright, TD (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA.	tom@salk.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH024600] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH024600] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Jagadeesh B, 2001, J NEUROPHYSIOL, V86, P290, DOI 10.1152/jn.2001.86.1.290; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Miller EK, 1996, J NEUROSCI, V16, P5154; Missal M, 1999, J NEUROPHYSIOL, V82, P131, DOI 10.1152/jn.1999.82.1.131; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Rainer G, 1999, J NEUROSCI, V19, P5493; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SATO T, 1995, EXP BRAIN RES, V105, P209; SATO T, 1989, EXP BRAIN RES, V77, P23; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x	29	26	27	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					359	371		10.1016/j.neuron.2005.08.035	http://dx.doi.org/10.1016/j.neuron.2005.08.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242414	Green Accepted, Bronze			2022-12-28	WOS:000232838700023
J	Hayashi, T; Rumbaugh, G; Huganir, RL				Hayashi, T; Rumbaugh, G; Huganir, RL			Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites	NEURON			English	Article							PROTEIN PALMITOYLATION; SF9 CELLS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; SURFACE EXPRESSION; MEMBRANE SKELETON; PHOSPHORYLATION; CHANNEL; PSD-95; IDENTIFICATION	Modification of AMPA receptor function is a major mechanism for the regulation of synaptic transmission and underlies several forms of synaptic plasticity. Post-translational palmitoylation is a reversible modification that regulates localization of many proteins. Here, we report that palmitoylation of the AMPA receptor regulates receptor trafficking. All AMPA receptor subunits are palmitoylated on two cysteine residues in their transmembrane domain (TMD) 2 and in their C-terminal region. Palmitoylation on TMD 2 is upregulated by the palmitoyl acyl transferase GODZ and leads to an accumulation of the receptor in the Golgi and a reduction of receptor surface expression. C-terminal palmitoylation decreases interaction of the AMPA receptor with the 4.1N protein and regulates AMPA- and NMDA-induced AMPA receptor internalization. Moreover, depalmitoylation of the receptor is regulated by activation of glutamate receptors. These data suggest that regulated palmitoylation of AMPA receptor subunits modulates receptor trafficking and may be important for synaptic plasticity.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Hayashi, Takashi/0000-0003-3591-2109				ALALUF S, 1995, J NEUROCHEM, V64, P1548; ANDERSON RA, 1984, NATURE, V307, P655, DOI 10.1038/307655a0; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Coleman SK, 2003, J NEUROSCI, V23, P798; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; NG GYK, 1994, J NEUROCHEM, V63, P1589; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Ponimaskin EG, 2001, BIOCHEM J, V353, P627, DOI 10.1042/0264-6021:3530627; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Shen L, 2000, J NEUROSCI, V20, P7932; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Walensky LD, 1999, J NEUROSCI, V19, P6457; Yamazaki M, 2001, NEUROSCI LETT, V304, P81, DOI 10.1016/S0304-3940(01)01766-9	52	192	204	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					709	723		10.1016/j.neuron.2005.06.035	http://dx.doi.org/10.1016/j.neuron.2005.06.035			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963DE	16129400	Bronze			2022-12-28	WOS:000231782700012
J	Kuhnen, CM; Knutson, B				Kuhnen, CM; Knutson, B			The neural basis of financial risk taking	NEURON			English	Article							EXPECTED-UTILITY-THEORY; INVESTOR PSYCHOLOGY; DECISION-MAKING; RIGHT INSULA; FMRI; BRAIN; AMPHETAMINE; ACTIVATION; VISUALIZATION; ANTICIPATION	Investors systematically deviate from rationality when making financial decisions, yet the mechanisms responsible for these deviations have not been identified. Using event-related fMRI, we examined whether anticipatory neural activity would predict optimal and suboptimal choices in a financial decision-making task. We characterized two types of deviations from the optimal investment strategy of a rational risk-neutral agent as risk-seeking mistakes and risk-aversion mistakes. Nucleus accumbens activation preceded risky choices as well as risk-seeking mistakes, while anterior insula activation preceded riskless choices as well as risk-aversion mistakes. These findings suggest that distinct neural circuits linked to anticipatory affect promote different types of financial choices and indicate that excessive activation of these circuits may lead to investing mistakes. Thus, consideration of anticipatory neural mechanisms may add predictive power to the rational actor model of economic decision making.	Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University	Kuhnen, CM (corresponding author), Stanford Univ, Grad Sch Business, 518 Mem Way,S479, Stanford, CA 94305 USA.	camelia@stanford.edu; knutson@psych.stanford.edu	van Lent, Laurence/G-5298-2010	van Lent, Laurence/0000-0002-9354-0932; Knutson, Brian/0000-0002-7669-426X	NIA NIH HHS [AG024957-02] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG024957] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bernheim BD, 2004, AM ECON REV, V94, P1558, DOI 10.1257/0002828043052222; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daniel K, 2002, J MONETARY ECON, V49, P139, DOI 10.1016/S0304-3932(01)00091-5; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Hirshleifer D, 2001, J FINANC, V56, P1533, DOI 10.1111/0022-1082.00379; Huang C, 1988, FDN FINANCIAL EC; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Lo AW, 2002, J COGNITIVE NEUROSCI, V14, P323, DOI 10.1162/089892902317361877; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Odean T, 1998, J FINANC, V53, P1775, DOI 10.1111/0022-1082.00072; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; ROBBINS TW, 1986, PSYCHOPHARMACOLOGY, V90, P72; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Simmons A, 2004, NEUROREPORT, V15, P2261, DOI 10.1097/00001756-200410050-00024; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Zink CF, 2003, J NEUROSCI, V23, P8092	37	707	719	1	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 1	2005	47	5					763	770		10.1016/j.neuron.2005.08.008	http://dx.doi.org/10.1016/j.neuron.2005.08.008			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	963DE	16129404	Bronze			2022-12-28	WOS:000231782700016
J	Stauffer, EA; Scarborough, JD; Hirono, M; Miller, ED; Shah, K; Mercer, JA; Holt, JR; Gillespie, PG				Stauffer, EA; Scarborough, JD; Hirono, M; Miller, ED; Shah, K; Mercer, JA; Holt, JR; Gillespie, PG			Fast adaptation in vestibular hair cells requires myosin-1c activity	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; BULLFROGS SACCULUS; FORCE GENERATION; BUNDLE MOVEMENTS; AMPLIFICATION; MECHANISMS; CHANNELS; MOTION; EXTENT; MODEL	In sensory hair cells of the inner ear, mechanical amplification of small stimuli requires fast adaptation, the rapid closing of mechanically activated transduction channels. In frog and mouse vestibular hair cells, we found that the rate of fast adaptation depends on both channel opening and stimulus size and that it is modeled well as a release of a mechanical element in series with the transduction apparatus. To determine whether myosin-1c molecules of the adaptation motor are responsible for the release, we introduced the Y61G mutation into the Myo1c locus and generated mice homozygous for this sensitized allele. Measuring transduction and adaptation in the presence of NMB-ADP, an allele-specific inhibitor, we found that the inhibitor not only blocked slow adaptation, as demonstrated previously in transgenic mice, but also inhibited fast adaptation. These results suggest that mechanical activity of myosin-1c is required for fast adaptation in vestibular hair cells.	Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA; Oregon Hlth Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97239 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA	University of Virginia; University of Virginia; Oregon Health & Science University; Oregon Health & Science University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; McLaughlin Research Institute for Biomedical Sciences, Inc.	Holt, JR (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.	jeffholt@virginia.edu; gillespp@ohsu.edu		Barr-Gillespie, Peter/0000-0002-9787-5860; Hirono, Moritoshi/0000-0001-6068-1045; Mercer, John/0000-0003-0307-4438	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC005439, R01DC002368, R01DC003279] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002368, R01 DC005439-04, P30 DC005983, R01 DC005439, R01 DC003279] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1992, J NEUROSCI, V12, P3291; Batters C, 2004, PHILOS T R SOC B, V359, P1895, DOI 10.1098/rstb.2004.1559; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Benser ME, 1996, J NEUROSCI, V16, P5629; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; CHEUNG EL, 2005, IN PRESS BIOPHYS J; COREY DP, 1983, J NEUROSCI, V3, P962; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; GILLESPIE PG, 2005, IN PRESS CURR OPIN N, V15; GOLDBERG JM, 1990, J NEUROPHYSIOL, V63, P781, DOI 10.1152/jn.1990.63.4.781; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Holt JR, 1997, J NEUROSCI, V17, P8739; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; Martin P, 2003, J NEUROSCI, V23, P4533; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; POLLARD TD, 1982, METHOD ENZYMOL, V85, P123; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171	40	112	117	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 18	2005	47	4					541	553		10.1016/j.neuron.2005.07.024	http://dx.doi.org/10.1016/j.neuron.2005.07.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957ZC	16102537	Green Accepted, Bronze			2022-12-28	WOS:000231411100011
J	Guo, XF; Macleod, GT; Wellington, A; Hu, F; Panchumarthi, S; Schoenfield, M; Marin, L; Charlton, MP; Atwood, HL; Zinsmaier, KE				Guo, XF; Macleod, GT; Wellington, A; Hu, F; Panchumarthi, S; Schoenfield, M; Marin, L; Charlton, MP; Atwood, HL; Zinsmaier, KE			The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses	NEURON			English	Article							MOTOR-NERVE TERMINALS; HEREDITARY SPASTIC PARAPLEGIA; SYNAPTIC-TRANSMISSION; CYTOCHROME-OXIDASE; CYTOSOLIC CA2+; PROTEIN; MUTATIONS; RELEASE; MICROTUBULES; STIMULATION	We have identified EMS-induced mutations in Drosophila Miro (dMiro), an atypical mitochondrial GTPase that is orthologous to human Miro (hMiro). Mutant dmiro animals exhibit defects in locomotion and die prematurely. Mitochondria in dmiro mutant muscles and neurons are abnormally distributed. Instead of being transported into axons and dendrites mitochondria accumulate in parallel rows in neuronal somata. Mutant neuromuscular junctions (NMJs) lack presynaptic mitochondria, but neurotransmitter release and acute Ca2+ buffering is only impaired during prolonged stimulation. Neuronal, but not muscular, expression of dMiro in dmiro mutants restored viability, transport of mitochondria to NMJs, the structure of synaptic boutons, the organization of presynaptic microtubules, and the size of postsynaptic muscles. In addition, gain of dMiro function causes an abnormal accumulation of mitochondria in distal synaptic boutons of NMJs. Together, our findings suggest that dMiro is required for controlling anterograde transport of mitochondria and their proper distribution within nerve terminals.	Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Program Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Undergrad Biol Res Program, Tucson, AZ 85721 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Penn, Sch Med, Program Neurosci, Philadelphia, PA 19104 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Toronto; University of Pennsylvania	Zinsmaier, KE (corresponding author), Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA.	kez@neurobio.arizona.edu		Macleod, Gregory/0000-0003-3782-6968; Wellington, Andrea/0000-0002-8679-9225				Babcock MC, 2003, GENETICS, V165, P171; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bindokas VP, 1998, J NEUROSCI, V18, P4570; BLOOM GS, 1993, J CELL BIOL, V120, P467, DOI 10.1083/jcb.120.2.467; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen B, 1998, GENETICS, V149, P157; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; David G, 2000, J NEUROSCI, V20, P7290; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; David G, 1999, J NEUROSCI, V19, P7495, DOI 10.1523/JNEUROSCI.19-17-07495.1999; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hurd DD, 1996, GENETICS, V144, P1075; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kammermeier L, 2003, DEV GENES EVOL, V213, P412, DOI 10.1007/s00427-003-0340-x; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; MORRIS RL, 1993, J CELL SCI, V104, P917; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; Ohnuma K, 1999, BIOPHYS J, V76, P1819, DOI 10.1016/S0006-3495(99)77342-X; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Stowers RS, 1999, GENETICS, V152, P1631; Suzuki S, 2002, J NEUROPHYSIOL, V87, P1816, DOI 10.1152/jn.00456.2001; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; WONGRILEY M, 1984, NATURE, V307, P262, DOI 10.1038/307262a0; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	52	437	446	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 4	2005	47	3					379	393		10.1016/j.neuron.2005.06.027	http://dx.doi.org/10.1016/j.neuron.2005.06.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055062	Bronze			2022-12-28	WOS:000231051900009
J	Das, A				Das, A			Cortical maps: Where theory meets experiments	NEURON			English	Editorial Material							VISUAL-CORTEX; SELECTIVITY; CAT	Primary visual cortex (V1) has remarkably systematic functional maps. One commonly used class of computational models proposes that such maps are generated by a mechanism that projects the multiple dimensions of neuronal responses smoothly onto the two dimensions of cortex. In this issue of Neuron, Mriganka Sur and colleagues find a close match between such model predictions and measurements from ferret V1.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Das, A (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.				NATIONAL EYE INSTITUTE [P30EY019007, R24EY015634] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY015634, R24 EY015634-03, R24 EY015634-04, R24 EY015634-02, R24 EY015634-01, P30 EY019007] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Buzas P, 2003, EUR J NEUROSCI, V18, P957, DOI 10.1046/j.1460-9568.2003.02808.x; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Hubener M, 1997, J NEUROSCI, V17, P9270; Kohonen T., 2001, SELF ORG MAPS; Koulakov AA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-30; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; WILLSHAW DJ, 1979, PHILOS T ROY SOC B, V287, P203, DOI 10.1098/rstb.1979.0056; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011	14	4	5	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					168	171		10.1016/j.neuron.2005.07.004	http://dx.doi.org/10.1016/j.neuron.2005.07.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039557	Green Accepted, Bronze			2022-12-28	WOS:000230693900002
J	Masliah, E; Rockenstein, E; Adame, A; Alford, M; Crews, L; Hashimoto, M; Seubert, P; Lee, M; Goldstein, J; Chilcote, T; Games, D; Schenk, D				Masliah, E; Rockenstein, E; Adame, A; Alford, M; Crews, L; Hashimoto, M; Seubert, P; Lee, M; Goldstein, J; Chilcote, T; Games, D; Schenk, D			Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease	NEURON			English	Article							LEWY-BODY-DISEASE; RECEPTOR-RELATED PROTEIN; AMYLOID-BETA IMMUNIZATION; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISORDERS; TRANSGENIC MICE; NACP/ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS	Abnormal folding of alpha-synucleln (alpha-syn) is thought to lead to neurodegeneration and the characteristic symptoms of Lewy body disease (LBD). Since previous studies suggest that immunization might be a potential therapy for Alzheimer's disease, we hypothesized that immunization with human (h)alpha-syn might have therapeutic effects in LBD. For this purpose, h alpha-syn transgenic (tg) mice were vaccinated with h alpha-syn. In mice that produced high relative affinity antibodies, there was decreased accumulation of aggregated h alpha-syn in neuronal cell bodies and synapses that was associated with reduced neurodegeneration. Furthermore, antibodies produced by immunized mice recognized abnormal h alpha-syn associated with the neuronal membrane and promoted the degradation of h alpha-syn aggregates, probably via lysosomal pathways. Similar effects were observed with an exogenously applied FITC-tagged h alpha-syn antibody. These results suggest that vaccination is effective in reducing neuronal accumulation of h alpha-syn aggregates and that further development of this approach might have a potential role in the treatment of LBD.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Elan Pharmaceut Inc, San Francisco, CA 94080 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067	NIA NIH HHS [AG022074, AG18440, AG5131] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG018440, R01AG018440, P50AG005131, P01AG022074] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALFORD MF, 1994, J HISTOCHEM CYTOCHEM, V42, P283, DOI 10.1177/42.2.8288869; Bainbridge J, 2003, CLIN EXP IMMUNOL, V133, P310, DOI 10.1046/j.1365-2249.2003.02242.x; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BRAAK H, 2002, J NEUROL S, V3, P1; Burton EA, 2003, GENE THER, V10, P1721, DOI 10.1038/sj.gt.3302116; Coleman T, 1996, J PHARMACOL EXP THER, V277, P685; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; DAMATO RJ, 1986, SCIENCE, V231, P987, DOI 10.1126/science.3080808; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; DODD P, 1981, BRAIN RES, V224, P419, DOI 10.1016/0006-8993(81)90871-4; DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; FABIAN RH, 1990, NEUROLOGY, V40, P419, DOI 10.1212/WNL.40.3_Part_1.419; FABIAN RH, 1987, NEUROLOGY, V37, P1780, DOI 10.1212/WNL.37.11.1780; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; FORNO L, 1996, ADV NEUROL, P217; Frenkel D, 2001, BIOLOGICALS, V29, P243, DOI 10.1006/biol.2001.0294; Games D, 2000, ANN NY ACAD SCI, V920, P274; Garzon J, 1999, MOL BRAIN RES, V65, P151, DOI 10.1016/S0169-328X(98)00350-7; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; HANSEN L, 1990, NEUROLOGY, V40, P1; HANSEN LA, 1992, CURR OPIN NEUROL NEU, V5, P889; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; HERZ J, 1990, J BIOL CHEM, V265, P21355; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; Hussain MM, 2001, FRONT BIOSCI, V6, pD417, DOI 10.2741/Hussain1; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; Iwatsubo T, 1996, AM J PATHOL, V148, P1517; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Kim DW, 2004, YONSEI MED J, V45, P23, DOI 10.3349/ymj.2004.45.6.1203; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P185; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lemere CA, 2003, NEUROCHEM RES, V28, P1017, DOI 10.1023/A:1023203122036; Luthi-Carter R, 2003, MOL THER, V7, P569, DOI 10.1016/S1525-0016(03)00107-2; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; MEEKER ML, 1987, BRAIN RES, V423, P45, DOI 10.1016/0006-8993(87)90823-7; Miller TW, 2003, MOL THER, V7, P572, DOI 10.1016/S1525-0016(03)00063-7; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Salmon DP, 1996, BRAIN COGNITION, V31, P148, DOI 10.1006/brcg.1996.0039; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Shastry BS, 2001, NEUROSCI RES, V41, P5, DOI 10.1016/S0168-0102(01)00254-1; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, LAB INVEST, V78, P1169; Takeda A, 1998, AM J PATHOL, V152, P367; Takeda A, 2000, ACTA NEUROPATHOL, V99, P296, DOI 10.1007/PL00007441; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; UBOL S, 1995, J VIROL, V69, P1990, DOI 10.1128/JVI.69.3.1990-1993.1995; Veldman BAJ, 1998, CLIN NEUROL NEUROSUR, V100, P15, DOI 10.1016/S0303-8467(98)00009-2; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Yoshizaki T, 2004, NEUROSCI LETT, V363, P33, DOI 10.1016/j.neulet.2004.03.074; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	82	429	510	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 16	2005	46	6					857	868		10.1016/j.neuron.2005.05.010	http://dx.doi.org/10.1016/j.neuron.2005.05.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937KH	15953415	Bronze			2022-12-28	WOS:000229922500006
J	Gotz, M; Barde, YA				Gotz, M; Barde, YA			Radial glial cells: Defined and major intermediates between embryonic, stern cells and CNS neurons	NEURON			English	Review							CENTRAL-NERVOUS-SYSTEM; ASYMMETRIC INHERITANCE; PROGENITOR CELLS; PAX6; LINEAGE; DIFFERENTIATION; TELENCEPHALON; SPECIFICATION; ARISE; FATE		GSF, Natl Res Ctr Environm & Hlth, Inst Stem Celll Res, D-85764 Neuherberg, Germany; Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Basel	Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Celll Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	magdalena.goetz@gsf.de; yves.barde@unibas.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; AUBERT J, 2002, NAT BIOTECHNOL, V12, P1208; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; GOTZ M, 2005, IN PRESS NAT REV MOL; HACK M, 2005, IN PRESS NAT NEUROSC; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MORI T, 2005, IN PRESS CURRENT TOP, V69; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	27	218	221	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 5	2005	46	3					369	372		10.1016/j.neuron.2005.04.012	http://dx.doi.org/10.1016/j.neuron.2005.04.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882633	Bronze			2022-12-28	WOS:000229011400005
J	Sampath, AP; Strissel, KJ; Elias, R; Arshavsky, VY; McGinnis, JF; Chen, J; Kawamura, SU; Rleke, F; Hurley, JB				Sampath, AP; Strissel, KJ; Elias, R; Arshavsky, VY; McGinnis, JF; Chen, J; Kawamura, SU; Rleke, F; Hurley, JB			Recoverin improves rod-mediated vision by enhancing signal transmission in the mouse retina	NEURON			English	Article							SINGLE-PHOTON RESPONSES; CALCIUM-BINDING PROTEINS; BIPOLAR; PHOTORESPONSE; TRANSDUCIN; CELLS; PHOTOTRANSDUCTION; TRANSLOCATION; VARIABILITY; MECHANISMS	Vision in dim light requires that photons absorbed by rod photoreceptors evoke signals that reliably propagate through the retina. We investigated how a perturbation in rod physiology affects propagation of those signals in the retina and ultimately visual sensitivity. Recoverin is a protein in rods that prolongs phototransduction and enhances visual sensitivity. It is not present in neurons postsynaptic to rods, yet we found that light-evoked responses of rod bipolar and ganglion cells were shortened when measured in recoverin-deficient retinas. Unexpectedly, the effect of recoverin on postsynaptic signals could not be explained by its effect on phototransduction. Instead, it is an effect of recoverin downstream of phototransduction in rods that prolongs signal transmission and enhances visual sensitivity. An important implication of our findings is that the recovery phase of the rod photoresponse does not contribute significantly to visual sensitivity near absolute threshold.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Ophthalmol, Los Angeles, CA 90089 USA; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 5600043, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Southern California; Osaka University	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	jbhhh@u.washington.edu			NEI NIH HHS [R01 EY006641, EY12703, EY11850, EY12190, EY06641, EY14784, EY10336, EY13050] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012703, R01EY010336, F32EY014784, R01EY006641, R01EY011850, P30EY012190, R01EY013050] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; BARLOW HB, 1971, VISION RES, V23, P87; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1986, J PHYSIOL-LONDON, V371, P115, DOI 10.1113/jphysiol.1986.sp015964; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; HAYES JM, 1993, BEHAV GENET, V23, P395, DOI 10.1007/BF01067442; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; McGinnis JF, 1997, J NEUROSCI RES, V50, P487, DOI 10.1002/(SICI)1097-4547(19971101)50:3<487::AID-JNR15>3.0.CO;2-3; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; STERLING P, 1988, J NEUROSCI, V8, P623; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Walraven J., 1990, NEUROPHYSIOLOGICAL F, P53; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9	40	83	83	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 5	2005	46	3					413	420		10.1016/j.neuron.2005.04.006	http://dx.doi.org/10.1016/j.neuron.2005.04.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924WL	15882641	Bronze			2022-12-28	WOS:000229011400013
J	Rogan, MT; Leon, KS; Perez, DL; Kandel, ER				Rogan, MT; Leon, KS; Perez, DL; Kandel, ER			Distinct neural signatures for safety and danger in the amygdala and striatum of the mouse	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; FEAR-POTENTIATED STARTLE; INDUCED DOPAMINE RELEASE; PAVLOVIAN CONDITIONED INHIBITION; TONICALLY ACTIVE NEURONS; LONG-TERM DEPRESSION; LATERAL AMYGDALA; GENICULATE-BODY; LATENT INHIBITION; VENTRAL STRIATUM	The ability to identify, develop, and exploit conditions of safety and security is central to survival and mental health, but little is known of the neurobiology of these processes or associated positive modulations of affective state. We studied electrophysiological and affective correlates of learned safety by negatively correlating an auditory conditioned stimulus (CS) with aversive events (US). This CS came to signify a period of protection, reducing fear responses to predictors of the US and increasing adventurous exploration of a novel environment. In nonaversive conditions, mice turn on the CS when given the opportunity. Thus, conditioned safety involves a reduction of learned and instinctive fear, as well as positive affective responses. Concurrent electrophysiological measurements identified a safety learning-induced long-lasting depression of CS-evoked activity in the lateral nucleus of the amygdala, consistent with fear reduction, and an increase of CS-evoked activity in a region of the striatum involved in positive affect, euphoric responses, and reward.	Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Kavli Inst Brain Sci, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Rogan, MT (corresponding author), Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA.	mr522@columbia.edu; erk5@columbia.edu	Perez, David/AAB-6453-2020	Perez, David/0000-0003-2721-583X	NIMH NIH HHS [F32 MH 12752, P01 MH 06970] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012752] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CHAPMAN PF, 1990, SYNAPSE, V6, P271, DOI 10.1002/syn.890060306; CHUDLER EH, 1995, BRAIN RES, V674, P33, DOI 10.1016/0006-8993(94)01427-J; CLUGNET MC, 1990, J NEUROSCI, V10, P1055; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Coutureau E, 2001, BRAIN RES BULL, V56, P49, DOI 10.1016/S0361-9230(01)00592-5; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DENNY MR, 1991, FEAR AVOIDANCE PHOBI, P199; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; EDELINE JM, 1992, BEHAV NEUROSCI, V106, P81, DOI 10.1037/0735-7044.106.1.81; FALLS WA, 1995, BEHAV NEUROSCI, V109, P379, DOI 10.1037/0735-7044.109.3.379; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Fudge JL, 2004, J COMP NEUROL, V476, P330, DOI 10.1002/cne.20228; Fudge JL, 2002, J NEUROSCI, V22, P10078; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; Gewirtz JC, 1997, BEHAV NEUROSCI, V111, P712, DOI 10.1037/0735-7044.111.4.712; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Grillon C, 2001, PSYCHOPHYSIOLOGY, V38, P807, DOI 10.1111/1469-8986.3850807; Heinbockel T, 2000, J NEUROSCI, V20; Heldt SA, 2003, BEHAV BRAIN RES, V144, P175, DOI 10.1016/S0166-4328(03)00092-5; Heldt SA, 1998, BRAIN RES, V813, P274, DOI 10.1016/S0006-8993(98)01047-6; HENDRY DP, 1969, PSYCHONOMIC SOC, V9, P261; Holstege G, 2003, J NEUROSCI, V23, P9185; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; IWATA J, 1986, BRAIN RES, V383, P195, DOI 10.1016/0006-8993(86)90020-X; Josselyn SA, 2005, NEUROPSYCHOPHARMACOL, V30, P17, DOI 10.1038/sj.npp.1300530; Konorski J., 1967, INTEGRATIVE ACTIVITY; Lane RD, 1997, AM J PSYCHIAT, V154, P926; LEDOUX JE, 1987, J COMP NEUROL, V264, P123, DOI 10.1002/cne.902640110; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; LEUNG LW, 1990, NEUROMETHODS, V15, P227; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Linke R, 1999, EUR J NEUROSCI, V11, P187, DOI 10.1046/j.1460-9568.1999.00422.x; LOLORDO VM, 1969, PSYCHOL BULL, V72, P193, DOI 10.1037/h0027907; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; MASUDA Y, 1994, PHYSIOL BEHAV, V56, P785, DOI 10.1016/0031-9384(94)90243-7; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; MCINTOSH AR, 1994, J NEUROPHYSIOL, V72, P1717, DOI 10.1152/jn.1994.72.4.1717; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MOWRER OH, 1956, PSYCHOL REV, V63, P114, DOI 10.1037/h0040613; ODonnell P, 1996, NEUROPSYCHOPHARMACOL, V15, P87, DOI 10.1016/0893-133X(95)00177-F; OGAN MT, 2001, NEURAL MECH MEMORY F, P58; Pavlov I.P., 1927, CONDITIONED REFLEXES; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pederson CL, 1997, BRAIN RES, V760, P261, DOI 10.1016/S0006-8993(97)00395-8; PETERSON SL, 1986, INT J NEUROSCI, V29, P245, DOI 10.3109/00207458608986154; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001; PREMACK D, 1968, NATURE, V217, P288, DOI 10.1038/217288a0; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Ravel S, 2003, J NEUROSCI, V23, P8489; RESCORLA RA, 1971, J COMP PHYSIOL PSYCH, V75, P77, DOI 10.1037/h0030694; RESCORLA RA, 1969, PSYCHOL BULL, V72, P77, DOI 10.1037/h0027760; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Schauz C, 2000, LEARN MEMORY, V7, P393, DOI 10.1101/lm.33800; Schiller D, 2004, NEUROSCIENCE, V128, P15, DOI 10.1016/j.neuroscience.2004.06.020; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Tang JR, 2001, BRAIN RES, V919, P232, DOI 10.1016/S0006-8993(01)03020-7; THOMAS E, 1991, BRAIN RES, V547, P303, DOI 10.1016/0006-8993(91)90975-2; Waddell J, 2003, BEHAV BRAIN RES, V142, P115, DOI 10.1016/S0166-4328(02)00405-9; WALASEK G, 1995, ACTA NEUROBIOL EXP, V55, P121; Walker DL, 2002, PSYCHOPHARMACOLOGY, V159, P304, DOI 10.1007/s002130100913; Weinberger Norman M., 1995, P1071; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; WIERTELAK EP, 1994, BRAIN RES, V634, P214, DOI 10.1016/0006-8993(94)91924-0; WILLIAMS DA, 1992, PSYCHOL BULL, V111, P275, DOI 10.1037/0033-2909.111.2.275; YADIN E, 1981, J COMP PHYSIOL PSYCH, V95, P331, DOI 10.1037/h0077769	82	161	162	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 21	2005	46	2					309	320		10.1016/j.neuron.2005.02.017	http://dx.doi.org/10.1016/j.neuron.2005.02.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920FM	15848808	Bronze			2022-12-28	WOS:000228674800016
J	Blitz, DM; Regehr, WG				Blitz, DM; Regehr, WG			Timing and specificity of feed-forward inhibition within the LGN	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; RELAY CELLS; POSTSYNAPTIC POTENTIALS; RETINOGENICULATE SYNAPSE; DENDRITIC OUTPUTS; THALAMIC NEURONS; PYRAMIDAL CELLS; RECEPTIVE-FIELD; NATURAL SCENES	Local interneurons provide feed-forward inhibition from retinal ganglion cells (RGCs) to thalamocortical (TC) neurons, but questions remain regarding the timing, magnitude, and functions of this inhibition. Here, we identify two types of inhibition that are suited to play distinctive roles. We recorded excitatory and inhibitory postsynaptic currents (EPSCs/IPSCs) in TC neurons in mouse brain slices and activated individual RGC inputs. In 34% of TC neurons, we identified EPSCs and IPSCs with identical thresholds that were tightly correlated, indicating activation by the same RGC. Such "locked" IPSCs occurred 1 ms after EPSC onset. The remaining neurons had only "nonlocked" inhibition, in which EPSCs and IPSCs had different thresholds, indicating activation by different RGCs. Nonlocked inhibition may refine receptive fields within the LGN by providing surround inhibition. In contrast, dynamic-clamp recordings suggest that locked inhibition improves the precision of synaptically evoked responses in individual TC neurons by eliminating secondary spikes.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NINDS NIH HHS [R01-NS432405] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BERARDI N, 1984, J PHYSIOL-LONDON, V357, P505, DOI 10.1113/jphysiol.1984.sp015514; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; CRUNELLI V, 1988, J PHYSIOL-LONDON, V399, P153; Dan Y, 1996, J NEUROSCI, V16, P3351; DOSSI RC, 1992, NEUROSCIENCE, V47, P279, DOI 10.1016/0306-4522(92)90244-V; Godwin DW, 1996, J NEUROSCI, V16, P8181; Govindaiah, 2004, NEURON, V41, P611, DOI 10.1016/S0896-6273(04)00013-3; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; HAMORI J, 1974, BRAIN RES, V80, P379, DOI 10.1016/0006-8993(74)91024-5; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; HIRSCH JC, 1987, NEUROSCIENCE, V23, P457, DOI 10.1016/0306-4522(87)90069-8; HOLDEFER RN, 1989, BRAIN RES, V488, P341, DOI 10.1016/0006-8993(89)90727-0; Hu B, 2000, BRAIN RES, V885, P87, DOI 10.1016/S0006-8993(00)02946-2; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KUFFLER SW, 1957, J GEN PHYSIOL, V40, P683, DOI 10.1085/jgp.40.5.683; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; NORTON TT, 1992, PROG BRAIN RES, V90, P193; NORTON TT, 1989, BRAIN RES, V488, P348, DOI 10.1016/0006-8993(89)90728-2; OHARA PT, 1983, NEUROSCIENCE, V8, P189, DOI 10.1016/0306-4522(83)90060-X; PARE D, 1991, J NEUROPHYSIOL, V66, P1190, DOI 10.1152/jn.1991.66.4.1190; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 2001, CURR OPIN NEUROBIOL, V11, P437, DOI 10.1016/S0959-4388(00)00231-2; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F., 1997, SPIKES EXPLORING NEU; Ruksenas O, 2000, VISUAL NEUROSCI, V17, P855, DOI 10.1017/S0952523800176059; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; SOLTESZ I, 1992, PROG BRAIN RES, V90, P151; STANFORD LR, 1987, J NEUROPHYSIOL, V57, P218, DOI 10.1152/jn.1987.57.1.218; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Steriade M, 1997, THALAMUS, VI; STONE J, 1974, J NEUROPHYSIOL, V37, P722, DOI 10.1152/jn.1974.37.4.722; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; TROY JB, 1994, VISUAL NEUROSCI, V11, P111, DOI 10.1017/S0952523800011159; Ulrich D, 1997, J NEUROSCI, V17, P2348; Usrey WM, 2002, PHILOS T ROY SOC B, V357, P1729, DOI 10.1098/rstb.2002.1157; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Ziburkus J, 2003, J NEUROPHYSIOL, V90, P1063, DOI 10.1152/jn.00178.2003	61	108	109	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					917	928		10.1016/j.neuron.2005.01.033	http://dx.doi.org/10.1016/j.neuron.2005.01.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797552	Bronze			2022-12-28	WOS:000228031300012
J	Singh, KK; Miller, FD				Singh, KK; Miller, FD			Activity regulates positive and negative neurotrophin-derived signals to determine axon competition	NEURON			English	Article							SUPERIOR CERVICAL-GANGLION; SYMPATHETIC NEURONS; NEUROMUSCULAR-JUNCTION; LOCAL-CONTROL; CA2+ INFLUX; INNERVATION; GROWTH; ACTIVATION; DEPOLARIZATION; RECEPTORS	Developmental axon competition plays a key role in sculpting neural circuitry. Here, we have asked how activity and neurotrophins could interact to select one axon over another. Using compartmented cultures of sympathetic neurons, we show that,. in the presence of NGF, local depolarization confers a competitive growth advantage on the depolarized axon collaterals and at the same time disadvantages the growth of unstimulated axons from the same and competing neurons. Depolarization mediates the competitive advantage by activating a CaMKII-MEK pathway, which converges to enhance local NGF-mediated downstream growth signals. Patterned electrical stimulation also acts via this pathway to enhance NGF-promoted axonal growth. In contrast, the competitive disadvantage is due to BDNF secreted from and acting on the unstimulated, competing axons through p75NTR. Thus, activity regulates both positive and negative wneurotrophin-derived signaling cascades to confer a competitive growth advantage on one axon versus another, thereby providing a cellular mechanism for developmental axon selection.	Univ Toronto, Hosp Sick Children, Dept Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Miller, FD (corresponding author), Univ Toronto, Hosp Sick Children, Dept Dev Biol, 100 Coll St, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca						Aloyz R, 1999, LEARN MEMORY, V6, P216; [Anonymous], [No title captured]; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Balkowiec A, 2002, J NEUROSCI, V22, P10399; BLACK IB, 1976, BRAIN RES, V101, P503, DOI 10.1016/0006-8993(76)90474-1; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; CAMPENOT RB, 1984, BRAIN RES, V293, P159, DOI 10.1016/0006-8993(84)91463-X; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Fawcett JP, 1997, J BIOL CHEM, V272, P8837; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HILL CE, 1989, INT J DEV NEUROSCI, V7, P539, DOI 10.1016/0736-5748(89)90013-0; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; KANTOR DB, 2000, CURR OPIN NEUROBIOL, V10, P381; Kohn J, 1999, J NEUROSCI, V19, P5393; LAWRENCE JM, 1979, BRAIN RES, V168, P13, DOI 10.1016/0006-8993(79)90124-0; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lomeli J, 1998, NATURE, V395, P600, DOI 10.1038/26975; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUBIN E, 1985, J NEUROSCI, V5, P685; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SPIRA ME, 1983, DEV BRAIN RES, V8, P311, DOI 10.1016/0165-3806(83)90014-7; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VIDOVIC M, 1987, DEV BRAIN RES, V32, P133, DOI 10.1016/0165-3806(87)90146-5; VIDOVIC M, 1988, J AUTONOM NERV SYST, V22, P57, DOI 10.1016/0165-1838(88)90154-3; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; YAROM Y, 1983, DEV BRAIN RES, V8, P321, DOI 10.1016/0165-3806(83)90015-9	41	61	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2005	45	6					837	845		10.1016/j.neuron.2005.01.049	http://dx.doi.org/10.1016/j.neuron.2005.01.049			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911UO	15797546	Bronze			2022-12-28	WOS:000228031300006
J	Tolias, KF; Bikoff, JB; Burette, A; Paradis, S; Harrar, D; Tavazoie, S; Weinberg, RJ; Greenberg, ME				Tolias, KF; Bikoff, JB; Burette, A; Paradis, S; Harrar, D; Tavazoie, S; Weinberg, RJ; Greenberg, ME			The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines	NEURON			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; PROTEIN-KINASE B; RHO-GTPASES; PHOSPHATIDYLINOSITOL 3-KINASE; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; IN-VIVO; MAMMALIAN-CELLS	NMDA-type glutamate receptors play a critical role in the activity-dependent development and structural remodeling of dendritic arbors and spines. However, the molecular mechanisms that link NMDA receptor activation to changes in dendritic morphology remain unclear. We report that the Rac1-GEF Tiam1 is present in dendrites and spines and is required for their development. Tiam1 interacts with the NMDA receptor and is phosphorylated in a calcium-dependent manner in response to NMDA receptor stimulation. Blockade of Tiam1 function with RNAi and dominant interfering mutants of Tiam1 suggests that Tiam1 mediates effects of the NMDA receptor on dendritic development by inducing Rac1-dependent actin remodeling and protein synthesis. Taken together, these findings define a molecular mechanism by which NMDA receptor signaling controls the growth and morphology of dendritic arbors and spines.	Harvard Univ, Sch Med, Neurobiol Program, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Neurobiol Program, Childrens Hosp, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu	Weinberg, Richard/AAC-1898-2020; Bikoff, Jay/N-8107-2018	Harrar, Dana/0000-0001-6382-8479; Tolias, Kimberley/0000-0002-2092-920X; Weinberg, Richard/0000-0001-9689-7278	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044306, R01NS045500, R01NS039444] Funding Source: NIH RePORTER; NICHD NIH HHS [P30-HD18655] Funding Source: Medline; NINDS NIH HHS [R01 NS045500, NS-44306, NS-04550, NS-07484, NS-39444] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cantrell DA, 2001, J CELL SCI, V114, P1439; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Garcia-Gallo M, 2001, BIOCHEM J, V356, P539, DOI 10.1042/0264-6021:3560539; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Goldin M, 2001, J NEUROSCI, V21, P186, DOI 10.1523/JNEUROSCI.21-01-00186.2001; Gomez LL, 2002, J NEUROSCI, V22, P7027; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Guo X, 2001, J NEUROBIOL, V48, P120, DOI 10.1002/neu.1046; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim CH, 1999, J NEUROSCI, V19, P4314; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; SHOLL DA, 1953, J ANAT, V87, P387; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773	84	284	291	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					525	538		10.1016/j.neuron.2005.01.024	http://dx.doi.org/10.1016/j.neuron.2005.01.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721239	Green Published, Bronze			2022-12-28	WOS:000227099700009
J	Betts, LR; Taylor, CP; Sekuler, AB; Bennett, PJ				Betts, LR; Taylor, CP; Sekuler, AB; Bennett, PJ			Aging reduces center-surround antagonism in visual motion processing	NEURON			English	Article							MACAQUE V1 NEURONS; CLASSICAL RECEPTIVE-FIELD; MINI-MENTAL-STATE; PRIMATE AREA MT; AGE; CORTEX; CELLS; INHIBITION; PERCEPTION; DISPARITY	Discriminating the direction of motion of a low-contrast pattern becomes easier with increasing stimulus area. However, increasing the size of a high-contrast pattern makes it more difficult for observers to discriminate motion. This surprising result, termed spatial suppression, is thought to be mediated by a form of center-surround suppression found throughout the visual pathway. Here, we examine the counterintuitive hypothesis that aging alters such center-surround interactions in ways that improve performance in some tasks. We found that older observers required briefer stimulus durations than did younger observers to extract information about stimulus direction in conditions using large, high-contrast patterns. We suggest that this age-related improvement in motion discrimination may be linked to reduced GABAergic functioning in the senescent brain, which reduces center-surround suppression in motion-selective neurons.	McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; CIHR, Training Program Commun & Social Interact Hlth Ag, Mississauga, ON L5L 1C6, Canada; CIHR, Grp Sensory Cognit Aging, Mississauga, ON L5L 1C6, Canada; York Univ, Ctr Vis Res, N York, ON M3J 1P3, Canada	McMaster University; York University - Canada	Sekuler, AB (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.	sekuler@mcmaster.ca; bennett@mcmaster.ca	Taylor, Christopher/W-1808-2019	Taylor, Christopher/0000-0002-6592-6328				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Bair W, 2003, J NEUROSCI, V23, P7690; BALL K, 1986, J GERONTOL, V41, P176, DOI 10.1093/geronj/41.2.176; Bennett PJ, 1999, J OPT SOC AM A, V16, P654, DOI 10.1364/JOSAA.16.000654; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Bradley DC, 1998, J NEUROSCI, V18, P7552; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Caspary DM, 1999, NEUROSCIENCE, V93, P307, DOI 10.1016/S0306-4522(99)00121-9; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Lund JS, 1995, J ANAT, V187, P563; Norman JF, 2000, PERCEPTION, V29, P1335, DOI 10.1068/p3111; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pernberg J, 1998, EUR J NEUROSCI, V10, P3596, DOI 10.1046/j.1460-9568.1998.00364.x; Poe BH, 2001, J COMP NEUROL, V439, P65, DOI 10.1002/cne.1335; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Sekuler AB, 2000, EXP AGING RES, V26, P103, DOI 10.1080/036107300243588; Sekuler R., 2000, OXFORD TXB GERIATRIC, P874; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Solomon SG, 2002, J NEUROSCI, V22, P338, DOI 10.1523/JNEUROSCI.22-01-00338.2002; Stanley DP, 2004, J NEUROCHEM, V89, P204, DOI 10.1111/j.1471-4159.2004.02318.x; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Weale R. A., 1992, SENESCENCE HUMAN VIS; WEALE RA, 1961, T ILLUMINATING ENG S, V26, P95, DOI DOI 10.1177/147715356102600204; Wist ER, 2000, EXP BRAIN RES, V134, P295, DOI 10.1007/s002210000466	39	187	189	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 3	2005	45	3					361	366		10.1016/j.neuron.2004.12.041	http://dx.doi.org/10.1016/j.neuron.2004.12.041			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	894JP	15694323	Bronze			2022-12-28	WOS:000226787700009
J	Cai, J; Qi, YC; Hu, XM; Tan, M; Liu, ZJ; Zhang, JS; Li, Q; Sander, M; Qiu, M				Cai, J; Qi, YC; Hu, XM; Tan, M; Liu, ZJ; Zhang, JS; Li, Q; Sander, M; Qiu, M			Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling	NEURON			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; VENTRAL NEURAL-TUBE; SONIC HEDGEHOG; MOTOR-NEURON; PROGENITOR-CELL; GENE-EXPRESSION; VERTEBRATE CNS; FACTOR OLIG2; DIFFERENTIATION; LINEAGE	In the developing spinal cord, early progenitor cells of the oligodendrocyte lineage are induced in the motor neuron progenitor (pMN) domain of the ventral neuroepithelium by the ventral midline signal Sonic hedgehog (Shh). The ventral generation of oligodendrocytes requires Nkx6-regulated expression of the bHLH gene Olig2 in this domain. In the absence of Nkx6 genes or Shh signaling, the initial expression of Olig2 in the pMN domain is completely abolished. In this study, we provide the in vivo evidence for a late phase of Olig gene expression independent of Nkx6 and Shh gene activities and reveal a brief second wave of oligodendrogenesis in the dorsal spinal cord. In addition, we provide genetic evidence that oligodendrogenesis can occur in the absence of hedgehog receptor Smoothened, which is essential for all hedgehog signaling.	Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Louisville; University of California System; University of California Irvine	Qiu, M (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	m0qiu001@louisville.edu	Messier, Claude/A-2322-2008; Sander, Maike/N-6615-2016	Messier, Claude/0000-0002-4791-1763; Sander, Maike/0000-0001-5308-7785; Liu, Zijing/0000-0001-7790-0590; /0000-0003-1721-7786	NINDS NIH HHS [NS37717] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037717] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 1999, DEV DYNAM, V216, P459, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<459::AID-DVDY14>3.3.CO;2-Z; Cai J, 2001, MOL CELL BIOL, V21, P4399, DOI 10.1128/MCB.21.13.4399-4403.2001; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; CHIANG C, 1996, NATURE, V383, P228; Davies JE, 2001, DEV BIOL, V233, P513, DOI 10.1006/dbio.2001.0224; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; Fu H, 2002, DEVELOPMENT, V129, P681; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gregori N, 2002, J NEUROSCI, V22, P248, DOI 10.1523/JNEUROSCI.22-01-00248.2002; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liu RG, 2003, DEVELOPMENT, V130, P6221, DOI 10.1242/dev.00868; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Qi YC, 2003, MOL CELL NEUROSCI, V23, P440, DOI 10.1016/S1044-7431(03)00067-8; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Spassky N, 2000, GLIA, V29, P143, DOI 10.1002/(SICI)1098-1136(20000115)29:2<143::AID-GLIA7>3.3.CO;2-4; Stiles CD, 2003, NEURON, V40, P447, DOI 10.1016/S0896-6273(03)00683-4; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Sussman CR, 2000, J NEUROSCI RES, V59, P413, DOI 10.1002/(SICI)1097-4547(20000201)59:3<413::AID-JNR16>3.3.CO;2-7; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Xu XH, 2000, MOL CELL NEUROSCI, V16, P740, DOI 10.1006/mcne.2000.0916; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	56	249	258	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					41	53		10.1016/j.neuron.2004.12.028	http://dx.doi.org/10.1016/j.neuron.2004.12.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629701	Bronze			2022-12-28	WOS:000226217100008
J	Philips, H				Philips, H			Brainstorming	NEURON			English	Article																			0	1	1	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2		S			2	5						4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866TN	15617359				2022-12-28	WOS:000224796300001
J	Chang, QA; Khare, G; Dani, V; Nelson, S; Jaenisch, R				Chang, QA; Khare, G; Dani, V; Nelson, S; Jaenisch, R			The disease progression mutant mice is affected of Mecp2 by the level of BDNF expression	NEURON			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; TRANSCRIPTIONAL REPRESSOR; MOUSE MODEL; NEUROTROPHIC FACTOR; METHYLATED DNA; CNS NEURONS; SURVIVAL; MUTATIONS; CHROMATIN	Mutations in the MECP2 gene cause Rett syndrome (RTT). Bdnf is a MeCP2 target gene; however, its role in RTT pathogenesis is unknown. We examined Bdnf conditional mutant mice for RTT-relevant pathologies and observed that loss of BDNF caused smaller brain size, smaller CA2 neurons, smaller glomerulus size, and a characteristic hindlimb-clasping phenotype. BDNF protein level was reduced in Mecp2 mutant mice, and deletion of Bdnf in Mecp2 mutants caused an earlier onset of RTT-like symptoms. To assess whether this interaction was functional and potentially therapeutically relevant, we increased BDNF expression in the Mecp2 mutant brain with a conditional Bdnf transgene. BDNF overexpression extended the lifespan, rescued a locomotor defect, and reversed an electrophysiological deficit observed in Mecp2 mutants. Our results provide in vivo evidence for a functional interaction between Mecp2and Bdnf and demonstrate the physiological significance of altered BDNF expression/signaling in RTT disease progression.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Brandeis University; Brandeis University	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Nelson, Sacha/0000-0002-0108-8599	NATIONAL CANCER INSTITUTE [R01CA087869] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA087869] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; BEARD C, 2005, IN PRESS GENESIS; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Cepeda C, 2004, J NEUROSCI RES, V78, P855, DOI 10.1002/jnr.20344; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Matarazzo V, 2004, MOL CELL NEUROSCI, V27, P44, DOI 10.1016/j.mcn.2004.05.005; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shieh PB, 1999, J NEUROBIOL, V41, P127, DOI 10.1002/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	37	425	450	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 2	2006	49	3					341	348		10.1016/j.neuron.2005.12.027	http://dx.doi.org/10.1016/j.neuron.2005.12.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011IF	16446138	Bronze			2022-12-28	WOS:000235260900006
J	Piper, M; Anderson, R; Dwivedy, A; Weinl, C; van Horck, F; Leung, KM; Cogill, E; Holt, C				Piper, M; Anderson, R; Dwivedy, A; Weinl, C; van Horck, F; Leung, KM; Cogill, E; Holt, C			Signaling mechanisms underlying Slit2-induced collapse of Xenopus retinal growth cones	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; ACTIN MESSENGER-RNA; AXON GUIDANCE; HEPARAN-SULFATE; ROUNDABOUT RECEPTOR; TYROSINE KINASE; VISUAL-SYSTEM; LIM-KINASE; F-ACTIN; ENDOCYTOSIS	Slits mediate multiple axon guidance decisions, but the mechanisms underlying the responses of growth cones to these cues remain poorly defined. We show here that collapse induced by Slit2-conditioned medium (Slit2-CM) in Xenopus retinal growth cones requires local protein synthesis (PS) and endocytosis. Slit2-CM elicits rapid activation of translation regulators and MAP kinases in growth cones, and inhibition of MAPKs or disruption of heparan sulfate blocks Slit2-CM-induced PS and repulsion. Interestingly, Slit2-CM causes a fast PS-dependent decrease in cytoskeletal F-actin concomitant with a PS-dependent increase in the actin-depolymerizing protein cofilin. Our findings reveal an unexpected link between Slit2 and cofilin in growth cones and suggest that local translation of actin regulatory proteins contributes to repulsion.	Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge	Holt, C (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England.	ceh@mole.bio.cam.ac.uk	Piper, Michael J/B-2805-2010	Piper, Michael J/0000-0002-6759-2560; Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Agnes F, 2004, NEUROREPORT, V15, P2567; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bassell GJ, 1998, J NEUROSCI, V18, P251; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Erskine L, 2000, J NEUROSCI, V20, P4975; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Irie A, 2002, DEVELOPMENT, V129, P61; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Keynes R, 1997, NEURON, V18, P889, DOI 10.1016/S0896-6273(00)80329-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Niclou SP, 2000, J NEUROSCI, V20, P4962; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Walz A, 1997, DEVELOPMENT, V124, P2421; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Wong EV, 2004, J NEUROBIOL, V59, P66, DOI 10.1002/neu.10342; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zakharenko S, 2000, NEUROSCIENCE, V97, P185, DOI 10.1016/S0306-4522(00)00022-1; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	68	222	227	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 19	2006	49	2					215	228		10.1016/j.neuron.2005.12.008	http://dx.doi.org/10.1016/j.neuron.2005.12.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007OV	16423696	Green Accepted, Bronze			2022-12-28	WOS:000234979900009
J	Landsberg, RL; Awatramani, RB; Hunter, NL; Farago, AF; DiPietrantonio, HJ; Rodriguez, CI; Dymecki, SM				Landsberg, RL; Awatramani, RB; Hunter, NL; Farago, AF; DiPietrantonio, HJ; Rodriguez, CI; Dymecki, SM			Hindbrain rhombic lip is comprised of discrete progenitor cell populations allocated by Pax6	NEURON			English	Article							DORSAL SPINAL-CORD; NEURAL-TUBE; ROOF PLATE; MEDULLA-OBLONGATA; FLP-RECOMBINASE; MATH1 EXPRESSION; NEURONAL FATES; GENE; MOUSE; CNS	The lower rhombic lip (LRL) is a germinal zone in the dorsal hindbrain productive of tangentially migrating neurons, streaming extramurally (mossy fiber neurons) or intramurally (climbing fiber neurons). Here we show that LRL territory, operationally defined by Wnt1 expression, is parceled into molecular subdomains predictive of cell fate. Progressing dorsoventrally, Lmx1a and Gdf7 expression identifies the primordium for hindbrain choroid plexus epithelial cells; Math 1, for mossy fiber neurons; and immediately ventral to Math1 yet within Wnt1(+)territory, a climbing fiber primordium dominated by Ngn1-expressing cells. Elimination of Pax6 results in expansion of this Ngn1(+) progenitor pool and reduction in the Math1(+) pool, with accompanying later enlargement of the climbing fiber nucleus and reductions in mossy fiber nuclei. Pax6 loss also disrupts Msx expression cell-nonautonomously, suggesting Pax6 may influence LRL progenitor identity indirectly through potentiating BMP signaling. These studies suggest that underlying the diversity and proportions of fates produced by the LRL is a precise suborganization regulated by Pax6.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu	Rodriguez, Carolyn I/K-8479-2014	Rodriguez, Carolyn I/0000-0001-6697-1692	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD049320, R01HD051936] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F31HG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY12196] Funding Source: Medline; NHGRI NIH HHS [F31 HG000180] Funding Source: Medline; NICHD NIH HHS [P01 HD036379, F31 HD049320, R01 HD051936] Funding Source: Medline; NIDDK NIH HHS [R21 DK618021, R01 DK067826] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMAN J, 1987, J COMP NEUROL, V257, P477, DOI 10.1002/cne.902570402; Ambrosiani J, 1996, NEUROREPORT, V7, P1285, DOI 10.1097/00001756-199605170-00013; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Belluardo N, 1997, J COMP NEUROL, V379, P226; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Cambronero F, 2000, J COMP NEUROL, V427, P522, DOI 10.1002/1096-9861(20001127)427:4<522::AID-CNE3>3.0.CO;2-Y; Chesnutt C, 2004, DEV BIOL, V274, P334, DOI 10.1016/j.ydbio.2004.07.019; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; DYMECKI SM, 2000, SITE SPECIFIC RECOMB; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; ELLENBERGER C, 1969, J COMP NEUROL, V137, P71, DOI 10.1002/cne.901370105; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Essick CR, 1912, AM J ANAT, V13, P25, DOI 10.1002/aja.1000130103; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Foletti DL, 2001, J NEUROSCI, V21, P5461, DOI 10.1523/JNEUROSCI.21-15-05461.2001; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Helms AW, 2000, DEVELOPMENT, V127, P1185; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; His W., 1891, ABHANDLUNGEN KONI MP, V29, P1; Horie M, 2003, EUR J NEUROSCI, V17, P49, DOI 10.1046/j.1460-9568.2003.02424.x; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Hunter NL, 2005, GENESIS, V41, P99, DOI 10.1002/gene.20101; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Liu Y, 2004, DEVELOPMENT, V131, P1017, DOI 10.1242/dev.00994; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Millen KJ, 2004, DEV BIOL, V270, P382, DOI 10.1016/j.ydbio.2004.03.008; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Osumi N, 1997, DEVELOPMENT, V124, P2961; ROBERTS RC, 1967, GENET RES, V9, P121, DOI 10.1017/S0016672300010387; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TABERPIERCE E, 1966, J COMP NEUROL, V126, P219; TAN K, 1991, ANAT EMBRYOL, V183, P321; Timmer JR, 2002, DEVELOPMENT, V129, P2459; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	64	111	112	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 22	2005	48	6					933	947		10.1016/j.neuron.2005.11.031	http://dx.doi.org/10.1016/j.neuron.2005.11.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16364898	Bronze			2022-12-28	WOS:000234301700010
J	Xie, Z; Huganir, RL; Penzes, P				Xie, Z; Huganir, RL; Penzes, P			Activity-dependent dendritic spine structural plasticity is regulated by small GTPase Rap1 and its target AF-6	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; BINDING PROTEIN; SILENT SYNAPSES; ACTIVATION; DYNAMICS; RAS; DOMAIN; GEF	Activity-dependent remodeling of dendritic spines is essential for neural circuit development and synaptic plasticity, but the mechanisms that coordinate synaptic structural and functional plasticity are not well understood. Here we investigate the signaling pathways that enable excitatory synapses to undergo activity-dependent structural modifications. We report that activation of NMDA receptors in cultured cortical neurons induces spine morphogenesis and activation of the small GTPase Rap1. Rap1 bimodally regulates spine morphology: activated Rap1 recruits the PDZ domain-containing protein AF-6 to the plasma membrane and induces spine neck elongation, while inactive Rap1 dissociates AF-6 from the membrane and induces spine enlargement. Rap1 also regulates spine content of AMPA receptors: thin spines induced by Rap1 activation have reduced GluR1-containing AMPA receptor content, while large spines induced by Rap1 inactivation are rich in AMPA receptors. These results identify a signaling pathway that regulates activity-dependent synaptic structural plasticity and coordinates it with functional plasticity.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Penzes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016; Xie, Zhong/B-6829-2011	Penzes, Peter/0000-0001-5449-1640; Xie, Zhong/0000-0002-8348-4455				Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Imamura Y, 2003, NEUROREPORT, V14, P1203, DOI 10.1097/00001756-200307010-00003; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wong WT, 2000, J NEUROSCI, V20, P5024; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	61	90	91	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 23	2005	48	4					605	618		10.1016/j.neuron.2005.09.027	http://dx.doi.org/10.1016/j.neuron.2005.09.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989MF	16301177	Bronze			2022-12-28	WOS:000233677300014
J	Barnabe-Heider, F; Wasylnka, JA; Fernandes, KJL; Porsche, C; Sendtner, M; Kaplan, DR; Miller, FD				Barnabe-Heider, F; Wasylnka, JA; Fernandes, KJL; Porsche, C; Sendtner, M; Kaplan, DR; Miller, FD			Evidence that embryonic the onset of cortical neurons regulate gliogenesis via cardiotrophin-1	NEURON			English	Article							LEUKEMIA INHIBITORY FACTOR; FETAL NEUROEPITHELIAL CELLS; ASTROCYTE DIFFERENTIATION; FACTOR-RECEPTOR; RAT-BRAIN; DEVELOPMENTAL-CHANGES; NERVOUS-SYSTEM; STEM-CELLS; GLIAL FATE; EXPRESSION	Precursor cells of the embryonic cortex sequentially generate neurons and then glial cells, but the mechanisms regulating this neurogenic-to-gliogenic transition are unclear. Using cortical precursor cultures, which temporally mimic this in vivo differentiation pattern, we demonstrate that cortical neurons synthesize and secrete the neurotrophic cytokine cardiotrophin-1, which activates the gp130-JAK-STAT pathway and is essential for the timed genesis of astrocytes in vitro. Our data indicate that a similar phenomenon also occurs in vivo. In utero electroporation of neurotrophic cytokines in the environment of embryonic cortical precursors causes premature gliogenesis, while acute perturbation of gp130 in cortical precursors delays the normal timed appearance of astrocytes. Moreover, the neonatal cardiotrophin-1(-l-) cortex contains fewer astrocytes. Together, these results describe a neural feedback mechanism; newly born neurons produce cardiotrophin-1, which instructs multipotent cortical precursors to generate astrocytes, thereby ensuring that gliogenesis does not occur until neurogenesis is largely complete.	Hosp Sick Children, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Physiol, Toronto, ON M5G 1X8, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Univ Wurzburg, Inst Clin Neurobiol, D-97080 Wurzburg, Germany	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; University of Wurzburg	Miller, FD (corresponding author), Hosp Sick Children, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974				Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Barres BA, 1996, MOL CELL NEUROSCI, V8, P146, DOI 10.1006/mcne.1996.0053; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Chen J, 2004, INVEST OPHTH VIS SCI, V45, P3538, DOI 10.1167/iovs.04-0393; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Jiang JJ, 2003, J GENE MED, V5, P977, DOI 10.1002/jgm.433; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Lemke R, 1996, NEUROSCI LETT, V215, P205, DOI 10.1016/S0304-3940(96)12986-4; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Martin A, 2003, J NEUROSCI, V23, P5416; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Morrow T, 2001, DEVELOPMENT, V128, P3585; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ochiai W, 2001, CYTOKINE, V14, P264, DOI 10.1006/cyto.2001.0883; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Raff M, 2001, NOVART FDN SYMP, V237, P100, DOI 10.1002/0470846666.ch9; Rajan P, 1998, J NEUROSCI, V18, P3620; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; SCHINELLI S, 1994, MOL BRAIN RES, V21, P162, DOI 10.1016/0169-328X(94)90389-1; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Sheng ZL, 1996, DEVELOPMENT, V122, P419; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Toma JG, 2000, J NEUROSCI, V20, P7648; Uemura A, 2002, CYTOKINE, V18, P1, DOI 10.1006/cyto.2002.1006; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; WARE CB, 1995, DEVELOPMENT, V121, P1283	44	249	254	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					253	265		10.1016/j.neuron.2005.08.037	http://dx.doi.org/10.1016/j.neuron.2005.08.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242406	Bronze			2022-12-28	WOS:000232838700015
J	Kayser, C; Petkov, CI; Augath, M; Logothetis, NK				Kayser, C; Petkov, CI; Augath, M; Logothetis, NK			Integration of touch and sound in auditory cortex	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; MULTISENSORY INTEGRATION; MACAQUE MONKEYS; RHESUS-MONKEY; RESPONSE PROPERTIES; VISUAL SPEECH; HUMAN BRAIN; AUDIOTACTILE INTERACTION; CORTICAL CONNECTIONS; ASSOCIATION CORTEX	To form a coherent percept of the environment, our brain combines information from different senses. Such multisensory integration occurs in higher association cortices; but supposedly, it also occurs in early sensory areas. Confirming the latter hypothesis, we unequivocally demonstrate supra-additive integration of touch and sound stimulation at the second stage of the auditory cortex. Using high-resolution fMRI of the macaque monkey, we quantified the integration of auditory broad-band noise and tactile stimulation of hand and foot in anaesthetized animals. Integration was found posterior to and along the lateral side of the primary auditory cortex in the caudal auditory belt. Integration was stronger for temporally coincident stimuli and obeyed the principle of inverse effectiveness: greater enhancement for less effective stimuli. These findings demonstrates that multisensory integration occurs early and close to primary sensory areas and-because it occurs in anaesthetized animals-suggests that this integration is mediated by preattentive bottom-up mechanisms.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Kayser, C (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	christoph.kayser@tuebingen.mpg.de	Kayser, Christoph/A-3203-2012; Petkov, Christopher/O-5318-2015; Logothetis, Nikos/U-9282-2019	Kayser, Christoph/0000-0001-7362-5704; Petkov, Christopher/0000-0002-4932-7907; 				AKBARIAN S, 1994, J COMP NEUROL, V339, P421, DOI 10.1002/cne.903390309; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Calvert G., 2004, HDB MULTISENSORY PRO; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Falchier A, 2002, J NEUROSCI, V22, P5749; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Foxe JJ, 2005, NEUROREPORT, V16, P419, DOI 10.1097/00001756-200504040-00001; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Fu KMG, 2004, J NEUROPHYSIOL, V92, P3522, DOI 10.1152/jn.01228.2003; Fu KMG, 2003, J NEUROSCI, V23, P7510; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gobbele R, 2003, NEUROIMAGE, V20, P503, DOI 10.1016/S1053-8119(03)00312-4; GORDON B, 1973, J NEUROPHYSIOL, V36, P157, DOI 10.1152/jn.1973.36.2.157; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Heinke W, 2001, ANESTHESIOLOGY, V94, P973, DOI 10.1097/00000542-200106000-00010; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; HYVARINEN J, 1979, BRAIN RES, V169, P561, DOI 10.1016/0006-8993(79)90404-9; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kosaki H, 1997, J COMP NEUROL, V386, P304; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Lederman SJ, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P97, DOI 10.1109/HAPTIC.2002.998946; LEDERMAN SJ, 1979, PERCEPTION, V8, P93, DOI 10.1068/p080093; LEINONEN L, 1980, ACTA PHYSIOL SCAND, V108, P381, DOI 10.1111/j.1748-1716.1980.tb06547.x; Levanen S, 1998, CURR BIOL, V8, P869, DOI 10.1016/S0960-9822(07)00348-X; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Lutkenhoner B, 2002, NEUROIMAGE, V15, P509, DOI 10.1006/nimg.2001.0991; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLSON CR, 1980, NATURE, V288, P479, DOI 10.1038/288479a0; Ortigue S, 2005, NEUROREPORT, V16, P865, DOI 10.1097/00001756-200505310-00017; Padberg J, 2003, J COMP NEUROL, V467, P418, DOI 10.1002/cne.10932; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; RIZZOLATTI G, 1981, BRAIN RES, V225, P421, DOI 10.1016/0006-8993(81)90847-7; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Sherk H, 1986, CEREBRAL CORTEX, V5; Spence C, 2000, NEUROREPORT, V11, P2057, DOI 10.1097/00001756-200006260-00049; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; Stein BE., 1993, MERGING SENSES; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4	76	255	260	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2005	48	2					373	384		10.1016/j.neuron.2005.09.018	http://dx.doi.org/10.1016/j.neuron.2005.09.018			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977YF	16242415	Bronze			2022-12-28	WOS:000232838700024
J	Zimmer, U; Macaluso, E				Zimmer, U; Macaluso, E			High binaural coherence determines successful sound localization and increased activity in posterior auditory areas	NEURON			English	Article							INTERAURAL CORRELATION; VOLUME MEASUREMENT; COMPLEX SOUNDS; HUMAN BRAIN; CORTEX; FMRI; SENSITIVITY; PERCEPTION; HUMANS; MONKEY	Our brain continuously receives complex combinations of sounds originating from different sources and relating to different events in the external world. Timing differences between the two ears can be used to localize sounds in space, but only when the inputs to the two ears have similar spectrotemporal profiles (high binaural coherence). We used fMRI to investigate any modulation of auditory responses by binaural coherence. We assessed how processing of these cues depends on whether spatial information is task relevant and whether brain activity correlates with subjects' localization performance. We found that activity in Heschl's gyrus increased with increasing coherence, irrespective of whether localization was task relevant. Posterior auditory regions also showed increased activity for high coherence, primarily when sound localization was required and subjects successfully localized sounds. We conclude that binaural coherence cues are processed throughout the auditory cortex and that these cues are used in posterior regions for successful auditory localization.	Fdn Santa Lucia, Neuroimaging Lab, I-00179 Rome, Italy	IRCCS Santa Lucia	Zimmer, U (corresponding author), Fdn Santa Lucia, Neuroimaging Lab, Via Ardeatina 306, I-00179 Rome, Italy.	u.zimmer@hsantalucia.it	Macaluso, Emiliano/AAE-9185-2019; Macaluso, Emiliano/H-3139-2017	Macaluso, Emiliano/0000-0002-1919-5288; Macaluso, Emiliano/0000-0002-1919-5288; Zimmer, Ulrike/0000-0002-4232-0550				Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alain C, 2003, J COGNITIVE NEUROSCI, V15, P1063, DOI 10.1162/089892903770007443; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; Blauert J., 1997, SPATIAL HEARING PSYC; Budd TW, 2003, NEUROIMAGE, V20, P1783, DOI 10.1016/j.neuroimage.2003.07.026; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Hall DA, 2000, HUM BRAIN MAPP, V10, P107, DOI 10.1002/1097-0193(200007)10:3<107::AID-HBM20>3.0.CO;2-8; Hart HC, 2004, HUM BRAIN MAPP, V21, P178, DOI 10.1002/hbm.10156; JEFFRESS LA, 1962, J ACOUST SOC AM, V34, P1122, DOI 10.1121/1.1918257; Krumbholz K, 2005, CEREB CORTEX, V15, P317, DOI 10.1093/cercor/bhh133; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Pavani F, 2002, CURR BIOL, V12, P1584, DOI 10.1016/S0960-9822(02)01143-0; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; Stecker GC, 2003, BIOL CYBERN, V89, P341, DOI 10.1007/s00422-003-0439-1; Stecker GC, 2003, J NEUROPHYSIOL, V89, P2889, DOI 10.1152/jn.00980.2002; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Weeks RA, 1999, NEUROSCI LETT, V262, P155, DOI 10.1016/S0304-3940(99)00062-2; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004; Zimmer U, 2003, J COGNITIVE NEUROSCI, V15, P694, DOI 10.1162/089892903322307410	39	51	54	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 15	2005	47	6					893	905		10.1016/j.neuron.2005.07.019	http://dx.doi.org/10.1016/j.neuron.2005.07.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	967IN	16157283	Bronze			2022-12-28	WOS:000232085000016
J	Lukaszewicz, A; Savatier, P; Cortay, V; Giroud, P; Huissoud, C; Berland, M; Kennedy, H; Dehay, C				Lukaszewicz, A; Savatier, P; Cortay, V; Giroud, P; Huissoud, C; Berland, M; Kennedy, H; Dehay, C			G1 phase regulation, area-specific cell cycle control, and cytoarchitectonics in the primate cortex	NEURON			English	Article							RADIAL GLIAL-CELLS; VISUAL-CORTEX; GENE-EXPRESSION; OLIGODENDROCYTE DIFFERENTIATION; SUBVENTRICULAR ZONE; RESTRICTION POINT; DEPENDENT KINASES; NEOCORTICAL AREAS; CEREBRAL-CORTEX; NERVOUS-SYSTEM	We have investigated the cell cycle-related mechanisms that lead to the emergence of primate areas 17 and 18. These areas are characterized by striking differences in cytoarchitectonics and neuron number. We show in vivo that (1) area 17 precursors of supragranular neurons exhibit a shorter cell cycle duration, a reduced G1 phase, and a higher rate of cell cycle reentry than area 18 precursors; (2) area 17 and area 18 precursors show contrasting and specific levels of expression of cyclin E (high in area 17, low in area 18) and p27(Kip1) (low in area 17, high in area 18); (3) ex vivo up- and downmodulation of cyclin E and P27(Kip1) show that both regulators influence cell cycle kinetics by modifying rates of cell cycle progression and cell cycle reentry; (4) modeling the areal differences in cell cycle parameters suggests that they contribute to areal differences in numbers of precursors and neuron production.	Univ Lyon 1, INSERM, U371, Dept Stem Cell & Cort Dev,IFR19, F-69500 Bron, France; Hop Lyon Sud, F-69495 Pierre Benite, France; PrimaStem, F-69500 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Dehay, C (corresponding author), Univ Lyon 1, INSERM, U371, Dept Stem Cell & Cort Dev,IFR19, 18 Ave Doyen Lepine, F-69500 Bron, France.	dehay@lyon.inserm.fr	SAVATIER, Pierre/J-4663-2014; Dehay, Colette/H-4437-2014; Kennedy, Henry/B-9636-2013; Giroud, Pascale/B-9313-2013; Huissoud, Cyril/B-6146-2013; huissoud, cyril/E-2231-2013	Dehay, Colette/0000-0002-5196-1464; Kennedy, Henry/0000-0002-2796-7663; 				Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; BEAULIEU C, 1989, J COMP NEUROL, V279, P228, DOI 10.1002/cne.902790206; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Craig C, 1997, ONCOGENE, V14, P2283, DOI 10.1038/sj.onc.1201064; DEHAY C, 1993, NATURE, V366, P464, DOI 10.1038/366464a0; Dehay C, 2001, J NEUROSCI, V21, P201, DOI 10.1523/JNEUROSCI.21-01-00201.2001; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; GAREY LJ, 1985, J COMP NEUROL, V240, P305, DOI 10.1002/cne.902400307; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Job C, 2003, DEV BIOL, V257, P221, DOI 10.1016/S0012-1606(03)00070-8; KENNEDY H, 1993, CEREB CORTEX, V3, P171, DOI 10.1093/cercor/3.3.171; Kennedy H, 2001, DEVELOPMENTAL SCI, V4, P147; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KOSTOVIC I, 1984, J NEUROSCI, V4, P25; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LUKASZEWICZ A, 2001, STEM PROG CELLS BIOL; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Meyer G, 2000, J NEUROSCI, V20, P1858; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; MUMMERY CL, 1987, DEV BIOL, V121, P10, DOI 10.1016/0012-1606(87)90133-3; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ohnuma S, 2002, METHODS, V28, P411, DOI 10.1016/S1046-2023(02)00260-8; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Polleux F, 2001, CEREB CORTEX, V11, P1027, DOI 10.1093/cercor/11.11.1027; Polleux F, 1997, J NEUROSCI, V17, P7763; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; QUASTLER H, 1959, EXP CELL RES, V17, P420, DOI 10.1016/0014-4827(59)90063-1; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2004, SCIENCE, V303, P1983, DOI 10.1126/science.1096414; RAKIC P, 1973, J COMP NEUROL, V147, P523, DOI 10.1002/cne.901470407; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Sestan N, 2001, CURR BIOL, V11, P39, DOI 10.1016/S0960-9822(00)00043-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skoglund TS, 1996, NEUROSCI LETT, V208, P97, DOI 10.1016/0304-3940(96)12569-6; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SMART IHM, 1982, J ANAT, V134, P415; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WIMMEL A, 1994, ONCOGENE, V9, P995; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462; Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139	71	233	239	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 4	2005	47	3					353	364		10.1016/j.neuron.2005.06.032	http://dx.doi.org/10.1016/j.neuron.2005.06.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953BX	16055060	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000231051900007
J	Fryer, JD; Holtzman, DM				Fryer, JD; Holtzman, DM			The bad seed in Alzheimer's disease	NEURON			English	Editorial Material							FAMILIAL BRITISH DEMENTIA; A-BETA; PROTEIN; A-BETA-42(43); PLAQUES	In this issue of Neuron, McGowan et al. report on a new mouse model of amyloid deposition as occurs in Alzheimer's disease. Unlike previous models in which overexpression of the amyloid precursor protein results in amyloid plaque formation, McGowan et al. have produced mice that overexpress only A beta 40 or A beta 42 and prove that A beta 42 is critical for the formation of amyloid deposits in vivo.	Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Dept Neurol & Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Fryer, JD (corresponding author), Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Dept Neurol & Mol Biol & Pharmacol, St Louis, MO 63110 USA.							Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Vidal R, 1999, NATURE, V399, P776	12	19	22	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 21	2005	47	2					167	168		10.1016/j.neuron.2005.07.002	http://dx.doi.org/10.1016/j.neuron.2005.07.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	948CP	16039556	Bronze			2022-12-28	WOS:000230693900001
J	Nakayama, K				Nakayama, K			Resolving border disputes in midlevel vision	NEURON			English	Editorial Material							DEPTH	Two papers in this issue of Neuron specify the coding of border ownership, the basis of figure-ground segmentation, in early extrastriate visual cortex (area V2). Recording from a population of neurons, Qiu and von der Heydt show that border ownership assignments based on 2D images show the same bias when tested with stereopsis. Zhaoping shows that a neural model of V2 can make appropriate border assignments based on 2D images.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Nakayama, K (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.							BORENSTEIN E, 2001, P EUR C COMP VIS, P110; CLOWES MB, 1971, ARTIF INTELL, V2, P79, DOI 10.1016/0004-3702(71)90005-1; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; HUFFMAN DA, 1977, MACH INTELL, V8, P493; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; McDermott J, 2004, PERCEPTION, V33, P1101, DOI 10.1068/p5265; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Sen MG, 2001, PERCEPTION, V30, P167, DOI 10.1068/p2789; Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	11	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					5	8		10.1016/j.neuron.2005.06.025	http://dx.doi.org/10.1016/j.neuron.2005.06.025			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996543	Bronze			2022-12-28	WOS:000230464000003
J	Qiu, FTT; von der Heydt, R				Qiu, FTT; von der Heydt, R			Figure and ground in the visual cortex: V2 combines stereoscopic cues with Gestalt rules	NEURON			English	Article							BINOCULAR DEPTH DISCRIMINATION; CONTEXTUAL MODULATION; ILLUSORY CONTOURS; NEURAL MECHANISM; BORDER OWNERSHIP; OCCLUDED OBJECTS; MONKEY; PERCEPTION; RESPONSES; NEURONS	Figure-ground organization is a process by which the visual system identifies some image regions as foreground and others as background, inferring 3D layout from 2D displays. A recent study reported that edge responses of neurons in area V2 are selective for side-of-figure, suggesting that figure-ground organization is encoded in the contour signals (border ownership coding). Here, we show that area V2 combines two strategies of computation, one that exploits binocular stereoscopic information for the definition of local depth order, and another that exploits the global configuration of contours (Gestalt factors). These are combined in single neurons so that the "near" side of the preferred 3D edge generally coincides with the preferred side-of-figure in 2D displays. Thus, area V2 represents the borders of 2D figures as edges of surfaces, as if the figures were objects in 3D space. Even in 3D displays, Gestalt factors influence the responses and can enhance or null the stereoscopic depth information.	Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	von der Heydt, R (corresponding author), Johns Hopkins Univ, Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	von.der.heydt@jhu.edu		von der Heydt, Rudiger/0000-0002-8741-813X	NATIONAL EYE INSTITUTE [R01EY002966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038034] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002966, EY-02966] Funding Source: Medline; NINDS NIH HHS [P01 NS038034, NS-38034] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Bakin JS, 2000, J NEUROSCI, V20, P8188; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Baumann R, 1997, EUR J NEUROSCI, V9, P1290, DOI 10.1111/j.1460-9568.1997.tb01484.x; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V211, P599, DOI 10.1113/jphysiol.1970.sp009296; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; Freeman RD, 2001, PROG BRAIN RES, V134, P157; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GREGORY RL, 1974, PERCEPT PSYCHOPHYS, V15, P411, DOI 10.3758/BF03199279; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; HE ZJ, 1995, P NATL ACAD SCI USA, V92, P11155, DOI 10.1073/pnas.92.24.11155; Heider B, 2002, J COGNITIVE NEUROSCI, V14, P1018, DOI 10.1162/089892902320474472; Heydt R., 2003, J VISUAL-JAPAN, V3, P666, DOI [DOI 10.1167/3.9.666, 10.1167/3.9.666]; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Idesawa M., 1991, JPN J APPL PHYS, V30, P751, DOI [10.1143/JJAP.30.L751, DOI 10.1143/JJAP.30.L751]; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; JULESZ B, 1960, AT&T TECH J, V39, P1125, DOI 10.1002/j.1538-7305.1960.tb03954.x; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KAPLAN GA, 1969, PERCEPT PSYCHOPHYS, V6, P193, DOI 10.3758/BF03207015; Koffka K, 1935, PRINCIPLES GESTALT P; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nakayama K., 1995, INVITATION COGNITIVE, P1; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Rensink RA, 1998, VISION RES, V38, P2489, DOI 10.1016/S0042-6989(98)00051-0; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Rubin E., 1921, VISUELL WAHRGENOMMEN; Rubin E., 2001, VISUAL PERCEPTION ES, P225; SCHUETZE H, 2003, J VIS, V3, P114; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; SPILLMANN L, 2003, VISUAL NEUROSCIENCES, P1573; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; von der Heydt R, 2004, PERCEPTION, V33, P46; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; VONDERHEYDT R, 1993, BIOMED RES-TOKYO, V14, P1; Wertheimer M., 2001, VISUAL PERCEPTION ES, P216; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; YONAS A, 1987, PERCEPT PSYCHOPHYS, V41, P53, DOI 10.3758/BF03208213; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376	47	180	183	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 7	2005	47	1					155	166		10.1016/j.neuron.2005.05.028	http://dx.doi.org/10.1016/j.neuron.2005.05.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XI	15996555	Bronze, Green Accepted			2022-12-28	WOS:000230464000015
J	Xu, JH; Wu, LG				Xu, JH; Wu, LG			The decrease in the presynaptic calcium current is a major cause of short-term depression at a calyx-type synapse	NEURON			English	Article							PAIRED-PULSE DEPRESSION; READILY RELEASABLE POOL; SQUID GIANT SYNAPSE; AUDITORY BRAIN-STEM; TRANSMITTER RELEASE; CLIMBING FIBER; VESICLE POOLS; NEUROTRANSMITTER RELEASE; POSTSYNAPTIC MECHANISMS; HIPPOCAMPAL SYNAPSES	Repetitive nerve firings cause short-term depression (STD) of release at many synapses. Its underlying mechanism is largely attributed to depletion of a readily releasable vesicle pool (RRP) and a decreased probability of releasing a readily releasable vesicle during an action potential. Which of these two mechanisms is dominant and the mechanism that decreases the release probability remain debated. Here, we report that a decreased release probability is caused by a calcium-induced inhibition of presynaptic calcium channels, particularly P/Q-type channels at the calyx of Held in rat brainstem. This mechanism was the dominant cause of STD in a wide range of stimulation conditions, such as during 2 to 20 action potential-equivalent stimuli (AP-e) at 0.2-30 Hz and after 2 to 20 AP-e at 0.2-100 Hz. Only during 100 Hz AP-e was depletion the dominant mechanism.	NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, LG (corresponding author), NINDS, Bethesda, MD 20892 USA.	wul@ninds.nih.gov		Xu, Jianhua/0000-0003-0084-8856	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003009, ZIANS003009] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Brody DL, 2000, J NEUROSCI, V20, P2480; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; Chen G, 2004, P NATL ACAD SCI USA, V101, P1063, DOI 10.1073/pnas.0307149101; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dittman JS, 1998, J NEUROSCI, V18, P6147; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Kirischuk S, 2002, J PHYSIOL-LONDON, V543, P99, DOI 10.1113/jphysiol.2002.021576; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Morgan JR, 1999, J NEUROSCI, V19, P10201; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sun JY, 2004, J NEUROSCI METH, V134, P121, DOI 10.1016/j.jneumeth.2003.11.018; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Weis S, 1999, BIOPHYS J, V77, P2418, DOI 10.1016/S0006-3495(99)77079-7; Wong AYC, 2003, J NEUROSCI, V23, P4868; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Wu XS, 2004, ANESTHESIOLOGY, V100, P663, DOI 10.1097/00000542-200403000-00029; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; YAZAWA M, 1992, BIOCHEMISTRY-US, V31, P3171, DOI 10.1021/bi00127a018; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	60	171	172	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 19	2005	46	4					633	645		10.1016/j.neuron.2005.03.024	http://dx.doi.org/10.1016/j.neuron.2005.03.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	928TJ	15944131	Bronze			2022-12-28	WOS:000229294300014
J	Chen, X; Ye, HH; Kuruvilla, R; Ramanan, N; Scangos, KW; Zhang, C; Johnson, NM; England, PM; Shokat, KM; Ginty, DD				Chen, X; Ye, HH; Kuruvilla, R; Ramanan, N; Scangos, KW; Zhang, C; Johnson, NM; England, PM; Shokat, KM; Ginty, DD			A chemical-genetic approach to studying neurotrophin signaling	NEURON			English	Article							NERVE GROWTH-FACTOR; DEPENDENT PROTEIN-KINASES; RECEPTOR GENE; SYMPATHETIC NEURONS; EMBRYONIC NEURONS; INHIBITOR; K-252A; K252A; TRKA; DISRUPTION	Trk tyrosine kinases are receptors for members of the neurotrophin family and are crucial for growth and survival of specific populations of neurons. Yet, the functions of neurotrophin-Trk signaling in postnatal development as well as maintenance and plasticity of the adult nervous system are less clear. We report here the generation of mice harboring Trk knockin alleles that allow for pharmacological control of Trk kinase activity. Nanomolar concentrations of either 1NMPP1 or 1NaPP1, derivatives of the general kinase inhibitor PP1, inhibit NGF and BDNF signaling in TrkA(F592A) and TrkB(F616A) neurons, respectively, while no such Trk inhibition is observed in wild-type neurons. Moreover, oral administration of 1NMPP1 leads to specific inhibition of TrkA(F592A), TrkB(F616A), and TrkC(F167A) signaling in vivo. Thus, Trk knockin mice provide valuable tools for selective, rapid, and reversible inhibition of neurotrophin signaling in vitro and in vivo.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018	Kuruvilla, Rejji/0000-0002-2851-675X; Ye, Haihong/0000-0001-7282-6280; Scangos, Katherine/0000-0001-7983-7767	NINDS NIH HHS [NS 34814] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034814, R01NS034814, R29NS034814] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BORASIO GD, 1990, NEUROSCI LETT, V108, P207, DOI 10.1016/0304-3940(90)90732-O; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Fagan AM, 1996, J NEUROSCI, V16, P6208; GOEDERT M, 1978, BRAIN RES, V148, P264, DOI 10.1016/0006-8993(78)90401-8; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KOIZUMI S, 1988, J NEUROSCI, V8, P715; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MITCHELL RD, 1995, BIOCHEMISTRY-US, V34, P528, DOI 10.1021/bi00002a018; NAKANISHI S, 1988, J BIOL CHEM, V263, P6215; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roux PP, 2002, J BIOL CHEM, V277, P49473, DOI 10.1074/jbc.M203428200; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TAPLEY P, 1992, ONCOGENE, V7, P371; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	29	175	184	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					13	21		10.1016/j.neuron.2005.03.009	http://dx.doi.org/10.1016/j.neuron.2005.03.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820690	Bronze			2022-12-28	WOS:000228228600005
J	Mattar, AAG; Gribble, PL				Mattar, AAG; Gribble, PL			Motor learning by observing	NEURON			English	Article							2-JOINT ARM MOVEMENTS; INTERNAL-MODELS; TRANSFORMATIONS; MODULATION; DYNAMICS; PREMOTOR; CORTEX; SYSTEM; PLANS; AREAS	Learning complex motor behaviors like riding a bicycle or swinging a golf club is based on acquiring neural representations of the mechanical requirements of movement (e.g., coordinating muscle forces to control the club). Here we provide evidence that mechanisms matching observation and action facilitate motor learning. Subjects who observed a video depicting another person learning to reach in a novel mechanical environment (imposed by a robot arm) performed better when later tested in the same environment than subjects who observed similar movements but no learning; moreover, subjects who observed learning of a different environment performed worse. We show that this effect is not based on conscious strategies but instead depends on the implicit engagement of neural systems for movement planning and control.	Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C2, Canada; Univ Western Ontario, Grad Program Neurosci, London, ON N6A 5C2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gribble, PL (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada.	pgribble@uwo.ca		Gribble, Paul/0000-0002-1368-032X				Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Carey DP, 1996, CURR BIOL, V6, P1087, DOI 10.1016/S0960-9822(02)70673-8; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; HASAN Z, 1989, EXP BRAIN RES, V76, P651, DOI 10.1007/BF00248921; Heyes CM, 2002, Q J EXP PSYCHOL-A, V55, P593, DOI 10.1080/02724980143000389; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KARST GM, 1991, J NEUROPHYSIOL, V66, P1594, DOI 10.1152/jn.1991.66.5.1594; Kelly SW, 2003, BRIT J PSYCHOL, V94, P355, DOI 10.1348/000712603767876271; Malfait N, 2002, J NEUROSCI, V22, P9656; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Petrosini L, 2003, BRAIN RES REV, V42, P252, DOI 10.1016/S0165-0173(03)00176-0; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Tulving E, 2000, OXFORD HDB MEMORY; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vinter A, 2002, MEM COGNITION, V30, P256, DOI 10.3758/BF03195286; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	37	282	288	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 7	2005	46	1					153	160		10.1016/j.neuron.2005.02.009	http://dx.doi.org/10.1016/j.neuron.2005.02.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914LH	15820701	Bronze			2022-12-28	WOS:000228228600016
J	Goldberg, MS; Pisani, A; Haburcak, M; Vortherms, TA; Kitada, T; Costa, C; Tong, Y; Martella, G; Tscherter, A; Martins, A; Bernardi, G; Roth, BL; Pothos, EN; Calabresi, P; Shen, J				Goldberg, MS; Pisani, A; Haburcak, M; Vortherms, TA; Kitada, T; Costa, C; Tong, Y; Martella, G; Tscherter, A; Martins, A; Bernardi, G; Roth, BL; Pothos, EN; Calabresi, P; Shen, J			Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1	NEURON			English	Article							SYNAPTIC PLASTICITY; MICE; NEURONS; DISEASE; MUTATIONS; MOTOR	The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the striatum. Loss-of-function mutations in the DJ-1 gene cause early-onset familial parkinsonism. To investigate a possible role for DJ-1 in the dopaminergic system, we generated a mouse model bearing a germline disruption of DJ-1. Although DJ-1(-/-) mice had normal numbers of dopaminergic neurons in the substantia nigra, evoked dopamine overflow in the striatum was markedly reduced, primarily as a result of increased reuptake. Nigral neurons lacking DJ-1 were less sensitive to the inhibitory effects of D2 autoreceptor stimulation. Corticostriatal long-term potentiation was normal in medium spiny neurons of DJ-1(-/-) mice, but long-term depression (LTD) was absent. The LTD deficit was reversed by treatment with D2 but not D1 receptor agonists. Furthermore, DJ-1(-/-) mice displayed hypoactivity in the open field. Collectively, our findings suggest an essential role for DJ-1 in dopaminergic physiology and D2 receptor-mediated functions.	Harvard Univ, Sch Med, Ctr Neurol Dis, Brigham & Womens Hosp,Program Neurosci, Boston, MA 02115 USA; Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; IRCCS, Fondaz Santa Lucia, Rome, Italy; Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Case Western Reserve Univ, Sch Med, Dept Biochem Psychiat & Neurosci, Cleveland, OH 44106 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Rome Tor Vergata; IRCCS Santa Lucia; Tufts University; Case Western Reserve University	Shen, J (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Brigham & Womens Hosp,Program Neurosci, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Goldberg, Matthew/T-7827-2019; Shen, Jie/GXH-9449-2022; Roth, Bryan L/F-3928-2010; G, Martella/H-5142-2018; Calabresi, Paolo/G-8496-2011; Costa, Cinzia/K-8485-2016; Pisani, Antonio/G-2492-2012; Martella, Giuseppina/L-9465-2019	G, Martella/0000-0002-8927-7107; Calabresi, Paolo/0000-0003-0326-5509; Costa, Cinzia/0000-0002-4862-4221; Pisani, Antonio/0000-0002-8432-594X; Martella, Giuseppina/0000-0002-8927-7107; Pothos, Emmanuel/0000-0001-8825-7852; Tscherter, Anne/0000-0002-6972-482X; Goldberg, Matthew/0000-0002-5172-9841; Haburcak, Marian/0000-0003-0662-0756				Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Donovan DM, 1999, MOL BRAIN RES, V73, P37, DOI 10.1016/S0169-328X(99)00235-1; Fowler SC, 2002, INT J DEV NEUROSCI, V20, P309, DOI 10.1016/S0736-5748(02)00009-6; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Jung MY, 1999, NEUROSCIENCE, V91, P911, DOI 10.1016/S0306-4522(98)00705-2; Kelly MA, 1998, J NEUROSCI, V18, P3470; Kitamura Y, 2003, NEUROCHEM RES, V28, P1035, DOI 10.1023/A:1023207222944; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; MERCURI NB, 1990, BRIT J PHARMACOL, V100, P257, DOI 10.1111/j.1476-5381.1990.tb15792.x; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Whone AL, 2002, NEUROLOGY, V58, pA82; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	28	409	416	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					489	496		10.1016/j.neuron.2005.01.041	http://dx.doi.org/10.1016/j.neuron.2005.01.041			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721235	Green Submitted, Bronze			2022-12-28	WOS:000227099700005
J	Javaherian, A; Cline, HT				Javaherian, A; Cline, HT			Coordinated motor neuron axon growth and neuromuscular synaptogenesis are promoted by CPG15 in vivo	NEURON			English	Article							NEUROTROPHIC FACTOR; RETINOTECTAL AXONS; SYNAPSE FORMATION; NMDA RECEPTOR; STOP SIGNAL; DYNAMICS; PROTEIN; MOTONEURONS; EXPRESSION; INDUCTION	We have used in vivo time-lapse two-photon imaging of single motor neuron axons labeled with GFP combined with labeling of presynaptic vesicle clusters and postsynaptic acetylcholine receptors in Xenopus laevis tadpoles to determine the dynamic rearrangement of individual axon branches and synaptogenesis during motor axon arbor development. Control GFP-labeled axons are highly dynamic during the period when axon arbors are elaborating. Axon branches emerge from sites of synaptic vesicle clusters. These data indicate that motor neuron axon elaboration and synaptogenesis are concurrent and iterative. We tested the role of Candidate Plasticity Gene 15 (CPG15, also known as Neuritin), an activity-regulated gene that is expressed in the developing motor neurons in this process. CPG15 expression enhances the development of motor neuron axon arbors by promoting neuromuscular synaptogenesis and by increasing the addition of new axon branches.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11790 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cline, HT (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	cline@cshl.edu						Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; CAMPANELLI JT, 1992, COLD SPRING HARB SYM, V57, P461, DOI 10.1101/SQB.1992.057.01.051; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992; HAAS H, 2001, NEURON, V29, P1; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Lau PM, 1999, J CELL BIOL, V145, P1265, DOI 10.1083/jcb.145.6.1265; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Nedivi E, 2001, J COMP NEUROL, V435, P464, DOI 10.1002/cne.1044; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Pinches EM, 1998, J NEUROBIOL, V35, P426, DOI 10.1002/(SICI)1097-4695(19980615)35:4<426::AID-NEU8>3.0.CO;2-0; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Ruthazer ES, 2002, REAL-TIME IMAGING, V8, P175, DOI 10.1006/rtim.2002.0284; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tang FJ, 2003, J NEUROSCI, V23, P927; Walsh FS, 2000, MOL CELL NEUROSCI, V15, P244, DOI 10.1006/mcne.1999.0815; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wong WT, 2000, J NEUROSCI, V20, P5024	39	98	109	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 17	2005	45	4					505	512		10.1016/j.neuron.2004.12.051	http://dx.doi.org/10.1016/j.neuron.2004.12.051			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	898TS	15721237	Bronze			2022-12-28	WOS:000227099700007
J	Brown, TC; Tran, IC; Backos, DS; Esteban, JA				Brown, TC; Tran, IC; Backos, DS; Esteban, JA			NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD	NEURON			English	Article							LONG-TERM DEPRESSION; ETHYLMALEIMIDE-SENSITIVE FACTOR; DOMAIN-CONTAINING PROTEINS; GLUTAMATE RECEPTORS; MEMBRANE ASSOCIATION; EXCITATORY SYNAPSES; ENDOCYTIC PATHWAY; GLUR1 SUBUNIT; KINASE-C; PLASTICITY	The activity-dependent removal of AMPA receptors from synapses underlies long-term depression in hippocampal excitatory synapses. In this study, we have investigated the role of the small GTPase Rab5 during this process. We propose that Rab5 is a critical link between the signaling cascades triggered by LTD induction and the machinery that executes the activity-dependent removal of AMPA receptors. We have found that Rab5 activation drives the specific internalization of synaptic AMPA receptors in a clathrin-dependent manner and that this activity is required for LTD. Interestingly, Rab5 does not participate in the constitutive cycling of AMPA receptors. Rab5 is able to remove both GluR1 and GluR2 AMPA receptor subunits, leading to GluR1 dephosphorylation. Importantly, NMDA receptor-dependent LTD induction produces a rapid and transient increase of active (GTP bound) Rab5. We propose a model in which synaptic activity leads to Rab5 activation, which in turn drives the removal of AMPA receptors from synapses.	Univ Michigan, Sch Med, Program Neurosci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Program Neurosci, Ann Arbor, MI 48109 USA.	estebanj@umich.edu	Esteban, Jose/L-4944-2014; Backos, Donald/Q-4791-2018; Backos, Donald/N-5265-2019	Esteban, Jose/0000-0002-3759-3300; Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210; Brown, Tyler/0000-0001-9543-8555	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070417, F31MH070205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008671] Funding Source: NIH RePORTER; NIA NIH HHS [P50-AG08671] Funding Source: Medline; NIMH NIH HHS [MH070417, F31-MH070205] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; GEAN PW, 1993, NEUROSCI LETT, V158, P170, DOI 10.1016/0304-3940(93)90256-K; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; KARNEYAMA K, 1998, NEURON, V21, P1163; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rush AM, 2002, J NEUROSCI, V22, P6121; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	78	169	176	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 6	2005	45	1					81	94		10.1016/j.neuron.2004.12.023	http://dx.doi.org/10.1016/j.neuron.2004.12.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629704	Bronze, Green Submitted			2022-12-28	WOS:000226217100011
J	Mann, EO; Suckling, JM; Hajos, N; Greenfield, SA; Paulsen, O				Mann, EO; Suckling, JM; Hajos, N; Greenfield, SA; Paulsen, O			Perisomatic feedback inhibition underlies cholinergically induced fast network oscillations in the rat hippocampus in vitro	NEURON			English	Article							GAMMA-FREQUENCY OSCILLATIONS; EVOKED-POTENTIALS; GAP-JUNCTIONS; PYRAMIDAL CELL; BEHAVING RAT; SLICES; INDUCTION; SYNCHRONIZATION; INTERNEURONS; CONNEXIN-36	Gamma frequency network oscillations are assumed to be important in cognitive processes, including hippocampal memory operations, but the precise functions of these oscillations remain unknown. Here, we examine the cellular and network mechanisms underlying carbachol-induced fast network oscillations in the hippocampus in vitro, which closely resemble hippocampal gamma oscillations in the behaving rat. Using a combination of planar multielectrode array recordings, imaging with voltage-sensitive dyes, and recordings from single hippocampal neurons within the CA3 gamma generator, active current sinks and sources were localized to the stratum pyramidale. These proximal currents were driven by phase-locked rhythmic inhibitory inputs to pyramidal cells from identified perisomatic-targeting interneurons. AMPA receptor-mediated recurrent excitation was necessary for the synchronization of interneuronal discharge, which strongly supports a synaptic feedback model for the generation of hippocampal gamma oscillations.	Univ Oxford, Univ Lab Physiol, Oxford OX1 3PT, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary	University of Oxford; University of Oxford; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Mann, EO (corresponding author), Univ Oxford, Univ Lab Physiol, Parks Rd, Oxford OX1 3PT, England.	ed.mann@physiol.ox.ac.uk	Hajos, Norbert/U-2640-2019; Paulsen, Ole/ABB-4843-2020	Hajos, Norbert/0000-0002-4582-2708; Paulsen, Ole/0000-0002-2258-5455; Mann, Edward/0000-0002-2468-7148				Batschelet E., 1981, CIRCULAR STAT BIOL; Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buhl DL, 2003, J NEUROSCI, V23, P1013; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dickinson R, 2003, NEUROPHARMACOLOGY, V44, P864, DOI 10.1016/S0028-3908(03)00083-2; Fellous JM, 2000, HIPPOCAMPUS, V10, P187, DOI 10.1002/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.3.CO;2-D; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fischer Y, 2004, J PHYSIOL-LONDON, V554, P156, DOI 10.1113/jphysiol.2003.055558; FREEMAN WJ, 1968, J NEUROPHYSIOL, V31, P337, DOI 10.1152/jn.1968.31.3.337; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; GRINVALD A, 1982, J PHYSIOL-LONDON, V333, P269, DOI 10.1113/jphysiol.1982.sp014453; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; HOLSHEIMER J, 1987, EXP BRAIN RES, V67, P402; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; LEUNG LWS, 1985, ELECTROEN CLIN NEURO, V60, P65, DOI 10.1016/0013-4694(85)90952-6; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Shimono K, 2000, J NEUROSCI, V20, P8462, DOI 10.1523/JNEUROSCI.20-22-08462.2000; SIK A, 1993, EUR J NEUROSCI, V5, P1719, DOI 10.1111/j.1460-9568.1993.tb00239.x; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; TARNAWA I, 1993, BIOORG MED CHEM LETT, V3, P99, DOI 10.1016/S0960-894X(00)80100-6; Tominaga T, 2000, J NEUROSCI METH, V102, P11, DOI 10.1016/S0165-0270(00)00270-3; Tominaga T, 2002, J NEUROPHYSIOL, V88, P1523, DOI 10.1152/jn.2002.88.3.1523; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Traub RD, 2003, P NATL ACAD SCI USA, V100, P11047, DOI 10.1073/pnas.1934854100; Traub RD, 2003, P NATL ACAD SCI USA, V100, P1370, DOI 10.1073/pnas.0337529100; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zar JH., 1999, BIOSTAT ANAL, V663rd	44	228	263	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 6	2005	45	1					105	117		10.1016/j.neuron.2004.12.016	http://dx.doi.org/10.1016/j.neuron.2004.12.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	886HI	15629706	Bronze			2022-12-28	WOS:000226217100013
